,Unnamed: 0,Unnamed: 0.1,cord_uid,sha,source_x,title,doi,pmcid,pubmed_id,license,abstract,publish_time,authors,journal,mag_id,who_covidence_id,arxiv_id,pdf_json_files,pmc_json_files,url,s2_id,cluster
564,564,587,nv228vte,1a7676018fd73150a122c2afb1362324dbab4918,PMC,A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants,10.1093/nar/gkn585,PMC2582611,18794177.0,cc-by-nc,study gene fusion solid tumor extensive hematological malignancy due several technical analytical problem associated tumor heterogeneity nevertheless growing interest role fusion gene common epithelial tumor discovery recurrent tmprssets fusion prostate cancer among reported fusion partner ets gene family tmprsserg prevalent one present simple sensitive microarraybased assay able simultaneously determine multiple fusion variant single rt–pcr impure rna specimen assay detected tmprsserg fusion transcript detection sensitivity cell presence time excess normal rna primary prostate tumor cancer cell ability detect multiple transcript variant single assay critically dependent primer probe design assay facilitate clinical basic study fusion gene screening clinical specimen readily adapted include multiple gene locus,2008-09-15,"Lu, Qing; Nunez, Esperanza; Lin, Chunrun; Christensen, Kimberly; Downs, Tracy; Carson, Dennis A.; Wang-Rodriguez, Jessica; Liu, Yu-Tsueng",Nucleic Acids Res,,,,document_parses/pdf_json/1a7676018fd73150a122c2afb1362324dbab4918.json,document_parses/pmc_json/PMC2582611.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582611/,,12
576,576,600,xu9llz9u,18e4bf7e0c2d81caa5795174a4f25d5a035e09b1,PMC,A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer,10.1371/journal.pone.0004171,PMC2614347,19137069.0,cc-by,lung cancer leading cause cancerrelated mortality worldwide lack tumor specificity remains major drawback effective chemotherapy result doselimiting toxicity however ligandmediated drug delivery system able render chemotherapy specific tumor cell le toxic normal tissue study isolated novel peptide ligand phagedisplayed peptide library bound nonsmall cell lung cancer nsclc cell line targeting phage bound several nsclc cell line normal cell targeting phage synthetic peptide recognized surgical specimen nsclc positive rate specimen severe combined immunodeficiency scid mouse bearing nsclc xenograft targeting phage specifically bound tumor mass tumor homing ability targeting phage inhibited cognate synthetic peptide control wtymutated peptide targeting peptide coupled liposome carrying doxorubicin vinorelbine therapeutic index chemotherapeutic agent survival rate mouse human lung cancer xenograft markedly increased furthermore targeting liposome increased drug accumulation tumor tissue fold compared free drug enhanced cancer cell apoptosis resulting higher concentration bioavailable doxorubicin current study suggests tumorspecific peptide may used create chemotherapy specifically targeting tumor cell treatment nsclc design targeted gene transfer vector may used one diagnosis malignancy,2009-01-12,"Chang, De-Kuan; Lin, Chin-Tarng; Wu, Chien-Hsun; Wu, Han-Chung",PLoS One,,,,document_parses/pdf_json/18e4bf7e0c2d81caa5795174a4f25d5a035e09b1.json,document_parses/pmc_json/PMC2614347.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614347/,,12
619,619,647,533xlisc,63205fe99a388f19fde06f422c9ce6c1ddfc52f4,PMC,"Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy",10.1371/journal.pone.0006314,PMC2707627,19617915.0,cc-by,background glioblastoma frequent malignant primary brain tumor poor prognosis translation therapeutic strategy glioblastoma experimental phase clinic limited insufficient animal model lack important feature human tumor lentiviral gene therapy attractive therapeutic option human glioblastoma validated clinically relevant animal model methodologyprincipal finding used rodent xenograft model recapitulates invasive angiogenic feature human glioblastoma analyze transduction pattern therapeutic efficacy lentiviral pseudotyped vector lymphocytic choriomeningitis virus glycoprotein lcmvgp vesicular stomatitis virus glycoprotein vsvg pseudotyped lentiviral vector efficiently transduced human glioblastoma cell vitro vivo contrast pseudotyped gammaretroviral vector similar evaluated clinical therapy glioblastoma showed inefficient gene transfer vitro vivo pseudotyped lentiviral vector transduced cancer stemlike cell characterized cd nestin soxexpression ability form spheroid neural stem cell medium express astrocytic neuronal differentiation marker serum condition therapeutic approach using suicide gene herpes simplex virus thymidine kinase hsvtk fused egfp lentiviral vector mediated complete remission solid tumor seen mri resulting highly significant survival benefit p compared control group recurrent tumor surviving egfppositive tumor cell found advocating prodrug application several cycle even enhance prolong therapeutic effect conclusionssignificance conclusion lentiviral pseudotyped vector promising candidate gene therapy glioma patient inefficient gene delivery gammaretroviral vector line result obtained clinical therapy gbm thus confirms high reproducibility invasive glioma animal model translational research,2009-07-20,"Huszthy, Peter C.; Giroglou, Tsanan; Tsinkalovsky, Oleg; Euskirchen, Philipp; Skaftnesmo, Kai Ove; Bjerkvig, Rolf; von Laer, Dorothee; Miletic, Hrvoje",PLoS One,,,,document_parses/pdf_json/63205fe99a388f19fde06f422c9ce6c1ddfc52f4.json,document_parses/pmc_json/PMC2707627.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707627/,,12
766,766,806,hd12p867,a4ee99345c99a1f9806c8d17dc7e6accaf5309d6,PMC,Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy,10.1155/2010/723798,PMC2864512,20454584.0,cc-by,solid tumor known recruit new blood vessel support growth therefore unique molecule expressed tumor endothelial cell function target antiangiogenic therapy cancer current effort focusing developing therapeutic agent capable specifically targeting cancer cell tumorassociated microenvironments including tumor blood vessel therapy hold promise high efficacy low toxicity one recognized strategy improving therapeutic effectiveness conventional chemotherapeutics encapsulate anticancer drug targeting liposome bind cell surface receptor expressed tumorassociated endothelial cell antiangiogenic drug delivery system could used target tumor blood vessel well tumor cell article review mechanism advantage various present potential method using peptideconjugated liposome specifically destroy tumor blood vessel anticancer therapy,2010-05-05,"Wu, Han-Chung; Chang, De-Kuan",J Oncol,,,,document_parses/pdf_json/a4ee99345c99a1f9806c8d17dc7e6accaf5309d6.json,document_parses/pmc_json/PMC2864512.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864512/,,12
983,983,1038,pe0dqif1,3887add10c9910d44375b33854a507cc500110c4,PMC,Claudins in lung diseases,10.1186/1465-9921-12-70,PMC3128860,21619599.0,cc-by,tight junction apically localized part epithelial junctional complex regulate permeability polarity cell layer create compartment cell membrane claudins structural molecule tight junction claudins known expression different claudins responsible change electrolyte solute permeability cell layer study shown claudins tight junction also protect multicellular organism infection infectious agent may use claudins target invade weaken host defense neoplastic disease claudin expression may downregulated since expression associated specific tumor type specific location tumor certain degree restricted sense also used tumor marker however regulation claudin expression complex involving growth factor integrins protein kinase protooncogens transcription factor review significance claudins discussed lung disease development,2011-05-27,"Soini, Ylermi",Respir Res,,,,document_parses/pdf_json/3887add10c9910d44375b33854a507cc500110c4.json,document_parses/pmc_json/PMC3128860.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128860/,,12
1559,1559,1680,ertnvzwk,9f9f59f3137c9871b1a0d7bfe92b9b9f4087b24b,PMC,Mannosylated Lipid Nano-emulsions Loaded with Lycorine-oleic Acid Ionic Complex for Tumor Cell-specific Delivery,10.7150/thno.4525,PMC3516834,23227126.0,cc-by-nc-nd,study prepare mannosylated lycorine lipid nanoemulsion formulation mlycoalnes aim achieving tumor targeting delivery lycorine lyc low lipophilicity lyc made hard dispersed lipid nanoemulsions lnes order increase lipophilicity lycorineoleic acid ionic complex lycoa made mlycoalnes uncoated lycorineoleic acid loaded lipid nanoemulsions lycoalnes prepared solvent injection method characterized transmission electron microscopy tem particle size polydispersity index zetapotential entrapment efficiency analysis vitro cellular uptake growth inhibition activity study performed cell line entrapment efficiency mlycoalnes ± cellular uptake study showed coated lnes preferably taken cell uncoated lnes effective test mtt assay showed better growth inhibition activity mlycoalnes cell line compared lycoalnes blank lnes result demonstrated mlycoalnes could promising formulation tumor targeting delivery lyc potential applied diagnosis treatment cancer,2012-11-19,"Guo, Yangming; Liu, Xing; Sun, Xun; Zhang, Qiang; Gong, Tao; Zhang, Zhirong",Theranostics,,,,document_parses/pdf_json/9f9f59f3137c9871b1a0d7bfe92b9b9f4087b24b.json,document_parses/pmc_json/PMC3516834.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516834/,,12
1633,1633,1757,ay5p49xh,b16173612f53649fbd4db78654874bee5d4d607f,PMC,An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase,10.4161/onci.22978,PMC3583941,23483532.0,cc-by-nc,vacuolar atpase vatpase play important role tumor progression metastasis novel peptide isoform vatpase called antd shown exert immunoregulatory role tumor microenvironment controlling maturation monocyte toward tumorassociated macrophage phenotype data indicate antd bind surface monocyte antd preferentially endocytosed proinflammatory monocyte bearing cdcd phenotype associated monocytetomacrophage maturation process antd binding internalization led production proinflammatory cytokine interleukin ilα ilβ cdcd classical cdcd intermediate monocyte antd internalized via macropinocytosis mechanism utilizing scavenger receptor however inhibition antd endocytosis reduce cytokine production monocyte point existence two receptor respond antd scavenger receptor mediate cellular uptake hitherto unidentified receptor stimulating production inflammatory cytokine monocyte receptor may important generating localized inflammation often required promote tumor growth hence may constitute novel target development anticancer drug,2013-01-01,"Kwong, Christina; Gilman-Sachs, Alice; Beaman, Kenneth",Oncoimmunology,,,,document_parses/pdf_json/b16173612f53649fbd4db78654874bee5d4d607f.json,document_parses/pmc_json/PMC3583941.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583941/,,12
1963,1963,2105,9kroonl1,2bae24fa42f6bd7e9a241b4456296f3af0ee4b2c,PMC,Glioblastoma extracellular vesicles: reservoirs of potential biomarkers,10.2147/pgpm.s39768,PMC3952682,24634586.0,cc-by-nc,glioblastoma multiforme gbm frequent devastating primary central nervous system tumor patient living beyond year postdiagnosis damage caused disease treatment patient often leave physically cognitively debilitated generally gbms appear short clinical history discovered imaging using magnetic resonance imaging mri diagnosis validated pathology following surgical resection treatment response diagnosis tumor recurrence also tracked mri numerous problem encountered monitoring modality ambiguous interpretation form pseudoprogression diagnostic prognostic predictive biomarkers would immense boon following treatment scheme determining recurrence often requires invasive intracranial biopsy verify imaging data extracellular vesicle ev stable membraneenclosed virussized particle released either cell surface endosomal pathway lead systemic release ev accessible biofluids serumplasma urine cerebrospinal fluid saliva ev carry wide variety protein nucleic acid lipid metabolite many common feature enough individuality able identify cell origin vesicle component properly interrogated could allow identification tumorderived ev biofluids indicating tumor progression relapse treatment failure knowledge would allow clinician continue treatment regimen actually effective change course therapy failing review feature gbm ev term ev content activity may lead use ev serially accessible biomarkers diagnosis treatment response neurooncology,2014-02-13,"Redzic, Jasmina S; Ung, Timothy H; Graner, Michael W",Pharmgenomics Pers Med,,,,document_parses/pdf_json/2bae24fa42f6bd7e9a241b4456296f3af0ee4b2c.json,document_parses/pmc_json/PMC3952682.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952682/,,12
2106,2106,2253,na8xecga,3c43e9e66c5b384ac03f0067bc8d16a9efdd5fb9; 8dcc9848e421e45ac829203e4e6fe58e6ac130e5,PMC,Choindroitinase ABC I-Mediated Enhancement of Oncolytic Virus Spread and Anti Tumor Efficacy: A Mathematical Model,10.1371/journal.pone.0102499,PMC4105445,25047810.0,cc-by,oncolytic virus genetically engineered virus designed kill cancer cell minimal damage normal healthy tissue injected tumor infect cancer cell multiply inside cancer cell killed move spread infect cancer cell chondroitinase abc chaseabc bacterial enzyme remove major glioma ecm component chondroitin sulfate glycosoamino glycans proteoglycans without deleterious effect vivo shown chaseabc treatment able promote spread virus increasing efficacy viral treatment paper develop mathematical model investigate effect chaseabc treatment glioma oncolytic virus ov show model prediction agree experimental result spherical glioma use model test various treatment option heterogeneous microenvironment brain model predicts separate injection ov one center tumor another outside tumor result better outcome total injection outside tumor particular injection ecmdegrading enzyme chaseabc periphery main tumor core need administered optimal strategy order infect eradicate infiltrating glioma cell outside tumor core addition proliferative cell bulk tumor core model also predicts size tumor satellite distance primary tumor multifocalsatellite lesion may important factor efficacy viral therapy chase treatment,2014-07-21,"Kim, Yangjin; Lee, Hyun Geun; Dmitrieva, Nina; Kim, Junseok; Kaur, Balveen; Friedman, Avner",PLoS One,,,,document_parses/pdf_json/3c43e9e66c5b384ac03f0067bc8d16a9efdd5fb9.json; document_parses/pdf_json/8dcc9848e421e45ac829203e4e6fe58e6ac130e5.json,document_parses/pmc_json/PMC4105445.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105445/,,12
2319,2319,2477,gbf3ivzc,f762eef06ad6975bb55dc425f10e33101d378379,PMC,Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity,10.1038/mtm.2014.27,PMC4362367,26015969.0,cc-by-nc-sa,previously discovered one particular hlaa mutant enhanced peptidespecific cytotoxic lymphocyte ctl recognition vitro compared wildtype hlaa mutant contains single amino acid substitution histidine leucine position hl located peptidebinding groove investigate effect hl mutation vivo ctl priming took advantage technology hla class singlechain trimer sct three component involving peptide β microglobulin hla class heavy chain joined together via flexible linkers generated recombinant adenovirus expressing sct comprised influenza matrix protein fmpderived peptide β microglobulin hl heavy chain hlaa transgenic mouse immunized adenovirus induction peptidespecific ctls antitumor immunity investigated clearly shown hl mutation enabled hlaa sct molecule dramatically enhance vivo priming fmpspecific ctls protection lethal challenge tumor cell expressing fmp data present first evidence simple point mutation hla class heavy chain sct beneficial improving ctlbased immunotherapy prophylaxis control tumor,2014-07-02,"Matsui, Masanori; Kawano, Masaaki; Matsushita, Sho; Akatsuka, Toshitaka",Mol Ther Methods Clin Dev,,,,document_parses/pdf_json/f762eef06ad6975bb55dc425f10e33101d378379.json,document_parses/pmc_json/PMC4362367.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362367/,,12
2422,2422,2587,fvoke2yc,4b2ef217cb3fedccaffa0ecdd43344810630987b,PMC,Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8,10.3892/mmr.2015.3673,PMC4463842,25936538.0,cc-by,tcellmediated immunotherapy hematological malignancy requires selection targeted tumorassociated antigen tcell epitope contained tumor protein epidermal growth factor receptor pathway substrate eps whose function pivotal tumor proliferation progression metastasis found overexpressed human tumor type expression normal tissue low aim present study identify human leukemia antigen hlaarestricted epitope eps using reverse immunology approach achieve computer algorithm used predict hlaa molecular binding proteasome cleavage pattern well translocation transporter associated antigen processing candidate peptide experimentally validated binding affinity assay brefeldina decay assay functional avidity peptidespecific cytotoxic lymphocyte ctls induced peripheral blood mononuclear cell healthy volunteer evaluated using enzymelinked immunosorbent spot assay cytotoxicity assay four peptide designated p p p p high affinity stability binding towards hlaa molecule specific ctls induced significantly responded corresponding peptide secreted ifnγ time ctls able specifically lyse epsexpressing cell line hlaarestricted manner present study demonstrated p p p p ctl epitope eps able used epitopedefined adoptive tcell transfer multiepitopebased vaccine design,2015-04-23,"TANG, BAISHAN; ZHOU, WEIJUN; DU, JINGWEN; HE, YANJIE; LI, YUHUA",Mol Med Rep,,,,document_parses/pdf_json/4b2ef217cb3fedccaffa0ecdd43344810630987b.json,document_parses/pmc_json/PMC4463842.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463842/,,12
2584,2584,2756,765ufb5i,75fbdec55c05102f8337e48dda0c8b6cf27dac52,PMC,Alteration of somatostatin receptor 2 expression in canine mammary gland tumor,10.1292/jvms.15-0002,PMC4638304,25985817.0,cc-by-nc-nd,somatostatin receptor sstr negative regulator cell proliferation human breast cancer since little information sstr canine mammary gland tumor mgt clarified distribution expression level normal mammary gland benign mgt malignant mgt sstr expression determined immunohistochemical staining observed cytoplasm luminal epithelial cell intensity negatively correlated malignancy normal tissue benign tumor highest level malignant tumor little sstr expression western blotting sstr protein level benign tumor significantly lower normal mammary gland hand sstr protein level two three malignant tumor higher group result suggest sstr expression alters according malignancy canine mgt,2015-05-18,"SAKAI, Kosei; YONEZAWA, Tomohiro; YAMAWAKI, Hideyuki; OYAMADA, Toshifumi",J Vet Med Sci,,,,document_parses/pdf_json/75fbdec55c05102f8337e48dda0c8b6cf27dac52.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638304/,,12
2671,2671,2843,jt81i0uc,b2511d6e6a5faa918701cd2bf6e2641ba7f4c9cd,PMC,Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis,10.2174/1874357901509010007,PMC4740969,26862355.0,cc-by,epsteinbarr virus ebv classified member order herpesvirales family herpesviridae subfamily gammaherpesvirinae genus lymphocytovirus virus exclusively human pathogen thus also termed human herpesvirus hhv first oncogenic virus recognized incriminated causation tumor lymphatic epithelial nature reported previous study population worldwide serologically positive virus clinically ebv primary infection almost silent persisting lifelong asymptomatic latent infection b cell although may responsible transient clinical syndrome called infectious mononucleosis following reactivation virus latency due immunocompromised status ebv found associated several tumor ebv linked oncogenesis detected lymphoid tumor burkitts lymphoma bl hodgkin disease hd posttransplant lymphoproliferative disorder ptld tcell lymphoma eg peripheral tcell lymphoma ptcl anaplastic large cell lymphoma alcl also linked epithelial tumor nasopharyngeal carcinoma npc gastric carcinoma oral hairy leukoplakia ohl vitro ebv many study demonstrated ability transform b cell lymphoblastoid cell line lcls despite malignancy showing different clinical epidemiological pattern studied genetic study suggested ebv associated transformation characterized generally low level virus gene expression latent virus protein lvps upregulated tumor lcls review summarize clinical epidemiological feature ebv associated tumor also discus ebv latent gene may lead oncogenesis different clinical malignancy,2015-11-03,"Ali, Abdelwahid Saeed; Al-Shraim, Mubarak; Al-Hakami, Ahmed Musa; Jones, Ian M",Open Virol J,,,,document_parses/pdf_json/b2511d6e6a5faa918701cd2bf6e2641ba7f4c9cd.json,document_parses/pmc_json/PMC4740969.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740969/,,12
2680,2680,2852,sxidmw7e,940fe55ad5d57c4e58076fb38e4aae64694a5baf,PMC,Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice,10.7150/jca.12899,PMC4747877,26918036.0,no-cc,purpose order improve immunogenicity whole tumor cell lysate tumor vaccine designed series cpg odns study transport evaluate antitumor activity b melanoma mouse model method study investigated whether cclass cpg odn cpg odn could facilitate tumor cell lysate induce vigorous antitumor activity tumor mouse prophylactically therapeutically result found combination tumor cell lysate cpg odn could inhibit growth b melanoma prolong survival tumorbearing mouse moreover cpg odn addition tumor cell lysate also cause generation tumor specific immune memory inducing specific cytotoxic lymphocyte helper lymphocyte mouse conclusion result suggest cpg odn could developed efficient adjuvant tumor vaccine melanoma,2016-01-05,"Sun, Wei; Fang, Mingli; Chen, Yajing; Yang, Zhaogang; Xiao, Yue; Wan, Min; Wang, Hua; Yu, Yongli; Wang, Liying",J Cancer,,,,document_parses/pdf_json/940fe55ad5d57c4e58076fb38e4aae64694a5baf.json,document_parses/pmc_json/PMC4747877.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747877/,,12
2726,2726,2900,bs9t0kf6,ed10157bad648117b93617e52d4c22f687ccec52,PMC,Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential,10.1038/leu.2015.125,PMC4788467,25987253.0,no-cc,wt rmfpnapyl human leukocyte antigena hlaarestricted peptide derived wilms tumor protein wt widely expressed broad spectrum leukemia lymphoma solid tumor novel tcellreceptor tcrlike singlechain variable fragment scfv antibody specific tcell epitope consisting wthlaa complex isolated human scfv phage library scfv affinitymatured mutagenesis combined yeast display structurally analyzed using homology model monovalent scfv showed fold affinity improvement dissociation constant kd nm exquisite specificity towards targeted epitope hlaawt tumor cell bivalent scfvhuiggfc fusion protein demonstrated even higher avidity kd pm binding tcell epitope tumor target capable mediating antibodydependent cellmediated cytotoxicity tumor lysis chimeric antigen receptorexpressing human nkmitransfected cell antibody demonstrated specific potent cytotoxicity vivo towards wtpositive leukemia xenograft hlaa restricted summary tcell epitope provide novel target antibodybased therapeutic combining phage yeast display scfvfc fusion platform strategy developing highaffinity tcrlike antibody could rapidly explored potential clinical development supplementary information online version article doileu contains supplementary material available authorized user,2015-05-19,"Zhao, Q; Ahmed, M; Tassev, D V; Hasan, A; Kuo, T-Y; Guo, H-F; O'Reilly, R J; Cheung, N-K V",Leukemia,,,,document_parses/pdf_json/ed10157bad648117b93617e52d4c22f687ccec52.json,document_parses/pmc_json/PMC4788467.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788467/,,12
2935,2935,3122,9v9tfhnd,ec0b7ac5c69486b4c914cf362fc49e176f401516,PMC,CD8 T Cell–Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas,10.3390/cancers8080071,PMC4999780,27472363.0,cc-by,malignant brain tumor continue represent devastating diagnosis real chance cure despite increasing list potential salvage therapy standardofcare patient changed decade immunotherapy seen exciting option potential offer specific long lasting tumor clearance “ gold standard ” immunotherapy development tumorspecific cd cell response potentiate tumor clearance immunological memory many advance made field immunotherapy therapy seen true success many principle used develop immunotherapy tumor peripheral organ applied brain tumor immunotherapy immunespecialized nature brain call question whether approach appropriate recent result experiment require rethinking current dogma perhaps cd cell response sufficient organ immunologically unique brain examination previously elucidated principle brain ’ immunespecialized status known immunological preference generate discussion experimentation address failure current therapy,2016-07-27,"Murphy, Katherine A.; Griffith, Thomas S.",Cancers (Basel),,,,document_parses/pdf_json/ec0b7ac5c69486b4c914cf362fc49e176f401516.json,document_parses/pmc_json/PMC4999780.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999780/,,12
3390,3390,3588,tr0gn3tm,b6deb91c6796184b969f10b262910634eeff4a33,PMC,Tumor Restrictions to Oncolytic Virus,10.3390/biomedicines2020163,PMC5423468,28548066.0,cc-by,oncolytic virotherapy advanced since day conception therapeutic efficacy clinic seem reach level animal model one reason premature oncolytic virus clearance human reasonable assumption considering immunestimulating nature oncolytic agent however several study beginning reveal layer restriction oncolytic virotherapy present adaptive neutralizing immune response barrier present constitutively halting infection even begin whereas others raised minute cue triggered virus infection indeed others noticed delivering virus tumor may biggest obstacle successful therapy instead physical makeup tumor capacity mount antiviral defense seem important efficacy determinant review summarize constitutive innate barrier oncolytic virotherapy discus strategy overcome,2014-04-17,"Vähä-Koskela, Markus; Hinkkanen, Ari",Biomedicines,,,,document_parses/pdf_json/b6deb91c6796184b969f10b262910634eeff4a33.json,document_parses/pmc_json/PMC5423468.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423468/,,12
3630,3630,3842,5wz79c2l,3ba5a8bec872feebb62f6a1f384690ba1cd63a8b,PMC,Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles,10.1038/s41598-017-16928-8,PMC5715114,29203786.0,cc-by,recombinant vaccine strainderived measles virus mv clinically tested vaccine platform protect pathogen oncolytic virus tumor treatment investigate potential synergism antitumoral efficacy oncolytic vaccine property chose ovalbumin ideal tumor antigen claudin preclinical proof concept enhance immunogenicity antigen presented retroviral viruslike particle produced situ mvinfection recombinant mv revealed normal growth genetic stability proper expression presentation antigen potent antigenspecific humoral cellular immunity found immunized mvsusceptible ifnar−−cdge mouse immune response significantly inhibited metastasis formation increased therapeutic efficacy compared control mv respective novel vivo tumor model using syngeneic bhcdmcldn murine melanoma cell data indicate potential mv trigger selected tumor antigenspecific immune response top direct tumor lysis enhanced efficacy,2017-12-04,"Hutzler, Stefan; Erbar, Stephanie; Jabulowsky, Robert A.; Hanauer, Jan R. H.; Schnotz, Jürgen H.; Beissert, Tim; Bodmer, Bianca S.; Eberle, Regina; Boller, Klaus; Klamp, Thorsten; Sahin, Ugur; Mühlebach, Michael D.",Sci Rep,,,,document_parses/pdf_json/3ba5a8bec872feebb62f6a1f384690ba1cd63a8b.json,document_parses/pmc_json/PMC5715114.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715114/,,12
3740,3740,3957,fie121ns,6ba9d2be64380669690c2e8a8a614100a7a5a50a,PMC,Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer,10.1371/journal.pone.0193131,PMC5825036,29474384.0,cc-by,pancreatic cancer th leading cause cancer death effective treatment developed poxvirus platform vaccine improved immunogenicity inserted mesothelin gene create antimesothelin cancer vaccine mesothelin expression mostly restricted tumor adult mammal thus may good target cancer treatment show modified vaccinia virus ankara mva virus expressing mesothelin enhanced mva virus missing immunosuppressive gene expressing mesothelin safe mouse able induce ifngamma secreting cell response mesothelin expressing tumor cell addition mva virus oncolytic property vitro replicate kill panc pancreatic adenocarcinoma cell line tumor cell even though unable replicate mammalian cell deletion gene mva improved cell response expected however unable demonstrate inhibition panc tumor growth immunocompetent mouse prevaccination mouse boost even intratumoral injection recombinant virus vaccine efficacy may limited shedding mesothelin tumor cell thus creating protective screen immune system,2018-02-23,"White, Michael; Freistaedter, Andrew; Jones, Gwendolyn J. B.; Zervos, Emmanuel; Roper, Rachel L.",PLoS One,,,,document_parses/pdf_json/6ba9d2be64380669690c2e8a8a614100a7a5a50a.json,document_parses/pmc_json/PMC5825036.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825036/,,12
3861,3861,4080,kqb475gu,2ba882c9ddb5e9db8ebb0db536788bff66b67f14,PMC,Beyond molecular tumor heterogeneity: protein synthesis takes control,10.1038/s41388-018-0152-0,PMC5945578,29463861.0,cc-by-nc-nd,one daunting challenge facing modern medicine lie understanding treatment tumor heterogeneity tumor show intratumor heterogeneity genomic proteomic level marked impact response therapeutic target therapeutic targetrelated gene expression pathway affected hypoxia cellular stress however finding target eukaryotic initiation factor eif e phosphorylated form peife generally homogenously expressed throughout tumor regardless presence hypoxia cellular stress condition open exciting possibility malignancy could treated therapy combine targeting eife phosphorylation immune checkpoint inhibitor chemotherapy,2018-02-21,"Ramon y Cajal, Santiago; Castellvi, Josep; Hümmer, Stefan; Peg, Vicente; Pelletier, Jerry; Sonenberg, Nahum",Oncogene,,,,document_parses/pdf_json/2ba882c9ddb5e9db8ebb0db536788bff66b67f14.json,document_parses/pmc_json/PMC5945578.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945578/,,12
4045,4045,4270,jsez2yrs,f1b81916fac1ca3d50dde774df2e1bb26bf0fb39,PMC,The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen,10.1371/journal.pone.0203053,PMC6133348,30204757.0,cc-by,vacuolartype hatpase vatpase major proton pump acidifies intracellular compartment eukaryotic cell since inhibition vatpase resulted antitumor antimetastatic effect different tumor model enzyme emerged promising strategy cancer used wellestablished vatpase inhibitor archazolid natural product first isolated myxobacterium archangium gephyra study consequence vatpase inhibition endothelial cell ec particular interaction ec cancer cell neglected far human endothelial cell treated archazolid showed increased adhesion tumor cell whereas transendothelial migration tumor cell reduced adhesion process independent ec adhesion molecule icam vcam eselectin ncadherin instead adhesion mediated βintegrins expressed tumor cell blocking integrin β subunit reversed process tumor cell preferentially adhered βintegrin ligand collagen archazolid led increase amount collagen surface ec accumulation collagen accompanied strong decrease expression activity protease cathepsin b overexpression cathepsin b ec prevented capability archazolid increase adhesion tumor cell onto ec study demonstrates inhibition vatpase archazolid induces proadhesive phenotype endothelial cell promotes interaction cancer cell whereas transmigration tumor cell reduced finding support archazolid promising antimetastatic compound,2018-09-11,"Luong, Betty; Schwenk, Rebecca; Bräutigam, Jacqueline; Müller, Rolf; Menche, Dirk; Bischoff, Iris; Fürst, Robert",PLoS One,,,,document_parses/pdf_json/f1b81916fac1ca3d50dde774df2e1bb26bf0fb39.json,document_parses/pmc_json/PMC6133348.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133348/,,12
4082,4082,4309,kk11lja4,59c41eef8e1d079fc6d1de1cf07cd989c8456d1c; 0a617f5467e92a9a638ee23204247128635e32aa,PMC,Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma,10.1371/journal.pone.0204865,PMC6171904,30286133.0,cc-by,cellular dispersion therapeutic control glioblastoma aggressive type primary brain cancer depends critically migration pattern surgery intracellular response individual cancer cell response external biochemical cue microenvironment recent study shown mir regulates downstream molecule including ampkcabmark mtor determine balance rapid proliferation invasion response metabolic stress harsh tumor microenvironment surgical removal main tumor inevitably followed recurrence tumor due inaccessibility dispersed tumor cell normal brain tissue order address complex process cell proliferation invasion response conventional treatment propose mathematical model analyzes intracellular dynamic mirampk mtorcell cycle signaling pathway within cell model identifies key mechanism underlying molecular switch proliferative phase migratory phase response metabolic stress response fluctuating glucose level show downregulation component pathway affect key cellular decision infiltrate proliferate complex microenvironment absence presence time delay stochastic noise glycosylated chondroitin sulfate proteoglycans cspgs major component extracellular matrix ecm brain contribute physical structure local brain microenvironment also induce inhibit glioma invasion regulating dynamic cspg receptor lar well spatiotemporal activation status resident astrocyte tumorassociated microglia using multiscale mathematical model investigate cspginduced switch invasive noninvasive tumor coordination ecmcell adhesion dynamic change stromal cell show cspgrich microenvironment associated noninvasive tumor lesion larcsgag binding absence glycosylated cspgs induce critical glioma invasion illustrate high molecular weight cspgs regulate exodus local reactive astrocyte main tumor lesion leading encapsulation noninvasive tumor inhibition tumor invasion different cspg condition also change spatial profile ramified activated microglia complex distribution cspgs tumor microenvironment determine nonlinear invasion behavior glioma cell suggests need careful therapeutic strategy,2018-10-04,"Kim, Yangjin; Kang, Hyunji; Powathil, Gibin; Kim, Hyeongi; Trucu, Dumitru; Lee, Wanho; Lawler, Sean; Chaplain, Mark",PLoS One,,,,document_parses/pdf_json/59c41eef8e1d079fc6d1de1cf07cd989c8456d1c.json; document_parses/pdf_json/0a617f5467e92a9a638ee23204247128635e32aa.json,document_parses/pmc_json/PMC6171904.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171904/,,12
4138,4138,4368,8pp9kou2,7d650d31956785474d9b36835d13006b28c508ea,PMC,Association of the Human Bocavirus With Tonsil Squamous Cell Carcinomas,10.3389/fmicb.2018.02450,PMC6232770,30459721.0,cc-by,background human bocavirus hbov known persist latently infected host cell seems replicate dna via dna damage response system frequently defect tumor correlate microsatellite instability msi hbov able persist infected tissue induces profibrotic pro cancerogenic cytokine vivo vitro detected colorectal lung tumor virus may involved cancerogenesis least cofactor recently shown adenotonsillar tissue important site hbov persistence replication considering background approximately oropharyngeal cancer thought attributable hpv infection coparticipation hbov term chronic virus infection might play role cancerogenesis tonsil tumor method formalinfixed paraffinembedded tonsil tumor sample screened hbov hpv dna positive tissue section afterward subjected fluorescence situ hybridization fish analysis identify hbov hpv infected cell use vitro cell culture model primary tonsil fibroblast keratinocytes lymphocyte infected hbov tried find target cell virus replication msi testing based previously published protocol using demultiplexed pcr followed fluorescent detection pcr product capillary sequencing device result total tonsil squamous cell carcinoma tested positive hbov dna sample identified hpv positive fish analysis revealed double infection hpv hbov cell well single infection virus within tumor tissue twentytwo hbov positive tumor tested hpv negative tissue section hbov hpv positive analyzed hbov positive tumor msi four tonsil displayed msi least microsatellite marker conclusion finding support hypothesis human bocavirus infection cofactor may impact tumor development tonsil although still remains possible hbov solely display tumor tropism,2018-10-16,"Höpken, Merle; Förster, Isabel; Maune, Steffen; Brockmann, Michael; Schildgen, Oliver; Schildgen, Verena",Front Microbiol,,,,document_parses/pdf_json/7d650d31956785474d9b36835d13006b28c508ea.json,document_parses/pmc_json/PMC6232770.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232770/,,12
4402,4402,4645,x8f598x2,b625ef49ed4b9e6f2d32150303199ca3fca8bddb,PMC,Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulfate-ES2-AF nanoparticle conjugate,10.2147/ijn.s195934,PMC6462165,31040673.0,cc-by-nc,background past year significant progress made inhibiting neovascularization tumor site cutting nutrient supply tumor inhibiting tumor growth metastasis however many proteinspeptides disadvantage poor stability short halflife uncertain targeting ability chemical modification used overcome disadvantage many polyethylene glycolmodified proteinspeptides approved u fda purpose study obtain novel antiangiogenic chondroitin sulfate cspeptide nanoparticle conjugate efficient antineovascularization tumor targeting ability acceptable halflife material method csesaf nanoparticle conjugate synthesized characterized using hnuclear magnetic resonance spectroscopy transmission electron microscopy particle size zeta potential analyzer antiangiogenic ability studied using mtt migration tube formation chick chorioallantoic membrane assay targeting ability csesaf studied elisa surface plasmon resonance bioimaging pharmacokinetics also studied result csesaf could selfassemble stable nanoparticles aqueous solution significantly enhances antineovascularization activity tumor targeting explicit prolongs halflife conclusion c effective proteinpeptide modifier csesaf displayed good potential tumor targeting therapy,2019-04-10,"Xing, Liang; Sun, Feng; Wang, Zhendong; Li, Yan; Yang, Zhifang; Wang, Fengshan; Zhai, Guangxi; Tan, Haining",Int J Nanomedicine,,,,document_parses/pdf_json/b625ef49ed4b9e6f2d32150303199ca3fca8bddb.json,document_parses/pmc_json/PMC6462165.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462165/,,12
4440,4440,4683,106tex7s,ae36c3fc53af891f884df86ac68bcebd0ad37229,PMC,Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients,10.1042/bsr20181952,PMC6481238,30910845.0,cc-by,purpose triplenegative breast cancer tnbc highly heterogeneous disease important explore novel biomarkers better clarify characteristic tnbc reported polymorphism claudin cldn associated risk several cancer till report polymorphism tnbc patient method january december patient stage i–iii primary tnbc included study investigated association polymorphism cldn gene clinicopathological characteristic survival patient used haploview software identify tag single nucleotide polymorphism snp massarray malditof system used genotyping result found r ga genotype associated older age p hazard ratio hr confidence interval ci – r aa genotype carrier likely develop grade tumor p hr ci – r genotype also related grade patient grade tumor r cc genotype carrier p hr ci – association polymorphism cldn survival tnbc patient multivariate analysis tumor size p hr ci – lymph node status p hr ci – demonstrated independent prognostic factor conclusion first demonstrated polymorphism cldn gene associated age differentiation tnbc patient,2019-04-23,"Hu, Aimin; Li, Junyu; Ruan, Shufang; Fan, Ying; Liao, Yuqian",Biosci Rep,,,,document_parses/pdf_json/ae36c3fc53af891f884df86ac68bcebd0ad37229.json,document_parses/pmc_json/PMC6481238.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481238/,,12
4568,4568,4818,q2w6kxb9,dbdb823e2dcebf23fa3525899b62e1cc82de9f98,PMC,Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors,10.1007/s40265-019-01071-7,PMC6613829,30796733.0,no-cc,impressive clinical response observed using chimeric antigen receptor car cell targeting cd hematologic malignancy limited clinical benefit observed using car cell variety solid tumor result clinical study highlighted several obstacle car cell face context solid tumor including insufficient homing tumor site lack expansion persistence encountering highly immunosuppressive tumor microenvironment heterogeneous antigen expression review review clinical outcome discus strategy improve antitumor activity car cell solid tumor,2019-02-23,"Mata, Melinda; Gottschalk, Stephen",Drugs,,,,document_parses/pdf_json/dbdb823e2dcebf23fa3525899b62e1cc82de9f98.json,document_parses/pmc_json/PMC6613829.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613829/,,12
4770,4770,5032,7an4qw4q,8a2a859f5920d1a81d0ab2e619f00f729331fedc,PMC,Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer,10.1038/s41598-019-51947-7,PMC6820718,31664114.0,cc-by,macrophage migration inhibitory factor mif pleiotropic cytokine increasingly studied cancer inflammatory disease though murine model instrumental understanding functional role mif different pathological condition information obtained model biased towards specific specie experimental science result obtained multiple clinically relevant animal model always provide convincing data might recapitulate human syrian golden hamster mesocricetus auratus clinically relevant animal model multiple human disease hence major objective study characterize structure function mesocricetus auratus mif mamif finally evaluate effect pancreatic tumor growth vivo initially recombinant mamif cloned expressed purified bacterial expression system mamif primary sequence biochemical property crystal structure analysis showed greater similarity human mif crystal structure mamif illustrates form homotrimer known human mouse however mamif exhibit minor structural variation compared human mouse mif vitro functional study show mamif tautomerase activity enhances activation migration hamster peripheral blood mononuclear cell pbmcs interestingly injection mamif hapt pancreatic tumorbearing hamster significantly enhanced tumor growth tumorassociated angiogenesis together current study show structural functional similarity hamster human mif moreover demonstrated high level circulating mif originating nontumor cell might also promote pancreatic tumor growth vivo,2019-10-29,"Suresh, Voddu; Sundaram, Rajivgandhi; Dash, Pujarini; Sabat, Surendra Chandra; Mohapatra, Debasish; Mohanty, Sneha; Vasudevan, Dileep; Senapati, Shantibhusan",Sci Rep,,,,document_parses/pdf_json/8a2a859f5920d1a81d0ab2e619f00f729331fedc.json,document_parses/pmc_json/PMC6820718.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820718/,,12
5940,5940,6325,s5w3azsd,de56bf4d5d5239ed9213f65751844a3c3204edce,PMC,Incidence of Gastrointestinal Stromal Tumor: A Retrospective Study Based on Immunohistochemical and Mutational Analyses,10.1007/s10620-006-9480-y,PMC7087581,17253141.0,no-cc,aim study estimate incidence gastrointestinal stromal tumor previous diagnosis confirmed andor revised immunohistochemical mutational analysis reviewed surgically excised gastrointestinal lesion hospital mesenchymal tumor examined cd expression immunohistochemistry every cdnegative mesenchymal tumor subjected mutational analysis kit pdgfra exon result showed approximately gastrointestinal stromal tumor misdiagnosed immunohistochemical analysis cd expression performed approximately misdiagnosed mutation analysis available approximately patient gastrointestinal malignancy taiwan treated hospital average newly diagnosed gastrointestinal stromal tumor hospital case per year estimated annual incident gastrointestinal stromal tumor taiwan therefore annual incidence gastrointestinal stromal tumor per million taiwanese,2007-01-26,"Tzen, Chi-Yuan; Wang, Jia-Hua; Huang, Ying-Jie; Wang, Man-Ning; Lin, Pei-Chun; Lai, Guan-Lin; Wu, Chiao-Yun; Tzen, Chin-Yuan",Dig Dis Sci,,,,document_parses/pdf_json/de56bf4d5d5239ed9213f65751844a3c3204edce.json,document_parses/pmc_json/PMC7087581.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087581/,,12
5970,5970,6357,8yglfmvm,b5d68432ec198dbb0216af9d942b15b953310ae2,PMC,"Comparative morphology of lymphoepithelial carcinoma in primary tumor, metastasis, and xenograft",10.1007/bf00455398,PMC7087651,6258549.0,no-cc,tissue lymphoepithelial tumor metastasis transplanted subcutaneously thymusaplastic “ nude ” mouse day peasize tumor developing transplanted murine passage second passage tumor growing faster material taken light electron microscopy result compaired data obtained primary nasopharyngeal carcinoma metastasis tumor cell metastasis xenograft showed morphological criterion nonceratinizing squamous epithelial carcinoma undifferentiated type ultrastructural criterion human npctumor cell present including cytoplasmic deposit corona virus herpes viruslike particle within nucleus cytoplasm,1980,"Arnold, W.; Huth, F.; Lindenberger, J.; Vosteen, K. H.",Arch Otorhinolaryngol,,,,document_parses/pdf_json/b5d68432ec198dbb0216af9d942b15b953310ae2.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087651/,,12
6034,6034,6443,2ee1b19o,2654a485689610f569be21dd9b24862bf0b10179,PMC,Functional and molecular analysis of mitochondria in thyroid oncocytoma,10.1007/bf02899539,PMC7087864,1675511.0,no-cc,report functional molecular analysis nine oncocytic tumor human thyroid abundance mitochondrion observed ultrastructurally accompanied increase enzymatic activity respiratory complex nadh dehydrogenase ii succinate dehydrogenase iv cytochrome c oxidase v atpase western blot analysis failed detect uncoupling protein tumor elevated respiratory enzyme activity paralleled increase mitochondrial dna content restriction analysis mitochondrial dna gave indication heteroplasmy gross alteration conclude mitochondrial proliferation oncocytic tumor probably result compensatory mechanism deficiency enzyme complex mitochondrial respiratory chain,1991,"Ebner, Doris; Rodel, Gerhard; Pavenstaedt, Iris; Haferkamp, Otto",Virchows Arch B Cell Pathol Incl Mol Pathol,,,,document_parses/pdf_json/2654a485689610f569be21dd9b24862bf0b10179.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087864/,,12
6080,6080,6498,a6ogjh92,b27454fa50d7c2fe640691ee98d44a3ec75b91d9,PMC,"Viren, virusähnliche und auf Viren hinweisende Strukturen beim Karzinom des Nasopharynx",10.1007/bf01261176,PMC7088000,224851.0,no-cc,five case nasopharyngeal carcinoma typically elevated eb virusantigentiter studied light electron microscopic method within cytoplasm corona virus different form regular capsidlike particle diameter nm tubuloreticular aggregate pathologic alteration membrane endoplasmatic reticulum could found nucleus tumor cell often showed particle within nucleoplasm average diameter nm containing central core appearance particle similar herpes virus shown literature concerning ebviruses atypic mitoses common well free nucleoplasmalike condensate within ground cytoplasm multiple doubling membrane endoplasmatic reticulum characteristic tumor cell cytoplasm myelin figure often situated within enlarged tubule e r within mitochondrion within nucleus result discussed concerning possible viral etiology nasopharyngeal carcinoma believe particle found within nucleoplasm relation nuclear pore argument discussed,1979,"Arnold, W.; Huth, F.",Arch Otorhinolaryngol,,,,document_parses/pdf_json/b27454fa50d7c2fe640691ee98d44a3ec75b91d9.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088000/,,12
6162,6162,6597,ajqu1qwy,9ac8c3bdf598413af7ad755c3d08c5f05918d0d6,PMC,Coronavirus-associated antibodies in nasopharyngeal carcinoma and infectious mononucleosis,10.1007/bf00505035,PMC7088257,6268032.0,no-cc,coronaviruslike particle found within cytoplasm npc tumor cell within cytoplasm tumor cell regional metastasis within tumor cell grown nude mouse immunologic identification coronaviruses culture human tracheal epithelium mrcc used inoculated known coronavirus strain whereas blood serum npc patient n contain significantly elevated antibody titer corona virus unselected serum patient without npc showed low antibody titer n patient suffering infectious mononucleosis n showed titer pattern similar npc patient demonstration antigenantibody reaction within npc tumor cell cytoplasm serum high antibody content coronaviruses deriving npc patient anticoronavirus serum rabbit used indirect immunofluorescence npc tumor cell showed bright cytoplasmic fluorescence fluorescence seen tumor cell exposed human serum known low absent corona antibody titer normal rabbit serum result indicate next dna virus infection ebv rna virus infection coronavirus may play role npc well infectious mononucleosis,1981,"Arnold, W.; Klein, M.; Wang, J. B.; Schmidt, W. A. K.; Trampisch, H. J.",Arch Otorhinolaryngol,,,,document_parses/pdf_json/9ac8c3bdf598413af7ad755c3d08c5f05918d0d6.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088257/,,12
6615,6615,7131,d99opco3,3d7a77ac2dd86e85883ca2e28569cfeb6e772f68,PMC,Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver,10.1038/sj.cgt.7700988,PMC7091580,17139321.0,no-cc,administered adenoviral vector onyx hepatic artery patient metastatic colorectal cancer involving liver thirtyfive patient enrolled multiinstitutional phase iii trial received eight arterial infusion × viral particle hepatic toxicity primary doselimiting toxicity observed preclinical model however nearly infusion adenoviral vector administered directly hepatic artery without significant toxicity therefore undertook analysis determine impact repeated adenoviral exposure hepatic function seventeen patient treated institution providing detailed data set change hepatic function following repeated exposure adenovirus change hepatic function occurred first treatment onyx among patient transient increase transaminase level occurred one patient starting second infusion transient increase bilirubin observed two patient starting fifth treatment change occurred early explained viralmediated lysis hepatocytes addition viremia observed starting – day viral infusion half patient associated hepatic toxicity understand basis minimal hepatic toxicity adenoviral vector evaluated replication adenovirus primary hepatocytes tumor cell culture expression coxsackieadenoviral receptor car normal liver colon cancer metastatic liver found adenovirus replicates poorly primary hepatocytes replicates efficiently tumor including tumor derived hepatocytes addition found car localized junction hepatocytes inaccessible hepatic blood flow car expressed tumor vasculature expressed tumor cell spatial restriction car intercellular space normal liver diminished replication adenovirus hepatocytes may explain minimal toxicity observed following repeated hepatic artery infusion onyx,2006-12-01,"Au, T; Thorne, S; Korn, W M; Sze, D; Kirn, D; Reid, T R",Cancer Gene Ther,,,,document_parses/pdf_json/3d7a77ac2dd86e85883ca2e28569cfeb6e772f68.json,document_parses/pmc_json/PMC7091580.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091580/,,12
6697,6697,7233,b49lvynx,7e44fbe01010454789c97dcd18dd3ce6f10598fe,PMC,Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice,10.1038/cgt.2011.18,PMC7091910,21566669.0,no-cc,approximately one third patient advanced human epidermal growth factor receptor herneupositive breast cancer respond trastuzumab monotherapy humanized antiherneu antibody however de novo acquired antibody resistance one major limitation trastuzumab therapy warranting search therapeutic strategy one remarkable feature adenovirus advbased vaccine ability induce exceptionally high sustained frequency transgene productspecific cd tcell response study constructed two recombinant advs advova advher expressing ovalbumin ovum herneu assessed advinduced antigenspecific cellular immune response preventivetherapeutic antitumor immunity demonstrate advova stimulates efficient ovaspecific cd cytotoxic lymphocyte ctl natural killer response leading preventive longterm immunity ovaexpressing blova melanoma wildtype cbl mouse demonstrate advher stimulates herneuspecific cd ctl response leading significant reduction breast carcinogenesis transgenic fvbneun mouse p little therapeutic effect preexisting tg tumor even early stage mm contrast antiherneu antibody therapy capable completely inhibiting tg tumor growth early stage fails eradicate wellestablished tg breast tumor mm interestingly combinatorial immunotherapy antiherneu antibody advher vaccine capable curing studied mouse bearing wellestablished tg breast tumor significantly delaying death remaining six tumorbearing mouse p taken together result suggest adjuvant effect advher antiherneu antibody therapy wellestablished breast tumor transgenic fvbneun mouse combinatorial immunotherapy trastuzumab advher vaccine may used new therapeutic strategy treatment advanced herneupositive breast cancer,2011-05-13,"Chen, Y; Xie, Y; Chan, T; Sami, A; Ahmed, S; Liu, Q; Xiang, J",Cancer Gene Ther,,,,document_parses/pdf_json/7e44fbe01010454789c97dcd18dd3ce6f10598fe.json,document_parses/pmc_json/PMC7091910.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091910/,,12
7019,7019,7701,88imh1gh,9a2f12f9b633c6b7b8f627f381c21505a628fafe,PMC,Krebspatienten in der operativen Intensivmedizin,10.1007/s00101-018-0406-9,PMC7095836,29368008.0,no-cc,cancer one leading cause death worldwide new targeted individualized therapy drug provide survival benefit increasing number patient also cause severe side effect increasing number oncology patient admitted intensive care unit icu cancerrelated complication treatmentassociated side effect postoperative care respiratory distress sepsis leading cause admission tumor mass syndrome tumor lysis may require urgent treatment traditional anticancer chemotherapy associated infection immunosuppression newer agent generally welltolerated side effect mild moderate overwhelming inflammation autoimmunity also occur cellular treatment chimeric antigen receptor modified t‑cells monoclonal bispecific antibody targeting immune effector tumor cell associated cytokine release syndrome cr hypotension skin reaction fever related excessively high level inflammatory cytokine immune checkpoint inhibitor lead immunerelated adverse event iraes colitis endocrine disorder noninfectious respiratory complication pneumonitis also occur recent study revealed shortterm mediumterm survival cancer patient better previously expected review article summarize diagnostic treatment strategy common lifethreatening complication emergency requiring icu admission furthermore strategy rational admission policy presented,2018-01-24,"Annecke, T.; Hohn, A.; Böll, B.; Kochanek, M.",Anaesthesist,,,,document_parses/pdf_json/9a2f12f9b633c6b7b8f627f381c21505a628fafe.json,document_parses/pmc_json/PMC7095836.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095836/,,12
7125,7125,7849,j6dn4o9z,3cc9332690ce3f235bc1dbda4e105d368320e824,PMC,Neutrophil extracellular traps in cancer progression,10.1007/s00018-014-1683-3,PMC7096049,25070012.0,no-cc,neutrophil increasingly recognized important element tumor progression shown exert important effect nearly every stage tumor progression number study demonstrating presence critical tumor development novel aspect neutrophil biology recently elucidated contribution tumorigenesis beginning appreciated neutrophil extracellular trap net neutrophilderived structure composed dna decorated antimicrobial peptide shown trap kill microorganism playing critical role host defense however contribution tumor development metastasis recently demonstrated number study highlighting net potentially important therapeutic target study implicating net facilitator tumor progression metastasis reviewed addition potential mechanism net may exert effect explored finally ability target net therapeutically human neoplastic disease highlighted,2014-07-29,"Cools-Lartigue, Jonathan; Spicer, Jonathan; Najmeh, Sara; Ferri, Lorenzo",Cell Mol Life Sci,,,,document_parses/pdf_json/3cc9332690ce3f235bc1dbda4e105d368320e824.json,document_parses/pmc_json/PMC7096049.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096049/,,12
7346,7346,8134,d5lj2uv0,3a8f6c0077259221ae45277df2e0af2e64a89acd,PMC,Rare cause of repeated pulmonary embolism: a case of primary pleural squamous cell carcinoma and literature review,10.1186/s12890-020-1077-2,PMC7099822,32216776.0,cc-by,background malignant tumor risk factor pulmonary embolism pe pe caused tumor uncommon primary pleural squamous cell carcinoma ppscc rare malignancy thus related pe extremely rare case presentation previously healthy yearold female patient admitted northern jiangsu people ’ hospital owing chest tightness cough breathing difficulty persisted day following admission computed tomography ct pulmonary angiography revealed embolism main pulmonary artery upper lower pulmonary artery branch patient treated alteplase warfarin antibiotic following year experienced recurrent chest pain tightness breathing difficulty multiple ct pulmonary angiography revealing thrombosis right left main pulmonary artery abnormality observed surrogate marker autoimmune disease tumor antigen testing ultrasonography thus cause recurrent pe identified subsequently positron emission tomographycomputed tomography petct examination revealed diffuse heterogeneous thickening right pleura substantially increased glucose metabolism ctguided pleural biopsy performed histopathological examination pleura eventually revealed diagnosis ppscc conclusion ppscc rare tumor lack specific clinical manifestation difficult detect imaging technique occurrence pe primary manifesting symptom patient ppscc extremely rare thus malignant tumor considered patient risk factor pe andor recurrent pe immediate diagnosis adequate intervention achieved increased awareness diagnosis subsequent related examination,2020-03-26,"Chen, Zhongzhong; Feng, Tingting; Wang, Meng; Xu, Xingxiang; Wang, Yuxiu; Li, Yiran; Min, Lingfeng",BMC Pulm Med,,,,document_parses/pdf_json/3a8f6c0077259221ae45277df2e0af2e64a89acd.json,document_parses/pmc_json/PMC7099822.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099822/,,12
7372,7372,8166,7uv4yfv2,a2429fc3b6dbc27c88a38f4c0f9c3345ef961e5c,PMC,Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children,10.1007/s11060-007-9478-0,PMC7100104,17906911.0,no-cc,autologous hematopoietic stem cell transplant ahsct advocated form salvage therapy child highrisk relapsed brain tumor limited data available currently report outcome pediatric brain tumor treated ahsct quaternary referral center hong kong year june –may thirteen patient medulloblastoma n cerebral primitive neuroectodermal tumor n ependymoma n germ cell tumor n cerebellar rhabdoid n transplanted tumor residual n recurrence n uniform upfront treatment protocol adopted according specific tumor type prior ahsct patient achieved complete remission partial remission conditioning employed thiotepa mgm etoposide mgm carboplatin mgm daily day toxicity included mucositis neutropenic fever patient grade hepatic toxicity patient including hepatic venoocclusive disease patient grade renal toxicity patient year eventfree survival five patient died disease recurrence progression – month transplant median diseasefree period month posttransplant one died transplantrelated complication early posttransplant period seven survived median year maximum followup year six lanskykarnofsky performance score survivor complete remission transplant though leptomeningeal spread conclude ahsct achieve longterm survival child recurrent brain tumor however macroscopic residual tumor transplant salvaged,2007-09-29,"Cheuk, Daniel Ka Leung; Lee, Tsz Leung; Chiang, Alan Kwok Shing; Ha, Shau Yin; Chan, Godfrey Chi Fung",J Neurooncol,,,,document_parses/pdf_json/a2429fc3b6dbc27c88a38f4c0f9c3345ef961e5c.json,document_parses/pmc_json/PMC7100104.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100104/,,12
7510,7510,8345,pldpknn8,2372ad555431eed74cb572d7025d34b938b70fff,PMC,Rare Benign Tumors of the Liver: Still Rare?,10.1007/s12029-014-9580-4,PMC7101630,24510731.0,no-cc,background benign liver tumor common spread area body usually pose serious health risk fact case benign liver tumor diagnosed patient asymptomatic detected ’ usually person medical imaging test ultrasound u computed tomography ct scan magnetic resonance imaging mri another condition material method search literature made using cancer literature pubmed scopus web science wos database following keywords “ hepatic benign tumor ” “ hepatic cystic tumor ” “ polycystic liver disease ” “ liver macroregenerative nodule ” “ hepatic mesenchymal hamartoma ” “ hepatic angiomyolipoma ” “ biliary cystadenoma ” “ nodular regenerative hyperplasia ” discussion conclusion hepatocellular carcinoma hcc one common malignant tumor area world increasing incidence worldwide approximately new case reported per year case occur asiapacific region largely association chronic hepatitis b virus hbv infection incidence hcc increasing usa europe increased incidence hepatitis c virus hcv infection unlike liver hcc benign tumor le frequent however represent chapter always interesting liver disease fact careful differential diagnosis form malignant tumor often required way direct patient correct therapy conclusion many tumor present typical feature various imaging study occasion biopsy required andor surgical removal needed majority case benign hepatic tumor treatment indicated main indication treatment presence significant clinical symptom suspicion malignancy fear malignant transformation,2014-02-09,"Bertino, Gaetano; Ardiri, Annalisa; Demma, Shirin; GiuseppeCalvagno, Stefano; Toro, Adriana; Basile, Elisa; Campagna, Davide; Ferraro, Giorgia; Frazzetto, Evelise; Proiti, Maria; Malaguarnera, Giulia; Bertino, Nicoletta; Malaguarnera, Mariano; Malaguarnera, Michele; Amaradio, Maria Domenica; Pricoco, Gabriele; Di Carlo, Isidoro",J Gastrointest Cancer,,,,document_parses/pdf_json/2372ad555431eed74cb572d7025d34b938b70fff.json,document_parses/pmc_json/PMC7101630.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101630/,,12
7563,7563,8405,ucthbqvt,1cdad2e9c9672251af14de4558fa968e6cce8bce,PMC,Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients,10.1245/aso.2003.03.026,PMC7101740,14597445.0,no-cc,background resection combined radiofrequency ablation rfa novel approach patient otherwise unresectable objective study investigate safety efficacy hepatic resection combined rfa method patient multifocal hepatic malignancy treated surgical resection combined rfa patient followed prospectively ass complication treatment response recurrence result seven hundred thirty seven tumor patient treated colorectal metastasis noncolorectal metastasis rfa used treat tumor combined modality treatment well tolerated low operative time minimal blood loss postoperative complication rate mortality rate median followup month tumor recurred patient failure rfa site uncommon combined total number tumor treated resection rfa associated faster time recurrence p median actuarial survival time month patient noncolorectal metastasis le operative blood loss improved survival p p respectively whereas radiofrequency ablating lesion cm adversely impacted survival hr p conclusion resection combined rfa provides surgical option group patient liver metastasis traditionally unresectable may increase longterm survival,2003,"Pawlik, Timothy M.; Izzo, Francesco; Cohen, Deborah S.; Morris, Jeffery S.; Curley, Steven A.",Ann Surg Oncol,,,,document_parses/pdf_json/1cdad2e9c9672251af14de4558fa968e6cce8bce.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101740/,,12
7663,7663,8520,of0x1h34,7c506ebb4a4c74b60b7b21616ad5c7f7b14b2e22,PMC,Tumor necrosis factor as a pharmacological target,10.1385/mb:31:3:239,PMC7101943,16230774.0,no-cc,indicated name tumor necrosis factor tnf cloned originally described macrophagederived endogenous mediator induce hemorrhagic necrosis solid tumor kill tumor cell line vitro unfortunately promising use anticancer agent biased toxicity clear soon first clinical trial tnf cancer almost time tnf developed anticancer drug became clear tnf identical mediator responsible cachexia associated sepsis termed cachectin research led finding tnf fact main lethal mediator sepsis publication huge number article showing tnf inhibits toxic effect bacterial endotoxin described systemic inflammatory response although clinical trial antitnf sepsis successful thus far undoubtedly result complexity clinical setting study ultimately led identification tnf key inflammatory mediator development antitnf molecule soluble receptor antibody important disease including rheumatoid arthritis crohn ’ disease side mechanism tnf related molecule induce cell death studied depth knowledge might future suggest mean improve therapeutic index tnf cancer,2005,"Ghezzi, Pietro; Cerami, Anthony",Mol Biotechnol,,,,document_parses/pdf_json/7c506ebb4a4c74b60b7b21616ad5c7f7b14b2e22.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101943/,,12
7674,7674,8531,y9tute2y,e65427dff8a5312e0c4d89211478368a15af7cfb,PMC,Einfluß des operationstraumas auf die NK-zell-aktivität beim ösophaguskarizinom nach transmediastinaler dissektion vs. transthorakaler en-bloc-resektion,10.1007/bf00187623,PMC7101962,8767378.0,no-cc,order ass impact surgical trauma involved therapy esophageal carcinoma cellular immune system perspective study performed involving perioperative hematological parameter activity natural killer cell serum concentration interleuin interleukin tnfα measured case transmediastinal dissection case transthioracic en bloc esophageal resection compared value control group thoracic abdominal surgical patient nonmalignant malady natural killer cell assume central role nonspecific immunological response tumor patient main function destruction tumor cell via cytotoxic activity amplified release interleukin tnfα natural killer cell activity measured prior surgery postoperative day using standardized europium chloride release assay utilizing k target cell lymphokine interleukin interleukin thfα also measured postoperative day using standardized elisa assay activity natural killer cell patient group sank significantly p postoperative day likewise control group study group activity sank original value control group natural killer cell activity averaged preoperative value comparison average following transmediastinal esophageal carcinoma resection one cavity procedure transthoracic en bloc resection patient reached preoperative value transmediastinal dissection patient assumed achieved control group member transthoracic en bloc resection esophagus led extreme reduction cytotoxic cellular activity owing greater surgical trauma suppression immunological tumor resistance especially vulnerable perisurgical pahse indirect negative effect manifestation risk hematogenic metastasis owing intraoperative tumor cell dissemination resulting tumor manipulation may thus prognostically relevant,1996-06-01,"Bruns, Ch.; Schäfer, H.; Wolfgarten, B.; Pichlmaier, H.",Langenbecks Arch Chir,,,,document_parses/pdf_json/e65427dff8a5312e0c4d89211478368a15af7cfb.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101962/,,12
7791,7791,8662,y1ueuxr5,cf94460c03893efcaa22c7847021c8a0af9f3b64,PMC,Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary,10.1007/s12032-020-01355-z,PMC7102179,32193648.0,no-cc,increased use medical imaging incidental detection benign solid liver tumor become frequent facing benign disease indication surgery still object discussion light stable natural course lesion obvious drawback surgical intervention therefore situation conservative approach recommended surgery mainly reserved case persistent worsening symptom risk complication malignant transformation advent ablative technique widened range treatment option available patient presenting valid alternative resection term safety efficacy selected case particularly patient considered poor surgical candidate smaller lesion review outline role percutaneous ablative method benign solid liver tumor encountered adult providing per histology analysis existing evidence uptodate strategy management common benign solid tumor recapitulated,2020-03-19,"Carnevale, Aldo; Pellegrino, Fabio; Cossu, Alberto; Ierardi, Anna Maria; Parenti, Gian Carlo; Carrafiello, Gianpaolo; Giganti, Melchiore",Med Oncol,,,,document_parses/pdf_json/cf94460c03893efcaa22c7847021c8a0af9f3b64.json,document_parses/pmc_json/PMC7102179.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102179/,,12
8332,8332,9421,fzrx5pbr,d3fd7a09ccd8419072c58707cc666c60e7207c5b,PMC,Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance,10.1093/abbs/gmx060,PMC7109844,28655144.0,no-cc,serum carcinoembryonic antigenrelated cell adhesion molecule ceacam dysregulated various malignant tumor associated tumor progression however expression regulatory mechanism serum ceacam gastrointestinal cancer still unclear expression ratio ceacaml ceacams isoforms seldom investigated gastrointestinal cancer study intended explore expression diagnostic value ceacam gastrointestinal cancer serum ceacam level measured enzymelinked immunosorbent assay protein expression distribution ceacam tumor examined immunohistochemical staining expression pattern ratio ceacamls analyzed reverse transcriptionpolymerase chain reaction result showed serum ceacam level significantly higher cancer patient healthy control ceacam found secreted form within neoplastic gland expression intense tumor invasion front ceacamls l ratio upregulated tumorigenesis data suggest serum level ceacam may used discriminate gastrointestinal cancer patient health control,2017-06-24,"Zhou, Muqing; Jin, Zhiming; Liu, Yiwen; He, Yiqing; Du, Yan; Yang, Cuixia; Wang, Yingzhi; Hu, Jiajie; Cui, Lian; Gao, Feng; Cao, Manlin",Acta Biochim Biophys Sin (Shanghai),,,,document_parses/pdf_json/d3fd7a09ccd8419072c58707cc666c60e7207c5b.json,document_parses/pmc_json/PMC7109844.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109844/,,12
8401,8401,9497,bics5ag5,,PMC,Effect of 26 week magnetic field exposures in a DMBA initiation–promotion mammary gland model in Sprague–Dawley rats,10.1093/carcin/20.5.899,PMC7109974,10334209.0,no-cc,several study suggested exposure hz magnetic field promote chemically induced breast cancer rat group female sprague–dawley rat initiated single mg gavage dose dimethylbenzaanthracene dmba day age followed exposure ambient field sham exposed hz magnetic field either gauss g field intensity hz field g hday daysweek week vehicle control group without dmba included rat palpated weekly presence tumor effect magnetic field exposure body weight gain time appearance mammary tumor end week animal killed mammary tumor counted measured mammary gland mass found grossly examined histologically mammary gland carcinoma incidence p decrease dmba control g hz g hz g hz group respectively total number carcinoma p decrease p decrease dmba control g hz g hz g hz group respectively number fibroadenoma varied lowest number g hz exposure group measurement tumor revealed difference tumor size group breast cancer initiation–promotion study female sprague–dawley rat evidence hz magnetic field promoted breast cancer condition assay study support hypothesis magnetic field exposure promote breast cancer rat model,1999-05-26,"Boorman, Gary A.; Anderson, Larry E.; Morris, James E.; Sasser, Lyle B.; Mann, Peter C.; Grumbein, Sondra L.; Hailey, James R.; McNally, Alan; Sills, Robert C.; Haseman, Joseph K.",Carcinogenesis,,,,,document_parses/pmc_json/PMC7109974.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109974/,,12
8817,8817,10043,phw8nzkw,,PMC,The tumor phenotype and the human gene map(),10.1016/0165-4608(83)90058-4,PMC7119902,6354430.0,no-cc,tumor phenotype associated rearrangement genetic information altered expression many gene product review gene associated tumor phenotype arranged human gene map indicate extent tumor phenotype involves human genome nonrandom chromosomal aberration frequently observed tumor presented altered metabolic demand tumor cell reflected altered gene expression wide range enzyme protein changed enzyme pattern described study oncogene increasingly suggests may significant certain cancer assignment gene tabulated biochemical metabolic change observed tumor complex studying pattern interaction change aid genetic understanding origin development tumor,2003-01-17,"Honey, Neville K.; Shows, Thomas B.",Cancer Genet Cytogenet,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119902/,,12
9575,9575,11807,kkp4jela,37ab6d18c3d7cbd082281df83560420461b53a84,PMC,Krebspatienten in der operativen Intensivmedizin,10.1007/s00740-018-0218-1,PMC7138133,32288864.0,no-cc,cancer one leading cause death worldwide new targeted individualized therapy drug provide survival benefit increasing number patient also cause severe side effect increasing number oncology patient admitted intensive care unit icu cancerrelated complication treatmentassociated side effect postoperative care respiratory distress sepsis leading cause admission tumor mass syndrome tumor lysis may require urgent treatment traditional anticancer chemotherapy associated infection immunosuppression newer agent generally welltolerated side effect mild moderate overwhelming inflammation autoimmunity also occur cellular treatment chimeric antigen receptor modified t‑cells monoclonal bispecific antibody targeting immune effector tumor cell associated cytokine release syndrome cr hypotension skin reaction fever related excessively high level inflammatory cytokine immune checkpoint inhibitor lead immunerelated adverse event iraes colitis endocrine disorder noninfectious respiratory complication pneumonitis also occur recent study revealed shortterm mediumterm survival cancer patient better previously expected review article summarize diagnostic treatment strategy common lifethreatening complication emergency requiring icu admission furthermore strategy rational admission policy presented,2018-02-27,"Annecke, Thorsten; Hohn, Andreas; Böll, Boris; Kochanek, Matthias",Wien Klin Mag,,,,document_parses/pdf_json/37ab6d18c3d7cbd082281df83560420461b53a84.json,document_parses/pmc_json/PMC7138133.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138133/,,12
9906,9906,12421,z8lg6bub,b62a750d2f1d82e92b1272f3fca99ff181cb67eb,PMC,Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth,10.1002/cncr.21149,PMC7162337,15952188.0,no-cc,background blood vessel tumor express higher level aminopeptidase n apn compared normal tissue reported peptide contain asparagine‐glycine‐arginine ngr sequence home apn tumor vasculature increased expression apn tumor vascular endothelium therefore offer opportunity target ngr peptide‐linked therapeutic reagent tumor method determine whether additional ngr sequence could improve endothelial homing biologic activity human endostatin modified genetically introduce ngr motif ngr‐endostatin expressed yeast vitro biologic activity ngr‐endostatin compared native protein endothelial cell proliferation migration ngr‐modified endostatin used tumor localization study finally effect endostatin ngr‐endostatin tumor growth determined two model system result human endostatin internal ngr sequence accessible bind apn however addition ngr‐sequence amino terminus resulted strong binding inhibition endothelial cell apn ngr‐endostatin showed increased binding endothelial cell compared native protein increased binding endostatin also coincided improved antiangiogenic property endostatin ngr modification improved tumor localization consequence effectively inhibited ovarian carcinoma growth athymic nude mouse conclusion study demonstrated human endostatin modified genetically improve ability inhibit tumor growth cancer © american cancer society,2005-06-10,"Yokoyama, Yumi; Ramakrishnan, Sundaram",Cancer,,,,document_parses/pdf_json/b62a750d2f1d82e92b1272f3fca99ff181cb67eb.json,document_parses/pmc_json/PMC7162337.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162337/,,12
10103,10103,12667,u0ys2xcm,ee2028f18c19056e6742d111157d17bb1019e0b7,PMC,TAP expression reduces IL‐10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma,10.1002/ijc.22371,PMC7165830,17278102.0,no-cc,many immune therapeutic strategy development melanoma treat metastatic disease prevent disease reoccurrence however human melanoma cell often deficient antigen processing appears play role expansion escape immunosurveillance example expression transporter associated antigen processing tap tap down‐regulated mouse melanoma cell line bf result lack tumor‐associated antigen processing low surface expression mhc class molecule low immunogenicity observe restoration tap expression transfection resurrects processing presentation viral antigen melanoma‐associated antigen trp‐ immunization irradiated bfrtap transfected cell generates ctls capable killing bfrtap transfected target bf target deficient tap furthermore bfrtap transfectants grow significantly slower rate mouse bf cell experimental model closely recapitulates clinical situation treatment bf tumor mouse vaccinia virus vector expressing tap also significantly decrease tumor growth vivo furthermore tumor treated vaccinia tap significantly reduced number immunosuppressive cdil‐ positive tumor infiltrating lymphocyte therefore tap expression restores antigen presentation immunogenicity bf melanoma cell concomitantly reduces immunosuppressive il‐ production local tumor site thereby increasing immunosurveillance mechanism tumor © wiley‐liss inc,2007-02-02,"Zhang, Qian‐Jin; Seipp, Robyn P.; Chen, Susan S.; Vitalis, Timothy Z.; Li, Xiao‐Lin; Choi, Kyung‐Bok; Jeffries, Andrew; Jefferies, Wilfred A.",Int J Cancer,,,,document_parses/pdf_json/ee2028f18c19056e6742d111157d17bb1019e0b7.json,document_parses/pmc_json/PMC7165830.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165830/,,12
10129,10129,12697,8bx5aup2,7beb9dbaab716d6e91e531deaad82d8697a9f196,PMC,Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation,10.1002/ijc.2910540122,PMC7165932,8097496.0,no-cc,investigated effect monoclonal antibody mabs specific aminopeptidase ncd invasion human metastatic tumor cell reconstituted basement membrane matrigel invasion human metastatic tumor cell snm renal‐cell carcinoma ht fibrosarcoma melanoma matrigel‐coated filter inhibited anti‐cd mab wm concentration‐dependent manner however mab effect tumor‐cell adhesion migration extracellular matrix may involved tumor‐cell invasion mab wm inhibited degradation type‐iv collagen tumor cell concentration‐dependent manner also found wm inhibited hydrolysing activity towards substrate aminopeptidases different tumor cell since previous study indicated bestatin aminopeptidase inhibitor able inhibit tumor‐cell invasion well aminopeptidase activity murine human metastatic tumor cell cell‐surface aminopeptidase ncd may partly involved activation mechanism type‐iv collagenolysis achieve tumor‐cell invasion anti‐cd mab wm may inhibit tumor‐cell invasion mechanism involving inhibitory action aminopeptidase n tumor cell,2006-07-17,"Saiki, Ikuo; Yoneda, Junya; Azuma, Ichiro; Fujii, Hideji; Abe, Fuminori; Nakajima, Motowo; Tsuruo, Takashi",Int J Cancer,,,,document_parses/pdf_json/7beb9dbaab716d6e91e531deaad82d8697a9f196.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165932/,,12
10535,10535,13215,ghr3djuk,73b5435972babb1a5cb0c0c45ee9f51fd5ce03f9,PMC,The dual role of thymidine phosphorylase in cancer development and chemotherapy,10.1002/med.20159,PMC7168469,19434693.0,no-cc,thymidine phosphorylase tp also known “ platelet‐derived endothelial cell growth factor ” pd‐ecgf enzyme upregulated wide variety solid tumor including breast colorectal cancer tp promotes tumor growth metastasis preventing apoptosis inducing angiogenesis elevated level tp associated tumor aggressiveness poor prognosis therefore tp inhibitor synthesized attempt prevent tumor angiogenesis metastasis tp also indispensable activation extensively used ‐fluorouracil prodrug capecitabine clinically used treatment colon breast cancer clinical trial combine capecitabine tp‐inducing therapy taxanes radiotherapy suggest increasing tp expression adequate strategy enhance antitumoral efficacy capecitabine thus tp play dual role cancer development therapy one hand tp inhibitor abrogate tumorigenic metastatic property tp tp activity necessary activation several chemotherapeutic drug duality illustrates complexity role tp tumor progression clinical response fluoropyrimidine‐based chemotherapy © wiley periodical inc med re rev –,2009-05-11,"Bronckaers, Annelies; Gago, Federico; Balzarini, Jan; Liekens, Sandra",Med Res Rev,,,,document_parses/pdf_json/73b5435972babb1a5cb0c0c45ee9f51fd5ce03f9.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168469/,,12
10914,10914,13797,zik7h675,dac07314c9c4c24eb358e00436469d15572fd624,PMC,Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy,10.1038/s41598-020-64473-8,PMC7192942,32355298.0,cc-by,triplenegative breast cancer tnbc highly aggressive disease poor prognosis important identify novel biomarkers predict therapeutic response outcome tnbc investigated association polymorphism parp gene clinicopathological characteristic survival patient stage iiii primary tnbc treated anthracyclinetaxane based adjuvant chemotherapy found adjusted age grade tumor size lymph node status vascular invasion r ta genotype carrier significantly better dfs rate tt genotype carrier dfs p hr ci – lymph node negative subgroup dfs r cc genotype carrier much better tt genotype carrier p hr ci – dfs r aa genotype carrier shorter tt genotype carrier p hr ci – subgroup age ≤ r tc genotype predicted favorable dfs tt genotype p hr ci – polymorphism parp gene influence treatment toxicity multivariate analysis tumor size p hr ci – lymph node status p hr ci – demonstrated independent prognostic factor result suggested polymorphism parp gene might predict dfs tnbc patient treated anthracyclinetaxane based adjuvant chemotherapy,2020-04-30,"Liao, Yuqian; Liao, Yulu; Li, Jun; Xiong, Jianping; Fan, Ying",Sci Rep,,,,document_parses/pdf_json/dac07314c9c4c24eb358e00436469d15572fd624.json,document_parses/pmc_json/PMC7192942.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192942/,,12
11805,11805,15800,wl1kuszc,92861b672bbd54127fc6aa57e3e3de1107fe17db,PMC,Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials,10.1007/1-4020-3623-x_8,PMC7119983,,no-cc,use ifnγ elispot assay evaluate cellular immune response gained increasing popularity especially surrogate measure ctl response developed validated modification ifnγ elispot assay optimize immunological monitoring various cancer vaccine trial taking consideration main mechanism cellmediated cytotoxicity release cytolytic granule contain among others cytolytic protein granzyme b grb developed grb elispot assay extensive study demonstrated grb elispot assay specific accurately measure rapid release grb sensitive crrelease assay may successfully applied measuring ctl precursory frequency pbmc cancer patient assuming immunological assay demonstrate recognition native tumor cell tumorspecific may clinically relevant assay demonstrate recognition tumor protein peptide antigenspecific developed validated autologous tumor ifnγ elispot assay using pbmc idiotype vaccinated lymphoma patient effector autologous b cell lymphoma tumor cell target precursor frequency tumorreactive cell significantly higher postvaccine pbmc compared prevaccine sample patient tested furthermore specificity cell established lack reactivity autologous normal b cell result demonstrate feasibility evaluating tumorspecific cell response autologous primary tumor cell available target modification elispot assay described chapter allow comprehensive assessment low frequency tumorspecific ctl specific effector function provide valuable insight regard immune response cancer vaccine trial,2005,"Malyguine, Anatoli",Analyzing T Cell Responses,,,,document_parses/pdf_json/92861b672bbd54127fc6aa57e3e3de1107fe17db.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119983/,,12
11887,11887,15893,uqinjzgc,,PMC,Pulmonary Medicine,10.1007/978-1-4419-6505-9_1,PMC7120112,,no-cc,• oropharynx—enlarged tonsil retropharyngeal abscess obesity postnasal drip • larynx—laryngeal edema laryngostenosis laryngocele epiglottitis anaphylaxis severe laryngopharyngeal reflux laryngospasm • vocal cords—vocal cord dysfunction paralysis hematoma tumor cricoarytenoid arthritis,2010-08-13,"Hui, David",Approach to Internal Medicine,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120112/,,12
11907,11907,15917,xphwfan6,5466747ababb77a6c3905aca5dc6211f3fc6f2ff,PMC,"Strategies of Gene Transfer and Silencing, and Technical Considerations",10.1007/978-3-540-74386-6_18,PMC7120147,,no-cc,cancer gene therapy relatively new modality might ultimately revolutionize oncology basic principle alter tumor genetically enhance traditional chemo radiation therapy schema last decade seen tremendous progress development new technology area vector delivery tumor targeting numerous clever way increase tumor killing including early attempt modulate tumor gene expression rna interference recent year attempt image affected cell also part effort many study proceeded preclinical stage fair number early clinical testing showing encouraging result however real impact patient survival remains seen one major problem still overcome quantitative delivery vector tumor mass next decade expected resolve many technical issue improve treatment patient chapter discus new technology provide brief overview field,2009,"Valerie, Kristoffer; Graves, Paul R.",The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies,,,,document_parses/pdf_json/5466747ababb77a6c3905aca5dc6211f3fc6f2ff.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120147/,,12
12097,12097,16132,4gbxlnbo,92ebcc4c85582ff806164fd6ceaa05d9222a4e2c,PMC,Vascular Lung Diseases,10.1007/978-3-662-50491-8_11,PMC7120439,,no-cc,discus infarct thromboembolic disease vasculitis vascular malformation pulmonary hypertension vascular tumor already discussed,2016-12-24,"Popper, Helmut",Pathology of Lung Disease,,,,document_parses/pdf_json/92ebcc4c85582ff806164fd6ceaa05d9222a4e2c.json,document_parses/pmc_json/PMC7120439.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120439/,,12
12502,12502,16587,6029wkno,32d5454b68948aec6713ab30fd259af5a7fa3104,PMC,Surgical Complications of Childhood Tumors,10.1007/978-3-662-48590-3_31,PMC7121030,,no-cc,childhood tumor first present physician tumor present atypical manner may mimic surgical condition diagnosis may missed surgeon aware possibility cancer great number rare presentation childhood cancer described literature important surgeon experienced management childhood cancer aware apparently benign condition could manifestation underlying malignancy,2016-04-29,"Arul, G. Suren",The Surgery of Childhood Tumors,,,,document_parses/pdf_json/32d5454b68948aec6713ab30fd259af5a7fa3104.json,document_parses/pmc_json/PMC7121030.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121030/,,12
12621,12621,16721,82b3f0li,cfa82c1fd5afbc2a2a17cda77a412c594733106e,PMC,Infectious Complications of Cancer Therapy,10.1007/0-387-31056-8_76,PMC7121206,,no-cc,advance management cancer particularly development new chemotherapeutic agent greatly improved survival outcome patient hematologic malignancy solid tumor overall year survival rate cancer patient improved however infection caused underlying malignancy cancer chemotherapy particularly myelosuppressive chemotherapy remains persistent challenge,2006,"Safdar, Nasia; Crnich, Christopher J.; Maki, Dennis G.",Oncology,,,,document_parses/pdf_json/cfa82c1fd5afbc2a2a17cda77a412c594733106e.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121206/,,12
13306,13306,17479,jkhvcjcb,b8169000e440aa5603fa70192ce4986b4b85f90c,PMC,Modeling Brain Tumors Using Avian Retroviral Gene Transfer,10.1007/978-1-60327-553-8_2,PMC7122153,,no-cc,rcastva system postnatal celltypespecific gene transfer used modeling glioma medulloblastomas system provides combination lineage tracing cell origin oncogenesis induced misexpression specific gene gene potent inducing tumor encode component signal transduction undifferentiated cell capable serving cell origin system effectively generates tumor histologic characteristic human disease mouse bearing rcastvainduced brain tumor currently used preclinical trial understand biology therapeutic response various cell type make glioma medulloblastomas,2008-12-12,"Holland, Tod D.; Holland, Eric C.",CNS Cancer,,,,document_parses/pdf_json/b8169000e440aa5603fa70192ce4986b4b85f90c.json,document_parses/pmc_json/PMC7122153.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122153/,,12
13348,13348,17524,rydmolif,84ad18a4dcc506f1901dad44af2c5596f99bfd9c,PMC,TLR Signaling and Tumour-Associated Macrophages,10.1007/978-1-4614-0662-4_9,PMC7122207,,no-cc,role tolllike receptor tlr signaling may stimulating macrophage become tumor promoting yet clearly defined however given role macrophage play restoring tissue homeostasis tissue repair response likely tumorinduced tlr signaling provides macrophage signal persistent injury chapter review molecular determinant tlr signaling role tlr signaling play infection wound healing tumorigenesis discus tlr signaling tumorassociated macrophage may result tumor progression,2011-06-14,"Colegio, Oscar R.; Medzhitov, Ruslan",Tumour-Associated Macrophages,,,,document_parses/pdf_json/84ad18a4dcc506f1901dad44af2c5596f99bfd9c.json,document_parses/pmc_json/PMC7122207.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122207/,,12
13419,13419,17599,dlxyym0p,b5ceb3f7fefb203914e45da4ed49051c920d5094,PMC,Dietary Phytochemicals Target Cancer Stem Cells for Cancer Chemoprevention,10.1007/978-1-4614-9326-6_5,PMC7122321,,no-cc,cancer multistep process involving genetic epigenetic change somatic genome genetic mutation well environmental factor lead initiation promotion progression cancer cancer progression end tumor metastasis distant site metastasis major reason cancer patient death recent experimental evidence suggests pivotal role cancer stem cell tumor heterogeneous composed different cell type cancer stem cell tumor capacity selfrenew differentiate sustain tumor feature cancer stem cell described review emphasis role dietary phytochemical may play cancer chemoprevention ingredient diet inhibit cancer cell cancer stem cell compound include curcumin curry epigallocatechin gallate green tea resveratrol red wine genistein soy sulforaphane broccoli many others current research finding advocate beneficial effect towards cancer chemoprevention via uptake combination different dietary phytochemical,2013-12-10,"Fong, Dunne; Chan, Marion M.",Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy,,,,document_parses/pdf_json/b5ceb3f7fefb203914e45da4ed49051c920d5094.json,document_parses/pmc_json/PMC7122321.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122321/,,12
13484,13484,17668,ofzm3x3a,ea63507d4eb29c88f587e4b8204241a5e547e3a9,PMC,Theories of Carcinogenesis,10.1007/978-1-4020-6016-8_1,PMC7122402,,no-cc,oldest description human cancer referring eight case tumor breast found egyptian edwin smith papyrus written around – bc oldest specimen human cancer detected remains female skull dating back bronze age – bc fossilized bone ancient egypt mummified skeletal remains peruvian inca dating year ago contained lesion suggestive malignant melanoma term “ cancer ” go back hippocrates – bc named group disease καρκινοσ καρκινομα ancient greek word crab metaphor hard center spiny projection tumor studied cancer latin word crab use traced back galen ad – snapshot theory carcinogenesis devised course last two century reflects progress insight cellular level via biochemistry understanding damaging influence oncogene wholistic approach regulatory theory show relative success reductionism well current need put insight various research endeavor broader paradigmatic context,2007,,Molecular Mechanisms of Cancer,,,,document_parses/pdf_json/ea63507d4eb29c88f587e4b8204241a5e547e3a9.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122402/,,12
13517,13517,17705,rhoisec4,85fff4119bbda69af9081d38c9bdb6288f1417f0,PMC,Lipidmediatoren und ihre Rolle bei Entzündungen und Allergien,10.1007/978-3-662-58140-7_6,PMC7122452,,no-cc,lipidmediatoren sind al lokal agierende lipide nach dem eindringen eines krankheitserregers oder nach gewebsverletzung im zusammenspiel mit interleukinen und chemokinen zunächst für die sinnvollen proinflammatorischen prozesse wie calor rubor dolor tumor verantwortlich nach erfolgreich abgewehrter infektion sind e wieder lipidmediatoren die mithelfen die unschädlich gemachten viren und bakterien sowie nekrotisches material au dem gewebe zu eliminieren die entzündungsreaktion zu stoppen und geschädigtes oder zerstörtes gewebe zu regenerieren mit den lipidmediatoren hat die evolution wunderbare molekulare netzwerke für kontrollierte immunantworten auf infektionen und verletzungen geschaffen die perfekt koordiniert zu einer restitutio ad integrum führen und die die homöostase im gewebe wiederherstellen lange zeit konzentrierte man sich auf die wissenschaftliche beobachtung der entzündungsauslösenden wirkung der prostaglandine und leukotriene letzter zeit fokussiert die forschung jedoch immer mehr auch die antiinflammatorischen und entzündungsauflösenden schützenden und die regeneration mediierenden effekte der lipidmediatoren weil diese vor der pathogenese von chronischen erkrankungen wie zum beispiel allergien schützen können,2020-03-25,"Stockert, Karin",Allergiepr&#x000e4;vention,,,,document_parses/pdf_json/85fff4119bbda69af9081d38c9bdb6288f1417f0.json,document_parses/pmc_json/PMC7122452.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122452/,,12
13622,13622,17822,m0tjqvql,90c1874a3313f709f01834dcb5213004d48d083a,PMC,Surgical Complications of Childhood Tumors,10.1007/978-3-540-29734-5_22,PMC7122594,,no-cc,childhood tumor first present physician tumor present atypical manner may mimic surgical condition diagnosis may missed surgeon aware possibility cancer great number rare presentation childhood cancer described literature important surgeon experienced management childhood cancer aware apparently benign condition could manifestation underlying malignancy table,2008,"Suren Arul, G.; Spicer, Richard D.",The Surgery of Childhood Tumors,,,,document_parses/pdf_json/90c1874a3313f709f01834dcb5213004d48d083a.json,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122594/,,12
13811,13811,18031,ohhhm2gf,9960d28d4b5d960483882bb43568b0e01d562669,PMC,Harnessing T-Cell Immunity to Target Brain Tumors,10.1007/978-1-60327-553-8_48,PMC7122908,,no-cc,tcell mediated immunotherapy conceptually attractive treatment option envisage glioma since lymphocyte actively seek neoplastic cell brain potential safely specifically eliminate tumor antigenic target glioma cell already defined optimistic discovered progress tcell epitope identification gene expression profiling brain tumor parallel advance immunology regional immunology neuroimmunology tumor immunology equip u build upon result current immunotherapy trial safety feasibility brain tumor immunotherapy already confirmed look next phase immunotherapy must harness promising basic science advance existing clinical expertise apply randomized clinical trial determine real clinical impact applicability approach treating patient currently incurable malignant brain tumor,2008-12-12,"Walker, Paul R.; Prins, Robert M.; Dietrich, Pierre-Yves; Liau, Linda M.",CNS Cancer,,,,document_parses/pdf_json/9960d28d4b5d960483882bb43568b0e01d562669.json,document_parses/pmc_json/PMC7122908.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122908/,,12
14298,14298,18579,1ka84lxi,,PMC,Gastroenterology,10.1007/978-3-319-11821-5_5,PMC7123601,,no-cc,organic—infections tumor multiple sclerosis vestibular nerve brain stem lesion,2015-04-13,"Chopra, Angeli",Approach to Internal Medicine,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123601/,,12
14425,14425,18709,ir0tzugn,6812b1d3fc1ede14dddc3d5e99258e16ef0cbb9a,PMC,Pulmonary System,10.1007/978-1-4899-7584-3_8,PMC7123763,,no-cc,pulmonary disease highly prevalent cause premature morbidity mortality longterm childhood cancer survivor pulmonary toxicity frequently reported survivor hodgkin lymphoma germ cell tumor acute lymphoblastic lymphoma metastatic wilms tumor survivor chemotherapy radiation surgery used treat pediatric cancer among others result permanent lung damage damage manifest acute pneumonitis late onset fibrosis structurally induced dysfunction developmental abnormality due impaired growth thorax attributable surgery radiation cumulative incidence pulmonary problem childhood cancer increase time since diagnosis lateeffects suggesting survivor elevated risk developing lateronset pulmonary morbidity age,2015-02-09,"Henderson, Tara O.",Handbook of Long Term Care of The Childhood Cancer Survivor,,,,document_parses/pdf_json/6812b1d3fc1ede14dddc3d5e99258e16ef0cbb9a.json,document_parses/pmc_json/PMC7123763.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123763/,,12
14659,14659,18969,mxw52ea9,2cf7df301d8bcb22fc1e675ed63e96eb636fe9e3,PMC,Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors,10.1007/978-3-319-33673-2_4,PMC7124104,,no-cc,tumor blood vessel formation angiogenesis essential tumor growth metastasis two main endothelial ligand–receptor pathway regulating angiogenesis vascular endothelial growth factor vegf receptor angiopoietintie receptor pathway angiopoietintie pathway required remodeling maturation blood lymphatic vessel embryonic development vegf vegfc mediated development primary vascular plexus angiopoietin angpt stabilizes vasculature angiogenic process via tyrosine kinase immunoglobulinlike egflike domain tie activation contrast angpt upregulated site vascular remodeling angpt secreted activated endothelial cell inflammation promoting vascular destabilization angpt found expressed many human cancer intriguingly preclinical model inhibition angpt provided promising result preventing tumor angiogenesis tumor growth metastasis making attractive candidate target tumor however first angpt targeting therapy le effective clinical trial experimental model additionally preclinical model combined therapy angpt vegf immune checkpoint inhibitor superior monotherapies pathway also targeted early clinical trial order improve current antiangiogenic therapy successfully exploit angpt target cancer treatment biology angiopoietintie pathway need profoundly clarified,2019-07-05,"Kiss, Elina A.; Saharinen, Pipsa",Tumor Angiogenesis,,,,document_parses/pdf_json/2cf7df301d8bcb22fc1e675ed63e96eb636fe9e3.json,document_parses/pmc_json/PMC7124104.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124104/,,12
15365,15365,22086,3q24qxsr,ed647b6f973c7f0036e463eddc051d6f9e4cf210,PMC,Explanation of Metastasis by Homeostatic Inflammation,10.1007/978-4-431-56024-1_15,PMC7153410,,no-cc,inflammation caused either nonself self molecule disseminate throughout body inflammatory site actively allow entry circulating tumor cell assist regrowth circulating tumor cell metastasize site inflammation however disrupted site homeostatic inflammation necessarily guarantee metastatic spread subsequent regrowth,2016-02-02,"Maru, Yoshiro",Inflammation and Metastasis,,,,document_parses/pdf_json/ed647b6f973c7f0036e463eddc051d6f9e4cf210.json,document_parses/pmc_json/PMC7153410.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153410/,,12
16323,16323,24546,dvjemi5t,c0d88326cb774b87525a111d640c88aef1403058,PMC,Correlation Matters: Multi-scale Fine-Grained Contextual Information Extraction for Hepatic Tumor Segmentation,10.1007/978-3-030-47426-3_36,PMC7206311,,no-cc,automatic tumor segmentation used diagnostic aid identification disease tumor liver ct scan treatment owing success computer vision task stateoftheart fully convolutional network fcns unet based model often employed many recent study automatic tumor segmentation learn numerous weightshared convolutional kernel extract various semantic feature however correlation different tumor region feature map easily captured due lack contextual dependency turn limit representative capability adopted model thus affect accuracy tumor segmentation result resolve issue propose novel framework segmentation tumor liver ct scan explicitly extract multiscale finegrained contextual information adaptively aggregating local feature global dependency proposed multiscale framework feature light model additional parameter also visualization capability significantly boost network ’ interpretability experimental result realworld liver tumor ct dataset illustrate proposed framework achieves stateoftheart performance term number widely used evaluation criterion hepatic tumor segmentation task,2020-04-17,"Pang, Shuchao; Du, Anan; Yu, Zhenmei; Orgun, Mehmet A.",Advances in Knowledge Discovery and Data Mining,,,,document_parses/pdf_json/c0d88326cb774b87525a111d640c88aef1403058.json,document_parses/pmc_json/PMC7206311.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206311/,,12
16451,16451,24868,4twrik80,766765f8e4b5ed73a3c4d376155ea3a853dc8ee1,PMC,The Role of Portoenterostomy with Aggressive Hilar Dissection in Biliary Tract Tumors: Report of Case Series and Review of the Literature,10.1007/s12262-020-02259-y,PMC7222060,,no-cc,hepaticojejunostomy challenging complex procedure done confidence condition contain large number segmental bile duct portoenterostomy defined joining multiple bile duct single cavity using segmenter bile duct end stent surrounding connective tissue surgery case advanced stage biliary tract tumor performed hepatectomy aggressive dissection provide negative surgical margin large number segmental bile duct revealed need ensure continuity bile flow clinical series portoenterostomy pe applied patient aggressive hilar dissection resection hilar cholangiocarcinomas biliary tract tumor discussed study included patient underwent pe biliary tract tumor hilar cholangiocarcinomas six patient tumornegative surgical margin mean followup month range month nine patient tumorpositive surgical margin mean followup month range month portoenterostomy instead hepaticojejunostomy small multiple biliary radicle bile duct cancer successfully performed patient bile duct cancer klatskin tumor presence active inflammation fibrosis major bile duct trauma thin bile duct radicle method described detail provides excellent salvage surgical procedure le morbidity,2020-05-12,"Dilek, Osman Nuri; Güngör, Feyyaz; Acar, Turan; Atay, Arif; Karasu, Şebnem; Bağ, Halis; Dilek, Fatma Hüsniye",Indian J Surg,,,,document_parses/pdf_json/766765f8e4b5ed73a3c4d376155ea3a853dc8ee1.json,document_parses/pmc_json/PMC7222060.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222060/,,12
16517,16517,24945,u3ssox1m,,Medline,Endoscopic extended transsphenoidal resection of tuberculum sellae meningiomas: nuances of neurosurgical technique.,10.3171/2013.8.focus13338,,24289131.0,unk,past decade advance endoscopic microsurgical technique resulted increasingly aggressive endonasal approach tumor midline skull base meningioma tuberculum sellae often closely associated cerebrovascular structure removal traditionally required transcranial approach endonasal approach offer many advantage including early tumor devascularization tumor debulking without manipulation optic apparatus direct access medial optic canal minimalaccess corridor although recent article focused technique reaching approaching area pathology get author report discus technical nuance endoscopic microsurgery operator already describe step technique endoscopic skull base bone removal tumor dissectionresection closure also augment description elaborate illustration,2013,"Kulwin, Charles; Schwartz, Theodore H; Cohen-Gadol, Aaron A",Neurosurgical focus,,,,,,https://doi.org/10.3171/2013.8.focus13338; https://www.ncbi.nlm.nih.gov/pubmed/24289131/,32694003.0,12
16695,16695,25148,ghe8h2du,,Medline,Spine Cryoablation: Pain Palliation and Local Tumor Control for Vertebral Metastases.,10.3174/ajnr.a4521,,26427837.0,unk,background purpose percutaneous cryoablation emerged minimally invasive technique management osseous metastasis purpose study ass safety effectiveness percutaneous imagingguided spine cryoablation pain palliation local tumor control vertebral metastasis material method imagingguided spine cryoablation performed patient tumor vertebral metastasis refractory conventional chemoradiation therapy analgesic achieve pain palliation local tumor control retrospective study spinal nerve softtissue thermal protection technique implemented ablation patient response evaluated pain numeric rating scale administered procedure week month month procedure pre postprocedural analgesic requirement expressed morphineequivalent dosage also analyzed time point pre postprocedural crosssectional imaging evaluated patient ass local control radiographic evidence disease treated site complication monitored analysis primary end point undertaken via pairedcomparison procedure using wilcoxon signed rank test result thirtyone tumor ablated patient woman men year age mean age year common tumor location lumbar spine n followed thoracic spine n sacrum n coccyx n cervical spine n statistically significant decrease median numeric rating scale score analgesic usage week month month time point p local tumor control achieved tumor median followup month two patient transient postprocedural unilateral lower extremity radiculopathy weakness conclusion percutaneous imagingguided spine cryoablation safe effective treatment pain palliation local tumor control vertebral metastasis,2016,"Tomasian, A; Wallace, A; Northrup, B; Hillen, T J; Jennings, J W",AJNR. American journal of neuroradiology,,,,,,https://doi.org/10.3174/ajnr.a4521; https://www.ncbi.nlm.nih.gov/pubmed/26427837/,23478866.0,12
16696,16696,25149,1fydqh86,,Medline,Diagnosis and management of rare inferior vena cava leiomyosarcoma guided by a novel minimally invasive vascular biopsy technique.,10.1002/ccd.27535,,29411530.0,unk,primary vascular tumor vascular leiomyosarcoma rare exhibit markedly different characteristic tumor invade vasculature secondary source establishing diagnosis essential determining appropriate treatment plan obtaining histologic specimen may prove challenging carry significant risk minimally invasive endovascular biopsy technique pivotal diagnosisand thus managementof vascular tumor present case primary inferior vena cava leiomyosarcoma able adequately assessed noninvasive imaging deemed risky approached traditional percutaneous biopsy technique accurate diagnosis tumor critical success surgical resection although high risk depends greatly upon type location extent malignancy,2018,"Balaney, Bhavna; Mitzman, Brian; Fung, John; Paul, Jonathan D",Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,,,,,,https://doi.org/10.1002/ccd.27535; https://www.ncbi.nlm.nih.gov/pubmed/29411530/,46856528.0,12
16726,16726,25184,gmvvtogn,,Medline,Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings.,10.1097/dcr.0000000000000096,,24807595.0,unk,background accuracy mri assessing mesorectal fascia predicting circumferential resection margin decrease low anterior rectal tumor objective purpose work evaluate accuracy endorectal ultrasound predicting pathologic circumferential resection margin low rectal anterior tumor compare mri finding design prospective series comparing preoperative circumferential resection margin assessed endorectal ultrasound mri pathologic examination setting study conducted specialized colorectal multidisciplinary team tertiary teaching hospital patient patient mid low rectal cancer preoperatively evaluated endorectal ultrasound mri underwent total mesorectal excision without neoadjuvant radiochemotherapy twentyseven patient posterior posterolateral tumor excluded leaving patient anterior anterolateral tumor present subanalysis compared preoperative circumferential resection margin status using endorectal ultrasound mri pathologic examination intervention conducted comparison preoperative circumferential resection margin status pathologic examination total mesorectal excision surgery main outcome measure accuracy predicting pathologic circumferential resection margin status measured result overall accuracy endorectal ultrasound mri assessing circumferential resection margin status negative predictive value focusing low rectal tumor overall accuracy endorectal ultrasound increased whereas accuracy mri decreased negative predictive value diagnostic test limitation sample size small interobserver variability radiologic assessment evaluated conclusion endorectal ultrasound help mri predicting circumferential resection margin involvement mid low anterior rectal cancer especially low third rectum high negative predictive value,2014,"Granero-Castro, Pablo; Muñoz, Elena; Frasson, Matteo; García-Granero, Alvaro; Esclapez, Pedro; Campos, Salvador; Flor-Lorente, Blas; Garcia-Granero, Eduardo",Diseases of the colon and rectum,,,,,,https://doi.org/10.1097/dcr.0000000000000096; https://www.ncbi.nlm.nih.gov/pubmed/24807595/,11757311.0,12
16731,16731,25189,ytv08wss,,Medline,A case of left frontal high-grade glioma diagnosed during pregnancy.,10.1186/s40981-017-0090-9,,29457062.0,unk,background pregnancy accelerates glioma growth therapeutic abortion recommended prior tumor resection additionally also suggested extent glioma resection closely correlated patient survival case presentation cm kg yearold righthanded primigravida referred institution week gestation obtain second opinion week gestation patient developed newonset generalized convulsive seizure gc poorly controlled anticonvulsant polytherapy early second trimester cm lesion located left frontal supplementary motor area sma suspected grade iii glioma classified according world health organization guideline due limited evidence use adjuvant therapy pregnancy tumor causing neurological symptom seizure must treated order stabilize maternal condition enable safe birth case pregnant patient awake craniotomy using intraoperative magnetic resonance imaging imri considered advantageous achieving gross total resection reduction direct cortical stimulation may induce seizure reducing fetal exposure anesthetic asleepawakeasleep technique performed week day gestation use propofol pregnant patient prohibited general anesthesia maintained administration sevoflurane remifentanil first scan imri subsequently reinduced dexmedetomidine tumor removal accomplished supraglottic airway sga used patient cranium opened complication either procedure postoperative period week gestation patient delivered healthy baby g pathological examination patient revealed anaplastic astrocytoma thus radiotherapy chemotherapy began month postdelivery evidence tumor recurrence patient child show medical developmental concern point month followup conclusion since evidence use adjuvant therapy pregnancy limited extensive resection functional monitoring recommended brain tumor presumed malignant awake craniotomy considered advantageous pregnant patient subjective movement preserve patient motor function reduces fetal exposure anesthetic therefore providing multidisciplinary discussion take place within decisionmaking process well careful perioperative preparation awake craniotomy considered even case pregnant patient,2017,"Kamata, Kotoe; Fukushima, Risa; Nomura, Minoru; Ozaki, Makoto",JA clinical reports,,,,,,https://doi.org/10.1186/s40981-017-0090-9; https://www.ncbi.nlm.nih.gov/pubmed/29457062/,3233012.0,12
16777,16777,25240,qw912bqd,,Medline,Optimal CT scanning parameters for commonly used tumor ablation applicators.,10.1016/j.ejrad.2017.01.005,,28267529.0,unk,purpose ctbeam hardening artifact make tumor margin visualization relationship ablation applicator tip challenging determine optimal scanning parameter commonlyused applicator material method applicator placed exvivo cow liver implanted mock tumor surrounded bolus gel various ct scan performed mm thickness changing kvp scan time asir scan type pitch reconstruction algorithm four radiologist blindly scored image image quality artifact quantitatively result significant relationship probe kvp level asir level reconstruction algorithm observed concerning image artifact image quality p specifically certain combination kvp asir reconstruction algorithm yield better image combination particular one probe performed equivalently better competing probe considered regardless kvp asir reconstruction algorithm combination conclusion finding illustrate overall interaction effect kvp asir reconstruction algorithm within probe radiologist may easily reference optimal imaging performance certain combination kvp asir reconstruction algorithm probe disposal optimum combination probe provided,2017,"Eltorai, Adam E M; Baird, Grayson L; Monu, Nicholas; Wolf, Farrah; Seidler, Michael; Collins, Scott; Kim, Jeomsoon; Dupuy, Damian E",European journal of radiology,,,,,,https://doi.org/10.1016/j.ejrad.2017.01.005; https://www.ncbi.nlm.nih.gov/pubmed/28267529/,25528056.0,12
16843,16843,25315,zq8d0b3v,,Medline,Simultaneous laparoendoscopic single-site radical nephrectomy for native kidney and open nonischemic partial nephrectomy to treat concomitant renal cell carcinomas in native and transplant kidneys and to preserve allograft function.,10.1016/j.urology.2011.09.015,,22055688.0,unk,objective report technique minimally invasive radical nephrectomy native renal cell carcinoma rcc nonischemic open partial nephrectomy transplant kidney rcc laparoendoscopic singlesite le incision concomitant rccs native transplant kidney rare conventional surgical approach requires long incision method yearold man year renal transplant found incidentally concomitant rccs native right kidney transplant kidney right lower abdomen gibson incision along transplant wound used initially le right radical nephrectomy lymphadenectomy wound used nonischemic open partial nephrectomy transplant kidney result le right radical nephrectomy took hour estimated blood loss ebl ml partial nephrectomy transplant kidney took hour ebl ml transfusion required pathologic examination revealed tumor rcc clear cell type cm right native kidney cm transplant kidney final wound measured cm postoperative recovery uneventful inpatient narcotic requirement mg morphine sulfate equivalent oral intake food resumed day allograft function well preserved serum creatinine unchanged mgdl discharge conclusion patient concomitant tumor native kidney transplant kidney unique approach provides exceptional benefit minimally invasive tumor excision tumor good preservation renal function,2012,"Sankari, Bashir R; Chueh, Shih-Chieh Jeff",Urology,,,,,,https://doi.org/10.1016/j.urology.2011.09.015; https://www.ncbi.nlm.nih.gov/pubmed/22055688/,186955.0,12
16846,16846,25318,yflk2mqo,,Medline,Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.,10.1021/nn402507d,,23802554.0,unk,perfluoropentane gas filled ironsilica nanoshells developed stationary ultrasound contrast agent marking tumor guide surgical resection critical establish longterm imaging efficacy well biodistribution work show nm fesio nanoshells imaged color doppler ultrasound course day py tumor bearing mouse nm nonbiodegradable sio biodegradable fesio nanoshells functionalized diethylenetriamine pentaacetic acid dtpa ligand radiolabeled biodistribution study nunu mouse majority radioactivity detected liver kidney following intravenous iv administration nanoshells healthy animal contrast nanoshells injected intratumorally radioactivity remained injection site however nanoshells escaped circulation distributed similarly given intravenously intratumoral delivery nanoshells iv delivery healthy animal little difference seen biodistribution sio biodegradable fesio nanoshells however nanoshells administered iv tumor bearing mouse significant increase observed liver accumulation sio nanoshells relative biodegradable fesio nanoshells sio fesio nanoshells accumulate passively proportion tumor mass intravenous delivery nanoshells first report biodistribution following intratumoral injection biodegradable silica particle well first report demonstrating utility dtpain labeling studying silica nanoparticle biodistributions,2013,"Liberman, Alexander; Wu, Zhe; Barback, Christopher V; Viveros, Robert; Blair, Sarah L; Ellies, Lesley G; Vera, David R; Mattrey, Robert F; Kummel, Andrew C; Trogler, William C",ACS nano,,,,,,https://doi.org/10.1021/nn402507d; https://www.ncbi.nlm.nih.gov/pubmed/23802554/,24900241.0,12
16856,16856,25330,88qlnxtc,,Medline,Complete radiofrequency ablation of hepatolithiasis-associated cholangiocarcinoma and successful management of post-ablation bronchobiliary fistula.,10.1007/s12013-013-9737-y,,23979984.0,unk,report documented use radiofrequency ablation rfa treatment hepatolithiasisassociated cholangiocarcinoma cyanoacrylate glue management postablation bronchobiliary fistula yearold chinese woman year history extrahepatic intrahepatic cholangiolithiasis multiple hepatic segmentectomy developed hepatolithiasisassociated cholangiocarcinoma tumor successfully treated rfa patient developed bronchobiliary fistula cyanoacrylate glue used occluding bronchobiliary fistula ct scan month showed complete restoration physiological separation biliary bronchial system repeat ct scan showed complete tumor ablation sign tumor recurrence month rfa conclusion rfa may safe effective treatment option patient hepatolithiasisassociated cholangiocarcinoma poor candidate surgical resection protection integrity bile duct diaphragm rfa minimize postoperative complication case development postablation bronchobiliary fistula cyanoacrylate glue used occlude fistula surgical resection considered,2014,"Jiang, Kai; Su, Ming; Zhang, Wenzhi; Zhao, Xiangqian; Wang, Jing; Dong, Jiahong; Huang, Zhiqiang",Cell biochemistry and biophysics,,,,,,https://doi.org/10.1007/s12013-013-9737-y; https://www.ncbi.nlm.nih.gov/pubmed/23979984/,6554803.0,12
16940,16940,25426,lp6xeo8u,,Medline,Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer.,10.1073/pnas.1710754114,,28900008.0,unk,antiangiogenic therapy antibody vegf bevacizumab vegfr ramucirumab proven efficacious colorectal cancer crc patient however improvement overall survival modest combination chemotherapy thus urgent need identify potential underlying mechanism resistance specific antiangiogenic therapy develop strategy overcome found antivegfr therapy upregulates cxc chemokine ligand cxcl cxc chemokine receptor cxcr orthotopic murine crc model including sl ct blockade cxcr signaling significantly enhanced treatment efficacy antivegfr treatment crc model cxcr predominantly expressed immunosuppressive innate immune cell recruited crcs upon antivegfr treatment blockade cxcr abrogated recruitment innate immune cell importantly myeloid cell mostly lyclow monocyte lychigh monocyte selectively deplete individual innate immune cell population targeted key pathway lyclow monocyte cxcr mouse lychigh monocyte ccr mouse neutrophil antilyg antibody combination cxcr blockade sl crcs depletion lyclow monocyte neutrophil improved antivegfrinduced sl tumor growth delay similar cxcr blockade ct crcs highly resistant antivegfr therapy cxcr blockade enhanced antivegfrinduced tumor growth delay specific depletion lyg neutrophil discovery cxcrdependent recruitment lyclow monocyte tumor unveiled heretofore unknown mechanism resistance antivegf therapy finding also provide rapidly translatable strategy enhance outcome antivegf cancer therapy,2017,"Jung, Keehoon; Heishi, Takahiro; Incio, Joao; Huang, Yuhui; Beech, Elizabeth Y; Pinter, Matthias; Ho, William W; Kawaguchi, Kosuke; Rahbari, Nuh N; Chung, Euiheon; Kim, Jun Ki; Clark, Jeffrey W; Willett, Christopher G; Yun, Seok Hyun; Luster, Andrew D; Padera, Timothy P; Jain, Rakesh K; Fukumura, Dai",Proceedings of the National Academy of Sciences of the United States of America,,,,,,https://doi.org/10.1073/pnas.1710754114; https://www.ncbi.nlm.nih.gov/pubmed/28900008/,4868306.0,12
16970,16970,25463,j19qpsvj,,Medline,Diagnosis and Management of Infantile Hemangioma.,10.1542/peds.2015-2485,,26416931.0,unk,infantile hemangioma ihs common tumor childhood unlike tumor unique ability involute proliferation often leading primary care provider assume resolve without intervention consequence unfortunately subset ihs rapidly develop complication resulting pain functional impairment permanent disfigurement result primary clinician task determining lesion require early consultation specialist although several recent review published clinical report first based input individual representing many specialty involved treatment ih purpose update pediatric community regarding recent discovery ih pathogenesis treatment clinical association provide basis clinical decisionmaking management ih,2015,"Darrow, David H; Greene, Arin K; Mancini, Anthony J; Nopper, Amy J",Pediatrics,,,,,,https://doi.org/10.1542/peds.2015-2485; https://www.ncbi.nlm.nih.gov/pubmed/26416931/,207167165.0,12
16989,16989,25484,uldy8hpn,,Medline,Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.,10.1186/s13058-017-0899-1,,28893303.0,unk,background neoadjuvantchemotherapy nac considered standard treatment locally advanced breast carcinoma accurate assessment disease response fundamental increase chance successful breastconserving surgery avoid local recurrence purpose study compare contrastenhanced spectral mammography cesm contrastenhancedmri mri evaluation tumor response nac method prospective study approved institutional review board written informed consent obtained fiftyfour consenting woman breast cancer indication nac consecutively enrolled october december patient underwent cesm mri nac mri performed first followed cesm within day response therapy evaluated patient comparing size residual lesion measured cesm mri performed nac pathological response surgical specimen gold standard independently blinded result test agreement measurement evaluated using lin coefficient agreement measurement using cesm mri tested step study nac last variation largest dimension tumor cesm mri assessed according parameter set recist criterion focusing pathological complete response pcr result total patient completed study cesm predicted pcr better mri lin coefficient respectively method tend underestimate real extent residual tumor mean mm cesm mm mri agreement measurement using cesm mri nac respectively distinction responder nonresponders cesm mri identical patient assessment cr sensitivity specificity respectively cesm mri conclusion cesm mri lesion size measurement highly correlated cesm seems least reliable mri assessing response nac may alternative mri contraindicated availability limited,2017,"Iotti, Valentina; Ravaioli, Sara; Vacondio, Rita; Coriani, Chiara; Caffarri, Sabrina; Sghedoni, Roberto; Nitrosi, Andrea; Ragazzi, Moira; Gasparini, Elisa; Masini, Cristina; Bisagni, Giancarlo; Falco, Giuseppe; Ferrari, Guglielmo; Braglia, Luca; Del Prato, Alberto; Malavolti, Ivana; Ginocchi, Vladimiro; Pattacini, Pierpaolo",Breast cancer research : BCR,,,,,,https://doi.org/10.1186/s13058-017-0899-1; https://www.ncbi.nlm.nih.gov/pubmed/28893303/,13428662.0,12
16995,16995,25491,sucpfan1,,Medline,Endoscopic skull base techniques for juvenile nasopharyngeal angiofibroma.,10.1016/j.otc.2012.03.008,,22588045.0,unk,review focus anatomy technique endoscopic resection juvenile nasopharyngeal angiofibroma jna well adjunctive potential alternative treatment jna benign locally aggressive vascular tumor primarily affect adolescent boy traditionally tumor removed via open surgical approach recent advance endoscopic equipment technique enabled endoscopic surgical excision tumor favorable outcome decreased morbidity institution others achieved successful outcome transnasal endoscopic resection jna including tumor significant extension adjacent compartment,2012,"Zanation, Adam M; Mitchell, Candace A; Rose, Austin S",Otolaryngologic clinics of North America,,,,,,https://doi.org/10.1016/j.otc.2012.03.008; https://www.ncbi.nlm.nih.gov/pubmed/22588045/,22609259.0,12
17002,17002,25498,bhpqoq6k,,Medline,Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy.,10.5468/ogs.2017.60.2.178,,28344959.0,unk,objective study aimed introduce method remove huge ovarian tumor ≥ cm intact singleport laparoscopic surgery spls using sw kims technique compare surgical outcome laparotomy method medical record retrospectively reviewed patient underwent either spls n sw kims technique using specially designed ×cmsized xl lapbag laparotomy n huge ovarian tumor december may perioperative surgical outcome compared result patient spls successfully performed without tumor spillage conversion multiport laparoscopy laparotomy significant difference patient characteristic including tumor diameter total operation time group postoperative hospital stay significantly shorter spls group laparotomy group median v day p number postoperative general diet buildup day also significantly shorter spls group median v day p immediate postoperative pain score lower spls group median v p patientcontrolled anesthesia used le spls group v conclusion spls successful removing large ovarian tumor without rupture showed quicker recovery le immediate postoperative pain comparison laparotomy spls using sw kims technique could feasible solution removing huge ovarian tumor,2017,"Kim, Jeong Sook; Lee, In Ok; Eoh, Kyung Jin; Chung, Young Shin; Lee, Inha; Lee, Jung-Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Young Tae; Kim, Sang Wun",Obstetrics & gynecology science,,,,,,https://doi.org/10.5468/ogs.2017.60.2.178; https://www.ncbi.nlm.nih.gov/pubmed/28344959/,15925988.0,12
17026,17026,25524,3qlg8uhb,,Medline,Safe endobag morcellation in a single-port laparoscopy subtotal hysterectomy.,10.3109/13645706.2015.1109521,,26902985.0,unk,recently american food drug administration fda published alert risk uterine tissue morcellation laparoscopic procedure particular possible risk spreading undiagnosed malignant tumor emphasized fervent debate medium led major scientific society express position matter present safe endobag abdominal morcellation single portaccess laparoscopy subtotal hysterectomy endobag abdominal morcellation feasible safe consequently development device dedicated intracavitary morcellation closed system encouraged,2016,"Angioni, Stefano; Pontis, Alessandro; Multinu, Angelo; Melis, Gianbenedetto",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.3109/13645706.2015.1109521; https://www.ncbi.nlm.nih.gov/pubmed/26902985/,207523797.0,12
17129,17129,25654,n4xr1dm1,,Medline,Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis.,10.1007/s11060-017-2697-0,,29204841.0,unk,hemangioblastomas rare benign vascular tumor central nervous system cns often associated vonhippel lindau vhl disease current therapeutic option include microsurgical resection stereotactic radiosurgery sr randomized controlled study minimal data beyond singleinstitution review optimal management approach patient cns hemangioblastomas unclear completed pubmedscopus literature search january january eligible study sr cns hemangioblastomas relevant article identified reviewed accordance preferred reporting item systematic review metaanalysis prisma guideline study met eligibility criterion qualitative synthesis representing subject tumor gamma knife published sr method cns hemangioblastomas critical study appraisal intrastudy bias study used quantitative metaanalysis year progression free survival pfs pooled year pfs across eligible study difference observed spine versus intracranial study individual patient data ipd extracted study representing tumor univariate analysis ipd revealed vhl patient younger smaller tumor compared sporadic disease adverse event associated increasing marginal dose independent tumor volume vhl status sex radiosurgical method tumor location tumor volume found significantly associated tumor progression multiple study show excellent tumor control year follow however longterm efficacy sr cns hemangioblastomas still need investigated study exploring role sr early treatment asymptomatic lesion wanting,2018,"Pan, James; Jabarkheel, Rashad; Huang, Yuhao; Ho, Allen; Chang, Steven D",Journal of neuro-oncology,,,,,,https://doi.org/10.1007/s11060-017-2697-0; https://www.ncbi.nlm.nih.gov/pubmed/29204841/,3431179.0,12
17142,17142,25670,s7lwl6xr,,Medline,Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes.,10.1016/j.bmcl.2013.08.050,,23999043.0,unk,describe synthesis mmp potency vitro evaluation series αsulfone hydroxmate mmp inhibitor conjugated series dye different absorptionemission lamina maximas used visualize tumor,2013,"Freskos, John N; Asmelash, Bethel; Gaston, Kimberly R; Karwa, Amol; Marzan, Tim A; Nickols, Maureen A; Rogers, Thomas E; Schoenstein, Tasha; Sympson, Carolyn J; Vu, Bich",Bioorganic & medicinal chemistry letters,,,,,,https://doi.org/10.1016/j.bmcl.2013.08.050; https://www.ncbi.nlm.nih.gov/pubmed/23999043/,32123461.0,12
17220,17220,25755,yqshhsl0,,Medline,Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties.,10.2967/jnumed.110.083592,,21321280.0,unk,unlabelled affibody molecule recently developed class targeting protein based nonimmunoglobulin scaffold small size kda subnanomolar affinity affibody molecule enables highcontrast imaging tumorassociated molecular target particularly human epidermal growth factor receptor type mtc label offer advantage clinical practice earlier study demonstrated mtclabeled recombinant affibody molecule cterminal cysteine could used imaging however renal retention radioactivity exceeded tumor uptake might complicate imaging metastasis lumbar region aim study develop agent low renal uptake preserved tumor targeting method series recombinant derivative herbinding zher affibody molecule cterminal chelating sequence gxxc x denoting glycine serine lysine glutamate designed construct labeled mtc evaluated vitro vivo result variant stably labeled mtc preserved capacity bind specifically herexpressing cell vitro vivo composition chelating sequence clear influence cellular processing biodistribution property affibody molecule best variant mtczherv cterminal chelating sequence gggc provided lowest radioactivity retention normal organ tissue including kidney mtczherv displayed high uptake radioactivity herexpressing xenograft ± ± percentage injected activity per gram tissue h injection skov high expression du low expression tumor respectively model tumor uptake exceeded renal uptake conclusion result demonstrate biodistribution property recombinant mtclabeled affibody molecule optimized modification cterminal cysteinecontaining chelating sequence mtczherv promising candidate development diagnostic radiopharmaceutical imaging herexpressing tumor result may useful development imaging agent based affibody molecule hopefully scaffold,2011,"Wållberg, Helena; Orlova, Anna; Altai, Mohammed; Hosseinimehr, Seyed Jalal; Widström, Charles; Malmberg, Jennie; Ståhl, Stefan; Tolmachev, Vladimir","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.110.083592; https://www.ncbi.nlm.nih.gov/pubmed/21321280/,20619764.0,12
17255,17255,25792,c3oc2bz8,,Medline,Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression.,10.1111/hepr.12049,,23356912.0,unk,aim demonstrate usefulness computed tomography ct fusion imaging evaluation treatment effect radiofrequency ablation rfa hepatocellular carcinoma hcc method eightyfive patient hcc complete ablation judged conventional sidebyside interpretation prerfa postrfa ct time rfa included retrospective study ct data retrospectively used create fusion image prerfa postrfa ct using automatic rigid registration manual correction referring intrahepatic structure hepatic contour around tumor clinical factor including minimal ablative margin mam measured fusion image examined prove risk factor local tumor progression ltp result ltp observed tumor median follow month range mean mam fusion image ± mm tumor judged protruding ablation zone multivariate analysis revealed protruding ablation zone significant factor ltp hazard ratio confidential interval p conclusion hcc assessed incomplete ablation ct fusion image although considered completely ablated sidebyside image time treatment incomplete ablation revealed independent risk factor ltp ct fusion imaging enables quantitative accurate evaluation treatment effect rfa,2013,"Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Hori, Masatoshi; Fukuda, Kazuto; Sawai, Yoshiyuki; Kogita, Sachiyo; Ohama, Hideko; Matsumoto, Yasushi; Nakahara, Masanori; Zushi, Shinichiro; Kurokawa, Masanori; Isotani, Keisuke; Takamura, Manabu; Fujita, Norihiko; Murakami, Takamichi",Hepatology research : the official journal of the Japan Society of Hepatology,,,,,,https://doi.org/10.1111/hepr.12049; https://www.ncbi.nlm.nih.gov/pubmed/23356912/,205163126.0,12
17381,17381,25945,a3zhds1u,,Medline,Long-term outcomes of percutaneous endoscopic intragastric surgery in the treatment of gastrointestinal stromal tumors at the esophagogastric junction.,10.1007/s00464-015-4439-8,,26201418.0,unk,background treatment option gastrointestinal stromal tumor git esophagogastric junction egj controversial report enucleation egj gist order avoid gastrectomy number patient small followup period short evaluate purpose study review experience patient egj gist treated enucleation percutaneous endoscopic intragastric surgery peigs ass clinical outcome method peigs performed described access port placed abdominal wall anterior wall stomach access port endoscope surgical instrument inserted gastric lumen tumor enucleation closure defect carried study patient egj gist treated peigs enrolled hospital record reviewed followup data year collected analyze outcome result enbloc enucleation achieved without tumor rupture average operation time min postoperative complication occurred one localized peritonitis one bleeding one surgical site infection average tumor size mm pathological finding confirmed negative margin specimen maximum followup period month multiple liver metastasis detected two patient month survival rate diseasefree rate month month respectively conclusion far short longterm outcome experience reviewed peigs seems curative aggressive resection method proximal gastrectomy tumor enucleation peigs offering chance preserve stomach preferable option carefully selected patient egj gist performed skilled surgeon,2016,"Kanehira, Eiji; Kamei, Aya; Umezawa, Akiko; Kurita, Atsushi; Tanida, Takashi; Nakagi, Masafumi",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-015-4439-8; https://www.ncbi.nlm.nih.gov/pubmed/26201418/,24033060.0,12
17417,17417,25985,hxi3vh1r,,Medline,Preliminary experience with the percutaneous embolization of juvenile angiofibromas using only ethylene-vinyl alcohol copolymer (Onyx) for preoperative devascularization prior to surgical resection.,10.3174/ajnr.a3043,,22499846.0,unk,background purpose juvenile angiofibromas hypervascular tumor may benefit preoperative devascularization reduce intraoperative blood loss purpose evaluate extent angiographic devascularization intraoperative blood loss using onyx percutaneous juvenile angiofibroma tumor embolization material method reviewed clinical record preoperative postoperative imaging study consecutive series patient juvenile angiofibromas treated preoperative embolization direct percutaneous injection onyx followed resection standard open surgical endoscopic approach result two fisch type fisch type ii fisch type iiia fisch type iva tumor treated complete devascularization achieved case percutaneously onyx complication average intraoperative blood loss ml range ml average needle range needle placed tumor average ml onyx range ml injected tumor four fisch type iiia tumor removed completely ene approach conclusion presurgical direct percutaneous embolization juvenile angiofibroma evoh surgical resection safe feasible preliminary experience suggests onyx may offer higher degree devascularization compared embolic agent may facilitate easier surgical resection lower blood loss,2012,"Gemmete, J J; Patel, S; Pandey, A S; Sullivan, S E; McKean, E L; Marentette, L J; Chaudhary, N",AJNR. American journal of neuroradiology,,,,,,https://doi.org/10.3174/ajnr.a3043; https://www.ncbi.nlm.nih.gov/pubmed/22499846/,22742281.0,12
17456,17456,26030,ubhza854,,Medline,Staple-line recurrence arising 10 years after functional end-to-end anastomosis for colon cancer: a case report.,10.1186/s40792-014-0011-3,,26943375.0,unk,report rare case late stapleline recurrence arising year functional endtoend anastomosis splenic flexure colon cancer yearold man underwent partial colectomy functional endtoend anastomosis splenic flexure colon cancer year earlier presented chief complaint anorexia complete blood count showed anemia fecal occult blood test positive lower gastrointestinal series showed irregular defect splenic flexure colonoscopy showed ulcerated tumor staple line primary surgery partial colectomy performed tumor pathologically diagnosed moderately differentiated tubular adenocarcinoma resembling pathology primary colon cancer case suggests importance considering stapleline recurrence functional endtoend anastomosis colon cancer even year primary surgery,2015,"Ouchi, Akira; Asano, Masahiko; Aono, Keiya; Watanabe, Tetsuya; Oya, Shingo",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-014-0011-3; https://www.ncbi.nlm.nih.gov/pubmed/26943375/,2164339.0,12
17551,17551,26139,8vacsoex,,Medline,"Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.",10.1097/mop.0000000000000042,,24362406.0,unk,purpose review part two twopart state arthepatoblastoma international hepatoblastoma specialist brought together highlight advance controversy future challenge treatment rare pediatric tumor recent finding pretreatment extent disease pretext grouping system introduced part multicenter international childhood liver tumor strategy group siopel study system refined ensuing year come adopted risk stratification major pediatric liver tumor multicenter trial group pretext intensively studied current childrens oncology group cog ahep trial attempt validate interobserver reproducibility ability monitor response neoadjuvant chemotherapy determine surgical resectability pretext used identify patient risk unresectable tumor referred liver specialty center transplant capability early treatment schema summary international collaborative effort hepatoblastoma led increased refinement use pretext posttreatment extent define prognosis surgical resectability pretext criterion suggest possible need liver transplantation discussed detail,2014,"Meyers, Rebecka L; Tiao, Greg; de Ville de Goyet, Jean; Superina, Riccardo; Aronson, Daniel C",Current opinion in pediatrics,,,,,,https://doi.org/10.1097/mop.0000000000000042; https://www.ncbi.nlm.nih.gov/pubmed/24362406/,19781366.0,12
17563,17563,26153,t888jz0e,,Medline,Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence.,10.1016/j.athoracsur.2011.11.043,,22296982.0,unk,background study characterizes management locoregional recurrence lrr patient highrisk stage nonsmall cell lung cancer nsclc treated lung radiofrequency ablation rfa method consecutive patient biopsyproven stage nsclc underwent computed tomographyguided lung rfa december patient deemed medically inoperable refused operation rfa performed curative intent result fiftyfive ablation performed patient age year stage nsclc median followup month lrr occurred within mean ± range month rfa recurrence observed locally tumor bed regional node distant mean maximal tumor diameter ± range cm tumor exceeding cm associated lrr recurrent lesion treated repeat rfa radiotherapy chemoradiotherapy chemotherapy local control achieved repeat rfa radiotherapy lesion regional nodal failure median followup ± month overall survival among patient experience lrr similar repeat rfa associated significant complication procedurerelated day mortality conclusion lung rfa associated increased rate local failure tumor exceeding cm contact larger segmental vessel patient local failure promptly salvaged sbrt repeat rfa without detriment overall survival,2012,"Lanuti, Michael; Sharma, Amita; Willers, Henning; Digumarthy, Subba R; Mathisen, Douglas J; Shepard, Jo-Anne O",The Annals of thoracic surgery,,,,,,https://doi.org/10.1016/j.athoracsur.2011.11.043; https://www.ncbi.nlm.nih.gov/pubmed/22296982/,25015085.0,12
17567,17567,26158,j7tr72b0,,Medline,Surgical resection of ruptured fibrolamellar hepatocellular carcinoma.,10.1155/2013/679565,,23956918.0,unk,fibrolamellar hepatocellular carcinoma flh rare primary tumor liver typically arises noncirrhotic liver affect patient age report yearold male patient presented ruptured flh treated surgical resection option treatment review management described,2013,"Minutolo, Vincenzo; Licciardello, Alessio; Arena, Manuel; Minutolo, Orazio; Lanteri, Raffaele; Arena, Goffredo",Case reports in surgery,,,,,,https://doi.org/10.1155/2013/679565; https://www.ncbi.nlm.nih.gov/pubmed/23956918/,16133246.0,12
17597,17597,26194,3nl3n4wj,,Medline,Endoscopic ultrasound-guided inoculation of transmissible venereal tumor in the colon: A large animal model for colon neoplasia.,10.4103/2303-9027.180471,,27080606.0,unk,background develop evaluate feasibility emerging intervention animal model accurate anatomical environment required objective aimed establish clinically relevant colorectal tumor model canine transmissible venereal tumor ctvt utilizing endoscopic ultrasound eu imaging guidance design survival study using canine model setting endoscopic animal research laboratory tertiary cancer center material method study involved five canine intervention colorectal tumor model established evaluated five canine cyclosporine immune suppression endoscopic imaging guidance saline injected submucosal layer forming bleb subsequently ctvt inoculated bleb eu guidance endoscopy primary method assessing tumor growth tumor developed day upon detection lesion cm animal euthanized tumor harvested histopathological characterization main outcome measurement success rate tumor growth presence absence vasculature inside tumor result colorectal tumor successfully developed three five animal among one tumor growth average inoculated ctvt volume incubation time tumor size cc day cm respectively two animal without tumor growth observed day tumor vascular structure characterized cd imunohistochemical stain limitation small number animal conclusion succeeded creating new colorectal tumor canine model ctvt utilizing eu,2016,"Bhutani, Manoop S; Uthamanthil, Rajesh; Suzuki, Rei; Shetty, Anil; Klumpp, Sherry A; Nau, William; Stafford, Roger Jason",Endoscopic ultrasound,,,,,,https://doi.org/10.4103/2303-9027.180471; https://www.ncbi.nlm.nih.gov/pubmed/27080606/,7881042.0,12
17657,17657,26266,hpumm35w,,Medline,18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.,10.1371/journal.pone.0192859,,29494598.0,unk,background lymph node stage prior treatment strongly related disease progression poor prognosis nonsmall cell lung cancer nsclc however study investigated metabolic imaging feature derived preradiotherapy ffluorodeoxyglucose fdg positronemission tomography pet metastatic hilarmediastinal lymph node lns hypothesized would provide complementary prognostic information fdgpet descriptor primary tumor tumor method two independent cohort nodepositive nsclc patient used model development validation image feature ie radiomics including shape size first order statistic texture intensityvolume histogram ivh httpwwwradiomicsio evaluated univariable cox regression development cohort prognostic modeling conducted fold crossvalidated least absolute shrinkage selection operator lasso automatically selecting amongst fdgpetradiomics descriptor tumor lns structure performance assessed concordanceindex development data publicly available wwwcancerdataorg dryad doidryadb result common suv descriptor maximum peak mean significantly related overall survival extracted lns ln volume tumor load summed tumor lns volume though true either suv metric tumor volume feature selection exclusively imaging information based fdgpetradiomics exhibited performance external derived tumor external lns external structure including least one feature subcategory except ivh conclusion combining imaging information based fdgpetradiomics feature tumor lns desirable achieve higher prognostic discriminative power nsclc,2018,"Carvalho, Sara; Leijenaar, Ralph T H; Troost, Esther G C; van Timmeren, Janna E; Oberije, Cary; van Elmpt, Wouter; de Geus-Oei, Lioe-Fee; Bussink, Johan; Lambin, Philippe",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0192859; https://www.ncbi.nlm.nih.gov/pubmed/29494598/,3635406.0,12
17691,17691,26303,e79vuxic,,Medline,γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.,10.1245/s10434-014-3724-4,,24748164.0,unk,purpose serum γglutamyltranspeptidase ggt level often elevated hepatocellular carcinoma hcc found oxidative stress marker correlate inflammation extracellular hepatic microenvironment aim study investigate prognostic significance ggt serum level patient undergoing radiofrequency ablation rfa therapy treatment hcc method retrospective study included patient small liver cancer tumor ≤ cm diameter nodule ≤ cm treated rfa baseline serum ggt examined therapy overall survival o recurrencefree survival evaluated kaplanmeier method univariate multivariate analysis used analyze significance ggt serum marker prognostic factor result median followup month patient died hepatic recurrence treatment rfa hcc patient elevated ggt shorter o versus normal ggt level p also higher recurrence p multivariate analysis albumin p ggt p tumor size p independent risk factor survival ggt p tumor size p significant risk factor recurrence conclusion serum ggt convenient prognostic biomarker related o recurrence hcc patient undergoing rfa treatment,2014,"Ma, Hui; Zhang, Lan; Tang, Bei; Wang, Yan; Chen, Rongxin; Zhang, Boheng; Chen, Yi; Ge, Ningling; Wang, Yanhong; Gan, Yuhong; Ye, Shenglong; Ren, Zhenggang",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-014-3724-4; https://www.ncbi.nlm.nih.gov/pubmed/24748164/,22204762.0,12
17743,17743,26362,m8pmq6xo,,Medline,Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.,10.1001/jama.2014.3741,,24846037.0,unk,importance targeting oncogenic driver genomic alteration critical cancer development maintenance transformed care patient lung adenocarcinoma lung cancer mutation consortium formed perform multiplexed assay testing adenocarcinoma lung driver gene enable clinician select targeted treatment enroll patient clinical trial objective determine frequency oncogenic driver patient lung adenocarcinoma use data select treatment targeting identified driver measure survival design setting participant site united state enrolled patient metastatic lung adenocarcinoma performance status tested tumor driver information collected patient therapy survival intervention tumor tested oncogenic driver result used select matched targeted therapy main outcome measure determination frequency oncogenic driver proportion patient treated genotypedirected therapy survival result tumor patient tested least gene gene patient full genotyping oncogenic driver found patient among tumor tumor kras driver sensitizing egfr alk rearrangement egfr gene erbb formerly braf pikca met amplification nra mek akt result used select targeted therapy trial patient median survival year interquartile range iqr patient oncogenic driver genotypedirected therapy compared year iqr patient oncogenic driver receive genotypedirected therapy propensity scoreadjusted hazard ratio ci p conclusion relevance actionable driver detected lung adenocarcinoma multiplexed testing aided physician selecting therapy although individual driver receiving matched targeted agent lived longer randomized trial required determine targeting therapy based oncogenic driver improves survival trial registration clinicaltrialsgov identifier nct,2014,"Kris, Mark G; Johnson, Bruce E; Berry, Lynne D; Kwiatkowski, David J; Iafrate, A John; Wistuba, Ignacio I; Varella-Garcia, Marileila; Franklin, Wilbur A; Aronson, Samuel L; Su, Pei-Fang; Shyr, Yu; Camidge, D Ross; Sequist, Lecia V; Glisson, Bonnie S; Khuri, Fadlo R; Garon, Edward B; Pao, William; Rudin, Charles; Schiller, Joan; Haura, Eric B; Socinski, Mark; Shirai, Keisuke; Chen, Heidi; Giaccone, Giuseppe; Ladanyi, Marc; Kugler, Kelly; Minna, John D; Bunn, Paul A",JAMA,,,,,,https://doi.org/10.1001/jama.2014.3741; https://www.ncbi.nlm.nih.gov/pubmed/24846037/,205058899.0,12
17855,17855,26496,3xrvg94g,,Medline,Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases.,10.1007/s00270-012-0500-3,,23070108.0,unk,purpose analyze factor associated favorable survival patient inoperable colorectal lung metastasis treated percutaneous imageguided radiofrequency ablation method total metastasis ablated patient male median age year range year procedure percutaneous ctguided cooltip radiofrequency ablation performed sedationgeneral anesthesia maximum tumor size number tumor ablated number procedure concurrentprior liver ablation previous liver lung resection systemic chemotherapy diseasefree interval primary resection lung metastasis survival first ablation recorded prospectively kaplanmeier analysis performed factor compared log rank test result initial number metastasis ablated range total number range maximum tumor diameter range cm number procedure range major complication rate overall median year survival rate month survival better patient smaller tumorsa median month year survival tumor cm smaller versus month tumor cm p number metastasis ablated whether tumor unilateral bilateral affect survival presence treated liver metastasis systemic chemotherapy prior lung resection affect survival conclusion threeyear survival patient inoperable colorectal lung metastasis better would expected chemotherapy alone patient inoperable smallvolume colorectal lung metastasis referred ablation,2013,"Gillams, Alice; Khan, Zahid; Osborn, Peter; Lees, William",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-012-0500-3; https://www.ncbi.nlm.nih.gov/pubmed/23070108/,32226185.0,12
17881,17881,26525,5eb3pbrs,,Medline,Predictive factors for complete renal tumor ablation using RFA.,10.1177/0284185115605681,,26452975.0,unk,background radiofrequency ablation rfa used treat renal mass patient surgery preferably avoided tumor size location affect ablation result procedural planning need identify factor limit treatment single session increase ablation success purpose identify factor may affect primary efficacy complete renal tumor ablation radiofrequency single session material method percutaneous rfa using impedance based system performed using computed tomography ct guidance fiftytwo renal tumor patient retrospectively studied median followup month data collection included patient demographic tumor data modified renal nephrometry score histopathological diagnosis rfa treatment data electrode placement followup result tumor relapse data analyzed generalized estimating equation result primary efficacy rate predictor complete ablation optimal electrode placement p increasing distance collecting system p tumor size predictor complete ablation median size mm p tumor ≤ cm completely ablated papillary tumor oncocytomas completely ablated single session common incompletely ablated tumor type clear cell carcinoma conclusion optimal electrode placement long distance collecting system associated increased primary efficacy renal tumor rfa variable need considered increase primary ablation success study needed evaluate effect rfa histopathologically different renal tumor,2016,"Acosta Ruiz, Vanessa; Lönnemark, Maria; Brekkan, Einar; Dahlman, Pär; Wernroth, Lisa; Magnusson, Anders",Acta radiologica,,,,,,https://doi.org/10.1177/0284185115605681; https://www.ncbi.nlm.nih.gov/pubmed/26452975/,45484860.0,12
17923,17923,26573,pya0ft5f,,Medline,Transanal Endoscopic Operation Versus Conventional Transanal Excision for Rectal Tumors: Case-Matched Study with Propensity Score Matching.,10.1007/s00268-017-4017-4,,28421262.0,unk,background although transanal endoscopic surgery practiced worldwide consensus comparative outcome transanal endoscopic operation teo transanal excision tae study reviewed experience technique compared patient underwent teo tae using propensity score matching psm method total patient underwent local rectal tumor excision january november overcome selection bias used psm achieve onetoone teo tae ratio included baseline characteristic age sex surgeon american society anesthesiologist score tumor location clockwise direction involved circumference quadrant tumor size pathology result psm patient included group tumor distance anal verge higher teo group v tae p complication rate differ group teo v tae p teo associated shorter hospital stay v day p higher negative margin rate v p nonfragmented specimen rate v tae v p conclusion teo beneficial patient higher rectal tumor regardless tumor location involved circumference quadrant tumor size teo may effectively achieve negative resection margin nonfragmented specimen consequently although local excision method according tumor distance may important teo become standard rectal tumor,2017,"Han, Jeonghee; Noh, Gyoung Tae; Cheong, Chinock; Cho, Min Soo; Hur, Hyuk; Min, Byung Soh; Lee, Kang Young; Kim, Nam Kyu",World journal of surgery,,,,,,https://doi.org/10.1007/s00268-017-4017-4; https://www.ncbi.nlm.nih.gov/pubmed/28421262/,4727118.0,12
17949,17949,26607,u8bml1vf,,Medline,Trans-arterial Onyx Embolization of a Functional Thoracic Paraganglioma.,10.5469/neuroint.2015.10.1.34,,25763296.0,unk,paragangliomas rare tumor endocrine system highly vascular case hormonally active making management challenging although strong evidence safety effectiveness preoperative embolization management spinal tumor five case reported setting thoracic paragangliomas present case yearold man large primary functional malignant paraganglioma thoracic spine causing vertebral fracture spinal cord compression knowledge first report preoperative transarterial balloon augmented onyx embolization thoracic paraganglioma,2015,"Chacón-Quesada, Tatiana; Rodriguez, Gustavo J; Maud, Alberto; Ramos-Duran, Luis; Torabi, Alireza; Fitzgerald, Tamara; Akle, Nassim; Cruz Flores, Salvador; Trier, Todd",Neurointervention,,,,,,https://doi.org/10.5469/neuroint.2015.10.1.34; https://www.ncbi.nlm.nih.gov/pubmed/25763296/,1333821.0,12
17955,17955,26616,zm1y42ds,,Medline,Image Analysis Reveals Microstructural and Volumetric Differences in Glioblastoma Patients with and without Preoperative Seizures.,10.3390/cancers12040994,,32316566.0,unk,purpose seizure related tumor growth common glioma patient especially lowgrade glioma patient often first tumor manifestation hypothesize association preoperative seizure morphologic feature eg tumor size location histogram feature patient glioblastoma gb method retrospectively consecutive patient initial diagnosis surgery gb iv preoperative mri analyzed preoperative mri sequence coregistered tflair tcontrast dti tumor segmented neuroradiologist using software itksnap blinded clinical data tumor volume flair tcontrast histogram analysis adc famaps recorded contrast enhancing tumor part cet nonenhancing peritumoral edema flair location determined coregistration data atlas permutationbased multipletesting adjusted statistic calculated compare imaging variable patient without seizure result patient seizure showed significantly smaller tumor cet adj p patient without preoperative seizure le seizure observed patient tumor location right cingulate gyrus adj p right caudate nucleus adj p significant difference histogram analysis fa contrast enhancing tumor part observed patient without seizure considering also tumor location size conclusion preoperative seizure gb patient associated lower preoperative tumor volume different histogram analysis suggest might microstructural difference contrast enhancing tumor part patient seizure measured fractional anisotropy higher variance gb presenting without seizure might indicate aggressive growth tumor,2020-04-17,"Bette, Stefanie; Barz, Melanie; Ly Nham, Huong; Huber, Thomas; Berndt, Maria; Sales, Arthur; Schmidt-Graf, Friederike; Meyer, Hanno S; Ryang, Yu-Mi; Meyer, Bernhard; Zimmer, Claus; Kirschke, Jan S; Wiestler, Benedikt; Gempt, Jens",Cancers,,,,,,https://doi.org/10.3390/cancers12040994; https://www.ncbi.nlm.nih.gov/pubmed/32316566/,216074163.0,12
17971,17971,26633,8bhvtrxr,,Medline,Transosseous Route for CT Fluoroscopy-Guided Radiofrequency Ablation of Lung Tumors.,10.1016/j.jvir.2015.08.012,,26432461.0,unk,purpose retrospectively evaluate radiofrequency rf ablation lung tumor performed via transosseous approach material method twelve lung tumor mean diameter cm range cm patient treated rf ablation via transscapular andor transrib route use bone biopsy needle computed tomographic fluoroscopy guidance therapeutic outcome evaluated included feasibility safety local efficacy complication assessed based national cancer institute common terminology criterion adverse event version result transosseous route successfully employed patient electrode successfully advanced tumor approach mean distance penetrated bone cm range cm complication occurred eight rf ablation session including six grade event two case pneumothorax one case asymptomatic rib fracture mo treatment neuralgia pulmonary hemorrhage hemothorax two grade event pneumonia high fever one grade event pneumothorax requiring pleurodesis adverse event grade ≥ occurred mean median tumor followup period mo range mo local progression occurred two case mo treatment successfully treated second rf ablation procedure technique efficacy rate mo conclusion transosseous approach feasible computed tomographic fluoroscopyguided rf ablation select lung tumor option available,2015,"Iguchi, Toshihiro; Hiraki, Takao; Ishii, Hiroaki; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2015.08.012; https://www.ncbi.nlm.nih.gov/pubmed/26432461/,23980648.0,12
18021,18021,26694,gbh49s1t,,Medline,Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells.,10.1089/scd.2019.0197,,31856674.0,unk,head neck squamous cell carcinoma hnsccs malignancy originate mucosal lining upper aerodigestive tract despite advance therapeutic intervention survival rate amongst hnscc patient remained static year cancer stem cell cscs tumor initiating cell highly resistant treatment hypothesized contribute significant fraction tumor recurrence consequently investigation cscs mediate recurrence may provide insight novel druggable target key element recurrence involves tumor ability evade immunosurveillance recent published report suggest cscs posse immunosuppressive property however underlying mechanism yet fully elucidated date group focused role cscderived secretory protein cytokine growth factor review established immunoregulatory role exosomes derived mixed tumor cell population propose study cscderived exosomes may warranted study may yield novel insight new druggable target lay foundation future exosomebased diagnostics,2019-12-20,"Clayton, Shannon M; Archard, Joehleen; Wagner, Joseph; Farwell, D Gregory; Bewley, Arnaud F; Beliveau, Angela; Birkeland, Andrew C; Rao, Shyam; Abouyared, Marianne; Belafsky, Peter; Anderson, Johnathon D",Stem cells and development,,,,,,https://doi.org/10.1089/scd.2019.0197; https://www.ncbi.nlm.nih.gov/pubmed/31856674/,209427859.0,12
18033,18033,26707,h1yk46e0,,Medline,Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment.,10.1016/j.cmpb.2020.105493,,32408237.0,unk,background objective although nanoparticle preparation great potential treatment tumor nanoparticle preparation achieved desired therapeutic effect reason abnormal tumor microenvironment prevents nanoparticles effective concentrating reaching tumor area therefore necessary better understand effect abnormal tumor microenvironment transvascular transport nanoparticles overcome critical problem method paper tumor abnormal vascularinterstitial model established transvascular transport process nanoparticles simulated model computational fluid dynamic cfd modeling result simulation result showed transport efficiency nanoparticles decreased increasing interstitial fluid pressure ifp nanoparticles could cross blood vessel wall ifp approached blood vessel wall pressure interestingly transport efficiency nanoparticles first increased blood flow velocity decreased blood flow velocity conclusion result showed continuous malignant development tumor ability nanoparticles passively diffuse almost disappeared enhanced permeability retention epr effect nanoparticles disappeared disappearance pressure gradient inside tumor result provided guidance future research vascular transport pathway mechanism nanoparticles,2020-05-05,"Gao, Yan; Shi, Yanbin; Fu, Mengguang; Feng, Yihua; Lin, Guimei; Kong, Deyin; Jiang, Bo",Computer methods and programs in biomedicine,,,,,,https://doi.org/10.1016/j.cmpb.2020.105493; https://www.ncbi.nlm.nih.gov/pubmed/32408237/,218648149.0,12
18054,18054,26735,l2r84wsp,,Medline,In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models.,10.1016/j.nucmedbio.2013.04.012,,23915801.0,unk,bone metastasis class cancerous metastasis result invasion tumor bone solid mass form inside bone often associated constant dull ache severe spike pain greatly reduce quality life patient numerous mtclabeled bisphosphonate functionalised complex well established tracer bone metastasis imaging objective research evaluate pharmacokinetics behaviour three dota based bisphosphonate functionalised ligand bpamd bpapd bpped using ga μpet vivo imaging ex vivo biodistribution study healthy wistar rat compound labelled ga high yield using ammonium acetate buffer subsequently purified using cation exchange resin high bone uptake value observed galabelled bisphosphonates minute pi highest uptake observed gabpped ± idg compare favourably mtcmdp ± idg ffluoride ± idg galabelled dotabisphosphonates showed rapid clearance blood renal system well low binding soft tissue resulting high bone blood ratio minute pi gabpped example although study required ass performance tumor model result obtained suggest ligand could useful imaging ga therapeutic treatment lu bone metastasis,2013,"Meckel, Marian; Fellner, Marco; Thieme, Natalie; Bergmann, Ralf; Kubicek, Vojteck; Rösch, Frank",Nuclear medicine and biology,,,,,,https://doi.org/10.1016/j.nucmedbio.2013.04.012; https://www.ncbi.nlm.nih.gov/pubmed/23915801/,207270196.0,12
18087,18087,26770,uz5whbsa,,Medline,Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.,10.3748/wjg.v23.i17.3111,,28533668.0,unk,aim evaluate whether pathologically early hepatocellular carcinoma hcc exhibited local tumor progression radiofrequency ablation rfa le often typical hcc method fifty pathologically early hccs tumor diameter mm mean range followup day rfa median range typical hccs tumor diameter mm mean range followup day rfa median range enrolled retrospective study presence stromal invasion namely tumor cell invasion intratumoral portal tract considered important pathologic finding diagnosis early hccs typical hcc defined presence hypervascular lesion accompanied delayed washout using contrastenhanced computed tomography contrastenhanced magnetic resonance imaging followup examination performed mo interval monitor sign local tumor progression local tumor progression rate pathologically early hccs typical hccs determined using kaplanmeier method result followup period pathologically early hccs nodule exhibit local tumor progression however nodule associated local tumor progression found rfa typical hccs nodule exhibited local recurrence rfa followup period local tumor progression typical hcc median ranging among case typical hccs local tumor progression occurred case year respectively pathologically early hcc statistically associated lower rate local tumor progression compared typical hcc evaluated using logrank test p conclusion rate local tumor progression pathologically early hccs rfa significantly lower typical hccs,2017,"Hao, Yoshiteru; Numata, Kazushi; Ishii, Tomohiro; Fukuda, Hiroyuki; Maeda, Shin; Nakano, Masayuki; Tanaka, Katsuaki",World journal of gastroenterology,,,,,,https://doi.org/10.3748/wjg.v23.i17.3111; https://www.ncbi.nlm.nih.gov/pubmed/28533668/,4035371.0,12
18105,18105,26791,zpe29s7k,,Medline,Endoscopic-assisted laparoscopic resection for gastric subepithelial tumors.,10.1007/s00464-015-4183-0,,25860952.0,unk,background laparoscopic resection considered treatment choice gastric subepithelial tumor occasionally necessary perform intraoperative gastroscopy localize lesion data literature addressing factor predict combined laparoscopicendoscopic approach needed method retrospective cohort study using prospectively collected database conducted january december patient undergoing laparoscopic gastric resection subepithelial tumor irresectable endoscopy reviewed potential predictive factor need intraoperative endoscopy analyzed result thirtyeight consecutive patient men woman mean age year underwent laparoscopic gastric resection subepithelial tumor fourteen patient required intraoperative endoscopic assessment significant factor related need endoscopic assessment surgery tumor growth pattern p size p conclusion accurate description tumor growth pattern size eu recommended preoperative assessment gastric subepithelial tumor small tumor ≤ mm intraluminal growth may need combined endoscopicassisted laparoscopic management,2016,"Dávila, Jaime Sampson; Momblán, Dulce; Ginès, Àngels; Sánchez-Montes, Cristina; Araujo, Isis; Saavedra-Pérez, David; Lacy, Antonio M; Fernández-Esparrach, Gloria",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-015-4183-0; https://www.ncbi.nlm.nih.gov/pubmed/25860952/,1786808.0,12
18110,18110,26796,rwzd5mda,,Medline,Papilloma and sebaceous gland hyperplasia of the lacrimal caruncle: a case report.,10.2147/imcrj.s162528,,29731668.0,unk,objective report case coincidence sebaceous gland hyperplasia papilloma detection human papillomavirus apical portion situ hybridization case presentation yearold man noted discomfort inner canthus left eye blinked tumor lacrimal caruncle identified resected base tumor smooth surface whitish addition navellike structure seen finding strongly suggested sebaceous gland hyperplasia lacrimal caruncle apical portion tumor papillomatous lesion histological examination resected tumor led diagnosis sebaceous gland hyperplasia human papillomavirus detected apical portion situ hybridization based result final diagnosis sebaceous gland hyperplasia papilloma recurrence either tumor observed year postoperatively conclusion might first report case coincidence sebaceous gland hyperplasia papilloma even though association two lesion unclear including developed first,2018,"Miura-Karasawa, Maria; Toshida, Hiroshi; Ohta, Toshihiko; Murakami, Akira",International medical case reports journal,,,,,,https://doi.org/10.2147/imcrj.s162528; https://www.ncbi.nlm.nih.gov/pubmed/29731668/,13681679.0,12
18165,18165,26862,ukx3k2uj,,Medline,Short term treatment results of local ablation with water-cooled microwave antenna for liver cancer: Comparison with radiofrequency ablation.,10.3892/mco.2020.1983,,32064099.0,unk,aim present study evaluate efficacy safety newgeneration percutaneous microwave ablation mwa compared radiofrequency ablation rfa system treatment hepatocellular carcinoma hcc retrospective study conducted january february total patient nodule mean tumor size ± mm treated mwa patient nodule mean tumor size ± mm treated rfa day treatment direct effect ablation assessed using dynamic ct discharge followup dynamic ct scan performed every month treatment efficacy complication local recurrence recorded mwa rfa average number ct session ± ± respectively mean ablation time ± ± min following mwa rfa ablation range evaluated axial image ± ± mm respectively longaxis diameter ± ± mm respectively shortaxis diameter flatness ratio ablation region ± ± axial image ± ± coronal image respectively rate complete tumor necrosis comparable complication rate mwa rfa significantly different cumulative local recurrence rate significantly different two method oneyear recurrence rate mwa rfa mwa therefore indicated effective treatment hcc respect session number treatment time spherical ablation,2020-03-01,"Suwa, Kanehiko; Seki, Toshihito; Tsuda, Rinako; Yamashina, Masao; Murata, Miki; Yamaguchi, Takashi; Nishio, Akiyoshi; Okazaki, Kazuichi",Molecular and clinical oncology,,,,,,https://doi.org/10.3892/mco.2020.1983; https://www.ncbi.nlm.nih.gov/pubmed/32064099/,211121328.0,12
18223,18223,26932,30shsg5u,,Medline,SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?,10.2967/jnumed.116.189035,,28450563.0,unk,recent study shown enhanced tumor targeting novel somatostatin receptor sstr antagonist compared clinically widely used agonist however result obtained mostly neuroendocrine tumor limited data available cancer type lower sstr expression including breast cancer bc date two study reported higher binding antagonist agonist bc study limited number case evaluated preclinical study investigated whether application sstr antagonist improve sstrmediated bc imaging large panel bc specimen also generated vivo bc mouse model performed spectmri biodistribution study method binding indotatyroctreotate sstr agonist indotajr sstr antagonist human bc specimen compared using vitro autoradiography sstr immunostaining performed confirm sstr expression tumor cell furthermore binding radiolabeled sstr agonist antagonist analyzed tissue material patientderived xenograft one patientderived xenograft estrogen receptorpositive model chosen generate vivo mouse model containing orthotopic breast tumor vivo spectmri biodistribution study injection ludotatyroctreotate ludotajr resultsindotajr binding human bc tissue significantly higher indotatyroctreotate binding p median ratio antagonist binding versus agonist binding interquartile range sstr immunostaining confirmed sstr expression tumor cell spectmri mouse model found better tumor visualization antagonist result line significantly higher tumor uptake radiolabeled antagonist agonist measured biodistribution study min radiotracer injection percentage injected dose per gram tissue ± v ± p conclusion sstr antagonist promising candidate bc imaging,2017,"Dalm, Simone U; Haeck, Joost; Doeswijk, Gabriela N; de Blois, Erik; de Jong, Marion; van Deurzen, Carolien H M","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.116.189035; https://www.ncbi.nlm.nih.gov/pubmed/28450563/,25154169.0,12
18226,18226,26936,5gqwddwv,,Medline,Meningioma embolization with the pressure cooker technique using Squid 12.,10.1177/1591019917707328,,28549393.0,unk,background preoperative meningioma embolization may performed microparticles liquid embolic agent pressure cooker technique pct recently described embolization brain arteriovenous malformation avms case present case yearold woman large frontal interhemispheric meningioma successfully preoperatively embolized pct using squid new ethylvinyl alcohol copolymer embolic agent pct present considerable advantage relative conventional embolization technique deeper faster tumor penetration embolization tumor difficult vascular access retrograde feeling pial afferent may achieved conclusion use pct squid may potentially increase effectiveness meningioma embolization increase tumor devascularization improve outcome surgical resection,2017,"Szatmáry, Zoltán; Hillman, Jan; Finitsis, Stephanos","Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences",,,,,,https://doi.org/10.1177/1591019917707328; https://www.ncbi.nlm.nih.gov/pubmed/28549393/,5312214.0,12
18234,18234,26946,zj1c2tcd,,Medline,Our technique of preceding diaphragm resection and partial mobilization of the hepatic right lobe using a vessel sealing device (LigaSure™) for huge hepatic tumors with diaphragm invasion.,10.1007/s00595-016-1306-8,,26787542.0,unk,describe ass technique preceding diaphragm resection partial mobilization hepatic right lobe treat huge hepatic tumor diaphragm invasion right hepatic artery portal vein divided hepatic hilum mesentery dissected vessel sealing device ligasure impact™ invaded diaphragm dissected roundly using vessel sealing device right lobe partially mobilized soft catheter passed along anterior aspect retrohepatic inferior vena cava liver parenchyma dissected via liver hanging maneuver performed eight hepatectomies using technique median blood loss ml mean excised liver weight g result demonstrate safety efficiency preceding diaphragm resection partial mobilization technique using vessel sealing device right hepatectomy resect large tumor diaphragm invasion,2016,"Wakayama, Kenji; Kamiyama, Toshiya; Yokoo, Hideki; Kakisaka, Tatsuhiko; Orimo, Tatsuya; Shimada, Shingo; Tsuruga, Yosuke; Kamachi, Hirofumi; Taketomi, Akinobu",Surgery today,,,,,,https://doi.org/10.1007/s00595-016-1306-8; https://www.ncbi.nlm.nih.gov/pubmed/26787542/,29251941.0,12
18277,18277,26993,qb2ir6c0,,Medline,68Ga DOTATATE PET/CT of Non-FDG-Avid Pulmonary Metastatic Hemangiopericytoma.,10.1097/rlu.0000000000001313,,27454598.0,unk,present fdg ga dotatate petct finding yearold woman pulmonary metastasis year initial diagnosis central nervous system hemangiopericytoma largest pulmonary lesion showed prominent ga dotatate uptake comparatively minimal fdg avidity hemangiopericytoma rare mesenchymal tumor arises malignant pericytes cell form wall capillary postcapillary venule case demonstrates potential radiolabeled somatostatin analog therapeutic option setting widespread metastatic disease,2016,"Hung, Te-Jui; Macdonald, William; Muir, Tracey; Celliers, Liesl; Al-Ogaili, Zeyad",Clinical nuclear medicine,,,,,,https://doi.org/10.1097/rlu.0000000000001313; https://www.ncbi.nlm.nih.gov/pubmed/27454598/,206018506.0,12
18318,18318,27042,k8b6tv27,,Medline,Pulmonary thermal ablation in patients with prior pneumonectomy.,10.2214/ajr.10.5154,,21512052.0,unk,objective purpose article review safety efficacy thermal ablation lung malignancy pneumonectomy material method reviewed patient underwent thermal ablation malignant lung tumor pneumonectomy patient demographic complication procedural success oncologic outcome recorded technique effectiveness evaluated imaging week ablation kaplanmeier method used evaluate overall survival cumulative incidence competing risk method used account progressionfree tumor time patient death result lung ablation performed treat tumor nine primary four metastatic patient single lung median tumor size cm range cm technical success documented case technical effectiveness documented patient local tumor progression occurred five lesion within median month range month ablation treated repeat ablation four lesion complication included six pneumothoraces requiring thoracostomy death occurred within day three ablation session median time primary local tumor progression month ci month reached median time assisted repeat ablation local tumor progression month ci reached median overall survival month ci month excluding two early death complicating initial ablation procedure median overall survival month conclusion thermal ablation offer local tumor control pneumonectomy despite relatively high postprocedure clinical risk,2011,"Sofocleous, Constantinos T; May, Benjamin; Petre, Elena N; Gonen, Mithat; Thornton, Raymond H; Alago, William; Rizk, Nabil P; Dupuy, Damian E; Solomon, Stephen B",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.10.5154; https://www.ncbi.nlm.nih.gov/pubmed/21512052/,207323527.0,12
18323,18323,27048,w491px9x,,Medline,Creation of a tumor-mimic model using a muscle paste for radiofrequency ablation of the lung.,10.1007/s00270-008-9463-9,,19002525.0,unk,purpose study develop easily created tumormimic model evaluate efficacy radiofrequency ablation rfa lung bilateral lung eight living adult swine used tumormimic model made percutaneous injection ml muscle paste bone biopsy needle lung rfa probe inserted tumor mimic immediately tumor creation ablation time tissue impedance temperature recorded tumor mimic coagulated region evaluated microscopically macroscopically muscle paste easily injected lung parenchyma bone biopsy needle well visualized fluoroscopy site tumor mimic oval shaped localized homogeneous gross specimen ten tumor mimic successfully ablated four location ablated normal lung parenchyma control tumor normal lung parenchyma ablation time min respectively tissue impedance start ablation omega respectively temperature end ablation degree c respectively mean size tumor mimic x mm coagulated area x mm lung parenchyma coagulated area x mm conclusion tumormimic model using muscle paste easily safely created ablated using ablation algorithm clinical setting,2009,"Kawai, T; Kaminou, T; Sugiura, K; Hashimoto, M; Ohuchi, Y; Adachi, A; Fujioka, S; Ito, H; Nakamura, K; Ogawa, T",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-008-9463-9; https://www.ncbi.nlm.nih.gov/pubmed/19002525/,20437369.0,12
18450,18450,27191,sw601q1y,,Medline,Laparoscopic adnexectomy of suspect ovarian masses: surgical technique used to avert spillage.,10.1016/j.jmig.2011.02.008,,21545961.0,unk,herein described evaluated safe laparoscopic adnexectomy technique retroperitoneal dissection suspect ovarian mass including underlying peritoneum fixed ovary adopting technique case suspect adnexal mass enables reduction spilling ensures intact specimen twentytwo consecutive patient suspect adnexal mass cm smaller underwent laparoscopic adnexectomy patient bilateral suspect ovarian mass required bilateral adnexectomy enrolled longer childbearing age laparoscopy feasible patient tumor spillage occurred patient minilaparotomy required extract specimen mean sd operating time minute estimated blood loss ml major intraoperative complication occurred median range postoperative stay day definitive pathologic analysis revealed benign pathologic condition patient ovarian tumor low malignant potential patient ovarian cancer patient finding frozensection analysis inconclusive median range followup malignant ovarian tumor tumor low malignant potential month recurrence portsite metastasis developed followup data encouraging adoption technique avert spillage laparoscopic management suspect adnexal mass especially firmly adherent peritoneum however procedure must validated larger series patient standardize technique,2011,"Perutelli, Alessandra; Garibaldi, Silvia; Basile, Stefano; Baldacci, Chiara; Gargini, Antonio; Domenici, Lavinia; Salerno, Maria Giovanna",Journal of minimally invasive gynecology,,,,,,https://doi.org/10.1016/j.jmig.2011.02.008; https://www.ncbi.nlm.nih.gov/pubmed/21545961/,5375543.0,12
18453,18453,27195,vcwhsm16,,Medline,Novel treatment options in stage I non-small-cell lung cancer.,10.1586/14737140.2014.929500,,24930519.0,unk,last year current management stage nonsmallcell lung cancer challenged due novel surgical approach advance radiation technology outcome sublobar resection promising especially tumor le cm treatment opportunity available high risk patient comorbidity impaired pulmonary function stereotactic ablative body radiotherapy good alternative treatment surgery especially elderly comorbid patient however randomized evidence comparing sublobar resection stereotactic radiotherapy presently lacking recent development radiotherapy hadron therapy presumed reduced toxicity peculiar physical biological effect promising thermal microwave ablative technique development specific niche indication,2014,"Tarasevych, Svitlana; Lauwers, Patrick; Vandaele, Frederik; van Meerbeeck, Jan P",Expert review of anticancer therapy,,,,,,https://doi.org/10.1586/14737140.2014.929500; https://www.ncbi.nlm.nih.gov/pubmed/24930519/,207188390.0,12
18623,18623,27388,8pihqdcd,,Medline,Magnetic resonance-based visualization of thermal ablative margins around hepatic tumors by means of systemic ferucarbotran administration before radiofrequency ablation: animal study to reveal the connection between excess iron deposition and T2*-weighted hypointensity in ablative margins.,10.1097/rli.0000000000000137,,25695671.0,unk,objective objective study demonstrate experimentally radiofrequency ablation rfa ferucarbotranaccumulated healthy liver tissue cause excess iron deposition ablated liver tissue postablation day produce sustained tweighted low signal indicative ablative margin surrounding hepatic tumor material method conducted experiment using rat experiment administered either ferucarbotran n saline n acquired tweighted image twis liver using magnetic resonance scanner subsequently performed rfa healthy liver lobe acquired followup twis day histologically analyzed liver specimen another rat performed sham operation instead rfa ferucarbotranaccumulated liver lobe followed image acquisition histological analysis experiment administered felabeled ferucarbotran subsequently performed either rfa n sham operation n liver acquired autoradiograms liver specimen day experiment conducted rfa treatment rat bearing orthotopic hepatic tumor ferucarbotran administration monitored tumor growth using serial twis result day experiment twis rat systemic ferucarbotran administration subsequent hepatic rfa showed lowsignal region indicative ablated liver tissue whereas highsignal area seen salineadministered rat neither high low signal area detected shamoperated rat histologically larger amount iron observed rfainduced necrotic liver tissue ferucarbotranadministered rat salineadministeredrats fe autoradiography rat experiment revealed accumulation ferucarbotranderived iron necrotic liver tissue among hepatic tumor grown rat experiment total tumor stable size increased markedly day retrospectively twis showed former tumor site surrounded completely lowsignal area day conclusion rfa ferucarbotranaccumulated healthy liver tissue rat caused excess iron deposition ablated liver tissue produced sustained tweighted hypointense region similar hypointense region surrounding hepatic tumor indicative ablative margin,2015,"Nagai, Michiko; Yamaguchi, Masayuki; Mori, Kensaku; Furuta, Toshihiro; Ashino, Hiroki; Kurosawa, Hiroyuki; Kasahara, Hiroyuki; Minami, Manabu; Fujii, Hirofumi",Investigative radiology,,,,,,https://doi.org/10.1097/rli.0000000000000137; https://www.ncbi.nlm.nih.gov/pubmed/25695671/,20119525.0,12
18704,18704,27484,2nlqvd5v,,Medline,Pneumoretroperitoneum and Sepsis After Transanal Endoscopic Resection of a Rectal Lateral Spreading Tumor.,10.3393/ac.2017.33.3.115,,28761873.0,unk,transanal endoscopic microsurgery considered safe appropriate minimally invasive approach complication endoscopic microsurgery rare report case sepsis pneumoretroperitoneum resection rectal lateral spreading tumor patient presented rectal mucous discharge colonoscopy revealed rectal lateral spreading tumor patient underwent endoscopic transanal resection lesion presented sepsis abdominal focus imaging test revealed pneumoretroperitoneum new surgical intervention performed loop colostomy despite existence report pneumoretroperitoneum transanal endoscopic microsurgery draw attention case association sepsis,2017,"Martins, Bruno Augusto Alves; Coura, Marcelo de Melo Andrade; de Almeida, Romulo Medeiros; Moreira, Natascha Mourão; de Sousa, João Batista; de Oliveira, Paulo Gonçalves",Annals of coloproctology,,,,,,https://doi.org/10.3393/ac.2017.33.3.115; https://www.ncbi.nlm.nih.gov/pubmed/28761873/,26264972.0,12
18764,18764,27554,e8f2lijk,,Medline,Robotic distal pancreatectomy combined with celiac axis resection.,10.21037/jovs.2017.08.18,,29302421.0,unk,subset pancreatic body tail cancer present locally advanced disease due involvement celiac axis previously considered unresectable tumor may extirpated distal pancreatectomy en bloc resection celiac trunk carefully selected patient setting multimodality treatment resection yield survival similar resectable borderline resectable lesion robotic surgery shown safe feasible complex pancreatic resection article summarizes patient selection criterion operative approach robotic distal pancreatectomy celiac axis resection dpcar locally advanced body tail tumor pancreas,2017,"Greer, Jonathan; Zureikat, Amer H",Journal of visualized surgery,,,,,,https://doi.org/10.21037/jovs.2017.08.18; https://www.ncbi.nlm.nih.gov/pubmed/29302421/,23128619.0,12
18854,18854,27662,q7v6vp5u,,Medline,"Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.",10.1159/000362430,,24853787.0,unk,neuroendocrine tumor net syn carcinoid tumor highly moderately differentiated neoplasm comprise large variety rare heterogeneous tumor estimated incidence year arise virtually every internal organ mainly occur gastroenteropancreatic bronchopulmonary system around net localized bronchopulmonary system approximately lung tumor net according world health organization classification lung tumor bronchopulmonary net subdivided typical carcinoid tc atypical carcinoid ac parameter highest impact net behavior prognosis histological classification staging according tumornodemetastasis tnm system diagnosis net established histological examination immunohistochemical detection general neuroendocrine marker chromogranin cga synaptophysin serum marker use functional imaging technique important additive tool establish diagnosis net curative option lung net complete surgical resection beyond currently available interdisciplinary therapeutic option local ablation biotherapy somatostatin analogue chemotherapy new therapeutic option peptide receptor radionuclide therapy prrt molecularly targeted therapy achieve promising result evaluation report consensus summary interdisciplinary symposium neuroendocrine tumor lung gastroenteropancreatic system gep net expert dialogue held february weimar germany conference panel german expert shared knowledge exchanged thought research diagnosis clinical management net whereby special attention paid net respiratory tract,2014,"Hörsch, Dieter; Schmid, Kurt W; Anlauf, Martin; Darwiche, Kaid; Denecke, Tim; Baum, Richard P; Spitzweg, Christine; Grohé, Christian; Presselt, Norbert; Stremmel, Christian; Heigener, David F; Serke, Monika; Kegel, Thomas; Pavel, Marianne; Waller, Cornelius F; Deppermann, Karl-Matthias; Arnold, Rudolf; Huber, Rudolf M; Weber, Matthias M; Hoffmann, Hans",Oncology research and treatment,,,,,,https://doi.org/10.1159/000362430; https://www.ncbi.nlm.nih.gov/pubmed/24853787/,19170531.0,12
18869,18869,27677,gzznisrf,,Medline,Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.,10.2967/jnumed.109.064790,,19837750.0,unk,unlabelled study examined vivo relationship functional tumor vasculature determined dynamic contrastenhanced dce mri tumor metabolism determined dynamic ffdg pet cytotoxic treatment patient colorectal liver metastasis method twentythree patient underwent dcemri using gadolinium dimeglumine dynamic ffdg pet baseline treatment cycle unless treatment terminated toxicity parameter vasculature rate constant extravascular extracellular space blood plasma kep volume transfer constant ktrans extracellular space tumor size maximal axial diameter included lesion mad metabolism glucose metabolic rate mrglc derived change treatment correlated overall survival o progressionfree survival pfs served outcome measure predictive ability pretreatment parameter treatmentrelated parameter change result pretreatment mrglc mad individually predictive o pfs treatment ktrans increased significantly increase could confirmed lesionbylesion analysis mrglc decreased significantly p correlation found change dcemri parameter deltamrglc relationship found change dcemri parameter o pfs deltamrglc able predict o p correction confounders conclusion efficacy cytotoxic chemotherapy assessed reduction tumor metabolism depend pretreatment property tumor vasculature determined dcemri cytotoxic chemotherapy alter dcemriderived property tumor vasculature decrease glucose consumption tumor cell,2009,"Vriens, Dennis; van Laarhoven, Hanneke W M; van Asten, Jack J A; Krabbe, Paul F M; Visser, Eric P; Heerschap, Arend; Punt, Cornelis J A; de Geus-Oei, Lioe-Fee; Oyen, Wim J G","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.109.064790; https://www.ncbi.nlm.nih.gov/pubmed/19837750/,5897616.0,12
18880,18880,27690,tekb73ur,,Medline,Stromal prostatic sarcoma: a rare tumor with rare clinical and imaging presentation.,10.3941/jrcr.v7i7.1177,,24421945.0,unk,adult prostatic stromal sarcoma rare malignant tumor main presenting symptom urinary retention secondary bladder outlet obstruction prostatic specific antigen level normal imaging feature show prostate mass without pelvic organ invasion depending aggressiveness tumor present patient prostatic stromal sarcoma debuted urinary obstruction leukocytosis neutrophilia prostate enlargement hypodense prostate area ct image simulating prostatitis abscess formation,2013,"Rojas-Jiménez, Anamaría; Otero-Garcia, Milagros; Mateos-Martin, Alejandro",Journal of radiology case reports,,,,,,https://doi.org/10.3941/jrcr.v7i7.1177; https://www.ncbi.nlm.nih.gov/pubmed/24421945/,16138410.0,12
18911,18911,27726,i8h0422g,,Medline,Effect of one-off complete tumor radiofrequency ablation on liver function and postoperative complication in small hepatocellular carcinoma.,10.1016/j.ejso.2013.12.004,,24387942.0,unk,objective radiofrequency ablation rfa effective treating hepatocellular carcinoma hcc le invasive surgical resection however oneoff complete tumor ablation liver function reported method retrospectively reviewed hccs met criterion oneoff complete tumor ablation tumor completed covered ablated zone confirmed postoperative enhanced ct single rfa sign recurrence least month categorized tumor two group near vascular tumor nvt distance le mm far vascular tumor fvt otherwise result thirteen hccs met criterion nvts hccs met fvts average tumor size ± cm fvts ± cm nvts although restored normal range postoperative day pod alt ast total bilirubin tb albumin prothrombin time showed significant fluctuation nvts compared fvts pod pod moreover patient nvt group fvt group developed postrfa transient ascites ci incidence postrfa pleural effusion nvt fvts ci conclusion oneoff complete tumor ablation may impair liver function led postoperative complication tumor within mm away large blood vessel ≥ mm particular caution made preoperative assessment anatomic relation tumor large blood vessel patient,2014,"Jiang, K; Dong, J; Zhang, W; Liu, Y; Su, M; Zhao, X; Wang, J; Yao, M; Huang, Z",European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,,,,,,https://doi.org/10.1016/j.ejso.2013.12.004; https://www.ncbi.nlm.nih.gov/pubmed/24387942/,19134475.0,12
18963,18963,27782,2pwlhikf,,Medline,Hyper-vascular giant cavernous malformation in a child: a case report and review.,10.1007/s00381-016-3234-8,,27585994.0,unk,introduction giant cavernous malformation gcm child rare vascular anomaly natural history unclear despite giant size intraparenchymal gcms lowflow vascular malformation herein report case hypervascular intraparenchymal gcm av shunt child case yearold boy enlarged head since infancy magnetic resonance mr image admission showed strikingly enhanced mass lesion cm size vessel cag demonstrated hypervascular mass av shunt transarterial embolization patient underwent total excision mass tumor bled easily surgery patient lost cm blood histopathological examination confirmed diagnosis cavernous hemangioma conclusion differential diagnosis intraparenchymal strikinglyenhanced tumor av shunt include hypervascular gcms consideration potential bleeding operation also important,2017,"Hirata, Koji; Ihara, Satoshi; Sato, Masayuki; Matsumaru, Yuji; Yamamoto, Tetsuya",Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,,,,,,https://doi.org/10.1007/s00381-016-3234-8; https://www.ncbi.nlm.nih.gov/pubmed/27585994/,19839859.0,12
19014,19014,27845,zm9dmt3m,,Medline,Laparoscopic microwave thermosphere ablation of malignant liver tumors: An analysis of 53 cases.,10.1002/jso.24127,,26659827.0,unk,background objective microwave thermosphere ablation mta new technology designed create spherical zone ablation using single antenna aim study ass result mta large series patient method prospective study assessing use mta patient malignant liver tumor procedure done mostly laparoscopically ablation zone created assessed completeness tumor response spherical geometry recurrence triphasic ct scan done followup result total patient average tumor measuring cm ablation performed laparoscopically eight patient morbidity n mortality zero postoperative scan tumor destruction roundness index b transverse respectively median followup month incomplete ablation seen lesion treated local tumor recurrence lesion conclusion result series confirm safety feasibility mta technology rate complete tumor ablation low rate local recurrence shortterm follow promising,2016,"Zaidi, Nisar; Okoh, Alexis; Yigitbas, Hakan; Yazici, Pinar; Ali, Noaman; Berber, Eren",Journal of surgical oncology,,,,,,https://doi.org/10.1002/jso.24127; https://www.ncbi.nlm.nih.gov/pubmed/26659827/,1453517.0,12
19057,19057,27890,h1s3dlgg,,Medline,Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors.,10.1007/s00270-011-0227-6,,21785888.0,unk,minimally invasive treatment option liver tumor therapy increasingly used last decade benefit proven primary inoperable secondary liver tumor among radiofrequency ablation gained widespread consideration optimal imageguidance offer precise anatomical information help position interventional device allows differentiation alreadytreated remaining tumor tissue patient safety complete ablation entire tumor overriding objective tumor ablation may achieved elegantly magnetic resonance mrguided therapy monitoring performed based precise softtissue imaging additional component diffusionweighted imaging temperature mapping new mr scanner type newly developed sequence technique enabled mrguided intervention move beyond experimental phase article review current role mr imaging guiding radiofrequency ablation signal characteristic primary secondary liver tumor identified signal alteration therapy described diffusionweighted imaging dwi temperature mapping special component mr therapy monitoring introduced practical information concerning coil sequence selection parameter well sequence gating given addition source artifact identified technique decrease introduced characteristic sign residual tumor dwi described hope enable reader choose mr sequence allow optimal therapy monitoring depending initial signal characteristic tumor well size location liver,2012,"Rempp, Hansjörg; Clasen, Stephan; Pereira, Philippe L",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-011-0227-6; https://www.ncbi.nlm.nih.gov/pubmed/21785888/,21492422.0,12
19066,19066,27901,18oed4e1,,Medline,Increase of mtDNA number and its mutant copies in rat brain after exposure to 150 MeV protons.,10.1007/s11033-020-05491-7,,32388700.0,unk,proton beam therapy widely used treating brain tumor despite efficacy treatment use therapy met limitation associated possible damage normal brain tissue located beyond tumor site context exploration harmful effect proton normal brain tissue particular interest investigated change total mitochondrial dna mtdna copy number identified mtdna mutant copy three brain region hippocampus cortex cerebellum rat irradiation wholehead mev proton dos gy study performed month old male spraque dawley rat n group mtdna copy number determined realtime pcr level mtdna heteroplasmy estimated using surveyor nuclease technology result show head exposure proton level mtdna copy number three rat brain region increase significantly level mtdna mutant copy increase significant elevation observed hippocampus conclusion increase mtdna mutant copy may contribute mitochondrial dysfunction accompanied increased oxidative stress different brain region promote development neurodegenerative disease induction carcinogenesis,2020-05-09,"Abdullaev, Serazhutdin; Bulanova, Tatiana; Timoshenko, Gennady; Gaziev, Azhub I",Molecular biology reports,,,,,,https://doi.org/10.1007/s11033-020-05491-7; https://www.ncbi.nlm.nih.gov/pubmed/32388700/,218562107.0,12
19089,19089,27929,pbm8ysxr,,Medline,The effect of mannitol on intraoperative brain relaxation in patients undergoing supratentorial tumor surgery: study protocol for a randomized controlled trial.,10.1186/1745-6215-15-165,,24884731.0,unk,background risk brain swelling dural opening high patient midline shift undergoing supratentorial tumor surgery brain swelling may result increased intracranial pressure impeded tumor exposure adverse outcome mannitol recommended firstline dehydration treatment reduce brain edema enable brain relaxation neurosurgery research indicated mannitol enhanced brain relaxation patient undergoing supratentorial tumor surgery however result need confirmation optimal mannitol dose yet established propose examine whether different dos mannitol improve brain relaxation dosedependent manner administered time incision examine patient preexisting mass effect midline shift undergoing elective supratentorial brain tumor surgery method singlecenter randomized controlled parallel group trial carried beijing tiantan hospital capital medical university randomization achieved using computergenerated table study include patient undergoing supratentorial tumor surgery whose preoperative computed tomographymagnetic resonance imaging result indicate brain midline shift patient group group b group c receive dehydration treatment incision mannitol solution gkg respectively rate mlh patient control group receive mannitol primary outcome improvement intraoperative brain relaxation dura tension dehydration mannitol secondary outcome postoperative outcome incidence mannitol side effect discussion aim study determine optimal dose mannitol intraoperative infusion examine brain relaxation outcome patient undergoing supratentorial tumor surgery result positive study indicate optimal dose mannitol improve brain relaxation avoid side effect brain tumor surgery trial registration study registered registry website httpwwwchictrorg registration number chictrtrc december,2014,"Peng, Yuming; Liu, Xiaoyuan; Wang, Aidong; Han, Ruquan",Trials,,,,,,https://doi.org/10.1186/1745-6215-15-165; https://www.ncbi.nlm.nih.gov/pubmed/24884731/,16138413.0,12
19107,19107,27952,qpkxujd7,,Medline,Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.,10.1530/erc-13-0365,,24351682.0,unk,welldifferentiated neuroendocrine tumor net group heterogeneous rare tumor often slowgrowing patient long survival even metastatic stage evaluation tumor progression therapeutic response currently based response evaluation criterion solid tumor v recist criterion malignancy recist criterion reexamined net era targeted therapy tumor response targeted therapy rarely associated shrinkage opposed prolonged progressionfree survival therefore sizebased criterion longer seem suitable assessment net progression therapeutic response especially considering targeted therapy new imaging criterion combining morphological functional technique proven relevant malignancy treated targeted therapy date study rarely conducted net moreover optimizing management net patient also requires considering clinical biological pathological aspect tumor evolution objective herein comprehensively review current knowledge assessment tumor progression early prediction therapeutic response broaden outlook welldifferentiated net era targeted therapy,2014,"de Mestier, Louis; Dromain, Clarisse; d'Assignies, Gaspard; Scoazec, Jean-Yves; Lassau, Nathalie; Lebtahi, Rachida; Brixi, Hedia; Mitry, Emmanuel; Guimbaud, Rosine; Courbon, Frédéric; d'Herbomez, Michèle; Cadiot, Guillaume",Endocrine-related cancer,,,,,,https://doi.org/10.1530/erc-13-0365; https://www.ncbi.nlm.nih.gov/pubmed/24351682/,28047525.0,12
19121,19121,27968,zr7wdkov,,Medline,A case-control study examining the benefits of laparoscopic colectomy using a totally intracorporeal technique for left-sided colon tumors.,10.1097/sle.0b013e318290155b,,25077639.0,unk,laparoscopicassisted colectomy extracorporeal anastomosis associated higher conversion rate leftsided colon tumor hypothesized totally intracorporeal laparoscopic colectomy tilc would minimize operative conversion morbidity conducted casecontrol study comparing tilc leftsided rightsided tumor matching based age asa status tilc performed colon tumor overall conversion rate complication rate median length stay day patient undergoing tilc leftsided colon tumor patient undergoing tilc rightsided colon tumor operative conversion leftsided tilc similar p rightsided tilc complication rate leftsided tilc different p compared rightsided tilc length stay leftsided tilc comparable p rightsided tilc laparoscopic left colectomy successfully performed equivalent result laparoscopic right colectomy using totally intracorporeal technique,2014,"Iorio, Tara; Blumberg, David","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e318290155b; https://www.ncbi.nlm.nih.gov/pubmed/25077639/,23816736.0,12
19186,19186,28041,w109v4xk,,Medline,Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.,10.1258/ar.2012.110333,,22961644.0,unk,background radiofrequency ablation rfa potential application salvage tool failure surgery chemotherapy radiotherapy nonsmall cell lung cancer nsclc although several study evaluated use rfa primary nsclc little literature potential application salvage tool purpose evaluate ctguided rfa employed salvage therapy pulmonary recurrence nsclc prior treatment chemotherapy radiation therapy andor surgery material method retrospective computer database search yielded patient biopsy proven primary nsclc underwent ctguided rfa recurrent tumor following surgery chemotherapy andor radiotherapy followup imaging performed ct petct endpoint interest progressionfree survival pfs time local progression ttlp pfs ttlp compared lesion size cm ≥ cm result median pfs month patient tumor size cm median pfs month whereas median pfs patient tumor size ≥ cm month difference reach statistical significance p median ttlp tumor month ttlp ablated tumor cm size month compared month ablated tumor ≥ cm size difference reach statistical significance p conclusion rfa recurrent nsclc may valuable salvage tool achieve local tumor control especially tumor measuring cm size,2012,"Schoellnast, Helmut; Deodhar, Ajita; Hsu, Meier; Moskowitz, Chaya; Nehmeh, Sadek A; Thornton, Raymond H; Sofocleous, Constantinos T; Alago, William; Downey, Robert J; Azzoli, Christopher G; Rosenzweig, Kenneth E; Solomon, Stephen B",Acta radiologica,,,,,,https://doi.org/10.1258/ar.2012.110333; https://www.ncbi.nlm.nih.gov/pubmed/22961644/,45959371.0,12
19197,19197,28054,64vckrg5,,Medline,Single-stage laparoscopic adrenalectomy for pheochromocytoma and enucleation of a pancreatic neuroendocrine tumor in Von Hippel-Lindau disease: A case report.,10.3892/mco.2017.1212,,28515932.0,unk,von hippellindau vhl disease inherited syndrome autosomaldominant transmission characterized central nervous system retinal hemangioblastomas visceral cyst tumor optimal surgical treatment including timing remains controversial topic present study report case yearold female patient adrenal pancreatic manifestation vhl laparoscopic cortexsparing left adrenalectomy cm pheochromocytoma pancreatic enucleation pancreatic polypeptidoma pancreas tail performed operative procedure total operative time min operative complication surgery completed laparoscopically minimal blood loss prolonged hospital stay necessary treat grade c postoperative pancreatic fistula histopathological result adrenal pheochromocytoma welldifferentiated neuroendocrine tumor secreting pancreatic polypeptide conclusion organsparing laparoscopic surgery important option treating simultaneous lesion several abdominal solid viscera vhl disease present case study represents best author knowledge first report singlestage laparoscopic adrenalectomy pancreatic tumor enucleation,2017,"Casaccia, Marco; Macina, Simona; Fornaro, Rosario",Molecular and clinical oncology,,,,,,https://doi.org/10.3892/mco.2017.1212; https://www.ncbi.nlm.nih.gov/pubmed/28515932/,20232247.0,12
19199,19199,28057,m18rf9sa,,Medline,Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET.,10.2967/jnumed.111.088906,,21852355.0,unk,unlabelled incidence prevalence gastroenteropancreatic neuroendocrine tumor increasing past decade high density somatostatin receptor sstrmainly sstron cell surface tumor indiethylenetriaminepentaacetic acidoctreotide scintigraphy become important part clinical management fradiolabeled analog suitable pharmacokinetics would permit pet rapid clinical protocol method compared affinity vitro tissue pharmacokinetics pet structurally related fffluoroethyltriazoletyroctreotate fettoca analog fetgpolyethylene glycol pegtoca fetepegtoca fetgtoca fetetoca fetβagtoca recently described faluminum fluoride notaoctreotide faifnotaoc clinical radiotracer gadotatate result ffluoroethyltriazoletyroctreotate compound retained high agonist binding affinity sstr vitro halfmaximal effective concentration nm v somatostatin nm dynamic pet showed incorporation peg linkers exemplified ffetgpegtoca ffetepegtoca reduced uptake high sstrexpressing arj pancreatic cancer xenograft ffetβagtoca showed lowest nonspecific uptake liver tumor uptake increased order gadotatate faifnota ≤ ffetβagtoca ffetgtoca uptake ffetβagtoca specific radiolabeled scrambled peptide ffetβagwcctftyck show tumor uptake lower uptake ffetβagtoca arj xenograft mouse pretreated mg unlabeled octreotide per kilogram low uptake ffetβagtoca low sstrexpressing hct xenograft conclusion developed novel fluoroethyltriazoletyroctreotate radioligands combine high specific binding rapid target localization rapid pharmacokinetics highcontrast pet ffetβagtoca ffetgtoca candidate future clinical evaluation,2011,"Leyton, Julius; Iddon, Lisa; Perumal, Meg; Indrevoll, Bard; Glaser, Matthias; Robins, Edward; George, Andrew J T; Cuthbertson, Alan; Luthra, Sajinder K; Aboagye, Eric O","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.088906; https://www.ncbi.nlm.nih.gov/pubmed/21852355/,3249400.0,12
19221,19221,28084,e85l7j4h,,Medline,Distal Pancreatectomy Combined with Multivisceral Resection Is Associated with Postoperative Complication Rates and Survival Comparable to Those After Standard Procedures.,10.1007/s11605-018-3804-z,,29748738.0,unk,background pancreatic tumor located body tail pancreas distal pancreatectomy dp remains surgical procedure choice achieve radical tumor removal purpose study evaluate outcome overall survival patient underwent dp combined multivisceral resection mvr method retrospective singlecenter casematched analysis january june consecutive patient entered prospective database patient undergoing dp mvr case matched patient undergoing dp control gender age underlying final diagnosis result significant difference patient demographic rate postoperative pancreatic fistula popf v p postpancreatectomy hemorrhage pph v p reveal significant difference although operative time ± v ± p necessity intraoperative transfusion v p significantly higher number patient major complication claviendindo ≥ increased v p dp mvr group midterm survival analysis indicated significant difference adenocarcinoma neuroendocrine tumor either group conclusion dp mvr feasible safe surgical procedure achieve radical tumor removal offer beneficial survival outcome although operative time intraoperative transfusion enhanced popf pph major complication claviendindo ≥ significantly increased dp mvr dp mvr therefore recommended selected patient resection extended tumor within concept interdisciplinary strategy,2018,"Malinka, Thomas; Klein, Fritz; Andreou, Andreas; Pratschke, Johann; Bahra, Marcus",Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,,,,,,https://doi.org/10.1007/s11605-018-3804-z; https://www.ncbi.nlm.nih.gov/pubmed/29748738/,13663813.0,12
19275,19275,28144,yntclqsl,,Medline,Microwave ablation therapy: clinical utility in treatment of pulmonary metastases.,10.1148/radiol.11101643,,22012906.0,unk,purpose prospectively evaluate safety efficacy microwave ablation therapy unresectable pulmonary metastasis material method patient provided informed consent prospective institutional review boardapproved study eighty patient men woman mean age year ± range year underwent computed tomographyguided percutaneous microwave ablation pulmonary metastatic lesion session tumor represented metastasis colorectal carcinoma breast carcinoma hepatocellular carcinoma renal cell carcinoma bronchogenic carcinoma evidence extrapulmonary metastasis tumor logistic regression analysis used evaluation statistical significance factor affecting end result microwave ablation therapy kaplanmeier method used estimation survival rate result complete successful ablation achieved lesion successful tumor ablation significantly frequent lesion maximal axial diameter cm smaller lesion greater cm maximal axial diameter five p peripheral lesion centrally located lesion p histopathologic type metastasis significantly correlate ablation result p month survival rate respectively intraprocedural death overall day mortality rate ablation higher survival rate observed patient tumorfree state successful ablation patient failed ablation p incidence pneumothorax intercostal chest tube applied one session pulmonary hemorrhage developed eight session conclusion microwave ablation therapy may safely effectively used therapeutic tool treatment pulmonary metastasis efficacy treatment primarily determined preablation tumor size location relation hilum,2011,"Vogl, Thomas J; Naguib, Nagy N N; Gruber-Rouh, Tatjana; Koitka, Karen; Lehnert, Thomas; Nour-Eldin, Nour-Eldin A",Radiology,,,,,,https://doi.org/10.1148/radiol.11101643; https://www.ncbi.nlm.nih.gov/pubmed/22012906/,36314276.0,12
19301,19301,28174,k51r3b9t,,Medline,Biodistribution of ultra small gadolinium-based nanoparticles as theranostic agent: application to brain tumors.,10.1177/0885328212454315,,22832216.0,unk,gadoliniumbased nanoparticles novel object interesting physical property allowing use diagnostic therapeutic application gadoliniumbased nanoparticles imaged following intravenous injection healthy rat rat grafted l gliosarcoma tumor using magnetic resonance imaging scintigraphic imaging quantitative biodistribution using gammacounting sampled organ confirmed nanoparticles rapidly cleared essentially renal excretion accumulation nanoparticles l gliosarcoma tumor implanted rat brain quantitated passive longduration accumulation gadoliniumbased nanoparticles tumor related disruption bloodbrain barrier good agreement use nanoparticles radiosensitizers brain tumor,2013,"Miladi, Imen; Duc, Géraldine Le; Kryza, David; Berniard, Aurélie; Mowat, Pierre; Roux, Stéphane; Taleb, Jacqueline; Bonazza, Pauline; Perriat, Pascal; Lux, François; Tillement, Olivier; Billotey, Claire; Janier, Marc",Journal of biomaterials applications,,,,,,https://doi.org/10.1177/0885328212454315; https://www.ncbi.nlm.nih.gov/pubmed/22832216/,2126180.0,12
19320,19320,28196,xd6swht9,,Medline,Single-incision laparoscopic adrenalectomy at Viet Duc University Hospital.,10.1111/j.1758-5910.2012.00157.x,,22989250.0,unk,introduction laparoscopic adrenalectomy technique choice treatment adrenal tumor sils recently introduced field applied viet duc university hospital herein report experience singleincision transperitoneal adrenalectomy method august january patient men woman underwent sils adrenalectomy institution diagnosis consisted patient pheochromocytoma nonfunctioning adenoma conn syndrome cushing syndrome adrenal cyst mean age year range year rightsided leftsided tumor mean diameter mm range mm patient flank position operated side cm pararectal incision level umbilicus made insert sils port result mean operating time min range min mean blood loss approximately ml leftsided tumor excised entirely sils technique rightsided lesion sometimes required additional trocar hybrid technique drainage needed operating site intraoperative postoperative complication one case converted conventional threeport technique mean length hospital stay day range day conclusion preliminary result show sils adrenalectomy safe technically feasible considered among surgical management selected patient adrenal tumor,2013,"Tran, Giang Binh; Nguyen, Tien Duc; Le, Khanh Viet",Asian journal of endoscopic surgery,,,,,,https://doi.org/10.1111/j.1758-5910.2012.00157.x; https://www.ncbi.nlm.nih.gov/pubmed/22989250/,3161228.0,12
19331,19331,28211,0xu08utg,,Medline,Complete preoperative embolization of hemangioblastoma vessels with Onyx 18.,10.1016/j.jocn.2010.06.016,,21237650.0,unk,author present preliminary experience ethylenevinylalcohol copolymer onyx hemangioblastoma vessel embolization surgical resection patient presented neck pain dizziness blurred vision vomiting loss balance diagnostic imaging revealed posterior fossa cystic mass nodular component angiography demonstrated significant vascular blush arteriovenous shunting characteristic hemangioblastoma tumor vessel originating left posterior inferior cerebellar artery embolized surgery using onyx ev covidien vascular therapy mansfield usa resulted complete obliteration tumor vessel transforming highly vascular tumor avascular mass safe uneventful surgical resection performed next day onyx valuable embolic agent preoperative hemangioblastoma vessel embolization low viscosity onyx penetrates deeply tumor vasculature allows complete obliteration tumor vessel risk intervention carefully weighed benefit preoperative embolization indicated use onyx strongly considered,2011,"Horvathy, Denes B; Hauck, Erik F; Ogilvy, Christopher S; Hopkins, L Nelson; Levy, Elad I; Siddiqui, Adnan H",Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,,,,,,https://doi.org/10.1016/j.jocn.2010.06.016; https://www.ncbi.nlm.nih.gov/pubmed/21237650/,23780378.0,12
19334,19334,28214,q69s9166,,Medline,"Anterior Transabdominal Laparoscopic Adrenalectomy, without Ligatures, for a Symptomatic Right Adrenal Myelolipoma with Intratumoral Hemorrhage.",10.21614/chirurgia.112.1.58,,28266294.0,unk,myelolipomas represent fromthe primary tumor adrenal gland often incidental finding case asymptomatic rarely present symptom pain abdominal discomfort hematuria sign internal hemorrhage histologically benign variety tumor requires local excision symptomatic form dimension generally cm laparoscopic approach seems appropriate present case year old patient electively operated right adrenal tumor formationalaparoscopic right adrenalectomy performed using anterior transabdominal approach ligature clip suture used intervention accomplished ligasure maryland forceps force triad platform covidien medtronicusa postoperative evolution favorable pathological examination highlighted adrenal myelolipoma intratumoral hemorrhage,2017,"Molnar, Cătălin; Lata, Laura; Pisica, Radu; Russu, Cristian; Gherghinescu, Mircea; Molnar, Claudiu; Borda, Angela; Butiurca, Vlad-Olimpiu; Suciu, Bogdan-Andrei; Copotoiu, Constantin",Chirurgia,,,,,,https://doi.org/10.21614/chirurgia.112.1.58; https://www.ncbi.nlm.nih.gov/pubmed/28266294/,26006822.0,12
19446,19446,28350,dz8f6z98,,Medline,Laparoscopy-assisted resection of an undiagnosed liver tumor and ascending colon cancer via mini median laparotomy: report of a case.,10.1007/s00595-010-4524-5,,21969197.0,unk,describe resected hepatic angiomyolipoma ascending colon cancer synchronously via laparoscopic left lateral segmentectomy laparoscopic right colectomy respectively patient yearold man admitted hospital liver tumor ascending colon cancer detected general health check computed tomography ct showed hypervascular liver tumor mimicking hepatocellular carcinoma cm diameter segment liver ascending colon cancer diagnosed tnm stage left lateral liver right colon mobilized laparoscopically hepatic transaction followed resection anastomosis colon performed extracorporeally cm upper median incision type laparoscopyassisted combined resection useful obtain pathological diagnosis liver tumor remove entire tumor minimally invasive cosmetic manner,2011,"Mima, Kosuke; Beppu, Toru; Chikamoto, Akira; Ishiko, Takatoshi; Horino, Kei; Hayashi, Naoko; Watanabe, Masayuki; Takamori, Hiroshi; Okabe, Kazutoshi; Yamanaka, Tsuyoshi; Baba, Hideo",Surgery today,,,,,,https://doi.org/10.1007/s00595-010-4524-5; https://www.ncbi.nlm.nih.gov/pubmed/21969197/,655723.0,12
19475,19475,28387,wvfmxchl,,Medline,Liver Ablation: Best Practice.,10.1016/j.rcl.2015.05.012,,26321447.0,unk,tumor ablation liver evolved become wellaccepted tool management increasing complex oncologic patient present percutaneous ablation considered firstline therapy early early hepatocellular carcinoma secondline therapy colorectal carcinoma liver metastasis thermal ablation treatment option primary secondary liver tumor understanding underlying tumor biology important weighing potential benefit ablation article review ablation modality indication patient selection imaging surveillance emphasizes techniquespecific consideration performance percutaneous ablation,2015,"Wells, Shane A; Hinshaw, J Louis; Lubner, Meghan G; Ziemlewicz, Timothy J; Brace, Christopher L; Lee, Fred T",Radiologic clinics of North America,,,,,,https://doi.org/10.1016/j.rcl.2015.05.012; https://www.ncbi.nlm.nih.gov/pubmed/26321447/,27055204.0,12
19519,19519,28436,ihlitwmt,,Medline,Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.,10.1016/j.jvir.2014.06.013,,25081202.0,unk,purpose determine oncologic outcome predictor primary efficacy including renal nephrometry score radius exophyticendophytic property nearness tumor collecting system sinus anteriorposterior location relative polar line percutaneous radiofrequency rf ablation proven renal cell carcinoma rcc material method patient underwent percutaneous computed tomography ultrasoundguided rf ablation histologically proven rcc evaluated clinical data pathologic finding technical detail outcome reviewed univariate multivariate logistic regression analysis performed determine predictor primary technique effectiveness complication local tumor progressionfree metastasisfree overall survival calculated one hundred rcc lesion underwent rf ablation session patient median followup month mean mo range mo result efficacy rf ablation defined per international working group imageguided tumor ablation criterion total primary secondary technique effectiveness rate nine respectively primary efficacy associated size p proximity collecting system p renal nephrometry score p number ablation zone p complication occurred patient without procedurerelated death median year local progressionfree metastasisfree diseasespecific overall survival rate respectively conclusion percutaneous imageguided rf ablation rcc provides excellent intermediate oncologic control location size proximity collecting system low renal nephrometry score number ablation zone predict primary efficacy,2014,"McClure, Timothy D; Chow, Daniel S; Tan, Nelly; Sayre, James A; Pantuck, Allan J; Raman, Steven S",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.06.013; https://www.ncbi.nlm.nih.gov/pubmed/25081202/,2867017.0,12
19524,19524,28442,6xm5a079,,Medline,Inflow Venous Occlusion for Intracardiac Resection of an Occluding Right Ventricular Tumor.,10.5326/jaaha-ms-6318,,27259022.0,unk,use normothermic venous inflow occlusion enabled removal intracardiac tumor yr old kg spayed female airedale terrier history appendicular osteosarcoma recent exertional syncope inflow venous occlusion via median sternotomy thoracotomy without hypothermia used access mineralized mass within right ventricular outflow tract duration circulatory arrest beating heart surgery circumscribed intracardiac chondrosarcoma tumor marginally resected dog successfully alleviating exertional syncope restoring normal echogenic appearance right heart asymptomatic intracardiac chondrosarcoma recurrence pulmonary metastasis detected day cardiopulmonary arrest occurred day following intracardiac surgery use inflow occlusion viable technique select intracardiac tumor dog preoperative planning,2016,"Worley, Deanna Rae; Orton, E Christopher; Kroner, Kevin Thomas",Journal of the American Animal Hospital Association,,,,,,https://doi.org/10.5326/jaaha-ms-6318; https://www.ncbi.nlm.nih.gov/pubmed/27259022/,2038313.0,12
19586,19586,28514,273tu3b7,,Medline,Single-port transumbilical laparoscopic excision of retroperitoneal schwannoma mimicking a nonfunctional endocrine tumor in the body of the pancreas: a case report.,10.1177/1553350612441864,,22441807.0,unk,schwannomas benign tumor arise neural sheath schwann cell solitary benign schwannoma generally located head neck rare neoplasm among tumor retroperitoneal space report laparoscopic excision retroperitoneal schwannomas recently increase however case singleport laparoscopic excision tumor reported moreover report singleport excision schwannomas attached body pancreas around splenic vessel first report schwannoma lying adjacent body pancreas splenic artery vein excised singleport laparoscopic surgery notable aspect procedure use bipolar forceps singleport laparoscopic excision using bipolar forceps feasible safe procedure retroperitoneal solitary tumor even close splenic artery vein,2013,"Kameyama, Noriaki; Tomita, Masato; Mitsuhashi, Hiroaki; Matsumoto, Nobuaki; Obuchi, Toru; Yoshikawa, Yusuke; Tagaya, Nobumi; Kitagawa, Yuko",Surgical innovation,,,,,,https://doi.org/10.1177/1553350612441864; https://www.ncbi.nlm.nih.gov/pubmed/22441807/,41359532.0,12
19590,19590,28519,kvu62701,,Medline,LigaSure meets endobronchial valve in a case of lung cancer with pneumoconiosis.,10.3978/j.issn.2218-6751.2012.12.09,,25806247.0,unk,resection lung cancer associated pneumoconiosis may difficult since fibrosis limit exposure hilum use stapler yet surgery may complicated persistent air leak due underlying disease setting ligasure used perform tumor resection postoperative treatment air leak patient treated placement endobronchial valve,2013,"Fiorelli, Alfonso; Accardo, Marina; Vicidomini, Giovanni; Santini, Mario",Translational lung cancer research,,,,,,https://doi.org/10.3978/j.issn.2218-6751.2012.12.09; https://www.ncbi.nlm.nih.gov/pubmed/25806247/,12228203.0,12
19814,19814,28779,cq74xx72,,Medline,Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry.,10.1007/978-3-642-27994-2_25,,22918775.0,unk,peptide receptor radionuclide therapy effective treatment option patient welldifferentiated somatostatin receptorexpressing neuroendocrine tumor however published data result mainly retrospective monocentric study initiated multiinstitutional prospective boardreviewed registry patient treated peptide receptor radionuclide therapy germany five center patient registered primary tumor mainly derived pancreas small intestine whereas unknown primary tumor well differentiated median ki proliferation rate range peptide receptor radionuclide therapy performed using mainly yttrium andor lutetium radionuclides cycle mean overall survival estimated month followup month initial diagnosis month followup month start peptide receptor radionuclide therapy median overall survival yet reached subgroup analysis demonstrated best result obtained neuroendocrine tumor proliferation rate result indicate peptide receptor radionuclide therapy effective treatment well moderately differentiated neuroendocrine tumor irrespective previous therapy regarded one primary treatment option patient somatostatin receptorexpressing neuroendocrine tumor,2013,"Hörsch, Dieter; Ezziddin, Samer; Haug, Alexander; Gratz, Klaus Friedrich; Dunkelmann, Simone; Krause, Bernd Joachim; Schümichen, Carl; Bengel, Frank M; Knapp, Wolfram H; Bartenstein, Peter; Biersack, Hans-Jürgen; Plöckinger, Ursula; Schwartz-Fuchs, Sabine; Baum, R P",Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,,,,,,https://doi.org/10.1007/978-3-642-27994-2_25; https://www.ncbi.nlm.nih.gov/pubmed/22918775/,29741606.0,12
19888,19888,28864,453q288g,,Medline,[COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie].,10.1016/j.bulcan.2020.05.001,,32425210.0,unk,work examines impact sarscov epidemic organizational recommendation issued since march tumor board tb activity tumor board activity measured tumor board sheet extracted oncologic electronic file january april precontainment activity compared activity containment period also equivalent period number meeting held average number file reviewed per meeting including first presentation average number physician attendance evaluation criterion study covered tb held multidisciplinary team meeting mtm reviewed file including first submission moderate decrease number meeting march number file examined decreased following month even third period physician number attended mtm also decreased negative impact higher mediterranean part region first study tumor board activity covering large region little affected pandemic show impact participation mtm moderate addition tumor board followed recommendation optimizing quorum however decrease average mtm activity particularly first submission suggests potential delay patient management complementary qualitative quantitative work warranted estimate real impact carcinologic outcome,2020-05-18,"Grosclaude, Pascale; Azria, David; Guimbaud, Rosine; Thibault, Séverine; Daubisse, Laetitia; Cartron, Guillaume; Renaudie, Marie-José; Dalbies, Pierre-Adrien; Delord, Jean-Pierre; Bauvin, Eric",Bulletin du cancer,,,,,,https://doi.org/10.1016/j.bulcan.2020.05.001; https://www.ncbi.nlm.nih.gov/pubmed/32425210/,218691497.0,12
19956,19956,28941,e5zrxld2,,Medline,Single-Incision Laparoscopic Liver Resection for Colorectal Metastasis through Stoma Site at Time of Reversal of Diversion Ileostomy: A Case Report.,10.1155/2011/502176,,22091359.0,unk,minimally invasive surgical technique liver tumor gaining increased acceptance alternative traditional resection laparotomy article describe laparoscopic liver resection metastatic lesion patient primarily operated colorectal cancer resection conducted single port procedure stoma aperture time reversal diversion ileostomy sigle incision liver resection may le traumatic conventional laparoscopy could applied selected patient benign malignant liver tumor,2011,"Røsok, Bård I; Edwin, Bjørn",Minimally invasive surgery,,,,,,https://doi.org/10.1155/2011/502176; https://www.ncbi.nlm.nih.gov/pubmed/22091359/,11764314.0,12
20105,20105,29113,i0dg3l7e,,Medline,ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116.,10.4161/mabs.29097,,24870719.0,unk,humanized monoclonal antibody high affinity human epidermal growth factor receptor rg glycoengineered igg class antibody labeling rg zirconium zr aimed visualize vivo expression study biodistribution antibody human tumorbearing mouse biodistribution zrrg studied subcutaneously xenografted fadu tumor cell herpositive dosedependency zrrg organ distribution specific tumor uptake assessed administering dos ranging mgkg rg scidbeige mouse biodistribution analyzed h injection micropet imaging performed day injection mgkg zrrg fadu h qg calu xenograft varying expression excised tumor analyzed expression biodistribution analysis showed dose timedependent zrrg tumor uptake fadu tumor highest tumor uptake zrrg observed mgkg dose group idg h tracer injection micropet imaging revealed specific tumor uptake zrrg fadu h model increase tumor uptake time biodistribution data consistent micropet finding fadu h qg calu xenograft correlated expression level conclusion zrrg specifically accumulates expressing tumor pet imaging tracer provides realtime noninvasive information rg distribution tumor targeting tumor expression level,2014,"Terwisscha van Scheltinga, Anton G T; Lub-de Hooge, Marjolijn N; Abiraj, Keelara; Schröder, Carolien P; Pot, Linda; Bossenmaier, Birgit; Thomas, Marlene; Hölzlwimmer, Gabriele; Friess, Thomas; Kosterink, Jos G W; de Vries, Elisabeth G E",mAbs,,,,,,https://doi.org/10.4161/mabs.29097; https://www.ncbi.nlm.nih.gov/pubmed/24870719/,7550798.0,12
20157,20157,29175,2j5i446e,,Medline,"Advances in Robotic Vena Cava Tumor Thrombectomy: Intracaval Balloon Occlusion, Patch Grafting, and Vena Cavoscopy.",10.1016/j.eururo.2016.06.024,,27423505.0,unk,robotic level iii inferior vena cava ivc tumor thrombectomy described recently present ongoing robotic advance arena case series six patient mayo level iiiii thrombus underwent robotic caval thrombectomy radical nephrectomy retroperitoneal lymphadenectomy four patient proximal intra retrohepatic ivc control obtained solely intracaval fogarty balloon catheter one patient robotguided flexible cystoscopy ivc lumen performed rule residual secondary skip thrombus one patient caval wall defect thrombus excision reconstructed robotically using bovine pericardial patch finally patient concomitant renal adrenal tumor two distinct thrombus level iii robotic double thrombectomy performed mean renal tumor size cm ± four thrombus level iii mean operative time h ± ivc clamp time min ± blood loss ml ± hospital stay ± two patient required blood transfusion complication included clavien grade n grade n grade n mean followup mo ± robotic ivc thrombectomy viable alternative open surgery appropriately selected case experienced team patient summary present ongoing robotic surgical advance case series six patient blood clot inferior vena cava innovation help advance field,2016,"Kundavaram, Chandan; Abreu, Andre Luis de Castro; Chopra, Sameer; Simone, Giuseppe; Sotelo, Rene; Aron, Monish; Desai, Mihir M; Gallucci, Michele; Gill, Inderbir S",European urology,,,,,,https://doi.org/10.1016/j.eururo.2016.06.024; https://www.ncbi.nlm.nih.gov/pubmed/27423505/,7696541.0,12
20159,20159,29177,gd3nmm1q,,Medline,"Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.",10.1021/bc300509k,,23110503.0,unk,engineering peptidebased targeting agent residue sitespecific stable complexation radionuclides highly desirable strategy producing diagnostic therapeutic agent cancer disease report model nsnpy ligand cysteinederived αmelanocyte stimulating hormone αmsh peptide used novel demonstration widely applicable chelation strategy incorporation mico mtc core peptidebased molecule radiopharmaceutical application structural detail core ligandmetal complex model system demonstrated full chemical characterization facreiconsnpy comparative highperformance liquid chromatography hplc analysis mtciconsnpy αmsh analogue bearing nsnpy chelate modified cysteine residue generated complexed mico confirm chelation strategy utility applied peptidebased targeting agent characterization reico peptide conjugate confirmed efficient incorporation metal center mtcico analogue explored potential single photon emission computed tomography spect compound imaging melanocortin receptor mcr melanoma peptide showed excellent radiolabeling yield vitro stability amino acid challenge serum stability assay vitro bf melanoma cell uptake reached modest value ± applied activity h °c uptake significantly reduced coincubation nonlabeled αmsh analogue napamide μm p vivo spectxray computed tomography spectct imaging biodistribution evaluated bf melanoma xenografted mouse model spectct imaging clearly visualized tumor h post injection pi high tumortobackground contrast blocking study coinjected napamide mg per kg mouse body weight confirmed vivo specificity mcrpositive tumor biodistribution result yielded moderate tumor uptake ± percentage injected radioactive dose per gram tissue idg h pi relatively high uptake also seen kidney liver h pi ± idg ± idg respectively although reduced kidney uptake seen h pi ± idg result demonstrate utility novel mico chelation strategy applied targeting peptide,2012,"Jiang, Han; Kasten, Benjamin B; Liu, Hongguang; Qi, Shibo; Liu, Yang; Tian, Mei; Barnes, Charles L; Zhang, Hong; Cheng, Zhen; Benny, Paul D",Bioconjugate chemistry,,,,,,https://doi.org/10.1021/bc300509k; https://www.ncbi.nlm.nih.gov/pubmed/23110503/,44894033.0,12
20203,20203,29226,vs2562m8,,Medline,Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors.,10.1016/j.jvir.2014.09.012,,25446425.0,unk,purpose retrospectively review result hepatocellular carcinoma hcc treatment highpower gascooled multiantennacapable microwave device material method total hccs patient men mean age year range treated via percutaneous approach combination microwave ablation transarterial chemoembolization performed tumor patient tumor larger cm n tumor larger cm illdefined margin n lesion identified ultrasonography n mean tumor size cm range cm median followup month ablation alone compared cm range cm month respectively combination therapy procedure performed single microwave system certus one three gauge antenna result mean ablation time minute range min treatment considered technically successful single session primary technique effectiveness rate overall tumor cm smaller nine tumor larger cm ablation alone combination therapy major complication procedurerelated mortality overall survival rate median month clinical followup death related endstage liver disease n multifocal hcc n conclusion treating hcc gascooled multiantennacapable microwave ablation device safe promising treatment effectiveness,2015,"Ziemlewicz, Timothy J; Hinshaw, J Louis; Lubner, Meghan G; Brace, Christopher L; Alexander, Marci L; Agarwal, Parul; Lee, Fred T",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.09.012; https://www.ncbi.nlm.nih.gov/pubmed/25446425/,22369317.0,12
20236,20236,29263,6m9wdoh8,,Medline,Preoperative endoscopy localization error rate in patients with colorectal cancer.,10.1007/s00464-014-3969-9,,25480606.0,unk,background preoperative repeat endoscopy colorectal cancer crc patient considered many integral component surgical planning little known however utility reendoscopy method retrospective review consecutive patient undergoing elective surgical resection crc january december performed patient included initial endoscopist different operating surgeon localization error recorded final tumor location identified surgery different anatomical segment identified endoscopy chisquared test used compare categorical variable error rate confidence interval obtained using exact binomial distribution result patient identified also underwent preoperative reendoscopy operating surgeon partner nineteen patient incorrect tumor localization initial endoscopy equivalent error rate ci comparison two localization error reendoscopy ci reendoscopy found protective localization error p correcting error made initial endoscopy sensitivity reendoscopy diagnostic tool detect error corresponding specificity overall accuracy reendoscopy preventing endoscopic localization error ci conclusion small important localization error rate preoperative endoscopic evaluation colorectal tumor reendoscopy appears safe may potentially identify correct error help preoperative planning expense delaying surgery research necessary find way improve localization identify patient would benefit reendoscopy,2015,"Saleh, Fady; Abbasi, Thamer Al; Cleghorn, Michelle; Jimenez, M Carolina; Jackson, Timothy D; Okrainec, Allan; Quereshy, Fayez A",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-3969-9; https://www.ncbi.nlm.nih.gov/pubmed/25480606/,2056500.0,12
20280,20280,29310,xu8g2064,,Medline,Principles of and advances in percutaneous ablation.,10.1148/radiol.10081634,,21273519.0,unk,imageguided tumor ablation thermal nonthermal source received substantial attention treatment many focal malignancy increasing interest accompanied continual advance energy delivery application technique therapeutic combination intent improve efficacy andor specificity ablative therapy review outline clinical percutaneous tumor ablation technology detailing science device technique technical obstacle current trend future goal percutaneous tumor ablation method chemical ablation cryoablation hightemperature ablation radiofrequency microwave laser ultrasound irreversible electroporation discussed advance technique also covered including combination therapy tissue property modulation role computer modeling treatment optimization,2011,"Ahmed, Muneeb; Brace, Christopher L; Lee, Fred T; Goldberg, S Nahum",Radiology,,,,,,https://doi.org/10.1148/radiol.10081634; https://www.ncbi.nlm.nih.gov/pubmed/21273519/,34800195.0,12
20350,20350,29393,cyn3y320,,Medline,Instant Abdominal Wall Reconstruction with Biologic Mesh following Resection of Locally Advanced Colonic Cancer.,10.1155/2012/959342,,22577393.0,unk,present case immediate abdominal wall reconstruction biologic mesh following resection locally advanced colonic cancer tumor right colon respond neoadjuvant chemotherapy surgical enbloc excision including excision invasion abdominal wall achieved defect reconstructed porcine dermal collagen mesh patient discharged complication adaptation mesh excellent sixmonth followup,2012,"Kaya, Oskay; Olcucuoglu, Engin; Seker, Gaye; Kulacoglu, Hakan",Case reports in medicine,,,,,,https://doi.org/10.1155/2012/959342; https://www.ncbi.nlm.nih.gov/pubmed/22577393/,12067621.0,12
20365,20365,29409,h90valfl,,Medline,MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.,10.26508/lsa.201900545,,32381551.0,unk,mapk pathway mutation affect onefifth head neck squamous cell carcinoma hnscc unexpectedly mapk pathway aberration associated remarkably long patient survival even among patient tp mutation median ∼ yr explored underlying outcomefavoring mechanism omics followed preclinical model strikingly multiple hotspot nonhotspot mapk mutation abraf hras mapk mapk abrogated erbb activation wellestablished hnscc progression signal inhibitor study functionally defined erk activity negatively regulating phosphoerbb mapkmutants furthermore panpathway immunoprofiling investigation identified mapkmutant tumor cd tcellinflamed tumor inherently bearing highimmunoreactive constitutive cytolytic tumor microenvironments immunocompetent mapkmutant hnscc model displayed active cell death massive cd tcell recruitment situ consistent cd tinflamed phenotype mapkmutant hnscc patient independent tumormutational burden survived time longer wt patient antipdpdl immunotherapy similar prognosticity noted pancancers uncovered clinical signaling immunological uniqueness mapkmutant hnscc potential biomarker utility predicting favorable patient survival,2020-06-01,"Ngan, Hoi-Lam; Liu, Yuchen; Fong, Andrew Yuon; Poon, Peony Hiu Yan; Yeung, Chun Kit; Chan, Sharon Suet Man; Lau, Alexandria; Piao, Wenying; Li, Hui; Tse, Jessie Sze Wing; Lo, Kwok-Wai; Chan, Sze Man; Su, Yu-Xiong; Chan, Jason Ying Kuen; Lau, Chin Wang; Mills, Gordon B; Grandis, Jennifer Rubin; Lui, Vivian Wai Yan",Life science alliance,,,,,,https://doi.org/10.26508/lsa.201900545; https://www.ncbi.nlm.nih.gov/pubmed/32381551/,218555758.0,12
20428,20428,29482,3ujsiio6,,Medline,Analysis of risk factors associated with acute pancreatitis after endoscopic papillectomy.,10.1038/s41598-020-60941-3,,32139734.0,unk,acute pancreatitis ap common adverse event ae endoscopic papillectomy ep prophylactic plastic pancreatic stent pps placement appears prevent ap evaluated factor associated postep ap retrospective analysis patient tumor duodenal papilla underwent ep january november tertiary care center clinical laboratory endoscopic ultrasound parameter pps placement evaluated seventytwo patient underwent ep men mean age year mean main pancreatic duct mpd diameter cm mean tumor size cm tumor staged utn utn utn thirtyeight aes occurred patient mortality total bilirubin tumor size mpd diameter pps placement odds ratio or ap multivariate analysis pps placement × mpd diameter showed or ci p ci p ap conclusion patient jaundice large tumor dilated mpd seem le likely postep ap pps placement associated higher risk ap may question use,2020-03-05,"Taglieri, Eloy; Micelli-Neto, Otávio; Bonin, Eduardo Aimoré; Goldman, Suzan Menasce; Kemp, Rafael; Dos Santos, José Sebastião; Ardengh, José Celso",Scientific reports,,,,,,https://doi.org/10.1038/s41598-020-60941-3; https://www.ncbi.nlm.nih.gov/pubmed/32139734/,212408798.0,12
20449,20449,29506,6ev6svke,,Medline,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",10.1038/s41596-018-0105-7,,30617350.0,unk,neurofibromatosis type ii nf disease lack effective therapy nf characterized bilateral vestibular schwannomas v cause progressive debilitating hearing loss leading social isolation increased rate depression major limitation nf basic translational research lack animal model allow full spectrum research biology molecular mechanism nf tumor progression well effect neurological function protocol describe inject schwannoma cell mouse brain cerebellopontine angle cpa region also describe apply stateoftheart intravital imaging hearing assessment technique study tumor growth hearing loss addition ataxia angiogenesis tumorstroma interaction assay applied model used test efficacy novel therapeutic approach studying disease every angle model offer potential unravel basic biological underpinnings nf develop novel therapeutic control devastating disease protocol adapted study disease within cpa including meningioma lipoma vascular malformation hemangioma epidermoid cyst cerebellar astrocytomas metastatic lesion entire surgical procedure take min per mouse allows subsequent longitudinal imaging well neurological hearing assessment month,2019,"Chen, Jie; Landegger, Lukas D; Sun, Yao; Ren, Jun; Maimon, Nir; Wu, Limeng; Ng, Mei R; Chen, John W; Zhang, Na; Zhao, Yingchao; Gao, Xing; Fujita, Takeshi; Roberge, Sylvie; Huang, Peigen; Jain, Rakesh K; Plotkin, Scott R; Stankovic, Konstantina M; Xu, Lei",Nature protocols,,,,,,https://doi.org/10.1038/s41596-018-0105-7; https://www.ncbi.nlm.nih.gov/pubmed/30617350/,57574586.0,12
20538,20538,29614,lmnykgci,,Medline,Microwave Ablation for the Treatment of Hepatic Adenomas.,10.1016/j.jvir.2015.09.021,,26830938.0,unk,microwave mw ablation used treat hepatocellular adenoma six patient five woman one man mean age mean treated tumor size cm ± tumor response evaluated serial crosssectional imaging mean followup month ± primary treatment effectiveness local tumor control instance hemorrhage malignant transformation new hepatic tumor extrahepatic metastasis early experience treatment hepatic adenoma mw ablation demonstrates safe feasible treatment modality shortterm followup continued investigation including comparison treatment modality warranted,2016,"Smolock, Amanda R; Cristescu, Mircea M; Potretzke, Theodora A; Ziemlewicz, Timothy J; Lubner, Meghan G; Hinshaw, J Louis; Brace, Christopher L; Lee, Fred T",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2015.09.021; https://www.ncbi.nlm.nih.gov/pubmed/26830938/,206660889.0,12
20615,20615,29703,hpcni41t,,Medline,Acute stroke from tumor embolus in a patient with cardiac sarcoma: Aspiration thrombectomy with Penumbra catheter.,10.1177/1591019915609782,,26515698.0,unk,common primary malignant cardiac tumor cardiac sarcoma mesenchymal origin case report describes patient hyperacute stroke caused cardiac sarcoma underwent rapid recanalization mechanical aspiration thrombectomy penumbra catheter,2016,"Byon, Jung Hee; Kwak, Hyo Sung; Chung, Gyung Ho; Jang, Kyu Yun","Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences",,,,,,https://doi.org/10.1177/1591019915609782; https://www.ncbi.nlm.nih.gov/pubmed/26515698/,32484370.0,12
20654,20654,29748,0wyn97y9,,Medline,Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.,10.1002/hep.29098,,28170115.0,unk,longterm year study radiofrequency ablation rfa hepatocellular carcinoma hcc bridging therapy patient listed orthotopic liver transplantation lt evaluated impact rfa waiting list dropout rate postlt tumor recurrence longterm intentiontotreat diseasespecific survival ds march october rfa performed initial standalone bridge therapy lt patient menwomen ratio mean age year de novo hccs mean size cm followup period initial rfa ranged month median month assessed overall tumorspecific waiting list dropout rate postlt tumor recurrence year postlt intentiontotreat survival rate dropout waiting list due tumor progression occurred patient hcc recurrence lt occurred patient postlt overall survival o rate year respectively recurrencefree survival rf rate respectively intentiontotreat o rf ds rate entire study population year respectively conclusion rfa firstline standalone bridge therapy lt achieves excellent longterm overall tumorspecific survival low dropout rate tumor progression despite long wait list time sustained low tumor recurrence rate upon postlt followup year hepatology,2017,"Lee, Min Woo; Raman, Steven S; Asvadi, Nazanin H; Siripongsakun, Surachate; Hicks, Robert M; Chen, Jeffrey; Worakitsitisatorn, Akeanong; McWilliams, Justin; Tong, Myron J; Finn, Richard S; Agopian, Vatche G; Busuttil, Ronald W; Lu, David S K",Hepatology,,,,,,https://doi.org/10.1002/hep.29098; https://www.ncbi.nlm.nih.gov/pubmed/28170115/,205904300.0,12
20702,20702,29801,mdfk4w4x,,Medline,Inhibition of inflammatory cytokines after early decompression may mediate recovery of neurological function in rats with spinal cord injury.,10.4103/1673-5374.152374,,25883619.0,unk,variety inflammatory cytokine involved spinal cord injury influence recovery neuronal function present study established rat model acute spinal cord injury cerclage cerclage suture released hour later simulate decompression surgery neurological function evaluated behaviorally week surgery tumor necrosis factor α immunoreactivity apoptosis quantified region injury rat underwent decompression surgery significantly weaker immunoreactivity tumor necrosis factor α significantly fewer apoptotic cell showed faster improvement locomotor function animal decompression surgery performed decompression hour resulted significantly faster recovery hour data indicate early decompression may improve neurological function spinal cord injury inhibiting expression tumor necrosis factor α,2015,"Xie, Jia-Bing; Zhang, Xin; Li, Quan-Hui; Xu, Zhu-Jun",Neural regeneration research,,,,,,https://doi.org/10.4103/1673-5374.152374; https://www.ncbi.nlm.nih.gov/pubmed/25883619/,32676170.0,12
20732,20732,29834,5cl0i780,,Medline,A new device for fiducial registration of image-guided navigation system for liver RFA.,10.1007/s11548-017-1647-9,,28718001.0,unk,purpose radiofrequency ablation liver tumor liver rfa widely performed ultrasound guidance however discriminating tumor needle often difficult cavitation caused rfainduced coagulation unclear ultrasound image lead complication tumor residue therefore imageguided navigation system based fiducial registration developed fiducial point usually set patient skin use internal fiducial point improve accuracy navigation study new device introduced use internal fiducial point using u method slicer navigation software polaris vicra position sensor two target tumor abdominal phantom puncture target used also new device make possible obtain tracking coordinate body invented first twodimensional reslice image ct image using slicer built virtual needle displayed twodimensional reslice image reflecting movement actual needle fiducial registration phantom experiment using three set fiducial point configuration one conventional case using surface point two case center target tumor selected fiducial point performed configuration one surgeon punctured target tumor ten time guidance slicer display finally statistical analysis examining puncture error performed result puncture error target tumor decreased significantly center target tumor included one fiducial point compared surface point used conclusion study introduces new device use internal fiducial point suggests accuracy imageguided navigation system liver rfa improved using new device,2018,"Doba, Nobutaka; Fukuda, Hiroyuki; Numata, Kazushi; Hao, Yoshiteru; Hara, Kouji; Nozaki, Akito; Kondo, Masaaki; Chuma, Makoto; Tanaka, Katsuaki; Takebayashi, Shigeo; Koizumi, Norihiro; Kobayashi, Akira; Tokuda, Junichi; Maeda, Shin",International journal of computer assisted radiology and surgery,,,,,,https://doi.org/10.1007/s11548-017-1647-9; https://www.ncbi.nlm.nih.gov/pubmed/28718001/,10681400.0,12
20741,20741,29843,k5ukdmqa,,Medline,Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factor.,10.1007/s00464-020-07456-0,,32076859.0,unk,background aim study analyze risk factor local recurrence lr exclusive laparoscopic thermoablation ta without associated liver resection method among patient underwent ta department patient hcc lm exclusive laparoscopic ta representing lesion hcc lm ta associated procedure case liver resection ta done without liver clamping median tumor size cm range lesion larger cm size close major liver vessel tumor location right liver s sssa result mortality nil morbidity rate including dindoclavien ii grade median followup month per lesion lr rate ta n patient mean time month among patient lr could retreated successfully new resection reta multivariate analysis revealed tumor location alone s andor sa independent risk factor lr ta conclusion exclusive laparoscopic ta safe effective tool treat liver malignancy without liver resection classical risk factor tumor location upper segment liver independent risk factor lr,2020-02-19,"Ledoux, Geoffrey; Amroun, Koceila; Rhaiem, Rami; Cagniet, Audrey; Aghaei, Arman; Bouche, Olivier; Hoeffel, Christine; Sommacale, Daniele; Piardi, Tullio; Kianmanesh, Reza",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-020-07456-0; https://www.ncbi.nlm.nih.gov/pubmed/32076859/,211169531.0,12
20834,20834,29956,cgcasjjg,,Medline,Preliminary assessment of a renal tumor materials model.,10.1089/end.2011.0050,,21740196.0,unk,purpose evaluate material model laparoscopic guided cryotherapy radiofrequency tissue ablation rfa kidney tumor expert surgeon assessment material method inaugural american urological association tissue ablative course content validity testing renal tumor model undertaken five expert faculty cryotherapy rfa technique renal tumor performed laparoscopic ultrasonography u examination tumor model performed u guided placement activation treatment probe tumor model completed questionnaire rated quality renal tumor model point likert scale result subject assigned score likert scale regarding ability identify tumor u able deploy ablative probe model u guidance would recommend use teaching model resident fellow thought tumor model appropriate teaching laparoscopic u imaging renal tumor ablative treatment procedure teaching practicing laparoscopic usguided cryotherapy teaching practicing laparoscopic usguided rfa conclusion developed unique model simulates small kidney tumor used training surgeon ablative technique,2011,"Fernandez, Alfonso; Chen, Elvis; Moore, John; Peters, Terry M; Cheung, Carling; Erdeljan, Petar; Fuller, Andrew; Pautler, Stephen E; McDougall, Elspeth M",Journal of endourology,,,,,,https://doi.org/10.1089/end.2011.0050; https://www.ncbi.nlm.nih.gov/pubmed/21740196/,37942917.0,12
20848,20848,29972,begxgfs1,,Medline,Percutaneous Renal Tumor Ablation: Radiation Exposure During Cryoablation and Radiofrequency Ablation.,10.1007/s00270-015-1169-1,,26159355.0,unk,introduction reserved solely nonsurgical case percutaneous ablation becoming increasingly popular treatment option wider array patient small renal mass radiation risk need better defined transition continues material method retrospective review renal tumor ablation database revealed patient underwent percutaneous ablation treatment renal tumor year time period imparted radiation dose information reviewed procedure converted effective patient dose skin dose using established technique statistical analysis performed ablative technique result cryoablation procedure mean dlp mgycm sd resulting mean effective dose msv sd mean ctdivol mgy sd resulting mean skin dose mgy sd rfa procedure mean dlp mgycm sd resulting mean effective dose msv sd mean ctdivol mgy sd resulting mean skin dose mgy sd difference patient radiation exposure two renal ablation technique statistically significant p conclusion cryoablation rfa imparted average skin dose well gy deterministic threshold appreciable sequela renal tumor cryoablation resulted mean skin effective radiation dose twice rfa radiation exposure renal tumor ablation technique high end medical imaging radiation dose spectrum,2016,"McEachen, James C; Leng, Shuai; Atwell, Thomas D; Tollefson, Matthew K; Friese, Jeremy L; Wang, Zhen; Murad, M Hassan; Schmit, Grant D",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-015-1169-1; https://www.ncbi.nlm.nih.gov/pubmed/26159355/,23481637.0,12
20884,20884,30009,vpbjcvlf,,Medline,Neurovascular Perfusion Study With DynaPBV During Preoperative Balloon Test Occlusion: A Feasibility Study on Aneurysm and Tumor Lesions.,10.1097/rct.0000000000000961,,31929377.0,unk,report feasibility safety technical advantage flatdetector computed tomography perfusion fdctp balloon test occlusion bto angiography study patient patient scheduled bto evaluated cerebral blood volume map extracted fdctp image acquired test fdctp perfusion combined bto feasible safe intracranial tumor aneurysm case vessel sacrifice considered,2020-01-10,"Ciceri, Elisa F; Caldiera, Valentina; Talenti, Giacomo; Caputi, Luigi; Cordella, Roberto; DʼOnofrio, Giovanni; Faragò, Giuseppe",Journal of computer assisted tomography,,,,,,https://doi.org/10.1097/rct.0000000000000961; https://www.ncbi.nlm.nih.gov/pubmed/31929377/,210192964.0,12
20888,20888,30015,ojvpdb3r,,Medline,Positive detection of exfoliated colon cancer cells on linear stapler cartridges was associated with depth of tumor invasion and preoperative bowel preparation in colon cancer.,10.1186/s12957-016-0991-5,,27577701.0,unk,background aim study investigate exfoliated cancer cell ecc linear stapler cartridge used anastomotic site colon cancer method prospectively analyzed ecc linear stapler cartridge used anastomosis colon cancer patient underwent colectomy completed functional endtoend anastomosis linear stapler cartridge irrigated saline collected cytological examination cytological diagnosis made boardcertified pathologist based papanicolaou staining result detection rate ecc linear stapler cartridge positive detection ecc significantly associated depth tumor invasion p preoperative bowel preparation p marked difference eccpositive eccnegative group term operation method tumor location histopathological classification surgical margin conclusion since ecc identified cartridge linear stapler used anastomosis preoperative mechanical bowel preparation using polyethylene glycol solution cleansing anastomotic site using tumoricidal agent anastomosis may necessary decrease ecc advanced colon cancer,2016,"Ikehara, Kishiko; Endo, Shungo; Kumamoto, Kensuke; Hidaka, Eiji; Ishida, Fumio; Tanaka, Jun-Ichi; Kudo, Shin-Ei",World journal of surgical oncology,,,,,,https://doi.org/10.1186/s12957-016-0991-5; https://www.ncbi.nlm.nih.gov/pubmed/27577701/,8128627.0,12
20905,20905,30033,r8f52q07,,Medline,Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer.,10.1016/j.jtho.2017.08.015,,28882585.0,unk,objective aim study investigate relationship clinicopathological prognostic factor including surgical margin distance tumor spread air space stas recurrence limited resection primary lung cancer method identified case limited resection examined clinicopathological feature using cox regression analysis examined significant prognostic factor recurrence limited resection finally conducted histopathological evaluation tumor stas result multivariate cox analysis showed risk local recurrence significantly associated stas hazard ratio p tumor margin le cm hazard ratio p however presence tumor stas significantly associated distant recurrence p lack association stas distant recurrence may due small number distant recurrence case adenocarcinoma nine squamous cell carcinoma seven others positive stas morphological stas pattern single cell small cell cluster large nest significant relationship recurrence rate morphological stas pattern staspositive group associated presence micropapillary p andor solid component p patient adenocarcinoma lymphovascular pleural invasion p conclusion presence stas tumor margin le cm significant risk factor local recurrence earlystage lung cancer limited resection thus presence tumor stas might pathological prognostic factor patient lung cancer undergone limited resection however pathological molecular significance stas remain clarified,2017,"Masai, Kyohei; Sakurai, Hiroyuki; Sukeda, Aoi; Suzuki, Shigeki; Asakura, Keisuke; Nakagawa, Kazuo; Asamura, Hisao; Watanabe, Shun-Ichi; Motoi, Noriko; Hiraoka, Nobuyoshi",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,https://doi.org/10.1016/j.jtho.2017.08.015; https://www.ncbi.nlm.nih.gov/pubmed/28882585/,23550418.0,12
20906,20906,30034,rnr02p2j,,Medline,Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma.,10.1007/s11604-017-0628-9,,28357723.0,unk,purpose retrospectively evaluate role curative treatment patient intermediatestage hepatocellular carcinoma hccs identify subgroup benefit curative treatment method april december patient intermediatestage hccs underwent either curative treatment hepatectomy n radiofrequency ablation rfa n n transarterial chemoembolization tace n initial treatment hccs overall survival influence treatment allocation prognosis factor affecting treatment allocation evaluated result year survival rate confidence interval ci curative group ci tace group treatment allocation significant prognostic factor p hazard ratio ci curative group consisted patient childpugh p tace group tumor number fewer p unilobar tumor location p within cm criterion p within upto criterion p childpugh within cm criterion unilobar tumor location significantly linked treatment allocation multivariate analysis conclusion curative treatment prolong survival selected patient intermediatestage hccs,2017,"Sugino, Yuichi; Yamakado, Koichiro; Yamanaka, Takashi; Fujimori, Masashi; Nakatsuka, Atsuhiro; Takaki, Haruyuki; Takei, Yoshiyuki; Sakuma, Hajime; Isaji, Shuji",Japanese journal of radiology,,,,,,https://doi.org/10.1007/s11604-017-0628-9; https://www.ncbi.nlm.nih.gov/pubmed/28357723/,27918163.0,12
20969,20969,30112,uik1ae2p,,Medline,Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation.,10.1007/s00270-017-1845-4,,29164309.0,unk,purpose evaluate possibility pathologic diagnosis genetic analysis percutaneous coreneedle biopsy cnb lung tumor specimen obtained immediately radiofrequency ablation rfa material method patient underwent cnb lung tumor immediately rfa may may analyzed patient men woman median age year range year lung tumor measuring cm median cm thirteen tumor solid predominantly groundglass opacity ggo computed tomography specimen pathologically examined using hematoxylin eosin staining additional immunostaining necessary specimen analyzed egfr kras genetic mutation safety technical success rate procedure possibility pathologic diagnosis genetic mutation analysis evaluated result major minor complication rate respectively tumor cell successfully obtained case technical success rate significantly lower ggodominant tumor compared solid lesion p pathologic diagnosis possible case based staining alone n additional immunostaining n although atypical cell obtained pathologic diagnosis could achieved case egfr kras mutation could analyzed specimen conclusion pathologic diagnosis genetic analysis could performed even lung tumor specimen obtained immediately rfa,2018,"Hasegawa, Takaaki; Kondo, Chiaki; Sato, Yozo; Inaba, Yoshitaka; Yamaura, Hidekazu; Kato, Mina; Murata, Shinichi; Onoda, Yui; Kuroda, Hiroaki; Sakao, Yukinori; Yatabe, Yasushi",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-017-1845-4; https://www.ncbi.nlm.nih.gov/pubmed/29164309/,3699980.0,12
21000,21000,30151,o8bbor4y,,Medline,Imaging of insulinlike growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule 111In-DOTA-ZIGF1R:4551.,10.2967/jnumed.111.090829,,22173843.0,unk,unlabelled one pathway leading androgen independence prostate cancer involves upregulation insulinlike growth factor type receptor igfr radionuclide imaging igfr tumor might used selection patient would likely benefit igfrtargeted therapy goal study evaluate feasibility vivo radionuclide imaging igfr expression prostate cancer xenograft using small nonimmunoglobulinderived binding protein called affibody molecule method igfrbinding zigfr affibody molecule sitespecifically conjugated maleimido derivative dota labeled binding radiolabeled zigfr igfrexpressing cell evaluated vitro vivo result dotazigfr stably labeled preserved specific binding igfrexpressing cell vitro mouse indotazigfr accumulated igfrexpressing organ pancreas stomach lung salivary gland receptor saturation experiment demonstrated targeting du prostate cancer xenograft nmri nunu mouse igfrspecific tumor uptake ± percentage injected dose per gram tumortoblood ratio ± h injection conclusion study demonstrates feasibility vivo targeting igfrexpressing prostate cancer xenograft using affibody molecule development radiolabeled affibody molecule might provide useful clinical tool stratification patient prostate cancer igfrtargeting therapy,2012,"Tolmachev, Vladimir; Malmberg, Jennie; Hofström, Camilla; Abrahmsén, Lars; Bergman, Thomas; Sjöberg, Anna; Sandström, Mattias; Gräslund, Torbjörn; Orlova, Anna","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.090829; https://www.ncbi.nlm.nih.gov/pubmed/22173843/,20571020.0,12
21002,21002,30153,7fc3nwxt,,Medline,"Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses.",10.1016/j.juro.2011.11.099,,22357170.0,unk,purpose increased incidence low stage renal cancer thermal ablation technology emerged viable treatment option current aua american urological association guideline include thermal ablation treatment modality select individual compared laparoscopic percutaneous approach radio frequency ablation renal tumor guidance urological surgeon material method reviewed radio frequency ablation database patient renal mass undergoing laparoscopic computerized tomography guided percutaneous radio frequency ablation simultaneous peripheral fiberoptic thermometry november january single tertiary care center data collected patient demographic surgical clinicopathological outcome stratified approach result total patient renal tumor underwent laparoscopic tumor computerized tomography guided tumor radio frequency ablation statistically significant difference laparoscopic computerized tomography guided radio frequency ablation group respect patient demographic complication rate renal functional outcome p year kaplanmeier estimation radiographic recurrencefree probability computerized tomography guided radio frequency ablation laparoscopic radio frequency ablation p subanalysis renal cell carcinoma tumor showed year kaplanmeier estimation oncologic recurrencefree probability postablation biopsy proven viable tumor computerized tomography guided radio frequency ablation laparoscopic radio frequency ablation p median followup month laparoscopic radio frequency ablation month computerized tomography guided radio frequency ablation conclusion laparoscopic computerized tomography guided radio frequency ablation appear safe effective statistically equivalent rate complication recurrence,2012,"Young, Ezekiel E; Castle, Scott M; Gorbatiy, Vladislav; Leveillee, Raymond J",The Journal of urology,,,,,,https://doi.org/10.1016/j.juro.2011.11.099; https://www.ncbi.nlm.nih.gov/pubmed/22357170/,206614838.0,12
21044,21044,30203,l5wucqc9,,Medline,Retroperitoneal mass presenting as recurrent inguinal hernia: A case report.,10.1016/j.ijscr.2016.01.005,,26812669.0,unk,introduction retroperitoneal mass presenting inguinal hernia rare condition presentation case year old male admitted symptom weight loss abdominal discomfort left sided recurrent inguinal hernia physical examination demonstrated abdominal mass left flank irreducible painless scrotal mass history left sided inguinal hernia surgery six year ago computed tomography revealed large enhancing left sided retroperitoneal mass invading colon pancreas kidney going towards left scrotum unblock tumor resection including neighboring organ left kidney left colon distal pancreas spleen performed scrotal extension tumor also excised inguinal canal repaired primarily histopathology mass myxoidliposarcoma patient disease free without hernia recurrence poor renal function twenty month followup discussion large retroperitoneal tumor may grow towards inguinal region mimic inguinal hernia irreducible painless hard scrotal mass considered perspective,2016,"Tardu, Ali; Yagci, Mehmet Ali; Karagul, Servet; Ertugrul, Ismail; Kayaalp, Cuneyt",International journal of surgery case reports,,,,,,https://doi.org/10.1016/j.ijscr.2016.01.005; https://www.ncbi.nlm.nih.gov/pubmed/26812669/,26050776.0,12
21047,21047,30206,9th2kbwp,,Medline,Important observations made managing carotid body tumors during a 25-year experience.,10.1016/j.jvs.2010.06.153,,21146747.0,unk,objective objective ass short longterm outcome patient carotid body tumor cbt resection discus potential pitfall treatment method analysis undertaken patient underwent cbt resection royal brisbane woman hospital greenslopes private hospital primary tumor characteristic surgical technique outcome recorded analyzed result total consecutive cbt resection recurrent tumor carried patient woman mean age year range year nontender neck mass presenting complaint followed screening familial contralateral tumor familial case occurred patient operative death complication occurred operation predominantly temporary nerve palsy likely occur tumor large volume case removal coexisting vagal tumor malignant disease present seven case patient followedup postoperatively mean year range year metachronous paragangliomas discovered six patient familial disease conclusion early resection carotid body tumor undertaken still small minimize risk neural injury increase tumor size case bilateral cbt recommend smaller tumor resected first staged resection larger contralateral tumor familial bilateral tumor case synchronous metachronous paragangliomas excluded mandatory lifelong followup essential,2010,"Kruger, Allan J; Walker, Philip J; Foster, Wallace J; Jenkins, Jason S; Boyne, Nicholas S; Jenkins, Julie",Journal of vascular surgery,,,,,,https://doi.org/10.1016/j.jvs.2010.06.153; https://www.ncbi.nlm.nih.gov/pubmed/21146747/,20311956.0,12
21101,21101,30266,aescshz4,,Medline,"A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.",10.1517/14712598.2015.1039979,,26094695.0,unk,hepatocellular carcinoma hcc third leading cause cancerrelated death worldwide disease immune microenvironment chronic hepatitis b virus hbv infection also immunerelated disease major etiological factor hcc especially asia immune regulator pleiotropic activity cell nature killer cell dendritic cell efficacy thymalfasin hcc patient proven several pilot study adjuvant therapy combination thymalfasin significantly improved survival prolonged time tumor recurrence patient received transcatheter arterial chemoembolization tumor resection improvement patient immunity also demonstrated however largescale randomized controlled study far resectable hcc patient confirm role thymalfasin adjuvant therapy patient hbvrelated hcc curative resection largescale multicenter randomized controlled trial planned china investigate effect thymalfasin mg twice week month year recurrencefree survival rate tumor immune microenvironment first announcement study protocol clinialtrialsgov identifier nct,2015,"Qiu, Shuang-Jian; Zhou, Zhong-Guo; Shen, Feng; Li, Ai-Jun; Chen, Min-Shan; Ying, Min-Gang; Chen, Zhong; Zhang, Yi-Xin; Sun, Hui-Chuan; Fan, Jia",Expert opinion on biological therapy,,,,,,https://doi.org/10.1517/14712598.2015.1039979; https://www.ncbi.nlm.nih.gov/pubmed/26094695/,28789593.0,12
21116,21116,30282,r9g7srcl,,Medline,Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.,10.1186/2191-219x-1-21,,22214201.0,unk,background several peptide hormone receptor identified specifically overexpressed cell surface certain human tumor example high incidence density subtype neuropeptide npy receptor found breast tumor recently demonstrated use potent radiolabeled somatostatin bombesin receptor antagonist considerably improved sensitivity vivo imaging compared agonist report first dotacoupled peptidic receptor affine dimer antagonist method based affine dimeric peptide scaffold previously reported competitively antagonize npymediated process developed new dimeric dotacoupled receptor affine antagonist scintigraphy radiotherapy dimeric peptide tested specific binding expressed sknmc cell expressed shsyy well ability mediate camp production sknmc cell result introduction two dota moiety ntermini dimeric npy analog well double asn replacement dprdota lysdota moiety dramatically reduced binding affinity however asymmetric introduction dota moiety one segment peptidic heterodimer resulted suitable antagonist receptor targeting high binding affinity compound devoid binding affinity conclusion design vitro characterization first dotacoupled dimeric npy receptor antagonist high affinity selectivity described compound may excellent candidate imaging ypositive tumor treatment,2011,"Chatenet, David; Cescato, Renzo; Waser, Beatrice; Erchegyi, Judit; Rivier, Jean E; Reubi, Jean Claude",EJNMMI research,,,,,,https://doi.org/10.1186/2191-219x-1-21; https://www.ncbi.nlm.nih.gov/pubmed/22214201/,1715937.0,12
21160,21160,30330,51g3a5nx,,Medline,Mandibular Reconstruction by Using a Liquid Nitrogen-Treated Autograft in a Dog with an Oral Tumor.,10.5326/jaaha-ms-6339,,28291396.0,unk,yr old intact female german shepherd dog presented large peripheral odontogenic fibroma malignant melanoma lower jaw tumor resected unilateral subtotal rostral hemimandibulectomy mandible removed devitalized intraoperatively freezing liquid nitrogen subsequently reimplanted new bone tissue formed gap frozen bone host bone regenerated bone contained osteocyte osteoblast blood vessel cosmetic appearance dog preserved dog normal mastication malignant melanoma recurred rostral left canine tooth day reconstruction surgery subtotal hemimandibulectomy consequently performed first reported case mandibular reconstruction using liquid nitrogentreated autograft dog oral tumor,2017,"Okamura, Yasuhiko; Heishima, Kazuki; Motegi, Tomoki; Sasaki, Jun; Goryo, Masanobu; Nishida, Hideji; Tsuchiya, Hiroyuki; Katayama, Masaaki; Uzuka, Yuji",Journal of the American Animal Hospital Association,,,,,,https://doi.org/10.5326/jaaha-ms-6339; https://www.ncbi.nlm.nih.gov/pubmed/28291396/,8098936.0,12
21183,21183,30361,e2rw6oiz,,Medline,Endovascular Reconstruction of Extrahepatic Portal Vein in Noncirrhotic and Nonmalignant Chronic Portal Vein Thrombosis Secondary to an Iatrogenic Stenotic Lesion.,10.1177/1538574416674640,,27770082.0,unk,portal vein pv thrombosis pvt absence liver disease thrombophilia rare report yearold male history stage chronic kidney disease presented emergency department month abdominal surgery progressive abdominal pain distention computed tomography revealed pvt multiple collateral moderate ascites undergone partial gastrectomy gastrojejunal anastomosis outside facility gastrointestinal stromal tumor caused iatrogenic stenotic lesion pv patient underwent balloon angioplasty endovascular deployment mm × mm viabahn covered stent w l gore associate flagstaff arizona extrahepatic pv via transhepatic approach device allowed complete restoration prograde portal flow clinical improvement month intervention remains symptomfree normal liver function test patent endoprosthesis antiplatelet therapy,2016,"Guerrero-Hernandez, Manuel; Hinojosa, Carlos A; Anaya-Ayala, Javier E; Elenes, Erika; Torre, Aldo",Vascular and endovascular surgery,,,,,,https://doi.org/10.1177/1538574416674640; https://www.ncbi.nlm.nih.gov/pubmed/27770082/,5487379.0,12
21195,21195,30373,giy99ttz,,Medline,A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer.,10.1016/j.jtho.2016.03.019,,27179848.0,unk,introduction presence ro protooncogene receptor tyrosine kinase gene ro rearrangement lung cancer confers sensitivity ro kinase inhibitor including crizotinib however rare abnormality ∼ nonsmall cell lung carcinoma typically identified fluorescence situ hybridization fish screening using immunohistochemical ihc staining would cost timeefficient method cohort lung tumor negative common mutation related targeted therapy screened ass sensitivity specificity ihc staining detecting ro gene rearrangement enriched four case first identified fish review published data also undertaken result ihc staining sensitive confidence interval specific confidence interval overall hscore higher used patient ro gene rearrangement younger typically neversmokers tumor adenocarcinoma highergrade architectural feature focal signet ring morphologic feature two five four patient treated crizotinib showed partial response three also showing partial response pemetrexed three four patient remain alive month respectively conclusion ihc staining used screen ro gene rearrangement patient herein showing response crizotinib patient tumor test positive according ihc staining negative according fish also identified may implication treatment selection,2016,"Viola, Patrizia; Maurya, Manisha; Croud, James; Gazdova, Jana; Suleman, Nadia; Lim, Eric; Newsom-Davis, Tom; Plowman, Nick; Rice, Alexandra; Montero, M Angeles; Gonzalez de Castro, David; Popat, Sanjay; Nicholson, Andrew G",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,https://doi.org/10.1016/j.jtho.2016.03.019; https://www.ncbi.nlm.nih.gov/pubmed/27179848/,46831729.0,12
21206,21206,30387,2mc6gftw,,Medline,Comparison of tumor cell numbers and 22C3 PD-L1 expression between cryobiopsy and transbronchial biopsy with endobronchial ultrasonography-guide sheath for lung cancer.,10.1186/s12931-019-1162-3,,31420048.0,unk,background previously reported cryobiopsy cryo endobronchial ultrasonographyguide sheath ebusgs peripheral pulmonary lesion ppls provides significantly larger tissue transbronchial biopsy tbb provides high quantity quality dna gene analysis next generation sequencing however tumor cell yield programmed death ligand pdl expression approach compared assessed tumor cell number pdl expression cryo ebusgs ppls tbb patient lung cancer method sixteen patient enrolled prospective study june november tokyo woman medical university hospital number tumor cell single biopsy total number tumor cell average number tumor cell c pdl expression ≥ ≥ compared cryo tbb result number tumor cell single biopsy total number tumor cell average number tumor cell obtained cryo significantly larger obtained tbb cryo mean ± standard error mean ± ± ± tbb ± ± ± p p p respectively pdl ≥ ≥ patient cryo respectively whereas tbb respectively sensitivity specificity positive predictive value negative predictive value concordance κ coefficient based cryo tbb respectively pdl ≥ respectively pdl ≥ conclusion cryo ebusgs may useful diagnostic approach lung cancer advantage tbb gene analysis whole exon sequencing particularly could contribute patient taking pembrolizumab firstline therapy pdl negative evaluating tbb specimen could also provide ample tissue pdl expression analysis addition accurate diagnosis gene analysis,2019,"Arimura, Ken; Kondo, Mitsuko; Nagashima, Yoji; Kanzaki, Masato; Kobayashi, Fumi; Takeyama, Kiyoshi; Tamaoki, Jun; Tagaya, Etsuko",Respiratory research,,,,,,https://doi.org/10.1186/s12931-019-1162-3; https://www.ncbi.nlm.nih.gov/pubmed/31420048/,201018127.0,12
21225,21225,30406,my5curi1,,Medline,Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.,10.1007/s00270-012-0377-1,,22535243.0,unk,purpose study designed evaluate relationship minimal margin size local tumor progression ltp following ctguided radiofrequency ablation rfa colorectal cancer liver metastasis clm method institutional review boardapproved hippacompliant review identified patient previously untreated clm underwent rfa march may resulting ablation zone completely covering tumor week rfa dynamic ct comparing pre postrfa ct minimal margin size categorized mm followup included ct every month kaplanmeier methodology cox regression analysis used evaluate effect minimal margin size tumor location size proximity vessel ltp result fortyfive clm progressed locally median ltpfree survival lpfs month twoyear lpfs rate ablated clm minimal margin mm mm mm p minimal margin p tumor size p independent risk factor ltp risk ltp decreased mm increase minimal margin size whereas additional mm increase tumor size increased risk ltp conclusion ablation zone minimal margin uniformly larger mm week postablation ct associated best local tumor control,2013,"Wang, Xiaodong; Sofocleous, Constantinos T; Erinjeri, Joseph P; Petre, Elena N; Gonen, Mithat; Do, Kinh G; Brown, Karen T; Covey, Anne M; Brody, Lynn A; Alago, William; Thornton, Raymond H; Kemeny, Nancy E; Solomon, Stephen B",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-012-0377-1; https://www.ncbi.nlm.nih.gov/pubmed/22535243/,25991390.0,12
21252,21252,30438,8d4ve2b8,,Medline,Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.,10.2967/jnumed.114.138180,,24700882.0,unk,unlabelled radionuclide imaging nearinfrared fluorescent nirf imaging high sensitivity detect tumor vivo combination modality using duallabeled antibody may allow preoperative intraoperative tumor localization may used imageguided surgery ensure complete resection tumor tissue evaluated potential dualmodality imaging prostate cancer monoclonal antibody db directed extracellular domain prostatespecific membrane antigen psma study db labeled nirf dye irdyecw method db conjugated nhydroxysuccinimideirdyecw pisothiocyanatobenzyldiethylenetriaminepentaacetic acid itcdtpa subsequently radiolabeled biodistribution nirf imaging indtpadbirdyecw μg mbqmouse injected intravenously balbc nude mouse subcutaneous psmaexpressing lncap tumor right flank psmanegative pc tumor left flank biodistribution determined injection addition microspectct nirf imaging indtpadbirdyecw μg mbqmouse performed mouse intraperitoneally growing lstpsma tumor result indtpadbirdyecw specifically accumulated subcutaneous psmapositive lncap tumor ± percentage injected dose per gram h injection whereas uptake subcutaneous psmanegative pc tumor significantly lower ± percentage injected dose per gram h injection intraperitoneal lstpsma tumor could visualized specifically microspectct nirf imaging injection feasibility imageguided resection intraperitoneal tumor demonstrated model conclusion duallabeled indtpadbirdyecw enables specific sensitive detection prostate cancer lesion vivo microspectct nirf imaging addition preoperative microspectct imaging detect tumor nirf imaging enables imageguided surgical resection preclinical finding warrant clinical study indtpadbirdyecw improve tumor detection resection prostate cancer patient,2014,"Lütje, Susanne; Rijpkema, Mark; Franssen, Gerben M; Fracasso, Giulio; Helfrich, Wijnand; Eek, Annemarie; Oyen, Wim J; Colombatti, Marco; Boerman, Otto C","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.114.138180; https://www.ncbi.nlm.nih.gov/pubmed/24700882/,7971677.0,12
21328,21328,30542,g5q0eacy,,Medline,Robotic transanal endoscopic microsurgery: technical details for the lateral approach.,10.1097/dcr.0b013e3182a2ac84,,24022537.0,unk,background transanal endoscopic microsurgery minimally invasive approach reserved resection selected rectal tumor however approach technically demanding although robotic technology may overcome limitation approach system difficult dock especially lithotomy position objective study aim thus report technical detail robotic transanal endoscopic microsurgery use lateral approach design setting study prospective evaluation robotic transanal endoscopic microsurgery single tertiary institution protocol approved local ethic committee intervention patient underwent routine mechanical bowel preparation placed left right lateral position according tumor location circular anal dilatator used together glove port technique robotic system docked hip ° optic articulated instrument used additional assistant trocar tumor excision realized atraumatic grasper articulated cautery hook defect closed barbed continuous stiches case main outcome measure primary outcome safety feasibility procedure result three patient underwent robotic transanal endoscopic microsurgery use lateral approach mean operative time minute including minute docking robot intraoperative complication pneumoperitoneum without intraabdominal lesion postoperative complication mean hospital stay day margin negative case limitation study limited small number patient conclusion robotic transanal endoscopic microsurgery use lateral approach feasible may facilitate local resection small lesion mid lower rectum might assume important place sphincterpreserving surgery especially selected early rectal cancer see video supplemental digital content httplinkslwwcomdcra,2013,"Buchs, Nicolas C; Pugin, François; Volonte, Francesco; Hagen, Monika E; Morel, Philippe; Ris, Frederic",Diseases of the colon and rectum,,,,,,https://doi.org/10.1097/dcr.0b013e3182a2ac84; https://www.ncbi.nlm.nih.gov/pubmed/24022537/,24849687.0,12
21415,21415,30643,pcewuzkq,,Medline,Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.,10.3171/2016.1.jns152238,,27153172.0,unk,objective craniopharyngiomas difficult remove completely based intimate relationship surrounding visual endocrine structure reoperations uncommon associated higher rate complication lower extent resection radiation often offered alternative reoperation endonasal endoscopic transsphenoidal approach used recent year craniopharyngiomas previously removed craniotomy impact approach reoperations widely investigated method author reviewed prospectively acquired database endonasal endoscopic resection craniopharyngiomas year weill cornell medical college newyorkpresbyterian hospital performed senior author reoperations separated first operation pre postoperative visual endocrine function tumor size body mass index bmi quality life qol extent resection eor impact prior radiation complication compared group eor divided grosstotal resection gtr neartotal resection ntr subtotal resection str univariate multivariate analysis performed result total endonasal surgical procedure reoperations firsttime operation reoperations differ tumor volume radiological configuration patient bmi hypopituitarism diabetes insipidus di common reoperations respectively compared first operation respectively p patient gtr intended rate gtr gtrntr significantly different first operation respectively reoperations respectively reoperations prior radiation larger tumor volume lower rate gtr vision improved equally first operation compared reoperations new anterior pituitary deficit common first operation compared reoperations v respectively p new di common reoperations compared firsttime operation v respectively p nonendocrine complication occurred firsttime operation reoperations tumor regrowth occurred patient median followup month different first versus reoperations associated str compared gtrntr p receiving radiation str v p overall bmi increased significantly kgm year six month surgery significant improvement qol similar firsttime operation reoperations negatively correlated str conclusion endonasal endoscopic transsphenoidal reoperation result similar eor visual outcome improvement qol firsttime operation significant increase complication eor impacted tumor volume prior radiation reoperations offered patient recurrent craniopharyngiomas may preferable radiation patient gtr ntr achieved,2017,"Dhandapani, Sivashanmugam; Singh, Harminder; Negm, Hazem M; Cohen, Salomon; Souweidane, Mark M; Greenfield, Jeffrey P; Anand, Vijay K; Schwartz, Theodore H",Journal of neurosurgery,,,,,,https://doi.org/10.3171/2016.1.jns152238; https://www.ncbi.nlm.nih.gov/pubmed/27153172/,2322547.0,12
21445,21445,30677,3lgw1es5,,Medline,Use of Imaging Prior to Referral to a Musculoskeletal Oncologist.,10.5435/jaaos-d-19-00109,,31206439.0,unk,musculoskeletal tumor society american academy orthopaedic surgeon recently collaborated clinical practice guideline use imaging prior referral orthopaedic oncologist complete manuscript available orthoguidelines wwworthoguidelinesorg musculoskeletal tumor society website wwwmstsorg clinical practice guideline designed assist practitioner without specialization musculoskeletal tumor determine efficacious imaging modality establishing accurate diagnosis treatment plan confronted bone softtissue lesion unknown etiology panel expert interest expertise orthopaedic surgery orthopaedic oncology musculoskeletal radiology created relevant question synthesized existing literature topic recommendation group considered several common clinical radiographic feature often seen initial presentation bone softtissue tumor pelvis extremity guideline intended inform frontline practitioner give insight imaging modality minimal clinical utility well critical establishing accurate diagnosis assessing urgency referral oncologic specialist addition summary primary finding report included three case illustrate clinical scenario guideline assist determining appropriate firstline management strength relevant guideline noted,2019,"Miller, Benjamin J",The Journal of the American Academy of Orthopaedic Surgeons,,,,,,https://doi.org/10.5435/jaaos-d-19-00109; https://www.ncbi.nlm.nih.gov/pubmed/31206439/,190528270.0,12
21477,21477,30711,gca4xjxn,,Medline,Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.,10.1007/s00270-018-2050-9,,30088062.0,unk,purpose compare outcome percutaneous ablation pa versus nephrectomy ne small renal mass srms patient renal cell carcinoma evaluate role preprocedural biopsy treatment srm material method retrospective cohort analysis patient subjected pa ne srm cm january august total patient srm included main analysis patient demographic tumor characteristic biopsy procedural detail clinical outcome complication rate change renal function compared patient malignant srms survival rate compared using logrank test result total patient underwent pa patient underwent ne respective mean followup period sd sd year p rate intervention benign tumor similar pa n ne n p without routine preprocedural biopsy routine preprocedural biopsy resulted zero benign tumor treated pa cohort tumor recurrence similar cumulative survival similar group p residual tumor observed pa patient complication rate lower pa ne v p significant reduction egfr observed ne mlmin p relative pa mlmin p conclusion pa safe alternative ne treatment srm similar overall survival decreased complication rate preprocedural biopsy decrease rate intervention benign tumor routinely performed,2018,"Lourenco, Pedro; Bilbey, Nicolas; Gong, Bo; Bahrabadi, Arvin; Halkier, Bradley",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-2050-9; https://www.ncbi.nlm.nih.gov/pubmed/30088062/,51936373.0,12
21482,21482,30716,pxw4b7t2,,Medline,Laparoscopic Distal Pancreatectomy of a Solid Pseudopapillary Tumor (SPT) Achieves Long-Term Oncologic Safety and Multiorgan Preservation.,10.1055/s-0039-1693999,,31440438.0,unk,oncological safety laparoscopic approach solid pseudopapillary tumor spts pancreas remains matter debate present longterm followup adolescent girl spt pancreatic tail multimodality workup including magnetic resonance imaging mri revealed complex spherical mass cm × cm × cm likely located pancreatic tail routine laboratory investigation tumor marker within normal limit alpha fetoprotein afp cancer antigen ca ca carcinoembryonic antigen cea adrenocorticotropic hormone acth diagnostic laparoscopy performed verify origin tumor pancreatic tail threeport technique tumor mobilized splenic vessel distal pancreatectomy could completed histopathological examination confirmed complete resection lowgrade malignant spt postoperative course unremarkable regular pediatric oncological followup examination year including mri every month ruled recurrence confirmed preservation splenic pancreatic function data technical feasibility laparoscopic approach pancreatic spt already available pediatric case report add longterm oncological functional success available literature,2019,"ElHaddad, Ahmed; Gasparella, Paolo; Castellani, Christoph; Singer, Georg; Sorantin, Erich; Zach, Klara; Till, Holger",European journal of pediatric surgery reports,,,,,,https://doi.org/10.1055/s-0039-1693999; https://www.ncbi.nlm.nih.gov/pubmed/31440438/,201251440.0,12
21536,21536,30775,2q6isc6v,,Medline,Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.,10.1021/mp300232n,,22747077.0,unk,insulinlike growth factor receptor igfr potential new target treatment breast cancer patient breast cancer lesion express igfr may benefit treatment antiigfr antibody igfr expression visualized using radiolabeled r monoclonal antibody directed igfr however antibody clear slowly circulation resulting low tumortobackground ratio early injection therefore aimed accelerate targeting igfr using radiolabeled r fab fab fragment vitro immunoreactivity binding affinity internalization r igg fab fab determined using triple negative igfrexpressing breast cancer cell line sum vivo pharmacokinetics inlabeled r igg fab fab studied mouse bearing subcutaneous sum xenograft spectct image acquired biodistribution measured ex vivo vitro binding characteristic radiolabeled r igg fab comparable whereas affinity fab fragment significantly lower kd nm nm nm r igg fab fab respectively biodistribution study showed maximum tumor uptake inr igg fab fab idg h pi idg h pi idg h pi respectively however maximal tumortoblood ratio fab h pi twice high obtained r h pi fab h pi injection excess unlabeled r significantly reduced tumor uptake suggesting uptake r igg fab specific igfr major fraction tumor uptake fab nonspecific igfrexpressing xenograft visualized infab spectct early h pi r igg tumor could visualized h specific targeting observed infab infab fragment showed improved targeting igfr expressing tumor tumortoblood ratio twice high obtained inr adequate tumor targeting spectct image observed early h pi individualization optimization igfr targeted therapy infab may tracer choice,2012,"Heskamp, Sandra; van Laarhoven, Hanneke W M; Molkenboer-Kuenen, Janneke D M; Bouwman, Wilbert H; van der Graaf, Winette T A; Oyen, Wim J G; Boerman, Otto C",Molecular pharmaceutics,,,,,,https://doi.org/10.1021/mp300232n; https://www.ncbi.nlm.nih.gov/pubmed/22747077/,12355181.0,12
21581,21581,30826,bqtvgp8i,,Medline,CT-guided radiofrequency ablation following high-dose chemotherapy of a liver-metastasizing pancreatoblastoma with tumor thrombus in the portal vein.,10.1007/s00247-013-2698-x,,23828484.0,unk,pancreatoblastoma rare neoplasm encountered commonly infant young child unresectable metastatic tumor poor prognosis despite adjuvant chemotherapy radiotherapy report successful use ctguided radiofrequency ablation subsequent intensive chemotherapy yearold girl livermetastasizing pancreatoblastoma right segment portal vein tumor thrombosis remission year,2013,"Zheng, Jiasheng; Zhang, Honghai; Sun, Yu; Sun, Bin",Pediatric radiology,,,,,,https://doi.org/10.1007/s00247-013-2698-x; https://www.ncbi.nlm.nih.gov/pubmed/23828484/,9084902.0,12
21592,21592,30839,ne1cmfgm,,Medline,Percutaneous ablation in the kidney.,10.1148/radiol.11091207,,22012904.0,unk,percutaneous ablation kidney performed standard therapeutic nephronsparing option patient poor candidate resection increasing use largely prompted rising incidental detection renal cell carcinoma crosssectional imaging need preserve renal function patient comorbid condition multiple renal cell carcinoma andor heritable renal cancer syndrome clinical study date indicate radiofrequency ablation cryoablation effective therapy acceptable short intermediateterm outcome low risk appropriate setting attention pre peri postprocedural detail result following percutaneous radiofrequency ablation cryoablation treatment renal cell carcinoma reviewed article including several larger scale study ablation ta tumor clinical technical consideration unique ablation kidney presented potential complication discussed,2011,"Venkatesan, Aradhana M; Wood, Bradford J; Gervais, Debra A",Radiology,,,,,,https://doi.org/10.1148/radiol.11091207; https://www.ncbi.nlm.nih.gov/pubmed/22012904/,207682616.0,12
21697,21697,30960,3t8bbvu2,,Medline,Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model.,10.1007/s40477-019-00366-5,,30811016.0,unk,purpose obtain complete response thermal ablation margin entire tumor volume must treated realtime ultrasound visualization limited ablation due gas production study ass feasibility fusing volumetric contrastenhanced ultrasound ceus obtained immediately prior microwave ablation realtime ceus following ablation machineperfused porcine liver method ten cm microwave ablation performed five explanted perfused liver prior ablation microbubbles injected vasculature ultrasound sweep across liver captured volumetric image maximum enhancement volumetric image fused overlay realtime ultrasound imaging since perfused liver tumor spherical marker circumscribing target volume placed image approximatively total intended circumscribed spherical volume ablated following ablation second bolus injection ultrasound contrast administered demonstrating continued enhancement intentionally nonablated second volumetric image postablation ceus fused overlay realtime ultrasound image guidance ablation remaining enhancing volume result technical success achieved case pre postablation ceus volume fused realtime imaging antenna placement initial subsequent ablation conclusion ceusceus fusion thermal ablation feasible greatly improves workflow approach may augment use dynamic ceus guidance improving antenna placement aiding identification ablation initial residual enhancing tissue,2019,"Monsky, Wayne; Keravnou, Christina; Averkiou, Michalakis",Journal of ultrasound,,,,,,https://doi.org/10.1007/s40477-019-00366-5; https://www.ncbi.nlm.nih.gov/pubmed/30811016/,73481493.0,12
21706,21706,30971,p3z3ush0,,Medline,Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.,10.1007/s00261-018-1800-0,,30327828.0,unk,purpose retrospectively evaluate utility fusion image pre postablation hepatobiliary phase hbp series ass ablation margin radiofrequency ablation rfa hepatocellular carcinoma hccs additionally identify factor indicative adequate ablation margin predictor local tumor progression ltp method fiftynine hccs patient treated rfa followedup year mean month fusion image pre postablation hbp series created using nonrigid registration manual correlation ablation margin appearance classified ablation margin ablation margin completely surrounding tumor ablation marginzero partially discontinuous ablation margin without protrusion hcc ablation margina partially discontinuous ablation margin protrusion hcc indeterminate index tumor visible minimal ablation margin measured clinical factor examined identify risk factor ltp result ltp observed followup tumor mean minimal ablation margin mm multivariate analysis revealed ablation margin status significant factor p cumulative ltp rate year respectively ablation margin nodule significantly lower p year respectively ablation marginzero nodule conclusion fusion image enable early assessment ablation efficacy majority hccs ablation margin status significant factor ltp,2019,"Takeyama, Nobuyuki; Mizobuchi, Naruki; Sakaki, Masashi; Shimozuma, Yu; Munechika, Jiro; Kajiwara, Atsushi; Uchikoshi, Manabu; Uozumi, Syojiro; Ohgiya, Yoshimitsu; Gokan, Takehiko",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-018-1800-0; https://www.ncbi.nlm.nih.gov/pubmed/30327828/,53528641.0,12
21745,21745,31016,683i7jlv,,Medline,Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.,10.1158/0008-5472.can-09-4663,,20406987.0,unk,emmprin extracellular matrix metalloproteinase inducer multifunctional glycoprotein expressed cancer cell stromal cell tumor microenvironment direct effect within tumor cell promotion tumorstroma interaction emmprin induces tumor cell invasiveness regional angiogenesis kaposis sarcomaassociated herpesvirus kshv common etiology cancer arising setting immune suppression including kaposis sarcoma primary effusion lymphoma however whether emmprin expression function regulated kshv oncogenic virus tumor microenvironment promote viral cancer pathogenesis remains unknown fibroblast endothelial cell support latent kshv infection represent cellular component kaposis sarcoma lesion therefore used primary human fibroblast endothelial cell determine whether kshv regulates emmprin expression whether kshvemmprin interaction mediate cell invasiveness found kshv promotes fibroblast endothelial cell invasiveness following de novo infection upregulation emmprin effect mediated kshvencoded latencyassociated nuclear antigen also found emmprin promotes invasiveness well colony formation primary effusion lymphoma cell derived human tumor collectively data implicate kshv activation emmprin important mechanism cancer progression support potential utility targeting emmprin novel therapeutic approach kshvassociated tumor,2010,"Qin, Zhiqiang; Dai, Lu; Slomiany, Mark G; Toole, Bryan P; Parsons, Chris",Cancer research,,,,,,https://doi.org/10.1158/0008-5472.can-09-4663; https://www.ncbi.nlm.nih.gov/pubmed/20406987/,11570413.0,12
21778,21778,31054,igev2234,,Medline,"Core needle biopsy of soft tissue tumors, CEUS vs US guided: a pilot study.",10.1007/s40477-015-0161-6,,26550072.0,unk,purpose purpose study evaluate usefulness contrastenhanced ultrasonography ceus bioptic sampling soft tissue tumor stt compared unenhanced ultrasonography alone method prospective longitudinal study patient subjected ultrasonography usguided core needle biopsy cnb characterize suspected stt three series bioptic sampling carried patient respectively using unenhanced u alone ceus area tumor enhanced contrast medium bioptic sample underwent histological evaluation result analyzed comparing histology biopsy definitive diagnosis surgically excised sample result patient completed entire study procedure case three bioptic sampling gave unanimous result also compared surgical specimen seven case use ceus allowed obtain additional accurate information mass question compared simple u guidance without contrast one patient sampling obtained using unenhanced ultrasonography guidance area enhanced contrast agent precisely result surgical specimen conclusion ceus due ability evaluate microvascular area proven promising method guiding bioptic sampling soft tissue tumor directing needle significant area tumor given small number patient evaluated study achieve statistically significant result would appropriate obtain larger sample size since first result seem encouraging justify increase population,2015,"Coran, Alessandro; Di Maggio, Antonio; Rastrelli, Marco; Alberioli, Enrico; Attar, Shady; Ortolan, Paolo; Bortolanza, Carlo; Tosi, Annalisa; Montesco, Maria Cristina; Bezzon, Elisabetta; Rossi, Carlo Riccardo; Stramare, Roberto",Journal of ultrasound,,,,,,https://doi.org/10.1007/s40477-015-0161-6; https://www.ncbi.nlm.nih.gov/pubmed/26550072/,25068457.0,12
21787,21787,31064,wgc4qw9v,,Medline,Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors.,10.1002/jmri.22644,,21761464.0,unk,purpose investigate hypothesis fourdimensional transcatheter intraarterial perfusion trip magnetic resonance imaging mri quantify immediate perfusion change radiofrequency rf ablation rabbit vx liver tumor material method nine new zealand white rabbit used surgically implant vx liver tumor ultrasoundguided rf ablation tumor received either true sham ablation selective catheterization left hepatic artery xray fluoroscopy acquired pre postrf ablation trip mr image using ml intraarterial gadopentetate dimeglumine two regionsofinterest drawn upon tumor generate signalintensity time curve area curve auc calculated provide semiquantitative perfusion measurement compared using paired ttest α ablated tissue visually confirmed pathology using evans blue dye result mean auc perfusion vx tumor true ablation group decreased confidence interval ci ci rf ablation ci rf ablation au p shamablated tumor demonstrated significant perfusion change conclusion trip mri quantify liver tumor perfusion reduction vx rabbit rf ablation mri technique potentially used improve tumor response assessment time rf ablation,2011,"Sato, Kent T; Wang, Dingxin; Lewandowski, Robert J; Ryu, Robert K; Klein, Rachel A; Salem, Riad; Larson, Andrew C; Omary, Reed A",Journal of magnetic resonance imaging : JMRI,,,,,,https://doi.org/10.1002/jmri.22644; https://www.ncbi.nlm.nih.gov/pubmed/21761464/,35220472.0,12
21820,21820,31104,4uvhggmr,,Medline,Evaluation of Lung Radiofrequency Ablation With Dual-Energy Computed Tomography: Analysis of Tumor Composition and Lung Perfusion.,10.1097/rct.0000000000000422,,27224234.0,unk,objective aim study evaluate radiofrequency ablation rfa lung tumor dualenergy computed tomography focusing tumor composition lung perfusion method tumor patient included dualenergy computed tomography performed rfa day month thereafter effective atomic number zeff tumor rfa compared zeff followup using paired test lung perfusion evaluated iodine map image decreased perfusion suspected rfa lung perfusion scintigraphy performed result mean zeff tumor significantly p decreased followup compared rfa lung perfusion parenchyma peripheral tumor appeared decrease day tumor confirmed scintigraphy tumor conclusion dualenergy computed tomography useful providing additional information tumor composition lung perfusion,2016,"Tomita, Koji; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Iguchi, Toshihiro; Matsui, Yusuke; Kanazawa, Susumu",Journal of computer assisted tomography,,,,,,https://doi.org/10.1097/rct.0000000000000422; https://www.ncbi.nlm.nih.gov/pubmed/27224234/,12439418.0,12
21827,21827,31111,mbkukepx,,Medline,Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors.,10.2214/ajr.09.3206,,20410411.0,unk,objective objective study ass characteristic locoregional lymph node enlargement successful radiofrequency ablation rfa treatment malignant lung tumor material method followup ct examination patient seven men seven woman age range year underwent rfa session treatment primary n metastatic n lung tumor mean followup sd month range month retrospectively reviewed two thoracic radiologist site size hilar mediastinal lymph node recorded baseline followup month rfa session addition size type location ablated lesion lesion recorded complication rfa recorded data analyzed using fisher exact test result increase lymph node size detected rfa session month followup four patient one node enlarged remaining six patient one nodal region enlarged average increase nodal size mm shortaxis diameter mm longaxis diameter twentyeight percent rfa session associated enlargement least one lymph node greater mm shortaxis diameter month followup ct showed node decreased size month followup lesion size location complication shown significantly associated mediastinal lymph node enlargement p conclusion recognition reversible locoregional lymph node enlargement rfa important prevent misdiagnosis nodal metastatic disease,2010,"Sharma, Amita; Digumarthy, Subba R; Kalra, Mannudeep K; Lanuti, Michael; Shepard, Jo-Anne O",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.09.3206; https://www.ncbi.nlm.nih.gov/pubmed/20410411/,3355478.0,12
21898,21898,31196,r295gzfp,,Medline,"Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.",10.1073/pnas.0900198106,,19667180.0,unk,chromosome allelic loss common nasopharyngeal carcinoma npc may reflect essential tumor suppressor gene loss tumorigenesis intact chromosome transferred npc cell line using microcellmediated chromosome transfer approach microcell hybrid mchs containing intact exogenously transferred chromosome tumor suppressive athymic mouse demonstrating intact chromosome npc mchs able suppress tumor growth mouse comparative analysis mchs derived tumor segregants identified commonly eliminated tumorsuppressive cr provide functional evidence gene mirrorimage polydactyly mipol map within single q cr hitherto reported associated developmental disorder specifically suppresses vivo tumor formation mipol gene expression downregulated npc cell line approximately npc tumor via promoter hypermethylation allelic loss slca foxa neighboring gene mapping region show frequent downregulated gene expression promoter hypermethylation precluding possible global methylation effect providing evidence mipol play unique role npc protein localizes mainly nucleus reexpression mipol stable transfectants induces cell cycle arrest mipol tumor suppression related upregulation pwafcip pkip protein pathway study provides compelling evidence chromosome harbor tumor suppressor gene associated npc candidate gene mipol associated tumor development,2009,"Cheung, Arthur Kwok Leung; Lung, Hong Lok; Ko, Josephine Mun Yee; Cheng, Yue; Stanbridge, Eric J; Zabarovsky, Eugene R; Nicholls, John M; Chua, Daniel; Tsao, Sai Wah; Guan, Xin-Yuan; Lung, Maria Li",Proceedings of the National Academy of Sciences of the United States of America,,,,,,https://doi.org/10.1073/pnas.0900198106; https://www.ncbi.nlm.nih.gov/pubmed/19667180/,8437698.0,12
21912,21912,31212,io8j0f4m,,Medline,Outcome after radiofrequency ablation of sarcoma lung metastases.,10.1007/s00270-013-0644-9,,23670570.0,unk,purpose resection mainstay management patient sarcoma lung metastasis limit many resection performed patient inoperable disease smallvolume lung metastasis amenable thermal ablation report result radiofrequency ablation rfa method retrospective study patient treated intention treat site disease minimum ct followup month treatment performed general anesthesiaconscious sedation using cooltip rfa followup ct scan analyzed local control primary tumor type location grade diseasefree interval prior resectionchemotherapy number size lung tumor uni bilateral disease complication overall progressionfree survival recorded result twentytwo patient woman median age range year lung metastasis treated session mean median tumor size initial number cm range cm respectively median ct clinical followup month respectively primary local control rate common terminology criterion grade complication longterm sequela mean median reached year overall survival month median year progressionfree survival month prior diseasefree interval significant factor affect overall survival conclusion rfa safe effective treatment patient smallvolume sarcoma metastasis,2014,"Koelblinger, Claus; Strauss, Sandra; Gillams, Alice",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0644-9; https://www.ncbi.nlm.nih.gov/pubmed/23670570/,11154699.0,12
21913,21913,31213,ca69sspv,,Medline,Cryoablation of sternal metastases for pain palliation and local tumor control.,10.1016/j.jvir.2014.08.011,,25255705.0,unk,purpose determine safety effectiveness cryoablation sternal metastasis pain palliation local tumor control material method tumor ablation database retrospectively reviewed sternal cryoablation procedure performed january june yielded procedure treat sternal metastasis patient five men median patient age year range metastasis arose five primary site breast lung kidney ampulla thyroid median tumor size cm range cm seven patient underwent cryoablation pain palliation five underwent cryoablation local tumor control oligometastatic disease clinical outcome including complication local tumor control pain response evaluated retrospectively result mean pain score decreased ± median range baseline ± median range following cryoablation p two patient durable pain palliation four greater month pain relief median duration month range mo two patient recurrent pain developed underwent repeat cryoablation durable pain relief allowing single repeat treatment local tumor control achieved four five patient treated indication median followup month range mo one patient infectious complication developed successfully treated antibiotic outpatient basis conclusion cryoablation safe potentially effective treatment patient painful sternal metastasis achieve local tumor control select patient,2014,"Hegg, Ryan M; Kurup, Anil Nicholas; Schmit, Grant D; Weisbrod, Adam J; Atwell, Thomas D; Olivier, Kenneth R; Moynihan, Timothy J; Callstrom, Matthew R",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.08.011; https://www.ncbi.nlm.nih.gov/pubmed/25255705/,8029254.0,12
21937,21937,31238,spfe7t7d,,Medline,Percutaneous radiofrequency ablation does not affect glomerular filtration rate.,10.1089/end.2010.0029,,20818985.0,unk,purpose study short intermediateterm global renal function patient undergoing single percutaneous radiofrequency ablation prfa solitary renal parenchymal tumor material method reviewed record patient underwent single prfa solitary renal parenchymal tumor used abbreviated modified diet renal disease equation calculate baseline month year glomerular filtration rate gfr defined normal moderately diminished severely diminished gfr ccminute used wilcoxon paired rank sum method compare month year gfr baseline fit linear regression model test association lesion size gfr controlling lesion location baseline gfr result difference gfr baseline month year v ccminute p v ccminute p respectively tumor size affect gfr month year controlling lesion location baseline gfr conclusion single application prfa affect gfr short intermediate term,2010,"Pettus, Joseph A; Werle, David M; Saunders, Weston; Hemal, Ashok; Kader, Andrew Karim; Childs, David; Zagoria, Ronald J",Journal of endourology,,,,,,https://doi.org/10.1089/end.2010.0029; https://www.ncbi.nlm.nih.gov/pubmed/20818985/,3230643.0,12
22093,22093,31415,47o6c1tx,,Medline,Therapeutic occlusion of the vertebral artery using a new penumbra occlusion device system and ruby coils (penumbra): A technical note.,10.4103/bc.bc_18_19,,32166201.0,unk,several method achieve therapeutic sacrifice vessel coiling brings commonly used penumbra occlusion device pod system newer modality therapeutic large vessel occlusion food drug administration approved peripheral vessel report case therapeutic vertebral artery va occlusion achieved pod system ruby coil first time patient diagnosed new malignantappearing tumor cervical spine conventional angiogram showed multiple tiny arterial feeder va beyond scope coilonyx embolization performed balloon occlusion test followed therapeutic sacrifice va successful va occlusion achieved significant reduction tumor blush followed open resection tumor patient favorable postoperative course without neurological symptom attributed va occlusion,2020,"Kinariwala, Jay P; Rajah, Gary B; Vaidya, Rahul; Narayanan, Sandra",Brain circulation,,,,,,https://doi.org/10.4103/bc.bc_18_19; https://www.ncbi.nlm.nih.gov/pubmed/32166201/,211260446.0,12
22212,22212,31554,tcp3eqyz,,Medline,Long-Term Survival Following Port-Site Metastasectomy in a Patient with Laparoscopic Gastrectomy for Gastric Cancer: A Case Report.,10.5230/jgc.2015.15.3.209,,26468419.0,unk,yearold man underwent laparoscopyassisted total gastrectomy gastric cancer ptnm multiple port site used including mm port videoscope umbilical point three working port sixmonth followup evaluation cm enhancing mass confined muscle layer found mm right lower quadrant port site suggesting metastatic desmoid tumor followup computed tomography imaging two month later showed mass increased size cm confirmed intraabdominal metastasis diagnostic laparoscopy performed wide resection recurrent mass histologic finding revealed poorly differentiated adenocarcinoma suggesting metastatic mass stomach cancer postoperative course uneventful patient completed adjuvant chemotherapy t tegafur gimeracil oteracil potassium evidence tumor recurrence month followup period,2015,"Kim, Sang Hyun; Kim, Dong Jin; Kim, Wook",Journal of gastric cancer,,,,,,https://doi.org/10.5230/jgc.2015.15.3.209; https://www.ncbi.nlm.nih.gov/pubmed/26468419/,14806761.0,12
22222,22222,31566,klkri05e,,Medline,A reproducible ex vivo model for transanal minimally invasive surgery.,10.4293/108680813x13693422518911,,24680145.0,unk,background rectal tumor excised number minimally invasive transanal technique including transanal excision transanal endoscopic microsurgery transanal minimally invasive surgery tamis specialty training often required master nuance approach study aimed create reproducible transanal excision training model suited laparoendoscopic technique method frozen porcine rectum anus intact perianal skin commercially obtained thawed specimen cut approximately cm length proximal end rectum everted suction applied mucosa create pseudopolyps various size sessile pedunculated larger pedunculated lesion made tying base pseudopolyps monofilament suture gather tissue methylene blue dye injected submucosally lesion simulate tattoo proximal rectum closed suture model suspended trainer box clamping distal end ringed clamp proximal end box transanal excision using tamis performed procedure done trained community colorectal surgeon attending course transanal minimally invasive surgery result partial fullthickness excision sessile pedunculated rectal lesion successfully performed simulated tamis trained community surgeon learning laparoendoscopic technique conclusion transanal laparoendoscopic procedure excise rectal tumor successfully reproducibly performed ex vivo porcine anorectal model,2014,"Campbell, Michael Larone; Vadas, Kimberly J; Rasheid, Sowsan H; Marcet, Jorge E; Sanchez, Jaime E",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/108680813x13693422518911; https://www.ncbi.nlm.nih.gov/pubmed/24680145/,18267021.0,12
22263,22263,31610,o44jqoaz,,Medline,Direct Tumor Embolization of Sinonasal Unclassified Spindle Cell Sarcoma with Onyx.,10.1055/s-0036-1586210,,27652195.0,unk,objective evaluate use new tumor embolization agent onyx covidien dublin ireland use intraoperative embolization sinonasal unclassified spindle cell sarcoma method yearold female patient presented rhinology clinic nasal mass biopsy revealed highly vascular mass consistent sinonasal unclassified spindle cell sarcoma secondary extensive vascularity patient underwent preoperative transarterial embolization tae definitive resection due complex vascular anatomy including feeding vessel emanating intracranial circulation incomplete embolization achieved subsequently intraoperative embolization onyx time resection performed result intraoperative onyx use resulted almost complete devascularization tumor decreased risk intracranial embolization conclusion intraoperative embolization onyx incomplete tae safe effective method achieving neartotal embolization sinonasal tumor,2016,"Kansal, Ankit; Srinet, Prateek; Manes, Richard Peter",Journal of neurological surgery reports,,,,,,https://doi.org/10.1055/s-0036-1586210; https://www.ncbi.nlm.nih.gov/pubmed/27652195/,5716458.0,12
22311,22311,31661,1sveh3bb,,Medline,Successful laparoscopic extirpation of a large omental lipoblastoma in a child.,10.1111/ases.12213,,26708589.0,unk,omental lipoblastoma extremely rare among benign tumor herein report case child underwent laparoscopic extirpation large omental lipoblastoma yearold girl diagnosed intraabdominal solid tumor abdominal imaging revealed fat density mass well encapsulated measured × × cm size considering mri finding movability tumor strongly suspected lesion omental lipoblastoma initially decided perform laparoscopic exploration possible extirpation solid tumor sequentially total five trocars used tumor found originate omentum successfully performed complete resection tumor laparoscopically histological examination revealed lipoblastoma large abdominal tumor child laparoscopic approach recommended first procedure tumor preoperatively considered benign resectable,2015,"Furukawa, Taizo; Aoi, Shigeyoshi; Sakai, Kohei; Higashi, Mayumi; Fumino, Shigehisa; Tajiri, Tatsuro",Asian journal of endoscopic surgery,,,,,,https://doi.org/10.1111/ases.12213; https://www.ncbi.nlm.nih.gov/pubmed/26708589/,5414065.0,12
22330,22330,31682,cx6exr31,,Medline,The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.,10.1126/scitranslmed.aaw4993,,31366581.0,unk,androgen receptor ar driver cellular differentiation prostate cancer development extensive body work linked normal aberrant cellular process mrna transcription however extent ar regulates posttranscriptional gene regulation remains unknown demonstrate ar us translation machinery shape cellular proteome show ar negative regulator protein synthesis identify unexpected relationship ar process translation initiation vivo mediated direct transcriptional control translation inhibitor ebp demonstrate lowering ar abundance increase assembly eiff translation initiation complex drive enhanced tumor cell proliferation furthermore uncover network proproliferation mrna characterized guaninerich cisregulatory element particularly sensitive eiff hyperactivity using genetic pharmacologic method demonstrate dissociation eiff complex revers proliferation program resulting decreased tumor growth improved survival preclinical model finding reveal druggable nexus functionally link process mrna transcription translation initiation emerging class lethal ardeficient prostate cancer,2019,"Liu, Yuzhen; Horn, Jessie L; Banda, Kalyan; Goodman, Asha Z; Lim, Yiting; Jana, Sujata; Arora, Sonali; Germanos, Alexandre A; Wen, Lexiaochuan; Hardin, William R; Yang, Yu C; Coleman, Ilsa M; Tharakan, Robin G; Cai, Elise Y; Uo, Takuma; Pillai, Smitha P S; Corey, Eva; Morrissey, Colm; Chen, Yu; Carver, Brett S; Plymate, Stephen R; Beronja, Slobodan; Nelson, Peter S; Hsieh, Andrew C",Science translational medicine,,,,,,https://doi.org/10.1126/scitranslmed.aaw4993; https://www.ncbi.nlm.nih.gov/pubmed/31366581/,199057426.0,12
22373,22373,31738,ccjzho3m,,Medline,Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomy.,10.1007/s11934-015-0495-9,,25698588.0,unk,nearinfrared fluorescence nirf imaging intraoperative administration indocyanine green icg technology emerging application urologic surgery icg watersoluble dye fluoresces bright green viewed nearinfrared light nm technology applied robotic partial nephrectomy first potentially allow differentiation renal tumor normal parenchyma application hypothesized normal kidney tissue fluoresces green tumor commonly remains hypofluorescent thereby aiding tumor excision secondly nirf imaging icg employed facilitate selective arterial clamping robotic partial nephrectomy allowing regional perfusion deficit kidney readily identified therefore targeted given tumor recent study shown associated decrease global ischemia minimize resultant loss renal function certain time endpoint review present recent study evidence intraoperative administration indocyanine green robotic partial nephrectomy,2015,"Bjurlin, Marc A; McClintock, Tyler R; Stifelman, Michael D",Current urology reports,,,,,,https://doi.org/10.1007/s11934-015-0495-9; https://www.ncbi.nlm.nih.gov/pubmed/25698588/,31967470.0,12
22377,22377,31744,eudcylmh,,Medline,Transarterial Ethanol Ablation for Small Hepatocellular Carcinoma (≤ 3 cm): A Comparative Study Versus Radiofrequency Ablation.,10.1007/s00270-020-02426-4,,32152720.0,unk,purpose objective evaluate local treatment efficacy transarterial ethanol ablation tea compared radiofrequency ablation rfa small hepatocellular carcinoma hcc material method retrospective study january april treatment outcome patient received either percutaneous tea rfa hcc tumor size ≤ cm childpugh grade b received prior treatment surgical resection compared tea mixture absolute ethanol ethiodized oil proportion volume administered superselectively tumor via microcatheter placed feeding artery tea group rfa group consisted consecutive patient treated target tumor consecutive patient tumor respectively result technical success achieved target tumor group grade complication cirse classification prolonged fever occurred case multifocal large tumor tea group statistically significant difference complete response rate tea group rfa group p time progression tea group median month interquartile range iqr month statistically different rfa group median month iqr month p conclusion tea could effective alternative rfa local treatment small hcc especially valuable tumor unfavorable location,2020-03-09,"Yu, Simon Chun Ho; Hui, Joyce Wai Yi; Chong, Charing Ching Ning; Chu, Cheuk Man; Cheung, Sunny; Wong, John; Lee, Kit Fai",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-020-02426-4; https://www.ncbi.nlm.nih.gov/pubmed/32152720/,212642431.0,12
22437,22437,31811,v3yzk4br,,Medline,Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.,10.2967/jnumed.110.074914,,20595511.0,unk,unlabelled strong overexpression glucagonlike peptide glp receptor human insulinoma provides attractive target imaging first clinical trial demonstrated glp receptor spectct using lysahx aminohexanoic aciddotainnhexendin localize hardly detectable insulinomas however lysahxdotainnhexendin imaging drawback related use costly carry relatively high radiation burden patient aim study preclinical evaluation lysahxdotaganhexendin petct lysahxhydrazinonicotinamide hynicmtcnhexendin spectct method internalization biodistribution dosimetry imaging study performed riptag mouse model pancreatic betacell carcinogenesis compared gold standard lysahxdotainnhexendin polyglutamic acid gelofusine gelatinbased plasma expander used renal uptake reduction study result tumor uptake lysahxdotaganhexendin percentage injected activity per gram tissue h glp receptorpositive organ showed time lower radioactivity uptake lysahxhynicmtcethylenediaminediacetic acid eddanhexendin compared galabeled sister compound showed significantly le tumor organ uptake significantly lower tumor organ uptake lysahxhynicmtceddanhexendin result inferior tumortoorgan ratio reduced image quality radiopeptides tested showed high tumortobackground ratio resulting visualization small tumor maximum diameter mm spect pet exception kidney also showed high uptake uptake could reduced using polyglutamic acid gelofusine combination estimated effective radiation dose musvmbq lysahxhynicmtceddanhexendin time le lysahxdotaganhexendin time le lysahxdotainnhexendin conclusion promising pharmacokinetic imaging data show lysahxdotaganhexendin lysahxhynicmtceddanhexendin suitable candidate clinical glp receptor imaging study,2010,"Wild, Damian; Wicki, Andreas; Mansi, Rosalba; Béhé, Martin; Keil, Boris; Bernhardt, Peter; Christofori, Gerhard; Ell, Peter J; Mäcke, Helmut R","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.110.074914; https://www.ncbi.nlm.nih.gov/pubmed/20595511/,25029377.0,12
22483,22483,31860,qgdumvdy,,Medline,DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity.,10.1172/jci.insight.126086,,30996140.0,unk,specific antibody therapy including mabs bispecific cell engagers bite important new tool cancer immunotherapy however approach slow develop may limited production thus restricting patient access treatment bite exhibit particularly short halflife difficult production development approach allowing simplified development delivery vivo production would important advance describe development designed synthetic dna plasmid optimized permit high expression antiher antibody herdmab delivered animal adaptive electroporation herdmab efficiently expressed vitro vivo reaching level μgml mouse serum mechanistically herdmab blocked signaling induced antibodydependent cytotoxicity herdmab delayed tumor progression herexpressing ovarian breast cancer model next used herdmab singlechain variable fragment portion engineer dnaencoded bite dbite herdbite expressed vivo approximately month single administration herdbite highly cytolytic delayed cancer progression mouse study illustrate approach generate dbites vivo represent promising immunotherapy tumor including ovarian potentially cancer,2019,"Perales-Puchalt, Alfredo; Duperret, Elizabeth K; Yang, Xue; Hernandez, Patricia; Wojtak, Krzysztof; Zhu, Xizhou; Jung, Seang-Hwan; Tello-Ruiz, Edgar; Wise, Megan C; Montaner, Luis J; Muthumani, Kar; Weiner, David B",JCI insight,,,,,,https://doi.org/10.1172/jci.insight.126086; https://www.ncbi.nlm.nih.gov/pubmed/30996140/,122347827.0,12
22555,22555,31949,d2sn16ai,,Medline,Single-incision video-assisted thoracoscopic resection of a pedunculated solitary fibrous tumor of the pleura: case report.,10.1186/1477-7819-11-105,,23697891.0,unk,report describe surgical resection pedunculated solitary fibrous tumor pleura sftp singleincision thoracoscopic surgery sits sits may suitable surgical option pedunculated sftps,2013,"Tamura, Masaya; Shimizu, Yosuke; Hashizume, Yasuo",World journal of surgical oncology,,,,,,https://doi.org/10.1186/1477-7819-11-105; https://www.ncbi.nlm.nih.gov/pubmed/23697891/,16701120.0,12
22575,22575,31974,rc1wp10v,,Medline,Tumor-induced rickets in a child with a central giant cell granuloma: a case report.,10.1542/peds.2014-2218,,26009620.0,unk,tumorinduced osteomalaciarickets rare paraneoplastic disorder associated tumorproducing fibroblast growth factor fgf present child symptom rickets first clinical sign central giant cell granuloma cgcg high serum level fgf hormone associated decreased phosphate resorption yearold boy presented limp month later painless growth jaw examination gingival hypertrophy genu varum observed investigation revealed hypophosphatemia normal oh vitamin high alkaline phosphatase mri showed osteolytic lesion maxilla radiograph revealed typical rachitic finding incisional biopsy tumor revealed cgcg mesenchymal matrix cgcg initially treated calcitonin lesion continued grow making necessary perform tracheostomy gastrostomy one year onset hyperphosphaturia worsened necessitating increasing oral phosphate supplement mgkg per day elemental phosphorus fgf level extremely high total removal tumor impossible partial reduction achieved percutaneous computed tomographyguided radiofrequency local instillation triamcinolone oral propranolol compassionate use cinacalcet unsuccessful preventing phosphaturia tumor slowly regressed third year disease phosphaturia improved allowing tapering phosphate supplement fgf level normalized tumorinduced osteomalaciarickets uncommon child challenging physician diagnose suspected patient intractable osteomalacia rickets tumor ruled fgf level high,2015,"Fernández-Cooke, Elisa; Cruz-Rojo, Jaime; Gallego, Carmen; Romance, Ana Isabel; Mosqueda-Peña, Rocio; Almaden, Yolanda; Sánchez del Pozo, Jaime",Pediatrics,,,,,,https://doi.org/10.1542/peds.2014-2218; https://www.ncbi.nlm.nih.gov/pubmed/26009620/,34582363.0,12
22701,22701,32122,d49rewyb,,Medline,Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods.,10.1007/s11548-020-02177-0,,32388693.0,unk,purpose highly accurate robust computeraided system based quantitative highthroughput breast imaging reporting data system birads feature dynamic contrastenhanced magnetic resonance imaging dcemri drive success radiomic application breast cancer diagnosis aim build stable system highly reproducible radiomics feature make diagnostic performance independent datasets bias segmentation method method applied dataset patient including malignant benign tumor two mri manufacturer case philip system case ge system first manual annotation dunet dunet applied different segmentation method second designed extracted feature six modality dcemri based birads third feature selection conducted betweenclass distance utilized eliminate effect dataset bias caused two machine concordance correlation coefficient intraclass correlation coefficient deviation employed evaluate influence three segmentation method eliminated feature redundancy using genetic algorithm finally three classifier including support vector machine svm bagged tree knearest neighbor evaluated performance diagnosing malignant benign tumor result total feature preserved high stability reproducibility final feature set showed robust performance factor achieved area curve accuracy sensitivity specificity differentiating benign malignant tumor svm classifier using manually segmentation result conclusion final selected feature reproducible show little dependence segmentation method data perturbation high stability effectiveness diagnosis across factor illustrate preserved feature used prognostic analysis help radiologist diagnosis breast cancer,2020-05-09,"Qiao, Mengyun; Li, Chengkang; Suo, Shiteng; Cheng, Fang; Hua, Jia; Xue, Dan; Guo, Yi; Xu, Jianrong; Wang, Yuanyuan",International journal of computer assisted radiology and surgery,,,,,,https://doi.org/10.1007/s11548-020-02177-0; https://www.ncbi.nlm.nih.gov/pubmed/32388693/,218552450.0,12
22705,22705,32126,bctramer,,Medline,Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression.,10.1245/s10434-011-1762-8,,21590455.0,unk,background local tumor progression ltp serious complication local ablation malignant liver tumor negatively influencing patient survival ltp may result incomplete ablation treated tumor study determined whether viable tumor cell attached needle applicator ablation associated ltp diseasefree survival method prospective study tissue collected consecutive patient underwent local liver ablation liver malignancy cell tissue attached needle applicator analyzed viability using glucosephosphatedehydrogenase staining autofluorescence intensity level stained section patient followedup disease progression result viable tumor cell found needle applicator local ablation patient type needle applicator used open approach omission track ablation significantly correlated viable tumor tissue adherent needle applicator presence viable cell independent predictor ltp attachment viable cell needle applicator associated shorter time ltp conclusion viable tumor cell adherent needle applicator found ablation patient independent risk factor viable cell adherent needle applicator omission track ablation recommend using rfa device track ablation functionality adherence viable tumor cell needle applicator local ablation independent risk factor ltp,2011,"Snoeren, Nikol; Huiskens, Joost; Rijken, Arjen M; van Hillegersberg, Richard; van Erkel, Arian R; Slooter, Gerrit D; Klaase, Joost M; van den Tol, Petrousjka M; Ten Kate, Fibo J W; Jansen, Maarten C; van Gulik, Thomas M",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-011-1762-8; https://www.ncbi.nlm.nih.gov/pubmed/21590455/,8724344.0,12
22734,22734,32159,rvlfusta,,Medline,Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule.,10.3892/ijo.2014.2782,,25434612.0,unk,carbonic anhydrase ix caix transmembrane enzyme involved regulation tissue ph balance cancer caix expression associated tumor hypoxia caix also overexpressed renal cell carcinoma molecular target therapeutic antibody cg girentuximab radionuclide imaging caix expression might used identification patient may benefit cg therapy treatment strategy hypoxic tumor affibody molecule small kda scaffold protein high potential probe radionuclide molecular imaging aim present study evaluate feasibility vivo imaging caixexpression using radiolabeled affibody molecule histidineglutamatehistidineglutamatehistidineglutamate hetagcontaining caixbinding affibody molecule hezcaix labeled mtcco binding property evaluated vitro using caixexpressing skrc renal carcinoma cell mtchezcaix evaluated nmri nunu mouse bearing skrc xenograft vivo specificity test confirmed caixmediated tumor targeting mtchezcaix cleared rapidly blood normal tissue except kidney optimal timepoint h pi tumor uptake ± idg tumortoblood ratio ± experimental imaging caixexpressing skrc xenograft h pi provided high contrast image use radioiodine label zcaix enabled reduction renal uptake resulted significantly lower tumor uptake tumortoblood ratio result present study suggest radiolabeled affibody molecule promising probe imaging caixexpression vivo,2015,"Honarvar, Hadis; Garousi, Javad; Gunneriusson, Elin; Höidén-Guthenberg, Ingmarie; Altai, Mohamed; Widström, Charles; Tolmachev, Vladimir; Frejd, Fredrik Y",International journal of oncology,,,,,,https://doi.org/10.3892/ijo.2014.2782; https://www.ncbi.nlm.nih.gov/pubmed/25434612/,5038955.0,12
22738,22738,32163,oyn3c7og,,Medline,Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.,10.1158/0008-5472.can-14-0594,,25252911.0,unk,radical removal malignant lesion may improved using tumortargeted dualmodality probe contain radiotracer fluorescent label allow enhanced intraoperative delineation tumor resection margin pretargeting strategy yield high signaltobackground ratio evaluated feasibility pretargeting strategy intraoperative imaging prostate cancer using antitrop x antihsg bispecific antibody tf conjunction duallabeled dihsg peptide rdc equipped dota chelate radiolabeling purpose fluorophore irdyecw allow nearinfrared optical imaging nude mouse implanted sc tropexpressing pc human prostate tumor cell pc metastasis scapular suprarenal region injected iv mg tf hour tumor accumulation blood clearance subsequently injected mbq nmolmouse either inrdc inimp control two hour injection microspectct fluorescence image acquired resection tumor nodule image acquisition biodistribution inrdc inimp determined tumor analyzed immunohistochemically biodistribution duallabel rdc showed specific accumulation tropexpressing pc tumor ± idg hour postinjection comparable inimp ± idg hour postinjection microspectct nearinfrared fluorescence nirf imaging confirmed tropspecific uptake duallabel inrdc sc metastatic growing tumor model addition pc metastasis could visualized preoperatively spectct could subsequently resected imageguided surgery using intraoperative nirf imaging showing preclinical feasibility pretargeted dualmodality imaging approach prostate cancer,2014,"Lütje, Susanne; Rijpkema, Mark; Goldenberg, David M; van Rij, Catharina M; Sharkey, Robert M; McBride, William J; Franssen, Gerben M; Frielink, Cathelijne; Helfrich, Wijnand; Oyen, Wim J G; Boerman, Otto C",Cancer research,,,,,,https://doi.org/10.1158/0008-5472.can-14-0594; https://www.ncbi.nlm.nih.gov/pubmed/25252911/,54552488.0,12
22794,22794,32224,hoszjtu2,,Medline,Laparoscopic endoscopic cooperative surgery (LECS) for the gastrointestinal tract: Updated indications.,10.1002/ags3.12238,,31131352.0,unk,laparoscopic endoscopic cooperative surgery lecs procedure combining laparoscopic gastric resection endoscopic submucosal dissection local resection gastric tumor appropriate minimal surgical resection margin lecs concept initially developed classical lecs procedure gastric submucosal tumor resection many researcher reported classical lecs safe feasible technique resection gastric submucosal tumor regardless tumor location including esophagogastric junction recently lecs approved insurance coverage japan national health insurance plan widely applied gastric submucosal tumor resection however limitation classical lecs risk abdominal infection scattering tumor cell abdominal cavity tumor cell seeding peritoneum development modified lecs procedure invertedlecs nonexposed endoscopic wallinversion surgery combination laparoscopic endoscopic approach neoplasia nonexposure technique closedlecs almost resolved drawback led recent increase indication modified lecs include patient gastric epithelial neoplasm lecs concept also beginning applied tumor excision organ duodenum colon rectum evolution lecs procedure expected future sentinel lymph node mapping could also combined lecs resulting portion early gastric cancer treated lecs sentinel node mapping,2019,"Hiki, Naoki; Nunobe, Souya",Annals of gastroenterological surgery,,,,,,https://doi.org/10.1002/ags3.12238; https://www.ncbi.nlm.nih.gov/pubmed/31131352/,86820171.0,12
22936,22936,32389,clkmhmk2,,Medline,"Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence?",10.1007/s12029-020-00408-w,,32388791.0,unk,purpose congenital adrenal hyperplasia cah rare autosomal recessive disease cah due hydroxylase deficiency account case aimed share first case coexistence simple virilizingtype congenital adrenal hyperplasia mutation cypa triple translocation ovarian granulose cell tumor method yearold female patient presented clinic complaining abdominal pain distension physical examination revealed palpable abdominal mass virilism ambiguous genitalia clitoramegaly hyperpigmentation contrastenhanced abdominal computed tomography showed giant mass originating right tuboovarian structure result patient operated light clinicoradiological feature mentioned giant mass weighing g detected right tuboovarian structure laparotomy mass excised right tuboovarian structure immunohistochemical examination revealed ovarian granulosa cell tumor high serum concentration oh progesterone measured baseline μg bolus synthetic acth genetic analysis screened sixpoint mutation large deletion noncommon mutation using restriction fragment length polymorphism rflp method pcr sequencing cyp gene respectively patient detected homozygous mutation addition metaphase examined triple translocation conclusion coexistence congenital adrenal hyperplasia triple chromosomal translocation ovarian granulosa cell tumor described previously coexistence may sign new syndrome,2020-05-09,"Akbulut, Sami; Ceylan, Senay Durmaz; Tuncali, Timur; Sogutcu, Nilgun",Journal of gastrointestinal cancer,,,,,,https://doi.org/10.1007/s12029-020-00408-w; https://www.ncbi.nlm.nih.gov/pubmed/32388791/,218552452.0,12
22944,22944,32398,jcw8mpis,,Medline,"Ablative Therapies for Renal Tumors: Patient Selection, Treatment Planning, and Follow-Up.",10.1053/j.sult.2016.11.009,,28237283.0,unk,increased use abdominal imaging led major increase small renal tumor incidence particularly elderly population management evolving development percutaneous ablation particularly radiofrequency ablation cryoablation microwave ablation typical indication must validated multidisciplinary committee include solid tumor le cm patient multiple comorbidity factor including age contraindication surgery hereditary renal cancer bilateral renal tumor solitary kidney preexisting chronic kidney disease high risk predialysis renal function partial nephrectomy tumor ablation offer almost similar oncologic outcome compared surgery new indication appearing larger tumor benign cystic neoplasm biopsy solid renal mass recommended case careful systematic treatment planning required avoid complication paying specific attention relationship bowel structure urinary tract specific maneuver necessary gas liquid dissection pyeloperfusion technique ablation depends availability training tumor size location preference cryotherapy central large lesion evaluation therapeutic efficacy relies contrastenhanced imaging computed tomography magnetic resonance imaging even ultrasound followup must continued year ablation overall efficacy reduced complication rate le renal tumor percutaneous ablation sparing renal function preferred treatment case preexisting chronic kidney disease,2017,"Correas, Jean-Michel; Delavaud, Christophe; Gregory, Jules; Le Guilchet, Thomas; Lamhaut, Lionel; Timsit, Marc-Olivier; Méjean, Arnaud; Hélénon, Olivier","Seminars in ultrasound, CT, and MR",,,,,,https://doi.org/10.1053/j.sult.2016.11.009; https://www.ncbi.nlm.nih.gov/pubmed/28237283/,19651132.0,12
22955,22955,32411,y8dezcjc,,Medline,3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma.,10.1186/s40658-016-0172-1,,28101733.0,unk,backround radiolabeled otsa monoclonal antibody targeting synovial sarcoma s developed oncotherapy science used treat relapsing s metastasis following theranostic procedure case significant inotsa tumor uptake favorable biodistribution patient randomly treated mbq yotsa monte carlobased dosimetry integrating timeactivity curve voi performed inotsa repeated spectct estimated absorbed dos ad normal tissue compared biological side effect admitted maximal tolerated absorbed dose mtd normal organ result tumor also compared disease evolution result biodistribution tracer quantification analyzed repeated spectct acquisition performed injection inotsa included patient spect image warped common coordinate system deformable registration volume interest voi various lesion normal tissue drawn first ct acquisition reported spect image tracer quantification residence time inotsa voi used evaluate estimated absorbed dos per mbq yotsa mean monte carlo simulation gate visual scale analysis applied ass tumor uptake grade result compared automated quantification result compared biological side effect reported selected patient treated yotsa also disease response treatment screening patient treated mbq yotsa demonstrated medullary toxicity one presented transient grade liver toxicity due disease progression two patient presented transient grade renal toxicity median absorbed dos highest liver median cgymbq far lower gy liver mtd lowest bone marrow median cgymbq closer gy bone marrow mtd patient demonstrated progressive disease recist criterion patient followup inotsa tumor tracer uptake visually appeared highly heterogeneous inter intrapatient analysis independently tumor size variable kinetics majority visual grade corresponded automated computed one estimated absorbed dos supracentimetric selected lesion ranged cgy per injected mbq median cgymbq maximal tumor ad obtained gy conclusion dosimetry result explain observed toxicity tumor response despite intense visual inotsa liver uptake liver toxicity dose limiting factor conversely bone marrow toxicity even though tumor inotsa avidity visually obvious treated patient low estimated tumor ad obtained dosimetry explain lack tumor response,2017,"Sarrut, David; Badel, Jean-Noël; Halty, Adrien; Garin, Gwenaelle; Perol, David; Cassier, Philippe; Blay, Jean-Yves; Kryza, David; Giraudet, Anne-Laure",EJNMMI physics,,,,,,https://doi.org/10.1186/s40658-016-0172-1; https://www.ncbi.nlm.nih.gov/pubmed/28101733/,9392764.0,12
22960,22960,32419,edqcr1au,,Medline,Bicomponent Conformal Electrode for Radiofrequency Sequential Ablation and Circumferential Separation of Large Tumors in Solid Organs: Development and In Vitro Evaluation.,10.1109/tbme.2016.2573043,,27244716.0,unk,objective complete destruction large tumor radiofrequency ablation rfa surrounding tumorfree margin difficult incomplete nonuniform heating due heatsink effect circulating blood limitation existing rf electrode design new rf electrode described overcome limitation method bicomponent conformal bcc rfa probe providing sectorial sequential ablation followed circumferential cutting designed evaluated threedimensional finiteelement analysis model developed temperature feedbackcontrolled simulation rfa electrode design optimization prototype bipolar bcc probe three embedded thermocouple constructed evaluated tissuemimicking phantom result maximum tissue temperature kept ºc power applied w min ablation time used sequence four sequential rfa large ablation zone cm achieved experiment confirmed lesion exceeding cm could ablated separated surrounded tissue conclusion new bcc probe thus capable controlled ablation followed circumferential separation lesion required significance result experiment provide proof concept validation bcc probe potential ablate sequential heating tumor solid organ cm separate electrosurgical cutting surrounding normal parenchyma combined rf ablation physical separation could completely destroy cancer cell ablation site thus avoid local recurrence cancer requires vivo validation study large animal,2017,"Wang, Zhigang; Luo, Hongyan; Coleman, Stuart; Cuschieri, Alfred",IEEE transactions on bio-medical engineering,,,,,,https://doi.org/10.1109/tbme.2016.2573043; https://www.ncbi.nlm.nih.gov/pubmed/27244716/,13642642.0,12
22988,22988,32451,iitfy0qz,,Medline,Cholecystectomy with gallbladder bed cautery might be sufficient for T1bN0M0 neuroendocrine carcinoma of gallbladders: Cases report and literature review.,10.1097/md.0000000000008778,,29381978.0,unk,introduction neuroendocrine carcinoma rare kind tumor gallbladder far consensus treatment gallbladder neuroendocrine carcinoma case presentation three patient male female admitted hospital right upper quadrant pain one complained fever jaundice weight loss carcinoid syndromerelated symptom diarrhea flushing edema wheezing mri detected broad base gallbladder tumor however refused radical surgery performed laparoscopic cholecystectomy gallbladder bed cautery pathology result showed case mixed neuroendocrine carcinoma nec case simple nec chromogranin synaptophysin positive case pathological tnm stage patient tbnm stage range ki least month followup case recurrence carcinoma without chemotherapy radiotherapy conclusion cholecystectomy gallbladder bed cautery might enough treatment tbnm gallbladder neuroendocrine carcinoma,2017,"Liu, Wei; Chen, Weijie; He, Xiaodong; Qu, Qiang; Hong, Tao; Li, Binglu",Medicine,,,,,,https://doi.org/10.1097/md.0000000000008778; https://www.ncbi.nlm.nih.gov/pubmed/29381978/,12622139.0,12
22992,22992,32457,9mpx1dbp,,Medline,A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer.,10.1007/s12282-010-0222-9,,20862572.0,unk,purpose reveal rate complete therapeutic effect radiofrequency ablation rfa correlation tumor size histopathological examination surgically resected early breast cancer method patient received rfa subsequent surgical therapy early breast cancer treatment effect rfa evaluated histopathological examination nicotinamide adenine dinucleotide nadhdiaphorase staining resected tumor specimen according criterion described seki et al issue correlation rfa effect tumor parameter including tumor size presence extensive intraductal component eic examined result mean size invasive size primary tumor cm ranging cm cm ranging cm respectively examining hematoxylineosin section effectiveness rfa found tumor however effectiveness rfa found case examined nadhdiaphorase staining frozen section containing part tumorous nontumorous tissue accuracy diagnosis complete rfa effect using nadhdiaphorase staining reference sensitivity specificity rate rfa effect examination higher eic tumor eic tumor p higher tumor ≤ cm tumor cm p five tumor ≤ cm showed rfa effect tumor ≤ cm tumor cm showed suboptimal rfa effect conclusion tumor size ≤ cm strictly ≤ cm could indication rfa complete histological therapeutic effect mandatory,2011,"Tsuda, Hitoshi; Seki, Kunihiko; Hasebe, Takahiro; Sasajima, Yuko; Shibata, Tatsuhiro; Iwamoto, Eriko; Kinoshita, Takayuki",Breast cancer,,,,,,https://doi.org/10.1007/s12282-010-0222-9; https://www.ncbi.nlm.nih.gov/pubmed/20862572/,25619627.0,12
22993,22993,32458,7nem3uqc,,Medline,Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.,10.1080/02656736.2018.1466369,,29719997.0,unk,purpose goal study define pattern tumor recurrence pet following rfa compare time imaging recurrence pet versus ct evaluate whether pretreatment tumor uptake predicts recurrence propose optimal postrfa surveillance strategy material method retrospective cohort study performed biopsy confirmed primary stage lung cancer treated rfa fdg pet near contemporaneous diagnostic ct imaging preablation within day postablation beyond month independently retrospectively evaluated feature supportive recurrence time imaging recurrence pet ttrpet ct ttrct determined compared fdg avidity untreated tumor compared recurrent nonrecurrent group result thirteen recurrence rfa treatment confirmed diagnostic ct recurrence associated focally intense increasing fdg uptake beyond month sensitivity specificity mean ttrpet month compared mean ttrct month statistically significant normalized suvmax total lesion glycolysis lung cancer recurred rfa respectively compared respectively cancer recur p conclusion pattern focally intense increasing fdg pet uptake high sensitivity specificity detecting recurrent lung cancer following rfa surveillance rfa include contrast enhanced diagnostic ct month diagnose procedural complication pet month posttreatment metabolic baseline diagnostic ct pet abnormal alternating diagnostic ct pet every month year,2018,"Wang, Yingbing; Lanuti, Michael; Bernheim, Adam; Shepard, Jo-Anne O; Sharma, Amita","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2018.1466369; https://www.ncbi.nlm.nih.gov/pubmed/29719997/,19233599.0,12
23017,23017,32487,lu9y2yg9,,Medline,Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.,10.1371/journal.pone.0221340,,31437208.0,unk,background hypoxia significantly influence treatment response clinical outcome solid tumor noninvasive marker hypoxia help physician treatment planning encourage efficient use hypoxia targeted therapy purpose study investigate whether pharmacokinetic dynamic contrastenhanced dce perfusion parameter associated specific marker hypoxia hypoxiainducible factor alpha hifα ovarian cancer oc material method thirtyeight patient primary oc enrolled prospective study approved local ethical committee patient underwent dynamic gadoliniumenhanced mri part staging investigation pharmacokinetic perfusion parameter including rate constant transfer contrast agent plasma extravascular extracellular space ee ktrans rate constant ee plasma kep measured drawing two type region interest roi large solid lesion lroi solid enhancing small area sroi nordicice platform tissue sample immunohistochemical analysis collected surgery kruskalwallis mannwhitney u chisquare test used statistical analysis receiver operating characteristic curve analyzes done dce parameter discriminate high hifα expression result pharmacokinetic perfusion parameter ktrans kep inversely associated hifα expression ktrans lroi p ktrans sroi p kep lroi p kep sroi p ktrans kep showed good accuracy identifying high hifα expression auc ktrans lroi ktrans sroi kep lroi kep lroi conclusion preliminary study demonstrated pharmacokinetic dcemri perfusion parameter associated hypoxia specific marker hifα oc dcemri may useful supplementary tool characterization oc tumor staging investigation,2019,"Lindgren, Auni; Anttila, Maarit; Rautiainen, Suvi; Arponen, Otso; Hämäläinen, Kirsi; Könönen, Mervi; Vanninen, Ritva; Sallinen, Hanna",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0221340; https://www.ncbi.nlm.nih.gov/pubmed/31437208/,201618692.0,12
23028,23028,32499,ebs8yk7d,,Medline,Peptide-receptor radionuclide therapy for endocrine tumors.,10.1038/nrendo.2009.105,,19488074.0,unk,peptidereceptor radionuclide therapy prrt radiolabeled somatostatin analog promising option treatment somatostatinreceptorpositive endocrine tumor treatment somatostatin analog labeled lu result symptomatic improvement although tumor remission seldom achieved inlabeled analog review finding several study use prrt endocrine tumor evaluated large variation antitumor effect yoctreotide reported study objective response tumor regression achieved patient treatment luoctreotate objective response achieved patient minor response tumor regression achieved patient stable disease present patient treatment luoctreotate resulted survival benefit several year markedly improved quality life serious delayed adverse effect rare prrt although randomized clinical trial yet performed data use prrt compare favorably treatment approach chemotherapy result replicated large controlled trial prrt might become preferred option patient metastatic inoperable gastroenteropancreatic neuroendocrine tumor,2009,"van Essen, Martijn; Krenning, Eric P; Kam, Boen L R; de Jong, Marion; Valkema, Roelf; Kwekkeboom, Dik J",Nature reviews. Endocrinology,,,,,,https://doi.org/10.1038/nrendo.2009.105; https://www.ncbi.nlm.nih.gov/pubmed/19488074/,22933835.0,12
23036,23036,32508,7s7ihukg,,Medline,Robotic-assisted minimally invasive central pancreatectomy: technique and outcomes.,10.1007/s11605-012-2137-6,,23325340.0,unk,background central pancreatectomy definitive treatment lowgrade tumor pancreatic neck preserve pancreatic splenic function potential expense postoperative pancreatic fistula analyzed outcome robotassisted central pancreatectomy racp reexamine riskbenefit profile era minimally invasive surgery method retrospective analysis nine racp performed august june single institution result average age cohort range year six woman indication surgery included five benign cystic neoplasm four pancreatic neuroendocrine tumor median operative time min range min ml median blood loss range ml one conversion open due poor visualization median tumor size cm range cm patient achieved r status pancreaticogastrostomy performed seven case pancreaticojejunostomy two median length hospital stay day range two clinically significant pancreatic fistula occurred one requiring percutaneous drainage patient exhibited worsening diabetes exocrine insufficiency day postoperative visit conclusion racp performed safety oncologic outcome equivalent published open series although rate pancreatic fistula high clinically significant event none developed worsening pancreatic endocrine exocrine dysfunction,2013,"Abood, Gerard J; Can, M Fatih; Daouadi, Mustapha; Huss, Harold T; Steve, Jennifer Y; Ramalingam, Lekshmi; Stang, Michael; Bartlett, David L; Zeh, Herbert J; Moser, A James",Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,,,,,,https://doi.org/10.1007/s11605-012-2137-6; https://www.ncbi.nlm.nih.gov/pubmed/23325340/,23986760.0,12
23047,23047,32520,6wqdav6c,,Medline,Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.,10.1093/neuonc/nos161,,23095826.0,unk,treatment patient lowgrade glioma still controversy surgical intervention radiation therapy chemotherapy contribute ameliorated progressionfree survival overall survival treatmentrelated neurotoxicity ongoing change treatment option patient neurocognitive functioning increasingly important outcome measure neurocognitive impairment large impact selfcare social professional functioning consequently healthrelated quality life many factor contribute neurocognitive outcome direct indirect tumor effect seizure medication oncological treatment although role radiotherapy studied extensively adverse effect neurocognitive function treatmentrelated factor remain elusive hold resective surgery use intraoperative stimulation mapping high potential benefit concerning survival patient functioning use chemotherapy might interesting new application facilitation total resection initially primary recurrent diffuse lowgrade glioma tumor article discus treatment option patient lowgrade glioma potential effect neurocognitive functioning,2012,"Klein, Martin",Neuro-oncology,,,,,,https://doi.org/10.1093/neuonc/nos161; https://www.ncbi.nlm.nih.gov/pubmed/23095826/,32876477.0,12
23076,23076,32555,986gmpva,,Medline,Perioperative neurocognitive functions in patients with neuroepithelial intracranial tumors.,10.1007/s11060-020-03398-8,,31970595.0,unk,purpose study aimed ass perioperative neurocognitive function patient surgery intracranial neuroepithelial tumor method seventyone patient male female mean age year range surgery intracranial neuroepithelial tumor included prospective singlecenter study minimental status examination mmse extensive neurocognitive testing divided category attention memory executive function adjusted age sex education performed pret early postoperatively part patient cohort n also underwent neurocognitive testing followup karnofsky performance status scale kp used ass patient functional independence patient quality life recorded short form sf pre postoperatively part patient cohort pre postoperative comparison performed using wilcoxontest paired sample post hoc bonferroni correction performed adjust multiple testing ass influence risk factor neurocognitive function spearman correlation chisquared test performed subgroup analysis patient lowgrade highgrade tumor performed result postoperative deterioration observed subtests extensive neurocognitive testing category whereas improvement shown patient grade tumor showed deterioration cognitive function patient grade ii iii tumor showed significantly worse result executive function category patient grade iv tumor showed deterioration attention category significantly worse functional independence recorded postoperatively followup p patient reported poorer physical health sf p whereas mental health differ significantly p risk factor postoperative deterioration cognition low kp score postoperative radiotherapy tumor location temporal lobe conclusion surgery intracranial neuroepithelial tumor early postoperative deterioration neurocognitive function functional independence physical health occur similar result also shown followup suggesting effect due postoperative systemic factor fatigue knowledge might improve perioperative surveillance neurocognitive function,2020-01-22,"Bette, Stefanie; Gradtke, Corinna V; Cammardella, Jasmin Hernandez; Albertshauser, Jennifer; Wiestler, Benedikt; Barz, Melanie; Meyer, Bernhard; Zimmer, Claus; Ryang, Yu-Mi; Ringel, Florian; Gempt, Jens",Journal of neuro-oncology,,,,,,https://doi.org/10.1007/s11060-020-03398-8; https://www.ncbi.nlm.nih.gov/pubmed/31970595/,210845043.0,12
23222,23222,32720,0cojxu6z,,Medline,Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung Cancer.,10.1007/s00270-017-1843-6,,29204695.0,unk,introduction percutaneous imageguided ablation emerging minimally invasive therapy patient metastatic bone disease radiation therapy ineffective contraindicated purpose study examine safety efficacy percutaneous ablation achieving pain palliation local tumor control osseous metastasis nonsmall cell lung cancer nsclc method retrospective review performed musculoskeletal metastasis patient treated percutaneous ablation treated radiofrequency ablation rfa cryoablation microwave ablation mwa case associated cementoplasty performed primary outcome measured pre postprocedure pain score week treatment local tumor control month followup result mean age cohort ± year median tumor diameter cm range cm mean median pain score treatment ± respectively postprocedure patient reported significantly decreased pain score week mean ± median p radiographic local tumor control rate month month month treatment overall complication rate conclusion percutaneous tumor ablation welltolerated minimally invasive procedure associated improving pain palliation achieving local tumor control osseous metastasis nsclc level evidence level case series,2018,"Ma, Yuntong; Wallace, Adam N; Waqar, Saiama N; Morgensztern, Daniel; Madaelil, Thomas P; Tomasian, Anderanik; Jennings, Jack W",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-017-1843-6; https://www.ncbi.nlm.nih.gov/pubmed/29204695/,4439323.0,12
23234,23234,32732,gxv5nv70,,Medline,"Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.",10.1016/j.jvir.2008.01.016,,18440460.0,unk,purpose radiofrequency rf ablation increasingly accepted treatment nonsurgical candidate limited number colorectal hepatic metastasis rf ablation effective tumor smaller cm report describes year survival patient single tumor maximum diameter cm material method forty patient men woman mean age year age range treated extrahepatic disease identified candidate resection minimum followup month sixteen undergone hepatic resection two undergone lung resection lung ablation thirtytwo received chemotherapy thirtyfive treated general anesthesia five conscious sedation standard ablation protocol used internally watercooled electrode introduced percutaneously ultrasonography computed tomography guidance monitoring followup data obtained primary care physician oncologist result mean tumor diameter cm range cm two successfully treated systemic complication chest infection exacerbation asthma local complication mean followup month range month median survival duration year survival rate month respectively ablation month respectively diagnosis liver metastasis history liver resection impact survival conclusion rf ablation solitary liver metastasis cm smaller performed minimal morbidity result excellent longterm survival approaching surgical resection even patient surgical candidate,2008,"Gillams, Alice R; Lees, William R",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2008.01.016; https://www.ncbi.nlm.nih.gov/pubmed/18440460/,206653948.0,12
23260,23260,32759,svuo7yn2,,Medline,Laparoscopy-Guided Transthoracic Transdiaphragmatic Radiofrequency Ablation for Hepatic Tumors Located Beneath the Diaphragm.,10.1089/lap.2015.0380,,26859794.0,unk,background often difficult perform percutaneous radiofrequency ablation rfa hepatic tumor beneath diaphragm diaphragmatic thermal damage one fatal late complication percutaneous transdiaphragmatic rfa experience laparoscopic transthoracic transdiaphragmatic intraoperative rfa lttirfa hepatic tumor beneath diaphragm reported method ten patient underwent lttirfa evaluated two case concomitant partial hepatectomy one underwent rfa two tumor time diagnosis hepatocellular carcinoma eight case metastatic hepatic tumor two case nine eleven tumor located segment nine tumor le mm diameter patient placed half left lateral decubitus position singlelumen tube intubation placement four abdominal port mm port inserted fourth fifth intercostal space diaphragm tumor ablated rfa needle port routine followup consisted laboratory test abdominal imaging every month result median operation time one tumor minute range minute median number time ablation three severe postoperative complication claviendindo iiia observed one case right upper limb paralysis median followup period month range month local tumor progression recurrent hepatic tumor appearance occurred part liver patient conclusion laparoscopic transthoracic transdiaphragmatic rfa acceptable procedure low rate local recurrence,2016,"Tanaka, Kimitaka; Kojima, Tetsufumi; Hiraguchi, Etsuo; Hashida, Hideaki; Noji, Takehiro; Hirano, Satoshi",Journal of laparoendoscopic & advanced surgical techniques. Part A,,,,,,https://doi.org/10.1089/lap.2015.0380; https://www.ncbi.nlm.nih.gov/pubmed/26859794/,26777090.0,12
23316,23316,32822,1aprd54b,,Medline,Review of first clinical experiences with a 1.5 Tesla ceiling-mounted moveable intraoperative MRI system in Europe.,10.17305/bjbms.2018.3777,,30589401.0,unk,highfield intraoperative mri imri system provide excellent imaging quality used resection control update image guidance system number center ceilingmounted intraoperative mri system several advantage compared conventional imri system article report first clinical experience using stateoftheart imri system europe total consecutive patient intracranial tumor vascular lesion operated imri unit analyzed patient data surgery preparation time intraoperative scan surgical time radicality tumor removal patient mean age year range year median surgical procedure time hour range hour lesion included lowgrade glioma grade iii astrocytomas glioblastoma metastasis pituitary adenoma cavernomas lymphoma cortical dysplasia aneurysm arteriovenous malformation extracranialintracranial bypass clival chordoma chiari malformation surgical treatment tumor lesion intraoperative imaging depicted tumor remnant case led change intraoperative strategy mobile imri system proved safe allowed optimal workflow imri unit due fact mri scanner moved operating room imaging working environment comparable regular operating room,2019,"Feigl, Guenther C; Heckl, Stefan; Kullmann, Marcel; Filip, Zoltan; Decker, Karlheinz; Klein, Jan; Ernemann, Ulrike; Tatagiba, Marcos; Velnar, Tomaz; Ritz, Rainer",Bosnian journal of basic medical sciences,,,,,,https://doi.org/10.17305/bjbms.2018.3777; https://www.ncbi.nlm.nih.gov/pubmed/30589401/,58538459.0,12
23345,23345,32853,tu4qbn7f,,Medline,Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map.,10.1007/s11548-016-1398-z,,27038962.0,unk,purpose contrastenhanced mr image widely used confirm adequacy ablation margin liver ablation early prediction local recurrence however quantitative assessment ablation margin comparing pre postprocedural image remains challenging developed tested novel method threedimensional quantitative assessment ablation margin based nonrigid image registration distance map method method tested pre postprocedural mr image acquired patient underwent imageguided percutaneous liver ablation two image coregistered using nonrigid intensitybased registration tumor ablation volume segmented target volume coverage percent tumor coverage dice similarity coefficient calculated metric representing overall adequacy ablation addition distance map around tumor computed superimposed ablation volume identify area insufficient margin patient local recurrence followup image registered postprocedural image threedimensional minimum distance recurrence area insufficient margin quantified result percent tumor coverage nonrecurrent case five case tumor recurrence distance map revealed insufficient tumor coverage mm margin also showed two recurrence remote insufficient margin conclusion nonrigid registration distance map allow u quantitatively evaluate adequacy ablation margin percutaneous liver ablation method may useful predict local recurrence immediately following ablation procedure,2016,"Tani, Soichiro; Tatli, Servet; Hata, Nobuhiko; Garcia-Rojas, Xavier; Olubiyi, Olutayo I; Silverman, Stuart G; Tokuda, Junichi",International journal of computer assisted radiology and surgery,,,,,,https://doi.org/10.1007/s11548-016-1398-z; https://www.ncbi.nlm.nih.gov/pubmed/27038962/,7622945.0,12
23414,23414,32928,mv8u9afb,,Medline,Upper extremity tumor embolization using a transradial artery approach: technical note.,10.1016/j.radcr.2016.05.018,,27594948.0,unk,transradial access used increasing frequency interventional radiology procedure offer several key advantage including decreased access site complication increased patient comfort report technique using transradial access perform preoperative embolization humeral renal cell carcinoma metastasis pathologic fracture transradial approach performing humeral preoperative tumor embolization previously reported knowledge appropriately selected patient approach may safely used perform upper extremity embolization,2016,"Zaw, Taryar; Ni, Jason C; Park, Jonathan K; Walsworth, Matthew",Radiology case reports,,,,,,https://doi.org/10.1016/j.radcr.2016.05.018; https://www.ncbi.nlm.nih.gov/pubmed/27594948/,17307129.0,12
23427,23427,32944,3ripizli,,Medline,Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.,10.1002/hep.23181,,19731239.0,unk,unlabelled treatment small hepatocellular carcinoma hcc radiofrequency ablation rfa center considered firstline therapeutic option however strategy still debate regard tumor patient characteristic singlecenter study assessed year survival prognosis factor consecutive patient cirrhosis childpugh ab received rfa firstline treatment three hcc cm tumor mean diameter mm multinodular form among patient satisfied criterion resection according barcelona clinic liver cancer complete ablation obtained patient overall rfa session performed including iterative rfa recurrence major complication occurred three patient including one treatmentrelated death month mean followup local distant tumor recurrence occurred patient respectively twentynine patient underwent transplantation removed study point overall year recurrencefree tumorfree including result iterative rfa survival rate respectively overall year survival rate operable patient factor associated overall survival prothrombin activity hazard ratio hr p serum level alphafetoprotein afp hr p factor associated tumor recurrence multinodular form hr p serum afp level hr p tumor size associated local recurrence overall tumorfree survival conclusion rfa safe effective firstline treatment hcc cm diameter especially patient single tumor low serum afp level wellpreserved liver function,2009,"N'Kontchou, Gisèle; Mahamoudi, Amel; Aout, Mounir; Ganne-Carrié, Nathalie; Grando, Véronique; Coderc, Emmanuelle; Vicaut, Eric; Trinchet, Jean Claude; Sellier, Nicolas; Beaugrand, Michel; Seror, Olivier",Hepatology,,,,,,https://doi.org/10.1002/hep.23181; https://www.ncbi.nlm.nih.gov/pubmed/19731239/,28063932.0,12
23469,23469,33002,3edzfr4m,,Medline,Initial experience of robotic nephron sparing surgery in cases of high renal nephrometry scores.,10.4103/iju.iju_331_16,,28717275.0,unk,introduction renal nephrometry scoring rn system enables prediction feasibility nephronsparing surgery n renal mass insufficient data regarding outcome robotassisted n tumor rn ≥ reviewed trifecta outcome patient undergoing robotic n high rn compare tumor low intermediate rn material method prospectively maintained data robotassisted n reviewed rn ≥ identified patient data outcome postoperative estimated glomerular filtration rate compared high intermediate low rn patient result high rn group mean age patient year malefemale mean diameter tumor cm cm mean operative time ± min mean warm ischemia time ± min mean estimated blood loss ebl ± ml mean hospital length stay ± day day compared low intermediate rn ebl need pelvicalyceal system repair significantly higher high rn group postoperative complication renal function preservation oncological outcome month comparable three group conclusion robotassisted n feasible comparable outcome tumor high rn,2017,"Bora, Girdhar S; Mavuduru, Ravimohan S; Sharma, Aditya P; Devana, Sudheer K; Kakkar, Nandita; Lal, Anupam; Singh, Shrawan K; Mandal, Arup K",Indian journal of urology : IJU : journal of the Urological Society of India,,,,,,https://doi.org/10.4103/iju.iju_331_16; https://www.ncbi.nlm.nih.gov/pubmed/28717275/,387004.0,12
23499,23499,33038,utpt34xz,,Medline,Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy.,10.1007/s00345-010-0562-2,,20454965.0,unk,objective radiofrequency ablation rfa increasingly finding place treatment small renal mass srm rfa may able provide better renal preservation achieving appropriate cancer control investigation take critical look pertinent aspect rfa principle review oncological renal function outcome method review current english literature using pubmed search done oncological renal function outcome reviewed selected article published oncological outcome determined single treatment success rate first followup single treatment success rate first followup renal function outcome determined either change creatinine creatinine clearance gfr rfa result mean tumor size cm study average mean median followup month study month study single treatment success rate average noted study average increase serum creatinine mgdl four study serum creatinine creatinine clearance change one solitary kidney study mmoll mlmin respectively conclusion rfa fast emerging safe efficacious treatment small renal mass compared extirpative treatment option rfa seems provide lowest rate renal impairment providing acceptable rate tumor ablation longterm result emerge may become one treatment modality renal tumor patient solitary kidney renal impairment,2010,"Salas, Nelson; Ramanathan, Rajan; Dummett, Scott; Leveillee, Raymond J",World journal of urology,,,,,,https://doi.org/10.1007/s00345-010-0562-2; https://www.ncbi.nlm.nih.gov/pubmed/20454965/,20864350.0,12
23519,23519,33064,a8ib98xo,,Medline,Radiofrequency ablation for treatment for osteoid osteoma of the scapula using a new three-dimensional fluoroscopic navigation system.,10.1007/s00590-013-1180-7,,23412321.0,unk,osteoid osteoma relatively common benign skeletal tumor traditional standard treatment surgical resection nidus recently computed tomography ctguided radiofrequency ablation rfa gained favor precise alternative due potentially le bone destruction however ctguided rfa limited treatment osteoid osteoma involving complex anatomic structure cervical spine pelvis scapula difficulty approach proximity neurovascular structure solve problem investigated rfa using new realtime threedimensional fluoroscopic navigation system report technical procedure use rare case osteoid osteoma scapula,2014,"Okada, Kiyoshi; Myoui, Akira; Hashimoto, Nobuyuki; Takenaka, Satoshi; Moritomo, Hisao; Murase, Tsuyoshi; Yoshikawa, Hideki",European journal of orthopaedic surgery & traumatology : orthopedie traumatologie,,,,,,https://doi.org/10.1007/s00590-013-1180-7; https://www.ncbi.nlm.nih.gov/pubmed/23412321/,3144002.0,12
23548,23548,33099,3wopiev7,,Medline,Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume.,10.1016/j.surg.2017.02.019,,28549521.0,unk,background parenchymasparing hepatectomy technique allow lesser volume resection adjacent segment tumor involving hepatic vein hepatocaval confluence assuring adequate volume future liver remnant report ability perform parenchymasparing hepatectomy planned preoperative imaging type vascular intervention used preserve hepatic outflow method analyzed consecutive parenchymasparing hepatectomies patient primary metastatic tumor colorectal located segment vii viii iva involving hepatocaval confluence patient median range lesion median diameter cm range bilateral result parenchymasparing hepatectomy performed case one case required resection adjacent segment hepatic veinsresections outflow assured preservation inferiorrighthepatic vein communicatingveins middlehepatic vein middlehepatic vein patchreconstruction case polytetrafluoroethylenegrafts hepatic veinsanastomosis case hepatic vein resected tangentially reconstructed direct suture venorraphy case hepatic vein skeletonized tumor grade iiib iv complication occurred median hospitalstay day day mortality occurred one cirrhotic patient median overall diseasefree survival month median followup month conclusion lesser volume parenchymasparing hepatectomy rather formal major hepatectomy tumor involving hepatocaval confluence performed low rate major complication parenchymasparing hepatectomy considered highly selected patient evaluating liver resection tumor involving hepatocaval confluence based appropriate accurate preoperative imaging,2017,"Urbani, Lucio; Colombatto, Piero; Balestri, Riccardo; Licitra, Gabriella; Leoni, Chiara; Forfori, Francesco; Masi, Gianluca; Boraschi, Piero; Castagna, Maura; Buccianti, Piero",Surgery,,,,,,https://doi.org/10.1016/j.surg.2017.02.019; https://www.ncbi.nlm.nih.gov/pubmed/28549521/,35263820.0,12
23604,23604,33165,62bhmjz1,,Medline,Acute pericarditis following treatment of a metastatic liver tumor with radiofrequency ablation: a case report.,10.1186/s12872-018-0937-7,,30348082.0,unk,background radiofrequency ablation common minimally invasive procedure used treat liver tumor however potential threat heat injury adjacent structure hepatic lesion near diaphragm often overlooked misunderstood rare cardiovascular complication reported best identify patient risk allow prompt treatment important issue case presentation yearold man underlying oral cancer received radiofrequency ablation metastatic liver tumor segment ii pleuritic chest pain developed day radiofrequency catheter ablation diffuse st elevation echocardiography showed new onset small moderate pericardial effusion without tamponade sign inflammatory marker also elevated acute pericarditis due heat penetration stimulation favored symptom sign resolved treatment antiinflammatory medication conclusion potential cardiovascular complication possible radiofrequency catheter ablation liver tumor located segment ii artificial ascites normal saline radiofrequency ablation may separate liver diaphragm prevent cardiac complication procedure electrocardiographic monitoring close observation patient symptom required echocardiography used confirm cardiac complication,2018,"Hsu, Jung-Chi; Tsai, Han-Lin; Lin, Yu-Ling; Chang, Rei-Yeuh",BMC cardiovascular disorders,,,,,,https://doi.org/10.1186/s12872-018-0937-7; https://www.ncbi.nlm.nih.gov/pubmed/30348082/,53039012.0,12
23717,23717,33306,edz84cea,,Medline,Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas.,10.3171/2011.6.jns11252,,21761971.0,unk,object greater extent resection eor patient lowgrade glioma lgg corresponds improved clinical outcome yet remains central challenge neurosurgical oncologist although aminolevulinic acid alainduced tumor fluorescence strategy improve eor glioma glioblastoma routinely fluoresce following ala administration intraoperative confocal microscopy adapts conventional confocal technology handheld probe provides realtime fluorescent imaging × magnification author report combined approach intraoperative confocal microscopy used visualize ala tumor fluorescence lggs course microsurgical resection method following ala administration patient newly diagnosed lgg underwent microsurgical resection intraoperative confocal microscopy conducted following point initial encounter tumor midpoint tumor resection presumed braintumor interface histopathological analysis site correlated tumor infiltration intraoperative cellular tumor fluorescence result ten consecutive patient grade ii glioma underwent microsurgical resection ala intraoperative confocal microscopy macroscopic tumor fluorescence evident patient however case intraoperative confocal microscopy identified tumor fluorescence cellular level finding corresponded tumor infiltration matched histological analysis conclusion intraoperative confocal microscopy visualize cellular alainduced tumor fluorescence within lggs braintumor interface ass clinical value ala highgrade glioma conjunction neuronavigation lggs combination intraoperative confocal microscopy neuronavigation phase iiia randomized placebocontrolled trial balance underway author institution,2011,"Sanai, Nader; Snyder, Laura A; Honea, Norissa J; Coons, Stephen W; Eschbacher, Jennifer M; Smith, Kris A; Spetzler, Robert F",Journal of neurosurgery,,,,,,https://doi.org/10.3171/2011.6.jns11252; https://www.ncbi.nlm.nih.gov/pubmed/21761971/,207681124.0,12
23748,23748,33337,9c5xlwk8,,Medline,Thirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysis.,10.3171/2016.5.focus16168,,27476847.0,unk,objective goal study use large national registry evaluate day cumulative incidence predictor adverse event readmission reoperations surgery primary secondary spinal tumor method data adult patient underwent surgery spinal tumor extracted prospective national surgical quality improvement program nsqip registry multivariable logistic regression used evaluate predictor reoperation readmission major complication death neurological cardiopulmonary venous thromboembolism vte surgical site infection ssi sepsis variable screened included patient age sex tumor location american society anesthesiologist asa physical classification preoperative functional status comorbidities preoperative laboratory value case urgency operative time additional variable evaluated analyzing readmission included complication surgical hospitalization hospital length stay los discharge disposition result among patient evaluated extradural tumor intradural extramedullary tumor intramedullary tumor spinal level cervical lesion thoracic lesion lumbar lesion sacral lesion readmission occurred patient median day interquartile range iqr day common reason readmission ssis systemic infection vte cns complication predictor readmission comorbidities dyspnea hypertension anemia disseminated cancer preoperative steroid use extended hospitalization reoperation occurred patient median day iqr day postoperatively associated preoperative steroid use asa class designation major complication occurred patient common complication median time occurrence vte day iqr day postoperatively ssis day iqr day sepsis day iqr day predictor major complication included dependent functional status emergency case status male sex comorbidities dyspnea bleeding disorder preoperative systemic inflammatory response syndrome preoperative leukocytosis asa class designation p median hospital los day iqr day day mortality rate median time death day iqr day conclusion nsqip analysis patient undergoing surgery spinal tumor readmitted within day underwent reoperation experienced major complication common complication ssis systemic infection vte often occurred late discharge surgical hospitalization patient primarily readmitted new complication developed following discharge rather exacerbation complication surgical hospital stay strongest predictor adverse event comorbidities preoperative steroid use higher asa classification model used surgeon riskstratify patient preoperatively identify may benefit increased surveillance following hospital discharge,2016,"Karhade, Aditya V; Vasudeva, Viren S; Dasenbrock, Hormuzdiyar H; Lu, Yi; Gormley, William B; Groff, Michael W; Chi, John H; Smith, Timothy R",Neurosurgical focus,,,,,,https://doi.org/10.3171/2016.5.focus16168; https://www.ncbi.nlm.nih.gov/pubmed/27476847/,43361497.0,12
23823,23823,33416,5frvnszu,,Medline,Open mini-flank partial nephrectomy: an essential contemporary operation.,10.4111/kju.2014.55.9.557,,25237456.0,unk,secondary widespread use modern imaging technique computed tomography magnetic resonance imaging ultrasound renal tumor today detected incidentally median tumor size le cm twenty year ago renal tumor regardless size treated radical nephrectomy rn elective partial nephrectomy pn emerged treatment choice small renal tumor basis paradigm shift three major factor cancer specific survival equivalent tumor cm le whether treated pn rn approximately renal tumor indolent benign pathology pn prevents delay onset chronic kidney disease condition associated increased cardiovascular morbidity mortality although pn technically demanding associated potential complication bleeding infection urinary fistula patient derived benefit operation far outweigh risk developed miniflank open surgical approach highly effective coupled rapid recovery postoperative care pathway associated day length hospital stay,2014,"Russo, Paul; Mano, Roy",Korean journal of urology,,,,,,https://doi.org/10.4111/kju.2014.55.9.557; https://www.ncbi.nlm.nih.gov/pubmed/25237456/,8222285.0,12
23852,23852,33449,ywu61dn3,,Medline,"Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.",10.1007/s00726-014-1859-z,,25425114.0,unk,overexpression insulinlike growth factor receptor igfr several cancer associated resistance therapy radionuclide molecular imaging igfr expression tumor may help selecting patient potentially respond igfrtargeted therapy affibody molecule small kda nonimmunoglobulinbased scaffold protein wellsuited probe radionuclide imaging aim study evaluation antiigfr affibody molecule labeled technetiumm using cysteinecontaining peptidebased chelator gggc cterminus zigfrgggc efficiently stably labeled technetiumm radiochemical yield ± mtczigfrgggc demonstrated specific binding igfrexpressing du prostate cancer mcf breast cancer cell line slow internalization vitro tumortargeting property studied balbc nunu mouse bearing du mcf xenograft mtccohezigfr used comparison biodistribution study demonstrated high tumortoblood ratio ± ± du mcf respectively h injection renal radioactivity concentration fold lower mtczigfrgggc mtccohezigfr h injection however liver uptake mtczigfrgggc fold higher comparison mtccohezigfr possible reason elevated hepatic uptake mtczigfrgggc high lipophilicity amino acid binding site zigfr compensated mtczigfrgggc conclusion mtczigfrgggc visualize igfr expression human tumor xenograft provides low retention radioactivity kidney development imaging agent include molecular design aimed reducing hepatic uptake,2015,"Mitran, Bogdan; Altai, Mohamed; Hofström, Camilla; Honarvar, Hadis; Sandström, Mattias; Orlova, Anna; Tolmachev, Vladimir; Gräslund, Torbjörn",Amino acids,,,,,,https://doi.org/10.1007/s00726-014-1859-z; https://www.ncbi.nlm.nih.gov/pubmed/25425114/,15981812.0,12
23959,23959,33579,3r4efwtl,,Medline,Intra-caval Percutaneous Radiofrequency Ablation for a Neuroendocrine Tumor (NET) Metastasis in Transplanted Liver.,10.1007/s00270-018-2032-y,,30014252.0,unk,le patient liver metastasis neuroendocrine tumor net susceptible liver transplantation report case patient transplanted year ago net metastasis lesion histologically proved net metastasis located cava vein anastomosis treated percutaneous radiofrequency ablation rfa first failed attempt endovascular approach vascular heat sink rfa susceptible considered advantage case since restricted propagation heat tissue located proximity rfa antenna protecting inferior vena cava vessel wall positive result may suggest additional use rfa selected challenging case,2018,"Ierardi, Anna Maria; Biondetti, Pierpaolo; Padovano, Barbara; Magenta Biasina, Alberto; Bongini, Marco; Carrafiello, Gianpaolo",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-2032-y; https://www.ncbi.nlm.nih.gov/pubmed/30014252/,49868727.0,12
24001,24001,33625,p7kr8ug1,,Medline,Diagnostic Ability of Percutaneous Needle Biopsy Immediately After Radiofrequency Ablation for Malignant Lung Tumors: An Initial Experience.,10.1007/s00270-016-1324-3,,26968406.0,unk,purpose evaluate safety diagnostic ability percutaneous needle biopsy performed immediately lung radiofrequency ablation rfa material method may april percutaneous needle biopsy performed immediately rfa patient men woman aged year lung tumor measuring cm diameter patient prior history malignancy tumor radiologically diagnosed malignant obtained specimen pathologically classified using standard hematoxylin eosin staining result completed three planned session rfa followed percutaneous needle biopsy obtained tumor tissue could pathologically diagnosed two tumor metastatic renal clear cell carcinoma rectal adenocarcinoma respectively one tumor primary lung adenocarcinoma death major complication related procedure although pneumothorax occurred two patient resolved without need aspiration chest tube placement tumor seeding observed month procedure one case developed local tumor progression treated additional rfa conclusion pathologic diagnosis possible needle biopsy immediately rfa lung tumor technique may reduce risk effort performing biopsy rfa separate occasion,2016,"Hasegawa, Takaaki; Kondo, Chiaki; Sato, Yozo; Inaba, Yoshitaka; Yamaura, Hidekazu; Kato, Mina; Murata, Shinichi; Onoda, Yui; Kuroda, Hiroaki; Sakao, Yukinori; Yatabe, Yasushi",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-016-1324-3; https://www.ncbi.nlm.nih.gov/pubmed/26968406/,3232483.0,12
24029,24029,33660,t23qmb4y,,Medline,Air-blocking ablation of osteoid osteoma; a technical note.,10.1007/s00256-017-2659-9,,28466103.0,unk,osteoid osteoma account approximately benign bone tumor surgery treatment choice osteoid osteoma percutaneous radiofrequency ablation rfa introduced although rfa generally considered curative treatment osteoid osteoma disease recurrence ablation reported report case rfa delayed presence air surrounding ablation probe case ablation could performed probe removed saline injected introducer needle displace air air reported decrease radiofrequency energy transmission simple measure like injecting saline introducer could prevent complication also suggest partial air ablation bed surrounding ablation probe could decrease energy transmission may one cause early recurrence saline injection could helpful providing reliable environment ablation,2017,"Kuyumcu, Gokhan; Mason, Evan Gregory; Ilaslan, Hakan",Skeletal radiology,,,,,,https://doi.org/10.1007/s00256-017-2659-9; https://www.ncbi.nlm.nih.gov/pubmed/28466103/,5646181.0,12
24040,24040,33673,7uvasxiq,,Medline,Semiautomated motion correction of tumors in lung CT-perfusion studies.,10.1016/j.acra.2010.10.008,,21295733.0,unk,rationale objective compare relative performance onedimensional manual rigidtranslational nonrigid registration technique correct misalignment lung tumor anatomy acquired computed tomography perfusion ctp datasets material method twentyfive datasets patient lung tumor undergone ctp protocol evaluated dataset consisted one reference ct image initial cine slab six subsequent breathhold helical volume row multidetector ct acquired intravenous contrast administration helical volume registered reference image using two semiautomated intensitybased registration method rigidtranslational nonrigid manual registration registration method available relevant application software performance technique align tumor region assessed quantitatively percent overlap distance center mass visual validation study using point scale registration method statistically compared using linear mixed ordinal probit regression model result quantitatively tumor alignment nonrigid method compared rigidtranslation borderline significant turn significantly better manual method average ± sd percent overlap ± ± ± respectively average ± sd dcom ± mm ± mm ± mm respectively p visual validation confirmed finding conclusion semiautomated registration method achieved superior alignment lung tumor compared manual method hopefully translate reliable ctp analysis,2011,"Chandler, Adam; Wei, Wei; Herron, Delise H; Anderson, Ella F; Johnson, Valen E; Ng, Chaan S",Academic radiology,,,,,,https://doi.org/10.1016/j.acra.2010.10.008; https://www.ncbi.nlm.nih.gov/pubmed/21295733/,12488830.0,12
24051,24051,33687,qzhktuss,,Medline,"Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.",10.1186/s12885-016-2549-x,,27439702.0,unk,background treatmentrefractory liver dominant metastatic colorectal cancer role liver directed therapy still unclear sought determine prognostic score radioembolization patient method analyzed patient refractory liver dominant mcrc undergone total radioembolizations resin microspheres collected potential factor influencing survival analyzed using cox regression log rank test served establish prognostic factor form clinical score outcome prediction radioembolization result median survival patient month neither age prior surgical systemic therapy metastatic spread effect survival contrast hepatic tumor load karnofsky index well cea ca serum level significant influence p p p p respectively three factor formed score point tumor load cea ngml ca uml karnofsky index patient score displayed median o month patient score demonstrated median o month p conclusion overaggressive patient selection radioembolization liver dominant chemorefractory mcrc questionable benefit scoring system comprising hepatic tumor load cea ca serum level karnofsky index tuckscore may support improved patient selection cohort liver versus liver dominant disease extrahepatic lung lymphatic metastasis significantly alter prognosis,2016,"Damm, Robert; Seidensticker, Ricarda; Ulrich, Gerhard; Breier, Leonie; Steffen, Ingo G; Seidensticker, Max; Garlipp, Benjamin; Mohnike, Konrad; Pech, Maciej; Amthauer, Holger; Ricke, Jens",BMC cancer,,,,,,https://doi.org/10.1186/s12885-016-2549-x; https://www.ncbi.nlm.nih.gov/pubmed/27439702/,6946657.0,12
24058,24058,33696,kh9n892k,,Medline,Extended Lifetime In Vivo Pulse Stimulated Ultrasound Imaging.,10.1109/tmi.2017.2740784,,28829305.0,unk,ondemand longlived ultrasound contrast agent activated single pulse stimulated imaging spsi developed using hard shell liquid perfluoropentane filled silica nm nanoparticles tumor ultrasound imaging spsi tested lncap prostate tumor model mouse tumor localization observed intravenous iv injection contrast agent consistent enhanced permeability retention silica nanoparticles displayed extended imaging lifetime ± day mean±standard deviation added tumor specific folate functionalization useful lifetime extended ± day contrast ligandbased tumor targeting effect ligand application enhanced nanoparticle retention tumor paper demonstrates first time iv injected functionalized silica contrast agent imaged vivo lifetime time longer current microbubblebased contrast agent functionalized longlived contrast agent may lead new application tumor monitoring therapy,2018,"Wang, James; Barback, Christopher V; Ta, Casey N; Weeks, Joi; Gude, Natalie; Mattrey, Robert F; Blair, Sarah L; Trogler, William C; Lee, Hotaik; Kummel, Andrew C",IEEE transactions on medical imaging,,,,,,https://doi.org/10.1109/tmi.2017.2740784; https://www.ncbi.nlm.nih.gov/pubmed/28829305/,3134917.0,12
24073,24073,33715,ctoaw5kp,,Medline,"In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.",10.1007/s11307-018-1185-z,,29556947.0,unk,purpose gastrinreleasing peptide receptor grpr overexpressed various tumor type attractive target receptormediated imaging therapy another interesting approach would use grpr radioligands preoperative imaging subsequent radioguided surgery goal improve surgical outcome grpr radioligands successfully implemented clinical study especially sarabesin sb appealing grpr antagonist high receptor affinity gallium labeled sb good vivo stability labeling indium however molecule show poor vivo stability negatively impact tumortargeting capacity novel approach increase vivo stability radiopeptides coadministration neutral endopeptidase nep inhibitor phosphoramidon pa studied vivo stability biodistribution insb withoutwith pa mouse furthermore spectmri novel stateoftheart platform performed procedure grpr affinity sb determined pc xenograft section using ityrbombesin tracer increasing concentration sb vivo stability mouse injected pmol insb μg pa blood collected analyzed biodistribution spectmri study performed h postinjection pi mbq pmol mbq pmol insb μg pa pcxenografted mouse result sb showed high affinity grpr ic nm coadministration pa resulted twice higher intact peptide vivo v insb alone biodistribution study h pi show higher tumor uptake value pa coadministration ± v ± ± v ± ± v ± idg tissue p tumor imaging spectmri clearly improved coinjection pa conclusion coadministration pa increased vivo tumor targeting capacity insb making attractive combination grprtargeted tumor imaging,2018,"Bakker, Ingrid L; van Tiel, Sandra T; Haeck, Joost; Doeswijk, Gabriela N; de Blois, Erik; Segbers, Marcel; Maina, Theodosia; Nock, Berthold A; de Jong, Marion; Dalm, Simone U",Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging,,,,,,https://doi.org/10.1007/s11307-018-1185-z; https://www.ncbi.nlm.nih.gov/pubmed/29556947/,4031192.0,12
24075,24075,33717,5i31p6o9,,Medline,Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.,10.2967/jnumed.110.079376,,21051650.0,unk,unlabelled pretargeted radioimmunotherapy prit bispecific antibody combination radiolabeled peptide reduces radiation dose normal tissue especially bone marrow study optimization therapeutic efficacy toxicity prit colon cancer lulabeled peptide determined mouse carcinoembryonic antigen ceaexpressing human tumor method obtain optimal therapeutic efficacy several strategy evaluated increase total amount radioactivity targeted subcutaneous lst colon cancer tumor balbc nude mouse first maximum amount bispecific anticea antihapten antibody tf peptide imp could targeted determined second tumor targeting repeated administration radiolabeled imp investigated mouse received tf injection followed multiple imp injection h interval multiple cycle imp administration preceded new tf injection h interval prit administered maximum dos tf lulabeled imp group mouse subcutaneous lst tumor mouse received successive cycle treatment mbqmousecycle carrier primary endpoint survival secondary endpoint tumor growth body weight bone marrow renal toxicity result highest amount radioactivity delivered subcutaneous colon tumor achieved administration nmol tf nmol imp successive cycle imp preceded new tf injection h interval prit effectively delayed tumor growth prolonged survival significantly higher activity dos administered successive cycle correlated longer survival median survival untreated mouse range whereas mouse treated cycle prit range range ≥ range ≥ day respectively toxicity limited significant change mean body weight measured minimal change leukocyte count measured wk injection full recovery within wk treatment platelet count unaffected serum creatinine level increased significantly thus indication acute renal toxicity conclusion study indicates prit mouse effective treatment modality colon cancer limited toxicity,2010,"Schoffelen, Rafke; van der Graaf, Winette T A; Franssen, Gerben; Sharkey, Robert M; Goldenberg, David M; McBride, William J; Rossi, Edmund A; Eek, Annemarie; Oyen, Wim J G; Boerman, Otto C","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.110.079376; https://www.ncbi.nlm.nih.gov/pubmed/21051650/,19842338.0,12
24076,24076,33718,06dsvbm8,,Medline,Clinical significance of mediastinoscope-assisted transhiatal esophagectomy in patients with esophageal cancer.,10.1007/s00423-015-1330-y,,26252999.0,unk,purpose mediastinoscopeassisted transhiatal esophagectomy mathe useful surgical procedure esophageal cancer patient limited indication transthoracic operation due preoperative complication method last year patient underwent mathe department examined clinical data patient assessed indication postoperative outcome prognostic factor mathe result year overall survival o rate diseasefree survival dfs rate postoperative complication observed case recurrent disease occurred case univariate analysis o location tumor tumor depth lymph node metastasis clinical stage simultaneous resection organ postoperative pneumonia blood loss significant prognostic factor multivariate analysis location tumor lymph node metastasis independent prognostic factor o univariate analysis location tumor tumor depth lymph node metastasis clinical stage blood loss significant prognostic factor dfs multivariate analysis dfs lymph node metastasis blood loss independent prognostic factor conclusion mathe useful procedure middle lower thoracic esophageal cancer patient without clinical lymph node metastasis serious complication unable undergo thoracotomy,2015,"Okumura, Hiroshi; Uchikado, Yasuto; Matsumoto, Masataka; Omoto, Itaru; Sasaki, Ken; Kita, Yoshiaki; Arigami, Takaaki; Uenosono, Yoshikazu; Nakajo, Akihiro; Owaki, Tetsuhiro; Mori, Shinichiro; Ishigami, Sumiya; Natsugoe, Shoji",Langenbeck's archives of surgery,,,,,,https://doi.org/10.1007/s00423-015-1330-y; https://www.ncbi.nlm.nih.gov/pubmed/26252999/,7388735.0,12
24200,24200,33863,nr02l4rx,,Medline,Recurrent Desmoid Tumor with Intra-Abdominal Extension After Abdominoplasty: A Rare Presentation.,10.12659/ajcr.916227,,31270310.0,unk,background desmoid tumor fibrous neoplasm originate musculoaponeurotic structure body abdominal wall desmoid tumor rare locally aggressive high incidence recurrence tumor common young fertile woman frequently occur pregnancy case report present case yearold postmenopausal woman desmoid tumor anterior abdominal wall relevant family history abdominoplasty incidental mass excised biopsied identified desmoid tumor free margin one year later patient presented vague abdominal discomfort feeling heaviness incision made previous abdominoplasty scar maintain aesthetic outcome large mass arising abdominal wall extending intraabdominally excised determined recurrent desmoid tumor conclusion recurrent anterior abdominal wall desmoid tumor postmenopausal woman rare locally aggressive high risk recurrence abdominal wall repair abdominoplasty desmoid tumor filament might seed deep intraabdominally therefore necessary take adequate safe margin abdominal wall repair postoperatively surgeon keep high index suspicion tumor recurrence,2019,"Muneer, Mohammed; Badran, Saif; Zahid, Rehan; Abdelmageed, Amal; AlDulaimi, Mohamed Murshid",The American journal of case reports,,,,,,https://doi.org/10.12659/ajcr.916227; https://www.ncbi.nlm.nih.gov/pubmed/31270310/,195798075.0,12
24212,24212,33877,6kxzdgum,,Medline,Establishment of Patient-derived Xenografts in Mice.,10.21769/bioprotoc.2008,,28184379.0,unk,patientderived xenograft pdx model cancer research recently attracted considerable attention academy industry hidalgo et al wilding bodmer pdx model developed different tumor type including lung cancer improve drug development process model used preclinical drug evaluation used predictive result clinical outcome conserve original tumor characteristic heterogeneity complexity molecular diversity kopetz et al additionally pdx model provides potential tool personalized drug therapy protocol present method establishment pdx mouse using primary tumor tissue patient small cell lung cancer sclc,2016,"Park, Dongkyoo; Wang, Dongsheng; Chen, Guo; Deng, Xingming",Bio-protocol,,,,,,https://doi.org/10.21769/bioprotoc.2008; https://www.ncbi.nlm.nih.gov/pubmed/28184379/,25117569.0,12
24225,24225,33894,wvvg3a54,,Medline,A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors.,10.1007/s00270-013-0615-1,,23589213.0,unk,purpose study designed ass role radiofrequency ablation rfa multimodality management gastrointestinal stromal tumor gist patient undergoing targeted tyrosine kinase inhibitor therapy tki liver metastasis method outcome patient underwent liver rfa metastatic gist tki therapy january march retrospectively analyzed mean maximum tumor diameter ± cm range cm seven patient group rfa residual tumor performed curative intent tki therapy discontinued five patient group b rfa residual tumor performed upon achieving best morphological response tki therapy maintained rfa another five patient group c rfa performed individual liver metastasis progressive tki therapy result targeted tumor completely ablated without local recurrence mean followup period month major complication occurred two minor complication reported two patient group c died month twoyear progressionfree survival pfs rfa group group b group c conclusion rfa patient previously treated tki feasible safe data suggest rfa useful therapeutic option patient metastatic gist performed time best clinical response patient maintained tki procedure,2014,"Hakimé, Antoine; Le Cesne, Axel; Deschamps, Frederic; Farouil, Geoffroy; Boudabous, Sana; Aupérin, Anne; Domont, Julien; Debaere, Thierry",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0615-1; https://www.ncbi.nlm.nih.gov/pubmed/23589213/,25018791.0,12
24235,24235,33906,c0kbiitx,,Medline,Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.,10.1016/j.jvir.2016.01.136,,27017124.0,unk,purpose compare efficacy major complication rate radiofrequency rf microwave mw ablation treatment hepatocellular carcinoma hcc material method retrospective singlecenter study included tumor patient treated rf ablation tumor patient treated mw ablation rf mw ablation device included straight gauge applicator overall survival rate local tumor progression ltp evaluated using kaplanmeier technique cox proportional hazard ratio hr model competing risk regression ltp result rf mw cohort similar age p model endstage liver disease score p tumor size mean cm range cm cm cm p median length followup month rf month mw rate ltp rf mw corresponding hr cox competing risk model confidence interval ci p ci p respectively improved survival patient treated mw ablation although statistically significant cox hr ci p major ≥ grade c complication rf mw p conclusion treating hcc percutaneously rf mw ablation associated high primary efficacy durable response lower rate ltp mw ablation,2016,"Potretzke, Theodora A; Ziemlewicz, Timothy J; Hinshaw, J Louis; Lubner, Meghan G; Wells, Shane A; Brace, Christopher L; Agarwal, Parul; Lee, Fred T",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2016.01.136; https://www.ncbi.nlm.nih.gov/pubmed/27017124/,206661231.0,12
24250,24250,33922,lamme19k,,Medline,Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.,10.1097/rct.0b013e3182732341,,23321827.0,unk,objective objective study evaluate ffluorodeoxyglucose positron emission tomography ffdgpet finding following complete radiofrequency ablation rfa treatment malignant lung tumor method followup pet computed tomography examination patient mean age ± year range year male female underwent rfa session treatment primary n metastatic n lung tumor mean followup month range month retrospectively reviewed thoracic radiologist tumor completely ablated maximum standardized uptake value suv tumor surrounding lung baseline month rfa measured addition size histology location tumor presence underlying emphysema electrode type complication rfa recorded data analyzed using fisher exact test result baseline tumor suv variable mean ± range postrfa ffdgpet appearance could divided group ring peripheral activity central photopenia seen following ablation ring noted following ablation ring ffdgpet activity present month month month case central photopenia month replaced increased activity ring resolved month mimicking local tumor progression presence ring activity associated use cluster electrode p lesion size histology location baseline suv electrode type development cavitation following rfa significantly associated postrfa ring p pet scan month suv center lesion equal greater suv baseline case conclusion recognition normal fdgpet appearance rfa important prevent misdiagnosis local tumor progression,2013,"Sharma, Amita; Lanuti, Michael; He, Wei; Palmer, Edwin L; Shepard, Jo-Anne O; Digumarthy, Subba R",Journal of computer assisted tomography,,,,,,https://doi.org/10.1097/rct.0b013e3182732341; https://www.ncbi.nlm.nih.gov/pubmed/23321827/,25293006.0,12
24251,24251,33923,9q2igtdy,,Medline,Minimally Invasive Surgery for Resection of Parapharyngeal Space Tumors.,10.1055/s-0037-1607315,,29765822.0,unk,background surgical removal parapharyngeal space tumor ppst pose challenge due complex anatomy region ppsts routinely resected transcervical approach using blind finger dissection large ppsts located high skull base often require transmandibular infratemporal fossa approach associated considerable morbidity objective describe approach ppst removal comprises transcervical endoscopic without transoral robotic technique material method retrospectively studied demographic clinical surgical outcome data consecutive patient underwent ppst excision june july center patient either underwent transcervical endoscopic procedure n transoral robotic procedure n combination two procedure n result complete tumor excision achieved case intra peri postoperative complication final histopathologic finding demonstrated pleomorphic adenoma seven patient cavernous hemangioma one patient malignant tumor three patient average tumor size ± cm range cm followup range month evidence recurrence conclusion approach described provides improved visualization safe vascular control minimum tumor stress preventing need blind finger dissection allowing complete tumor removal minimizing tumor spillage nerve injury blood loss maintaining excellent cosmetic functional result approach could utilized removal large benign ppst small ppst located high,2018,"Duek, Irit; Sviri, Gill E; Billan, Salem; Gil, Ziv","Journal of neurological surgery. Part B, Skull base",,,,,,https://doi.org/10.1055/s-0037-1607315; https://www.ncbi.nlm.nih.gov/pubmed/29765822/,21703365.0,12
24258,24258,33933,3apzpxfr,,Medline,Successful laparoscopic resection of a sacrococcygeal teratoma in an adult: report of a case.,10.1007/s00595-010-4274-4,,21431497.0,unk,sacrococcygeal teratoma relatively rare congenital retroperitoneal tumor adult standard treatment complete tumor resection report describes successful laparoscopic resection sacrococcygeal teratoma patient yearold woman welldemarcated cystic mass cm diameter retroperitoneum overlying anterior surface sacrum mass resected laparoscopically histopathological examination showed mature teratoma magnifying function laparoscope allowed en bloc resection narrow pelvic cavity without damaging tumor aesthetic outcome excellent patient remains relapsefree year month surgery,2011,"Tsutsui, Atsuko; Nakamura, Takatoshi; Mitomi, Hiroyuki; Onozato, Wataru; Sato, Takeo; Ozawa, Heita; Naito, Masanori; Ikeda, Atsushi; Ihara, Atsushi; Watanabe, Masahiko",Surgery today,,,,,,https://doi.org/10.1007/s00595-010-4274-4; https://www.ncbi.nlm.nih.gov/pubmed/21431497/,19674478.0,12
24275,24275,33952,jsqbjp14,,Medline,Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors.,10.1097/mpa.0b013e318220e3a4,,21785385.0,unk,objective limited involvement major peripancreatic vessel longer considered contraindication resection case locally advanced pancreatic cancer extended open pancreatectomy associated vascular resection performed experienced center mortality morbidity rate comparable standard pancreatic resection evaluate safety feasibility outcome robotic extended pancreatectomy vascular resection method reviewed data patient median age year range year underwent robotic surgery pancreatic tumor vascular involvement may march institution type resection included leftsided splenopancreatectomy celiac axis resection leftsided splenopancreatectomy portal vein resection pancreaticoduodenectomy portal vein resection result conversion occurred overall mean operating time ± minute range min overall mean blood loss ± ml range ml transfusion mortality occurred median followup month range month patient alive disease free conclusion early series single surgeon support feasibility safety robotic pancreatectomy vascular resection selected patient locally advanced pancreatic tumor,2011,"Giulianotti, Pier Cristoforo; Addeo, Pietro; Buchs, Nicolas Christian; Ayloo, Subhashini M; Bianco, Francesco Maria",Pancreas,,,,,,https://doi.org/10.1097/mpa.0b013e318220e3a4; https://www.ncbi.nlm.nih.gov/pubmed/21785385/,46618450.0,12
24424,24424,34123,sffuejo1,,Medline,In vivo comparison of two navigation systems for abdominal percutaneous needle intervention.,10.1007/s00261-017-1083-x,,28217826.0,unk,purpose compare accuracy kinectoptical navigation system electromagnetic em navigation system percutaneous liver needle intervention material method five beagle nine artificial tumor used validation veran ig em navigation system custommade kinectoptical navigation system used needle insertion tumor conducted two guidance method target positioning error tpe time cost puncture procedure evaluated result total needle insertion performed evaluate navigation accuracy two guidance approach targeting error ± mm ± mm kinectoptical navigation system em navigation system respectively statistically significant difference tpe kinectoptical navigation system em navigation system p processing time kinectoptical system min similar veran ig system min conclusion accuracy kinectoptical navigation system comparable em navigation system,2017,"Xiao, Deqiang; Li, Yong; Luo, Huoling; Zhang, Yanfang; Guo, Xuejun; Zheng, Huimin; Hu, Qingmao; Jia, Fucang",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-017-1083-x; https://www.ncbi.nlm.nih.gov/pubmed/28217826/,41558957.0,12
24436,24436,34137,w6eqwdez,,Medline,Laparoscopic reduced port surgery for schwannoma of the sigmoid colon: a case report.,10.1111/ases.12102,,25131324.0,unk,yearold woman developed schwannoma sigmoid colon referred hospital colonography determine cause stool occult blood colonoscopy revealed submucosal tumor measured cm diameter sigmoid colon endoscopic ultrasonography revealed low echoic homogeneous demarcated submucosal tumor continued fourth layer colonic wall gastrointestinal stromal myogenic neurogenic tumor suspected thus laparoscopic sigmoidectomy carried used two port operation sils port umbilical region mm port right lower abdominal wall performed sigmoidectomy lymph node dissection histological finding revealed spindlelike tumor cell multiform nucleus tumor diagnosed immunostaining benign schwannoma sigmoid colon conventional surgical treatment schwannoma digestive tract partial resection preoperative diagnosis unknown radical resection lymphadenectomy acceptable submucosal tumor digestive tract case laparoscopic reduced port surgery using one two port may feasible beneficial regard cosmesis reduced postoperative pain conventional laparoscopic colectomy,2014,"Tokuhara, Katsuji; Nakatani, Kazuyoshi; Oishi, Masaharu; Iwamoto, Shigeyoshi; Inoue, Kentaro; Kwon, A-Hon",Asian journal of endoscopic surgery,,,,,,https://doi.org/10.1111/ases.12102; https://www.ncbi.nlm.nih.gov/pubmed/25131324/,28274831.0,12
24442,24442,34144,7w8yclq4,,Medline,Increase in FLAIR Signal of the Fluid Within the Resection Cavity as Early Recurrence Marker: Also Valid for Brain Metastases?,10.1055/s-0042-119686,,28002859.0,unk,purpose increase flair signal fluid within resection cavity described highly specific early sign tumor recurrence glioma aim study ass prognostic value flair signal increase partially completely resected brain metastasis material method case surgery brain metastasis assessed case least two followup mri retrospectively included study quantitative qualitative assessment flair signal intensity fluid within resection cavity performed mri examination recurrent diseaselast contact previous mri examination result case local tumor recurrence showed flair signal increase sensitivity specificity one case sign observed even month tumor recurrence specificity flair signal increase overall tumor recurrence local distant also lower sensitivity quantitative analysis showed significant difference signal intensity resection cavity well change signal intensity resection cavity case without local tumor recurrence conclusion increase flair signal fluid within resection cavity might highly specific early sign local tumor recurrencetumor progression also brain metastasis key point · increase flair signal intensity fluid within resection cavity also observed previously resected brain metastasis · pathophysiology sign might due cellproliferative process citation format · bette gempt j wiestler b et al increase flair signal fluid within resection cavity early recurrence marker also valid brain metastasis fortschr röntgenstr,2017,"Bette, Stefanie; Gempt, Jens; Wiestler, Benedikt; Huber, Thomas; Specht, Hanno; Meyer, Bernhard; Zimmer, Claus; Kirschke, Jan S; Boeckh-Behrens, Tobias",RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,,,,,,https://doi.org/10.1055/s-0042-119686; https://www.ncbi.nlm.nih.gov/pubmed/28002859/,3076745.0,12
24444,24444,34146,en6r381a,,Medline,Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.,10.1016/j.jvir.2014.06.030,,25156828.0,unk,purpose evaluate retrospectively outcome radiofrequency rf ablation pulmonary metastasis esophageal cancer material method study included consecutive patient met inclusion criterion men mean age pulmonary metastasis esophageal cancer tumor mean size cm treated planned ablation session initial rf ablation session patient viable extrapulmonary recurrence patient viable recurrence confined lung primary study endpoint included patient survival determination prognostic factor secondary endpoint included local efficacy safety treatment logrank test used identify prognostic factor adverse event evaluated according national cancer institute common terminology criterion adverse event version result median followup duration initial rf ablation month range mo estimated overall survival rate year year year initial rf ablation session presence viable extrapulmonary recurrence initial rf ablation session unfavorable prognostic factor p local tumor progression observed tumor occurred month median mo rf ablation grade adverse event occurred session including pleural effusion requiring chest tube placement pneumoderma requiring surgical intervention grade greater adverse event occurred conclusion rf ablation promising treatment option patient pulmonary metastasis esophageal cancer,2014,"Matsui, Yusuke; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Iguchi, Toshihiro; Shirakawa, Yasuhiro; Fujiwara, Toshiyoshi; Toyooka, Shinichi; Kanazawa, Susumu",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.06.030; https://www.ncbi.nlm.nih.gov/pubmed/25156828/,7706888.0,12
24530,24530,34246,3k0lssk3,,Medline,Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?,10.1007/s11548-018-1765-z,,29651715.0,unk,purpose ass predictive value local tumor progression ltp geometrical tumor coverage using contrastenhanced cect image acquired within h radiofrequency rf ablation method twenty patient male female median age year focal hypovascular liver metastasis colorectal carcinoma melanoma breast carcinoma underwent rf ablation ctguidance received cepetct scan within h postprocedure pre postablation cectimages aligned using interactive procedure used verify tumor coverage rf ablation result correlated ltp recorded followup performed every month intervention mean followup week compared standard reading performed three reader cect image result eleven tumor showed ltp followup period one lesion show ltp excluded analysis due poor quality alignment remaining tumor completely covered ablation zone tumor edge coincided edge ablation zone sensitivity specificity ppv npv ltp incomplete tumor coverage apparent ablative margin versus standard reading cect versus respectively conclusion verifying tumor coverage liver metastasis ablation zone alignment pre early postablation cect image high predictive value ltp,2018,"Vandenbroucke, Frederik; Vandemeulebroucke, Jef; Buls, Nico; Thoeni, Ruedi F; de Mey, Johan",International journal of computer assisted radiology and surgery,,,,,,https://doi.org/10.1007/s11548-018-1765-z; https://www.ncbi.nlm.nih.gov/pubmed/29651715/,4799907.0,12
24573,24573,34298,0hu38ptb,,Medline,Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.,10.1371/journal.pone.0173112,,28245291.0,unk,purpose unambiguous evaluation glioblastoma gb progression crucial clinical trial well day day routine management gb patient dvolumetry followup gb provides quantitative data tumor extent growth therefore potential facilitate objective disease assessment present study investigated utility absolute change volume delta regional segmentationbased subtraction detecting disease progression longitudinal mri followup method high resolution tesla mri gb patient mean age retrospectively included single center study contrast enhancement cv tumorrelated signal alteration flair image fv semiautomatically segmented delta volume dcv dfv regional subtraction scv sfv calculated disease progression classified every followup according histopathologic result decision local multidisciplinary cns tumor board consensus rating neuroradiologic report result generalized logistic mixed model disease progression yes dcv dfv scv sfv input variable revealed dcv significantly associated prediction disease progression p delta volume better accuracy regional segmentationbased subtraction versus higher area curve trend roc curve versus conclusion absolute volume change contrast enhancing tumor part accurate volumetric determinant detect progressive disease assessment gb outweighed flair change well regional segmentationbased image subtraction parameter might useful upcoming objective response criterion glioblastoma,2017,"Huber, Thomas; Alber, Georgina; Bette, Stefanie; Kaesmacher, Johannes; Boeckh-Behrens, Tobias; Gempt, Jens; Ringel, Florian; Specht, Hanno M; Meyer, Bernhard; Zimmer, Claus; Wiestler, Benedikt; Kirschke, Jan S",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0173112; https://www.ncbi.nlm.nih.gov/pubmed/28245291/,18512173.0,12
24577,24577,34304,gy7yhv7d,,Medline,Endovascular Renal Artery Stent Retriever Embolectomy in a Young Patient With Cardiac Myxoma: Case Report and Review of the Literature.,10.1177/1538574417739746,,29162028.0,unk,purpose cardiac myxoma common tumor heart disproportionate impact young patient occasionally dramatic systemic dissemination tumor embolus catastrophic multiorgan system ischemia coincident comorbidities increase risk traditional treatment tumor embolus region case report young patient previously unknown cardiac myxoma presented seizure found stress cardiomyopathy multiple cerebral large vessel occlusion acute ischemic stroke bilateral lower extremity tumor embolus rhabdomyolysis renal tumor embolus acute tubular necrosis describe multidisciplinary approach applying cerebrovascular stent retriever device tumor embolectomy renal artery young patient systemic morbidity preventing safe laparotomy open surgical tumor embolectomy conclusion describe month renal function outcome consideration applying neuroendovascular mechanical thrombectomy device within renal artery radiographically successful technique renal function appears improving month followup although complicated renal insult support,2018,"Silva, Michael A; See, Alfred P; Shah, Samir K; Khandelwal, Priyank; Patel, Nirav J; Lyu, Heather; Menard, Matthew T; Aziz-Sultan, Mohammad Ali",Vascular and endovascular surgery,,,,,,https://doi.org/10.1177/1538574417739746; https://www.ncbi.nlm.nih.gov/pubmed/29162028/,40872664.0,12
24583,24583,34311,3k9fpfh9,,Medline,Patterns of recurrence after ablation of colorectal cancer liver metastases.,10.1245/s10434-011-2048-x,,21879262.0,unk,purpose determine local recurrence rate factor associated recurrence intraoperative ablation colorectal cancer liver metastasis method retrospective analysis prospectively maintained database performed patient underwent ablation hepatic colorectal cancer metastasis operating room april march kaplanmeier survival curve cox model used determine recurrence rate ass significance result ablation performed n patient case study period seventyeight percent performed conjunction liver resection tumor ablated tumor ≤ cm maximum diameter radiofrequency ablation used treat tumor thirtysix tumor local recurrence part recurrence pattern disease recurred liver systemically tumor ablated univariate analysis tumor size greater cm associated significantly increased risk local recurrence hazard ratio confidence interval p year ablation zone recurrencefree survival tumor ≤ cm compared tumor cm multivariate analysis tumor size cm lack postoperative chemotherapy use cryotherapy significantly associated higher local recurrence rate conclusion intraoperative ablation appears highly effective treatment hepatic colorectal tumor ≤ cm,2012,"Kingham, T Peter; Tanoue, Michael; Eaton, Anne; Rocha, Flavio G; Do, Richard; Allen, Peter; De Matteo, Ronald P; D'Angelica, Michael; Fong, Yuman; Jarnagin, William R",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-011-2048-x; https://www.ncbi.nlm.nih.gov/pubmed/21879262/,23291089.0,12
24648,24648,34390,o60xh3nj,,Medline,Cone beam computed tomography images fusion in predicting lung ablation volumes: a feasibility study.,10.1177/0284185115574874,,25824206.0,unk,background recently different software ability plan ablation volume developed order minimize number attempt positioning electrode improve safe overall tumor coverage purpose ass feasibility threedimensional cone beam computed tomography cbct fusion imaging virtual probe positioning predict ablation volume lung tumor treated percutaneously material method preprocedural computed tomography contrastenhanced scan cect merged cbct volume obtained plan ablation offline tumor segmentation performed determine number antenna positioning within tumor volume ablation obtained evaluated cect performed month compared preprocedural predicted one feasibility assessed basis accuracy evaluation visual evaluation quantitative evaluation qe technical success t technical effectiveness te result seven patient lung tumor treated percutaneous thermal ablation selected treated basis cbct fusion imaging case volume ablation predicted accordance obtained difference volume predicted ablation volume obtained one cect month cm sd ± min max mw cm sd ± min max rf conclusion use preprocedural cbct fusion imaging could useful define expected ablation volume however patient needed ensure stronger evidence,2016,"Ierardi, Anna Maria; Petrillo, Mario; Xhepa, Genti; Laganà, Domenico; Piacentino, Filippo; Floridi, Chiara; Duka, Ejona; Fugazzola, Carlo; Carrafiello, Gianpaolo",Acta radiologica,,,,,,https://doi.org/10.1177/0284185115574874; https://www.ncbi.nlm.nih.gov/pubmed/25824206/,206503979.0,12
24656,24656,34398,qz4ibqwk,,Medline,Outcome of laparoscopic adrenalectomy for resection of unilateral noninvasive adrenocortical tumors in 11 cats.,10.1111/vsu.12655,,28390062.0,unk,objective describe technique outcome laparoscopic adrenalectomy la cat adrenocortical neoplasia study design retrospective case series animal eleven clientowned cat unilateral adrenal tumor method medical record cat underwent la unilateral functional adrenal tumor veterinary teaching hospital reviewed data collected included signalment clinical sign physical examination finding diagnostic imaging result preoperative laboratory test laparoscopic port placement technique duration anesthesia surgery complication concomitant procedure need conversion open celiotomy histopathological diagnosis postoperative survival result eleven cat included rightsided leftsided tumor tumor aldosteronesecreting n progesteronesecreting n testosteronesecreting n adrenalectomy successfully performed cat although case required conversion open celiotomy due poor visualization n close adherence tumor caudal vena cava n inability maintain adequate pneumoperitoneum n ten cat discharged hospital median survival time day range day one cat died severe pancreatitis cardiogenic pulmonary edema conclusion adrenalectomy performed cat via laparoscopy technically challenging associated relatively high conversion rate,2017,"Mitchell, Jeffrey W; Mayhew, Philipp D; Culp, William T N; Brad Case, J; Singh, Ameet; Fuller, Mark C; Della Maggiore, Ann",Veterinary surgery : VS,,,,,,https://doi.org/10.1111/vsu.12655; https://www.ncbi.nlm.nih.gov/pubmed/28390062/,46466348.0,12
24679,24679,34423,zh7ovfq7,,Medline,High-Flow Arterio-Hepatic Venous Shunt in Hepatocellular Carcinoma: Use of Multi-Electrode Radiofrequency for Shunt Obliteration.,10.1007/s00270-014-0990-2,,25189667.0,unk,intratumoral arteriohepatic venous shunting ahvs pose impediment transarterial chemoembolization liver tumor present potential hazard systemic shunting embolization also altered flow dynamic may also result poor delivery drugembolics target tumor bed current available technique overcome avhs include arterial embolization particle coil glue etc temporary venous occlusion using balloon hereby illustrate use radiofrequency ablation obliterate complex ahvs consisting varixlike venous aneurysm,2015,"Pua, Uei",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-014-0990-2; https://www.ncbi.nlm.nih.gov/pubmed/25189667/,19349060.0,12
24736,24736,34489,fpue5la9,,Medline,Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.,10.1016/j.jhep.2018.02.026,,29524532.0,unk,background aim therapeutic outcome surgical resection sr radiofrequency ablation rfa perivascular hepatocellular carcinoma hcc compared aim study compare sr rfa firstline treatment patient perivascular hcc evaluate longterm outcome therapy method retrospective study approved institutional review board requirement informed consent waived january december total consecutive patient small perivascular hccs ≤ cm barcelona clinic liver cancer stage underwent sr n rfa n firstline treatment progressionfree survival pfs overall survival o rate compared propensity score matching subgroup analysis outcome conducted according type hepatic vessel result median followup year matching yielded pair patient two matched group pfs rate year respectively sr group respectively rfa group p corresponding o rate year sr group rfa group respectively p contrast patient perivenous hccs subgroup analysis indicated extrahepatic recurrence o significantly different according treatment modality patient periportal hccs p p respectively conclusion patient small perivascular hccs sr provided better longterm tumor control o rfa particularly periportal tumor lay summary surgical resection radiofrequency ablation treatment option perivascular hepatocellular carcinoma compared outcome patient treated either method surgical resection provided better longterm tumor control overall survival radiofrequency ablation patient small perivascular hepatocellular carcinoma ≤ cm firstline treatment particularly periportal tumor location tumor type peritumoral hepatic vessel need considered choosing surgical resection radiofrequency ablation small hccs,2018,"Lee, Sunyoung; Kang, Tae Wook; Cha, Dong Ik; Song, Kyoung Doo; Lee, Min Woo; Rhim, Hyunchul; Lim, Hyo Keun; Sinn, Dong Hyun; Kim, Jong Man; Kim, Kyunga",Journal of hepatology,,,,,,https://doi.org/10.1016/j.jhep.2018.02.026; https://www.ncbi.nlm.nih.gov/pubmed/29524532/,4873235.0,12
24784,24784,34539,180hsyfx,,Medline,PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.,10.1016/j.nucmedbio.2011.02.014,,21982571.0,unk,introduction radiolabeled bombesin bn conjugate promising radiotracers imaging therapy breast prostate tumor bngastrinreleasing peptide grp receptor overexpressed however low vivo stability bn conjugate may limit clinical application attempt improve pharmacokinetics counteract rapid enzymatic degradation prepared series polyethylene glycol pegylated bn analogue radiolabeling mtcco evaluated vitro vivo method derivatization stabilized nαhisacbnchanle analogue linear peg molecule various size kda peg kda peg kda peg performed pegylation ɛamino group βhlysβalaβala spacer stabilized bn sequence nαhisac chelator analogue radiolabeled employing mtctricarbonyl technique binding affinity internalizationexternalization study performed vitro human prostate carcinoma pc cell stability investigated vitro human plasma vivo balbc mouse finally single photon emission computed tomography spectxray computed tomography study performed nude mouse bearing pc tumor xenograft result pegylation affect binding affinity bn analogue binding affinity bngrp receptor remained high kd nm however vitro binding kinetics pegylated analogue slower steadystate condition reached h total cell binding time lower nonpegylated counterpart besides pegylation improved stability bn conjugate vitro vivo bn derivative conjugated peg molecule showed best pharmacokinetics vivo ie faster blood clearance preferential renal excretion tumor uptake mtcpeglysbn conjugate slightly higher compared nonpegylated analogue ± v ± injected dose per gram h postinjection pi tumor retention also increased resulting threefold higher amount radioactivity tumor h pi furthermore decreased hepatobiliary excretion increased tumortonontarget ratio tumortoblood v tumortokidney v tumortoliver v h pi observed confirmed via smallanimal spect image h pi conclusion pegylation proved effective strategy enhance tumortargeting potential mtclabeled bnbased radiopharmaceutical probably radiolabeled peptide,2011,"Däpp, Simone; García Garayoa, Elisa; Maes, Veronique; Brans, Luc; Tourwé, Dirk A; Müller, Cristina; Schibli, Roger",Nuclear medicine and biology,,,,,,https://doi.org/10.1016/j.nucmedbio.2011.02.014; https://www.ncbi.nlm.nih.gov/pubmed/21982571/,45029220.0,12
24840,24840,34604,fici615g,,Medline,Laparoscopic sleeve gastrectomy for a large gastrointestinal stromal tumor.,10.1097/sle.0b013e318244ec34,,22487640.0,unk,biological behavior gastrointestinal stromal tumor gist make resection tumor adequate margin mode curative treatment gist lymphatic permeation hence goal therapy complete resection visible microscopic disease achieved adequate tumorfree margin laparoscopic management large gist tumor discouraged fear spillage tumor rupture tumor capsule handling large tumor thus causing metastasis,2012,"Thakkar, Dimple V; Wani, Sachin V; Shetty, Vishwanath; Patankar, Roy V","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e318244ec34; https://www.ncbi.nlm.nih.gov/pubmed/22487640/,12391576.0,12
24861,24861,34627,caekkg3d,,Medline,The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.,10.1634/theoncologist.2015-0085,,26354526.0,unk,metastatic spine disease multidisciplinary working group consists medical radiation oncologist surgeon interventional radiologist multiple comprehensive cancer center developed evidence expert opinionbased algorithm managing metastatic spine disease purpose algorithm facilitate interdisciplinary referral providing physician straightforward recommendation regarding use available treatment option including emerging modality stereotactic body radiation therapy percutaneous tumor ablation consensus document detail evidence supporting working group algorithm includes illustrative case demonstrate algorithm may applied,2015,"Wallace, Adam N; Robinson, Clifford G; Meyer, Jeffrey; Tran, Nam D; Gangi, Afshin; Callstrom, Matthew R; Chao, Samuel T; Van Tine, Brian A; Morris, Jonathan M; Bruel, Brian M; Long, Jeremiah; Timmerman, Robert D; Buchowski, Jacob M; Jennings, Jack W",The oncologist,,,,,,https://doi.org/10.1634/theoncologist.2015-0085; https://www.ncbi.nlm.nih.gov/pubmed/26354526/,42999727.0,12
24889,24889,34661,ioaj97jp,,Medline,The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin.,10.3390/molecules190710455,,25036155.0,unk,overexpression gastrinreleasing peptide receptor grpr cancer used peptidereceptor mediated radionuclide imaging therapy previously shown antagonist analog bombesin rm conjugated triazacyclononanennntriacetic acid nota via diethyleneglycol peg spacer notapegrm labeled ga used imaging grprexpressing tumor study evaluated variation minipeg spacer length used optimization targeting property notaconjugated rm series analog different peglength n synthesized radiolabeled evaluated vitro vivo ic value natganotapegnrm n ± ± ± ± nm respectively normal mouse conjugate demonstrated similar biodistribution pattern however ganotapegrm showed lower liver uptake biodistribution ganotapegrm evaluated nude mouse bearing pc prostate cancer bt breast cancer xenograft high uptake tumor ± idg ± idg pc bt xenograft respectively high tumortobackground ratio tumorblood ± ± pc bt xenograft respectively found already h pi ganotapegrm result study suggest variation length peg spacer used optimization targeting property peptidechelator conjugate however influence minipeg length biodistribution minor di tri tetra hexaethylene glycol compared,2014,"Varasteh, Zohreh; Rosenström, Ulrika; Velikyan, Irina; Mitran, Bogdan; Altai, Mohamed; Honarvar, Hadis; Rosestedt, Maria; Lindeberg, Gunnar; Sörensen, Jens; Larhed, Mats; Tolmachev, Vladimir; Orlova, Anna",Molecules,,,,,,https://doi.org/10.3390/molecules190710455; https://www.ncbi.nlm.nih.gov/pubmed/25036155/,17645899.0,12
24933,24933,34710,zga30eym,,Medline,Laparoscopic distal pancreatectomy for multiple epithelial cysts in an intrapancreatic accessory spleen. A case report and review of literature.,10.6092/1590-8577/1784,,24216550.0,unk,context accessory spleen congenital abnormality consisting normal splenic tissue ectopic site found approximately general population however intrapancreatic accessory spleen seldom reported multiple epithelial cyst intrapancreatic accessory spleen extremely rare case report yearold woman clinical manifestation presented two cystic lesion tail pancreas tumor marker ca uml span uml increased computed tomography showed multilocular cyst mm size unilocular cyst mm size tail pancreas gallstone cystic component hypointense tweighted magnetic resonance image hyperintense tweighted magnetic resonance image laparoscopic distal pancreatectomy performed presumptive diagnosis mucinous cystic neoplasm intraductal papillary mucinous neoplasm gallstone pathological examination showed wall two cyst covered nonkeratinized stratified squamous epithelium surrounded normal splenic tissue final pathological diagnosis two epithelial cyst originating intrapancreatic accessory spleen conclusion even though multiple mass detected pancreatic tail possibility epithelial cyst originating accessory spleen considered laparoscopic distal pancreatectomy might safe effective procedure provide good cosmetic result benign lowgrade malignant tumor pancreas,2013,"Wakasugi, Masaki; Tori, Masayuki; Akamatsu, Hiroki; Ueshima, Shigeyuki; Omori, Takeshi; Tei, Mitsuyoshi; Masuzawa, Toru; Tsujimoto, Masahiko; Nishida, Toshirou",JOP : Journal of the pancreas,,,,,,https://doi.org/10.6092/1590-8577/1784; https://www.ncbi.nlm.nih.gov/pubmed/24216550/,2613160.0,12
25072,25072,34867,1k7b53r7,,Medline,Primary Functioning Neuroendocrine Tumor of the Appendix with Hypoglycemia Syndrome: A Case Report and Review of Neuroendocrine Tumors.,10.7812/tpp/19.142,,32240090.0,unk,introduction primary neuroendocrine tumor net appendix uncommon present usually hyperfunctioning case represents extraordinarily rare primary hyperfunctioning net appendix clinical presentation symptomatic hypoglycemia otherwise healthy man case presentation previously healthy yearold man found symptomatically hypoglycemic early workup apparent explanation tumor midappendix referred surgical oncology service resection patient clinical course described detail including imaging well surgical pathologic description appendiceal net discussion literature review demonstrates case series report primary hyperfunctioning net appendix presenting hypoglycemic crisis symptom tumorinduced hypoglycemia typically arise islet cell tumor pancreatic net insulinomas believe case represents nonislet cell tumorinduced hypoglycemia patient elevated serum proinsulin level preoperatively implies secretion proinsulin tumor however tumorinduced hypoglycemia caused proinsulin described previously pancreatic tumor unique case add knowledge possible glycemic endocrine effect nonpancreatic net specifically arise primarily appendix,2020,"Layman, Peter F; Davis-Merritt, Deborah; Neff, Phillip",The Permanente journal,,,,,,https://doi.org/10.7812/tpp/19.142; https://www.ncbi.nlm.nih.gov/pubmed/32240090/,214738008.0,12
25086,25086,34883,f2h0wo9w,,Medline,Endoscopic and Laparoscopic Full-Thickness Resection of Endophytic Gastric Submucosal Tumors Very Close to the Esophagogastric Junction.,10.5230/jgc.2015.15.4.278,,26819807.0,unk,purpose gastric submucosal tumor smts located close esophagogastric junction egj challenge gastric surgeon therefore study report experience using endoscopic laparoscopic fullthickness resection elfr laparoscopic twolayer suturing tumor material method six patient gastric smts close egj underwent elfr laparoscopic twolayer suturing kyungpook national university medical center patient general anesthesia lesser curvature posterior aspect adjacent egj meticulously dissected visualized using laparoscopic approach partially circumferential fullthickness incision distal margin tumor made using endoscopic approach laparoscopic guidance smt resected using laparoscopic ultrasonic shear gastric wall closed using twolayer suturing thereafter patency leakage checked endoscopy result elfr procedure laparoscopic twolayer suturing performed successfully without open conversion mean operation time ± minute blood loss minimal measured tumor four patient leiomyoma tumor two patient gastrointestinal stromal tumor clear resection margin patient started oral intake third postoperative day morbidity mortality mean hospital stay ± day conclusion elfr laparoscopic twolayer suturing safe treatment option patient smt close egj major resection stomach avoided,2015,"Kwon, Oh Kyoung; Yu, Wansik",Journal of gastric cancer,,,,,,https://doi.org/10.5230/jgc.2015.15.4.278; https://www.ncbi.nlm.nih.gov/pubmed/26819807/,6105843.0,12
25105,25105,34903,vyxgpjr6,,Medline,Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga-Compared to 111In-Labeled Conjugates.,10.2310/7290.2014.00034,,28650299.0,unk,affibody molecule small kda scaffold protein promising class probe radionuclide molecular imaging radiolabeling affibody molecule positronemitting nuclide ga would permit use positron emission tomography pet providing better resolution sensitivity quantification accuracy singlephoton emission computed tomography spect synthetic antiher zhers affibody molecule conjugated dota nterminus middle helix cterminus biodistribution ga inlabeled affibody molecule directly compared nmri nunu mouse bearing skov xenograft position chelator strongly influenced biodistribution tracer influence pronounced galabeled affibody molecule inlabeled counterpart best galabeled variant gadotaazhers provided tumor uptake ± idg tumor blood ratio ± hour injection indotaazhers indotakzhers equally good time point providing tumor uptake idg tumor blood ratio range conclusion selection best position chelator affibody molecule used optimization imaging property may important development affibodybased proteinbased imaging probe,2014,"Honarvar, Hadis; Strand, Joanna; Perols, Anna; Orlova, Anna; Selvaraju, Ram Kumar; Karlström, Amelie Eriksson; Tolmachev, Vladimir",Molecular imaging,,,,,,https://doi.org/10.2310/7290.2014.00034; https://www.ncbi.nlm.nih.gov/pubmed/28650299/,47565636.0,12
25196,25196,35008,g2l6wzbn,,Medline,Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.,10.1002/cncr.24799,,20127959.0,unk,background antibodybased imaging agent available commercially success limited mainly low contrast emergence fluorodeoxydglucosepositron emission tomography fdgpet scanning pretargeting administration radionuclide separated antibody thereby enhancing image contrast allowing detection earlier time point injection method author conducted openlabel singlearm trial assessed pretargeting procedure anticarcinoembryonic antigen x anticea x antidiethylenetriaminepentaacetic acid antidtpaindum antibody used combination inlabeled didtpa peptide diagnostic imaging ceaexpressing colorectal cancer three patient received peptide alone investigate tumor targeting organ distribution clearance peptide thereafter patient received bispecific antibody bsab mg pretarget tumor day patient injected megabecquerels inlabeled peptide ass optimal interval best image quality result fourteen patient primary colorectal cancer enrolled one patient received peptide alone lowlevel tumor uptake patient tumor observed patient fdgpetpositive lymph node observed clearly pretargeted immunoscintigraphy peptide pharmacokinetics revealed enhanced circulating level inlabeled peptide patient day interval cohort compared cohort tumortobackground ratio ranged day interval group day interval group day interval group best image acquired day interval hour injection radiolabeled peptide grade adverse event observed patient conclusion imaging colorectal cancer using step pretargeting system produced best imaging result hour peptide administration using day interval injection bsab peptide,2010,"Aarts, Frits; Boerman, Otto C; Sharkey, Robert M; Hendriks, Thijs; Chang, Chien-Hsing; McBride, William J; Bleichrodt, Robert P; Oyen, Wim J G; Goldenberg, David M",Cancer,,,,,,https://doi.org/10.1002/cncr.24799; https://www.ncbi.nlm.nih.gov/pubmed/20127959/,205659523.0,12
25211,25211,35025,0bn4thoz,,Medline,Microwave ablation for hepatic malignancies: a multiinstitutional analysis.,10.1097/sla.0000000000000234,,24096760.0,unk,objective study hypothesized tumor size number tumor surgical approach tumor histology significantly affected microwave ablation mwa success recurrencefree survival background although many hepatobiliary center adopted mwa factor influence local control well described method consecutive patient hepatic malignancy treated mwa included highvolume institution grouped histology hepatocellular carcinoma hcc colorectal liver metastasis neuroendocrine liver metastasis cancer independent significance outcome variable established logistic regression cox proportional hazard model result four hundred fifty patient treated procedure hcc colorectal liver metastasis neuroendocrine liver metastasis total tumor median followup month concurrent hepatectomy performed patient performed associated greater morbidity complete ablation confirmed tumor followup crosssectional imaging unevaluable surgical approach open laparoscopic percutaneous significant impact complication rate recurrence survival local recurrence rate overall highest hcc p percutaneously treated lesion p adjusted model tumor size cm predicted poorer recurrencefree survival hazard ratio ci p conclusion large data set patient cm tumor showed propensity early recurrence regardless histology higher rate local recurrence noted hcc patient may reflect underlying liver disease significant difference morbidity survival based surgical approach however local recurrence rate highest percutaneously ablated tumor,2014,"Groeschl, Ryan T; Pilgrim, Charles H C; Hanna, Erin M; Simo, Kerri A; Swan, Ryan Z; Sindram, David; Martinie, John B; Iannitti, David A; Bloomston, Mark; Schmidt, Carl; Khabiri, Hooman; Shirley, Lawrence A; Martin, Robert C G; Tsai, Susan; Turaga, Kiran K; Christians, Kathleen K; Rilling, William S; Gamblin, T Clark",Annals of surgery,,,,,,https://doi.org/10.1097/sla.0000000000000234; https://www.ncbi.nlm.nih.gov/pubmed/24096760/,19212715.0,12
25222,25222,35037,2g4ujw3j,,Medline,Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.,10.1677/erc-09-0078,,19995807.0,unk,somatostatin receptor imaging sri indtpaoctreotide proven role diagnosis staging gastroenteropancreatic neuroendocrine tumor gepnets newer radiolabeled somatostatin analog used positron emission tomography pet imaging higher affinity somatostatin receptor especially receptor subtype developed would desirable however one radiolabeled analog became new standard pet imaging current application multitude analog implies fragmented knowledge interpretation image obtained clinical practice view likely candidate universal pet tracer sri gadotatyroctreotate gadotatyroctreotide treatment radiolabeled somatostatin analog promising new tool management patient inoperable metastasized neuroendocrine tumor symptomatic improvement may occur lulabeled somatostatin analog used peptide receptor radionuclide therapy prrt result obtained ydotatyroctreotide ludotatyroctreotate encouraging term tumor regression also kidney protective agent used side effect therapy mild median duration therapy response radiopharmaceutical month respectively patient selfassessed quality life increase significantly treatment ludotatyroctreotate lastly compared historical control benefit overall survival several year time diagnosis patient treated ludotatyroctreotate data compare favorably limited number alternative treatment approach widespread use prrt guaranteed therapy may well become therapy first choice patient metastasized inoperable gepnets,2010,"Kwekkeboom, Dik J; Kam, Boen L; van Essen, Martijn; Teunissen, Jaap J M; van Eijck, Casper H J; Valkema, Roelf; de Jong, Marion; de Herder, Wouter W; Krenning, Eric P",Endocrine-related cancer,,,,,,https://doi.org/10.1677/erc-09-0078; https://www.ncbi.nlm.nih.gov/pubmed/19995807/,13321789.0,12
25248,25248,35066,oea8teqy,,Medline,Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.,10.1007/s00270-013-0716-x,,23934115.0,unk,purpose study designed determine feasibility safety ultrasoundguided transhepatic radiofrequency ablation rfa mass right kidney method june december patient underwent transhepatic renal rfa procedure treat tumor retrospectively identified complication claviendindo classification system local tumor control evaluated patient result median maximal diameter treated renal tumor range cm major complication developed procedure hepatic tumor seeding identified imaging followup single technical failure median crosssectional imaging followup range month primary technique failure local recurrence occurred tumor followup imaging conclusion percutaneous ultrasoundguided transhepatic rfa renal neoplasm technically feasible effective associated low rate complication transhepatic approach may allow safe ablation renal tumor would otherwise difficult treat,2014,"Hegg, Ryan M; Schmit, Grant D; Kurup, A Nicholas; Weisbrod, Adam J; Boorjian, Stephen A; Atwell, Thomas D",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0716-x; https://www.ncbi.nlm.nih.gov/pubmed/23934115/,21444917.0,12
25301,25301,35124,1elv5ip7,,Medline,"Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.",10.1007/s00259-019-04677-x,,31953672.0,unk,purpose imaging glioma biology hold great promise unravel complex nature tumor besides wellestablished imaging technique offluoroethylltyrosine fetpet dynamic susceptibility contrast dsc perfusion imaging amide proton transferweighted aptw imaging emerged promising novel mr technique study aimed better understand relation imaging biomarkers well capture cellularity vascularity newly diagnosed glioma method preoperative mri fetpet data patient glioblastoma lowergrade glioma segmented contrastenhancing flairhyperintense area using established cutoff calculated hotspot volume hsv spatial overlap investigated aptw cbv value fethsv subset glioblastoma patient compared cellularity vascularization stereotactically targeted biopsy imaging result glioblastoma largest hsv found aptw followed pet cbv p lowergrade glioma aptwhsv clearly lower glioblastoma spatial overlap hsv highest aptw fet tumor entity region aptw correlated significantly cellularity similar fet association vascularity pronounced cbv fet conclusion found relevant spatial overlap glioblastoma hotspot aptw fet contrastenhancing flairhyperintense tumor suggested earlier study aptw lower lowergrade glioma compared glioblastoma aptw meaningfully contributes biological imaging glioma,2020-01-17,"Schön, S; Cabello, J; Liesche-Starnecker, F; Molina-Romero, M; Eichinger, P; Metz, M; Karimov, I; Preibisch, C; Keupp, J; Hock, A; Meyer, B; Weber, W; Zimmer, C; Pyka, T; Yakushev, I; Gempt, J; Wiestler, B",European journal of nuclear medicine and molecular imaging,,,,,,https://doi.org/10.1007/s00259-019-04677-x; https://www.ncbi.nlm.nih.gov/pubmed/31953672/,210709322.0,12
25319,25319,35145,9xvndua0,,Medline,Robot-assisted Level II-III Inferior Vena Cava Tumor Thrombectomy: Step-by-Step Technique and 1-Year Outcomes.,10.1016/j.eururo.2016.08.066,,27663048.0,unk,background level iiiii inferior vena cava ivc tumor thrombectomy renal cell carcinoma among challenging urologic oncologic surgery reported initial series robotassisted level iii caval thrombectomy objective describe university southern california technique stepbystep fashion robotassisted ivc level iiiii tumor thrombectomy design setting participant twentyfive selected patient renal neoplasm level iiiii ivc tumor thrombus underwent robotassisted surgery minimum yr followup july march surgical procedure standardized anatomicbased ivcfirst kidneylast technique robotassisted ivc thrombectomy focus minimizing chance intraoperative tumor thromboembolism major hemorrhage outcome measurement statistical analysis baseline demographic pathology data yr complication oncologic outcome last followup assessed result limitation robotassisted ivc thrombectomy successful patient level iii n level ii n one patient electively converted open surgery failure progress median data included operative time h estimated blood loss ml hospital stay five patient received intraoperative blood transfusion surgical margin negative complication occurred four patient two clavien one clavien one clavien b patient alive mo median followup range mo conclusion robotic ivc tumor thrombectomy feasible level iiiii thrombus maximize intraoperative safety chance success thorough understanding applied anatomy altered vascular collateral flow channel careful patient selection meticulous crosssectional imaging highly experienced robotic team essential patient summary present detailed operative step new minimally invasive robotassisted surgical approach treat patient advanced kidney cancer type surgery performed safely low blood loss excellent outcome even patient advanced kidney cancer could benefit robotic surgery quicker recovery,2017,"Chopra, Sameer; Simone, Giuseppe; Metcalfe, Charles; de Castro Abreu, Andre Luis; Nabhani, Jamal; Ferriero, Mariaconsiglia; Bove, Alfredo Maria; Sotelo, Rene; Aron, Monish; Desai, Mihir M; Gallucci, Michele; Gill, Inderbir S",European urology,,,,,,https://doi.org/10.1016/j.eururo.2016.08.066; https://www.ncbi.nlm.nih.gov/pubmed/27663048/,13670543.0,12
25403,25403,35244,trxnpdrv,,Medline,Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.,10.1007/s00270-019-02313-7,,31451888.0,unk,purpose radiofrequency cryoablation cryo widely used technique treatment ta renal tumor nonsurgical candidate yet microwave ablation mwa gaining popularity study tested hypothesis mwa comparable safety efficacy cryo treatment selected ta renal mass material method retrospective comparative analysis two patient cohort carried nodule consecutive patient treated using imageguided percutaneous ablation either cryo mwa patient demographic tumor histology characteristic technical success procedure time adverse event complication nephrometry score mrenal renal function evaluated local recurrence evaluated month result fiftyone nodule treated cryo mwa patient respectively statistical difference observed following cryo mwa median tumor size p mrenal p technical success p median procedure time significantly lower using microwave ablation p median followup time similar two group month respectively occurrence complication differ cryo mwa p probability complication technical success adjusted mrenal reach statistical significance p renal function preserved patient regardless technique disease recurrence observed treated nodule cryo mwa group respectively without reaching statistical significance p conclusion patient population studied mwa showed comparable safety efficacy relative cryo level evidence level nonrandomized cohort study,2019,"De Cobelli, Francesco; Papa, Maurizio; Panzeri, Marta; Colombo, Michele; Steidler, Stephanie; Ambrosi, Alessandro; Cao, Roberta; Gusmini, Simone; Marra, Paolo; Capitanio, Umberto; Bertini, Roberto; Venturini, Massimo; Losa, Andrea; Gaboardi, Franco; Montorsi, Francesco; Cardone, Gianpiero",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-019-02313-7; https://www.ncbi.nlm.nih.gov/pubmed/31451888/,201755976.0,12
25472,25472,35328,daop6ufj,,Medline,Three cases of immature teratoma diagnosed after laparoscopic operation.,10.4137/ccrep.s17455,,25232281.0,unk,mature cystic teratoma ovary common ovarian tumor young woman immature teratoma rare tumor representing ovarian cancer three case presented young woman suspected mature cystic teratoma based ct scan mri ultimately diagnosed immature teratoma ic b g laparoscopic operation underwent salpingooophorectomy affected side shown sign recurrence followup sometimes encounter patient immature teratoma finding pointing malignancy ct mri generally component immature nerve cell represent immature teratoma difficult diagnose entity immature teratoma imaging evaluation ct mri many hospital laparoscopic surgery selected patient ovarian mature teratoma therefore essential attempt much possible disseminate fluid content tumor intraabdominal space laparoscopic operation rare case tumor turn benign mature teratoma,2014,"Nishida, Masakazu; Kawano, Yasushi; Yuge, Akitoshi; Nasu, Kaei; Matsumoto, Harunobu; Narahara, Hisashi",Clinical medicine insights. Case reports,,,,,,https://doi.org/10.4137/ccrep.s17455; https://www.ncbi.nlm.nih.gov/pubmed/25232281/,15763669.0,12
25480,25480,35338,kl6jpb5e,,Medline,Three-Dimensional Simulation of Collision-Free Paths for Combined Endoscopic Third Ventriculostomy and Pineal Region Tumor Biopsy: Implications for the Design Specifications of Future Flexible Endoscopic Instruments.,10.1227/neu.0000000000001177,,29506110.0,unk,background recent innovation expand scope intraventricular neuroendoscopy focused transitioning multipleincision procedure singlecorridor approach however successful adoption combined procedure requires minimizing unwanted torque applied surrounding healthy structure objective define geometry relevant anatomical structure endoscopic third ventriculostomy etv pineal region tumor biopsy etb second determine optimal instrument shaft path required collisionfree single burr hole combined etvetb method magnetic resonance computed tomography data pediatric patient underwent etv etb procedure segmented using dslicer software package create virtual patient model anatomical region interest measured including foramen monro massa intermedia floor third ventricle tumor margin utilizing matlab software package virtual dexterous instrument inserted model optimal dimension calculated result diameter foramen monro massa intermedia anteriorposterior superiorinferior anterior third ventricle tumor margin mm respectively average optimal burr placement determined mm anterior coronal mm lateral sagittal suture optimal flexible instrument geometry novel instrument calculated conclusion established platform estimating shape novel curved dexterous instrument collisionfree targeting multiple intraventricular point patient tool specific integrated image guidance data aid developing novel dexterous instrument,2016,"Eastwood, Kyle W; Bodani, Vivek P; Drake, James M",Operative neurosurgery,,,,,,https://doi.org/10.1227/neu.0000000000001177; https://www.ncbi.nlm.nih.gov/pubmed/29506110/,3745477.0,12
25507,25507,35370,qk6ryses,,Medline,Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.,10.1097/sla.0000000000000964,,25379849.0,unk,objective evaluate histopathologic response neoadjuvant therapy esophageal adenocarcinoma according impact prognosis suggest classification clinical routine background measure histopathologic response neoadjuvant treatment esophageal cancer mandard tumor regression grading focus effect primary tumor although lymph node infiltration significant prognostic importance criterion mostly included response classification method total patient male median age year neoadjuvant radiochemotherapy gy fu cisplatin chemotherapy magic flot ct nx esophageal adenocarcinoma included analysis patient undergone transthoracic en bloc esophagectomy median resected lymph node rresection rate histopathologic regression grading differentiated major minor response according le vital cell primary tumor lymph node classified ypn ypn result patient r resection category group significantly different year survival rate ysr could differentiated major response ypn n ysr either major response ypn n ysr minor response ypn n ysr together ysr minor response ypn n ysr conclusion combined classification primary tumor regression lymph node status grade represents simple reproducible prognostic classification effect neoadjuvant treatment esophageal adenocarcinoma,2014,"Hölscher, Arnulf H; Drebber, Uta; Schmidt, Henner; Bollschweiler, Efriede",Annals of surgery,,,,,,https://doi.org/10.1097/sla.0000000000000964; https://www.ncbi.nlm.nih.gov/pubmed/25379849/,5597413.0,12
25528,25528,35396,s1fuch1z,,Medline,Microwave ablation of renal tumors: state of the art and development trends.,10.1007/s11547-014-0426-8,,25001585.0,unk,last decade increased incidence new renal tumor case clinically localized small tumor cm trend small lowstage tumor reflection earlier diagnosis primarily result widespread increasing use noninvasive abdominal imaging modality ultrasound computerized tomography magnetic resonance imaging renal tumor often diagnosed elderly patient medical comorbidities risk surgical complication may pose greater risk death due tumor patient unsuitable surgical approach thermal ablation represents valid alternative traditional surgery thermal ablation le invasive le morbid treatment option thanks reduced blood loss lower incidence complication procedure le long convalescence present widely used thermal ablative technique cryoablation radiofrequency ablation microwave ablation mwa mwa offer many benefit ablation technique offer several advantage higher intratumoral temperature larger tumor ablation volume faster ablation time ability use multiple applicator simultaneously optimal heating cystic mass tumor close vessel le procedural pain review aim provide reader overview state art microwave ablation renal tumor cast glance new development trend technique,2014,"Floridi, Chiara; De Bernardi, Irene; Fontana, Federico; Muollo, Alessandra; Ierardi, Anna Maria; Agostini, Andrea; Fonio, Paolo; Squillaci, Ettore; Brunese, Luca; Fugazzola, Carlo; Carrafiello, Gianpaolo",La Radiologia medica,,,,,,https://doi.org/10.1007/s11547-014-0426-8; https://www.ncbi.nlm.nih.gov/pubmed/25001585/,19885076.0,12
25582,25582,35465,whtx258e,,Medline,Palliative Percutaneous Cryoablation and Cementoplasty of Acetabular Metastases: Factors Affecting Pain Control and Fracture Risk.,10.1007/s00270-018-1998-9,,29881934.0,unk,purpose characterize response patient acetabular metastasis following combined cryoablation cementoplasty ccc pain palliation fracture risk reduction based completeness ablation presence preexisting pathologic fracture material method thirtynine consecutive acetabular ccc procedure performed patient mf age ± year pain assessed using numeric rating scale development new progression preexisting fracture local tumor progression ltp determined followup imaging pain score reduction fracture development rate compared ablation completeness presence preexisting fracture result twentythree patient evaluable pain score reduced pain decreasing ± ± p tumor completely ablated significant difference pain reduction complete versus incomplete ablation p six patient followup imaging demonstrated newprogressive acetabular fracture four patient ltp developed newprogressive fracture compared without tumor progression p preexisting fracture associated subsequent fracturefracture progression p however patient prior acetabular radiation therapy surgery increased fracture following treatment p conclusion complete acetabular tumor ablation ccc associated superior pain relief compared subtotal ablation result improved fracture stabilization pretreatment pathologic fracture associated fracture progression newprogressive fracture frequent patient prior radiation therapy surgery,2018,"Kurup, A Nicholas; Schmit, Grant D; Atwell, Thomas D; Sviggum, Erik B; Castaneda, Wilfrido R; Rose, Peter S; Callstrom, Matthew R",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-1998-9; https://www.ncbi.nlm.nih.gov/pubmed/29881934/,46968731.0,12
25605,25605,35493,j4abclax,,Medline,Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas.,10.1038/s41598-017-13679-4,,29042619.0,unk,hypothesized machine learning analysis based texture information preoperative mri predict idh mutational status newly diagnosed grade ii iii glioma retrospective study included total consecutive patient newly diagnosed grade ii iii glioma local binary pattern texture feature generated preoperative b fractional anisotropy fa diffusion tensor imaging using training set patient single hidden layer neural network trained texture feature predict idh status model validated based prediction accuracy calculated previously unseen set glioma prediction accuracy generated model case auc training auc validation cohort ten important feature comprised tumor size b fa texture information underlining joint contribution imaging data classification machine learning analysis dti texture information tumor size reliably predicts idh status preoperative mri glioma information may increasingly support individualized surgical strategy supplement pathological analysis highlight potential radiogenomics,2017,"Eichinger, Paul; Alberts, Esther; Delbridge, Claire; Trebeschi, Stefano; Valentinitsch, Alexander; Bette, Stefanie; Huber, Thomas; Gempt, Jens; Meyer, Bernhard; Schlegel, Juergen; Zimmer, Claus; Kirschke, Jan S; Menze, Bjoern H; Wiestler, Benedikt",Scientific reports,,,,,,https://doi.org/10.1038/s41598-017-13679-4; https://www.ncbi.nlm.nih.gov/pubmed/29042619/,3288858.0,12
25617,25617,35509,ug6owrtz,,Medline,Image-guided percutaneous ablation of lung malignancies: A minimally invasive alternative for nonsurgical patients or unresectable tumors.,10.1097/lbr.0000000000000008,,24419192.0,unk,lung cancer remains malignancy highest mortality second highest incidence men woman within united state imageguided ablative therapy safe effective localized control unresectable liver renal bone lung tumor local ablative therapy shown slow disease progression prolong diseasefree survival patient surgical candidate either due local extent disease medical comorbidities commonly encountered complication percutaneous ablation lung tumor include pneumothorax pleural inflammation pleural effusion pneumonia usually easily managed review discus merit imageguided ablation treatment lung tumor underlying mechanism procedural technique clinical utility toxicity imaging tumor response future development focus radiofrequency ablation,2014,"Chamarthy, Murthy R; Gupta, Mohit; Hughes, Terence W; Velasco, Noel B; Cynamon, Jacob; Golowa, Yosef",Journal of bronchology & interventional pulmonology,,,,,,https://doi.org/10.1097/lbr.0000000000000008; https://www.ncbi.nlm.nih.gov/pubmed/24419192/,9238263.0,12
25727,25727,35638,x490z1mf,,Medline,Radiofrequency ablation of atypical cartilaginous tumors in long bones: a retrospective study.,10.1080/02656736.2019.1687943,,31884842.0,unk,purpose determine size ablation zone radiofrequency ablation rfa atypical cartilaginous bone tumor act using temperaturecontrolled mm rfa straight noncooled electrodesmaterials method sixteen patient act long bone undergone singlesession singleapplication ctguided temperaturecontrolled rfa included retrospectively study tumor diameter mm treated mm electrode n tumor mm mm electrode n ablated zone measured three month mri imagesresults tumor within ablated zone month followup mri scan mean ablation time electrode target temperature °c minute range median largest ablation diameter applying mm electrode mm iqr range mm mm iqr range mm respectivelyconclusions retrospectively viewed tumor long bone act patient treated rfa completely ablated ablation zone diameter bone larger expected compared tissue liver,2019,"Rivas, Ricardo; Overbosch, Jelle; Kwee, Thomas; Kraeima, Joep; Dierckx, Rudi A J O; Jutte, Paul C; van Ooijen, Peter M","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2019.1687943; https://www.ncbi.nlm.nih.gov/pubmed/31884842/,209511871.0,12
25732,25732,35643,j6o82gu7,,Medline,Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma.,10.1111/hepr.12022,,23198863.0,unk,aim evaluate feasibility fusion conventional imaging modality facilitate assessment ablative margin radiofrequency ablation rfa hepatocellular carcinoma hcc method two hundred thirtynine liver lesion patient underwent percutaneous rfa ultrasound hcc january december within patient lesion patient developed local tumor progression followup period least month retrospectively reviewed imaging obtained rfa used creating fused image workstation ablative margin assessed using axial image fused image result ablative margin assessed sufficient lesion using sidebyside axial image however lesion assessed insufficient fused imaging evaluation reason discrepancy assessment result difference respiratory dislocation liver pre postrfa image eight lesion rotational displacement liver torso five site local tumor recurrence relative hcc lesion craniocaudal lesion dorsoventral seven lateral seven lesion site local tumor recurrence congruent area thinnest ablative margin conclusion assessment ablative margin fused imaging revealed insufficiency ablation previously evaluated sufficient conventional axial imaging fused imaging evaluation proved accurate useful tool assessment rfa margin,2013,"Tomonari, Akiko; Tsuji, Kunihiko; Yamazaki, Hajime; Aoki, Hironori; Kang, Jong-Hon; Kodama, Yoshihisa; Sakurai, Yasuo; Maguchi, Hiroyuki",Hepatology research : the official journal of the Japan Society of Hepatology,,,,,,https://doi.org/10.1111/hepr.12022; https://www.ncbi.nlm.nih.gov/pubmed/23198863/,26081731.0,12
25756,25756,35672,fspwoq7h,,Medline,Optimal approach for complete liver tumor ablation using radiofrequency ablation: a simulation study.,10.1080/13645706.2017.1330757,,28612670.0,unk,purpose investigate effect radiofrequency ablation rfa electrode trajectory complete tumor ablation using computational simulation material method rfa spherical tumor cm diameter along cm clinical safety margin simulated using finite element analysis software total point inside oneeighth tumor volume along axial sagittal coronal plane selected target site electrodetip placement angle electrode insertion craniocaudal orbital plane ranged ° ° ° increment rfa electrode simulated pas target site different angle combination craniocaudal orbital plane advanced edge tumor result complete tumor ablation observed whenever electrodetip penetrated epicenter tumor regardless angle electrode insertion craniocaudal orbital plane complete tumor ablation also achieved placing electrodetip several optimal site angle conclusion identification tumor epicenter central slice axial image essential enhance success rate complete tumor ablation rfa procedure,2018,"Givehchi, Sogol; Wong, Yin How; Yeong, Chai Hong; Abdullah, Basri Johan Jeet",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.1080/13645706.2017.1330757; https://www.ncbi.nlm.nih.gov/pubmed/28612670/,3513079.0,12
25803,25803,35722,pqkqg0na,,Medline,Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases.,10.1007/s00270-014-0897-y,,24806953.0,unk,purpose study designed ass feasibility usctmri fusionguided ablation liver tumor undetectable u method tumor hccs metastasis mean diameter ± cm range cm detectable contrastenhanced ctmri completely undetectable unenhanced u either totally undetectable incompletely conspicuous contrastenhanced u ceus treated session using either internally cooled radiofrequency microwave standard ablation protocol guided image fusion system virtual navigation system esaote spa genova italy combine u ct mri image correct targeting successful ablation tumor verified hour ct mri result total tumor correctly targeted successful ablation achieved sixteen tumor correctly targeted unsuccessfully ablated tumor unsuccessfully ablated due inaccurate targeting perioperative death major complication observed treatment session conclusion realtime virtual navigation system usctmri fusion imaging precise targeting achieving successful ablation target tumor undetectable u alone therefore larger population could benefit ultrasound guided ablation procedure,2015,"Mauri, Giovanni; Cova, Luca; De Beni, Stefano; Ierace, Tiziana; Tondolo, Tania; Cerri, Anna; Goldberg, S Nahum; Solbiati, Luigi",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-014-0897-y; https://www.ncbi.nlm.nih.gov/pubmed/24806953/,19582382.0,12
25857,25857,35788,lymrydzx,,Medline,A case of a resected thymoma in the middle mediastinum.,10.1093/jscr/rju077,,25107941.0,unk,experienced extremely rare case thymoma middle mediastinum yearold woman presented cmsized abnormal mass middle mediastinum chest computed tomography resect tumor performed surgery using thoracoscopic lateral approach right side subsequently followed median sternotomy resection tumor intraoperative quick pathological examination diagnosed tumor thymoma extended thymectomy performed additionally,2014,"Tokuno, Junko; Cho, Hiroyuki; Yamanashi, Keiji; Ueda, Yuichiro; Sumitomo, Ryota; Shoji, Tsuyoshi; Huang, Cheng-Long",Journal of surgical case reports,,,,,,https://doi.org/10.1093/jscr/rju077; https://www.ncbi.nlm.nih.gov/pubmed/25107941/,17034152.0,12
25890,25890,35827,rm6qwn07,,Medline,Combined chemoembolization and thermal ablation for the treatment of metastases to the liver.,10.1007/s00261-018-1536-x,,29500644.0,unk,purpose purpose study evaluate safety time recurrence overall survival o patient liver metastasis lm treated transarterial chemoembolization tace followed ablation material method retrospective study included patient lm treated combined tace ablation august september fortytwo patient woman men age ± year treated lm tumor characteristic imaging response treatment recurrence o data reviewed statistical analysis included kaplanmeier estimation cox regression fisher exact wilcoxon rank sum log rank test result median followup month eighteen patient hepatic lesion median index lesion size cm range cm tumor response mrecist available treated lesion cr pr pd longterm imaging followup available patient freedom local recurrence year year o year year median o month tumor size histology predictor time progression o complication occurred patient major complication occurred patient included hospitalization fever n hepatic abscess n fall requiring transfusion portal vein thrombus causing lobar infarct biliary fistula retroperitoneal hematoma n conclusion combined tace ablation effective local tumor control liver metastasis cm part multidisciplinary treatment strategy major complication occurred patient,2018,"Alexander, Erica S; Mick, Rosemarie; Nadolski, Gregory J; Mondschein, Jeffrey I; Stavropoulos, S William; Soulen, Michael C",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-018-1536-x; https://www.ncbi.nlm.nih.gov/pubmed/29500644/,3675186.0,12
26040,26040,35998,omsi1edl,,Medline,Temporal Chondroblastoma with a Novel Chromosomal Translocation (2;5) (q33;q13).,10.1055/s-0031-1275638,,23984205.0,unk,case yearold man large temporal mass presented mass eroded floor middle fossa medially sphenoid sinus combined approach neurosurgery otolaryngology performed achieve maximal resection mass pathology typical chondroblastoma rare benign locally invasive chondroid tumor genetic testing revealed translocation qq unique genetic mutation chondroid tumor knowledge diagnostic utility role mutation pathobiology tumor remains determined,2011,"Carlson, Andrew P; Yonas, Howard; Olson, Garth T; Reichard, Kaaren K; Medina-Flores, Rafael",Skull base reports,,,,,,https://doi.org/10.1055/s-0031-1275638; https://www.ncbi.nlm.nih.gov/pubmed/23984205/,16940830.0,12
26100,26100,36070,i71frqou,,Medline,Comparing Angiographic Devascularization with Histologic Penetration after Preoperative Tumor Embolization with Onyx: What Indicates an Effective Procedure?,10.1055/s-0034-1394191,,25594815.0,unk,background purpose ass onyx covidien irvine california united state efficacy preoperative embolic agent neoplasm head neck spine compare angiographic histologic evidence tumor penetration predictor intraoperative blood loss material method retrospective analysis preoperative onyx embolization procedure treatment head neck spine tumor patient demographic information relating embolization procedure operation recorded measure onyx efficacy included intraoperative blood loss length surgery angiographic histologic penetration addition percentage tumor devascularization assessed predictor efficacy result total patient head neck spinal lesion underwent transarterial preoperative onyx embolization good angiographic penetration reported tumor central histologic penetration mean tumor devascularization standard deviation sd relationship angiographic histologic onyx penetrance mean surgical blood loss ml sd ml length surgery minute sd minute neither angiographic histologic onyx penetration predicted intraoperative blood loss p p respectively surgical length p respectively devascularization associated blood loss p negative predictor surgical length p conclusion preoperative onyx embolization head neck spine tumor capable deep histologic tumor penetration even visualized angiography lack association measure procedural adequacy suggests using angiographic devascularization measure procedural efficacy may limited utility,2015,"Grandhi, Ramesh; Hunnicutt, Christopher T; Harrison, Gillian; Zwagerman, Nathan T; Snyderman, Carl H; Gardner, Paul A; Hartman, Douglas J; Horowitz, Michael","Journal of neurological surgery. Part A, Central European neurosurgery",,,,,,https://doi.org/10.1055/s-0034-1394191; https://www.ncbi.nlm.nih.gov/pubmed/25594815/,5960111.0,12
26146,26146,36124,pti6k9s5,,Medline,Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.,10.1007/s10585-016-9829-3,,27812769.0,unk,liver frequent metastatic site colorectal cancer crc relevant orthotopic vivo model needed study efficacy anticancer drug metastatic setting challenge utilizing model monitoring tumor growth experiment study experimental liver metastasis established nude mouse splenic injection crc cell line ht hct mouse treated antiangiogenic drug aflibercept tumor growth monitored using magnetic resonance imaging mri bioluminescence imaging bli aflibercept treatment well tolerated resulted increased animal survival hct ht inhibited tumor growth observed model treatment efficacy monitored high precision using mri bli detected smallvolume disease high sensitivity le accurate endstage disease apparent diffusion coefficient adc value obtained diffusion weighted mri dwmri highly predictive treatment response increased adc corresponding well area necrosis observed histological evaluation aflibercepttreated xenograft result showed efficacy antiangiogenic drug aflibercept varied two model possibly reflecting unique growth pattern liver may representative human disease noninvasive imaging especially mri dwmri used effectively monitor tumor growth treatment response orthotopic liver metastasis model,2017,"Fleten, Karianne G; Bakke, Kine M; Mælandsmo, Gunhild M; Abildgaard, Andreas; Redalen, Kathrine Røe; Flatmark, Kjersti",Clinical & experimental metastasis,,,,,,https://doi.org/10.1007/s10585-016-9829-3; https://www.ncbi.nlm.nih.gov/pubmed/27812769/,21955784.0,12
26239,26239,36228,6zebjiew,,Medline,Alfred W. Adson (1887-1951): his contributions to surgery for tumors of the spine and spinal cord in the context of spinal tumor surgery in the late 19th and early 20th centuries.,10.3171/2013.9.spine13220,,24138061.0,unk,alfred w adson pioneer field neurosurgery described operation variety neurosurgical disease developed surgical instrument leadership section neurological surgery mayo clinic established functioned first chair adsons contribution understanding spinal spinal cord tumor le well known article review related medical record publication set contribution context work important pioneer spinal tumor surgery time,2013,"Griessenauer, Christoph J; Tubbs, R Shane; Shoja, Mohammadali M; Raborn, Joel; Boes, Christopher J; Mortazavi, Martin M; Lanzino, Giuseppe",Journal of neurosurgery. Spine,,,,,,https://doi.org/10.3171/2013.9.spine13220; https://www.ncbi.nlm.nih.gov/pubmed/24138061/,207574191.0,12
26308,26308,36306,d0myq93x,,Medline,First-in-human uPAR PET: Imaging of Cancer Aggressiveness.,10.7150/thno.12956,,26516369.0,unk,firstinhuman clinical trial positron emission tomography pet imaging urokinasetype plasminogen activator receptor upar patient breast prostate bladder cancer described upar expressed many type human cancer expression predictive invasion metastasis indicates poor prognosis upar pet imaging therefore hold promise new innovative method improved cancer diagnosis staging individual risk stratification upar specific peptide ae conjugated macrocyclic chelator dota labeled cu targeted molecular imaging pet safety pharmacokinetic biodistribution profile radiation dosimetry single intravenous dose cudotaae assessed serial pet computed tomography ct prostate breast bladder cancer patient safety assessment laboratory blood screening test performed pet ligand injection subgroup patient vivo stability targeted pet ligand determined collected blood urine adverse clinically detectable side effect patient found ligand exhibited good vivo stability fast clearance plasma tissue compartment renal excretion addition high uptake primary tumor lesion lymph node metastasis seen paralleled high upar expression excised tumor tissue overall firstinhuman study therefore provides promising evidence safe use cudotaae upar pet imaging cancer patient,2015,"Persson, Morten; Skovgaard, Dorthe; Brandt-Larsen, Malene; Christensen, Camilla; Madsen, Jacob; Nielsen, Carsten H; Thurison, Tine; Klausen, Thomas Levin; Holm, Søren; Loft, Annika; Berthelsen, Anne Kiil; Ploug, Michael; Pappot, Helle; Brasso, Klaus; Kroman, Niels; Højgaard, Liselotte; Kjaer, Andreas",Theranostics,,,,,,https://doi.org/10.7150/thno.12956; https://www.ncbi.nlm.nih.gov/pubmed/26516369/,11410477.0,12
26351,26351,36354,62ki1ej1,,Medline,Transanal single-port microsurgery for rectal tumors: minimal invasive surgery under spinal anesthesia.,10.1007/s00464-013-3184-0,,24061623.0,unk,background transanal minimally invasive surgery tamis rectal tumor introduced alternative approach transanal endoscopic microsurgery tem tem limitation need special equipment expensive cost steep learning curve study address technical feasibility tamis spinal anesthesia shortterm postoperative outcome method july september consecutive patient middle upper third rectal mass underwent tamis tumor located cm anal verge spinal anesthesia singleincision laparoscopic surgery port inserted anal canal access conventional laparoscopic instrument including grasper monopolar electrocautery suction device used perform transanal excision hooktype monopolar electrocautery harmonic scalpel used dissection defect rectum closed interrupted suture data concerning demographic detail operative procedure postoperative pain pathologic result collected prospectively evaluate anal sphincter injury endoanal ultrasonography fecal incontinence severity index survey performed month operation result patient nine adenocarcinoma nine neuroendocrine tumor three tubular adenoma highgrade dysplasia three tubular adenoma one tubulovillous adenoma one gastrointestinal stromal tumor median distance tumor mass anal verge range cm median operative time range min patient received tamis without conversion laparoscopic resection intraoperative complication postoperative morbidity median postoperative hospital stay range day sphincter injury detected endoanal ultrasonography conclusion tamis spinal anesthesia safe feasible technique resection middle upper rectal mass spinal anesthesia adequate procedure,2014,"Lee, Taek-Gu; Lee, Sang-Jeon",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-013-3184-0; https://www.ncbi.nlm.nih.gov/pubmed/24061623/,22962352.0,12
26420,26420,36434,1voyd8rq,,Medline,The expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.,10.4103/2152-7806.157442,,26015870.0,unk,background past two decade setting remarkable advancement endonasal endoscopic neurosurgery refinement camera definition surgical instrumentation navigation surgical technique including dual surgeon team facilitated purely endonasal endoscopic approach majority midline skull base previously difficult access transsphenoidal microscopic approach method review article look many article citing endonasal endoscopic surgery regard approach reconstructive technique pathology treated outcome new technology consideration result refinement approach closure technique reduced risk cerebrospinal fluid leak infection allowed surgeon aggressively treat variety pathology four main pathology outcome treatment identified discussion pituitary adenoma craniopharyngiomas anterior skull base meningioma chordomas within four tumor type article demonstrated efficacy certain case advantage traditional microscopebased technique endonasal endoscopic technique conclusion endonasal endoscopic approach necessary tool modern skull base surgeon armamentarium efficacy treatment wide variety skull base pathology repeatedly demonstrated experienced surgeon hand technique may offer advantage greater tumor removal reduced overall complication traditional craniotomy select tumor pathology centered near midline skull base,2015,"Lobo, Bjorn; Heng, Annie; Barkhoudarian, Garni; Griffiths, Chester F; Kelly, Daniel F",Surgical neurology international,,,,,,https://doi.org/10.4103/2152-7806.157442; https://www.ncbi.nlm.nih.gov/pubmed/26015870/,20443817.0,12
26429,26429,36445,3xkvvny0,,Medline,Is duodenojejunal anastomosis to the left of the superior mesenteric vessels a feasible option for tumors of the angle of Treitz?,10.5301/tj.5000391,,26350177.0,unk,tumor angle treitz rare entity gastrointestinal stromal tumor gist occur level duodenum location duodenojejunal junction uncommon surgery treatment choice adjuvant medical therapy used basis degree radicality excision tumor proliferative profile factor primarily influence prognosis due frailty vascular viability left duodenum injured surgery generally recommended perform digestive reconstruction level right portion duodenum report case patient large gist located duodenojejunal junction behind ligament treitz found reconstructive digestive anastomosis level third part duodenum safe procedure,2016,"Caruso, Francesco; Nencioni, Marco; Zefelippo, Arianna; Rossi, Giorgio; Caccamo, Lucio",Tumori,,,,,,https://doi.org/10.5301/tj.5000391; https://www.ncbi.nlm.nih.gov/pubmed/26350177/,27061337.0,12
26470,26470,36494,m6xeef1s,,Medline,Radiofrequency ablation of hepatic metastases: factors influencing local tumor progression.,10.1245/s10434-014-3738-y,,24788556.0,unk,background although radiofrequency ablation rfa nonresectable hepatic metastasis gained wide acceptance showing survival benefit selected patient scattered report available regarding risk factor local control percutaneous rfa purpose study prospectively evaluate factor influencing local tumor progression percutaneous rfa hepatic metastasis method sixtynine hepatic metastatic lesion patient treated percutaneous rfa efficacy evaluated contrastenhanced computed tomography magnetic resonance imaging month ablation month interval first year biannually thereafter result result logrank test showed tumor size cm p absence tumor contiguous large vessel p significantly correlated local control hepatic metastasis cox regression analysis showed tumor size cm absence tumor contiguous large vessel independent factor p respectively result logrank test showed neither threshold postablation margin cm p presence tumor subcapsular location p correlated success local control conclusion percutaneous rfa effective achieving local control patient hepatic metastasis tumor size cm contiguous large vessel,2014,"Liu, Chang-Hsien; Yu, Chih-Yung; Chang, Wei-Chou; Dai, Ming-Shen; Hsiao, Cheng-Wen; Chou, Yu-Ching",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-014-3738-y; https://www.ncbi.nlm.nih.gov/pubmed/24788556/,8105052.0,12
26548,26548,36587,ddlpptjt,,Medline,Oncologic Efficacy of Radio Frequency Ablation for Small Renal Masses: Clear Cell vs Papillary Subtype.,10.1016/j.juro.2015.03.115,,25846416.0,unk,purpose current radio frequency ablation series distinguish renal cell carcinoma subtypes reporting oncologic efficacy papillary neoplasm may amenable radio frequency ablation clear cell carcinoma le vascular may limit heat energy loss report longterm outcome patient treated radio frequency ablation small renal mass renal cell carcinoma subtype material method record patient undergoing radio frequency ablation small renal mass cta institution march july retrospectively reviewed patient included analysis biopsy confirmed clear cell papillary renal cell carcinoma histology patient least contrast enhanced crosssectional image following radio frequency ablation demographic data tumor subtypes compared using paired ttest oncologic outcome determined kaplanmeier survival analysis survivor curve compared log rank test result total patient met study inclusion criterion clear cell tumor papillary tumor median followup month difference tumor group based patient age tumor size grade month followup fiveyear diseasefree survival clear cell tumor papillary tumor p significant difference overall survival v p conclusion radio frequency ablation outcome seem determined part renal cell carcinoma subtype clear cell renal tumor le favorable outcome hypothesize due difference tumor vascularity experience suggests future tumor ablation study consider reporting outcome based tumor cell type,2015,"Lay, Aaron H; Faddegon, Stephen; Olweny, Ephrem O; Morgan, Monica; Lorber, Gideon; Trimmer, Clayton; Leveillee, Raymond; Cadeddu, Jeffrey A; Gahan, Jeffrey C",The Journal of urology,,,,,,https://doi.org/10.1016/j.juro.2015.03.115; https://www.ncbi.nlm.nih.gov/pubmed/25846416/,24757024.0,12
26584,26584,36626,7z6dgnfe,,Medline,A case of primary gastric undifferentiated high-grade pleomorphic sarcoma diagnosed with chief complaint of fever: a case report and literature review.,10.1186/s40792-017-0317-z,,28276003.0,unk,background undifferentiated highgrade pleomorphic sarcoma gastrointestinal tract extremely rare prognosis poor case presentation yearold man visited previous hospital complaining fever general fatigue shaking chill received antibiotic therapy fever continued referred hospital computed tomography upper gastrointestinal endoscopy showed cm gastric tumor preoperative biopsy consistent malignant mesenchymal tumor could provide definitive pathological diagnosis prove causeandeffect relationship chief complaint gastric tumor gastric tumor grown cm diameter within month performed partial gastrectomy pathological postoperative diagnosis undifferentiated highgrade pleomorphic sarcoma produced granulocyte colonystimulating factor patient fever quickly improved showed good postoperative course conclusion herein report case rapidly growing undifferentiated highgrade pleomorphic gastric sarcoma presented chief complaint fever,2017,"Kabashima, Akira; Kimura, Koichi; Sanefuji, Kensaku; Masunari, Satoru; Haraoka, Seiji; Maekawa, Soichiro",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-017-0317-z; https://www.ncbi.nlm.nih.gov/pubmed/28276003/,8775592.0,12
26625,26625,36673,b23qemx2,,Medline,PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.,10.2967/jnumed.111.092809,,22072706.0,unk,unlabelled transforming growth factorβ tgfβ promotes cancer invasion metastasis therefore potential drug target cancer treatment fresolimumab neutralizes mammalian active isoforms tgfβ radiolabeled zr pet analyze tgfβ expression antibody tumor uptake organ distribution method zr conjugated fresolimumab using chelator nsuccinyldesferrioxaminebtetrafluorphenol zrfresolimumab analyzed conjugation ratio aggregation radiochemical purity stability immunoreactivity zrfresolimumab tumor uptake organ distribution assessed using protein dos μg compared inigg human tgfβtransfected chinese hamster ovary xenograft model human breast cancer mdamb xenograft metastatic model latent active tgfβ expression analyzed tissue homogenate enzymelinked immunosorbent assay result zr labeled fresolimumab high specific activity gbqmg high yield high purity vitro validation zrfresolimumab showed fully preserved immunoreactivity long wk stability solution human serum vivo validation showed zrfresolimumab distribution similar igg organ except higher uptake liver mouse higher kidney uptake μg group zrfresolimumab induced toxicity mouse accumulated primary tumor metastasis manner similar igg latent active tgfβ detected tumor homogenate whereas latent tgfβ could detected liver homogenate remarkably high zrfresolimumab uptake seen site tumor ulceration scar tissue process tgfβ known highly active conclusion fresolimumab tumor uptake organ distribution visualized quantified zrfresolimumab pet technique used guide clinical development fresolimumab could possibly identify patient likely benefit,2011,"Oude Munnink, Thijs H; Arjaans, Marlous E A; Timmer-Bosscha, Hetty; Schröder, Carolina P; Hesselink, Jan W; Vedelaar, Silke R; Walenkamp, Annemiek M E; Reiss, Michael; Gregory, Richard C; Lub-de Hooge, Marjolijn N; de Vries, Elisabeth G E","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.092809; https://www.ncbi.nlm.nih.gov/pubmed/22072706/,20087491.0,12
26631,26631,36681,xs2h8ewf,,Medline,Gynandroblastoma with a Juvenile Granulosa Cell Component in an Adolescent: Case Report and Literature Review.,10.1016/j.jpag.2016.10.005,,27751908.0,unk,background gynandroblastoma extremely rare ovarian sex cord tumor malignant potential case yearold adolescent experienced intermittent vaginal bleeding year later right adnexal mass heterogeneous imaging appearance identified laparoendoscopic singlesite ovarian tumorectomy performed histopathological examination showed gynandroblastoma composed juvenile granulosa sertolileydig cell tumor upstaged stage ic cyst rupture surgery three cycle adjuvant chemotherapy carboplatin paclitaxel added three year surgery sign recurrence noted summary conclusion present finding help clinician make accurate preoperative imaging diagnosis gynandroblastoma juvenile granulosa cell component plan adequate treatment strategy rare potentially malignant neoplasm,2017,"Takeda, Akihiro; Watanabe, Kazuko; Hayashi, Shotaro; Imoto, Sanae; Nakamura, Hiromi",Journal of pediatric and adolescent gynecology,,,,,,https://doi.org/10.1016/j.jpag.2016.10.005; https://www.ncbi.nlm.nih.gov/pubmed/27751908/,29951050.0,12
26638,26638,36689,xqmhqfpk,,Medline,Stabilization of mobile pulmonary nodules during radiofrequency ablation.,10.2214/ajr.10.4287,,20966333.0,unk,objective lung tumor exhibit high degree mobility insertion radiofrequency applicator owing respiratory motion inherent characteristic pulmonary parenchyma purpose report describe technique used secure lung tumor insertion radiofrequency applicator conclusion experience percutaneous imagingguided radiofrequency ablation increase technical challenge become increasingly apparent technique whereby mobile pulmonary tumor anchored prior placement ablation electrode one method overcoming challenge,2010,"Healey, Terrance T; Beland, Michael D; Bowkley, Charles W; Dupuy, Damian E",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.10.4287; https://www.ncbi.nlm.nih.gov/pubmed/20966333/,11808319.0,12
26704,26704,36768,bl2tbm2o,,Medline,The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.,10.1007/s00330-017-5266-1,,29536242.0,unk,objective study ratio ablation zone volume applied energy computed tomography ctguided radiofrequency ablation rfa microwave ablation mwa patient hepatocellular carcinoma hcc cirrhotic liver patient colorectal liver metastasis crlm method total liver tumor hccs cirrhotic liver crlms treated rfa one two mwa device mwaa mwab resulting procedure tumor type per device device setting recorded applied energy calculated ablation volume segmented contrastenhanced ct scan obtained week procedure ratio ablation zone volume milliliter applied energy kilojoules determined procedure compared hcc rhcc crlm rcrlm stratified according ablation device result rfa rhcc rcrlm mlkj mlkj mlkj mlkj p respectively mwaa rhcc mlkj rcrlm mlkj p mwab rhcc mlkj rcrlm mlkj p conclusion rfa significant difference energy deposition ratio tumor type mwa device ratio higher hccs tailoring microwave ablation device protocol tumor type might prevent incomplete ablation key point • hccs crlms respond differently microwave ablation • mwa crlms required energy achieve similar ablation volume • tailoring ablation protocol tumor type might prevent incomplete ablation,2018,"Heerink, Wouter J; Solouki, A Millad; Vliegenthart, Rozemarijn; Ruiter, Simeon J S; Sieders, Egbert; Oudkerk, Matthijs; de Jong, Koert P",European radiology,,,,,,https://doi.org/10.1007/s00330-017-5266-1; https://www.ncbi.nlm.nih.gov/pubmed/29536242/,3825785.0,12
26748,26748,36817,6vql8j01,,Medline,Extending the indication for robot-assisted retroperitoneal partial nephrectomy to antero-lateral renal tumors.,10.1002/rcs.1755,,27273340.0,unk,background robotassisted retroperitoneal partial nephrectomy rarpn typically employed posterior renal tumor work aimed extend indication rarpn patient selected anterolateral renal tumor method patient underwent rarpn december september author institution enrolled two intersecting line drawn axial ct image define mediallateral nature anterior renal tumor patient anterolateral tumor posterior tumor compared result anterolateral tumor constituted total case perioperative outcome two group comparable although operation time longer anterolateral tumor group show statistical significance case positive margin one case claviendindo grade iiia complication anterolateral tumor group conclusion rarpn safe effective procedure posterior renal tumor also carefully selected anterolateral renal tumor copyright © john wiley son ltd,2017,"Kim, Hee Youn; Choe, Hyun-Sop; Lee, Dong Sup; Yoo, Jae Mo; Lee, Seung-Ju",The international journal of medical robotics + computer assisted surgery : MRCAS,,,,,,https://doi.org/10.1002/rcs.1755; https://www.ncbi.nlm.nih.gov/pubmed/27273340/,4053036.0,12
26755,26755,36824,csjwwe2w,,Medline,Thermal ablation of malignant lung tumors.,10.3238/arztebl.2013.0394,,23826028.0,unk,background new case nonsmallcell carcinoma lung diagnosed germany year affected patient offered radical resection comorbidity alone lung also second common site distant metastasis extrathoracic tumor site metastasis case recent year imageguided thermoablation used increasing frequency patient unable undergo surgery medical reason method pubmed database selectively searched publication indication complication result thermoablative technique currently clinical use special attention radiofrequency ablation rfa result small evidence base date concerning treatment malignant lung tumor thermoablation retrospective prospective case series published randomized controlled trial yet conducted rfa common technique involves imageguided percutaneous placement one probe tumor thermal energy applied peripherally located tumor measure le cm diameter local control tumor growth achieved case longterm result available smaller series provisionally indicate year survival rate common complication pneumothorax requiring drainage occurs case intermediate term thermoablation cause clinically relevant loss pulmonary function conclusion imageguided thermoablation considered alternative surgery treatment malignant lung tumor curative intent however widen spectrum therapeutic option patient medically unable undergo surgical procedure,2013,"Schneider, Thomas; Heussel, Claus Peter; Herth, Felix J F; Dienemann, Hendrik",Deutsches Arzteblatt international,,,,,,https://doi.org/10.3238/arztebl.2013.0394; https://www.ncbi.nlm.nih.gov/pubmed/23826028/,6270390.0,12
26775,26775,36847,l90v8si1,,Medline,FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?,10.3171/2016.8.jns16752,,27767397.0,unk,objective recent study indicated signal intensity increase fluid within resection cavity flair image may predict tumor recurrence glioma surgery aim study ass increase flair signal intensity large patient cohort subgroup ass prognostic value early tumor recurrence glioma patient method total patient case undergone surgery intracranial glioma grade iv n grade iii n grade ii n included retrospective study flair signal within resection cavity time tumor recurrencelast contact previous mri study assessed qualitatively quantitatively appearance flair signal increase studied time using kaplanmeier estimate subgroup result patient grade ii glioma connection resection cavity csf undergo radiotherapy regularly develop sign excluded analysis remaining case flair signal intensity increase observed case recurrent disease found case resulting specificity sensitivity positive negative predictive value respectively case sign observed prior range month tumor recurrence defined standard criterion quantitative analysis underlined result qualitative analysis add diagnostic value conclusion signal intensity increase fluid within resection cavity flair image rare highly specific early sign tumor recurrencetumor progression completely incompletely resected highgrade glioma without connection resection cavity csf radiotherapy,2017,"Bette, Stefanie; Gempt, Jens; Huber, Thomas; Delbridge, Claire; Meyer, Bernhard; Zimmer, Claus; Kirschke, Jan S; Boeckh-Behrens, Tobias",Journal of neurosurgery,,,,,,https://doi.org/10.3171/2016.8.jns16752; https://www.ncbi.nlm.nih.gov/pubmed/27767397/,207694488.0,12
26821,26821,36898,4ps58i2n,,Medline,Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.,10.1007/s00330-018-5868-2,,30506222.0,unk,objective compare therapeutic outcome safety radiofrequency rf ablation subcardiac nonsubcardiac hepatocellular carcinoma hcc evaluate risk factor technical failure procedure method retrospective study approved institutional review board september may patient subcardiac hcc number patient nonsubcardiac hcc matched tumor size included subcardiac hcc defined index tumor located ≤ cm pericardium axial coronal image cumulative local tumor progression ltp compared two group using logrank test prognostic factor technical failure assessed using multivariable logistic analysis result technical success rate group significantly different subcardiac hcc group v nonsubcardiac hcc group p cumulative ltp rate year respectively subcardiac hcc group nonsubcardiac hcc group without significant difference p distance index tumor pericardium odds ratio p tumor segment iv reference left lateral sector p significant factor technical failure patient subcardiac hcc conclusion rf ablation effective treatment subcardiac hcc however tumor location considered planning treatment avoid technical failure key point • rf ablation subcardiac hcc technically feasible without major complication • rf ablation effective treatment subcardiac hcc term ltp • risk factor technical failure distance index tumor heart cutoff value cm location tumor segment iv,2019,"Cha, Dong Ik; Kang, Tae Wook; Song, Kyoung Doo; Lee, Min Woo; Rhim, Hyunchul; Lim, Hyo Keun; Sinn, Dong Hyun; Kim, Kyunga",European radiology,,,,,,https://doi.org/10.1007/s00330-018-5868-2; https://www.ncbi.nlm.nih.gov/pubmed/30506222/,53971680.0,12
26862,26862,36945,hkz6qfle,,Medline,Impact of Helicobacter pylori on the growth of hepatic orthotopic graft tumors in mice.,10.3892/ijo.2015.3107,,26238296.0,unk,helicobacter pylorus wellknown causative organism chronic gastric disease found many hepatic carcinoma sample explore expression apoptosisrelated protein carcinoma development h pyloriinfected liver utilized balbcanslac mouse establish h pyloriinfected model oral inoculation orthotopic graft hepatic tumor h cell respectively found h pylorus colony could cultured liver tumor sample however rrna detectable liver tumor infected mouse inflammatory cell observed thinly distributed lobule portion liver h pylorus mainly existed infected hepatic sinusoid necrotic area infected tumor significant difference found liver body weight ratio infected uninfected moreover pathological tumor difference unremarkable two proliferating cell nuclear antigen pcna bclassociated x protein bax expression infected tumor significantly higher lower respectively uninfected tumor however significant difference bcl bcell lymphoma expression existed result indicate h pylorus found liver infected h pylorus oral inoculation could contribute infiltration inflammatory cell liver although h pylorus significant impact liver body weight ratio tumor bcl expression may upregulate pcna expression downregulate bax expression respectively finding show h pylorus may promote proliferation inhibit apoptosis tumor cell,2015,"Wang, Junwei; Wang, Xiaoqian; Tang, Nanhong; Chen, Yanling; She, Feifei",International journal of oncology,,,,,,https://doi.org/10.3892/ijo.2015.3107; https://www.ncbi.nlm.nih.gov/pubmed/26238296/,14943463.0,12
26969,26969,37065,684zyii6,,Medline,Chondroblastoma of the Clivus: Case Report and Review.,10.1055/s-0035-1564601,,26623238.0,unk,background importance chondroblastoma benign primary bone tumor typically develops epiphysis long bone chondroblastoma craniofacial skeleton extremely rare case occurring squamosal portion temporal bone report describe first case chondroblastoma clivus presenting cranial neuropathy treated endoscopic endonasal resection review literature craniofacial chondroblastomas particular emphasis extratemporal lesion case presentation yearold woman presented severe headache left facial dysesthesias diplopia physical examination revealed hypesthesia left maxillary nerve dermatome complete left abducens nerve palsy imaging demonstrated expansile intraosseous mass originating upper clivus extension superiorly sella turcica laterally involve medial wall left cavernous sinus tumor completely resected via endoscopic endonasal approach postoperative improvement lateral gaze palsy histopathology consistent chondroblastoma conclusion chondroblastoma rare tumor craniofacial skeleton included differential diagnosis osteolytic lesion clivus complete surgical resection remains mainstay treatment,2015,"Liu, Jonathan; Ahmadpour, Arjang; Bewley, Arnaud F; Lechpammer, Mirna; Bobinski, Matthew; Shahlaie, Kiarash",Journal of neurological surgery reports,,,,,,https://doi.org/10.1055/s-0035-1564601; https://www.ncbi.nlm.nih.gov/pubmed/26623238/,18497351.0,12
27070,27070,37184,lf6wxhwr,,Medline,Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.,10.1016/j.jvir.2008.09.007,,18948025.0,unk,focal tumor ablationwhether applied percutanously laparoscopically mean open surgeryis effective therapy selected liver tumor choice liver ablation well choice percutaneous surgical approach dependent tumor factor patient factor viable treatment option currently largest cumulative reported experience radiofrequency rf ablation hepatocellular carcinoma colorectal metastasis document position statement interventional oncology task force standard division society interventional radiology regarding use percutaneous rf ablation treatment liver tumor,2009,"Gervais, Debra A; Goldberg, S Nahum; Brown, Daniel B; Soulen, Michael C; Millward, Steven F; Rajan, Dheeraj K",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2008.09.007; https://www.ncbi.nlm.nih.gov/pubmed/18948025/,9844884.0,12
27298,27298,37457,pcyeiz6m,,Medline,Plastic freezer bags: a cost-effective method to protect extraction sites in laparoscopic colorectal procedures?,10.1097/sle.0b013e318274b719,,24105287.0,unk,purpose review surgicalsite infection ssi retrievalsite tumor recurrence rate laparoscopic colorectal procedure using plastic freezer bag wound protector method laparoscopic colorectal procedure plastic freezer bag used wound protector extraction site reviewed prospectively collected database χ test used compare ssi tumor recurrence rate group costing data obtained operating room supply department result total case surgicalsite infection identified ssi rate differ comparing group based demographic factor diagnosis location procedure retrievalsite tumor recurrence rate cost plastic freezer bag including sterilization ranged conclusion plastic freezer bag wound protector laparoscopic colorectal procedure cost effective ssi retrievalsite tumor recurrence rate compare favorably published data,2013,"Huynh, Hai P; Musselman, Reilly P; Trottier, Daniel C; Soto, Claudia M; Poulin, Eric C; Mamazza, Joseph; Boushey, Robin P; Auer, Rebecca C; Moloo, Husein","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e318274b719; https://www.ncbi.nlm.nih.gov/pubmed/24105287/,2657726.0,12
27302,27302,37461,59fvniib,,Medline,Successful extirpation of thoracic pleural lipoma by single-port thoracoscopic surgery.,10.1016/j.asjsur.2011.08.006,,22208690.0,unk,videoassisted thorascopic surgery vat common technique thoracic operation surgery access via single port gradually become popular herein report unusual case yearold japanese male patient whose chest xrays revealed abnormal shadow continued increase size tumor excised singleport access surgery resected tumor pedunculated pleural mass yellowish color pathological diagnosis confirmed lipoma describe first known successful treatment singleport vat,2011,"Oka, Soichi; Uramoto, Hidetaka; Hanagiri, Takeshi",Asian journal of surgery,,,,,,https://doi.org/10.1016/j.asjsur.2011.08.006; https://www.ncbi.nlm.nih.gov/pubmed/22208690/,19489982.0,12
27372,27372,37547,8feupo1i,,Medline,The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours.,10.4274/mirt.68552,,24416622.0,unk,objective aim study ass diagnostic efficiency mtceddahynicoctreotate comparison inpentetrotide scintigraphy detection neuroendocrine tumor study also evaluates impact spectct hybrid imaging somatostatin receptor scintigraphy sr interpretation clinical management tumor method fourteen patient included study patient underwent whole body spectct imaging mtc eddahynicoctreotate inpentetrotide image evaluated visually semiquantitatively result patient basis diagnostic result study similar number lesion detected mtc eddahynicoctreotate higher number lesion detected inpentetrotide however difference significant p semiquantitative analysis showed higher tumororgan count ratio wholebody spect mtc eddahynicoctreotate scan conclusion result study suggested mtc eddahynicoctreotate may better alternative pentetrotide due high image quality lower radiation dose spectct valuable tool assessment neuroendocrine tumor providing precise anatomic localization scintigraphic finding thus improving lesion detectability characterization conflict interest none declared,2013,"Koçyiğit Deveci, Emel; Ocak, Meltem; Bozkurt, Murat Fani; Türker, Selcan; Kabasakal, Levent; Uğur, Omer",Molecular imaging and radionuclide therapy,,,,,,https://doi.org/10.4274/mirt.68552; https://www.ncbi.nlm.nih.gov/pubmed/24416622/,2749839.0,12
27378,27378,37558,xuto1vd2,,Medline,A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial RAS wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol study.,10.3892/ol.2018.9763,,30675264.0,unk,efficacy safety continuous use panitumumab first secondline treatment colorectal cancer crc yet determined liquid biopsy circulating tumor dna capable assessing gene mutation status several timepoints could predict efficacy ongoing panitumumab treatment address two point multicenter singlearm phase ii clinical trial conducted evaluating effect folfiri panitumumab secondline chemotherapy patient crc failure intolerance firstline treatment folfox panitumumab primary endpoint month progressionfree survival rate gene mutation status using circulating tumor dna assessed multiple timepoints study period one secondary endpoint observed month pfs rate compared threshold month pfs rate onesided significance level using binomial exact test target number case study patient study protocol approved institutional review board epidemiological clinical research information network conducted approval institutional review board participating institute study registered umin umin march result present study presented related international congress disseminated peerreviewed journal,2019,"Maeda, Hiromichi; Nagata, Naoki; Nagasaka, Takeshi; Oba, Koji; Mishima, Hideyuki; Kato, Takeshi; Yoshida, Kazuhiro; Muro, Kei; Sakamoto, Junichi",Oncology letters,,,,,,https://doi.org/10.3892/ol.2018.9763; https://www.ncbi.nlm.nih.gov/pubmed/30675264/,57525573.0,12
27457,27457,37650,2y1iazx9,,Medline,Imaging findings after radiofrequency ablation of adrenal tumors.,10.2214/ajr.10.4680,,21257891.0,unk,objective purpose study describe imaging finding radiofrequency ablation adrenal tumor material method retrospectively reviewed imaging finding patient adrenal tumor treated radiofrequency ablation department january august study reviewed consensus two attending abdominal imaging radiologist abdominal imaging fellow imaging finding immediately short longterm followup ablation recorded result fourteen patient seven men seven woman mean age ± year underwent radiofrequency ablation adrenal tumor one case small pneumothorax one case small hemothorax minor complication complication rate expected side effect radiofrequency ablation found patient two patient adjacent liver parenchyma ablated two patient diaphragmatic crus injured two patient local hematoma occurred one patient adjacent liver diaphragmatic crus ablated immediate softtissue finding radiofrequency ablation included air bubble patient fat stranding around adrenal gland patient fat rim sign found patient longterm followup attenuation tumor immediately procedure increased average hu median hu range hu tended decrease longterm followup longterm followup tumor decreased size attenuation conclusion air bubble fat stranding frequently seen immediately radiofrequency ablation adrenal tumor fat rim sign common finding longterm followup attenuation ablated zone increase immediately procedure decrease longterm followup volume ablated zone variable size response suggesting need baseline imaging,2011,"Brook, Olga R; Mendiratta-Lala, Mishal; Brennan, Darren; Siewert, Bettina; Faintuch, Salomao; Goldberg, S Nahum",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.10.4680; https://www.ncbi.nlm.nih.gov/pubmed/21257891/,19873279.0,12
27458,27458,37651,etk9bbdc,,Medline,Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration.,10.2967/jnumed.111.098665,,22496587.0,unk,unlabelled megalinmediated renal retention radiolabeled somatostatin analog may lead nephrotoxicity peptide receptor radionuclide therapy prrt cytoprotective agent amifostine protected rat longterm nephrotoxicity prrt ludotatyroctreotate study describes direct effect amifostine kidney tumor uptake indotatyroctreotate method vivo biodistribution study performed using ca tumorbearing rat without amifostine coadministration via several route vitro uptake studied somatostatin receptorexpressing ca megalin cubilin receptorexpressing bn cell absence presence amifostine active metabolite wr result coadministration amifostine decreased renal uptake radiolabeled octreotate vivo whereas tumor uptake affected agreement amifostine wr coincubation reduced uptake bn ca cell conclusion amifostine may provide renal protection prrt using somatostatin analog mitigation radiation damage currently observed reduction absorbed kidney radiation dose,2012,"Melis, Marleen; Valkema, Roelf; Krenning, Eric P; de Jong, Marion","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.098665; https://www.ncbi.nlm.nih.gov/pubmed/22496587/,22285765.0,12
27572,27572,37782,vkpi41ng,,Medline,Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.,10.1038/ajg.2011.425,,22158026.0,unk,objective radiofrequency ablation rfa widely performed hepatocellular carcinoma hcc however report year outcome rfa objective study report year consecutive case series tertiary referral center method performed rfa treatment primary hcc patient analyzed collected database result final computed tomography image showed complete tumor ablation treatment performed primary hcc patient median followup month year survival rate confidence interval ci ci respectively multivariate analysis demonstrated age antibody hepatitis c virus antihcv childpugh class tumor size tumor number serum desγcarboxyprothrombin dcp level serum lectinreactive αfetoprotein level afpl significantly related survival five year local tumor progression rate ci serum dcp level alone significantly related local tumor progression five year distant recurrence rate ci ci respectively antihcv childpugh class platelet count tumor size tumor number serum afp level serum dcp level significantly related distant recurrence complication death conclusion rfa could locally curative hcc resulting survival long year safe procedure rfa might firstline treatment selected patient earlystage hcc,2012,"Shiina, Shuichiro; Tateishi, Ryosuke; Arano, Toru; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Asaoka, Yoshinari; Sato, Takahisa; Masuzaki, Ryota; Kondo, Yuji; Goto, Tadashi; Yoshida, Haruhiko; Omata, Masao; Koike, Kazuhiko",The American journal of gastroenterology,,,,,,https://doi.org/10.1038/ajg.2011.425; https://www.ncbi.nlm.nih.gov/pubmed/22158026/,7335746.0,12
27604,27604,37818,77sxi9y8,,Medline,Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.,10.1021/jm3015348,,23234246.0,unk,carbonic anhydrase ix caix upregulated cancer response hypoxic tumor microenvironment making attractive molecular target detection hypoxic solid tumor series small molecule benzenesulfonamide based caix inhibitor containing novel tridentate chelate complexed mco core mtc designed synthesized vitro binding affinity benzenesulfonamide rhenium complex yielded ic value ranging nm hypoxic caix expressing hela cell one potent compound ic nm radiolabeled technetium tricarbonyl mtcco afford mtcco complex excellent yield high purity mtccod bound specifically caix expressing hypoxic hela cell effort led identification diverse series promising high affinity mtcco radiolabeled caix inhibitor potential significantly impact diagnosis staging treatment selection hypoxic solid tumor,2013,"Lu, Genliang; Hillier, Shawn M; Maresca, Kevin P; Zimmerman, Craig N; Eckelman, William C; Joyal, John L; Babich, John W",Journal of medicinal chemistry,,,,,,https://doi.org/10.1021/jm3015348; https://www.ncbi.nlm.nih.gov/pubmed/23234246/,29424144.0,12
27648,27648,37865,9l4kdhoe,,Medline,Laparoscopic Radiofrequency Ablation Combined with Surgical Excision for Exophytic Renal Angiomyolipoma: A Novel Technique Based on Tumor Vasculature Features of Enhancing Renal Masses Toward Hilar Off-Clamping Nephron-Sparing Surgery.,10.1089/lap.2016.0348,,27805457.0,unk,objective symptomatic angiomyolipoma aml asymptomatic aml larger cm size usually treated nephronsparing surgery transarterial embolization used radiofrequency ablation treat vascular pedicle exophytic aml low renal nephrometry score investigated feasibility hilar offclamping nephronsparing surgery method contrastenhanced computed tomography ct showed enhanced welldefined lipomatous tumor maximum diameter cm kidney patient result indicated exophytic tumor featured enlarged tumor vasculatures extended parenchyma involved kidney patient underwent radiofrequency ablation using cooltip™ probe placed root aml mass different direction laparoscopic ultrasonography guidance sealing vascular pedicle tumor bloodless tumor resected en bloc without renal hilar clamping suturing resection defect kidney result patient underwent procedure smoothly perioperative complication occurred contrastenhanced ct scan showed small defect contrastenhanced renal parenchyma third month procedure decrease function treated kidney month followup conclusion initial experience suggests sealing tumor vessel radiofrequency ablation based tumor vasculature feature renal mass alternative hilar clamping laparoscopic nephronsparing surgery laparoscopic radiofrequency ablation tumor excision definitive safe minimally invasive procedure allows successful removal exophytic sporadic aml mass low renal nephrometry score,2017,"Xiong, Wei; Ran, Qing; Du, Yangchun; Lv, Ji; Chen, Fang; Zhong, Shan; Guo, Pu; Dou, Ke; Sun, Minghan",Journal of laparoendoscopic & advanced surgical techniques. Part A,,,,,,https://doi.org/10.1089/lap.2016.0348; https://www.ncbi.nlm.nih.gov/pubmed/27805457/,4716918.0,12
27678,27678,37897,4z2qv22o,,Medline,Minimally invasive central pancreatectomy and pancreatogastrostomy: current surgical technique and outcomes.,10.21037/jovs.2016.07.22,,29078525.0,unk,recent improvement imaging technique frequent use crosssectional imaging led increase identification benign lowgrade lesion pancreas patient resectable cancer commonly treated either whipple procedure distal pancreatectomy dp based location tumor central pancreatectomy cp le commonly performed operation recently utilized resection frequently diagnosed lowgrade benign lesion located mid pancreas lesion may relatively indolent nature include branchtype intraductal papillary mucinous neoplasm ipmns mucinous cystic neoplasm neuroendocrine tumor solid pseudopapillary tumor goal cp complete extirpation lesion preserving pancreatic parenchyma reduce risk developing diabetes exocrine insufficiency ei although open cp shown safe efficacious outcome minimally invasive approach still relatively underreported therefore unknown paper describe surgical approach performing cp accompanying video demonstration key portion operation,2016,"Ronnekleiv-Kelly, Sean M; Javed, Ammar A; Weiss, Matthew J",Journal of visualized surgery,,,,,,https://doi.org/10.21037/jovs.2016.07.22; https://www.ncbi.nlm.nih.gov/pubmed/29078525/,30000450.0,12
27686,27686,37908,5q7oqpcn,,Medline,Radiofrequency ablation: technique and clinical applications.,10.4261/1305-3825.dir.5168-11.1,,22407695.0,unk,radiofrequency ablation commonly used percutaneous ablation technique welldocumented literature focal therapy become imageguided ablation method choice efficacy safety ease use radiofrequency ablation shown promise treating selected solid tumor particularly involving liver kidney lung musculoskeletal system minimally invasive technique often used inoperable patient comorbidities radiofrequency ablation requires minimal hospital stay performed outpatient basis aim article review radiofrequency ablation technique clinical application,2012,"Tatli, Servet; Tapan, Umit; Morrison, Paul R; Silverman, Stuart G",Diagnostic and interventional radiology,,,,,,https://doi.org/10.4261/1305-3825.dir.5168-11.1; https://www.ncbi.nlm.nih.gov/pubmed/22407695/,36005304.0,12
27720,27720,37944,4j5g5j5r,,Medline,Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report.,10.1007/s40477-019-00361-w,,30864004.0,unk,purpose hepatocellular carcinoma hcc common form liver cancer advanced cancer stage metastatic disease andor vascular invasion generally accepted standard care systemic therapy using sorafenib firstline treatment recently regorafenib nivolumab secondline treatment quality life prognosis patient remain poor paper report case usguided radiofrequency ablation rfa intraparenchymal hcc inferior vena cava tumor thrombus method treated patient hcc associated tumor thrombus extending vena cava failure sorafenib therapy using usguided radiofrequency ablation rfa result good radiological clinical response observed association excellent tolerability patient followed month ablation alive good clinical condition without evidence tumor recurrence conclusion first case minimally invasive percutaneous procedure successfully used treat hcc thrombus entering vena cava,2019,"Gatti, Pietro; Giorgio, Antonio; Ciracì, Emanuela; Roberto, Italia; Anglani, Alessandro; Sergio, Spano; Rizzello, Fernando; Giorgio, Valentina; Semeraro, Stefano",Journal of ultrasound,,,,,,https://doi.org/10.1007/s40477-019-00361-w; https://www.ncbi.nlm.nih.gov/pubmed/30864004/,76660027.0,12
27816,27816,38052,h7wfxhrq,,Medline,"R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.",10.1016/j.jvir.2015.01.008,,25769213.0,unk,purpose investigate prognostic value renal radius exophyticendophytic nearness collecting system sinus anteriorposterior location relative polar line nephrometry score percutaneous ablation renal cell carcinoma rcc material method retrospective year study performed participant consecutive patient median age male female biopsyproven rccs underwent percutaneous ablation cryoablation radiofrequency ablation followup computed tomography magnetic resonance imaging performed case mean followup mo ± renal score analyzed determine association score treatment outcome complication result tumor corresponded stage disease mean tumor size cm range cm lesion measured cm nephrometry score lesion overall recurrence rate firstyear recurrence rate complication rate nephrometry score associated increased complication percutaneous ablation p increased overall recurrence p increased risk firstyear recurrence p immediate complication associated tumor size cm p risk local recurrence p age gender percutaneous ablation technique correlated recurrence immediate complication patient undergoing cryoablation higher nephrometry score significant difference recurrence rate compared rf ablation p conclusion renal nephrometry score ≥ predicts recurrence complication percutaneous renal ablation,2015,"Camacho, Juan C; Kokabi, Nima; Xing, Minzhi; Master, Viraj A; Pattaras, John G; Mittal, Pardeep K; Kim, Hyun S",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2015.01.008; https://www.ncbi.nlm.nih.gov/pubmed/25769213/,206660057.0,12
27833,27833,38072,340dh4wa,,Medline,Solitary painful osseous metastases: correlation of imaging features with pain palliation after radiofrequency ablation--a multicenter american college of radiology imaging network study.,10.1148/radiol.13122398,,23657892.0,unk,purpose identify correlation pre postablation imaging feature pain relief pain intensity patient mood radiofrequency rf ablation solitary painful osseous metastasis material method prospective multicenter group trial approved institutional review board participant enrolled november april written informed consent obtained subject patient confidentiality protocol followed compliance hipaa computed tomography ctguided rf ablation contrast materialenhanced month followup ct andor magnetic resonance imaging performed subject men woman age range year confirmed malignant solitary bone lesion maximum dimension cm smaller causing intractable pain pain intensity patient mood measured rf ablation tumor imaging feature recorded unadjusted adjusted linear mixedeffects model random intercept subject used model patient mood pain relief pain intensity score three time ablation function tumor characteristic result decreased postablation tumor pain correlated preablation tumor volume p pathologic fracture p pain relief correlated pathologic fracture p percentage bonetumor interface bti ablated p conversely presence irregular rim ablation p rim thickness p correlated increased pain evidence study rf ablation larger tumor percentage larger volume lead better pain relief decreased pain p conclusion existing pathologic fracture smaller tumor size appear predictive parameter success selecting patient palliative rf ablation painful solitary osseous metastasis successful palliation also appears related percentage bti ablated,2013,"Guenette, Jeffrey P; Lopez, Michael J; Kim, Eunhee; Dupuy, Damian E",Radiology,,,,,,https://doi.org/10.1148/radiol.13122398; https://www.ncbi.nlm.nih.gov/pubmed/23657892/,207729647.0,12
27902,27902,38149,01tuj60u,,Medline,Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.,10.1007/s10147-014-0741-z,,25130494.0,unk,background retrospective study conducted compare clinical outcome radiofrequency ablation rfa stereotactic body radiotherapy sbrt patient lung tumor method local tumor progression adverse event overall survival compared patient underwent either rfa sbrt single lung tumor measuring cm smaller study approved institutional review board two institution informed consent waived result september june patient male female mean age ± standard deviation sd ± year underwent rfa one institution patient male female mean age ± sd ± year underwent sbrt another mean maximum tumor diameter ± sd ± cm range cm rfa group ± cm range cm p sbrt group rfa sbrt group showed similar year local tumor progression confidence interval ci v ci p overall survival rate ci v ci p factor significantly affected local tumor progression maximum tumor size cm identified prognostic factor univariate multivariate analysis death related treatment procedure major complication rate grade adverse event rfa sbrt p group similar conclusion lung tumor patient lung rfa provided local tumor control survival similar achieved using sbrt equal safety,2015,"Ochiai, Satoru; Yamakado, Koichiro; Kodama, Hiroshi; Nomoto, Yoshihito; Ii, Noriko; Takaki, Haruyuki; Sakuma, Hajime",International journal of clinical oncology,,,,,,https://doi.org/10.1007/s10147-014-0741-z; https://www.ncbi.nlm.nih.gov/pubmed/25130494/,19882980.0,12
27917,27917,38166,ks9oum4d,,Medline,Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors.,10.2967/jnumed.111.089276,,21976529.0,unk,unlabelled hypothesized gadotatate uptake neuroendocrine tumor sensitive therapy nonradioactive somatostatin analog method gadotatate petct used examine patient pretreated longacting octreotide maximum standardized uptake value suvmax target tissue well metastasis compared group patient group without group octreotide treatment result suvmax spleen liver significantly lower group group p significant group difference suvmax primary tumor ± v ± metastasis liver ± v ± lymph node ± v ± skeleton ± v ± patient available intraindividual comparison tumor uptake unaffected treatment somatostatin analog v p conclusion treatment longacting somatostatin analog significantly reduce gadotatate binding neuroendocrine tumor tended improve tumortobackground ratio,2011,"Haug, Alexander R; Rominger, Axel; Mustafa, Mona; Auernhammer, Christoph; Göke, Burkhard; Schmidt, Gerwin P; Wängler, Björn; Cumming, Paul; Bartenstein, Peter; Hacker, Marcus","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.089276; https://www.ncbi.nlm.nih.gov/pubmed/21976529/,20592000.0,12
27982,27982,38244,xo2gky3x,,Medline,Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis.,10.1016/j.suronc.2009.02.001,,19268571.0,unk,background surgical resection malignant hepatic tumor demonstrated increase overall survival however majority patient candidate resection patient unresectable tumor various chemical thermal ablation modality developed microwave coagulation therapy mct one thermal ablation modality purpose review evaluate presently available data mct ass level evidence support clinical use method review limited published study english literature including least patient per study mct hepatocellular cancer hcc colorectal hepatic metastasis crhm pattern local recurrence complication survival outcome mct ablation presented discussed including assessment asian experience using ghz device american experience using mhz device conclusion although randomized controlled trial comparing rfa mct hepatic ablation lacking review based level data support mct may optimal larger necrosis zone andor ablation multiple lesion objective data support potential procedural advantage noted ablation crhm hcc cm supported hcc cm moreover mct share ablation modality high rate locoregional recurrence hcc likely due multicentricity disease process,2010,"Boutros, C; Somasundar, P; Garrean, S; Saied, A; Espat, N J",Surgical oncology,,,,,,https://doi.org/10.1016/j.suronc.2009.02.001; https://www.ncbi.nlm.nih.gov/pubmed/19268571/,22139422.0,12
27987,27987,38250,sbgc6vdq,,Medline,Isobaric laparoendoscopic single-site surgery with wound retractor for adnexal tumors: a single center experience with the initial 100 cases.,10.1016/j.ejogrb.2011.02.018,,21470765.0,unk,objective report experience isobaric gasless transumbilical laparoendoscopic singlesite le surgery patient adnexal tumor single center study design case wound retractor used working port cm vertical umbilical incision surgical view secured subcutaneous abdominal walllift method surgical procedure performed using conventional laparoscopic instrument vision rigid ° mm endoeye laparoscope clinical data regarding patient demographic surgical outcome retrospectively analyzed result august july one hundred seventeen tumor case treated isobaric le surgery unilateral salpingooophorectomy unilateral cystectomy bilateral cystectomy bilateral salpingooophorectomy unilateral cystectomy contralateral cyst wall ablation unilateral cystectomy contralateral salpingooophorectomy unilateral salpingectomy three normal adnexa prophylactically resected time contralateral salpingooophorectomy diseased ovary previous abdominal surgery noted case emergency surgery performed case six pregnant woman treated late first trimester median tumor diameter cm median surgical duration min median blood loss ml conversion conventional laparoscopic surgery noted one case recurrent endometriotic cyst severe adhesion laparotomic conversion experienced prolonged administration antibiotic extended hospitalization required case due elevated inflammatory parameter major surgical complication series technique yielded excellent cosmetic result minimum postoperative scar concealed within umbilicus exclusion endometriotic cyst treated cyst wall ablation pathological diagnosis obtained tumor dermoid cyst endometriotic cyst serous cystadenoma mucinous cystadenoma paraovarian cyst serous borderline tumor paraovarian serous papillary borderline tumor conclusion efficient wound retraction create wide flexible orifice instrumentation transumbilical wound retraction system combined subcutaneous abdominal walllift method contributes favorably le surgery safe feasible reproducible alternative variety ablative reconstructive application management adnexal tumor,2011,"Takeda, Akihiro; Imoto, Sanae; Mori, Masahiko; Nakano, Tomoko; Nakamura, Hiromi","European journal of obstetrics, gynecology, and reproductive biology",,,,,,https://doi.org/10.1016/j.ejogrb.2011.02.018; https://www.ncbi.nlm.nih.gov/pubmed/21470765/,5344132.0,12
28043,28043,38317,k0zkbkmz,,Medline,Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers.,10.1159/000371786,,26285674.0,unk,background cystic pancreatic lesion often found malignant risk range nil precise diagnosis required adapt surveillance therapeutic strategy method tried identify difficult differential diagnosis encountered tertiary center pancreatology guide reader reach correct strategy diagnosis situation result identified eight clinically difficult situation chronic pancreatitis versus intraductal papillary mucinous neoplasm ii serous versus mucinous cystic neoplasm iii serous cystic neoplasm versus branchduct intraductal papillary mucinous neoplasm iv intraductal papillary mucinous neoplasm versus acinar cell cystadenoma v pseudo solid serous cystic neoplasm versus neuroendocrine tumor vi pancreatic neuroendocrine tumor versus solid pseudopapillary tumor vii cystic form solid tumor viii rare pancreatic peripancreatic cystic lesion workup rely computed tomography scan pancreatic magnetic resonance imaging necessary endoscopic ultrasound without fine needle aspiration conclusion expert analysis imaging data allows precise diagnosis case pancreatic resection longer performed case diagnostic doubt,2015,"Lévy, Philippe; Rebours, Vinciane",Viszeralmedizin,,,,,,https://doi.org/10.1159/000371786; https://www.ncbi.nlm.nih.gov/pubmed/26285674/,2142937.0,12
28055,28055,38330,4ahde8sx,,Medline,Periprocedural outcome after laparoscopic partial nephrectomy versus radiofrequency ablation for T1 renal tumors: a modified R.E.N.A.L nephrometry score adjusted comparison.,10.1177/0284185118780891,,29911400.0,unk,background comparable oncological outcome seen surgical nephrectomy thermal ablation renal tumor recently however periprocedural outcome need assessed aiding treatment decision purpose compare efficacy rate periprocedural outcome technical success session time hospitalization time complication renal tumor treatment laparoscopic partial nephrectomy lpn radiofrequency ablation rfa material method initial experience treated lpn treated rfa consecutive patient single renal tumor diameter ≤ cm limited kidney evaluated patient tumor characteristic efficacy rate periprocedural outcome collected retrospectively stratified mantel haenzel van elteren test adjusted tumor complexity modified renal nephrometry score mrns used ass difference treatment outcome result primary efficacy rate lpn rfa secondary efficacy rate lpn rfa technical success rate lpn rfa median session mrns adjusted p lpn min rfa min median hospitalization time longer lpn mrns adjusted p lpn day rfa day side effect uncommon lpn rfa complication frequent lpn mrns adjusted p lpn rfa conclusion method achieved equivalent secondary efficacy rate rfa included several treatment session session hospitalization time shorter complication le frequent lpn difference remained adjustment renal tumor complexity,2019,"Acosta Ruiz, Vanessa; Ladjevardi, Sam; Brekkan, Einar; Häggman, Michael; Lönnemark, Maria; Wernroth, Lisa; Magnusson, Anders",Acta radiologica,,,,,,https://doi.org/10.1177/0284185118780891; https://www.ncbi.nlm.nih.gov/pubmed/29911400/,49275496.0,12
28070,28070,38347,toxfzmts,,Medline,Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.,10.1186/bcr3404,,23506710.0,unk,introduction surgery currently definitive treatment earlystage breast cancer however rate positive surgical margin remains unacceptably high human sodium iodide symporter hnis naturally occurring protein human thyroid tissue enables cell concentrate radionuclides hnis exploited image treat thyroid cancer therefore investigated potential novel oncolytic vaccinia virus glvh engineered express hnis gene identifying positive surgical margin tumor resection via positron emission tomography pet furthermore studied role adjuvant therapeutic agent achieving local control remaining tumor orthotopic breast cancer model method glvh replicationcompetent vaccinia virus tested breast cancer cell line various multiplicity infection mois cytotoxicity viral replication determined mammary fat pad tumor generated athymic nude mouse determine utility glvh identifying positive surgical margin mammary fat pad tumor surgically resected subsequently injected glvh phosphate buffered saline pb surgical wound serial focus micropet image obtained six hour posttail vein injection approximately μci iiodide result viral infectivity measured green fluorescent protein gfp expression time concentrationdependent cell line showed le cell survival five day treatment moi glvh replicated efficiently cell line peak titer million viral plaque forming unit pfu fold increase initial viral dose day administration glvh surgical wound allowed positive surgical margin identified via pet scanning vivo mean volume infected surgically resected residual tumor four week treatment mm versus mm untreated control p conclusion first study knowledge demonstrate novel vaccinia virus carrying hnis imaging tool identifying positive surgical margin breast cancer orthotopic murine model moreover result suggest glvh promising therapeutic agent achieving local control positive surgical margin resected breast tumor,2013,"Gholami, Sepideh; Chen, Chun-Hao; Belin, Laurence J; Lou, Emil; Fujisawa, Sho; Antonacci, Caroline; Carew, Amanda; Chen, Nanhai G; De Brot, Marina; Zanzonico, Pat B; Szalay, Aladar A; Fong, Yuman",Breast cancer research : BCR,,,,,,https://doi.org/10.1186/bcr3404; https://www.ncbi.nlm.nih.gov/pubmed/23506710/,2905588.0,12
28143,28143,38434,j6xdgv4i,,Medline,Hybrid approach for left-sided colonic carcinoma obstruction; a case report.,10.1186/1477-7819-9-42,,21507272.0,unk,traditionally several approach manage leftsided colonic carcinoma obstruction tumor resection primary anastomosis tumor resection endcolostomy loopcolostomy recently colonic stent insertion introduced bridge prior definite surgery demonstrated hybrid approach obstructed sigmoid carcinoma using colonic stent followed single incision laparoscopic colectomy silc yearold man presented complete leftsided colonic obstruction underwent emergency colonoscopy metallic stent placement one week later performed silc recovered well operation without postoperative complication pathological result showed adequacy oncologic resection hybrid approach colonic stent insertion silc safely performed,2011,"Trakarnsanga, Atthaphorn; Akaraviputh, Thawatchai; Methasate, Asada; Chinswangwatanakul, Vitoon",World journal of surgical oncology,,,,,,https://doi.org/10.1186/1477-7819-9-42; https://www.ncbi.nlm.nih.gov/pubmed/21507272/,10514525.0,12
28166,28166,38459,n797nfng,,Medline,Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.,10.1007/s11701-016-0596-6,,27146858.0,unk,patient undergoing nephrectomy central renal tumor suspicious renal cell carcinoma rcc may carry small risk transitional cell carcinoma tcc final pathology even absence filling defect abnormal cytology describe outcome patient undergoing robotic nephrectomy suspected rcc intraoperative specimen assessment guide completion ureterectomy tcc present september august ten patient central renal mass suspicious rcc amenable nephronsparing surgery patient underwent fourarm robotic nephrectomy technique using gelpoint® access port following hilar ligation ureter divided adjacent hemolok clip placed endocatch bag extracted gelpoint incision frozen section analysis intraoperative assessment confirmed tcc robotic completion ureterectomy bladder cuff excision performed ten patient central tumor underwent robotic nephrectomy suspected rcc four tcc frozen section analysis underwent completion ureterectomy five patient rcc one patient oncocytoma mean age year mean tumor size cm mean operating time min patient negative margin mean length stay day recurrence documented median month followup patient undergoing robotic nephrectomy central renal tumor intraoperative specimen evaluation help determine need minimally invasive completion ureterectomy,2016,"Lieberman, Leedor; Barod, Ravi; Tapper, Alex; Kumar, Ramesh; Rogers, Craig",Journal of robotic surgery,,,,,,https://doi.org/10.1007/s11701-016-0596-6; https://www.ncbi.nlm.nih.gov/pubmed/27146858/,12307982.0,12
28235,28235,38541,jluuc8xf,,Medline,The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2.,10.1159/000367755,,26989656.0,unk,outcome hepatocellular carcinoma hcc lesion cm size including barcelona clinic liver cancer bclc stage b radiofrequency ablation rfa single electrode remain unsatisfactory study aimed investigate outcome rfa multiple electrode merfa hcc tumor cm size bclc stage b retrospective study included consecutive patient medium cm large cm sized hccs merfa using controller outcome term complete response primary technique effectiveness local tumor progression overall survival investigated application merfa rate complete response pte mediumsized tumor respectively large tumor respectively overall major complication rate median month followup period two threeyear estimated overall survival rate significant difference overall survival local tumor progression rate medium largesize tumor among bclc stage b b complete response merfa significant factor associated improved survival p conclusion merfa effectively treat cm sized hccs comparable outcome medium largesize tumor among bcla stage b,2016,"Lin, Chen-Chun; Cheng, Ya-Ting; Chen M, Wei-Ting; Lin, Shi-Ming",Liver cancer,,,,,,https://doi.org/10.1159/000367755; https://www.ncbi.nlm.nih.gov/pubmed/26989656/,26852892.0,12
28331,28331,38660,ilnofspc,,Medline,The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.,10.1371/journal.pone.0228030,,31971966.0,unk,background wavelet transformed reconstruction dynamic susceptibility contrast dsc mr perfusion waveletmrp new elegant way visualizing vascularization waveletmrp map yield clear depiction hypervascular tumor region recently shown objective aim study elucidate possible connection waveletmrp power spectrum glioblastoma gbm local vascularity cell proliferation method irbapproved study patient histologically confirmed idhwildtype gbm included target region biopsy prospectively marked tumor region seen preoperative mri subsequent neurosurgical tumor resection targeted biopsy taken target region matching sample analyzed specimen immunohistochemically analyzed endothelial cell marker cd proliferation marker ki correlated waveletmrp power spectrum derived dsc perfusion weighted imaging result strong correlation waveletmrp power spectrum median conventional relative cerebral blood volume median mlg spearmans rankorder correlation κ p logistic regression model waveletmrp power spectrum showed significant correlation cd dichotomized present staining p rcbv show significant correlation cd p significant association ki rcbv waveletmrp found p p respectively conclusion waveletmrp power spectrum derived existing dscmri data might promising new surrogate tumor vascularity gbm,2020,"Rotkopf, Lukas T; Wiestler, Benedikt; Preibisch, Christine; Liesche-Starnecker, Friederike; Pyka, Thomas; Nörenberg, Dominik; Bette, Stefanie; Gempt, Jens; Thierfelder, Kolja M; Zimmer, Claus; Huber, Thomas",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0228030; https://www.ncbi.nlm.nih.gov/pubmed/31971966/,210882973.0,12
28347,28347,38679,65bnvhzy,,Medline,"Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?",10.1148/rg.345140054,,25208284.0,unk,imageguided thermal ablation evolving growing treatment option patient malignant disease multiple organ system treatment indication expanding include benign tumor well specifically prevalent indication date liver primary metastatic disease well benign tumor hemangioma adenoma kidney primarily renal cell carcinoma also benign tumor angiomyolipomas oncocytomas lung primary metastatic disease soft tissue andor bone primarily metastatic disease osteoid osteoma organ system different underlying tissue characteristic profound effect resulting thermal change ablation zone understanding issue important optimizing clinical result addition thermal ablation technology evolved rapidly past several decade substantial technical procedural improvement help improve clinical outcome safety profile staying date development challenging critical physical property underlying different ablation modality appropriate use adjunct tremendous effect treatment result ultimately combining understanding physical property ablation modality understanding thermal kinetics tissue using appropriate ablation modality patient key optimizing clinical outcome suggested algorithm described help physician choose among various ablation modality individual patient,2014,"Hinshaw, J Louis; Lubner, Meghan G; Ziemlewicz, Timothy J; Lee, Fred T; Brace, Christopher L","Radiographics : a review publication of the Radiological Society of North America, Inc",,,,,,https://doi.org/10.1148/rg.345140054; https://www.ncbi.nlm.nih.gov/pubmed/25208284/,37911788.0,12
28468,28468,38815,kolvyei6,,Medline,Treatment of pulmonary colorectal metastases by radiofrequency ablation.,10.1016/j.clcc.2012.07.003,,23026111.0,unk,unlabelled evaluated local tumor control survival benefit achieved radiofrequency ablation rfa nonoperable lung metastasis patient colorectal cancer median survival time rfa month one year local tumor progression ltpfree survival rate respectively rfa offer good local control patient pulmonary metastasis colorectal cancer background radiofrequency ablation emerged potential lung functionpreserving treatment colorectal lung metastasis patient method fortyfive patient colorectal pulmonary metastasis underwent computed tomographyguided rfa december june baseline posttreatment scan obtained week rfa followup imaging study every month thereafter obtained compared evaluate tumor progression site ablation elsewhere primary end point ltpfree survival overall survival rfa procedure kaplanmeier method used analyze end point cox proportional hazard model robust inference used estimate association baseline factor survival end point result sixtynine metastasis ablated patient tumor size ranged cm median number metastasis ablated per patient range median followup rfa month median survival time rfa month confidence interval ci one year overall survival rate time rfa ci ci ci respectively nine lesion progressed retreated progression second rfa median time progression reached ltpfree survival rfa ci year ci year ci year conclusion radiofrequency ablation lung metastasis effective minimally invasive parenchymalsparing technique good local control rate patient pulmonary metastasis colorectal cancer ltpfree survival year,2013,"Petre, Elena N; Jia, Xiaoyu; Thornton, Raymond H; Sofocleous, Constantinos T; Alago, William; Kemeny, Nancy E; Solomon, Stephen B",Clinical colorectal cancer,,,,,,https://doi.org/10.1016/j.clcc.2012.07.003; https://www.ncbi.nlm.nih.gov/pubmed/23026111/,5248995.0,12
28534,28534,38890,5imdhq6c,,Medline,Intradural hemangiopericytoma of the thoracic spine: a case report.,10.1016/j.spinee.2011.04.030,,21641873.0,unk,background context hemangiopericytoma hpc occurs infrequently central nervous system spinal involvement particularly uncommon intradural localization rare describe intradural extramedullary thoracic hpc went undiagnosed initially computed tomography scan abdomen purpose describe clinical presentation operative management patient diagnosed intradural extramedullary thoracic hpc missed initial workup also describe pathologic feature hpc study design case report method chart review literature search case yearold man presented acute weakness lower extremity bladder bowel incontinence magnetic resonance imaging spine revealed intradural extramedullary lesion displaced cord right result patient taken emergently surgery tt laminectomy en bloc resection tumor lesion identified resected histology revealed randomly oriented tumor cell irregular capillary consistent hpc postoperatively patient improved neurological examination continued intense physical therapy conclusion standard treatment hpc surgery lesion resectable despite gross total resection still high risk recurrence metastasis therefore patient followed closely physician serial postoperative clinical examination radiographic imaging,2011,"Ackerman, Paul D; Khaldi, Ahmad; Shea, John F",The spine journal : official journal of the North American Spine Society,,,,,,https://doi.org/10.1016/j.spinee.2011.04.030; https://www.ncbi.nlm.nih.gov/pubmed/21641873/,205226874.0,12
28546,28546,38907,na9g7l97,,Medline,Massive malignant solitary fibrous tumor arising from the bladder serosa: a case report.,10.1186/s13256-014-0505-4,,25884588.0,unk,introduction solitary fibrous tumor rare neoplasm mesenchymal origin often low malignant potential rarely metastasize frequently arise pleura occur soft tissue site body present case large × cm malignant solitary fibrous tumor arising bladder serosa addition clinicopathologic feature differential diagnosis cytogenetics management rare disease discussed along review existing literature topic case presentation otherwise healthy yearold caucasian man presented weight loss progressive abdominal bloating subsequent computed tomography scan chest abdomen pelvis revealed × cm intraabdominal mass occupying abdominal cavity inferior vena cava compressed mass extended inferiorly upper pelvis abutting superior dome bladder underwent operative resection resected mass measured × × cm weighed kg cut surface revealed graywhite mass illdefined whorledlike pattern randomly assorted tan fleshy nodule histologic evaluation revealed variable alternating hypercellular hypocellular area area necrosis tumor cell varied spindle epithelioid within hyalinized stroma hypercellular area tumor cell showed moderate atypia high mitotic activity histological feature combined immunophenotyping suggestive malignant solitary fibrous tumor grossly appeared growing bladder serosa specifically intraperitoneal superior dome bladder patient currently eight month postsurgery without evidence recurrence conclusion extrapleural occurrence solitary fibrosis tumor increasingly observed malignant solitary fibrosis tumor urinary bladder however rare pathognomonic feature malignancy surgical resection often diagnostic therapeutic case report,2015,"Dozier, Jordan; Jameel, Zena; McCain, Donald A; Hassoun, Patrice; Bamboat, Zubin M",Journal of medical case reports,,,,,,https://doi.org/10.1186/s13256-014-0505-4; https://www.ncbi.nlm.nih.gov/pubmed/25884588/,6467359.0,12
28573,28573,38937,paq4efxl,,Medline,Prototype development of an electrical impedance based simultaneous respiratory and cardiac monitoring system for gated radiotherapy.,10.1186/1475-925x-13-144,,25316509.0,unk,background radiotherapy temporary translocation internal organ tumor induced respiratory cardiac activity undesirably lead significantly lower radiation dose targeted tumor harmful radiation surrounding healthy tissue respiratory cardiac gated radiotherapy offer potential solution treatment tumor located upper thorax present study focus design development simultaneous acquisition respiratory cardiac signal using electrical impedance technology use dual gated radiotherapy method electronic circuitry developed monitoring bioimpedance change due respiratory cardiac motion extracting cardiogenic ecg signal system analyzed term reliability signal acquisition time delay functionality high energy radiation environment resulting signal system developed also compared output commercially available realtime position management™ rpm system time frequency domain result result demonstrate bioimpedancebased method potentially provide reliable tracking respiratory cardiac motion human alternative currently available method compared rpm system impedancebased system developed present study show similar output pattern different sensitivity monitoring different respiratory rate tracking cardiac motion susceptible interference source respiratory motion also provided synchronous output compared ecg signal extracted proposed hardwarebased implementation observed worstcase time delay approximately m respiratory monitoring m cardiac monitoring significant effect functionality system observed tested radiation environment electrode lead wire directly exposed highenergy xrays conclusion developed system capable rendering quality signal tracking respiratory cardiac motion potentially provide solution simultaneous dualgated radiotherapy,2014,"Kohli, Kirpal; Liu, Jeff; Schellenberg, Devin; Karvat, Anand; Parameswaran, Ash; Grewal, Parvind; Thomas, Steven",Biomedical engineering online,,,,,,https://doi.org/10.1186/1475-925x-13-144; https://www.ncbi.nlm.nih.gov/pubmed/25316509/,3920644.0,12
28645,28645,39021,quacnyiy,,Medline,Preclinical and clinical studies of peptide receptor radionuclide therapy.,10.1053/j.semnuclmed.2009.12.001,,20350630.0,unk,inlabeled somatostatin analog octreoscan covidien hazelwood mo developed imaging somatostatin receptor subtype sst overexpressing tumor basis success peptide receptor radionuclide therapy prrt developed using similar somatostatin analog different therapeutic radionuclides clinical application prrt demonstrated impressive result tumor response overall survival quality life patient gastroenteropancreatic neuroendocrine tumor peptide tetraazacyclododecanetetraacetic acid dota tyroctreotate dotatate dota tyroctreotide dotatoc brand name onalta predominantly targeting sst granted orphan drug status european medicine agency u food drug administration application prrt besides somatostatin receptortargeting peptide multiple radiopeptide analog developed targeting several receptor overexpressed various tumor peptide analog including cholecystokinin gastrin gastrinreleasing peptide arginineglycineaspartate rgdpeptides glucagonlike peptide analog appeared promising preclinical clinical imaging prrt study although success prrt radiolabeled somatostatin analog established still room improvement therapeutic window prrt could enlarged use new improved targeting compound new antagonist excellent tumor background ratio promising furthermore locoregional administration improved healthy tissue protection combination treatment applied increase effectiveness prrt combination treatment might include cocktail different peptide analog different therapeutic radionuclides radiolabeled peptide chemotherapeutic radiosensitizing agent review summarizes result prrt describes clinical preclinical study regarding prrt optimizing strategy,2010,"Pool, Stefan E; Krenning, Eric P; Koning, Gerben A; van Eijck, Casper H J; Teunissen, Jaap J M; Kam, Boen; Valkema, Roelf; Kwekkeboom, Dik J; de Jong, Marion",Seminars in nuclear medicine,,,,,,https://doi.org/10.1053/j.semnuclmed.2009.12.001; https://www.ncbi.nlm.nih.gov/pubmed/20350630/,37403054.0,12
28660,28660,39038,p1zwd83m,,Medline,Surgical nuances for removal of retrochiasmatic craniopharyngioma via the endoscopic endonasal extended transsphenoidal transplanum transtuberculum approach.,10.3171/2011.1.focus10297,,21456925.0,unk,retrochiasmatic craniopharyngiomas challenging tumor remove given deep location proximity critical neurovascular structure complete surgical removal offer best chance cure prevention recurrence endoscopic endonasal extended transsphenoidal approach offer direct midline access retrochiasmatic space transplanum transtuberculum corridor excellent visualization undersurface optic chiasm hypothalamus obtained facilitate bimanual extracapsular dissection permit complete removal formidable tumor report author review endoscopic endonasal extended transsphenoidal approach specific emphasis technical operative nuance removing retrochiasmatic craniopharyngiomas illustrative intraoperative video demonstrating technique also presented,2011,"Liu, James K; Christiano, Lana D; Patel, Smruti K; Eloy, Jean Anderson",Neurosurgical focus,,,,,,https://doi.org/10.3171/2011.1.focus10297; https://www.ncbi.nlm.nih.gov/pubmed/21456925/,8939234.0,12
28662,28662,39040,3rddra52,,Medline,Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.,10.1093/jjco/hyv057,,25900903.0,unk,objective previous trial small groundglass opacity nodule highresolution computed tomography suggested cancer might radically managed limited resection good correlation radiologic pathologic finding early lung adenocarcinoma reported aimed confirm limited resection efficacy radical surgery patient highresolution computed tomographyindicated minimally invasive lung cancer purpose interim analysis report detail patient nodule characteristic intraoperative cytology capability negative margin indicator patient outcome median followup period year month method enrollment required patient tumor ≤ cm diagnosed suspected ctnm carcinoma lung periphery depicted highresolution computed tomography subsolid nodule tumor disappearance ratio ≥ performed wedge segmental resection appropriate primary endpoint year local recurrencefree survival rate result study started november patient enrolled november eligible analysis men woman aged averaging year tumor size ranged mm computed tomography averaging mm noguchi type tumor type b tumor type c tumor one malignant lymphoma noncancerous lesion cancer showed vessel invasion median followup period month recurrence conclusion far highresolution computed tomography appears predict non minimally invasive groundglass opacity lung cancer high reliability warranting limited resection curative surgery cohort,2015,"Yoshida, Junji; Ishii, Genichiro; Hishida, Tomoyuki; Aokage, Keiju; Tsuboi, Masahiro; Ito, Hiroyuki; Yokose, Tomoyuki; Nakayama, Haruhiko; Yamada, Kouzo; Nagai, Kanji",Japanese journal of clinical oncology,,,,,,https://doi.org/10.1093/jjco/hyv057; https://www.ncbi.nlm.nih.gov/pubmed/25900903/,25796033.0,12
28665,28665,39043,e5hwnt8i,,Medline,Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma.,10.1111/hepr.12370,,24917381.0,unk,aim accurate assessment coagulated area imperative achieve excellent outcome percutaneous radiofrequency ablation prfa treatment hepatocellular carcinoma hcc evaluated efficacy contrastenhanced ultrasonography ceus contrastenhancing agent sonazoid precisely assessing therapeutic effect prfa hcc method enrolled consecutive patient solitary naïve hcc le cm diameter prfa treatment performed g cooltip needle ceus performed ass ablative margin h procedure coagulated tumor outline easiest discern treatment repeated ablative margin greater mm confirmed ceus assessment therapeutic response patient followed investigate local tumor recurrence result patient outline coagulated tumor could recognized ultrasonography ceus assessment ablative margin successful remaining nine patient assessed computed tomography year cumulative survival rate assessment treatment response ceus year cumulative total recurrence rate year cumulative local tumor recurrence rate low conclusion assessment ceus h prfa procedure successful majority patient yielded low rate local recurrence,2015,"Nishigaki, Yoichi; Hayashi, Hideki; Tomita, Eiichi; Suzuki, Yusuke; Watanabe, Naoki; Watanabe, Satoshi; Watanabe, Chiaki; Takagi, Yui; Kato, Tomohiro; Naiki, Takafumi",Hepatology research : the official journal of the Japan Society of Hepatology,,,,,,https://doi.org/10.1111/hepr.12370; https://www.ncbi.nlm.nih.gov/pubmed/24917381/,205164155.0,12
28682,28682,39066,ss5ep0qt,,Medline,Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery.,10.1007/s00404-017-4575-6,,29128980.0,unk,purpose review cover recent evidence discus incidence occult uterine sarcoma whether morcellation increase tumor dissemination mortality whether difference different type morcellation also discus technique reduce spread undiagnosed uterine sarcoma method comprehensive literature search made pubmed medline cochrane library google scholar article related incidence occult uterine sarcoma morcellation result fibroid benign uterine tumor common indication gynecologic surgery increasingly gynecologist approaching surgery minimally invasive technique uterine sarcoma rare malignant mesenchymal tumor difficult distinguish preoperatively uterine fibroid conclusion minimally invasive surgery risk disseminating occult sarcoma tissue extraction minimally invasive gynecologist tasked balancing taking minimally invasive approach shown result better patient outcome minimizing risk spreading occult sarcoma,2018,"Wong, Marron; De Wilde, Rudy Leon; Isaacson, Keith",Archives of gynecology and obstetrics,,,,,,https://doi.org/10.1007/s00404-017-4575-6; https://www.ncbi.nlm.nih.gov/pubmed/29128980/,35087528.0,12
28738,28738,39128,wejn2fjk,,Medline,"Laparoscopic liver resection in the semiprone position for tumors in the anterosuperior and posterior segments, using a novel dual-handling technique and bipolar irrigation system.",10.1007/s00464-014-3469-y,,24622763.0,unk,background hepatic tumor lower edge lateral segment commonly treated laparoscopic liver resection tumor anterosuperior posterior segment often large locally invasive resection associated higher risk insufficient surgical margin massive intraoperative bleeding breaching tumor laparoscopic surgery tumor often involves major hepatectomy including resection large volume normal liver tissue developed novel method laparoscopic resection tumor segment patient semiprone position using dualhandling technique intercostal transthoracic port aim study evaluate safety usefulness technique method patient underwent laparoscopic liver resection center june may retrospectively reviewed tumor anterosuperior posterior segment patient placed supine semilateral surgery january semiprone february result introduction semiprone position february total patient tumor anterosuperior posterior segment underwent laparoscopic liver resection introduction semiprone position patient tumor anterosuperior posterior segment underwent laparoscopic liver resection p conversion open surgery reoperations death semiprone group significantly higher proportion patient underwent partial resection segmentectomy lower intraoperative blood loss shorter hospital stay supine group p postoperative complication rate similar group conclusion laparoscopic liver resection semiprone position safe increase number patient treated laparoscopic surgery without increasing frequency major hepatectomy,2014,"Ikeda, Tetsuo; Toshima, Takao; Harimoto, Norifumi; Yamashita, Youichi; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Shirabe, Ken; Maehara, Yoshihiko",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-3469-y; https://www.ncbi.nlm.nih.gov/pubmed/24622763/,16286985.0,12
28740,28740,39130,7taemytb,,Medline,Surgical Technique: Endoscopic Endonasal Transphenoidal Resection of a Large Suprasellar Mixed Germ Cell Tumor.,10.7759/cureus.503,,27014537.0,unk,endoscopic endonasal transphenoidal approach proven versatile surgical approach resection small midline skull base tumor due minimally invasive nature potentially fewer neurological complication lower morbidity comparison traditional craniotomy surgical approach le commonly utilized large midline tumor suprasellar germ cell tumor due numerous reason including surgeon comfort surgical approach higher chance postoperative cerebrospinal fluid csf leak limited visualization due arterialvenous bleeding limited working space present surgical technique case large suprasellar third ventricular mixed germ cell tumor resected via endoscopic endonasal approach favorable neurological outcome postoperative csf leak,2016,"Ajayi, Olaide; Chakravarthy, Vikram; Hanna, George; DeLos Reyes, Kennethy",Cureus,,,,,,https://doi.org/10.7759/cureus.503; https://www.ncbi.nlm.nih.gov/pubmed/27014537/,13911162.0,12
28746,28746,39136,3iowa3b2,,Medline,Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.,10.1002/ijc.28046,,23335047.0,unk,bevacizumab antivascular endothelial growth factor antivegf cetuximab antiepidermal growth factor receptor antiegfr approved antibody treatment cancer however advanced colorectal cancer combination fails improve survival reason lack activity unknown study aim determine effect bevacizumab targeting antiegfr insulinlike growth factor receptor igfr antibody tumor singlephoton emission computed tomography spectct imaging mouse subcutaneous egfr igfrexpressing sum xenograft received single dose bevacizumab mgkg saline day mouse injected radiolabeled cetuximab r antiigfr antibody control group received radiolabeled irrelevant igg hll three day later spectct image acquired mouse dissected determine concentration antibody tissue tumor analyzed immunohistochemically determine vascular density cd vegf egfr igfr expression spectct imaging revealed bevacizumab treatment significantly reduced tumor targeting radiolabeled cetuximab ± idg ± idg p untreated bevacizumabtreated tumor respectively similar effect found inr tumor targeting r decreased significant difference tumor uptake observed mouse received irrelevant igg uptake normal organ altered bevacizumab immunohistochemical analysis showed vascular density decreased whereas egfr igfr expression unaltered conclusion bevacizumab treatment significantly reduces tumor targeting antiegfr antiigfr antibody emphasizes importance timing sequencing bevacizumab combination antibody,2013,"Heskamp, Sandra; Boerman, Otto C; Molkenboer-Kuenen, Janneke D M; Oyen, Wim J G; van der Graaf, Winette T A; van Laarhoven, Hanneke W M",International journal of cancer,,,,,,https://doi.org/10.1002/ijc.28046; https://www.ncbi.nlm.nih.gov/pubmed/23335047/,205947411.0,12
28808,28808,39207,wx2gd9rk,,Medline,Pure Laparoscopic Liver Resection for Malignant Liver Tumor: Anatomic Resection Versus Nonanatomic Resection.,10.4103/0366-6999.172567,,26712431.0,unk,background laparoscopic liver resection llr considered safe feasible however study focused comparison anatomic nonanatomic llr therefore purpose study compare perioperative factor outcome anatomic nonanatomic llr especially area liver parenchymal transection blood loss per unit area method study surgical oncological data patient underwent pure llr procedure malignant liver tumor prospectively collected blood loss per unit area liver parenchymal transection measured considered important parameter procedure conducted single surgeon result nearly year patient malignant liver tumor received pure llr procedure included among patient received anatomic llr received nonanatomic llr respectively patient two group similar term demographic feature tumor characteristic despite tumor size significantly larger anatomic llr group nonanatomic llr group ± v ± cm p patient underwent anatomic resection longer operation time ± v ± min p le blood loss per unit area ± v ± mlcm p nonanatomic llr associated blood loss area parenchymal transection equal anatomic llr mortality occurred hospital stay day operation moreover difference incidence postoperative complication diseasefree overall survival rate showed significant difference anatomic llr nonanatomic llr group conclusion anatomic nonanatomic pure llr safe feasible measuring area parenchymal transection simple effective method estimate outcome liver resection surgery blood loss per unit area important parameter comparable anatomic llr nonanatomic llr group,2016,"Chen, Ya-Xi; Xiu, Dian-Rong; Yuan, Chun-Hui; Jiang, Bin; Ma, Zhao-Lai",Chinese medical journal,,,,,,https://doi.org/10.4103/0366-6999.172567; https://www.ncbi.nlm.nih.gov/pubmed/26712431/,16188207.0,12
28841,28841,39244,79qjq4l4,,Medline,Laparoendoscopic single-site surgery for partial nephrectomy without ischemia using a microwave tissue coagulator.,10.1177/1553350612459682,,22964264.0,unk,background herein report initial experience laparoendoscopic singlesite surgery partial nephrectomy lesspn using microwave tissue coagulator mtc method two patient small exophytic renal tumor underwent lesspn multichannel port inserted peritoneal retroperitoneal space cm skin incision tumor exposure surgeon introduced laparoscopic mtc instrument mm port tumor margin coagulated circumferentially coagulation tumor resected without renal pedicle clamping result procedure successfully performed without conversion standard laparoscopy need placement additional trocars operative time minute respectively estimated blood loss ml case final length le wound cm using transumbilical approach operative scar receded umbilicus hardly visible conclusion novel surgical technique feasible enables bloodless resection renal tumor without renal pedicle clamping clinical experience longer followup needed define benefit new technique,2013,"Nozaki, Tetsuo; Watanabe, Akihiko; Fuse, Hideki",Surgical innovation,,,,,,https://doi.org/10.1177/1553350612459682; https://www.ncbi.nlm.nih.gov/pubmed/22964264/,44355694.0,12
28885,28885,39294,1b5yesb2,,Medline,Sternal tumor resection and reconstruction with titanium mesh: a preliminary study.,10.1111/os.12169,,26033997.0,unk,objective explore clinical efficacy complication treating sternal tumor resection titanium mesh thoracic reconstruction method retrospective analysis eight patient sternal tumor treated department orthopedic surgery first affiliated hospital zhengzhou university january june included five men three woman aged year mean year histological diagnosis chondrosarcoma two case osteosarcoma one malignant fibrous histiocytoma two eosinophilic granuloma one sternal metastasis breast cancer two tumor invading manubrium sterni three case manubrium sterni body three sternal body two patient underwent needle incisional biopsy prior sternal tumor resection titanium mesh thoracic reconstruction result patient followed month year intraoperative complication operative postoperative death one patient developed deep wound hematoma week postoperatively incisional drainage debridement resulting healing within week loosening exsertion titanium mesh patient developed respiratory complication thoracic deformity one patient malignant fibrous histiocytoma died lung metastasis month postoperatively another malignant fibrous histiocytoma died liver metastasis month postoperatively remaining patient survived without tumor recurrence conclusion titanium mesh chest reconstruction sternal tumor resection advantage simplifying procedure achieving good shape complication titanium mesh ideal material reconstruction sternum,2015,"Zhang, Yan; Li, Jia-zhen; Hao, Ying-jie; Lu, Xin-chang; Shi, Hai-long; Liu, Yuan; Zhang, Peng-fei",Orthopaedic surgery,,,,,,https://doi.org/10.1111/os.12169; https://www.ncbi.nlm.nih.gov/pubmed/26033997/,46605772.0,12
28907,28907,39319,nyghc4ct,,Medline,Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.,10.1245/s10434-018-07133-6,,30830537.0,unk,background study aimed evaluate whether rapid fluorescent tissue examination immediately colorectal cancer liver metastasis clm ablation correlate standard pathologic immunohistochemical ihc assessment method prospective national institute healthsupported study enrolled consecutive patient clms ablated january december immediately ablation core needle sampling ablation zone performed tissue sample evaluated fluorescent viability mitotracker red nuclear hoechst stain confocal microscope imaging performed within min ablation sample subsequently fixed stained hematoxylin eosin identified tumor cell underwent ihc staining proliferation ki viability oxphos study pathologist blinded ihc assessment evaluated fluorescent image separately detect viable tumor cell sensitivity specificity overall concordance fluorescent versus ihc assessment calculated result total tissue sample collected processed overall concordance rate immediate fluorescent subsequent ihc assessment fluorescent assessment sensitivity specificity identification tumor cell respectively conclusion study showed high concordance rate immediate fluorescent assessment standard ihc assessment ablation zone given documented prognostic value ablation zone tissue characteristic outcome ablation clm fluorescent assessment offer potential intraprocedural biomarker complete tumor ablation,2019,"Sotirchos, Vlasios S; Fujisawa, Sho; Vakiani, Efsevia; Solomon, Stephen B; Manova-Todorova, Katia O; Sofocleous, Constantinos T",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-018-07133-6; https://www.ncbi.nlm.nih.gov/pubmed/30830537/,71145742.0,12
28933,28933,39347,jtoyslfw,,Medline,Large inflammatory fibroid polyp of cardia managed laparoscopically - a case report and review of the literature.,10.5114/wiitm.2014.46448,,25562003.0,unk,inflammatory fibroid polyp vaneks tumor gastrointestinal tract rare benign neoplasm lesion may occur age commonest sixth seventh decade often found woman mostly situated stomach especially antrum symptom depend location size lesion present case yearold woman large inflammatory polyp cardia diameter cm × cm × cm imitating gastrointestinal stromal tumor gist patient complained abdominal pain nausea mild anemia performed laparoscopic topical excision tumor postoperative course uneventful month followup reveal recurrence clinical image large vaneks tumor imitate symptom gastric cancer gist topical laparoscopic excision cm healthy wall margin sufficient adequate way treatment,2014,"Kwiatkowski, Andrzej P; Paśnik, Krzysztof",Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques,,,,,,https://doi.org/10.5114/wiitm.2014.46448; https://www.ncbi.nlm.nih.gov/pubmed/25562003/,18515249.0,12
28946,28946,39362,e1d83f67,,Medline,Salvage surgery for a super-responder by gefitinib therapy for advanced lung cancer.,10.1007/s11748-012-0087-2,,22688581.0,unk,salvage surgery gefitinib therapy yearold female ctnma lung adenocarcinoma right middle lobe gene mutation epidermal growth factor receptor presented patient bulky hilar lymph node pleural dissemination pulmonary metastasis ipsilateral lobe course chemotherapy patient treated gefitinib resulting partial response ie primary tumor middle lobe atelectasis remained performed middle lobe lobectomy aimed local control pathological confirmation remaining tumor hilum middle lobe occupied scar tissue pulmonary vein cut within pericardium pulmonary artery bronchus transected simultaneously stapler pathological stage yptann ef salvage surgery good response gefitinib therapy taken care expose pulmonary vessel,2012,"Hashimoto, Kohei; Horinouchi, Hirohisa; Ohtsuka, Takashi; Kohno, Mitsutomo; Izumi, Yotaro; Hayashi, Yuichiro; Nomori, Hiroaki",General thoracic and cardiovascular surgery,,,,,,https://doi.org/10.1007/s11748-012-0087-2; https://www.ncbi.nlm.nih.gov/pubmed/22688581/,207314246.0,12
28976,28976,39395,6yuimqf9,,Medline,Arena Roof Technique for Complex Reconstruction After Extensive Chest Wall Resection.,10.1016/j.athoracsur.2015.04.094,,26434458.0,unk,extensive primary resection redos may produce significant chest wall defect requiring creative reconstruction order avoid reduction intrathoracic volume describe successful use innovative technique chest wall reconstruction based concept roof coverage sport arena fact titanium plate anchored residual rib stump along parasternal paravertebral line acellular collagen matrix prosthesis sutured free edge titanium plate create roof reproducing chest wall dome geometric configuration yearold female patient diagnosed extensive desmoid tumor involving lateral segment second fifth rib right side arena roof technique allowed adequate expansion uninvolved lung optimal chest wall functional recovery,2015,"Rocco, Gaetano; La Rocca, Antonello; La Manna, Carmine; Martucci, Nicola; De Luca, Giuseppe; Accardo, Rosanna",The Annals of thoracic surgery,,,,,,https://doi.org/10.1016/j.athoracsur.2015.04.094; https://www.ncbi.nlm.nih.gov/pubmed/26434458/,27477989.0,12
29146,29146,39587,nbeg1iav,,Medline,A laparoscopic approach to benign retrorectal tumors.,10.1007/s10151-014-1146-8,,24718777.0,unk,background retrorectal tumor rts rare adult surgical excision often difficult anatomic location aim study evaluate result straight laparoscopic resection rts institution method eight patient six woman two men benign rts treated laparoscopic resection tertiary care center september june exclusion criterion included malignant tumor lesion fistula formation anterior sacral meningocele clinical data imaging feature operative detail pathological result treatment outcome reviewed analyzed result eight case benign rt average diameter ± cm treated straight laparoscopic procedure mean operative time ± min average intraoperative blood loss ± ml median postoperative stay day range day patient discharged without serious complication median followup month tumor recurrence observed conclusion experience laparoscopic approach safe removing benign tumor retrorectal space approach may provide access difficulttoreach space advantage allowing excellent visualization meticulous dissection le morbidity fast recuperation,2014,"Zhou, J L; Wu, B; Xiao, Y; Lin, G L; Wang, W Z; Zhang, G N; Qiu, H Z",Techniques in coloproctology,,,,,,https://doi.org/10.1007/s10151-014-1146-8; https://www.ncbi.nlm.nih.gov/pubmed/24718777/,25597876.0,12
29154,29154,39597,g1roodi5,,Medline,Evaluation of novel 99mTc(I)-labeled homobivalent α-melanocyte-stimulating hormone analogs for melanocortin-1 receptor targeting.,10.1007/s00775-011-0871-y,,22286955.0,unk,aiming apply multivalency concept melanoma imaging assessed vivo melanocortin type receptor mcrtargeting property mtcilabeled homobivalent peptide conjugate contain copy αmelanocytestimulating hormone αmsh analog acnle asp dphe lysαmsh separated linkers different length l nine atom l atom mcrbinding affinity l l significantly higher monovalent conjugate l metallation conjugate yielded complex facmcokl mtcre l l l l l l ic value subnanomolar nanomolar range mcrmediated internalization higher bf melanoma cell biodistribution study melanomabearing mouse shown low nonspecific accumulation tumor uptake correlate ic value however correlation tumor uptake valency found nevertheless displayed highest tumor retention best tumor nontarget organ ratio,2012,"Morais, Maurício; Raposinho, Paula D; Oliveira, Maria Cristina; Correia, João D G; Santos, Isabel",Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,,,,,,https://doi.org/10.1007/s00775-011-0871-y; https://www.ncbi.nlm.nih.gov/pubmed/22286955/,16998736.0,12
29157,29157,39600,88hvu7rq,,Medline,"Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis.",10.1245/s10434-020-08231-0,,32016632.0,unk,background whether hepatic resection hr combined radiofrequency ablation rfa hr alone treatment choice early moderately advanced multifocal hepatocellular carcinoma hccs matter debate study compared short longterm outcome patient multifocal tumor meeting university california san francisco ucsf criterion hr plus intraoperative rfa hr alone method total consecutive patient multifocal hccs meeting ucsf criterion january january underwent combined treatment n hr n included propensity score matching performed adjust baseline difference overall survival o recurrencefree survival rf calculated subgroup analysis along univariate multivariate analysis performed result year o rate combined treatment hr alone respectively p combined treatment provided similar rf rate hr year v respectively p propensity matching model showed similar result subgroup analysis showed hr associated better rf hr plus rfa patient two tumor major tumor ≤ cm multivariate analysis revealed portal hypertension three tumor independent risk factor conclusion multifocal hcc patient meeting ucsf criterion combined treatment may offer similar o rf hr however hr may suitable combined treatment patient two tumor major tumor ≤ cm,2020-02-03,"Huang, Yang; Song, Jiulin; Zheng, Jinli; Jiang, Li; Yan, Lunan; Yang, Jiayin; Zeng, Yong; Wu, Hong",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-020-08231-0; https://www.ncbi.nlm.nih.gov/pubmed/32016632/,211017514.0,12
29203,29203,39655,9xm5pwrg,,Medline,Simultaneous laparoscopic resection of distal pancreas and liver nodule for pancreatic neuroendocrine tumor.,10.21037/jovs.2016.11.08,,29078561.0,unk,laparoscopic distal pancreatectomy ldp without splenic preservation increasingly performed benign borderline neoplasm body tail pancreas pancreatic neuroendocrine tumor appear excellent indication laparoscopic resection procedure becoming gold standard surgical treatment neoplasm safety advantage laparoscopic resection open distal pancreatectomy odp proven video present ldp splenectomy neuroendocrine tumor distal pancreas associated wedge resection liver nodule technical consideration also discussed,2016,"Passuello, Nicola; Valmasoni, Michele; Pozza, Gioia; Pierobon, Elisa Sefora; Ponzoni, Alberto; Sperti, Cosimo",Journal of visualized surgery,,,,,,https://doi.org/10.21037/jovs.2016.11.08; https://www.ncbi.nlm.nih.gov/pubmed/29078561/,31646665.0,12
29212,29212,39664,hv0eeled,,Medline,Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.,10.1002/hed.25126,,29509281.0,unk,background fluorescent probe glutamylprolyl hydroxymethyl rhodamine green ephmrg becomes fluorescent cleavage dipeptidyl peptidaseiv dppiv reported useful detection esophageal cancer thus investigated whether head neck squamous cell carcinoma hnscc detected spraying ephmrg method fluorescence imaging case hnsccs resected using endoscopic surgical resection performed ex vivo spraying ephmrg fluorescence intensity tumor normal mucosa measured result iodinevoiding lesion became fluorescent within minute application ephmrg resected tumor without history radiotherapy observed normal mucosa fluorescence intensity tumor lesion significantly higher normal lesion however tumor developed radiotherapy sufficient contrast normal mucosa conclusion fluorescence imaging ephmrg would useful rapid detection superficial hnscc without history radiotherapy,2018,"Mizushima, Takeshi; Ohnishi, Shunsuke; Shimizu, Yuichi; Hatanaka, Yutaka; Hatanaka, Kanako C; Kuriki, Yugo; Kamiya, Mako; Homma, Akihiro; Yamamoto, Keiko; Ono, Shouko; Urano, Yasuteru; Sakamoto, Naoya",Head & neck,,,,,,https://doi.org/10.1002/hed.25126; https://www.ncbi.nlm.nih.gov/pubmed/29509281/,3695521.0,12
29432,29432,39909,834yw7er,,Medline,High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.,10.1159/000506991,,32408308.0,unk,backgroundaim great proportion patient rectal cancer initially present locally advanced disease potentially benefit neoadjuvant concurrent chemoradiotherapy ccrt downstaging surgery however risk clinical outcome stratification remain great challenge aimed find potential biomarker predict effect neoadjuvant ccrt rectal cancer method identified epiregulin ereg significant predictive marker neoadjuvant ccrt response published rectal cancer transcriptome data set gse collected biopsy specimen rectal cancer patient received neoadjuvant ccrt followed radical proctectomy performed ereg immunohistochemistry analyzed hscores examined correlation expression level ereg clinicopathological feature tumor regression grade survival including diseasespecific survival ds locoregional recurrencefree survival lrfs metastasisfree survival mefs result high ereg expression significantly related early pretreatment pretx posttreatment posttx tumor status p p pretx posttx negative nodal status n p p le vascular perineurial invasion p p higher tumor regression grade p survival analysis high ereg expression significantly associated better ds p lrfs p mefs p multivariate analysis high ereg expression remained prognostically significant better ds p hazard ratio conclusion data suggest ereg potential predictive marker therapeutic target rectal cancer patient receiving neoadjuvant ccrt,2020-05-14,"Lin, Cheng-Yi; Hsieh, Pei-Ling; Chou, Chia-Lin; Yang, Ching-Chieh; Lee, Sung-Wei; Tian, Yu-Feng; Shiue, Yow-Ling; Li, Wan-Shan",Oncology,,,,,,https://doi.org/10.1159/000506991; https://www.ncbi.nlm.nih.gov/pubmed/32408308/,218650087.0,12
29437,29437,39916,6kmr6uhr,,Medline,Safety and Efficacy of Preoperative Embolization of Intracranial Hemangioblastomas.,10.1227/neu.0000000000001014,,29506092.0,unk,background intracranial hemangioblastomas highly vascular tumor account central nervous system tumor preoperative embolization proposed limit often significant intraoperative blood loss associated resection potentially make tumor softnecrotic thus amenable gross total resection safety efficacy preoperative embolization intracranial hemangioblastomas however well characterized objective evaluate safety efficacy preoperative endovascular embolization intracranial hemangioblastomas using variety embolic agent method retrospective review surgically resected intracranial hemangioblastomas treated preoperative embolization highvolume center performed clinical radiographic criterion including von hippellindau status magnetic resonance imaging tumor characteristic embolizationrelated complication degree angiographic devascularization intraoperative blood loss ability obtain gross total resection transfusion requirement operative time analyzed result total patient underwent surgery undergoing preoperative embolization followed surgical resection patient undergoing surgical resection alone embolizationrelated neurological complication seen patient including hemorrhage polyvinyl alcohol particle p used infarction liquid embolic agent used p permanent neurological deficit seen conclusion preoperative embolization intracranial hemangioblastomas performed caution given potential neurological morbidity study needed help guide patient embolic agent selection,2016,"Ene, Chibawanye I; Xu, David; Morton, Ryan P; Emerson, Samuel; Levitt, Michael R; Barber, Jason; Rostomily, Robert C; Ghodke, Basavaraj V; Hallam, Danial K; Albuquerque, Felipe C; McDougall, Cameron G; Sekhar, Laligam N; Ferreira, Manuel; Kim, Louis J; Chang, Steve W",Operative neurosurgery,,,,,,https://doi.org/10.1227/neu.0000000000001014; https://www.ncbi.nlm.nih.gov/pubmed/29506092/,3735217.0,12
29478,29478,39959,ww35ry1a,,Medline,Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.,10.2967/jnumed.110.076695,,20956465.0,unk,unlabelled variety radiolabeled somatostatin analog developed targeting somatostatin receptor sstpositive tumor bicyclic somatostatinbased radiopeptides studied yet hypothesizing introduction conformational constraint may lead receptor subtype selectivity may help delineate structural feature determining pansomatostatin potency developed evaluated first example new class potential radiotracers imaging therapy neuroendocrine tumor method bicyclic peptide synthesized standard solidphase peptide synthesis dota coupled resinassembled peptide labeling lu ga binding affinity receptor subtype profile determined using human ssts ca flux internalization efflux studied human embryonic kidney heksst heksst cell line biodistribution petct study performed corresponding nude mouse model result new analog showed high affinity sst sst moderate affinity sst sst sst exhibiting agonistic property analog comprising octreotide ring headtotailcoupled argdiaminobutyric aciddota cycle showed highest receptor affinity agonist potency luam showed high receptormediated uptake vivo sst sst tumor low background kidney tissue accumulating radioactivity could reduced preinjection lysine petct study gaam h injection characterized clear localization tumor visualization kidney negligible background conclusion high rigidity new bicyclic somatostatinbased radiopeptides led agonistic ligand good affinity ssts pharmacokinetic data lugaam make peptide excellent candidate imagingand especially petradiotracer,2010,"Fani, Melpomeni; Mueller, Andreas; Tamma, Maria-Luisa; Nicolas, Guillaume; Rink, Hans R; Cescato, Renzo; Reubi, Jean Claude; Maecke, Helmut R","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.110.076695; https://www.ncbi.nlm.nih.gov/pubmed/20956465/,2827126.0,12
29681,29681,40193,idxwk9dc,,Medline,Single-incision sleeve gastrectomy for successful treatment of a gastrointestinal stromal tumor.,10.4293/108680813x13693422522033,,24018090.0,unk,background gastrointestinal stromal tumor gist rare mesenchymal tumor located specifically gastrointestinal tract occurrence stomach small intestine esophagus colon rectum annual incidence gist case per million united state equal case per year case tumor asymptomatic found incidentally computed tomography scan endoscopy preoperative evaluation based location size anatomic feature help confirm diagnosis gist ass outcome surgical intervention gold standard treatment nonmetastatic gist case presentation report case yearold man gastric mass posterior surface greater curvature stomach junction gastric antrum pylorus found incidentally computed tomography scan patient underwent diagnostic laparoscopy singleincision laparoscopic sleeve gastrectomy histologic evaluation resected lesion determined gastrointestinal stromal tumor conclusion singleincision laparoscopic sleeve gastrectomy resection gist feasible appropriate method lesion safe distance pylorus gastroesophageal junction gross negative margin obtained advantage include decreased pain shorter hospital stay compared method,2013,"Ong, Evan; Abrams, Andrew I; Lee, Elizabeth; Jones, Carol",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/108680813x13693422522033; https://www.ncbi.nlm.nih.gov/pubmed/24018090/,16634232.0,12
29697,29697,40213,ganqkabp,,Medline,Detection of circulating tumor cells in pulmonary venous blood for resectable non-small cell lung cancer.,10.3892/ol.2017.7405,,29422972.0,unk,intraoperative manipulation cause circulating tumor cell ctc shedding blood accelerates metastasis nonsmall cell lung cancer nsclc present study conducted ass degree dissemination resulting surgery explore biological feature ctc patient nsclc underwent complete resection pulmonary vein pv isolated stapled following thoracotomy number ctc retained per ml pv blood ctcpv peripheral blood detected following hematopoietic cell depletion xenograft assay performed using ctcpv total consecutive patient enrolled study majority ctc pv blood n circulating tumor microemboli ctm identified patient ctcpv ctmpv count positively correlated tumor size p p respectively patient small tumor cm also considerable ctcpv ctmpv total patient received platinumbased chemotherapy prior surgery ctcpv ctmpv count patient partial response significantly lower patient stable disease receive induction therapy p p respectively enriched ctcpv patient injected immunodeficient mouse mouse developed xenograft tumor conclude present study indicates intraoperative manipulation contributes hematogenous dissemination tumorigenic ctc ctm lobectomy recommended lung cancer tumor size stage according oncological principle addition ligating pv possible prior treatment,2018,"Lv, Chao; Zhao, Bingtian; Wang, Limin; Zhang, Panpan; Ma, Yuanyuan; Wang, Yuzhao; Wu, Nan; Wu, Ying; Yang, Yue",Oncology letters,,,,,,https://doi.org/10.3892/ol.2017.7405; https://www.ncbi.nlm.nih.gov/pubmed/29422972/,21743115.0,12
29730,29730,40253,9il6i6w9,,Medline,Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.,10.1007/s00261-014-0201-2,,25052767.0,unk,purpose ass feasibility fusion pre postablation gadolinium ethoxybenzyl diethylenetriamine pentaacetic acidenhanced magnetic resonance imaging gdeobdtpamri evaluate effect radiofrequency ablation rfa hepatocellular carcinoma hcc compared similarly fused ct image patient method retrospective study included patient hccs treated rfa fusion image pre postrfa dynamic ct pre postrfa gdeobdtpamri created using rigid registration method minimal ablative margin measured fusion imaging categorized three group tumor protruding outside ablation zone boundary ablative margin mm beyond tumor boundary ablative margin ≥ mm beyond tumor boundary categorization minimal ablative margin compared ct mr fusion image result hccs treatment evaluation possible ct mr fusion image overall agreement categorization minimal ablative margin good κ coefficient p mr fusion imaging enabled treatment evaluation significantly larger number hccs ct fusion imaging v p conclusion fusion pre postablation gdeobdtpamri feasible treatment evaluation rfa may enable accurate treatment evaluation case ct fusion imaging helpful,2015,"Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Hori, Masatoshi; Fukuda, Kazuto; Sawai, Yoshiyuki; Kogita, Sachiyo; Fujita, Norihiko; Takehara, Tetsuo; Murakami, Takamichi",Abdominal imaging,,,,,,https://doi.org/10.1007/s00261-014-0201-2; https://www.ncbi.nlm.nih.gov/pubmed/25052767/,7628769.0,12
29750,29750,40276,6kzvpi9r,,Medline,Surgical glove-port single-incision laparoscopic gastric wedge resection of gastrointestinal stromal tumors: initial experience with 2 cases.,10.1097/sle.0b013e31828b891b,,23917606.0,unk,gastrointestinal stromal tumor localized mainly stomach therapeutic approach surgical resection laparoscopy performed tumor located greater curvature stomach among treatment alternative singleincision laparoscopic technique used frequently standard laparoscopy due successful result laparoscopic surgery report use singleincision surgical gloveport laparoscopy resection gastrointestinal stromal tumor localized greater curvature stomach,2013,"Orozakunov, Erkinbek; Akyol, Cihangir; Tantoglu, Utku; Basceken, Salim I; Kayilioglu, Ilgaz S; Bumin, Cihan S; Cakmak, Atil","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e31828b891b; https://www.ncbi.nlm.nih.gov/pubmed/23917606/,46698499.0,12
29818,29818,40361,4f70snds,,Medline,The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.,10.1016/j.jtho.2015.12.114,,26940530.0,unk,introduction separate tumor nodule histologic appearance occur lung small proportion patient primary lung cancer article address tumor classified inform eighth edition anatomic classification lung cancer separate tumor nodule distinguished second primary lung cancer multifocal ground glasslepidic tumor pneumonictype lung cancer addressed separate analysis method survival patient separate tumor nodule international association study lung cancer database analyzed compared systematic literature review result survival clinically staged patient decreased according location separate tumor nodule relative index tumor lobe side side n nany cohort except possible otherside nodule however also decrease proportion patient resected among surgically resected among nonresected patient survival difference noted survival difference patient samelobe nodule tumor patient sameside nodule tumor patient otherside nodule tumor data correlated identified literature review conclusion tumor samelobe separate tumor nodule histologic appearance recommended classified sameside nodule otherside nodule thus recommended change seventh eighth edition tnm classification lung cancer,2016,"Detterbeck, Frank C; Bolejack, Vanessa; Arenberg, Douglas A; Crowley, John; Donington, Jessica S; Franklin, Wilbur A; Girard, Nicolas; Marom, Edith M; Mazzone, Peter J; Nicholson, Andrew G; Rusch, Valerie W; Tanoue, Lynn T; Travis, William D; Asamura, Hisao; Rami-Porta, Ramón",Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,,,,,,https://doi.org/10.1016/j.jtho.2015.12.114; https://www.ncbi.nlm.nih.gov/pubmed/26940530/,46817882.0,12
29891,29891,40444,14505zti,,Medline,Image-guided thermal ablation of lung malignancies.,10.1148/radiol.11091126,,21846760.0,unk,primary secondary lung malignancy often treated surgery many patient poor surgical candidate owing advanced age medical comorbidities alternative surgery localized disease include radiation therapy newer treatment known imageguided thermal ablation imageguided thermal ablation involves use needlelike applicator placed directly tumor using imaging guidance tumor destroyed application either intense heat cold specific ablative modality radiofrequency ablation microwave ablation laser ablation cryoablation reviewed respect various clinical indication treatment primary secondary lung malignancy,2011,"Dupuy, Damian E",Radiology,,,,,,https://doi.org/10.1148/radiol.11091126; https://www.ncbi.nlm.nih.gov/pubmed/21846760/,25304579.0,12
29974,29974,40540,p4ikitf1,,Medline,The efficacy of electromagnetic navigation to assist with computed tomography-guided percutaneous thermal ablation of lung tumors.,10.1097/imi.0b013e318265b127,,22885459.0,unk,objective electromagnetic em navigation increasingly used assist bronchoscopic intervention biopsy fiducial placement electromagnetic navigation also useful adjunct computed tomography ctguided thermal ablation biopsy lung tumor study compare procedure carried using em navigation system veran medical technology inc st louis mo procedure using ct fluoroscopy method month period patient scheduled thermal ablation prospectively enrolled study mean age year range year seven patient woman patient randomized em navigation n ct fluoroscopy alone n case additional ablation biopsy performed without em navigation depending randomization arm procedure performed general anesthesia either thoracic surgeon radiologist result total procedure performed patient ablation procedure biopsy fourteen performed nonsmall cell lung cancer pulmonary metastasis organ despite randomization patient receiving em navigation trend smaller tumor mean diameter v cm p thermal ablation procedure time complete intervention significantly le em navigation used mean v minute p although statistically significant fewer skin puncture mean v p fewer adjustment mean v p le ct fluoroscopy time mean v second p fewer ct scan mean v p whenever em navigation used conclusion electromagnetic navigation reduces time successfully place ablation probe target tumor study required determine whether em navigation may also reduce number adjustment skin puncture ct scan well decrease ct fluoroscopy time,2012,"Narsule, Chaitan K; Sales Dos Santos, Ricardo; Gupta, Avneesh; Ebright, Michael I; Rivas, Roberto; Daly, Benedict D T; Fernando, Hiran C",Innovations,,,,,,https://doi.org/10.1097/imi.0b013e318265b127; https://www.ncbi.nlm.nih.gov/pubmed/22885459/,205688358.0,12
29984,29984,40552,8b1ur1ta,,Medline,Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.,10.1016/j.ijrobp.2017.12.014,,29485074.0,unk,purpose stereotactic body radiation therapy sbrt radiofrequency ablation rfa widely used therapy treatment intrahepatic metastasis however direct comparison lacking sought compare outcome modality method material patient pathologically diagnosed unresectable liver metastasis treated rfa n sbrt n single institution primary outcome freedom local progression fflp effect treatment covariates fflp modeled using mixedeffects cox model application inverse probability treatment weighting adjust potential imbalance treatment modality result median followup period month patient receiving sbrt larger tumor treated rfa median cm v cm p univariate analysis tumor size associated worse fflp rfa hazard ratio hr confidence interval ci p sbrt hr ci p year fflp rate compared favoring sbrt p tumor ≥ cm diameter sbrt associated improved fflp hr ci p multivariate analysis treatment sbrt hr ci p smaller tumor size hr ci p associated improved fflp year overall survival rate difference group p grade ≥ treatmentrelated toxicity rare difference sbrt n rfa n conclusion treatment sbrt rfa well tolerated provides excellent similar local control intrahepatic metastasis cm size tumor ≥ cm size treatment sbrt associated improved fflp may preferable treatment,2018,"Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal; Bazzi, Latifa; Wahl, Dan R; Schipper, Matthew J; Feng, Mary; Cuneo, Kyle C; Lawrence, Theodore S; Owen, Dawn","International journal of radiation oncology, biology, physics",,,,,,https://doi.org/10.1016/j.ijrobp.2017.12.014; https://www.ncbi.nlm.nih.gov/pubmed/29485074/,3600690.0,12
30001,30001,40570,ulw5m045,,Medline,Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls.,10.1148/rg.305095166,,20833843.0,unk,lung cancer leading cause cancerrelated death worldwide dismal year survival rate tnm tumornodemetastasis classification system lung cancer vital guide determining treatment prognosis despite importance accuracy lung cancer staging however correct staging remains challenging task many radiologist new th edition tnm classification system feature number revision including subdivision tumor category basis size differentiation local intrathoracic distant metastatic disease recategorization malignant pleural pericardial disease stage iii stage iv reclassification separate tumor nodule lung lobe primary tumor reclassification separate tumor nodule lung lobe primary tumor radiologist must understand detail set forth tnm classification system familiar change th edition attempt better correlate disease prognostic value treatment strategy recognizing relevant radiologic appearance lung cancer understanding appropriateness staging disease tnm classification system familiar potential imaging pitfall radiologist make significant contribution treatment outcome patient lung cancer,2010,"UyBico, Stacy J; Wu, Carol C; Suh, Robert D; Le, Nanette H; Brown, Kathleen; Krishnam, Mayil S","Radiographics : a review publication of the Radiological Society of North America, Inc",,,,,,https://doi.org/10.1148/rg.305095166; https://www.ncbi.nlm.nih.gov/pubmed/20833843/,3185277.0,12
30069,30069,40645,w533l3e7,,Medline,Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.,10.2967/jnumed.116.183004,,28209913.0,unk,cell death important target imaging early response tumor treatment describe validation phosphatidylserinebinding agent detecting tumor cell death vivo based ca domain synaptotagmini method capability nearinfrared fluorophorelabeled mtc inlabeled derivative cam imaging tumor cell death using planar nearinfrared fluorescence imaging spect respectively evaluated implanted genetically engineered mouse model lymphoma human colorectal xenograft result fluorophorelabeled cam derivative showed predominantly renal clearance high specificity sensitivity detecting low level tumor cell death significant correlation r p fluorescently labeled cam binding histologic marker cell death including cleaved caspase whereas correlation sitedirected mutant cam icam bind phosphatidylserine mtccam incam also showed favorable biodistribution profile predominantly renal clearance low nonspecific retention liver spleen h probe administration mtccam incam generated tumortomuscle ratio drugtreated tumor × × respectively h × × respectively h administration conclusion given favorable biodistribution profile mtc inlabeled cam ability produce rapid cell deathspecific image contrast agent potential clinical translation,2017,"Neves, André A; Xie, Bangwen; Fawcett, Sarah; Alam, Israt S; Witney, Timothy H; de Backer, Maaike M; Summers, Julia; Hughes, William; McGuire, Sarah; Soloviev, Dmitry; Miller, Jodi; Howat, William J; Hu, De-En; Rodrigues, Tiago B; Lewis, David Y; Brindle, Kevin M","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.116.183004; https://www.ncbi.nlm.nih.gov/pubmed/28209913/,25806349.0,12
30137,30137,40728,ks59cw3y,,Medline,Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization.,10.1016/j.jvir.2015.04.030,,26091800.0,unk,purpose hepatocellular carcinoma hccs bridging two couinaudbismuth segment liver watershed tumor recruit multiple segmental artery primary hypothesis study fewer watershed tumor show complete response cr chemoembolization shorter time local recurrence secondary analysis impact transplantation eligibility presence progressive disease also performed material method total transplantationeligible patient whose hcc met milan criterion watershed n nonwatershed n treated chemoembolization included conebeam computed tomography ct used guidance confirmation circumferential uptake local response chemoembolization per modified response evaluation criterion solid tumor local diseasefree survival dfs index tumor calculated difference assessed univariate multivariate analysis result cr single chemoembolization observed watershed tumor nonwatershed tumor p estimated dfs interval day confidence interval ci day ci p watershed nonwatershed group respectively worse dfs observed model endstage liver disease score p higher childpughturcotte score p watershed location p waiting list dropoff rate statistically similar group conclusion hepatocellular carcinoma located watershed region liver poorer response chemoembolization located elsewhere tumor associated worse dfs require additional treatment maintain transplantation eligibility per milan criterion conebeam ct identify crossover supply confirm complete geographic drug uptake possibly reducing eliminating risk incomplete response,2015,"Kothary, Nishita; Takehana, Chris; Mueller, Kerstin; Sullivan, Patrick; Tahvildari, Ali; Sidhar, Vishal; Rosenberg, Jarrett; Louie, John D; Sze, Daniel Y",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2015.04.030; https://www.ncbi.nlm.nih.gov/pubmed/26091800/,5186594.0,12
30191,30191,40784,ease3phh,,Medline,Tumor complexity predicts malignant disease for small renal masses.,10.1016/j.juro.2012.08.027,,23083863.0,unk,purpose approximately suspicious small renal tumor benign significant proportion malignant tumor low grade potentially indolent evaluated whether preoperative patient tumor characteristic associated adverse pathological feature material method total patient underwent robotassisted partial nephrectomy done high volume surgeon demographic clinical data compared patient benignmalignant disease clear cellnonclear cell renal cell carcinoma highlow grade tumor tumor complexity quantified renal radius exophyticendophytic nearness tumor collecting system sinus anteriorposterior hilar location relative polar line nephrometry score described low intermediate high greater logistic regression analysis performed test association tumor patient characteristic high grade renal cell carcinoma subanalyses done patient renal tumor cm le result high grade renal cell carcinoma larger likely develop men patient malignant tumor clear cell histology likely intermediate high complexity tumor increasing tumor complexity independently predicted malignancy high grade malignancy clear cell histology multivariate regression analysis p male gender independently associated malignancy high grade renal cell carcinoma considering tumor cm le tumor complexity predicted malignancy tumor grade conclusion high renal nephrometry score male gender associated increased risk malignancy high grade malignancy tumor treated partial nephrectomy,2012,"Mullins, Jeffrey K; Kaouk, Jihad H; Bhayani, Sam; Rogers, Craig G; Stifelman, Michael D; Pierorazio, Phillip M; Tanagho, Youssef S; Hillyer, Shahab P; Kaczmarek, Bartosz F; Chiu, Yichun; Allaf, Mohamad E",The Journal of urology,,,,,,https://doi.org/10.1016/j.juro.2012.08.027; https://www.ncbi.nlm.nih.gov/pubmed/23083863/,30576782.0,12
30197,30197,40792,aaxdhqxp,,Medline,Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice.,10.3390/pharmaceutics11050241,,31137479.0,unk,use nanoparticles tumortargeting agent steadily increasing influence nanoparticle characteristic size stealthiness established large number nanocarrier system however much known impact tumor presence nanocarrier circulation time paper report influence tumor presence vivo circulation time biodistribution polybutadienepolyethylene oxide pbdpeo polymersomes purpose polymersomes loaded gammaemitter administered intravenously followed timed ex vivo biodistribution large reduction circulation time observed tumorbearing mouse circulation halflife merely min r v min r healthy mouse determine whether rapid polymersome clearance observed tumorbearing mouse mediated macrophage chlodronate liposome administered healthy tumorbearing mouse prior intravenous injection radiolabeled polymersomes deplete macrophage pretreatment chlodronate liposome depleted macrophage spleen liver restored circulation time polymersomes significant difference circulation time healthy mouse tumorbearing mouse pretreated clodronate liposome ± idg ± idg respectively h pi p indicates activation macrophage due tumor presence indeed affected polymersome clearance rate thus next particle design presence tumor also greatly impact circulation time taken account designing study evaluate distribution polymersomes,2019,"de Kruijff, Robin M; Raavé, René; Kip, Annemarie; Molkenboer-Kuenen, Janneke; Roobol, Stefan J; Essers, Jeroen; Heskamp, Sandra; Denkova, Antonia G",Pharmaceutics,,,,,,https://doi.org/10.3390/pharmaceutics11050241; https://www.ncbi.nlm.nih.gov/pubmed/31137479/,169032329.0,12
30224,30224,40821,i4ll57kt,,Medline,Treatment of glomus tympanicum tumors by preoperative embolization and total surgical resection.,10.1016/j.amjoto.2016.08.011,,27650391.0,unk,purpose purpose study evaluate effectiveness function preservation tumor control treatment glomus tympanicum tumor preoperative embolization followed total surgical resection material method describe series patient glomus tympanicum tumor treated hospital using technique day surgery selective tumor embolization due denaturation ethanol following parameter considered tumor classification tumor control clinical audiological outcome effectiveness embolization percentage tumor necrosis treatment complication result severe complication due embolization surgery tumor blush disappeared completely patient dsa post embolization histologic evaluation resected tissue showed median tumor necrosis pulsatile tinnitus disappeared patient patient symptom hearing ameliorated patient patient without hearing loss pre treatment still normal hearing treatment patient hearing worse treatment average followup month conclusion treatment glomus tympanicum tumor preoperative embolization ethanol surgical resection described result show safe procedure good long term tumor control good clinical audiological outcome,2016,"Devuyst, Lien; Defreyne, Luc; Praet, Marleen; Geukens, Sven; Dhooge, Ingeborg",American journal of otolaryngology,,,,,,https://doi.org/10.1016/j.amjoto.2016.08.011; https://www.ncbi.nlm.nih.gov/pubmed/27650391/,19165802.0,12
30265,30265,40865,qgvmh92g,,Medline,Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507.,10.1158/1078-0432.ccr-11-1488,,22038993.0,unk,purpose investigate whether indiumlabeled r inr immunospect singlephoton emission computed tomography novel noninvasive vivo screening method visualize membranous insulinlike growth factor receptor igfr expression accessibility used predict igfr treatment r response bone sarcoma experimental design balbc nude mouse subcutaneously implanted igfrexpressing human bone sarcoma xenograft o ew ew showed high modest response respectively r monoclonal antibody targeting extracellular domain igfr igfrnegative tumor o unresponsive igfr inhibitor examined well mouse injected inr biodistribution immunospectcomputed tomography imaging study carried day pi mouse o ew xenograft day pi mouse ew o xenograft result biodistribution study showed specific accumulation inr o ew xenograft ± idg ± idg day pi respectively importantly inr uptake igfr positive unresponsive ew xenograft ± idg day pi similar igfrnegative o tumor ± idg day pi uptake normal tissue low nonspecific corresponding immunospect image clearly discriminated high modest nonresponding tumor showing homogeneous o heterogeneous ew nonspecific ew o tumor uptake inr conclusion inr immunospect excellent method visualize membranous igfr expression target accessibility vivo human bone sarcoma xenograft may serve independent marker predict igfr therapy r response bone sarcoma patient,2011,"Fleuren, Emmy D G; Versleijen-Jonkers, Yvonne M H; van de Luijtgaarden, Addy C M; Molkenboer-Kuenen, Janneke D M; Heskamp, Sandra; Roeffen, Melissa H S; van Laarhoven, Hanneke W M; Houghton, Peter J; Oyen, Wim J G; Boerman, Otto C; van der Graaf, Winette T A",Clinical cancer research : an official journal of the American Association for Cancer Research,,,,,,https://doi.org/10.1158/1078-0432.ccr-11-1488; https://www.ncbi.nlm.nih.gov/pubmed/22038993/,1084278.0,12
30282,30282,40886,iam1yyo6,,Medline,Electromagnetic tracking navigation to guide radiofrequency ablation of a lung tumor.,10.1097/lbr.0b013e31827157c9,,23207535.0,unk,radiofrequency ablation rfa may option patient lung tumor unresectable disease suitable available palliative modality rfa electrode positioning may take several attempt necessitating multiple imaging acquisition continuous use computed tomography electromagnetic tracking us miniature sensor integrated rfa equipment guide tool real time referencing preprocedure imaging technology demonstrated successfully lung tumor ablation accurate targeting tumor compared traditional freehand needle insertion possible although speculative anecdotal accuracy could prevent unnecessary repositioning puncture decrease radiation exposure electromagnetic tracking theoretical potential benefit minimally invasive intervention,2012,"Amalou, Hayet; Wood, Bradford J",Journal of bronchology & interventional pulmonology,,,,,,https://doi.org/10.1097/lbr.0b013e31827157c9; https://www.ncbi.nlm.nih.gov/pubmed/23207535/,40364895.0,12
30293,30293,40897,8rboimfg,,Medline,A Novel Technique for Duodenal Resection and Primary Anastomosis With Robotic Assistance and OrVil.,10.4293/jsls.2016.00094,,28144127.0,unk,background objective benign duodenal neoplasm rare occurrence minimally invasive tumor resection anastomosis formation orvil catheter novel approach treating disease article present new technique duodenojejunal anastomosis technique applied patient benign distal duodenal tumor treated minimally invasive surgery robotic assistance method patient removal distal duodenal mass robotic technique orifice duodenum opened allow passage guidewire guidewire removed orifice holding forceps upper endoscopy orvil catheter sutured guidewire outside allow catheter proceed consecutively removal anvil endlateral duodenojejunostomy performed circular stapler result patient included men woman average age duration operation minute complication observed patient postoperative period patient began oral intake fifth day postoperative period discharged sixth postoperative day histopathologic analysis indicated removed tumor adenoma patient gastrointestinal stromal tumor gist patient clear surgical margin observed patient conclusion placement orvil catheter anastomosis benign neoplasm distal duodenum localization subsequent achievement duodenojejunal anastomosis circular stapler constitute novel treatment approach,2017,"Bedirli, Abdulkadir; Salman, Bulent; Nasirov, Mahir; Dogan, Ibrahim",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/jsls.2016.00094; https://www.ncbi.nlm.nih.gov/pubmed/28144127/,14278110.0,12
30314,30314,40920,y261rhh9,,Medline,"Hemobilia after CT-guided radiofrequency ablation of liver tumors: frequency, risk factors, and clinical significance.",10.1007/s00261-018-1693-y,,29987402.0,unk,purpose purpose study evaluate frequency risk factor clinical significance hemobilia percutaneous computed tomography ctguided radiofrequency ablation rfa liver tumor material method january september patient received session ctguided rfa liver tumor institution ct image immediately rfa retrospectively reviewed frequency hemobilia development clinical outcome patient hemobilia studied risk factor identified comparison hemobilia nonhemobilia group using univariate multivariate analysis clinical course patient hemobilia also reviewed result frequency ct detected hemobilia rfa majority clinical course selflimited univariate analysis showed tumor number p central type puncture track p length puncture track p platelet count p significantly associated development hemobilia multivariate analysis demonstrated central type puncture track p platelet count p significant independent risk factor conclusion detection hemobilia ct image immediately percutaneous rfa liver tumor rare low platelet count central type puncture track independent risk factor case hemobilia presented minor complication favorable prognosis,2019,"Hsieh, Mei-Fang; Chen, Chia-Bang; Chen, Yao-Li; Chou, Chen-Te",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-018-1693-y; https://www.ncbi.nlm.nih.gov/pubmed/29987402/,49671540.0,12
30319,30319,40925,qqfytl2c,,Medline,Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy.,10.1016/j.jcma.2015.07.013,,26507775.0,unk,background imageguided percutaneous radiofrequency ablation rfa commonly used modality treatment nonresectable hepatic malignancy however tumor subcapsular location still technically challenging study undertaken evaluate feasibility safety efficacy computed tomographicguided percutaneous rfa hydrodissection hepatic malignancy subcapsular location method total patient hepatic lesion treated computed tomographicguided percutaneous rfa computed tomographicguided percutaneous rfa hydrodissection performed patient hepatic nodule tumor located hepatic subcapsular location considered difficult treat planning sonography hydrodissection performed dextrose water saline solution displacing adjacent structure ≥ mm away liver capsule two rfa system multitined expandable electrode straight internally cooled single electrode used treatment hepatic malignancy feasibility safety efficacy technique analyzed followup contrastenhanced computed tomography magnetic resonance imaging result hydrodissection successfully achieved patient displacing adjacent structure ≥ mm originally mm away liver capsule administration mean ml dextrose water saline solution average distance adjacent structure liver capsule hydrodissection ± cm ± cm prior hydrodissection statistically significant p complication related hydrodissection occurred followup period primary technical success rate percutaneous rfa tumor month followup imaging three minor complication related rfa procedure conclusion computed tomographicguided percutaneous rfa hydrodissection feasible safe effective technique treatment hepatic malignancy subcapsular location,2016,"Liu, Chang-Hsien; Yu, Chih-Yung; Chang, Wei-Chou; Dai, Ming-Shen; Hsiao, Cheng-Wen; Chou, Yu-Ching; Huang, Guo-Shu",Journal of the Chinese Medical Association : JCMA,,,,,,https://doi.org/10.1016/j.jcma.2015.07.013; https://www.ncbi.nlm.nih.gov/pubmed/26507775/,205848042.0,12
30342,30342,40950,pnn6kb4h,,Medline,Operative techniques in robotic thoracic surgery for inferior or posterior mediastinal pathology.,10.1016/j.jtcvs.2011.12.021,,22244566.0,unk,objective thoracic surgeon performing robotic resection anterior mediastinal tumor however tumor located posterior especially inferior chest difficult approach robotically objective study evaluate efficacy robot resection tumor method performed retrospective review evolution outcome surgical technique inferior posterior mediastinal pathology result month period patient underwent robotic surgery pathology mediastinum located inferior posterior mediastinum patient common indication surgery posterior mediastinal mass lymph node patient esophageal bronchogenic cyst patient esophageal leiomyoma patient diaphragmatic elevation patient median tumor size cm median length stay day one patient converted thoracotomy patient converted bleeding morbidity occurred patient major patient delayed esophageal leak epiphrenic diverticulectomy mortality technical improvement included using robotic arm posteriorly retraction sidedocking coming back patient tumor inferior inferior pulmonary vein diaphragmatic plication using lateral decubitus position extraction tumor larger cm via access port tenth rib diaphragmatic fiber conclusion robot affords safe access using completely portal approach resection surgical intervention inferior posterior chest pathology anterior tumor specific technique used improve operation,2012,"Cerfolio, Robert James; Bryant, Ayesha S; Minnich, Douglas J",The Journal of thoracic and cardiovascular surgery,,,,,,https://doi.org/10.1016/j.jtcvs.2011.12.021; https://www.ncbi.nlm.nih.gov/pubmed/22244566/,7192152.0,12
30448,30448,41073,z3hyhzew,,Medline,Hybrid surgery in excision of a Shamblin II glomus tumor.,10.1590/1677-5449.012218,,31236106.0,unk,glomus tumor rare benign neoplasm originating paraganglionic cell neural crest developing adventitious layer vessel nonencapsulated highly vascularized yearold female patient identified hypervascularized glomus tumor measuring cm posterior left carotid bifurcation contralateral carotid occlusion performed preoperative embolization via endovascular access followed direct percutaneous puncture guided angiography fill remaining area embolization surgical excision tumor performed reduced bleeding easier find cleavage plane adjacent structure late followup patient free tumor recurrence tumor classified shamblin ii measuring cm moderate arterial insertion double approach observed relative reduction intraoperative bleeding improved identification cleavage plane facilitating excision avoiding surgical clamping,2019,"Amato, Alexandre Campos Moraes; Ferreira, Diego Daniel Gomes; da Silva, Fernanda Teixeira Fonseca; Uemura, Marielly Ayako; Stucchi, Thais de Oliveira; Dos Santos, Ricardo Virgínio",Jornal vascular brasileiro,,,,,,https://doi.org/10.1590/1677-5449.012218; https://www.ncbi.nlm.nih.gov/pubmed/31236106/,164213419.0,12
30488,30488,41122,cyofw5h3,,Medline,Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series.,10.1016/j.surg.2017.10.026,,29273176.0,unk,background microwave thermosphere ablation new treatment modality creates spherical ablation zone using single antenna study aim analyze local recurrence associated new treatment modality patient malignant liver tumor method prospective clinical study patient underwent microwave thermosphere ablation malignant liver tumor september march clinical operative oncologic parameter analyzed using kaplanmeier survival cox proportional hazard model result one hundred patient underwent ablation ablation performed laparoscopically open patient pathology included neuroendocrine liver metastasis n colorectal liver metastasis n hepatocellular cancer n tumor type n ninetyday morbidity one procedurerelated mortality median followup month patient completing least month followup rate local tumor recurrence rate per lesion local tumor new hepatic extrahepatic recurrence detected patient respectively local recurrence rate per pathology colorectal liver metastasis metastatic tumor local recurrence observed date neuroendocrine liver metastasis limited number patient hepatocellular cancer tumor size cm tumor type independent predictor local recurrence conclusion first study analyze local recurrence microwave thermosphere ablation malignant liver tumor shortterm local tumor control rate compare favorably reported radiofrequency microwave technology literature,2018,"Takahashi, Hideo; Kahramangil, Bora; Berber, Eren",Surgery,,,,,,https://doi.org/10.1016/j.surg.2017.10.026; https://www.ncbi.nlm.nih.gov/pubmed/29273176/,3989747.0,12
30505,30505,41141,b1pqwnwd,,Medline,Tumors affecting the spinal cord of cats: 85 cases (1980-2005).,10.2460/javma.232.2.237,,18275391.0,unk,objective determine prevalence lymphosarcoma tumor affecting spinal cord cat relate specific type tumor signalment history clinical finding design retrospective case series animal cat tumor affecting spinal cord procedure medical record cat histologically confirmed primary metastatic tumor spinal cord tumor causing spinal cord disease local extension adjacent tissue examined reviewed data signalment clinical history result neurologic examination diagnostic imaging clinical pathologic evaluation location tumor within spinal cord obtained medical record analyzed use logistic regression model result lymphosarcoma common tumor affected spinal cord cat followed osteosarcoma cat cat lymphosarcoma typically younger initial examination shorter duration clinical sign lesion region cns cat type tumor cat lymphosarcoma tumor also found extraneural site conclusion clinical relevance data spinal cord tumor population cat analyzed logistic regression analysis effectively distinguished cat lymphosarcoma cat type tumor additional clinical information reported help increase index suspicion definitive antemortem diagnosis spinal cord tumor cat,2008,"Marioni-Henry, Katia; Van Winkle, Thomas J; Smith, Sionagh H; Vite, Charles H",Journal of the American Veterinary Medical Association,,,,,,https://doi.org/10.2460/javma.232.2.237; https://www.ncbi.nlm.nih.gov/pubmed/18275391/,5324159.0,12
30594,30594,41251,la0mppdw,,Medline,Laparoscopic adrenalectomy in a patient with situs inversus.,10.4293/108680813x13693422522114,,24018094.0,unk,background situs inversus relatively rare congenital disease patient right adrenal tumor complicated total situs inversus treated laparoscopy case discussion patient yold male lower limb weakness diagnosed situs inversus general health checkup infant blood pressure mm hg serum potassium level meql abdominal ultrasonography magnetic resonance imaging showed mass cm diameter contact right adrenal gland total situs inversus simultaneously confirmed plasma aldosterone concentration elevated pgml renin activity suppressed ngmlhr discussion finding indicated diagnosis primary aldosteronism due adrenal tumor right adrenal tumor resected laparoscopically right adrenal gland approached resected lateral side spleen located right side situs inversus resected specimen cm x cm intraoperative complication occurred histopathological examination showed tumor aldosteroneproducing adrenocortical adenoma,2013,"Kashiwagi, Shinichiro; Ishikawa, Tetsuro; Onoda, Naoyoshi; Kawajiri, Hidemi; Takashima, Tsutomu; Hirakawa, Kosei",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/108680813x13693422522114; https://www.ncbi.nlm.nih.gov/pubmed/24018094/,14791395.0,12
30619,30619,41281,28axoftw,,Medline,In vitro chemoresponse analysis of cervical cancer patient specimens.,10.1097/igc.0000000000000186,,24987911.0,unk,purpose objective study report result vitro chemoresponse analysis primary metastatic recurrent human cervical cancer method tumor specimen submitted testing august june single agent tested cisplatin carboplatin paclitaxel docetaxel epirubicin fluorouracil hydroxy ifosfamide active metabolite ifosfamide sn active metabolite irinotecan topotecan vinorelbine doublet tested carboplatinpaclitaxel cisplatintopotecan tumor response determined doseresponse curve result scored responsive intermediate nonresponsive chemoresponse reported combined responsive intermediate result result three hundred fiftythree submitted specimen successfully assayed confirmation histology tumor status primary metastatic recurrent available specimen chemoresponse active agent primary cancer n sn hydroxy ifosfamide topotecan carboplatinpaclitaxel chemoresponse metastatic cancer n sn hydroxy ifosfamide epirubicin carboplatinpaclitaxel chemoresponse recurrent cancer n epirubicin hydroxy ifosfamide vinorelbine paclitaxel topotecan carboplatinpaclitaxel cisplatintopotecan overall chemoresponse greater primary cancer recurrent cancer p conclusion vitro chemoresponse analysis cervical cancer biospecimens feasible chemoresponse result variable depending tumor status clinical study assaydirected therapy developed,2014,"Grigsby, Perry W; Gan, Christine M; Tillmanns, Todd D; Del Priore, Giuseppe",International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,,,,,,https://doi.org/10.1097/igc.0000000000000186; https://www.ncbi.nlm.nih.gov/pubmed/24987911/,5847138.0,12
30626,30626,41288,gigah4xo,,Medline,Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats.,10.1016/j.jconrel.2017.03.007,,28279797.0,unk,glioblastoma multiforme gbm highly invasive uniformly fatal median survivalmonths diagnosis even aggressive treatment includes surgery radiation systemic chemotherapy cisplatin particularly potent chemotherapeutic agent use treat gbm limited severe systemic toxicity inefficient penetration brain tumor tissue even placed directly brain within standard delivery system describe development cisplatinloaded nanoparticles small enough nm diameter move within porous extracellular matrix cell posse dense polyethylene glycol peg corona prevents trapped adhesion move brain tumor parenchyma result brain penetrating nanoparticles penetrate much deeper brain tumor tissue compared nanoparticles without dense peg corona following local administration either manual injection convection enhanced delivery nanoparticles also provide controlled release cisplatin effective concentration kill tumor cell reach without causing toxicityrelated death observed cisplatin infused brain without delivery system median survival time rat bearing orthotopic glioma significantly enhanced cisplatin delivered brain penetrating nanoparticles median survival reached longterm survivor compared cisplatin conventional unpegylated particle median survivaldays cisplatin alone median survivaldays salinetreated control median survivaldays,2017,"Zhang, Clark; Nance, Elizabeth A; Mastorakos, Panagiotis; Chisholm, Jane; Berry, Sneha; Eberhart, Charles; Tyler, Betty; Brem, Henry; Suk, Jung Soo; Hanes, Justin",Journal of controlled release : official journal of the Controlled Release Society,,,,,,https://doi.org/10.1016/j.jconrel.2017.03.007; https://www.ncbi.nlm.nih.gov/pubmed/28279797/,205881982.0,12
30633,30633,41295,6iwpy3ck,,Medline,The Influence of Liver Resection on Intrahepatic Tumor Growth.,10.3791/53946,,27166736.0,unk,high incidence tumor recurrence resection metastatic liver lesion remains unsolved problem small tumor cell deposit detectable routine clinical imaging may stimulated hepatic regeneration factor liver resection entirely clear however factor crucial tumor recurrence presented mouse model may useful explore mechanism play role development recurrent malignant lesion liver resection model combine easytoperform reproducible technique defined amount liver tissue removal tumor induction injection mouse animal treated either single laparotomy liver resection liver resection animal subsequently received tumor cell injection remaining liver tissue two week observation liver tumor evaluated size weight examined immunohistochemistry liver resection tumor volume weight significantly increased compared laparotomy alone p addition immunohistochemistry ki showed increased tumor proliferation rate resection group p finding demonstrate influence hepatic regeneration mechanism intrahepatic tumor growth combined method like histological workup rna analysis described mouse model could serve foundation close examination different factor involved tumor growth metastatic disease recurrence within liver considerable number variable like length postoperative observation cell line used injection timing injection liver resection offer multiple angle exploring specific question context posthepatectomy metastasis limitation procedure authorization perform procedure animal access appropriate animal testing facility acquisition certain equipment,2016,"Brandt, Hannes H; Nißler, Valérie; Croner, Roland S",Journal of visualized experiments : JoVE,,,,,,https://doi.org/10.3791/53946; https://www.ncbi.nlm.nih.gov/pubmed/27166736/,4716343.0,12
30662,30662,41328,2oiccsno,,Medline,An Alternative Method for Airway Management With Combined Tracheal Intubation and Rigid Bronchoscope.,10.1016/j.athoracsur.2018.12.058,,30738796.0,unk,innovative technique airway management using smalldiameter shortcuffed orotracheal tube assisting rigid bronchoscopy critical airway obstruction reported device part translaryngeal tracheostomy kit fantoni method dar tlt covidien minneapolis mn placed beyond stenosis used combination rigid bronchoscope procedure improves safety management critical tracheal stenosis airway constantly anesthesiologist control consequently inhalation anesthesia feasible use neuromuscular blockade possible endtidal carbon dioxide monitoring reliable distal airway protected blood debris soilage tumor debulking surgery faster uninterrupted,2019,"Puma, Francesco; Meattelli, Mattia; Kolodziejek, Miroslawa; Properzi, Marina Giuliana; Capozzi, Rosanna; Matricardi, Alberto; Cagini, Lucio; Vannucci, Jacopo",The Annals of thoracic surgery,,,,,,https://doi.org/10.1016/j.athoracsur.2018.12.058; https://www.ncbi.nlm.nih.gov/pubmed/30738796/,73455226.0,12
30677,30677,41343,prz2ovco,,Medline,Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective.,10.2214/ajr.14.12879,,25539257.0,unk,objective purpose study evaluate incidence clinically significant diaphragmatic injury local tumor progression microwave ablation hepatic tumor abutting diaphragm material method retrospective study included peripheral hepatic tumor abutting diaphragm treated microwave ablation versus control group centrally located tumor treated tumor subdivided according use artificial ascites fluid v fluid whether instilled fluid achieved displacement liver surface away diaphragm displaced v nondisplaced measurement tumor size distance diaphragm ablation zone size displacement distance length ablation zone along liver capsule diaphragm thickness diaphragmatic hernia local tumor progression made pre postablation ct mri electronic medical record reviewed patient selfreported pain score symptom data analyzed use kruskalwallis fisher exact test result case diaphragmatic hernia peripheral central tumor postablation diaphragm thickness higher peripheral hepatic tumor control tumor peripheral tumor overall higher incidence postprocedure shoulder pain v local tumor progression v compared control tumor difference achieve statistical significance p p respectively conclusion study show microwave ablation peridiaphragmatic hepatic tumor safe without incidence diaphragmatic hernia performed low rate local tumor progression,2015,"Smolock, Amanda R; Lubner, Meghan G; Ziemlewicz, Timothy J; Hinshaw, J Louis; Kitchin, Douglas R; Brace, Christopher L; Lee, Fred T",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.14.12879; https://www.ncbi.nlm.nih.gov/pubmed/25539257/,9824620.0,12
30708,30708,41379,q83h3u3p,,Medline,Craniotomy for anterior cranial fossa meningiomas: historical overview.,10.3171/2014.1.focus13569,,24684326.0,unk,surgical treatment meningioma located base anterior cranial fossa often challenging evolution surgical strategy resect tumor parallel development craniotomy neurosurgery general past century early successful operation treat tumor pioneered prominent figure sir william macewen francesco durante following early report harvey cushing made significant contribution allowing better understanding treatment meningioma general particularly involving anterior cranial base initially largesized unilateral bilateral craniotomy necessary approach deepseated lesion technical advance introduction electrosurgery operating microscope refined microsurgical instrument allowed neurosurgeon perform le invasive surgical procedure better result today wide variety surgical strategy including endoscopic surgery radiosurgery used treat tumor review author trace evolution craniotomy anterior cranial fossa meningioma,2014,"Morales-Valero, Saul F; Van Gompel, Jamie J; Loumiotis, Ioannis; Lanzino, Giuseppe",Neurosurgical focus,,,,,,https://doi.org/10.3171/2014.1.focus13569; https://www.ncbi.nlm.nih.gov/pubmed/24684326/,41442367.0,12
30823,30823,41522,yrgnnb7g,,Medline,Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.,10.1007/s13402-020-00513-9,,32418122.0,unk,background ovarian cancer lethal gynecologic cancer fifth leading cause cancerrelated mortality woman worldwide despite various attempt improve diagnosis therapy ovarian cancer patient survival rate patient still dismal mainly diagnosed late stage ovarian cancer arise neoplastic transformation ovarian surface epithelial cell usually referred epithelial ovarian cancer eoc unlike human cancer disseminated bloodborne metastatic route eoc traditionally thought disseminated direct migration ovarian tumor cell peritoneal cavity omentum via peritoneal fluid recently shown however eoc also disseminated bloodborne metastatic route challenging previous thought ovarian cancer metastasis conclusion review current understanding updated cellular molecular mechanism underlying eoc metastasis discus detail two main metastatic route eoc ie transcoelomic metastasis hematogenous metastasis emerging concept bloodborne eoc metastasis led exploration significance circulating tumor cell ctc novel noninvasive prognostic marker daunting cancer also evaluate role tumor stroma including cancer associated fibroblast cafs tumor associated macrophage tam endothelial cell adipocytes dendritic cell extracellular matrix ecm component eoc growth metastasis lastly discus therapeutic approach targeting eoc unraveling mechanism underlying eoc metastasis open avenue design new therapeutic option instance understanding molecular mechanism involved hematogenous metastasis eoc biology ctc detailed mechanism eoc cell take advantage stromal cell may help find new opportunity targeting eoc metastasis,2020-05-16,"Yousefi, Meysam; Dehghani, Sadegh; Nosrati, Rahim; Ghanei, Mahmoud; Salmaninejad, Arash; Rajaie, Sara; Hasanzadeh, Malihe; Pasdar, Alireza",Cellular oncology,,,,,,https://doi.org/10.1007/s13402-020-00513-9; https://www.ncbi.nlm.nih.gov/pubmed/32418122/,218652525.0,12
30937,30937,41652,93ougauf,,Medline,COMPUTED TOMOGRAPHIC FEATURES OF PHARYNGEAL NEOPLASIA IN 25 DOGS.,10.1111/vru.12278,,26173553.0,unk,computed tomography ct commonly used investigate head tumor dog however little information available lesion pharyngeal area purpose multicentric retrospective crosssectional study describe ct finding sample dog pathologically confirmed pharyngeal neoplasia determine whether ct feature allowed differentiation tumor type location lesion size shape margin relationship surrounding structure vessel attenuation characteristic enhancement pattern regional lymph node change presence metastasis recorded three observer decvdi effect final diagnosis ct feature tested total dog included carcinoma five sarcoma four melanoma one lymphoma oropharynx laryngopharynx frequently involved among tumor group lesion similar size irregularly shaped illdefined margin moderatetomarked heterogeneous contrast enhancement lysis hyoid bone recorded two carcinoma infiltration lingual artery occurred one case marked medial retropharyngeal lymphoadenomegaly recorded carcinoma sarcoma two four melanoma single lymphoma case showed illdefined thickening oropharyngeal laryngeal wall retropharyngeal mandibular lymphadenomegaly lung metastasis found two five sarcoma two four melanoma finding current study support hypothesis ct feature could used predict pharyngeal tumor type dog however ct helpful determining mass extension lymph node involvement distant metastatic spread,2015,"Carozzi, Gregorio; Zotti, Alessandro; Alberti, Monica; Rossi, Federica",Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association,,,,,,https://doi.org/10.1111/vru.12278; https://www.ncbi.nlm.nih.gov/pubmed/26173553/,24005629.0,12
30945,30945,41660,3soh5nq4,,Medline,Predictors for postoperative esophageal stricture after balloon-based radiofrequency ablation for early esophageal squamous neoplasia: a multicenter validation study.,10.1177/1756283x16633051,,27134656.0,unk,background endoscopic radiofrequency ablation rfa rapidly evolving therapeutic modality early flat esophageal squamous cell neoplasm escns risk factor postoperative stricture elucidated objective study identify validate predictor postrfa stenosis method consecutively enrolled patient flattype large length le cm extending le half circumference esophagus early escns treated balloonbased rfa jcmclean jcm regimen tumor technical factor postoperative stricture investigated validated result externally societybased multicenter cohort using ablation regimen result total patient enrolled development set validation set complete remission rate month rate perforation postoperative stenosis respectively patient postrfa stenosis significantly larger longitudinal tumor size mean versus mm p significant difference age body mass index tumor circumferential extension pretreatment histological grade treatment efficacy size balloon catheter group without stenosis optimal cutoff value set cm predict postrfa stenosis receiver operating characteristic curve area curve auc confirmed reliable predictor multivariate analysis odds ratio confidence interval p good predictive performance validation set auc conclusion frequent adverse event rfa esophageal stenosis longitudinal tumor size significant predictive factor early intervention prevention stricture applied long segment ⩾ cm escns,2016,"Wang, Wen-Lun; Chang, I-Wei; Chen, Chien-Chuan; Chang, Wei-Lun; Chu, Yin-Yi; Wu, Ping-Hsiu; Tai, Wei-Chen; Chen, Po-Yueh; Hsieh, Ping-Hsin; Chung, Chen-Shuan; Chang, Chi-Yang; Lin, Jaw-Town; Wang, Hsiu-Po; Lee, Ching-Tai",Therapeutic advances in gastroenterology,,,,,,https://doi.org/10.1177/1756283x16633051; https://www.ncbi.nlm.nih.gov/pubmed/27134656/,36131083.0,12
30979,30979,41702,voi66r0w,,Medline,Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer.,10.3791/58600,,30663668.0,unk,rabbit vx tumor animal model commonly utilized translational research regarding hepatocellular carcinoma hcc field interventional radiology model employ anaplastic squamous cell carcinoma easily reliably propagated skeletal muscle donor rabbit eventual harvest allograft implantation liver naïve recipient tumor graft rapidly grows within liver recipient rabbit angiographically identifiable tumor characterized necrotic core surrounded viable hypervascular capsule physical size rabbit anatomy sufficient facilitate vascular instrumentation allowing application testing various interventional technique despite benefit exists paucity technical resource act concrete reference researcher working model herein present comprehensive visual outline technical aspect development growth propagation angiographic utilization rabbit vx tumor model use novice experienced researcher alike,2019,"Khabbaz, Ramzy C; Huang, Yu-Hui; Smith, Alexandra A; Garcia, Kelly D; Lokken, R Peter; Gaba, Ron C",Journal of visualized experiments : JoVE,,,,,,https://doi.org/10.3791/58600; https://www.ncbi.nlm.nih.gov/pubmed/30663668/,58558840.0,12
30997,30997,41722,1t6w08yt,,Medline,Current status of robot-assisted partial nephrectomy.,10.1007/s11934-011-0223-z,,22113862.0,unk,incidence incidentally diagnosed small renal mass rising although open partial nephrectomy opn remains reference standard clinically localized renal lesion growing experience minimally invasive pn demonstrated equivalent oncologic efficacy improved shortterm perioperative outcome compared open technique compared technically demanding laparoscopic pn lpn robotic pn rpn overcomes number technical hurdle lpn shorter learning curve emerged attractive minimally invasive treatment option amenable tumor although experience rpn limited date early series demonstrated shortterm oncologic outcome comparable opn equivalent perioperative outcome lpn ≤ level iii evidence although prospective evidence would ideal clinical trial comparison lpn opn fraught accrual challenge expected near future review summarizes advantage indication robotic approach operative principle emerging technology early functional oncologic outcome expected future advance rpn localized renal tumor,2012,"Reyes, Jose M; Smaldone, Marc C; Uzzo, Robert G; Viterbo, Rosalia",Current urology reports,,,,,,https://doi.org/10.1007/s11934-011-0223-z; https://www.ncbi.nlm.nih.gov/pubmed/22113862/,38099978.0,12
31001,31001,41727,yspfrmm5,,Medline,Flat-panel cone-beam CT-guided radiofrequency ablation of very small (≤ 1.5 cm) liver tumors: technical note on a preliminary experience.,10.1007/s00270-014-1019-6,,25373799.0,unk,purpose aim present study investigate technical feasibility flatpanel conebeam ct cbctguided radiofrequency ablation rfa small cm liver tumor material method patient included candidate hepatic percutaneous rfa single biopsyproven hepatic tumor sized ≤ cm poorly defined ultrasonography following apnea induction unenhanced cbct scan acquired used deploy rf electrode aid virtual navigation system tumor clearly identified unenhanced cbct scan right retrograde arterial femoral access established carry hepatic angiography localize tumor patient lesion procedural variable recorded analyzed result three patient male female aged year included lesion hepatocellular carcinoma metastasis colorectal cancer treated one patient required hepatic angiography cycle apnea used acquire cbct image deploy electrode lasted mean fluoroscopic time needed deploy electrode ± min mean overall procedural time ± min peri postprocedural complication noted case incomplete ablation noted month followup conclusion percutaneous cbctguided liver rfa without arterial hepatic angiography technically feasible,2015,"Cazzato, Roberto Luigi; Buy, Xavier; Alberti, Nicolas; Fonck, Mariane; Grasso, Rosario Francesco; Palussière, Jean",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-014-1019-6; https://www.ncbi.nlm.nih.gov/pubmed/25373799/,21451037.0,12
31033,31033,41762,dtflb99p,,Medline,Phospholipid Oxygen Microbubbles for Image-Guided Therapy.,10.7150/ntno.43808,,32190535.0,unk,recent work oxygen microbubbles omb shown oxygenate hypoxic tumor increase radiosensitivity improve tumor control radiation therapy compared intratumoral injection intravenous delivery adjuvant agent omb radiotherapy offer attractive mean achieving true theranostic function minimally invasive manner via contrastenhanced ultrasound ceus reducing risk injury infection displacing tumor cell however short intravascular circulation time conventional dspclipid omb may lead premature offtarget dissolution omb associated reduction tumoral oxygen delivery prior work microbubble stability gas exchange suggests increasing phospholipid acylchain length encapsulating shell omb size may increase circulation persistence delivery dissolved oxygen content following study investigate effect two phospholipid shell composition dspc c dbpc c well three size distribution µm µm polydisperse omb circulation persistence utilizing ceus kidney live cb male female mouse six week age dbpc omb formulation demonstrated increased circulation halflives versus dspc formulation ± v ± p µm well increased maximum intensity tenfold p sizedependent effect remained consistent across formulation larger µm microbubbles demonstrating significantly increased halflives ± v ± p compared smaller µm formulation dbpc study indicate dbpc µm omb may improved adjuvant agent radiotherapy significant potential ceus interrogation,2020,"Reusser, Traci D; Song, Kang-Ho; Ramirez, David; Benninger, Richard Kp; Papadopoulou, Virginie; Borden, Mark A",Nanotheranostics,,,,,,https://doi.org/10.7150/ntno.43808; https://www.ncbi.nlm.nih.gov/pubmed/32190535/,211538693.0,12
31058,31058,41790,f7tru24k,,Medline,Clinical experience of 528 laparoscopic gastrectomies on gastric cancer in a single institution.,10.1016/j.surg.2012.10.019,,23294878.0,unk,background laparoscopic gastrectomy lg locally advanced gastric cancer agc well early gastric cancer egc gradually gained popularity however longterm experience lg agc well egc rarely reported method total patient gastric cancer enrolled study clinical experience lg evaluated result study included men woman mean age ± year patient underwent distal gastrectomy total gastrectomy proximal gastrectomy ta tb ta lesion patient lymph node metastasis observed rate ta tb ta median followup period month range month year survival diseasefree survival rate according stage tumor stage stage ii stage iii respectively operation related morbidity occurred patient mortality tumor recurred patient consisting ta tb ta carcinomatosis peritonei observed commonly conclusion experience oncologic result safety lg egc serosanegative agc acceptable treatment may considered alternative operative approach,2013,"Lee, Junhyun; Kim, Wook",Surgery,,,,,,https://doi.org/10.1016/j.surg.2012.10.019; https://www.ncbi.nlm.nih.gov/pubmed/23294878/,23948060.0,12
31069,31069,41801,neeml5up,,Medline,Comparison of trans-anal endoscopic operation and trans-anal excision of rectal tumors.,10.1016/j.amsu.2016.12.049,,28127423.0,unk,background transanal endoscopic operation teo developed facilitate proper tumor location ensure excision safely method reviewed patient enrolled database diagnosed early rectal tumor underwent conventional transanal excision tae teo clinical data collected prospectively compare safety feasibility two technique result ninetytwo patient underwent transanal local excision lower rectal tumor teo tae performed patient respectively age sex comorbidities similar significant difference tumor diameter ± cm v ± respectively tumor height however higher teo ± cm tae group ± cm p four complication perianal abscess two perforation occurred teo group whereas major complication occurred tae seven patient underwent teo underwent salvage operation compared single patient tae group p eight patient diagnosed adenocarcinoma developed recurrence four group diseasefree survival similar group teo month ri tae month ri however tae patient n teo patient n underwent chemotherapy conclusion teo treatment local rectal tumor safe feasible achieve adequate resection margin local recurrence similar group however number salvage operation minor complication higher teo group,2017,"Al Bandar, Mahdi Hussain; Han, Yoon Dae; Razvi, Syed Asim; Cho, Min Soo; Hur, Hyuk; Min, Byung Soh; Lee, Kang Young; Kim, Nam Kyu",Annals of medicine and surgery,,,,,,https://doi.org/10.1016/j.amsu.2016.12.049; https://www.ncbi.nlm.nih.gov/pubmed/28127423/,18751307.0,12
31097,31097,41830,pjswd7op,,Medline,Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.,10.1158/0008-5472.can-10-3978,,21531761.0,unk,wntβcatenin pathway activation caused adenomatous polyposis coli apc mutation occurs approximately sporadic colorectal cancer crc antihelminth compound niclosamide downregulates component wnt pathway specifically dishevelled dvl expression resulting diminished downstream βcatenin signaling study determined whether niclosamide could inhibit wntβcatenin pathway human crcs whether inhibition might elicit antitumor effect presence apc mutation found niclosamide inhibited wntβcatenin pathway activation downregulated dvl decreased downstream βcatenin signaling exerted antiproliferative effect human colon cancer cell line crc cell isolated surgical resection metastatic disease regardless mutation apc contrast inhibition nfκb mtor exert similar antiproliferative effect crc model system mouse implanted human crc xenograft orally administered niclosamide well tolerated achieved plasma tumor level associated biologic activity led tumor control finding support clinical exploration reposition niclosamide treatment crc,2011,"Osada, Takuya; Chen, Minyong; Yang, Xiao Yi; Spasojevic, Ivan; Vandeusen, Jeffrey B; Hsu, David; Clary, Bryan M; Clay, Timothy M; Chen, Wei; Morse, Michael A; Lyerly, H Kim",Cancer research,,,,,,https://doi.org/10.1158/0008-5472.can-10-3978; https://www.ncbi.nlm.nih.gov/pubmed/21531761/,6832803.0,12
31147,31147,41883,j4d9aiag,,Medline,Cecal schwannoma with laparoscopic wedge resection: report of a case.,10.1111/j.1758-5910.2011.00089.x,,22776304.0,unk,schwannomas large intestine relatively rare present case schwannoma cecum yearold woman successfully resected laparoscopic wedge resection medical checkup colonoscopy revealed cm submucosal lesion without mucosal change located cecum wall contralateral bauhins valve abdominal contrast ct contrast mri indicated smoothsurfaced semiround tumor cm gave enhanced homogeneous signal cecum laparoscopic wedge resection performed diagnosis benign submucosal tumor lesion × cm histologically composed spindle neoplastic cell arranged cord positive vimentin diagnosed schwannoma detail case reported herein focus successful application laparoscopic wedge resection treatment colonic submucosal lesion,2011,"Matsumoto, T; Yamamoto, S; Fujita, S; Akasu, T; Moriya, Y",Asian journal of endoscopic surgery,,,,,,https://doi.org/10.1111/j.1758-5910.2011.00089.x; https://www.ncbi.nlm.nih.gov/pubmed/22776304/,24997956.0,12
31178,31178,41923,pvz5euta,,Medline,VATS lobectomy combined with limited Shaw-Paulson thoracotomy for posterolateral Pancoast tumor.,10.5301/tj.5000430,,26429643.0,unk,purpose several technique proposed challenging surgical resection pancoast tumor describe hybrid approach combine videoassisted thoracic surgery vat lobectomy limited shawpaulson thoracotomy method report case pancoast tumor yearold man staged ctnm treated induction chemoradiotherapy prior hybrid surgical approach thoracoscopic pleural cavity inspection upper right vat lobectomy port standard approach performed chest wall resected limited paravertebral incision allowing extraction lobe together rib segment posterior chest wall defect repaired synthetic patch result postoperative period uneventful pain never exceed score visual analogue scale pathological examination revealed nonvital tumor cell specimen yptnm patient disease free month followup conclusion approach experienced excellent access apical hilar structure experience needed validate role vat lobectomy multidisciplinary management posterior pancoast tumor,2016,"Rosso, Lorenzo; Nosotti, Mario; Palleschi, Alessandro; Tosi, Davide",Tumori,,,,,,https://doi.org/10.5301/tj.5000430; https://www.ncbi.nlm.nih.gov/pubmed/26429643/,10270944.0,12
31420,31420,42214,feitdnhn,,Medline,Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.,10.1080/02656736.2019.1687945,,31813295.0,unk,objective randomized controlled trial rct aim compare clinical application value contrastenhanced ultrasound ceus computed tomographymagnetic resonanceceus ctmrceus threedimensional ultrasoundceus dusceus fusion imaging fi technique assistance thermal ablation hepatocellular carcinoma hccmethods rct conducted patient hccs january september ceus ctmrceus dusceus fi technique randomly used assist hcc ablation lesion ablated according previously determined plan fi group required mm ablative margin primary endpoint technical efficacy thermal ablation local tumor progression ltpresults according randomization ± cm ± cm ± cm hccs assigned ctmrceus dusceus ceus group respectively technical efficacy rate v v achieved three group showing statistical difference p median followup time month ltp rate year ctmrceus fi dusceus fi ceus respectively p result subgroup analysis ltp statistically significant patient albuminbilirubin albi grade p tumor located risky position p addition p value group multiple tumor close p conclusion three technique feasible intraoperative hcc thermal ablation compared ceus fi technique suitable patient albi grade multiple tumor tumor risky location,2019,"Huang, Qiannan; Zeng, Qingjing; Long, Yinglin; Tan, Lei; Zheng, Rongqin; Xu, Erjiao; Li, Kai","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2019.1687945; https://www.ncbi.nlm.nih.gov/pubmed/31813295/,208955016.0,12
31421,31421,42216,ygml4pie,,Medline,"Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.",10.1186/s13550-014-0021-y,,24995150.0,unk,background previously reported unexpected development distant metastasis subcutaneous rat pancreas ca tumor model week treatment radonly combination ludotatyroctreotate ludotatate cancer re moreover combination therapy le effective compared ludotatateonly current study address following question combination therapy le effective ludotatate tumor uptake affected pretreatment rad could sudden cessation rad therapy cause development distant metastasis ludotatate effective treatment option metastasis method lewis rat hanhsd ssnhsd substrain slight difference immune response bearing subcutaneous ca tumor treated either mbq ludotatate rad combination rad given twice week week whereas ludotatate given single injection combined rad started either day prior day post administration ludotatate spectct performed quantify ludotatate tumor uptake indicated primary tumor surgically removed tumor size mm enable monitoring possible metastasis metastasis suspected indtpaoctreotide spectct scan performed seven rat metastasis treated mbq ludotatate result ludotatate tumor uptake significantly affected rad pretreatment occurrence metastasis rad treatment dose dependent dose range tested related duration rad treatment experiment lewssnsd substrain used radtreated rat showed complete response cr compared tumor regression control group retreatment high dose ludotatate resulted cr two seven animal conclusion le effective antitumor effect combination rad ludotatate could explained reduced ludotatate tumor uptake rad current data support radinduced immune suppression reason observation evidence found cessation rad treatment caused development metastasis metastasis appeared le sensitive ludotatate treatment primary tumor,2014,"Bison, Sander M; Pool, Stefan E; Koelewijn, Stuart J; van der Graaf, Linda M; Groen, Harald C; Melis, Marleen; de Jong, Marion",EJNMMI research,,,,,,https://doi.org/10.1186/s13550-014-0021-y; https://www.ncbi.nlm.nih.gov/pubmed/24995150/,4839369.0,12
31465,31465,42264,nazgwskr,,Medline,A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.,10.1111/jth.13387,,27306689.0,unk,unlabelled essential clinician may hesitant administer anticoagulation setting brain metastasis glioma metaanalysis identified nine retrospective cohort study met inclusion criterion anticoagulation increase risk intracranial hemorrhage brain metastasis setting glioma anticoagulation resulted fold increase intracranial hemorrhage summary background venous thromboembolism commonly occurs patient brain tumor high rate spontaneous intracranial hemorrhage ich safety therapeutic anticoagulation commonly questioned objective performed metaanalysis evaluate whether therapeutic anticoagulation associated increased risk intracranial hemorrhage patient brain tumor patientsmethods systematic literature search strategy conducted summary statistic ich obtained calculating odds ratio using random effect model heterogeneity across study estimated statistic result total nine retrospective cohort study met criterion inclusion odds ratio ich patient receiving therapeutic anticoagulation versus receive anticoagulation confidence interval ci study evaluating anticoagulation patient brain metastasis apparent increased risk ich ci however patient glioma increase risk ich associated administration anticoagulation ci conclusion risk ich patient brain tumor receiving therapeutic anticoagulation depends diagnosis primary metastatic brain tumor although anticoagulation associated increased risk ich setting brain metastasis use resulted greater fold increased risk ich patient glioma,2016,"Zwicker, J I; Karp Leaf, R; Carrier, M",Journal of thrombosis and haemostasis : JTH,,,,,,https://doi.org/10.1111/jth.13387; https://www.ncbi.nlm.nih.gov/pubmed/27306689/,3413451.0,12
31552,31552,42359,6cyl76ly,,Medline,Massive hematemesis after radiofrequency ablation of metastatic liver tumor with successful hemostasis achieved through transarterial embolization.,10.1016/j.clinimag.2018.03.007,,29859483.0,unk,hemorrhagic complication common major complication occur radiofrequency ablation hematemesis complication radiofrequency ablation hepatic tumor mentioned hepatogastric fistula delayed complication also rare present case yearold man severe hematemesis occurred month radiofrequency ablation liver metastasis gastric cancer ruptured hepatic artery pseudoaneurysm hepatogastric fistula confirmed serial imaging examination current case reported combination rare major complication radiofrequency ablation liver tumor,2018,"Liu, Chien-An; Chiu, Nai-Chi; Chiou, Yi-You",Clinical imaging,,,,,,https://doi.org/10.1016/j.clinimag.2018.03.007; https://www.ncbi.nlm.nih.gov/pubmed/29859483/,44115745.0,12
31594,31594,42408,2gubjkc2,,Medline,CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.,10.1016/j.jvir.2016.01.010,,26922977.0,unk,purpose evaluate technique efficacy safety clinical outcome ctguided microwave ablation tumor hepatic dome material method retrospective review conducted consecutive patient men woman mean age treated ctguided microwave ablation hepaticdome tumor june december baseline demographic sex tumor diagnosis tumor location tumor size technical detail recorded technical success evaluated treatment response assessed per european association study liver criterion overall success overall survival calculated complication recorded result fortyeight tumor treated tumor location included segment viii n vii n via n mean tumor size cm range cm thirtyfour tumor treated following creation artificial ascites normal saline solution mean volume ml range ml technical success rate complete response rate overall survival rate month followup major complication two patient experienced small asymptomatic pneumothoraces aspirated time procedure required treatment conclusion ctguided microwave ablation tumor hepatic dome associated high technical success rate high complete response rate low complication rate,2016,"Asvadi, Nazanin H; Anvari, Arash; Uppot, Raul N; Thabet, Ashraf; Zhu, Andrew X; Arellano, Ronald S",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2016.01.010; https://www.ncbi.nlm.nih.gov/pubmed/26922977/,32892626.0,12
31595,31595,42409,8t91eoyw,,Medline,Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors.,10.1245/s10434-012-2617-7,,22941169.0,unk,background neuroendocrine ne tumor pose diagnostic challenge need utilize combination biochemical analysis standard crosssectional imaging recently nuclear medicine scan indiumpentetreotide scintigraphy somatostatin receptor scintigraphy sr octreoscan covidien imaging solution hazelwood mo study sought evaluate clinical utility scintigraphy diagnosis management patient ne tumor major university hospital method retrospective chart review performed patient underwent indiumpentetreotide scintigraphy computed tomographymagnetic resonance imaging ctmri single institution february july chart reviewed patient demographic symptom ne disease result biochemical testing imaging study histopathologic diagnosis medical andor surgical management result one hundred fortyfive patient received indiumpentetreotide scintigraphy sr concurrent crosssectional imaging ctmri year period studied evaluation primary disease tumor localized anatomic imaging significantly greater detection rate achieved sr evaluation recurrent disease ne tumor localized crosssectional imaging significantly greater detection rate sr scintigraphy identified disease focus seen ctmri cohort evidence disease altered surgical management case conclusion crosssectional ctmri imaging sufficient localization ne tumor indiumpentetreotide scintigraphy significantly alter surgical management patient ne tumor suggest selectively reserved patient disease occult crosssectional imaging,2013,"Shaverdian, Narek; Pinchot, Scott N; Zarebczan, Barbara; Gillis, Holly C; Schiro, Adam; Chen, Herbert",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-012-2617-7; https://www.ncbi.nlm.nih.gov/pubmed/22941169/,6683429.0,12
31655,31655,42484,sea5ce13,,Medline,Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis.,10.1007/s11701-020-01086-3,,32358741.0,unk,objective compare surgical outcome transperitoneal tp retroperitoneal rp approach robotassisted laparoscopic partial nephrectomy rapn lateral tumor method study included patient underwent rapn lateral renal tumor lateral tumor defined x factor renal nephrometry score total patient tp rp respectively included analysis minimize effect selection bias following variable adjusted using propensity score matching age sex body mass index american society anesthesiologist score preoperative estimated glomerular filtration rate tumor size renal nephrometry score result matching patient allocated group mean age year mean preoperative estimated glomerular filtration rate egfr mlmin mean tumor size mm rp group shorter operative time v min p shorter console time v min p shorter warm ischemic time v min p lower estimated blood loss ebl v ml p shorter postoperative length hospital stay plo v day p tp group change egfr incidence rate perioperative complication positive surgical margin rate significantly differ two group conclusion rp better surgical outcome including shorter operative time lower ebl shorter plo lateral renal tumor may suggest rp optimal approach selected lateral renal tumor,2020-05-01,"Takagi, Toshio; Yoshida, Kazuhiko; Kondo, Tsunenori; Kobayashi, Hirohito; Iizuka, Junpei; Okumi, Masayoshi; Ishida, Hideki; Tanabe, Kazunari",Journal of robotic surgery,,,,,,https://doi.org/10.1007/s11701-020-01086-3; https://www.ncbi.nlm.nih.gov/pubmed/32358741/,217166621.0,12
31711,31711,42554,4uvl3p5r,,Medline,Single port VATS mediastinal tumor resection: Taiwan experience.,10.21037/acs.2016.03.10,,27134836.0,unk,background present technique singleport videoassisted thoracoscopic mediastinal tumor resection includes limited thymectomy extended thymectomy cyst excision posterior mediastinal tumor excision early result resection use technique method forty patient mediastinal tumor treated singleport thoracoscopic mediastinal resection chang gung memorial hospital april september surgical intervention performed fourth fifth intercostal space anterior axillary line mm degree video camera working instrument employed simultaneously incision site throughout surgery result among case included final analysis extended thymectomies limited thymectomies nine cyst excision tumor excision performed successfully without need conversion patient underwent singleport videoassisted thoracoscopic surgery vat mean operation time ± min average blood loss ± ml average length incision wound ± cm average length postoperative hospital stay ± day mortality mobility achieved within day postoperatively conclusion preliminary report suggests uniportal vat mediastinal tumor resection promising safe technique within shortterm period,2016,"Wu, Ching-Yang; Heish, Ming-Ju; Wu, Ching-Feng",Annals of cardiothoracic surgery,,,,,,https://doi.org/10.21037/acs.2016.03.10; https://www.ncbi.nlm.nih.gov/pubmed/27134836/,21819492.0,12
31754,31754,42605,suec0wif,,Medline,Transanal Minimally Invasive Surgery for Rectal Lesions.,10.4293/jsls.2016.00032,,27547025.0,unk,background objective transanal minimally invasive surgery tamis emerged alternative transanal endoscopic microsurgery tem author report experience tamis treatment mid high rectal tumor method november may patient female median age year underwent singleport tamis prospectively enrolled mean distance anal verge rectal tumor cm seventeen patient presented cancer large adenoma gastrointestinal stromal tumor gist carcinoid tumor data concerning demographic operative procedure pathologic result analyzed result tamis successfully completed case tamis converted standard park transanal technique median postoperative stay day overall complication rate including urinary tract infection subcutaneous emphysema hemorrhoidal thrombosis tamis allowed r resection case case single case local recurrence large adenoma resection encountered conclusion tamis safe technique short learning curve laparoscopic surgeon already proficient singleport procedure provides effective oncological outcome compared technique,2016,"Quaresima, Silvia; Balla, Andrea; Franceschilli, Luana; La Torre, Marco; Iafrate, Corrado; Shalaby, Mostafa; Di Lorenzo, Nicola; Sileri, Pierpaolo",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/jsls.2016.00032; https://www.ncbi.nlm.nih.gov/pubmed/27547025/,17177835.0,12
31776,31776,42629,qztkpinh,,Medline,Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.,10.1007/s00330-019-06497-x,,31822975.0,unk,purpose evaluate therapeutic efficacy complication percutaneous thermal ablation subcapsular hepatocellular carcinoma hccs may influenced degree tumor liver surface contact tumor protrusion liver surface material method retrospective study approved institutional review board january december patient woman men mean age year range year subcapsular within cm liver surface hccs mean size mm range mm underwent percutaneous thermal ablation hccs divided surface contact group n nonsurface contact group n former subdivided exophytic nonexophytic hccs technical success primary technique efficacy local tumor progression ltp secondary technique efficacy rate analyzed compared chisquare test fisher exact test prognostic factor ltp secondary technique efficacy assessed using cox regression model major complication also assessed result median followup month range month technical success primary technique efficacy nonsurface contact group nonexophytic group exophytic group p tumor size cm significant predictor ltp secondary efficacy overall major complication rate different among three group conclusion subcapsular hccs effectively treated thermal ablation technique degree tumorsurface contact including moderate protrusion appear limit feasibility procedure effectiveness key point • subcapsular hccs effectively treated thermal therapy proper imageguided technique assistive technique applied • degree tumor surface contact including moderate protrusion appear limit feasibility procedure effectiveness • major complication percutaneous thermal ablation subcapsular hccs tumor seeding minimized avoiding breach tumor capsule exposed peritoneal surface use tract ablation,2019-12-10,"Worakitsitisatorn, Akeanong; Lu, David S; Lee, Min Woo; Asvadi, Nazanin H; Moshksar, Amin; Yuen, Alexander D; McWilliams, Justin; Raman, Steven S",European radiology,,,,,,https://doi.org/10.1007/s00330-019-06497-x; https://www.ncbi.nlm.nih.gov/pubmed/31822975/,208957140.0,12
31790,31790,42649,58fhzxma,,Medline,Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation.,10.1371/journal.pone.0103342,,25072388.0,unk,introduction defining tumor nontumor tissue one major challenge cancer surgery surgeon depend visual tactile clue select tissue removed patient recently others hypothesized nearinfrared nir imaging used surgery differentiate tumor normal tissue method enrolled canine human undergoing cancer surgery nir imaging patient injected indocyanine green icg fda approved nonreceptor specific nir dye accumulates hyperpermeable tissue hour prior surgery surgery nir imaging used discriminate tumor nontumor tissue result nir imaging identified tumor mean signaltobackground ratio optical image useful surgery discriminating normal tissue cancer canine case human case tissue surrounding tumor inflamed due obstruction vascular supply due mass effect instance nir imaging could distinguish tumor tissue tissue congested edematous contain cancer conclusion study show nir imaging identify tumor normal tissue provides excellent tissue contrast facilitates resection tumor however situation significant peritumoral inflammation nir imaging icg helpful suggests nontargeted nir dye accumulate hyperpermeable tissue significant limitation future receptorspecific nir dye may necessary overcome problem,2014,"Holt, David; Okusanya, Olugbenga; Judy, Ryan; Venegas, Ollin; Jiang, Jack; DeJesus, Elizabeth; Eruslanov, Evgeniy; Quatromoni, Jon; Bhojnagarwala, Pratik; Deshpande, Charuhas; Albelda, Steven; Nie, Shuming; Singhal, Sunil",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0103342; https://www.ncbi.nlm.nih.gov/pubmed/25072388/,2117827.0,12
31801,31801,42661,4irdgylf,,Medline,Distinct functions of AKT isoforms in breast cancer: a comprehensive review.,10.1186/s12964-019-0450-3,,31752925.0,unk,background akt also known protein kinase b key element pikakt signaling pathway moreover akt regulates hallmark cancer eg tumor growth survival invasiveness tumor cell akt discovered early study revealed three different akt isoforms namely akt akt akt despite high similarity distinct akt isoforms exert nonredundant partly even opposing effect physiological pathological condition breast cancer common cancer entity woman frequently show alteration pikakt signaling main content plethora study addressed impact akt isoforms tumor growth metastasis angiogenesis breast cancer well therapy response overall survival patient therefore review aimed give comprehensive overview isoformspecific effect akt breast cancer summarize known downstream upstream mechanism taking account conflicting finding among study majority study reported tumor initiating role akt whereas akt mainly responsible tumor progression metastasis detail akt increase cell proliferation cell cycle protein like p p cyclin impairs apoptosis eg via p downside akt decrease migration breast cancer cell instance regulating tsc palladin emtproteins however akt promotes migration invasion notably regulation βintegrins emtproteins factin whilst akt associated negative erstatus finding role akt regulation key property breast cancer sparse accordingly akt mutated akt amplified case breast cancer akt isoforms associated overall survival therapy response isoformspecific manner conclusion although several discussed hypothesis isoform specificity achieved mechanism behind isoformspecific effect remain mostly unrevealed consequence effort necessary achieve deeper insight isoformspecific akt signaling breast cancer mechanism behind,2019-11-21,"Hinz, Nico; Jücker, Manfred",Cell communication and signaling : CCS,,,,,,https://doi.org/10.1186/s12964-019-0450-3; https://www.ncbi.nlm.nih.gov/pubmed/31752925/,208209337.0,12
31894,31894,42766,pl19qq6r,,Medline,Role of thermal ablation in the management of colorectal liver metastasis.,10.21037/hbsn.2019.06.08,,32140478.0,unk,recent randomized prospective trial revealing thermal ablative therapy local tumor control improved overall survival o patient unresectable colorectal cancer liver metastasis crlm thermal ablation continues remain important treatment option patient population aim article review current role ablative therapy management crlm patient main indication thermal ablation include unresectable liver lesion ii combination hepatectomy iii patient significant medical comorbidities poor performance status p iv small cm solitary lesion would otherwise necessitate major liver resection v patient preference several approach modality ablative therapy including open percutaneous laparoscopic approach well radiofrequency ablation rfa microwave ablation mwa approach ablation modality pro con percutaneous laparoscopic approach preferred due minimally invasive nature yet laparoscopic approach benefit thorough intraoperative ultrasound u exam well complete peritoneal staging laparoscopy similarly whereas high local tumor failure rate major concern rfa mwa microwave thermosphere ablation mta demonstrated significantly improved local tumor control due homogenous tissue heating ability reach higher tissue temperature le susceptible heatsink effect although liver resection standard care crlm retrospective study demonstrating similar oncological outcome ablative therapy surgical resection selected population small cm solitary crlm lastly ablative therapy liver resection mutually exclusive especially management bilobar liver metastasis concomitant ablative therapy hepatectomy may spare patient twostage hepatectomy le morbidity role thermal ablation continue evolve patient resectable ablatable lesion owing newly emerging technology addition new systemic treatment option including immunotherapy metastatic colorectal cancer crc,2020-02-01,"Takahashi, Hideo; Berber, Eren",Hepatobiliary surgery and nutrition,,,,,,https://doi.org/10.21037/hbsn.2019.06.08; https://www.ncbi.nlm.nih.gov/pubmed/32140478/,198306086.0,12
32006,32006,42896,ehxvxg61,,Medline,Endovascular management of posttraumatic and iatrogenic large pelvic pseudoaneurysms following biopsy: case report.,10.1016/j.radcr.2016.11.012,,28228890.0,unk,pelvic traumatic iatrogenic pseudoaneurysms supplied internal iliac artery rare present pain nerve compression rupture particularly chronic pseudoaneurysms imaging appearance confusing mistaken tumor present two case pelvic pseudoaneurysms supplied superior gluteal artery initially mistaken mass subsequently biopsied report subsequent successful endovascular embolization technique subsequently utilized case high index suspicion maintained avoid biopsy lesion appropriately selected patient endovascular approach may safely used perform embolization,2017,"Phyu, Win; Zaw, Taryar; Park, Jonathan K; Chang, Megan; Lee, Hsin-Yi",Radiology case reports,,,,,,https://doi.org/10.1016/j.radcr.2016.11.012; https://www.ncbi.nlm.nih.gov/pubmed/28228890/,16514571.0,12
32008,32008,42898,5ow9cpy4,,Medline,Transanal Endoscopic Operation for Benign Rectal Lesions and T1 Carcinoma.,10.4293/jsls.2016.00093,,28144126.0,unk,background objective transanal endoscopic operation teo minimally invasive technique used local excision benign selected malignant rectal lesion purpose study investigate feasibility safety oncological outcome procedure report experience center method retrospective review prospectively collected database performed patient benign lesion ≤ctn rectal cancer underwent teo curative intent belgian center result eightythree patient underwent teos rectal lesion adenoma adenocarcinoma gastrointestinal stromal tumor lipoma neuroendocrine tumor scar tissue operative time associated lesion size p postoperative complication occurred patient hemorrhage urinary tract infection urinary retention abscess anastomotic stenosis entrance peritoneal cavity median hospital stay day range median followup month range recurrence conclusion although longer followup still necessary teo appears effective method excising benign tumor lowrisk carcinoma rectum however teo considered part diagnostic workup furthermore resected specimen teo procedure allows adequate local staging contrast endoscopic piecemeal excision nevertheless definitive histology must appreciated case unfavorable histology radical salvage resection still performed,2017,"D'Hondt, Mathieu; Yoshihara, Emi; Dedrye, Lieven; Vindevoghel, Koen; Nuytens, Frederiek; Pottel, Hans",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/jsls.2016.00093; https://www.ncbi.nlm.nih.gov/pubmed/28144126/,17233893.0,12
32081,32081,42983,exakq59k,,Medline,Modified Thoracoscopic Hepatectomy For Segment VIII: A Case Report.,10.1097/md.0000000000003801,,27258516.0,unk,although previous study reported use total thoracoscopic hepatectomy th malignant liver tumor technically impossible perform intraoperative ultrasonography iuso exclude intrahepatic metastasis whole liver via thoracic approach therefore total th may inappropriate patient report first case modified th malignant liver tumor chinathe patient yearold man year hbv infection preoperative ct showed cm × cm mass located segment viii alphafetal protein level ngml childpugh grade whereas icg test yielded hcc diagnosed preoperatively indication th difficult tumor location hcc young patient good resiliencethe modified th included step patient placed supine position iuso used locate tumor segment viii determine intrahepatic metastasis occurred hepatoduodenal ligament hanged using pringle maneuver patient placed leftlateral position singlelung ventilation three trocars placed right thoracic cavity intrathoracic space observed using regular mm rigid scope diaphragm transected retracted iuso used confirm tumor location pringle maneuver every min superficial portion liver transected ultrasonic shear whereas deeper tissue transected ligasure bipolar used hemostasis specimen put retrieval bag removed abdominal trocar diaphragm repaired running suturing operation time minute estimated blood loss ml patient discharged postoperative day normal liver function complication arosetotal th may inappropriate malignant liver tumor due limitation iuso whole liver step modified th technically feasible suitable malignant liver tumor located segment vii viiivideo httplinkslwwcommdb,2016,"Li, Hongyu; Wei, Yonggang; Li, Bo; Peng, Bing",Medicine,,,,,,https://doi.org/10.1097/md.0000000000003801; https://www.ncbi.nlm.nih.gov/pubmed/27258516/,5373868.0,12
32319,32319,43255,dzdaa6iu,,Medline,Endoscopically Assisted Transumbilical Single-Incision Laparoscopic Gastric Resection for GIST Treatment.,10.3109/08941939.2015.1081309,,26631974.0,unk,purpose complete surgical resection negative margin without lymphadenectomy treatment choice nonmetastatic gastrointestinal stromal tumor gist laparoscopic resection gastric gist cm acceptable oncologically feasible safe effective treatment present experience endoscopically assisted minimally invasive transumbilical singleincision laparoscopic sils technique gastric gist resection method four patient small gastric gist ≤ cm located greater curvature anterior wall resected sils using lesionlifting technique guidance flexible gastroscopy result technique feasible safe offered significant advantage locating tumor controlling resection margin major intraoperative postoperative complication conversion tumor rupture pathology showed lowrisk gist resected diseasefree margin without tumor rupture recurrence observed conclusion endoscopically assisted sils wedge gastrectomy feasible safe advantageous technique treatment greater curvature anterior wall gastric gist,2016,"Pitiakoudis, Michail; Zezos, Petros; Kouklakis, Georgios; Tsalikidis, Christos; Romanidis, Konstantinos; Vradelis, Stergios; Tsaroucha, Alexandra K; Kakolyris, Stylianos; Simopoulos, Constantinos",Journal of investigative surgery : the official journal of the Academy of Surgical Research,,,,,,https://doi.org/10.3109/08941939.2015.1081309; https://www.ncbi.nlm.nih.gov/pubmed/26631974/,34760931.0,12
32407,32407,43358,is0j89mq,,Medline,Laparoendoscopic single-site radical nephrectomy for large renal masses.,10.1089/end.2012.0115,,22984849.0,unk,purpose report operative experience shortterm outcome laparoendoscopic singlesite le management large renal tumor tumor advanced stage patient method ten consecutive patient underwent lessradical nephrectomy rn large ≥ cm andor locally advanced tumor intraoperative postoperative shortterm followup data analyzed result median surgical time minute range min median estimated blood loss ml range ml procedure needed conversion open rn handassisted laparoscopic rn median hospital stay hour range hour day one patient minor complication postoperative fever treated antibiotic one patient major complication small bowel obstruction necessitating reoperation tumor pathologic stage tb pathologic stage stage ta median followup month range mo six patient alive without evidence recurrence patient alive disease four patient four known metastatic disease surgery conclusion lessrn large advanced stage renal mass technically challenging operation experienced hand however safe feasible therapeutic option management tumor,2013,"Rosoff, James S; Fine, Ronnie G; Velez, Marissa C; Del Pizzo, Joseph J",Journal of endourology,,,,,,https://doi.org/10.1089/end.2012.0115; https://www.ncbi.nlm.nih.gov/pubmed/22984849/,5522038.0,12
32464,32464,43429,04o4bf4t,,Medline,Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis.,10.1016/j.dib.2018.08.209,,30263912.0,unk,performed whole transcriptome sequencing fu resistant fu sensitive tumor generated mouse model de novo carcinogenesis closely recapitulates tumor initiation progression maintenance vivo tumor generated using dmbatpa model chemically induced carcinogenesis tumorbearing mouse subsequently treated fu tumor growth well response treatment monitored measuring tumor volume twice week based measurement selected two fu resistant two fu sensitive tumor performed whole transcriptome sequencing order identify differentially expressed transcript two set data obtained deposited available ncbi sra reference number srp httpswwwncbinlmnihgovsratermsrp,2018,"Iacovides, Demetris; Loizides, Charalambos; Mitsis, Georgios; Strati, Katerina",Data in brief,,,,,,https://doi.org/10.1016/j.dib.2018.08.209; https://www.ncbi.nlm.nih.gov/pubmed/30263912/,52876090.0,12
32503,32503,43478,zlfioj6y,,Medline,Virtual surgical planning: a novel aid to robot-assisted laparoscopic partial nephrectomy.,10.1089/end.2012.0093,,22642371.0,unk,background purpose incidental detection small renal mass significantly increased last two decade advent crosssectional imaging shift stage met shift treatment modality preservation renal parenchyma prevent adverse outcome robotassisted laparoscopic partial nephrectomy ralpn need significant surgeon expertise preoperative planning imperative patient method december september virtual surgical planning vsp used consecutive patient renal tumor suspicious renalcell carcinoma undergoing ralpn single surgeon threedimensional reconstruction examined manipulated preoperatively operative plan formulated intraoperative anatomy preoperative reconstruction compared real time result total patient underwent ralpn preoperative vsp average patient age intervention year average tumor size cm range cm tumor laterality evenly distributed nephrometry score ranged p final tumor pathology result revealed malignancy complication occurred intraoperatively excellent correlation noted preoperative reconstruction intraoperative anatomy patient underwent successful partial nephrectomy positive margin final pathology result mean length surgery minute range min mean estimated blood loss ml range ml warm ischemia time ranged minute mean min data regarding postoperative renal function available six patient average loss function range conclusion implementation novel technology significantly improved ability plan ralpn preoperatively tumor depth complexity tumor resection assessed appropriate operative intervention approach planned tumor proximity vascular structure collecting system reliably predicted therefore anticipated overall advantage created safer surgical endeavor,2012,"Lasser, Michael S; Doscher, Matthew; Keehn, Aryeh; Chernyak, Victoria; Garfein, Evan; Ghavamian, Reza",Journal of endourology,,,,,,https://doi.org/10.1089/end.2012.0093; https://www.ncbi.nlm.nih.gov/pubmed/22642371/,28145837.0,12
32585,32585,43570,lp1zdquy,,Medline,COMPARISONS AMONG COMPUTED TOMOGRAPHIC FEATURES OF ADIPOSE MASSES IN DOGS AND CATS.,10.1111/vru.12445,,27804181.0,unk,better understanding ct feature different form canine feline adipose tumor would valuable improving patient management treatment purpose retrospective crosssectional study describe compare ct feature pathologically confirmed lipoma infiltrative lipoma liposarcoma sample canine feline patient total animal dog four cat total lesion lipoma infiltrative lipoma liposarcoma included study lipoma appeared round ovalshaped n wellmarginated n fatattenuating lesion infiltrative lipoma appeared homogeneous fatattenuating mass unlike lipoma commonly characterized irregular shape p linear component hyperattenuating relative surrounding fat p liposarcoma represented exclusively heterogeneous lesion soft tissue attenuating component multinodular appearance p regional lymphadenopathy n amorphous mineralization n also observed association liposarcoma computed tomography provide useful information regarding disease location extent involvement adjacent structure tumor definition shape useful parameter differentiate lipoma infiltrative lipoma presence heterogeneous mass multinodular soft tissue component associated regional lymphadenopathy mineralization feature favoring diagnosis liposarcoma,2017,"Spoldi, Elisa; Schwarz, Tobias; Sabattini, Silvia; Vignoli, Massimo; Cancedda, Simona; Rossi, Federica",Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association,,,,,,https://doi.org/10.1111/vru.12445; https://www.ncbi.nlm.nih.gov/pubmed/27804181/,26076348.0,12
32595,32595,43584,hzvp586m,,Medline,Use of high-frequency jet ventilation for percutaneous tumor ablation.,10.1007/s00270-013-0620-4,,23636246.0,unk,purpose report feasibility potential benefit highfrequency jet ventilation hfjv tumor ablation technique liver kidney lung lesion method prospective study included patient woman mean age year bearing tumor hepatic pulmonary renal tumor median size ± mm referred tumor ablation intentiontotreat fashion preoperative anesthesiology visit cancellation complication hfjv prospectively recorded anesthesia procedure duration well mean co capnea recorded computed tomography guidance used spacial coordinate anatomical target mm diameter slab slice mm slice thickness registered result hfjv used patient ten patient candidate hfjv two patient contraindication hfjv severe copd three lesion invisible hfjv requiring deep inspiration apnea tumor targeting five patient could hfjv unavailability trained anesthetic team specific complication hypercapnia related hfjv observed despite mean anesthetic duration h ventilation performed procubitus n lateral decubitus n measured internal target movement mm x yaxis slice thickness mm zaxis patient conclusion hfjv feasible patient allowing near immobility internal organ liver kidney lung tumor ablation,2014,"Denys, Alban; Lachenal, Yann; Duran, Rafael; Chollet-Rivier, Madeleine; Bize, Pierre",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0620-4; https://www.ncbi.nlm.nih.gov/pubmed/23636246/,26063319.0,12
32634,32634,43625,4fmmqvia,,Medline,The single incision laparoscopic intragastric wedge resection of gastric submucosal tumor.,10.5230/jgc.2011.11.4.225,,22324014.0,unk,purpose laparoscopic wedge resection gastric submucosal tumor may difficult case endophytic mass mass located unreachable area cardia intragastric approach useful would present experience intragastric wedge resection material method patient diagnosed gastric submucosal tumor underwent intragastric wedge resection surgery chungnam national university hospital reviewed medical record result male female mean age yearsold mean body mass index kgm location lesion cardia fundus midbody respectively mean operation time minute patient healed without complication mean postoperative hospital stay day mean size cm pathologic finding gastrointestinal stromal tumor leiomyoma conclusion single incision intragastric wedge resection gastric submucosal tumor feasible acceptable especially mass gastric upper part,2011,"Na, Jin-Uk; Lee, Sang-Il; Noh, Seung-Moo",Journal of gastric cancer,,,,,,https://doi.org/10.5230/jgc.2011.11.4.225; https://www.ncbi.nlm.nih.gov/pubmed/22324014/,8202681.0,12
32725,32725,43731,9of6ydtg,,Medline,Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.,10.1007/s00270-011-0220-0,,21748451.0,unk,purpose retrospective evaluation done clinical utility lung radiofrequency rf ablation recurrent nonsmallcell lung cancer nsclc surgical intervention method may october consecutive patient male female received curative lung rf ablation recurrent nsclc mean diameter ± cm range surgical intervention safety tumor progression rate overall survival recurrencefree survival evaluated prognostic factor evaluated multivariate analysis result total lung rf session performed pneumothorax requiring pluerosclerosis n surgical suture n grade adverse event mean followup ± month range local tumor progression found patient year overall survival rate respectively year recurrencefree survival rate respectively tumor size sex independent significant prognostic factor multivariate analysis year survival rate woman patient small tumor measuring≤ cm conclusion result suggest lung rf ablation safe useful therapeutic option obtaining longterm survival treated patient,2012,"Kodama, Hiroshi; Yamakado, Koichiro; Takaki, Haruyuki; Kashima, Masataka; Uraki, Junji; Nakatsuka, Atsuhiro; Takao, Motoshi; Taguchi, Osamu; Yamada, Tomomi; Takeda, Kan",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-011-0220-0; https://www.ncbi.nlm.nih.gov/pubmed/21748451/,10030075.0,12
32782,32782,43801,nqonweef,,Medline,Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.,10.1002/ijc.25727,,20957635.0,unk,noninvasive imaging epidermal growth factor receptor egfr headandneck squamous cell carcinoma could value select patient egfrtargeted therapy assessed dose optimization indiumdtpacetuximab incetuximab egfr imaging headandneck squamous cell carcinoma xenograft model incetuximab slowly internalized fadu cell vitro amounting × molecule cetuximab per cell hr added activity nude mouse subcutaneous fadu xenograft tumor protein dose escalation study incetuximab showed highest specific accumulation tumor protein dos μg per mouse mean tumor uptake ± idg day postinjection pi biodistribution incetuximab icetuximab determined day pi optimal protein dose tumor uptake favorable incetuximab compared icetuximab pixelbypixel analysis good correlation found intratumoral distribution incetuximab determined autoradiography egfr expression tumor section determined immunohistochemically mean r ± correlation p micro single photon emission computed tomography microspect scan clearly visualized fadu tumor day pi onward tumortobackground contrast increased day pi tumortoliver ratio ± ± ± ± day day day day pi respectively study suggests optimal cetuximab imaging dose incetuximab used visualization egfr expression headandneck squamous cell carcinoma using spect,2011,"Hoeben, Bianca A W; Molkenboer-Kuenen, Janneke D M; Oyen, Wim J G; Peeters, Wenny J M; Kaanders, Johannes H A M; Bussink, Johan; Boerman, Otto C",International journal of cancer,,,,,,https://doi.org/10.1002/ijc.25727; https://www.ncbi.nlm.nih.gov/pubmed/20957635/,205942301.0,12
32798,32798,43822,u9jnxdj1,,Medline,"EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer.",10.1002/ijc.31275,,29363116.0,unk,order identify anaplastic lymphoma kinasedriven nonsmall cell lung cancer alk nsclc patient worse outcome might require alternative therapeutic approach retrospectively analyzed stage iv case treated institution one main echinoderm microtubuleassociated proteinlike emlalk fusion variant v v v detected nextgeneration sequencing reverse transcriptionpolymerase chain reaction n progression tyrosine kinase inhibitor tki treatment evaluated according response evaluation criterion solid tumor recist need change systemic therapy emlalk fusion variant v v v found case respectively patient vdriven tumor metastatic site diagnosis case v v variant mean v p suggests increased disease aggressiveness furthermore vpositive status associated earlier failure treatment first secondgeneration alk tki median progressionfree survival pfs recist first line v month p platinumbased combination chemotherapy median pfs v month first line p cerebral radiotherapy median brain pfs month v reached cerebral radiotherapy firstline treatment p inferior overall survival v month median p thus emlalk fusion variant v highrisk feature alk nsclc determination v status considered part initial workup entity order select patient aggressive surveillance treatment strategy,2018,"Christopoulos, Petros; Endris, Volker; Bozorgmehr, Farastuk; Elsayed, Mei; Kirchner, Martina; Ristau, Jonas; Buchhalter, Ivo; Penzel, Roland; Herth, Felix J; Heussel, Claus P; Eichhorn, Martin; Muley, Thomas; Meister, Michael; Fischer, Jürgen R; Rieken, Stefan; Warth, Arne; Bischoff, Helge; Schirmacher, Peter; Stenzinger, Albrecht; Thomas, Michael",International journal of cancer,,,,,,https://doi.org/10.1002/ijc.31275; https://www.ncbi.nlm.nih.gov/pubmed/29363116/,4959977.0,12
32803,32803,43827,450hpgza,,Medline,Season of birth and primary central nervous system tumors: a systematic review of the literature with critical appraisal of underlying mechanisms.,10.1016/j.annepidem.2017.08.016,,28888834.0,unk,purpose season birth considered proxy seasonally varying exposure around perinatal period potentially implicated etiology several health outcome including malignancy method following preferred reporting item systematic review metaanalyses guideline systematically reviewed published literature association birth seasonality risk central nervous system tumor child adult result seventeen eligible study using various methodology identified encompassing case eight study child versus four eight adult showed statistically significant association birth seasonality central nervous system tumor tumor subtype occurrence pointing clustering birth mostly fall winter month albeit consistent pattern identified histologic subtype plethora perinatal factor might underlie confound association variation birth weight maternal diet pregnancy perinatal vitamin level pesticide infectious agent immune system maturity epigenetic modification conclusion inherent methodological weakness todate published individual investigation including mainly underpowered size explore hypothesis histological subtype call elegant concerted action using primary data large datasets taking also account interplay potential underlying etiologic factor,2017,"Georgakis, Marios K; Ntinopoulou, Erato; Chatzopoulou, Despoina; Petridou, Eleni Th",Annals of epidemiology,,,,,,https://doi.org/10.1016/j.annepidem.2017.08.016; https://www.ncbi.nlm.nih.gov/pubmed/28888834/,4553957.0,12
32848,32848,43877,9tnqs5jj,,Medline,MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.,10.1007/s00261-015-0436-6,,25906343.0,unk,purpose purpose study evaluate feasibility protocol optimization wholebody hybrid mrpet system performed month postlocoregional thermoablative procedure hepatocellular carcinoma hccs material method eight patient men woman mean age ± year ablated hccs constituted study population three reader interpreted study determine presence absence residual malignancy two reader independently assessed fused mrpet image compare registration accuracy two type tweighted triggered halffourier acquisition singleshot turbo spinecho turbo spinecho tweighted cartesian radial gradient echo gre image quality evaluation dgre tweighted sequence evaluated kappa statistic used measure interobserver agreement nonparametric kruskalwallis wilcoxon signedrank test used qualitative data analysis result definite residual tumor observed ablation two pet positive residual tumor isovascular mri radial dgre demonstrated significantly superior mrpet subjective coregistration comparison remaining sequence showed nonsignificant trend toward higher image quality score cartesian gre conclusion wholebody hybrid mrpet feasible part month followup postlocoregional thermoablative treatment hcc radial dgre offer improved coregistration pet data overall good image quality,2015,"Ramalho, Miguel; AlObaidy, Mamdoh; Burke, Lauren M; Dale, Brian M; Gerber, David A; Wong, Terence Z; Semelka, Richard C",Abdominal imaging,,,,,,https://doi.org/10.1007/s00261-015-0436-6; https://www.ncbi.nlm.nih.gov/pubmed/25906343/,21531047.0,12
32860,32860,43890,5hck8p6n,,Medline,ER and PR expression and survival after endometrial cancer.,10.1016/j.ygyno.2017.11.027,,29217139.0,unk,objective measure association endometrial carcinoma er pr status endometrial cancer ec survival accounting interobserver variation method intensity proportion tumor cell expression er pr ec assessed independently semiquantitatively two pathologist using digital image duplicate tumor tissue microarrays tmas case inconsistent initial assessment reviewed final scoring agreed association overall ecspecific survival hormone receptor expression intensity proportion combined assessed using cox regression analysis cindex used evaluate model discrimination addition er pr status result tumor er pr analysis possible tmas patient tmas patient respectively initial er pr scoring consistent case respectively multivariate analysis decreased er pr expression associated increased tumorrelated mortality association reached statistical significance er proportion score p er intensity score p pr combined score p decreased expression combined erpr expression associated poorer ecspecific survival decreased expression either hormone receptor alone p however hormone receptor status significantly improve mortality prediction individual case conclusion er pr expression combined using cutpoints capture variation scoring across core significantly associated ecspecific survival analysis adjusting known prognostic factor however individual level er pr expression improve mortality prediction,2018,"Smith, Deborah; Stewart, Colin J R; Clarke, Edward M; Lose, Felicity; Davies, Claire; Armes, Jane; Obermair, Andreas; Brennan, Donal; Webb, Penelope M; Nagle, Christina M; Spurdle, Amanda B",Gynecologic oncology,,,,,,https://doi.org/10.1016/j.ygyno.2017.11.027; https://www.ncbi.nlm.nih.gov/pubmed/29217139/,25217952.0,12
32901,32901,43939,2pf0qyze,,Medline,Preoperative Diagnosis and Surgical Approach of Appendiceal Mucinous Cystadenoma: Usefulness of Volcano Sign.,10.1159/000480374,,29033775.0,unk,report case appendiceal mucinous cystadenoma successfully diagnosed preoperatively treated laparoscopic resection could find volcano sign colonoscopy cystic lesion without nodule appendix computed tomography ct without malignant factor preoperative examination performed laparoscopic appendectomy including cecal wall could avoid performing excessive operation cystadenoma accurate preoperative diagnosis intraoperative finding pathological diagnosis surgery appendiceal mucocele rare disease divided pathological type hyperplasia cystadenoma cystadenocarcinoma surgical approach remain controversial oversurgery sometimes done benign tumor preoperative diagnosis difficult rupturing appendiceal tumor result dissemination based study volcano sign colonoscopy ct finding important preoperative diagnosis appendiceal mucocele furthermore think laparoscopic resection become surgical option treatment appendiceal mucocele,2017,"Shiihara, Masahiro; Ohki, Takeshi; Yamamoto, Masakazu",Case reports in gastroenterology,,,,,,https://doi.org/10.1159/000480374; https://www.ncbi.nlm.nih.gov/pubmed/29033775/,29285727.0,12
32921,32921,43960,y9vz6yih,,Medline,Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.,10.7150/jca.10970,,25663938.0,unk,novel therapy lung cancer explored nowadays local therapy tip arrow intratumoral chemotherapy administration local microwave ablation investigated several study previously proposed lipiodol ability modify microenvironment matrix current study investigated theory balbc mouse total balbc mouse divided eight group control b cisplatin c microwave microwave lipiodol e cisplatin lipiodol f microwave cisplatin g lipiodol h lipiodol cisplatin microwave lewis lung carcinoma cell line injected right back leg mouse th day tumor volume mm therapy application initiated per week four week magnetic resonance imaging performed tumor mouse died sacrificed still alive end experiment canal multifunctional spool noras mri product gmbh germany imaging survival revealed efficient tumor apoptosis group bcde f however severe toxicity observed group h follow available group second week therapy administration lipiodol current form assist efficient way distribution cisplatin microwave apoptotic effect future modification lipiodol might provide efficient method therapy enhancement combination drug microwave ablation possible efficient apoptotic effect,2015,"Hohenforst-Schmidt, Wolfgang; Zarogoulidis, Paul; Stopek, Joshua; Kosmidis, Efstratios; Vogl, Thomas; Linsmeier, Bernd; Tsakiridis, Kosmas; Lampaki, Sofia; Lazaridis, George; Mpakas, Andreas; Browning, Robert; Papaiwannou, Antonis; Drevelegas, Antonis; Baka, Sofia; Karavasilis, Vasilis; Mpoukovinas, Ioannis; Turner, J Francis; Zarogoulidis, Konstantinos; Brachmann, Johannes",Journal of Cancer,,,,,,https://doi.org/10.7150/jca.10970; https://www.ncbi.nlm.nih.gov/pubmed/25663938/,11798385.0,12
32923,32923,43962,lxyxa9sw,,Medline,Endoscopic Management of Spinal Intradural Extramedullary Tumors.,10.1055/s-0036-1594014,,27951615.0,unk,introduction posterior midline laminectomy associated risk postoperative instability spinal deformity extensive bilateral subperiosteal muscle stripping partial total facetectomy especially foraminal tumor extension increased cerebrospinal fluid leakage wound infection minimally invasive approach help microscope endoscope using hemilaminectomy found safe effective report initial experience patient using endoscopic technique material method retrospective study intradural extramedullary tumor extending two vertebral level studied pre postoperative clinical status magnetic resonance imaging done patient destandau technique used resection ipsilateral lamina medial part facet joint base spinous process undercutting opposite lamina performed dura repair done using endoscopic technique fibrin glue used reinforce repair later part study result sagittal axial diameter tumor ranged mm mm respectively four cervical two cervicothoracic five thoracic three thoracolumbar four lumbar tumor respectively patient improved total excision tumor average duration surgery blood loss minute ml respectively postoperative stay followup ranged day month respectively conclusion although study limited small number patient short followup technically demanding procedure endoscopic management intradural extramedullary tumor effective safe alternative technique microsurgery patient,2017,"Parihar, Vijay Singh; Yadav, Nishtha; Yadav, Yad Ram; Ratre, Shailendra; Bajaj, Jitin; Kher, Yatin","Journal of neurological surgery. Part A, Central European neurosurgery",,,,,,https://doi.org/10.1055/s-0036-1594014; https://www.ncbi.nlm.nih.gov/pubmed/27951615/,204984216.0,12
32932,32932,43971,9nw64suw,,Medline,Laparoscopic liver packing to protect surrounding organs during thermal ablation.,10.3109/13645706.2014.897956,,24641527.0,unk,purpose evaluate feasibility liver packing prevention injury adjacent organ thermal ablation liver tumor material method january march session patient nonresectable liver tumor treated tumor primary carcinoma metastasis isolated adjacent organ laparoscopic liver mobilization packing stereotactic radiofrequency ablation srfa comprised body fixation contrastenhanced ct planning navigation needle placement control ct needle position image fusion thermal ablation control ct image fusion liver packing removed laparoscopically thereafter complication primary success local recurrence rate analyzed result total liver lesion median size cm range cm treated laparoscopic packing could performed patient primary success rate ablation local recurrence rate one perioperative death remaining complication could managed radiological intervention despite broad surface contact thermal injury surrounding organ could prevented patient conclusion liver packing present viable safe option rfa tumor broad surface contact surrounding organ excellent local tumor control,2014,"Schullian, Peter; Weiss, Helmut; Klaus, Alexander; Widmann, Gerlig; Kranewitter, Christof; Mittermair, Christof; Margreiter, Raimund; Bale, Reto",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.3109/13645706.2014.897956; https://www.ncbi.nlm.nih.gov/pubmed/24641527/,10464276.0,12
32940,32940,43981,43qbks58,,Medline,"Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.",10.21037/qims.2017.01.02,,28275556.0,unk,background angiomyolipoma aml common renal benign tumor treatment considered symptomatic patient risk complication especially retroperitoneal bleeding correlated tumor size grade angiogenic component presence tuberous sclerosis complex tsc study report singlecenter experience use selective arterial embolization sae management symptomatic asymptomatic renal amls method retrospective monocentric study demographic imaging data medical record angiographic feature outpatient chart followup visit patient underwent prophylactic emergency sae amls january july reviewed tumor size treatment outcome assessed baseline procedure followup computed tomography ct magnetic resonance imaging mri ultrasonography used evaluate aml shrinkage renal function measured pre postprocedure result twentythree patient female male median age year range year underwent sae either treat bleeding aml n prophylactic treatment n included overall amls embolized tsc status confirmed patient immediate technical success rate patient benefitted additional procedure major complication occurred patient minor postembolization syndrome pe patient mean aml size reduction rate mean followup month range month nontsc status significantly associated better shrinkage tumor p intralesional aneurysm significantly frequent patient hemorrhagic presentation p change mean creatinine level sae conclusion sae safe effective technique manage renal amls preventive treatment well emergency setting significant reduction tumor size followup multidisciplinary approach remains fundamental especially tsc patient addition size presence intralesional aneurysm considered prophylactic treatment decision,2017,"Bardin, Florian; Chevallier, Olivier; Bertaut, Aurélie; Delorme, Emmanuel; Moulin, Morgan; Pottecher, Pierre; Di Marco, Lucy; Gehin, Sophie; Mourey, Eric; Cormier, Luc; Mousson, Christiane; Midulla, Marco; Loffroy, Romaric",Quantitative imaging in medicine and surgery,,,,,,https://doi.org/10.21037/qims.2017.01.02; https://www.ncbi.nlm.nih.gov/pubmed/28275556/,22943634.0,12
32978,32978,44024,lol6s3or,,Medline,SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody.,10.2967/jnumed.114.142141,,24982436.0,unk,unlabelled intraoperative visualization technique promise significantly improve detection resection tumor study used anticarcinoembryonic antigen cea antibody mn tagged radiolabel fluorophore irdye cw radionuclide detection intraoperative fluorescence imaging respectively method purpose prepared characterized duallabeled antibody indiethylenetriaminepentaacetic acid dtpamnirdye cw performed study mouse subcutaneous intraperitoneal ceaexpressing tumor dose escalation study determine optimal mn protein dose biodistribution study comparing duallabeled mn radiolabeled mn study determine optimal time spect fluorescence imaging injection duallabeled mn finally spect fluorescence imageguided surgery study using duallabeled antibody result optimal protein dose duallabeled mn μg per mouse yielding tumortoblood ratio within h biodistribution indtpamnirdye cw mouse subcutaneous lst tumor showed tumor uptake ± injected doseg comparable indtpamn higher accumulation liver optimal time imaging administration duallabeled antibody injection finally mouse intraperitoneally growing lst tumor nodule received indtpamnirdye cw intraperitoneal tumor nodule could localized spect imaging subsequently resected using fluorescence imageguided surgery conclusion thus showed feasibility assessment imageguided resection cea antigenexpressing tumor using duallabeled mn radionuclide detection fluorescence imaging may provide useful information improve localization tumor radical excision tumor tissue humanized mn labetuzumab available clinical use translation clinical setting next step,2014,"Rijpkema, Mark; Oyen, Wim J; Bos, Desiree; Franssen, Gerben M; Goldenberg, David M; Boerman, Otto C","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.114.142141; https://www.ncbi.nlm.nih.gov/pubmed/24982436/,20052409.0,12
33026,33026,44082,rjy12w2c,,Medline,Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution.,10.3892/ijo.2014.2376,,24718894.0,unk,correct staging prostate cancer unmet clinical need radionuclide targeting prostatespecific membrane antigen psma inlabeled capromab pendetide prostascint clinical option prostate cancer staging propose use ilabeled capromab decrease retention radioactivity healthy organ due nonresidualizing property radiolabel use label increase imaging sensitivity due advantage pet imaging modality capromab target intracellular domain psma accumulation radioactivity tumor depend internalization antigenantibody complex capromab iodinated targeting property compared indium labeled counterpart lncap xenograft dual isotope mode psmanegative xenograft pc used negative control radioiodinated capromab bound psma specifically biodistribution iincapromab showed rapid clearance iodine radioactivity liver spleen kidney bone colon tissue well tumor maximum tumor uptake ± idg iodine ± idg indium tumortonontumor ratio agent measured day postinjection pi high tumor accumulation low uptake radioactivity normal organ confirmed using micropetct day pi icapromab,2014,"Tolmachev, Vladimir; Malmberg, Jennie; Estrada, Sergio; Eriksson, Olof; Orlova, Anna",International journal of oncology,,,,,,https://doi.org/10.3892/ijo.2014.2376; https://www.ncbi.nlm.nih.gov/pubmed/24718894/,6046537.0,12
33032,33032,44090,9xxkunzt,,Medline,Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.,10.1002/cmmi.1523,,23606427.0,unk,integrin αv β receptor expressed activated endothelial cell neovascularization maintain tumor growth many radiolabeled probe utilize tight specific association arginineglycineaspartatic acid rgd peptide integrin αv β one main obstacle clinical application probe laborious multistep radiosynthesis f study dimeric rgd peptide ecrgdfk conjugated nodaga radiolabeled f simple onepot process radiolabeling yield whole process lasting min nodagaecrgdfk labeled f specific activity mbq nmol radiochemical purity could achieved logp value flabeled nodagaecrgdfk ± biodistribution study fnodagaecrgdfk cleared rapidly blood ± percentage injected dose per gram id g blood h pi mainly via kidney showed good vivo stability tumor uptake fnodagaecrgdfk ± id g h pi significantly lower reference compound galabeled nodagaecrgdfk ± id g p inlabeled nodagaecrgdfk ± id g p coinjection excess unlabeled nodagaecrgdfk along fnodagaecrgdfk resulted significantly reduced radioactivity concentration tumor ± id g αv β integrinexpressing skrc tumor could successfully visualized micropet flabeled nodagaecrgdfk conclusion nodagaecrgdfk could labeled rapidly f using direct aqueous onepot method accumulated specifically αv β integrinexpressing skrc tumor allowing visualization micropet,2013,"Dijkgraaf, Ingrid; Terry, Samantha Y A; McBride, William J; Goldenberg, David M; Laverman, Peter; Franssen, Gerben M; Oyen, Wim J G; Boerman, Otto C",Contrast media & molecular imaging,,,,,,https://doi.org/10.1002/cmmi.1523; https://www.ncbi.nlm.nih.gov/pubmed/23606427/,205650514.0,12
33050,33050,44110,dfthlmrp,,Medline,Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.,10.1016/j.urology.2010.12.028,,21324512.0,unk,objective ass efficacy morbidity microwave ablation mwa small renal tumor initial cohort patient mwa recently introduced thermal needle ablation treatment modality theoretical advantage compared radiofrequency ablation greater intratumoral temperature lack grounding pad superior convection profile however experience limited human kidney method ten patient single solidenhancing renal tumor june november received laparoscopic computed tomographyguided percutaneous mwa tertiary referral center ≥ month followup mwa performed using valleylab evident mhz mwa system w intraoperative biopsy ablation peripheral fiberoptic thermometry determine treatment endpoint patient followed contrastenhanced computed tomography month month year annually monitor tumor recurrence result followup duration male female patient mean tumor size cm range mean age year month recurrence rate defined persistent enhancement intraoperative postoperative complication rate respectively conclusion mwa resulted poor oncologic outcome significant complication rate intermediate level followup however mwa promising theoretical advantage discarded additional study considered better understand microwavetissue interaction treatment endpoint different size renal mass widespread use,2011,"Castle, Scott M; Salas, Nelson; Leveillee, Raymond J",Urology,,,,,,https://doi.org/10.1016/j.urology.2010.12.028; https://www.ncbi.nlm.nih.gov/pubmed/21324512/,27141701.0,12
33139,33139,44213,y96s0jsw,,Medline,Microwave ablation of focal hepatic malignancies regardless of size: A 9-year retrospective study of 64 patients.,10.1016/j.ejrad.2015.02.027,,25818732.0,unk,purpose retrospectively evaluate safety efficacy microwave ablation mwa treatment single focal hepatic malignancy material method institutional review board approval obtained hipaacompliant study december may patient treated mwa single hepatic lesion session hepatocellular carcinoma hcc treated patient geometric mean tumor size cm ci cm range cm metastatic colorectal cancer crc treated patient geometric mean tumor size cm ci cm range cm histologicaltypes treated patient geometric mean tumor size cm ci cm range cm kaplanmeier km method used analyze time event data chisquare correlation evaluated relationship tumor size treatment parameter result technical success rate treatment parameter tailored tumor size size increased antenna used p treatment multiple activation increased p treatment time increased p statistically significant relationship time recurrence tumor size number activation number antenna treatment time oneyear km analysis predicted likelihood local recurrence hcc patient crc metastasis patient patient metastasis median cancer specific survival patient month hcc patient month crc metastasis month histologicaltypes complication occurred session conclusion sample tumor size appear impact complete ablation rate local recurrence rate focal hepatic malignancy treated mwa,2015,"Alexander, Erica S; Wolf, Farrah J; Machan, Jason T; Charpentier, Kevin P; Beland, Michael D; Iannuccilli, Jason D; Haas, Richard H; Dupuy, Damian E",European journal of radiology,,,,,,https://doi.org/10.1016/j.ejrad.2015.02.027; https://www.ncbi.nlm.nih.gov/pubmed/25818732/,5724450.0,12
33161,33161,44240,eynb8dep,,Medline,CD74-NRG1 fusions in lung adenocarcinoma.,10.1158/2159-8290.cd-13-0633,,24469108.0,unk,unlabelled discovered novel somatic gene fusion cdnrg transcriptome sequencing lung adenocarcinoma never smoker screening lung adenocarcinoma negative known oncogenic alteration found four additional fusionpositive tumor invasive mucinous subtype mechanistically cdnrg lead extracellular expression egflike domain nrg iiiβ thereby providing ligand erbberbb receptor complex accordingly erbb erbb expression high index case expression phosphoerbb specifically found tumor bearing fusion p ectopic expression cdnrg lung cancer cell line expressing erbb erbb activated erbb pikakt pathway led increased colony formation soft agar thus cdnrg gene fusion activating genomic alteration invasive mucinous adenocarcinoma may offer therapeutic opportunity lung tumor subtype far effective treatment significance cd–nrg fusion may represent therapeutic opportunity invasive mucinous lung adenocarcinoma tumor effective treatment frequently present multifocal unresectable disease,2014,"Fernandez-Cuesta, Lynnette; Plenker, Dennis; Osada, Hirotaka; Sun, Ruping; Menon, Roopika; Leenders, Frauke; Ortiz-Cuaran, Sandra; Peifer, Martin; Bos, Marc; Daßler, Juliane; Malchers, Florian; Schöttle, Jakob; Vogel, Wenzel; Dahmen, Ilona; Koker, Mirjam; Ullrich, Roland T; Wright, Gavin M; Russell, Prudence A; Wainer, Zoe; Solomon, Benjamin; Brambilla, Elisabeth; Nagy-Mignotte, Hélène; Moro-Sibilot, Denis; Brambilla, Christian G; Lantuejoul, Sylvie; Altmüller, Janine; Becker, Christian; Nürnberg, Peter; Heuckmann, Johannes M; Stoelben, Erich; Petersen, Iver; Clement, Joachim H; Sänger, Jörg; Muscarella, Lucia A; la Torre, Annamaria; Fazio, Vito M; Lahortiga, Idoya; Perera, Timothy; Ogata, Souichi; Parade, Marc; Brehmer, Dirk; Vingron, Martin; Heukamp, Lukas C; Buettner, Reinhard; Zander, Thomas; Wolf, Jürgen; Perner, Sven; Ansén, Sascha; Haas, Stefan A; Yatabe, Yasushi; Thomas, Roman K",Cancer discovery,,,,,,https://doi.org/10.1158/2159-8290.cd-13-0633; https://www.ncbi.nlm.nih.gov/pubmed/24469108/,9165621.0,12
33198,33198,44280,t6svbort,,Medline,Thermal ablation: update and technique at a high-volume institution.,10.1007/s00261-008-9385-7,,18379836.0,unk,era nephronsparing surgery small renal tumor thermal ablation gaining popularity cryoablation radiofrequency ablation welldemonstrated shortterm oncologic efficacy safety article share current literature radiofrequency ablation technique highvolume institution case presented illustrate solution obstacle frequently encountered percutaneous ablation renal mass,2008,"Krehbiel, Kyle; Ahmad, Asma; Leyendecker, John; Zagoria, Ronald",Abdominal imaging,,,,,,https://doi.org/10.1007/s00261-008-9385-7; https://www.ncbi.nlm.nih.gov/pubmed/18379836/,7855146.0,12
33218,33218,44301,y0zo7eni,,Medline,Prevention of Postoperative Cerebrospinal Fluid Leaks After Translabyrinthine Tumor Resection With Resorbable Mesh Cranioplasty.,10.1097/mao.0000000000000835,,26208128.0,unk,objective evaluate effectiveness resorbable mesh cranioplasty reducing postoperative cerebrospinal fluid csf leak pseudomeningocele formation translabyrinthine tumor resection study design case series chart review setting tertiary academic referral center patient fiftythree consecutive case using resorbable mesh cranioplasty translabyrinthine tumor resection reviewed intervention temporal bone defect repaired dural substitute layered fat graft resorbable mesh plate secured screw main outcome measure primary outcome measure included incidence postoperative csf wound leak rhinorrhea pseudomeningocele formation surgical site infection result fiftythree case average age yr range yr analyzed average body mass index kgm range kgm average tumor size mm range mm one patient experienced csf rhinorrhea postoperative day resolved transmastoid middle ear eustachian tube packing one patient experienced surgical site infection requiring surgical debridement mesh removal month surgery compared prior translabyrinthine surgery analyzed institution using traditional fat graft closure without mesh rate postoperative csf leak significantly le using resorbable mesh cranioplasty technique p conclusion resorbable mesh cranioplasty safe effective method reduce postoperative csf leak pseudomeningocele formation translabyrinthine craniotomy tumor excision,2015,"Hunter, Jacob B; Sweeney, Alex D; Carlson, Matthew L; Wanna, George B; Rivas, Alejandro; Weaver, Kyle D; Chambless, Lola B; Thompson, Reid S; Haynes, David S; Bennett, Marc L","Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,,,,,https://doi.org/10.1097/mao.0000000000000835; https://www.ncbi.nlm.nih.gov/pubmed/26208128/,26329966.0,12
33222,33222,44306,qc3o8o7l,,Medline,Mucoepidermoid Carcinoma of the Tracheobronchial Tree.,10.14797/mdcj-11-3-192,,26634030.0,unk,primary salivary type lung cancer extremely rare intrathoracic malignancy mucoepidermoid tumor one salivary gland tumor originates submucosal gland tracheobronchial tree slowgrowing lowgrade malignant tumor surgery mainstay treatment rarely requires adjuvant therapy case report describe yearold woman presented solitary cough yet investigation found mucoepidermoid tumor originating hilum left lung,2015,"Abu Saleh, Walid K; Aljabbari, Odeaa; Ramchandani, Mahesh",Methodist DeBakey cardiovascular journal,,,,,,https://doi.org/10.14797/mdcj-11-3-192; https://www.ncbi.nlm.nih.gov/pubmed/26634030/,5185414.0,12
33258,33258,44350,4irb8e28,,Medline,Transanal Endoscopic Operation for Rectal Tumor: Short-term Outcomes and Learning Curve Analysis.,10.1097/sle.0000000000000258,,27077220.0,unk,purpose aim report outcome learning curve transanal endoscopic operation teo rectal tumor using standard laparoscopic instrument magnifying laparoscopic monitor view material method january july local excision performed using teo system consecutive patient rectal tumor patient tumor characteristic perioperative outcome prospectively assessed result median patient age year woman men mean tumor size cm mean distance anal verge cm mean operative time minute mean postoperative hospital stay day postoperative pathologic diagnosis adenocarcinoma patient adenoma patient carcinoid tumor patient leiomyoma lipoma remaining patient positive resection margin documented patient mortality associated procedure although postoperative bleeding leakage perianal fistula fecal incontinence voiding difficulty developed patient according cumulative sum cusum analysis operation time hospital stay significantly decreased case experience conclusion teo feasible safe treatment option local excision rectal tumor teo advantage precise surgical procedure stable magnifying endoscopic view however teo requires learning period careful selection patient proper indication preoperative diagnostics,2016,"Hur, Hyuk; Bae, Sung Uk; Han, Yoon Dae; Kang, Jeonghyun; Min, Byung Soh; Baik, Seung Hyuk; Lee, Kang Young; Kim, Nam Kyu","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0000000000000258; https://www.ncbi.nlm.nih.gov/pubmed/27077220/,683440.0,12
33259,33259,44352,xip58k77,,Medline,Evaluation of a minimally invasive image-guided surgery system for hepatic ablation procedures.,10.1177/1553350613508019,,24201739.0,unk,background explorer minimally invasive liver mil system us imaging create dimensional model liver intraoperatively system display position instrument relative virtual liver prospective clinical study compared intraoperative ultrasound ius laparoscopic liver ablation method patient undergoing ablation accrued clinical site procedure probe positioned standard fashion using ius position synchronously recorded using explorer system distance probe tip tumor boundary center measured ultrasound image corresponding virtual image captured explorer system result data obtained placement ablation probe procedure absolute difference ius explorer system probe tip tumor boundary distance ± mm statistically significant difference absolute difference probe tip tumor center distance ± mm statistically different mm discussion initial clinical experience explorer mil system show strong correlation ius positioning ablation probe explorer mil system promising tool provide supplemental guidance information laparoscopic liver ablation procedure,2014,"Hammill, Chet W; Clements, Logan W; Stefansic, James D; Wolf, Ronald F; Hansen, Paul D; Gerber, David A",Surgical innovation,,,,,,https://doi.org/10.1177/1553350613508019; https://www.ncbi.nlm.nih.gov/pubmed/24201739/,41459665.0,12
33289,33289,44388,capcrpah,,Medline,Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia time.,10.1186/1471-2490-13-31,,23786969.0,unk,background date elective nephronsparing surgery established method exstirpation renal tumor open partial nephrectomy remains reference standard management renal mass laparoscopic partial nephrectomy lpn continues evolve conventional technique include clamping renal vessel risking ischaemic damage clamped organ thus new technique needed combine sufficient tissue incision exstirpation tumor efficient coagulation assure haemostasis abandon renal vessel clamping lpn laserexcision renal tumor laparoscopic surgery seems logical solution method performed nephronsparing surgery without clamping renal vessel patient renal tumor exophytic position mean size mm ranging mm lasersupported lpn result regular ultrasound monitoring insertion temporary drainage showed evidence postoperative hemorrhage tumor removed histopathologically confirmed surrounding margin normal renal tissue r resection serum creatinine hemoglobin hematocrit nearly unaltered surgery conclusion experience patient confirmed laserassisted lpn without clamping renal vessel could safe gentle alternative classic partial nephrectomy patient exophytic position renal tumor,2013,"Loertzer, Hagen; Strauß, Arne; Ringert, Rolf Herrmann; Schneider, Philine",BMC urology,,,,,,https://doi.org/10.1186/1471-2490-13-31; https://www.ncbi.nlm.nih.gov/pubmed/23786969/,16615483.0,12
33325,33325,44433,ykulxnsb,,Medline,How did lomustine become standard of care in recurrent glioblastoma?,10.1016/j.ctrv.2020.102029,,32408220.0,unk,glioblastoma common malignant primary intrinsic brain tumor incidence increase age male often affected firstline management includes maximum safe surgical resection followed involvedfield radiotherapy plus concomitant six cycle maintenance temozolomide chemotherapy standard care recurrence much le well defined minority patient offered second surgery reirradiation data positive impact survival randomized trial lacking majority patient eligible salvage therapy receive systemic treatment mostly nitrosoureabased regimen depending availability bevacizumab alone various combination clinical trial lomustine alone increasingly used control arm assigning drug standardofcare position setting recurrent glioblastoma review activity lomustine treatment diffuse glioma adulthood various setting compelling data lomustine stem three randomized trial lomustine combined procarbazine vincristine pcv regimen newly diagnosed setting together radiotherapy improved survival pcv restricted patient isocitrate dehydrogenasemutant tumor agent possible exception regorafenib shown superior activity lomustine recurrent glioblastoma activity largely restricted patient tumor omethylguanine dna methyltransferase mgmt promoter methylation hematological toxicity notably thrombocytopenia often limit adequate exposure,2020-05-04,"Weller, Michael; Le Rhun, Emilie",Cancer treatment reviews,,,,,,https://doi.org/10.1016/j.ctrv.2020.102029; https://www.ncbi.nlm.nih.gov/pubmed/32408220/,218648915.0,12
33410,33410,44528,3foy3uo2,,Medline,Laparoscopic approach for Wilms tumor.,10.1097/sle.0b013e31829cebf1,,24487153.0,unk,introduction traditionally radical nephrectomy wilms tumor performed open approach advance minimally invasive surgery led application technique malignant lesion including wilms tumor aim present experience laparoscopic nephrectomy ln wilms tumor patient method four patient wilms tumor treated preoperatively chemotherapy afterwards underwent ln lymph node sampling four port placed tumor removed without morcellation endoscopic bag incision extending umbilical suprapubic port site result average age time surgery year month range mo intraoperative complication blood loss minimal case mean operative time minute range min among patient stage iv stage case mean time hospitalization day range longterm complication mean followup year month conclusion ln wilms tumor may considered option selected patient minimally invasive surgery allows surgeon follow oncologic principle required surgical treatment neoplasm provides advantage technique cancer patient preoperative chemotherapy essential decrease tumor size facilitate dissection avoiding tumor rupture,2014,"Cabezalí Barbancho, Daniel; Guerrero Ramos, Felix; López Vázquez, Francisco; Aransay Bramtot, Adolfo; Gómez Fraile, Andrés","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e31829cebf1; https://www.ncbi.nlm.nih.gov/pubmed/24487153/,11890805.0,12
33420,33420,44539,s2l8ox4q,,Medline,Minimally invasive surgery in childhood cancer: a challenging future.,10.1055/s-0034-1396419,,25478667.0,unk,introduction minimally invasive surgery mi emerged alternative open approach cancer diagnosis child ∼ year ago recently tumor resection purpose review update use mi pediatric oncological surgery past five year method author conducted systematic review paper published focusing indication result technique result new indication wilms tumor pheochromocytoma lung nodule emerged thanks growing use mi benign urological thoracic surgery satisfactory result case control study comparing mi open approach published first time classical indication neurogenic tumor robotassisted procedure shown concern result early experience solid tumor conclusion mi promising method removal thoracic abdominal malignancy long oncological principle strictly followed longterm followup mandatory delineate objective indication,2014,"Peycelon, Matthieu; Audry, Georges; Irtan, Sabine",European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie,,,,,,https://doi.org/10.1055/s-0034-1396419; https://www.ncbi.nlm.nih.gov/pubmed/25478667/,25731543.0,12
33443,33443,44569,0dxs788e,,Medline,Ablative therapies in adrenal tumors: primary and metastatic.,10.1002/jso.23191,,22806550.0,unk,large number adrenal tumor identified either incidentally associated metastatic workup cancer vast majority lesion benign prove primary secondary cancer traditionally treated surgical resection wide variety alternative le invasive therapy exist one thermal ablation examined herein,2012,"Pua, Bradley B; Solomon, Stephen B",Journal of surgical oncology,,,,,,https://doi.org/10.1002/jso.23191; https://www.ncbi.nlm.nih.gov/pubmed/22806550/,206173800.0,12
33450,33450,44578,medcr7nx,,Medline,Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.,10.3892/ijo.2016.3429,,26983776.0,unk,bombesin bn analog bind high affinity gastrinreleasing peptide receptor grprs upregulated prostate cancer used visualization prostate cancer aim study investigate influence radionuclidechelator complex biodistribution pattern inlabeled bombesin antagonist pegdpheglntrpalavalglyhisstaleunh pegrm identify optimal construct spect imaging series rm analog nterminally conjugated nota nodaga dota dotaga via peg spacer radiolabeled evaluated vitro vivo conjugate successfully labeled purity retained binding specificity grpr high stability cellular processing compound characterized slow internalization ic value low nanomolar range lower ic value positively charged natinnotapegrm ± nm higher value negatively charged natindotagapegrm ± nm kinetic binding study showed kd value picomolar range followed pattern ic data biodistribution compound studied balbc nunu mouse bearing pc prostate cancer xenograft tumor targeting biodistribution study displayed rapid clearance radioactivity blood normal organ via kidney excretion conjugate showed similar uptake tumor h pi radioactivity accumulation grprexpressing organ significantly lower dota dotagacontaining construct compared containing nota nodaga innotapegrm positively charged complex showed highest initial uptake slowest clearance radioactivity liver h pi dota dotagacoupled analog showed significantly higher tumortoorgan ratio compared nota nodagacontaining variant nodaga conjugate demonstrated best retention radioactivity tumor h pi highest contrast blood muscle bone,2016,"Mitran, Bogdan; Varasteh, Zohreh; Selvaraju, Ram Kumar; Lindeberg, Gunnar; Sörensen, Jens; Larhed, Mats; Tolmachev, Vladimir; Rosenström, Ulrika; Orlova, Anna",International journal of oncology,,,,,,https://doi.org/10.3892/ijo.2016.3429; https://www.ncbi.nlm.nih.gov/pubmed/26983776/,4680315.0,12
33476,33476,44607,pwr8i4xz,,Medline,Coexistence of DIPNECH and carotid body paraganglioma: is it just a coincidence?,10.1530/edm-19-0141,,32408270.0,unk,summary describe case yearold woman almost simultaneous appearance diffuse idiopathic pulmonary neuroendocrine cell hyperplasia dipnech carotid body paraganglioma interest year earlier patient underwent total thyroidectomy due papillary thyroid carcinoma meantime submitted mastectomy treat invasive ductal carcinoma breast order explain lesion extensive genetic study performed result showed positivity presence tumor suppressor gene palb whose presence already detected niece breast cancer patient underwent different procedure treat lesion currently symptomfree year followup learning point presence two rare neoplasm single person raise suspicion common etiology best knowledge first case show coexistence dipnech paraganglioma contribution palb gene etiology rare neoplasm possibility,2020-05-13,"Pedro, J; Cunha, F M; Neto, V; Hespanhol, V; Martins, D F; Guimarães, S; Varela, A; Carvalho, D","Endocrinology, diabetes & metabolism case reports",,,,,,https://doi.org/10.1530/edm-19-0141; https://www.ncbi.nlm.nih.gov/pubmed/32408270/,218649219.0,12
33493,33493,44624,gnr9s33s,,Medline,Laparoscopic Treatment of Sclerosing Stromal Tumor of the Ovary in a Woman With Gorlin-Goltz Syndrome: A Case Report and Review of the Literature.,10.1016/j.jmig.2015.03.002,,25764974.0,unk,gorlingoltz syndrome rare hereditary multisystemic disease multiple basal cell carcinoma odontogenic keratocysts skeletal abnormality main clinical manifestation syndrome several organ involved moreover condition associated development various benign malignant tumor even genital tract report describes rare association gorlingoltz syndrome sclerosing stromal tumor ovary ultrasound magnetic resonance imaging pattern tumor similar malignant neoplasm prompt surgical intervention histological confirmation diagnosis mandatory however benign lesion thus approached laparoscopic fertilitysparing surgery gynecologist aware possible association provide appropriate counseling woman take fertilitysparing laparoscopic approach whenever possible,2015,"Grechi, Gianluca; Clemente, Nicolò; Tozzi, Alessandra; Ciavattini, Andrea",Journal of minimally invasive gynecology,,,,,,https://doi.org/10.1016/j.jmig.2015.03.002; https://www.ncbi.nlm.nih.gov/pubmed/25764974/,5489326.0,12
33512,33512,44644,et7e0wgy,,Medline,Radiofrequency ablation and breast cancer: a review.,10.3978/j.issn.2227-684x.2014.03.05,,25083506.0,unk,background radiofrequency ablation rfa use breast cancer developing area research number published study last decade explores feasibility minimally invasive technique breast cancer treatment review discus recent data radiofrequency ablation examine current method outcome complication limitation rfa breast cancer therapy method pub med search english language article rfa breast cancer result study reviewed searched number tumor average size electrode used successfully ablated tumor tumor resected patient experienced complication ablation conclusion radiofrequency ablation emerging minimally invasive therapy small localized breast cancer currently clinical trial published directly compare rfa current standard surgical resection ultimately rfa need clinical trial evaluate oncologic outcome involving long interval followup determine survival local control disease progression becomes reasonable alternative surgical resection,2014,"Nguyen, Tiffany; Hattery, Eleanor; Khatri, Vijay P",Gland surgery,,,,,,https://doi.org/10.3978/j.issn.2227-684x.2014.03.05; https://www.ncbi.nlm.nih.gov/pubmed/25083506/,22354912.0,12
33549,33549,44684,gejpua37,,Medline,Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software.,10.1155/2019/4049287,,31641353.0,unk,purpose radiofrequency ablation rfa hepatocellular carcinoma hcc pre postinterventional contrastenhanced ct cect image usually qualitatively interpreted determine technical success eyeballing objective study evaluate feasibility quantitative assessment using nonrigid ctct coregistration algorithm material method patient treated rfa hcc retrospectively included semiautomated coregistration pre posttreatment cect performed independently two radiologist scan reliable registration tumor ablation area delineated identify side size narrowest rfa margin addition qualitative assessment performed independently two radiologist determine technical success anatomical side size narrowest margin interobserver agreement rate determined method outcome compared occurrence local tumor progression ltp result ctct coregistration technically feasible patient almost perfect interobserver agreement quantitative analysis κ interobserver agreement qualitative rfa margin analysis κ using quantitative assessment negative ablative margin found patient ltp occurring patient remaining patient quantitative analysis demonstrated complete tumor ablation ltp occurred conclusion feasibility quantitative rfa margin assessment using nonrigid coregistration pre postablation ct limited appears valuable tool predicting ltp hcc patient p,2019,"Hendriks, P; Noortman, W A; Baetens, T R; van Erkel, A R; van Rijswijk, C S P; van der Meer, R W; Coenraad, M J; de Geus-Oei, L F; Slump, C H; Burgmans, M C",Journal of oncology,,,,,,https://doi.org/10.1155/2019/4049287; https://www.ncbi.nlm.nih.gov/pubmed/31641353/,203824945.0,12
33567,33567,44705,253t8e5p,,Medline,Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.,10.1055/s-0029-1246002,,21259183.0,unk,purpose aim study evaluate efficacy microwave mw ablation liver metastasis guided bmode ultrasound u contrastenhanced u ceus material method patient woman men total liver metastasis treated percutaneous intraoperative ceusguided mw ablation primary tumor colorectal cancer n breast cancer n carcinoid tumor n gastrointestinal stromal tumor gist n median number metastasis ablated treatment session range median size maximum diameter metastasis cm range cm nineteen metastasis bigger cm metastasis smaller cm treated single needle metastasis bigger cm treated parallel needle result mw ablation session performed percutaneously n laparotomy n laparotomy combined liver resection n patient followed least month median duration month range month technical success rate clinical effectiveness complete coverage metastasis avascular coagulation zone evaluated immediate postablation ceus local tumor progression local recurrence seen treated metastasis affected patient one major complication observed form liver abscess easily resolved percutaneous drainage four minor complication observed three case pain located puncture site one case ascites ceus valuable phase ablation including preablation staging procedure planning placement mw needle tumor immediate postablation control coagulation size finally long term followup regime conclusion ceusguided mw ablation liver metastasis efficient safe ablation technique several advantage compared ablation modality,2011,"Lorentzen, T; Skjoldbye, B O; Nolsoe, C P",Ultraschall in der Medizin,,,,,,https://doi.org/10.1055/s-0029-1246002; https://www.ncbi.nlm.nih.gov/pubmed/21259183/,6039574.0,12
33631,33631,44779,orduowdi,,Medline,Initial experiences using robot-assisted central pancreatectomy with pancreaticogastrostomy: a potential way to advanced laparoscopic pancreatectomy.,10.1007/s00464-010-1324-3,,20835724.0,unk,background benign borderline malignant pancreatic tumor increasing functionpreserving minimally invasive pancreatectomy may ideal approach tumor method author retrospectively evaluated initial experience five consecutive robotic central pancreatectomy cps also compared perioperative outcome open cps performed institution result five woman study median age year range year solid pseudopapillary tumor pancreas found four patient pancreatic endocrine tumor found one patient tumor relatively small median size cm range cm remnant pancreas managed using pancreaticogastrostomy median operation time min range min median estimated intraoperative bleeding ml range ml transfusion given perioperative period median hospital stay day range day one patient experienced postoperative pancreatic fistula grade b managed using percutaneous drainage procedure operative morality noted comparative analysis open cp robotic cp group demonstrated smaller asymptomatic patient v none p tumor ± v ± cm p longer operation time ± v ± min p le intraoperative bleeding ± v ± ml p conclusion central pancreatectomy selected carefully appropriate surgical option benign borderline malignant lesion limited pancreatic neck area robotic surgical system may allow surgeon perform complex difficult laparoscopic procedure easily effectively precisely,2011,"Kang, Chang Moo; Kim, Dong Hyun; Lee, Woo Jung; Chi, Hoon Sang",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-010-1324-3; https://www.ncbi.nlm.nih.gov/pubmed/20835724/,30085352.0,12
33632,33632,44781,qdpaxp2u,,Medline,Laparoendoscopic single-site retroperitoneoscopic adrenalectomy versus conventional retroperitoneoscopic adrenalectomy: initial experience by the same laparoscopic surgeon.,10.1159/000351407,,24051557.0,unk,purpose purpose study demonstrate initial experience feasibility laparoendoscopic singlesite retroperitoneoscopic adrenalectomy lessra patient method patient undergoing conventional retroperitoneoscopic adrenalectomy compared patient undergoing lessra adrenal tumor considered benign preoperatively cm age sex laterality body mass index surgical indication time resuming oral intake tumor size operation time estimated blood loss intravenous intramuscular analgesic pethidine postoperative hospital stay compared two group analysis covariance applied analyze postoperative hospital stay time resuming oral intake result length postoperative hospital stay significantly higher conventional retroperitoneoscopic adrenalectomy group adjusted unadjusted model time resuming oral intake significant shorter lessra group significant adjusting opioid analgesic dosage conversion open conventional retroperitoneoscopic approach necessary neither complication blood transfusion group conclusion lessra benign adrenal tumor feasible surgical procedure tumor cm clinical research warranted define role le adrenal surgery prove efficacy conventional laparoscopic surgery,2013,"Wen, Sheng-Chen; Yeh, Hsin-Chih; Wu, Wen-Jeng; Chou, Yii-Her; Huang, Chun-Hsiung; Li, Ching-Chia",Urologia internationalis,,,,,,https://doi.org/10.1159/000351407; https://www.ncbi.nlm.nih.gov/pubmed/24051557/,207694862.0,12
33668,33668,44819,tngy0gfj,,Medline,Breast Contrast Enhanced MR Imaging: Semi-Automatic Detection of Vascular Map and Predominant Feeding Vessel.,10.1371/journal.pone.0161691,,27571255.0,unk,purpose obtain breast vascular map ass correlation predominant feeding vessel tumor location semiautomatic method compared conventional radiologic reading method malignant benign breast lesion included patient underwent bilateral mr imaging written informed consent obtained patient mri local ethic committee granted approval study semiautomatic breast vascular map predominant vessel detection performed mri patient semiautomatic detection depending grey level threshold manually chosen radiologist compared result two expert radiologist interobserver variability reliability semiautomatic approach assessed result anatomic analysis breast lesion revealed patient mass internal half external half subareolarcentral area regard tumor internal half based radiologic consensus demonstrated predominant feeding vessel supplied internal thoracic vessel lateral thoracic vessel thoracic vessel predominant feeding vesselp based semiautomatic detection tumor demonstrated predominant feeding vessel supplied internal thoracic vessel lateral thoracic vessel thoracic vessel predominant feeding vesselp regard tumor external half based radiologic consensus demonstrated predominant feeding vessel supplied internal thoracic vessel lateral thoracic vessel thoracic vessel predominant feeding vesselp based semiautomatic detection demonstrated predominant feeding vessel supplied internal thoracic vessel lateral thoracic vessel thoracic vessel predominant feeding vesselp excellent agreement two radiologic assessment k radiologic consensus semiautomatic assessment k found identify origin predominant feeding vessel excellent reliability semiautomatic assessment cronbachs alpha reported conclusion predominant feeding vessel location correlated breast lesion location internal thoracic artery supplied highest proportion breast tumor internal half lateral thoracic artery supplied highest proportion breast lateral tumor,2016,"Petrillo, Antonella; Fusco, Roberta; Filice, Salvatore; Granata, Vincenza; Catalano, Orlando; Vallone, Paolo; Di Bonito, Maurizio; D'Aiuto, Massimiliano; Rinaldo, Massimo; Capasso, Immacolata; Sansone, Mario",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0161691; https://www.ncbi.nlm.nih.gov/pubmed/27571255/,14610234.0,12
33698,33698,44851,dqmz8rq4,,Medline,Initial experience with dual-lumen balloon catheter injection for preoperative Onyx embolization of skull base paragangliomas.,10.3171/2015.5.jns15124,,26495945.0,unk,object paragangliomas highly vascular head neck tumor preoperative embolization often considered facilitate resection author evaluated initial experience using duallumen balloon facilitate preoperative embolization consecutive patient underwent preoperative transarterial onyx embolization assisted scepter duallumen balloon catheter object author reviewed demographic clinical record patient underwent scepterassisted onyx embolization paraganglioma followed resection descriptive statistic clinical outcome assessed result five patient jugular vagal paraganglioma identified three paragangliomas embolized single session completed staged session mean volume onyx used ml range ml twentyseven vessel selectively catheterized embolization patient required selective embolization via multiple vessel two patient required sacrifice parent vessel petrocavernous internal carotid artery vertebral artery successful balloon test occlusion one patient underwent embolization onyx alone onyx alone onyx case migration onyx achieved within tumor parenchyma mean time embolization resection day range day grosstotal resection achieved patient patient minimal residual tumor mean estimated blood loss resection ml range ml mean postoperative hematocrit level change two patient required blood transfusion one patient underwent extensive tumor penetration onyx developed temporary partial cranial nerve vii palsy resolved housebrackmann grade vi month followup one patient experienced improvement existing facial nerve weakness embolization conclusion scepter catheterbased onyx embolization seems safe effective associated excellent distal tumor vasculature penetration hold promise adjunct conventional transarterial onyx embolization paragangliomas however ease tumor penetration encourage caution practitioner may able effect comparable improvement blood loss conservative proximal onyx penetration,2016,"Ladner, Travis R; He, Lucy; Davis, Brandon J; Yang, George L; Wanna, George B; Mocco, J",Journal of neurosurgery,,,,,,https://doi.org/10.3171/2015.5.jns15124; https://www.ncbi.nlm.nih.gov/pubmed/26495945/,8783544.0,12
33710,33710,44864,m1kfwhli,,Medline,Robot-assisted partial nephrectomy for hilar tumors: perioperative outcomes.,10.1016/j.urology.2012.10.072,,23601446.0,unk,objective compare perioperative outcome robotassisted partial nephrectomy rapn hilar v nonhilar tumor material method study retrospectively reviewed patient available computed tomography scan undergoing rapn demographic data perioperative outcome result compared hilar group n nonhilar tumor group n multivariate analysis used identify predictor warm ischemia time wit estimated blood loss ebl major perioperative complication postoperative renal function result difference respect demographic variable hilar tumor higher renal radius exophyticendophytic property tumor nearness tumor deepest portion collecting system sinus anteriorposterior descriptor location relative polar line score p larger v cm p surgery hilar tumor associated greater operative time v minute p longer wit v minute p increased ebl v ml p difference noted transfusion rate length stay complication overall major positive margin postoperative estimated glomerular filtration rate showed significant difference hilar v nonhilar patient postoperative day v mlmin p last followup v mlmin p respectively multivariate analysis found hilar location independently associated increased wit without significant change ebl major complication postoperative renal function conclusion rapn represents safe effective procedure hilar tumor hilar location patient undergoing rapn highvolume institution seems associated increased risk transfusion major complication decline early postoperative renal function,2013,"Eyraud, Rémi; Long, Jean-Alexandre; Snow-Lisy, Devon; Autorino, Riccardo; Hillyer, Shahab; Klink, Joseph; Rizkala, Emad; Stein, Robert J; Kaouk, Jihad H; Haber, Georges-Pascal",Urology,,,,,,https://doi.org/10.1016/j.urology.2012.10.072; https://www.ncbi.nlm.nih.gov/pubmed/23601446/,13024635.0,12
33729,33729,44888,yzgcaxky,,Medline,Radiofrequency ablation of pulmonary neoplasm complicated by pulmonary hemorrhage.,10.1055/s-0031-1280659,,22654257.0,unk,pulmonary hemorrhage potentially serious complication radiofrequency ablation pulmonary neoplasm may occur without hemoptysis several factor influence development parenchymal hemorrhage including tumor size tumor location procedural technique radiofrequency ablation become common prompt diagnosis appropriate treatment hemorrhage vital author report case radiofrequency ablation solitary pulmonary metastasis complicated pulmonary hemorrhage hemoptysis,2011,"Dillon, P; Sato, Kent T",Seminars in interventional radiology,,,,,,https://doi.org/10.1055/s-0031-1280659; https://www.ncbi.nlm.nih.gov/pubmed/22654257/,5361462.0,12
33796,33796,44962,sdn5zve2,,Medline,Machine learning approach for prediction of hearing preservation in vestibular schwannoma surgery.,10.1038/s41598-020-64175-1,,32346085.0,unk,vestibular schwannoma patient functional hearing status surgical resection preserving hearing feasible hearing level tumor size location tumor known candidate predictor used machine learning approach predict hearing outcome vestibular schwannoma patient underwent hearing preservation surgery middle cranial fossa retrosigmoid approach reviewing medical record patient pathologically confirmed vestibular schwannoma included patient record study hearing preservation regarded positive postoperative hearing within serviceable hearing rule categorical variable included surgical approach continuous variable covered audiometric vestibular function test largest diameter tumor four different algorithm lined comparison accuracy support vector machinesvm gradient boosting machinegbm deep neural networkdnn diffuse random forestdrf average accuracy predicting hearing preservation ranged svm dnn current study first incorporate machine learning methodology prediction successful hearing preservation surgery although larger population may needed better generalization study could aid surgeon decision perform hearing preservation approach vestibular schwannoma surgery,2020-04-28,"Cha, Dongchul; Shin, Seung Ho; Kim, Sung Huhn; Choi, Jae Young; Moon, In Seok",Scientific reports,,,,,,https://doi.org/10.1038/s41598-020-64175-1; https://www.ncbi.nlm.nih.gov/pubmed/32346085/,216560038.0,12
33864,33864,45044,swm4qrr0,,Medline,PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response.,10.1007/s00270-015-1285-y,,26721589.0,unk,purpose purpose study determine relationship dose deposition measured petmri individual lesion response yttrium microsphere radioembolization material method patient undergoing lobar treatment microspheres underwent petmri within h treatment followup imaging available adequate visualization tumor available patient contour drawn simultaneously acquired petmri data dose volume histogram dvhs extracted dose map generated using voxelized dose kernel similar contour capture dimensional volumetric change tumor drawn followup imaging response analyzed using recist volumetric recist vrecist criterion result total hepatocellular carcinoma hcc neuroendocrine tumor net colorectal metastasis crc patient patient metastatic disease met inclusion criterion average dose useful predicting response responder nonresponders lesion type crc lesion alone using response criterion p minimum dose volume also useful predicting response using vrecist significant trend seen tumor type crc lesion average dose gy offered sensitivity specificity response conclusion petmri microsphere distribution showed significantly higher dvh value responder nonresponders patient crc dvh analysis microsphere distribution following treatment may important predictor response could used guide future adaptive therapy trial,2016,"Fowler, Kathryn J; Maughan, Nichole M; Laforest, Richard; Saad, Nael E; Sharma, Akash; Olsen, Jeffrey; Speirs, Christina K; Parikh, Parag J",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-015-1285-y; https://www.ncbi.nlm.nih.gov/pubmed/26721589/,13302185.0,12
33882,33882,45062,o290g0yp,,Medline,EUS-guided ethanol ablation therapy for gastric stromal tumors.,10.17235/reed.2017.5361/2017,,29271220.0,unk,eusguided fineneedle ethanol injection fni therapy type cystic solid tumor documented however reported case date gastrointestinalstromal tumor gist treated technique scarce ethanol ablation alternative treatment low rate adverse event selected case,2018,"Hernández-Ludeña, Lucía; Consiglieri, Claudia F; Gornals, Joan B",Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva,,,,,,https://doi.org/10.17235/reed.2017.5361/2017; https://www.ncbi.nlm.nih.gov/pubmed/29271220/,6049577.0,12
33901,33901,45081,u8gohh79,,Medline,Adenoid Cystic Carcinoma of Bartholin's Gland: What Is the Best Approach?,10.1159/000506485,,32408297.0,unk,background summary among vulvar cancer primary adenoid cystic carcinoma acc bartholin gland rare tumor characterized slow growth high local aggressiveness remarkable recurrence rate due rarity treatment remains challenge oncologist gynecological surgeon key message present paper report clinical radiological histological feature acc bartholin gland review literature data treatment option particular focus potential role particle radiation therapy,2020-05-14,"Barcellini, Amelia; Gadducci, Angiolo; Laliscia, Concetta; Imparato, Sara; Vitolo, Viviana; Preda, Lorenzo; Valvo, Francesca",Oncology,,,,,,https://doi.org/10.1159/000506485; https://www.ncbi.nlm.nih.gov/pubmed/32408297/,218650436.0,12
33912,33912,45093,so61sg5g,,Medline,Maxillofacial prosthodontic rehabilitation of a patient with oral complications during and after multimodality therapy for the management of oral squamous cell carcinoma.,10.1016/j.prosdent.2014.12.010,,25858211.0,unk,multimodality cancer therapy involving surgical resection chemotherapy radiation therapy frequently employed management head neck cancer patient undergone therapy face substantial challenge treatment prosthodontic rehabilitation essential tumor ablation restore function esthetic minimize interruption daily routine clinical report describes challenge faced patient undergoing multimodality therapy squamous cell carcinoma maxillary sinus stage involved prosthodontic rehabilitation,2015,"Acharya, Varun; Chambers, Mark S",The Journal of prosthetic dentistry,,,,,,https://doi.org/10.1016/j.prosdent.2014.12.010; https://www.ncbi.nlm.nih.gov/pubmed/25858211/,44355140.0,12
33945,33945,45131,7d6qbd9s,,Medline,Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.,10.1002/psc.1327,,21351319.0,unk,development suitable radioligands targeting cck receptor expressing tumor medullary thyroid carcinoma great clinical interest search best cckr binding peptide synthesized evaluated compared cck peptide asptyrmetglytrpmetaspphenh two gastrin analog commonly referred mg dgluglualatyrglytrpmetaspphenh mg dglualatyrglytrpmetaspphenh nterminal portion three peptide sequence derivatized introducing dtpaglu dota chelators allow radiolobeling iniii gaiii respectively saturation binding cellular internalization experiment performed cell overexpressing cckr acckr compound showed kd value nm range internalized similar rate cck receptor overexpressing cell biodistribution experiment showed higher specific uptake mgbased compound compared conjugate containing cck mg peptide sequence higher retention level mgbased peptide associated markedly elevated undesired kidney uptake compared compound current indication suggest glu nterminal residue improving peptide stability receptormediated tumor uptake cause unacceptably high kidney retention although displaying lower absolute tumor uptake value dotacoupled cck peptide provided best tumor kidney uptake ratio appears suitable lead compound improvement radiopharmaceutical property,2011,"Tornesello, Anna Lucia; Aurilio, Michela; Accardo, Antonella; Tarallo, Laura; Barbieri, Antonio; Arra, Claudio; Tesauro, Diego; Morelli, Giancarlo; Aloj, Luigi",Journal of peptide science : an official publication of the European Peptide Society,,,,,,https://doi.org/10.1002/psc.1327; https://www.ncbi.nlm.nih.gov/pubmed/21351319/,5115731.0,12
33959,33959,45148,6inmzfio,,Medline,Endoscopic extended transsphenoidal resection of craniopharyngiomas: nuances of neurosurgical technique.,10.3171/2014.7.focus14364,,25270129.0,unk,endoscopic approach midline ventral skull base extensively developed refined resection cranial base tumor past several year technique improved degree resection complication rate proven comparable transcranial approach visual outcome may better via endoscopic endonasal surgery hospital stay recovery time often shorter yet progress made steep learning curve associated technique hampered widespread implementation adoption author address obstacle coupling thorough description technical nuance endoscopic endonasal craniopharyngioma resection detailed illustration important step operation traditionally transsphendoidal approach craniopharyngiomas restricted lesion mostly confined sella however recently endoscopic endonasal resection frequently employed extrasellar purely third ventricle craniopharyngiomas whose typical retrochiasmatic location make ideal candidate endoscopic transnasal surgery endonasal endoscopic approach offer many advantage including direct access long axis tumor early tumor debulking minimal manipulation optic apparatus precise visualization tumor plane particularly along undersurface chiasm roof third ventricle minimalaccess corridor obviates need brain retraction although much emphasis placed technical tenet exposure get article focus nuance tumor resection three operative video illustrate discussion technical tenet,2014,"Conger, Andrew R; Lucas, Joshua; Zada, Gabriel; Schwartz, Theodore H; Cohen-Gadol, Aaron A",Neurosurgical focus,,,,,,https://doi.org/10.3171/2014.7.focus14364; https://www.ncbi.nlm.nih.gov/pubmed/25270129/,34801248.0,12
33976,33976,45166,u8c3onue,,Medline,The Falciform Ligament for Mesenteric and Portal Vein Reconstruction in Local Advanced Pancreatic Tumor: A Surgical Guide and Single-Center Experience.,10.1155/2018/2943879,,30364084.0,unk,background since local tumor infiltration mesentericportal axis might represent challenging assignment curative intended resectability pancreatic surgery appropriate technique venous reconstruction essential study acknowledge falciform ligament feasible convenient substitute mesenteric portal vein reconstruction high reliability patency local advanced pancreatic tumor method retrospective singlecenter analysis june january total eleven consecutive patient underwent pancreatic resection venous reconstruction using falciform ligament among venous resection performed nine case wedge two case full segment patency rate perioperative detail reviewed result mean clamping time mesentericportal blood flow min perioperative mortality rate mean duplex ultrasonography nine patient shown patent day discharge two case revealed entire occlusion mesentericportal axis orthograde flow demonstrated mean value cm patent graft discharge revealed persistent patency within various followup assessment conclusion falciform ligament appears feasible reliable autologous tissue venous blood flow reconstruction high postoperative patency especially possibility customizing graft dimension individual need based local finding allows optimal size matching conduit risk stenosis andor segmental occlusion may thus reduced,2018,"Malinka, T; Klein, F; Denecke, T; Pelzer, U; Pratschke, J; Bahra, M","HPB surgery : a world journal of hepatic, pancreatic and biliary surgery",,,,,,https://doi.org/10.1155/2018/2943879; https://www.ncbi.nlm.nih.gov/pubmed/30364084/,53026698.0,12
33990,33990,45182,gc1116ac,,Medline,S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501.,10.1111/1759-7714.13319,,32020735.0,unk,thymic carcinoma rare epithelial tumor thymus poor prognosis multimodal approach important treatment recently number study indicated treatment effective thymic carcinoma plus cisplatin concurrent radiotherapy commonly used treatment malignancy including nonsmall cell lung cancer nsclc addition safety confirmed reported marked effect thymic carcinoma therefore conducted phase ii study plus cisplatin concurrent thoracic radiotherapy locally advanced thymic carcinoma overall response rate employed primary endpoint secondary endpoint overall survival progressionfree survival safety,2020-02-05,"Fukuda, Minoru; Funaki, Soichiro; Yamazaki, Takuya; Sato, Shuntaro; Mukae, Hiroshi; Takenoyama, Mitsuhiro; Fukuoka, Junya; Nabeshima, Kazuki; Tateyama, Hisashi; Ashizawa, Kazuto; Hara, Masaki; Seto, Takashi; Okumura, Meinoshin; Sugio, Kenji",Thoracic cancer,,,,,,https://doi.org/10.1111/1759-7714.13319; https://www.ncbi.nlm.nih.gov/pubmed/32020735/,211034835.0,12
34004,34004,45198,ohb5gs3d,,Medline,Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone.,10.1126/scitranslmed.aao5726,,30068572.0,unk,intravital multiphoton microscopy impm mouse provides access cellular molecular mechanism metastatic progression cancer underlying interaction tumor stroma whereas impm malignant disease performed soft tissue noninvasive impm solid tumor bone lacking combined miniaturized tissueengineered bone construct nude mouse skin window noninvasively repetitively monitor prostate cancer lesion threedimensional impm vivo ossicle developed large central cavity containing mature bone marrow surrounded thin cortex enabled tumor implantation longitudinal impm week tumor grew inside bone cavity along cortical bone interface induced niche osteoclast activation focal osteolysis interventional bisphosphonate therapy reduced osteoclast kinetics osteolysis without perturbing tumor growth indicating dissociation tumorstroma axis ossicle window high cavitytocortex ratio longterm functionality thus allows mechanistic dissection reciprocal epithelial tumorbone interaction therapy response,2018,"Dondossola, Eleonora; Alexander, Stephanie; Holzapfel, Boris M; Filippini, Stefano; Starbuck, Michael W; Hoffman, Robert M; Navone, Nora; De-Juan-Pardo, Elena M; Logothetis, Christopher J; Hutmacher, Dietmar W; Friedl, Peter",Science translational medicine,,,,,,https://doi.org/10.1126/scitranslmed.aao5726; https://www.ncbi.nlm.nih.gov/pubmed/30068572/,51893175.0,12
34045,34045,45249,anzxno28,,Medline,Development of (99m)Tc-N4-NIM for molecular imaging of tumor hypoxia.,10.1155/2012/828139,,22719210.0,unk,nitro group nitroimidazole nim enters tumor cell bioreductively activated fixed hypoxia cell tetraazacyclotetradecane n shown stable chelator mtc present study aimed develop mtccyclamnitroimidazole mtcnnim tumor hypoxia imaging nnim precursor synthesized reacting noxalate dibromopropanenim yielded total synthesis cell uptake mtcnnim mtcn obtained rat mammary tumor cell mesothelioma cell well plate tissue distribution mtcnnim evaluated breasttumorbearing rat hr tumor oxygen tension measured using oxygen probe planar imaging performed tumorbearing rat rabbit model radiochemical purity mtcnnim hplc cell uptake mtcnnim higher mtcn cell line biodistribution mtcnnim showed increased tumortoblood tumortomuscle count density ratio function time oxygen tension tumor tissue mmhg compared mmhg normal muscle tissue planar imaging study confirmed tumor could visualized clearly mtcnnim animal model efficient synthesis nnim achieved mtcnnim novel hypoxic probe may useful evaluating cancer therapy,2012,"Ali, Mohammad S; Kong, Fan-Lin; Rollo, Alex; Mendez, Richard; Kohanim, Saady; Smith, Daniel Lee; Yang, David J",Journal of biomedicine & biotechnology,,,,,,https://doi.org/10.1155/2012/828139; https://www.ncbi.nlm.nih.gov/pubmed/22719210/,14224215.0,12
34081,34081,45292,wpz3rno2,,Medline,Primary inflammatory myofibroblastic tumor of the stomach in an adult woman: a case report and review of the literature.,10.1186/1477-7819-11-35,,23374227.0,unk,inflammatory myofibroblastic tumor defined histologically distinctive lesion uncertain behaviour term inflammatory myofibroblastic tumor commonly referred pseudostumor denotes pseudosarcomatous inflammatory lesion contains spindle cell myofibroblasts plasma cell lymphocyte histiocyte exhibit variable biological behavior range frequently benign lesion aggressive variant inflammatory myofibroblastic tumor mostly occurs soft tissue child young adult lung commonly affected site recognized anatomic localization involved inflammatory myofibroblastic tumor adult rare especially stomach present case year old woman primary inflammatory myofibiroblastic tumor stomach review literature,2013,"Bjelovic, Milos; Micev, Marjan; Spica, Bratislav; Babic, Tamara; Gunjic, Dragan; Djuric, Aleksandra; Pesko, Predrag",World journal of surgical oncology,,,,,,https://doi.org/10.1186/1477-7819-11-35; https://www.ncbi.nlm.nih.gov/pubmed/23374227/,6850105.0,12
34090,34090,45301,201duxkc,,Medline,Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma.,10.1159/000355257,,24281025.0,unk,objective developed novel technique extractedoverlay function ctmrultrasonography u fusion imaging radiofrequency ablation rfa tumor extracted ctmr image virtual ablative margin arbitrary thickness overlaid u usefulness function investigated preliminary report method volume data extracted tumor virtual ablative margin created imageprocessing workstation transported u unit equipped ctmrus fusion imaging system positional registration u transported image extracted tumor ablative margin could overlaid u rfa using function electrode inserted targeting overlaid tumor ablative safety margin mm u treatment effect evaluated dynamic ct treatment result consecutive hepatocellular carcinoma hccs underwent rfa using function retrospectively analyzed result complete tumor ablation achieved hccs treatment session respectively conclusion due visualization extracted tumor ablative safety margin u image even ablation function useful treatment planning guidance rfa,2013,"Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Kogita, Sachiyo; Sawai, Yoshiyuki; Fukuda, Kazuto; Hori, Masatoshi; Kudo, Masatoshi; Murakami, Takamichi",Digestive diseases,,,,,,https://doi.org/10.1159/000355257; https://www.ncbi.nlm.nih.gov/pubmed/24281025/,46506745.0,12
34098,34098,45310,vk3q0t63,,Medline,Robot-assisted low anterior resection after aluminum potassium sulfate and tannic acid sclerosing therapy for internal hemorrhoids.,10.1186/s40792-019-0715-5,,31664540.0,unk,background internal hemorrhoid common anal disease aluminum potassium sulfate tannic acid alta injection new sclerosing therapy treatment internal hemorrhoid although alta injection widely used previous report rectal cancer patient underwent robotassisted low anterior resection roblar alta injection treat internal hemorrhoid case presentation yearold man rectal cancer presented hospital alta injection month presentation clinic due hematochezia internal hemorrhoid rectal tumor located cm anal verge roblar da vinci xi system performed patient sclerosis stump anal side made difficult transect rectum linear stapler required multiple repeat compression smartclamp feedback anastomosis doublestapling technique constructed diverting ileostomy conclusion although alta injection promising strategy internal hemorrhoid rectal cancer excluded sclerosing therapy,2019,"Itatani, Yoshiro; Okada, Tomoaki; Kawada, Kenji; Hida, Koya; Oshima, Nobu; Inamoto, Susumu; Mizuno, Rei; Okuchi, Yoshihisa; Sakai, Yoshiharu",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-019-0715-5; https://www.ncbi.nlm.nih.gov/pubmed/31664540/,204962413.0,12
34101,34101,45313,ikwx4z9t,,Medline,Single-incision laparoscopic surgery using an articulating monopolar for juvenile cystic adenomyoma.,10.3109/13645706.2013.789060,,23590394.0,unk,demonstrate feasibility singleincision laparoscopic surgery sils using novel monopolar cautery technique based conventional multiport laparoscopic surgery patient juvenile cystic adenomyoma jca yearold woman severe dysmenorrhea cm uterine lesion diagnosed jca cm absorbable string tied tumor parenchyma used extract tumor end string positioned extracorporeally intraabdominal part string adjacent anchored tumor grasped laparoscopic needle holder clarifying incision line surrounding tumor lesion completely excised using singleuse articulating hook monopolar cautery hysterotomy site sutured using barbed string complication occurred intraoperatively dysmenorrhea significantly improved three month surgery sils jca feasible minimally invasive surgery woman desiring esthetic benefit,2013,"Kumakiri, Jun; Kikuchi, Iwaho; Sogawa, Yuko; Jinushi, Makoto; Aoki, Yoichi; Kitade, Mari; Takeda, Satoru",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.3109/13645706.2013.789060; https://www.ncbi.nlm.nih.gov/pubmed/23590394/,5286322.0,12
34139,34139,45361,gqap46xv,,Medline,Simultaneous resection of colorectal cancer and liver metastases in the right lobe using pure laparoscopic surgery.,10.1007/s00595-013-0801-4,,24343172.0,unk,common resect colorectal cancer laparoscopic surgery hepatectomy become standard treatment patient colorectal cancer resectable liver metastasis resection liver tumor done partly laparoscopic surgery however metastatic tumor right lobe often difficult resect laparoscopically furthermore simultaneous resection colorectum liver may also difficult study evaluated new method resect colorectal cancer liver metastasis right lobe laparoscopic surgery two case presented underwent total laparoscopic resection right lobe tumor associated laparoscopic colorectal resection metastatic tumor right lobe first resected left hemiprone position colorectal cancer resected lithotomy position method resecting right lobe liver tumor colorectal cancer safe feasible mean duration surgery min mean blood loss ml postoperative course uneventful selected patient laparoscopic hepatectomy right lobe synchronous metastatic tumor safely performed simultaneously colorectal surgery,2014,"Ando, Koji; Oki, Eiji; Ikeda, Tetsuo; Saeki, Hiroshi; Ida, Satoshi; Kimura, Yasue; Soejima, Yuuji; Morita, Masaru; Shirabe, Ken; Kusumoto, Tetuya; Maehara, Yoshihiko",Surgery today,,,,,,https://doi.org/10.1007/s00595-013-0801-4; https://www.ncbi.nlm.nih.gov/pubmed/24343172/,2892319.0,12
34144,34144,45367,7256sawo,,Medline,Strategic Approach to the Splenic Artery in Laparoscopic Spleen-preserving Distal Pancreatectomy.,10.1097/sle.0000000000000182,,26121549.0,unk,background laparoscopic spleenpreserving distal pancreatectomy lspdp ideal procedure selected patient benign lowgrade malignant tumor bodytail pancreas describe procedure experience splenic vesselpreserving lspdp svplspdp retrospective case series method six consecutive patient underwent svplspdp january september evaluated course splenic artery preoperative computed tomography applied individualized approach superior approach inferior approach splenic artery result operation successful median surgical duration minute median blood loss ml pathologic examination revealed case insulinoma case solid pseudopapillary tumor case pancreatic metastasis renal carcinoma conclusion performing svplspdp effective make strategic choice different approach according course splenic artery,2015,"Inoko, Kazuho; Ebihara, Yuma; Sakamoto, Keita; Miyamoto, Noriyuki; Kurashima, Yo; Tamoto, Eiji; Nakamura, Toru; Murakami, Soichi; Tsuchikawa, Takahiro; Okamura, Keisuke; Shichinohe, Toshiaki; Hirano, Satoshi","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0000000000000182; https://www.ncbi.nlm.nih.gov/pubmed/26121549/,6543166.0,12
34184,34184,45414,mop6z78t,,Medline,Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.,10.2967/jnumed.112.106609,,23100452.0,unk,unlabelled mesoporous silica nanoparticles msns explored carrier material stable isotope ho neutron capture subsequent therapeutic radionuclide ho halflife h use radionuclide therapy ovarian cancer metastasis method homsns prepared using hoacetylacetonate mcm silica particle stability determined irradiation nuclear reactor reactor power mw thermal neutron flux approximately × neutronscms spectct tissue biodistribution study performed intraperitoneal administration homsns skov ovarian tumorbearing mouse radiotherapeutic efficacy studied using petct ffdg determine tumor volume monitoring survival result holmiummsns able withstand long irradiation time nuclear reactor release ho significant dilution spectct image tissue distribution result revealed homsns accumulated predominantly tumor ± injected doseg h ± injected doseg wk intraperitoneal administration petct image showed reduced ffdg uptake tumor correlated marked increase survival treatment approximately mbq homsns conclusion retention holmium nanoparticles irradiation vivo intraperitoneal administration well efficacy extending survival tumorbearing mouse underscore potential radiotherapeutic agent ovarian cancer metastasis,2013,"Di Pasqua, Anthony J; Yuan, Hong; Chung, Younjee; Kim, Jin-Ki; Huckle, James E; Li, Chenxi; Sadgrove, Matthew; Tran, Thanh Huyen; Jay, Michael; Lu, Xiuling","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.112.106609; https://www.ncbi.nlm.nih.gov/pubmed/23100452/,7107050.0,12
34246,34246,45486,3fpmflao,,Medline,Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.,10.1016/j.surg.2011.02.022,,21683859.0,unk,background tumor size criterion staging nonfunctioning pancreatic endocrine tumor well predictor outcome curative resection study analyzes correlation tumor size malignancy patient nonfunctioning pancreatic endocrine tumor method patient nonfunctioning pancreatic endocrine tumor underwent curative resection r institution considered clinicopathologic characteristic compared among different group according tumor size univariate multivariable analysis performed result study period patient identified overall patient tumor size ≤ cm group tumor size cm ≤ cm group tumor size cm group tumor ≤ cm frequently incidentally discovered group v group v group p benign group v group v group p presence nonfunctioning pancreatic endocrine tumor cm nonincidental diagnosis tumor independent predictor malignancy multivariable analysis none patient pancreatic endocrine tumor ≤ cm incidentally diagnosed died disease conclusion strict correlation tumor size malignancy nonfunctioning pancreatic endocrine tumor demonstrated nonoperative management could advocated tumor ≤ cm discovered incidentally,2011,"Bettini, Rossella; Partelli, Stefano; Boninsegna, Letizia; Capelli, Paola; Crippa, Stefano; Pederzoli, Paolo; Scarpa, Aldo; Falconi, Massimo",Surgery,,,,,,https://doi.org/10.1016/j.surg.2011.02.022; https://www.ncbi.nlm.nih.gov/pubmed/21683859/,5208453.0,12
34251,34251,45494,4sjh9rq7,,Medline,Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.,10.1016/j.jvir.2012.02.014,,22513393.0,unk,purpose retrospectively investigate incidence risk factor phrenic nerve injury radiofrequency rf ablation lung tumor material method study included rf ablation procedure lung tumor evaluate development phrenic nerve injury chest radiograph obtained procedure examined phrenic nerve injury assumed developed diaphragmatic level elevated procedure identify risk factor phrenic nerve injury multiple variable compared case phrenic nerve injury randomly selected control using univariate analysis multivariate analysis performed identify independent risk factor result evaluation phrenic nerve injury chest radiograph possible procedure evidence phrenic nerve injury developed case univariate analysis revealed larger tumor size ≥ mm p proximity phrenic nerve tumor mm p use larger electrode array diameter noninsulated tip length ≥ cm p higher maximum power applied ablation ≥ w p significantly associated development phrenic nerve injury multivariate analysis demonstrated proximity phrenic nerve tumor mm p significant independent risk factor conclusion incidence phrenic nerve injury rf ablation proximity phrenic nerve tumor independent risk factor phrenic nerve injury,2012,"Matsui, Yusuke; Hiraki, Takao; Gobara, Hideo; Uka, Mayu; Masaoka, Yoshihisa; Tada, Akihiro; Toyooka, Shinichi; Mitsuhashi, Toshiharu; Mimura, Hidefumi; Kanazawa, Susumu",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2012.02.014; https://www.ncbi.nlm.nih.gov/pubmed/22513393/,20506620.0,12
34309,34309,45557,xysad40m,,Medline,Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.,10.1186/s40644-016-0061-9,,26873307.0,unk,background primary epithelial ovarian carcinoma subclassified serous mucinous endometrioid clear cell subtypes neoadjuvant chemotherapy become alternative treatment option past several year serous carcinoma common subtype known chemotherapysensitive tumor hand mucinous clear cell carcinoma known chemotherapyresistive therefore may meaningful estimate subtype ovarian carcinoma using imaging modality purpose study study whether ct mri determine subtypes epithelial ovarian cancer method imaging clinical finding obtained consecutive patient primary ovarian carcinoma retrospectively analyzed fortyfour patient serous carcinoma mucinous carcinoma clear cell carcinoma endometrioid carcinoma studied bilateralism morphological type tumor diameter solid portion ratio relative signal intensity twi dwi contrast ratio endometriosis mri calcification peritoneal dissemination lymph node metastasis clinical staging thromboembolism ct also studied tumor marker serum calcium concentration parameter statistically analyzed univariate multivariate analysis result serous carcinoma showed significantly higher incidence bilateral disease smaller tumor size higher signal intensity dwi le frequent hypercalcemia ca level significantly higher mucinous carcinoma tumor appeared multilocular cystic mass clear cell carcinoma appeared unilateral disease larger solid portion hypercalcemia younger patient endometrioid carcinoma showed lower incidence intraperitoneal dissemination conclusion ct mri combined clinical data especially tumor marker presence paraneoplastic syndrome could partly predict epithelial ovarian cancer subtypes,2016,"Tanaka, Yumiko Oishi; Okada, Satoshi; Satoh, Toyomi; Matsumoto, Koji; Oki, Akinori; Saida, Tsukasa; Yoshikawa, Hiroyuki; Minami, Manabu",Cancer imaging : the official publication of the International Cancer Imaging Society,,,,,,https://doi.org/10.1186/s40644-016-0061-9; https://www.ncbi.nlm.nih.gov/pubmed/26873307/,10517013.0,12
34312,34312,45563,rojq0kg0,,Medline,Laparoscopic Resection of An Extragastrointestinal Stromal Tumor in the Presacral Area.,10.1016/j.jmig.2018.10.023,,30395935.0,unk,study objective show surgical video retroperitoneal extragastrointestinal stromal tumor resected laparoscopic approach presacral area design case report canadian task force classification iii local ethic committee waived requirement approval setting small proportion extragastrointestinal stromal tumor egists located retroperitoneal region insufficient data clinical pathologic feature longterm followup tumor case reported presacral region literature gold standard treatment egists complete surgical excision mass possible en bloc excision surrounding tissue important patient yearold woman patient provided informed consent use image video procedure intervention stepbystep illustration resection retroperitoneal egist presacral area patient yearold gravida para white woman presented abdominal pain month magnetic resonance imaging showed cm diameter solid mass localized presacral area laboratory test result tumor biomarkers follows cancer antigen ca uml normal value uml ca uml normal value uml carcinoembryonic antigen ngml normal value ngml ca uml normal value uml malignancy suspicion gastroscopy colonoscopy performed revealed abnormality papanicolaou smear endometrial biopsy result negative preparation patient laparoscopy performed placement mm umbilical port three mm abdominal port pelvis abdomen explored revealed cm retroperitoneal mass presacral area peritoneum overlying presacral mass incised retroperitoneum explored given proximity mass left ureterolysis performed mass located left internal iliac vein dissected carefully retroperitoneal attachment resected presacral mass removed without complication order widen abdominal incision posterior colpotomy performed culdesac equal distance uterosacral ligament endobag covidien dublin ireland introduced mm port site posterior colpotomy specimen removed endobag posterior colpotomy measurement main result procedure performed without complication patient uneventful postoperative course discharged home postoperative day pathology revealed cm retroperitoneal egist negative margin immunohistochemistry measurement revealed hematoxylineosin cd positivity cd cd desmin dog negativity cell type mixed spindle epithelioid type mitotic rate highpower field patient disease free since completion surgery conclusion laparoscopic complete resection retroperitoneal egist presacral area successfully performed patient patient presented u example showing minimally invasive procedure used treatment type tumor presacral area key point operation control relationship vascular structure ureter tumor every step avoid injury,2018,"Sezgin, Burak; Camuzcuoğlu, Aysun; Camuzcuoğlu, Hakan",Journal of minimally invasive gynecology,,,,,,https://doi.org/10.1016/j.jmig.2018.10.023; https://www.ncbi.nlm.nih.gov/pubmed/30395935/,53245467.0,12
34482,34482,45765,w712y2k8,,Medline,Scatter imaging during lung stereotactic body radiation therapy characterized with phantom studies.,10.1088/1361-6560/ab9355,,32408276.0,unk,collecting photon scattered therapy beam scatter imaging creates image treated volume two phantom used ass possible application scatter imaging markerless tracking lung tumor stereotactic body radiation therapy sbrt treatment scatterimaging camera assembled csi flatpanel detector mm diameter pinhole collimator scatter image collected irradiation phantom megavoltage photon ass scatter image quality spherical phantom lung tumor cm diameter placed inside static anthropomorphic phantom show efficacy technique moving target cm diameter position simulated tumor tracked scatter image sinusoidal motion mm amplitude hz frequency dynamic lung phantom openfield dynamic conformal arc dca volumetric modulated arc therapy vmat delivery anatomical feature identifiable static phantom scatter image collected mu delivered dose cm diameter lung tumor contrasttonoise ratio contrasttonoise ratio increase tumor size delivered dose dynamic motion position cm diameter lung tumor identified rootmeansquare error mm open field frame integration dca vmat respectively based phantom study scatter imaging potential technique markerless lung tumor tracking sbrt without additional imaging dose quality scatter image may collected low clinically relevant dos mu scatter image capable submillimeter tracking precision modulation decrease accuracy,2020-05-14,"Jones, Kevin C; Turian, Julius V; Redler, Gage; Cifter, Gizem; Strologas, John; Templeton, Alistair; Bernard, Damian; Chu, James C H",Physics in medicine and biology,,,,,,https://doi.org/10.1088/1361-6560/ab9355; https://www.ncbi.nlm.nih.gov/pubmed/32408276/,218646806.0,12
34516,34516,45803,pteluzem,,Medline,Sternal metastasis of breast cancer: ex vivo hypothermia and reimplantation.,10.1016/j.athoracsur.2010.08.029,,21256319.0,unk,breast cancer frequently metastasizes bone sternum involved usually present solitary lesion case resection indicated including intention cure case report describes technique complete exeresis sternum ex vivo repair hypothermia reimplantation cryosurgery wellknown technique resect bone metastasis procedure used patient followup year show evidence tumor recurrence excellent result aesthetic level,2011,"Rosenberg, Moisés; Castagno, Aldo; Nadal, Jorge; Rosales, Adolfo; Pueyrredon, Erik Pebe; Patané, Ana K",The Annals of thoracic surgery,,,,,,https://doi.org/10.1016/j.athoracsur.2010.08.029; https://www.ncbi.nlm.nih.gov/pubmed/21256319/,1647296.0,12
34572,34572,45868,mxmdvjy7,,Medline,Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma.,10.1080/2162402x.2018.1550342,,30723580.0,unk,radiofrequency ablation rfa colorectal liver metastasis activates specific tcell response ineffective avoiding recurrence recently local immunomodulation garnered interest way improve immune response interested improving rfa immune response priming propose curative treatment colorectal cancer crc based antitumor immunity first demonstrated rfa increase tumor infiltrating lymphocyte secondary distant tumor patient mouse model could avoid relapse remarkably rfa situ immunomodulation gmcsfbcg hydrogel induced complete cure microscopic secondary lesion mouse related strong specific immune response demonstrated immune escape large secondary lesion reversed addition systemic pd blockade situ immunomodulation lack effective distant immune response patient treated rfa confirmed relevance new combination strategy increasing situ priming response radiofrequency ablation provides effective adjuvant induce abscopal effect case large lesion synergy pd blockade inhibitor ineffective alone single rfa situ immunomodulation could lead reconsideration use checkpoint inhibition metastatic ms crc,2019,"Lemdani, Katia; Mignet, Nathalie; Boudy, Vincent; Seguin, Johanne; Oujagir, Edward; Bawa, Olivia; Peschaud, Frédérique; Emile, Jean-François; Capron, Claude; Malafosse, Robert",Oncoimmunology,,,,,,https://doi.org/10.1080/2162402x.2018.1550342; https://www.ncbi.nlm.nih.gov/pubmed/30723580/,59605440.0,12
34581,34581,45880,pyz6cny0,,Medline,Endoscopic specimen pouch technique for removal of giant fibroadenomas of the breast.,10.1016/j.jpedsurg.2012.01.064,,22498401.0,unk,giant juvenile cellular fibroadenoma breast common tumor present adolescent girl benign tumor exceed cm diameter giant fibroadenoma historically necessitated large incision remove mass resulting large unsightly scar describe novel use endoscopic specimen pouch facilitate removal large tumor minimal incision patient followup patient excellent cosmetic outcome recurrence postoperative complication,2012,"Cheng, Philip J; Vu, Lan T; Cass, Darrell L; Hicks, M John; Brandt, Mary L; Kim, Eugene S",Journal of pediatric surgery,,,,,,https://doi.org/10.1016/j.jpedsurg.2012.01.064; https://www.ncbi.nlm.nih.gov/pubmed/22498401/,33769842.0,12
34630,34630,45936,6v06t0ay,,Medline,Intraductal papillary mucinous neoplasm in an annular pancreas: a case report.,10.1186/s40792-015-0068-7,,26943411.0,unk,annular pancreas rare anomaly ring pancreatic tissue encircles second portion duodenum herein report case involving yearold japanese man intraductal papillary mucinous neoplasm ipmn pancreas imaging study showed pancreatic tissue encircled descending part duodenum mmdiameter cystic tumor present annular segment leading diagnosis pancreatic ipmn limited pancreatic resection successfully performed careful division annular segment second portion duodenum postoperative course uneventful patient pancreatic function retained without need supplementation best knowledge first report ipmn occurring annular segment pancreas limited resection pancreatic annular segment feasible surgical treatment noninvasive ipmn annular pancreas,2015,"Kobayashi, Shinichiro; Kamohara, Yukio; Nagata, Yasuhiro; Ito, Masahiro; Fujioka, Hikaru",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-015-0068-7; https://www.ncbi.nlm.nih.gov/pubmed/26943411/,37560676.0,12
34644,34644,45951,sj0u7t60,,Medline,Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process.,10.1007/s10585-018-9873-2,,29335811.0,unk,surgery remains curative treatment modality colorectal cancer stage including stage iv resectable liver metastasis emerging evidence stress response caused surgery well perioperative therapy anesthesia analgesia may promote growth preexisting micrometastasis potentially initiate tumor dissemination therapeutically targeting perioperative period may therefore reduce effect surgical treatment promoting metastasis example combining βadrenergic receptor antagonist cyclooxygenase cox inhibitor perioperative setting paper highlight mechanism may underlie surgeryrelated metastatic development colorectal cancer include direct tumor spillage time surgery suppression antitumor immune response direct stimulatory effect tumor cell activation coagulation system summarize detail result support role catecholamine major driver prometastatic effect induced surgical stress response predominantly activation βadrenergic signaling additionally argue improved understanding surgical stressinduced dissemination specifically whether impact level nature heterogeneity within residual tumor cell would contribute successful clinical targeting process finally provide proofofconcept demonstration exvivo analysis colorectal cancer patientderived sample using rgblabeling technology provide important insight heterogeneous sensitivity tumor cell stress signal suggests intratumor heterogeneity likely influence efficacy perioperative βadrenergic receptor cox inhibition exvivo characterization heterogeneous stress response tumor sample synergize model optimize perioperative treatment improve outcome colorectal solid cancer,2018,"Behrenbruch, Corina; Shembrey, Carolyn; Paquet-Fifield, Sophie; Mølck, Christina; Cho, Hyun-Jung; Michael, Michael; Thomson, Benjamin N J; Heriot, Alexander G; Hollande, Frédéric",Clinical & experimental metastasis,,,,,,https://doi.org/10.1007/s10585-018-9873-2; https://www.ncbi.nlm.nih.gov/pubmed/29335811/,3129271.0,12
34758,34758,46085,sp9j04ea,,Medline,Percutaneous radiofrequency ablation of a bleeding pseudoaneurysm during CT-guided renal cancer treatment. A case report.,10.1007/s10140-016-1432-z,,27530739.0,unk,describe new emergency interventional radiology approach percutaneous procedure complication present case yearold male small renal cancer approached percutaneous radiofrequency ablation rta complicated pseudoaneurysm bleeding renal artery branch emergency setting pseudoaneurysm treated ct room rta needle without complication local tumor recurrence next month followup,2016,"Faiella, Eliodoro; Frauenfelder, Giulia; Santucci, Domiziana; Luppi, Giacomo; Zobel, Bruno Beomonte; Grasso, Rosario Francesco",Emergency radiology,,,,,,https://doi.org/10.1007/s10140-016-1432-z; https://www.ncbi.nlm.nih.gov/pubmed/27530739/,20688122.0,12
34787,34787,46119,vgy9z9pj,,Medline,Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.,10.1016/j.drup.2015.02.002,,25791797.0,unk,glioma common primary brain tumor particularly adult patient vast majority glioma belongs heterogeneous group diffuse glioma ie glial tumor characterized diffuse infiltrative growth preexistent brain tissue unfortunately glioblastoma aggressive grade iv diffuse glioma also far frequent one standard treatment year overall survival glioblastoma patient approximately advanced knowledge molecular pathology underlying malignant transformation offered new handle better treatment several cancer type unfortunately glioblastoma multiforme gbm patient yet profited although numerous experimental drug tested clinical trial failed miserably grim prognosis gbm least partly due lack successful drug delivery across bloodbrain tumor barrier bbtb human brain comprises billion capillary total length mile total surface area median intercapillary distance μm making best perfused organ body bbtb encompasses existing newly formed blood vessel contribute delivery nutrient oxygen tumor facilitate glioma cell migration part brain high metabolic demand highgrade glioma create hypoxic area trigger increased expression vegf angiogenesis leading formation abnormal vessel dysfunctional bbtb even though bbtb considered leaky core part glioblastoma large part glioblastoma even lower grade diffuse glioma bbtb closely resembles intact bloodbrain barrier bbb prevents efficient passage cancer therapeutic including small molecule antibody thus many drug still blocked reaching many infiltrative glioblastoma cell demonstrate withinorganmetastasis away core part brain area displaying organized le leaky bbtb hence drug delivery glioblastoma deserves explicit attention otherwise new experimental therapy continue fail current review highlight different aspect bbtb glioma patient preclinical model discus advantage drawback drug delivery approach treatment glioma patient provide overview method overcome bbtb including osmotic bloodbrain barrier disruption bbbd bradykinin receptormediated bbtb opening inhibition multidrug efflux transporter receptormediated transport system physiological circumvention bbtb knowledge molecular biology glioma cell rapidly expanding extent already assisting u design tumortailored therapeutic still struggling develop modality expose entire tumor therapeutic pharmacologically meaningful quantity therefore must expand knowledge fundamental bbtb step toward design practical safe device approach enhanced drug delivery diseased brain area,2015,"van Tellingen, O; Yetkin-Arik, B; de Gooijer, M C; Wesseling, P; Wurdinger, T; de Vries, H E",Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,,,,,,https://doi.org/10.1016/j.drup.2015.02.002; https://www.ncbi.nlm.nih.gov/pubmed/25791797/,6424700.0,12
34806,34806,46141,o692zuj6,,Medline,Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors.,10.1097/mcg.0b013e3181b7ed76,,19809357.0,unk,background although radiofrequency ablation rfa widely accepted percutaneous treatment liver tumor serious complication may occur resulting mortality study analyzed risk factor management hemorrhagic complication hemoperitoneum hemothorax hemobilia method performed rfa treatment patient primary metastatic liver tumor february december enrolled patient hemorrhagic complication reviewed medical record thoroughly risk factor hemorrhagic complication analyzed using unconditional logistic regression result hemorrhagic complication occurred treatment including hemoperitoneum hemothorax hemobilia eleven patient respectively categorized major complication requiring blood transfusion drainage two patient died hemoperitoneum logistic regression analysis revealed large tumor size odds ratio per mm increase diameter low platelet count per microl increase significant risk factor hemoperitoneum location tumor nodule significant risk factor hemothorax segment hemobilia segment factor including number needle insertion duration ablation significant conclusion although hemorrhagic complication relatively rare percutaneous rfa specific treatment blood transfusion drainage required case care must taken especially highrisk patient,2010,"Goto, Eriko; Tateishi, Ryosuke; Shiina, Shuichiro; Masuzaki, Ryota; Enooku, Kenichiro; Sato, Takahisa; Ohki, Takamasa; Kondo, Yuji; Goto, Tadashi; Yoshida, Haruhiko; Omata, Masao",Journal of clinical gastroenterology,,,,,,https://doi.org/10.1097/mcg.0b013e3181b7ed76; https://www.ncbi.nlm.nih.gov/pubmed/19809357/,25953656.0,12
34820,34820,46160,fvcdpxvs,,Medline,Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.,10.1172/jci93182,,28691930.0,unk,current antivegf therapy colorectal cancer crc provide limited survival benefit tumor rapidly develop resistance agent uncovered immunosuppressive role nonclassical lyclo monocyte mediates resistance antivegfr treatment found chemokine cxcl upregulated human murine tumor following vegf signaling blockade resulting recruitment cxcrlyclo monocyte tumor also found treatment vegfa reduced expression cxcl endothelial cell vitro intravital microscopy revealed cxcr critical lyclo monocyte transmigration across endothelium murine crc tumor moreover lyclo monocyte recruit lyg neutrophil via cxcl produce il inhibits adaptive immunity preventing lyclo monocyte lyg neutrophil infiltration tumor enhanced inhibition tumor growth antivegfr therapy furthermore gene therapy using nanoparticle formulated sirna cxcl reduced lyclo monocyte recruitment improved outcome antivegfr therapy mouse crcs study unveils immunosuppressive function lyclo monocyte knowledge yet reported context also reveal molecular mechanism underlying antiangiogenic treatment resistance suggesting potential immunomodulatory strategy enhance longterm clinical outcome antivegf therapy,2017,"Jung, Keehoon; Heishi, Takahiro; Khan, Omar F; Kowalski, Piotr S; Incio, Joao; Rahbari, Nuh N; Chung, Euiheon; Clark, Jeffrey W; Willett, Christopher G; Luster, Andrew D; Yun, Seok Hyun; Langer, Robert; Anderson, Daniel G; Padera, Timothy P; Jain, Rakesh K; Fukumura, Dai",The Journal of clinical investigation,,,,,,https://doi.org/10.1172/jci93182; https://www.ncbi.nlm.nih.gov/pubmed/28691930/,4823042.0,12
34883,34883,46239,swgr5xow,,Medline,Risk factors for the local recurrence of hepatocellular carcinoma after single-session percutaneous radiofrequency ablation with a single electrode insertion.,10.3892/mmr_00000067,,21475796.0,unk,radiofrequency ablation rfa new local therapy hepatocellular carcinoma hcc study investigated risk factor associated local recurrence hcc singlesession rfa single electrode insertion april december treated hcc lesion singlesession rfa single electrode insertion using cooltip rfa rtc rtc system risk factor local recurrence lesion complication rfa analyzed mean size lesion ± mm diameter range mm local recurrence rate year respectively mean followup period month univariate analysis showed tumor diameter ≥ mm tumor location pretreatment afpl fraction level ablation pattern significant variable multivariate analysis four variable identified tumor diameter independent risk factor local recurrence complication occurred lesion singlesession rfa effective treatment hcc reduces serious complication study demonstrated tumor size ≥ mm influenced local recurrence singlesession rfa single electrode insertion,2009,"Shiozawa, Kazue; Watanabe, Manabu; Wakui, Noritaka; Ikehara, Takashi; Iida, Kazunari; Sumino, Yasukiyo",Molecular medicine reports,,,,,,https://doi.org/10.3892/mmr_00000067; https://www.ncbi.nlm.nih.gov/pubmed/21475796/,14008791.0,12
34933,34933,46303,o4qqcvd7,,Medline,Is robotic partial nephrectomy convenient for solitary kidney?,10.5152/tud.2016.69851,,27635284.0,unk,nephron sparing surgery n gold standard treatment option patient solitary kidney order preserve renal function open partial nephrectomy opn long considered standard care n robotic partial nephrectomy rpn gradually used commonly even solitary kidney complex tumor difference rpn opn regarding rate intraoperativepostoperative complication positive surgical margin psm rpn opn patient solitary kidney underwent partial nephrectomy small renal mass warm ischemia time wit study within safe range minute acceptable ischemia time robotic approach study needed order evaluate kidney function conclusion increasing experience solitary kidney tumor managed safely robotic approach patient complex tumor potential wit minute administration intracorporeal ice slush surgery may considered,2016,"Kaouk, Jihad H; Malkoç, Ercan",Turkish journal of urology,,,,,,https://doi.org/10.5152/tud.2016.69851; https://www.ncbi.nlm.nih.gov/pubmed/27635284/,26685100.0,12
35166,35166,46570,lc6l9bbf,,Medline,Massive ameloblastoma: A case report of difficult fiberoptic intubation.,10.1016/j.amsu.2018.05.011,,30013771.0,unk,introduction intubation sometimes difficult patient lesion mouth floor ameloblastoma frequently encountered tumor maxillofacial area extensive lesion might occupy floor mouth prevent displacement tongue limiting space inserting laryngoscope blade resulting difficult intubation even fiberoptic bronchoscopy case presentation yearold man kg cm mental swelling diagnosed ameloblastoma scheduled surgical resection tumor extensive occupying anterior floor mouth concerned impossible direct laryngoscopy massive tumor floor mouth compressed base tongue posterior wall pharynx restricting space inserting laryngoscope blade therefore planned perform awake nasal fiberoptic intubation secure airway although procedure complicated massive tumor successful intubation achieved handassisted alteration direction endotracheal tube ett direct laryngoscopy discussion awake fiberoptic intubation complicated tumor protrusion deviate ett discovering ett deviation insufficient blade insertion facilitated visualizing vocal cord fiberoptic scope conclusion identification ett deviation even insufficient blade insertion handassisted alteration direction ett might raise chance successful fiberoptic intubation anesthesiologist aware likelihood failed fiberoptic intubation plan alternative approach secure airway,2018,"Shindo, Yuki; Toda, Shinichi; Kido, Kanta; Masaki, Eiji",Annals of medicine and surgery,,,,,,https://doi.org/10.1016/j.amsu.2018.05.011; https://www.ncbi.nlm.nih.gov/pubmed/30013771/,49862178.0,12
35212,35212,46626,74dtyciu,,Medline,Avoiding Complications in Bone and Soft Tissue Ablation.,10.1007/s00270-016-1487-y,,27826789.0,unk,percutaneous ablation tumor liver lung kidney ablation bone nonvisceral soft tissue tumor carry risk primarily collateral damage vital structure proximity target tumor certain risk particular interest ablating bone nonvisceral soft tissue tumor namely neural skin injury bowel injury fracture gas embolism damaged applicator ablation large volume tumor also carry special risk many technique may employed interventional radiologist minimize complication treating tumor musculoskeletal system method include depict displace monitor critical structure thus measure provide thermoprotection may active careful ablation applicator placement use various displacement technique well passive including employment direct temperature radiographic neurophysiologic monitoring technique cementoplasty considered certain skeletal location risk fracture patient treated large volume tumor monitored renal dysfunction properly hydrated finally ablation applicator cautiously placed constrained environment intact bone,2017,"Kurup, A Nicholas; Schmit, Grant D; Morris, Jonathan M; Atwell, Thomas D; Schmitz, John J; Weisbrod, Adam J; Woodrum, David A; Eiken, Patrick W; Callstrom, Matthew R",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-016-1487-y; https://www.ncbi.nlm.nih.gov/pubmed/27826789/,6189577.0,12
35332,35332,46758,3h4zixtc,,Medline,"Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.",10.1371/journal.pone.0059040,,23593129.0,unk,background treatment hepatocellular carcinoma hcc hepatic resection advantage radiofrequency ablation rfa term systematic removal hepatic segment method enrolled consecutive patient single naïve hcc treated rfa university tokyo hospital recurrence categorized either intra extrasubsegmental according couinauds segment original nodule ass relationship subsegments original recurrent nodule calculated kappa coefficient assessed risk factor intra extrasubsegmental recurrence independently using univariate multivariate cox proportional hazard regression also assessed impact mode recurrence survival outcome result followup period patient cohort showed tumor recurrence distributed total subsegments recurrence categorized exclusively intrasubsegmental exclusively extrasubsegmental simultaneously intra extrasubsegmental patient respectively kappa coefficient measured ci p multivariate analysis revealed tumor size afp value platelet count risk factor intra extrasubsegmental recurrence patient recurrent hcc found exclusively intrasubsegmental extrasubsegmental simultaneously intra extrasubsegmental respectively treated using rfa survival outcome recurrence similar patient exclusively intra extrasubsegmental recurrence conclusion effectiveness systematic subsegmentectomy may limited patient hcc chronic liver disease frequently undergo multifocal tumor recurrence,2013,"Tateishi, Ryosuke; Shiina, Shuichiro; Akahane, Masaaki; Sato, Jiro; Kondo, Yuji; Masuzaki, Ryota; Nakagawa, Hayato; Asaoka, Yoshinari; Goto, Tadashi; Otomo, Kuni; Omata, Masao; Yoshida, Haruhiko; Koike, Kazuhiko",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0059040; https://www.ncbi.nlm.nih.gov/pubmed/23593129/,13796999.0,12
35335,35335,46762,l60yqzmk,,Medline,"Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed ""click"" cycloaddition and thio acid/sulfonyl azide ""sulfo-click"" amidation and their in vivo evaluation.",10.1021/jm100246m,,20411957.0,unk,herein describe design synthesis biological evaluation series dotaconjugated monomeric dimeric tetrameric tyroctreotidebased analogue tool tumor imaging andor radionuclide therapy compound synthesized using cuicatalyzed dipolar cycloaddition click reaction peptidic azide dendrimerderived alkyne subsequent metalfree introduction dota via thio acidsulfonyl azide amidation sulfoclick reaction competitive binding assay using rat pancreatic arj tumor cell monomeric tyroctreotide conjugate displayed highest binding affinity ic nm followed dimeric tyroctreotide nm dotatyroctreotide nm tetrameric tyroctreotide nm biodistribution study balbc nude mouse subcutaneous arj tumor showed inlabeled monomeric tyroctreotide conjugate highest tumor uptake idg h pi better indotatyroctreotide idg inlabeled dimeric tyroctreotide conjugate showed long tumor retention idg h pi idg h pi promising result exploited therapeutic application,2010,"Yim, Cheng-Bin; Dijkgraaf, Ingrid; Merkx, Remco; Versluis, Cees; Eek, Annemarie; Mulder, Gwenn E; Rijkers, Dirk T S; Boerman, Otto C; Liskamp, Rob M J",Journal of medicinal chemistry,,,,,,https://doi.org/10.1021/jm100246m; https://www.ncbi.nlm.nih.gov/pubmed/20411957/,1729418.0,12
35362,35362,46793,i5jva5ao,,Medline,Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative: Two Case Reports.,10.1097/md.0000000000001122,,26166111.0,unk,hepatocellular carcinoma hcc bile duct tumor thrombus bdtt formation rare entity found microscopically resected specimen ideal treatment hcc surgical resection however poor hepatic functional reserve patient hcc tumor unresectable report case hcc bdtt type iii accompanied hepatic dysfunction successfully treated radiofrequency rf ablation used rf ablation radical therapeutic method efficient way control bleeding origin bdtt bdtt removal time writing patient diseasefree month respectivelyour result show rf ablation may used radical therapeutic alternative hcc bdtt patient liver cirrhosis obstructive jaundice,2015,"Gao, Jun; Zhang, Qingshuai; Zhang, Jun; Kong, Jian; Wang, Shaohong; Ding, Xuemei; Ke, Shan; Sun, Wenbing",Medicine,,,,,,https://doi.org/10.1097/md.0000000000001122; https://www.ncbi.nlm.nih.gov/pubmed/26166111/,15632573.0,12
35363,35363,46794,kbgkrrui,,Medline,Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.,10.1148/radiol.11110361,,22025735.0,unk,purpose determine therapeutic efficacy rhenium relabeled pegylated liposomal doxorubicin reliposomal doxorubicin combination radiofrequency rf ablation human head neck squamous cell carcinoma hnscc xenograft nude rat material method investigation approved animal care committee sixty nude rat subcutaneously implanted hnscc xenograft six per group treated rf ablation °c minute b pegylated liposome c liposomal doxorubicin repegylated liposome mbqkg e reliposomal doxorubicin mbqkg f pegylated liposome plus rf ablation g liposomal doxorubicin plus rf ablation h repegylated liposome plus rf ablation reliposomal doxorubicin plus rf ablation six rat receive treatment control group tumor uptake therapy group monitored smallanimal single photon emission computed tomography day therapeutic efficacy monitored week measurement tumor volume calculation percentage injected dose fluorine fluorodeoxyglucose fdg tumor smallanimal positron emission tomography pet image determination viable tumor volume histopathologic examination significant difference group determined analysis variance result average tumor volume ± standard deviation day therapy cm ± week therapy control tumor growth better reliposomal doxorubicin liposomal doxorubicin alone tumor volume cm ± v cm ± respectively p use rf ablation liposomal doxorubicin reliposomal doxorubicin improved tumor control tumor volume cm ± cm ± respectively tumor growth trend correlated change percentage injected dose fdg tumor group r p viable tumor volume significantly decreased group treated reliposomal doxorubicin plus rf ablation cm ± p v group except reliposomal doxorubicin alone conclusion triple dual therapy observable trend reliposomal doxorubicin plus rf ablation reliposomal doxorubicin liposomal doxorubicin plus rf ablation liposomal doxorubicin improved tumor growth control decreased viable tumor compared therapy fdg pet could used noninvasive surrogate marker tumor growth viability tumor model,2011,"Soundararajan, Anuradha; Dodd, Gerald D; Bao, Ande; Phillips, William T; McManus, Linda M; Prihoda, Thomas J; Goins, Beth A",Radiology,,,,,,https://doi.org/10.1148/radiol.11110361; https://www.ncbi.nlm.nih.gov/pubmed/22025735/,13157366.0,12
35368,35368,46800,r603g6nm,,Medline,Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.,10.1097/dcr.0000000000000349,,25944427.0,unk,background implementation preoperative chemoradiation combined total mesorectal excision reduced local recurrence rate rectal cancer however use type treatment upper rectal cancer controversial objective purpose work ass oncological result radical resection upper rectal cancer compared sigmoid middle lower rectal cancer determine risk factor local recurrence upper rectal cancer design retrospective analysis prospectively collected data setting study conducted tertiary care referral hospital valencia spain patient analysis included patient underwent colorectal resection primary curative intent primary sigmoid n rectosigmoid n upper rectal n middle rectal n lower rectal n cancer main outcome measure oncological result including local recurrence diseasefree survival cancerspecific survival compared different tumor location univariate multivariate analysis performed identify risk factor local recurrence upper rectal cancer result total patient upper rectal tumor underwent partial mesorectal excision patient group received preoperative chemoradiation year actuarial local recurrence diseasefree survival cancerspecific survival rate upper rectal tumor local recurrence rate showed difference compared among location p whereas diseasefree survival cancerspecific survival shorter lower rectal tumor p p independent risk factor local recurrence upper rectal cancer involved circumferential resection margin pathologic analysis hr ci p limitation singleinstitution retrospective study conclusion upper rectal tumor treated partial mesorectal excision without systematic use preoperative chemoradiation involvement mesorectal fascia independent risk factor local recurrence tumor,2015,"Marinello, Franco G; Frasson, Matteo; Baguena, Gloria; Flor-Lorente, Blas; Cervantes, Andres; Roselló, Susana; Espí, Alejandro; García-Granero, Eduardo",Diseases of the colon and rectum,,,,,,https://doi.org/10.1097/dcr.0000000000000349; https://www.ncbi.nlm.nih.gov/pubmed/25944427/,33498968.0,12
35454,35454,46903,t2b87lta,,Medline,"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.",10.1258/ebm.2010.010278,,21330360.0,unk,immunogenic tcell epitope central role cellular immunity pathogen tumor however early stage cellular immunity study complicated timeconsuming identify characterize tcell epitope currently epitope screening experiencing renewed enthusiasm due advance novel technique theory moreover application tcell epitopebased diagnosis tuberculosis new data epitopebased vaccine development also revived field growing knowledge emphasis epitopestimulated tcell immune response elimination pathogen tumor review outline significance identification characterization tcell epitope also summarize method strategy epitope definition importantly address relevance cytotoxic tlymphocyte epitope clinical diagnosis therapy vaccine development,2011,"Liu, Jun; Zhang, Shihong; Tan, Shuguang; Zheng, Beiwen; Gao, George F",Experimental biology and medicine,,,,,,https://doi.org/10.1258/ebm.2010.010278; https://www.ncbi.nlm.nih.gov/pubmed/21330360/,6483489.0,12
35595,35595,47076,qa4crpbx,,Medline,Laparoscopic excision of a giant splenic vascular tumor.,10.1016/j.jpedsurg.2012.03.054,,22813826.0,unk,splenic vascular tumor referred hemangioma rare typically present small asymptomatic lesion report case giant splenic cyst yearold boy abdominal distension underwent laparoscopic excision splenic cyst without complication pathology revealed vascular tumor month followup continued asymptomatic abdominal ultrasound showed recurrence disease laparoscopic excision giant splenic cyst viable option child allowing preservation normal splenic tissue,2012,"Knott, E Marty; Valusek, Patricia A; St Peter, Shawn D",Journal of pediatric surgery,,,,,,https://doi.org/10.1016/j.jpedsurg.2012.03.054; https://www.ncbi.nlm.nih.gov/pubmed/22813826/,22226765.0,12
35615,35615,47098,crt1pndv,,Medline,Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts.,10.1007/s11604-016-0569-8,,27450190.0,unk,purpose panel japanese expert tumor ablation therapy gathered reach general consensus topic surrounding ablation therapy material method questionnaire relating ablation protocol radiofrequency ablation rfa cryoablation well ancillary procedure required safe secure ablation therapy sent seven institution expert institution discussed topic based evidence questionnaire data consensus reached annual meeting japan imageguided ablation group maebashi japan october result consensus reached six topic including management antiplatelet anticoagulation drug therapy pain control perioperative period arterial embolization combined ablation therapy protection nontarget organ rfa cryoablation protocol ablative margin conclusion consensus achieved serve framework tumor ablation therapy japan,2016,"Miyazaki, Masaya; Iguchi, Toshihiro; Takaki, Haruyuki; Yamanaka, Takashi; Tamura, Yoshitaka; Tokue, Hiroyuki; Sato, Yozo; Ikeda, Osamu; Shimizu, Tadashi; Yamakado, Koichiro",Japanese journal of radiology,,,,,,https://doi.org/10.1007/s11604-016-0569-8; https://www.ncbi.nlm.nih.gov/pubmed/27450190/,23995679.0,12
35658,35658,47147,tymtlhc0,,Medline,Strategic and Technical Considerations for the Endovascular Embolization of Intracranial Meningiomas.,10.1016/j.nec.2015.11.005,,27012380.0,unk,endovascular embolization frequently used adjunct operative resection meningioma embolization may decrease intraoperative blood loss operative time surgical difficulty associated resection specific clinical application treatment defined clearly procedural indication preferred embolic agent latency tumor resection differ across operator clear strategic patient selection comprehensive anatomic understanding sound operative technique critical success embolization procedure article review management technical consideration associated preoperative meningioma embolization,2016,"James, Robert F; Kramer, Daniel R; Page, Paul S; Gaughen, John R; Martin, Lacey B; Mack, William J",Neurosurgery clinics of North America,,,,,,https://doi.org/10.1016/j.nec.2015.11.005; https://www.ncbi.nlm.nih.gov/pubmed/27012380/,8712359.0,12
35673,35673,47162,y6mgjbld,,Medline,Jejunostomy-technique and controversies.,10.21037/jovs.2019.03.15,,31321215.0,unk,malnutrition quite common patient esophageal cancer secondary tumor related dysphagia treatment side effect traditionally open feeding jejunostomy tube performed patient undergoing surgical treatment esophageal cancer advent minimally invasive approach placement jejunostomy tube currently accomplished either robotic laparoscopic assistance discus technical aspect well pro con minimally invasive jejunostomy feeding tube placement,2019,"Bakhos, Charles; Patel, Shrey; Petrov, Roman; Abbas, Abbas",Journal of visualized surgery,,,,,,https://doi.org/10.21037/jovs.2019.03.15; https://www.ncbi.nlm.nih.gov/pubmed/31321215/,133402010.0,12
35734,35734,47231,pirvypg3,,Medline,Fusion following lateral mass reconstruction in the cervical spine.,10.3171/2014.10.spine13858,,25431961.0,unk,object recently aggressive surgical technique push toward en bloc resection certain tumor resulted need creative spinal column reconstruction iatrogenic instability following resection requires thoughtful approach adequately transfer loadbearing force skull upper cervical spine subaxial spine method author present series case lateral mass reconstruction cage fibular strut graft used provide loadbearing support including case bilateral cage placement result author discus surgical nuance en bloc resection high cervical tumor explain technique lateral mass cage placement additionally provide rationale use construct throughout craniocervical junction subaxial spine conclusion lateral mass reconstruction provides potential alternative adjuvant method restoring loadbearing capability cervical spine,2015,"Clarke, Michelle J; Zadnik, Patricia L; Groves, Mari L; Sciubba, Daniel M; Witham, Timothy F; Bydon, Ali; Gokaslan, Ziya L; Wolinsky, Jean-Paul",Journal of neurosurgery. Spine,,,,,,https://doi.org/10.3171/2014.10.spine13858; https://www.ncbi.nlm.nih.gov/pubmed/25431961/,23946897.0,12
35740,35740,47237,63ha4u9u,,Medline,Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model.,10.1038/labinvest.2011.128,,21894147.0,unk,distinguishing feature highgrade glioma infiltration neoplastic cell adjacent brain tissue mark tumor surgically incurable study factor associated tumor invasion established new murine brain tumor model altsc derived sv large antigentransfected astrocyte new brain tumor model recapitulates several histopathological feature human highgrade glioma including increased cellularity prominent cellular pleomorphism geographic necrosis active mitosis extensive invasion tumor cell adjacent brain tissue importantly altsc expressed relatively high level stromalderived factor sdfcxcl vitro vivo higher microvascular density mvd vivo define role sdf tumor model expression sdf altsc cell inhibited specific sirna sdfknockdown altsc sdfkd cell took longer parental altsc cell form tumor contrast wildtype tumor welldefined regular border lacked infiltration tract sdfkd tumor also associated lower mvd hypoxic area contrast parental tumor density fpositive tumorassociated macrophage tam sdfkd tumor higher nonhypoxic hypoxic region sdf production tumor cell therefore seems critical aggregation tam area hypoxia tumor invasiveness study provides new insight role sdf brain tumor invasion relationship tam hypoxia also provides new preclinical brain tumor model designing new treatment option invasive case,2012,"Wang, Shu-Chi; Hong, Ji-Hong; Hsueh, Chuen; Chiang, Chi-Shiun",Laboratory investigation; a journal of technical methods and pathology,,,,,,https://doi.org/10.1038/labinvest.2011.128; https://www.ncbi.nlm.nih.gov/pubmed/21894147/,23743281.0,12
35741,35741,47239,cnuzfxaq,,Medline,Balloon-assisted osteoplasty of periacetabular tumors following percutaneous cryoablation.,10.1016/j.jvir.2014.11.023,,25805541.0,unk,purpose describe feasibility safety effectiveness technique using vertebral augmentation balloon promote delivery cement periacetabular tumor cryoablation fracture prevention material method retrospective review performed seven consecutive patient six men one woman mean age ± unilateral periacetabular tumor mean size cm ± treated cryoablation balloonassisted osteoplasty fracture prevention cortical defect seen six tumor additional pathologic fracture occurred five tumor treatment cohort included six harrington class defect one class ii defect procedure performed computed tomography fluoroscopic guidance general anesthesia vertebral augmentation balloon mean range inflated within ablation cavity immediately cement injection result procedure technically successful median percentage tumor fill range minor cement leakage occurred two patient symptomatic intraarticular extravasation new nondisplaced fracture occurred one patient conservatively managed major complication occurred local tumor progression occurred one five patient imaging followup conclusion balloonassisted osteoplasty cryoablation periacetabular tumor appears feasible safe effective fracture prevention technique directs cement instillation ablation defect high degree filling minimal leakage,2015,"Kurup, A Nicholas; Morris, Jonathan M; Schmit, Grant D; Atwell, Thomas D; Schmitz, John J; Rose, Peter S; Callstrom, Matthew R",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.11.023; https://www.ncbi.nlm.nih.gov/pubmed/25805541/,5140899.0,12
35792,35792,47295,lx33lvys,,Medline,Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.,10.1016/j.jvir.2014.10.047,,25534635.0,unk,purpose compare retrospectively outcome complication transcatheter arterial chemoembolization drugeluting embolic agent combined radiofrequency rf ablation microwave mw ablation treatment hepatocellular carcinoma hcc material method patient hcc received combination therapytranscatheter arterial chemoembolization plus rf ablation patient transcatheter arterial chemoembolization plus mw ablation patient local tumor response tumor progressionfree survival pfs overall pfs overall survival o complication compared overall pfs o compared two treatment group multivariate analysis controlling childpugh class barcelona clinic liver classification stage index tumor size result complete local tumor response achieved tumor treated transcatheter arterial chemoembolization plus rf ablation tumor treated transcatheter arterial chemoembolization plus mw ablation p median tumor pfs overall pfs month month p transarterial chemoembolization plus rf ablation month month transarterial chemoembolization plus mw ablation p median o transcatheter arterial chemoembolization plus rf ablation group month median o transcatheter arterial chemoembolization plus mw ablation group month significant difference survival experience two group logrank test p multivariate analysis barcelona clinic liver classification stage factor associated overall pfs o one patient transcatheter arterial chemoembolization plus rf ablation cohort two patient transcatheter arterial chemoembolization plus mw ablation cohort required prolonged hospitalization h pain management procedure p conclusion based similar safety efficacy outcome combination therapy transcatheter arterial chemoembolization plus rf ablation transcatheter arterial chemoembolization plus mw ablation effective treatment hcc,2015,"Ginsburg, Michael; Zivin, Sean P; Wroblewski, Kristen; Doshi, Taral; Vasnani, Raj J; Van Ha, Thuong G",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.10.047; https://www.ncbi.nlm.nih.gov/pubmed/25534635/,24679855.0,12
35831,35831,47339,2vfbnn3f,,Medline,Nephron-sparing probe ablative therapy: long-term outcomes.,10.1097/mou.0b013e3282f4a869,,18303535.0,unk,purpose review cryoablation radiofrequency ablation two utilized form ablative therapy mature recent followup study published highlight possible role relevant treatment option select patient renal cell carcinoma recent finding three fiveyear outcome following cryoablation radiofrequency ablation recently published respectively showing cancerspecific survival small cohort several singleinstitution series published showing favorable outcome based imaging finding alone albeit much shorter followup time finding mitigated probability treated small tumor may benign malignant may indolent summary longestterm outcome probeablative therapy cryoablation radiofrequency ablation suggest satisfactory outcome imaging careful patient selection rigorous attention technical detail utilized imaging finding alone usually provide surrogate measure success given limitation current imaging technique indolent growth rate many tumor however continued stringent selection criterion rigorous followup patient undergoing ablative therapy required,2008,"Matin, Surena F; Ahrar, Kamran",Current opinion in urology,,,,,,https://doi.org/10.1097/mou.0b013e3282f4a869; https://www.ncbi.nlm.nih.gov/pubmed/18303535/,5759323.0,12
35893,35893,47406,nz3s5spe,,Medline,Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor.,10.1186/s40792-017-0391-2,,29198012.0,unk,background cholangiolocellular carcinoma cocc rare liver tumor arising canal hering found cholangioles interlobular bile duct although morphologically cocc mimic intrahepatic cholangiocarcinoma icc cocc exhibit unique intermediate biologic behavior hepatocellular carcinoma hcc icc curative resection required prolonged survival patient cocc however effective therapy postoperative hepatic recurrence yet standardized case presentation yearold man asymptomatic liver mass found regular medical examination contrastenhanced computed tomography revealed wellenhanced mass cm diameter right liver underwent right hemihepatectomy local hospital preoperative diagnosis hepatocellular carcinoma pathologic examination confirmed moderately differentiated tubular adenocarcinoma leading diagnosis ordinary icc twelve month surgery referred hospital due three hepatic recurrence left medial segment underwent partial hepatectomy recurrence followed adjuvant chemotherapy using gemcitabine alone second hepatectomy hepatic recurrence developed additional seven time number size recurrent tumor limited recurrence satisfying standard criterion percutaneous radiofrequency ablation rfa treatment hcc lesion treated percutaneous rfa although exceptional approach icc alive without evidence disease year first hepatectomy clinical outcome satisfactory compatible typical negative outcome ordinary icc rereviewed histological finding tumor tumor composed small glandforming cell proliferating anastomosing pattern cell membrane strongly immunoreactive epithelial membrane antigen finding accordance typical feature cocc revising final diagnosis icc cocc conclusion case report demonstrates satisfactory outcome using repeated local treatment hepatectomy rfa hepatic recurrence cocc suggesting localized treatment approach considered therapeutic option careful making definitive diagnosis icc ruling cocc diagnosis potentially dictate treatment strategy recurrence,2017,"Shinohara, Kentaro; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Yamaguchi, Junpei; Shimoyama, Yoshie; Shiina, Shuichiro; Tateishi, Ryosuke; Arano, Toru; Nagino, Masato",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-017-0391-2; https://www.ncbi.nlm.nih.gov/pubmed/29198012/,32738444.0,12
35943,35943,47467,t7tx39ak,,Medline,Evolving ablative therapies for hepatic malignancy.,10.1155/2014/230174,,24877069.0,unk,liver common site primary secondary malignancy hepatic resection transplantation two treatment modality shown achieve complete cure patient candidate treatment remaining patient tumor ablation emerged promising alternative modality addition providing local control improving survival outcome tumor ablation also help stage patient potential curative treatment alone well combination treatment tumor ablation achieved multiple way introduction newer ablative technique shifted focus palliation potentially curative treatment longterm safety survival benefit substantive present important strive evaluate result study using appropriate comparative outcome methodology,2014,"Singla, Smit; Hochwald, Steven N; Kuvshinoff, Boris",BioMed research international,,,,,,https://doi.org/10.1155/2014/230174; https://www.ncbi.nlm.nih.gov/pubmed/24877069/,16499462.0,12
35975,35975,47505,2ppbn6ij,,Medline,Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers.,10.1002/hep.30406,,30520063.0,unk,retrospective study performed evaluate efficacy threedimensional dnavigated multiprobe radiofrequency ablation rfa intraprocedural image fusion treatment hepatocellular carcinoma hcc histopathological examination patient men woman median age year range transplanted bridging therapy hccs stereotactic rfa srfa median interval first srfa transplantation month range rate residual vital tissue rvt could assessed lesion patient histological examination explanted liver using hematoxylin eosin tdtmediated utp nickend labeling tunel stain histopathological result compared finding last computed tomography ct imaging liver transplantation lt median number size treated tumor range cm range complete radiological response achieved nodule patient complete pathological response explanted liver specimen nodule patient respectively lesion ≥ cm complete tumor cell death achieved nodule residual tumor correlate tumor size p conclusion multiprobe srfa intraprocedural image fusion represents efficient minimally invasive therapy hcc even tumor size larger cm without need combination additional treatment result seem justify additional effort related stereotactic approach,2018,"Bale, Reto; Schullian, Peter; Eberle, Gernot; Putzer, Daniel; Zoller, Heinz; Schneeberger, Stefan; Manzl, Claudia; Moser, Patrizia; Oberhuber, Georg",Hepatology,,,,,,https://doi.org/10.1002/hep.30406; https://www.ncbi.nlm.nih.gov/pubmed/30520063/,54566261.0,12
35985,35985,47519,2ueq6ot6,,Medline,A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes.,10.1007/s11255-016-1323-y,,27262849.0,unk,purpose compared surgical outcome robotassisted laparoscopic partial nephrectomy rapn open partial nephrectomy opn using volumetric analysis propensity scorematched analysis method analyzed record patient normal contralateral kidney underwent rapn opn renal tumor volumetric study ass vascularized parenchymal volume operated kidney performed month preoperatively month postoperatively patient data including age body mass index presence hypertension andor diabetes mellitus american society anesthesiologist score tumor size preoperative estimated glomerular filtration rate tumor complexity using renal nephrometry score matched using propensity score matching group result cohort included patient underwent rapn underwent opn matching patient included group mean tumor diameter mm highcomplexity tumor renal score rapn opn group showed significant difference rate preservation global renal function v parenchymal volume operated kidney v similarly urological complication significantly differ group surgical margin negative tumor patient underwent rapn lower estimated blood loss p shorter postoperative length hospital stay p underwent opn conclusion rapn offer acceptable surgical outcome precision compared opn decreased estimated blood loss hospital stay,2016,"Takagi, Toshio; Kondo, Tsunenori; Tachibana, Hidekazu; Iizuka, Junpei; Omae, Kenji; Kobayashi, Hirohito; Yoshida, Kazuhiko; Hashimoto, Yasunobu; Tanabe, Kazunari",International urology and nephrology,,,,,,https://doi.org/10.1007/s11255-016-1323-y; https://www.ncbi.nlm.nih.gov/pubmed/27262849/,23382411.0,12
36028,36028,47573,idyu1pnd,,Medline,Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance.,10.1148/radiol.15141215,,25734550.0,unk,purpose evaluate frequency risk factor clinical significance aggressive intrasegmental recurrence air found radiofrequency rf ablation hepatocellular carcinoma hcc material method institutional review board approval obtained retrospective study march december patient men woman mean age year age range year underwent ultrasonographyguided percutaneous rf ablation firstline treatment single hcc classified barcelona clinic liver cancer bclc stage air hcc defined initial tumor recurrence diseasefree status least month initial rf ablation b simultaneous development multiple nodular least three infiltrative tumor recurrence treated segment patient stratified two group air n without air n followup risk factor air assessed logistic regression analysis risk factor longterm overall survival assessed timedependent cox proportional hazard model result median followup period month range month air observed patient patient frequency increasing subgroup periportal hcc patient air manifested either multiple nodular type n bclc stage b diffusely infiltrative type tumor thrombus formation n bclc stage c multivariate analysis periportal tumor location younger patient age significant risk factor air presence air followup period significant effect overall survival rate hazard ratio p conclusion overall frequency air rf ablation hcc low periportal location patient age showing significant relationship development air occurrence air adverse effect overall survival rate,2015,"Kang, Tae Wook; Lim, Hyo Keun; Lee, Min Woo; Kim, Young-Sun; Rhim, Hyunchul; Lee, Won Jae; Gwak, Geum-Youn; Paik, Yong Han; Lim, Ho Yeong; Kim, Min Ji",Radiology,,,,,,https://doi.org/10.1148/radiol.15141215; https://www.ncbi.nlm.nih.gov/pubmed/25734550/,207681858.0,12
36039,36039,47586,ws0ia39c,,Medline,"Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression.",10.1007/s00261-018-1656-3,,29869103.0,unk,purpose evaluate safety oncologic efficacy percutaneous thermal ablation intrahepatic cholangiocarcinoma icc identify risk factor local tumor progression ltp material method retrospective review institutional tumor ablation registry demonstrated patient male female mean age ± year icc mean size ± cm treated percutaneous radiofrequency ablation rfa microwave ablation mwa thirtyeight treated icc metastasis developed surgical resection primary tumor patient demographic procedure technical parameter clinical outcome reviewed cox proportional hazard model used examine risk ltp ablation modality survival analysis performed using kaplanmeier method result mean imaging followup time ± month fortyfour icc treated rfa mwa eleven case ltp developed patient median time ltp among tumor month range month risk ltp significantly different icc treated mwa compared rfa hr ci p median diseasefree survival month month median overall survival month month major complication occurred conclusion percutaneous thermal ablation safe effective treatment patient icc may particularly valuable unresectable patient already undergone hepatic surgery tumor size ablation modality associated ltp whereas primary tumor superficially located tumor likely subsequently recur,2018,"Takahashi, Edwin A; Kinsman, Kristin A; Schmit, Grant D; Atwell, Thomas D; Schmitz, John J; Welch, Brian T; Callstrom, Matthew R; Geske, Jennifer R; Kurup, A Nicholas",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-018-1656-3; https://www.ncbi.nlm.nih.gov/pubmed/29869103/,46933995.0,12
36044,36044,47591,0o07s9e3,,Medline,Ablation of perivascular hepatic malignant tumors with irreversible electroporation.,10.1016/j.jamcollsurg.2012.04.029,,22704820.0,unk,background ablation increasingly used treat primary secondary liver cancer ablation near portal pedicle hepatic vein challenging irreversible electroporation ire new ablation technique rely heat animal appears safe effective applied near hepatic vein portal pedicle study evaluated safety shortterm outcome ire ablate perivascular malignant liver tumor study design retrospective review patient treated ire january november performed patient selected ire resection thermal ablation indicated due tumor location treatment outcome classified local regional systemic recurrence complication local failure defined abnormal enhancement periphery ablation defect postprocedure contrast imaging result twentyeight patient tumor treated twentytwo patient treated via open approach treated percutaneously median tumor size cm range cm twentyfive tumor cm major hepatic vein cm major portal pedicle complication included intraoperative arrhythmia postoperative portal vein thrombosis overall morbidity treatmentassociated mortality median followup month tumor persistent disease tumor recurred locally conclusion early analysis ire treatment perivascular malignant hepatic tumor demonstrates safety treating liver malignancy larger study longer followup necessary determine longterm efficacy,2012,"Kingham, T Peter; Karkar, Ami M; D'Angelica, Michael I; Allen, Peter J; Dematteo, Ronald P; Getrajdman, George I; Sofocleous, Constantinos T; Solomon, Stephen B; Jarnagin, William R; Fong, Yuman",Journal of the American College of Surgeons,,,,,,https://doi.org/10.1016/j.jamcollsurg.2012.04.029; https://www.ncbi.nlm.nih.gov/pubmed/22704820/,15908310.0,12
36052,36052,47599,lwtguju5,,Medline,Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA-In).,10.3389/fmed.2015.00083,,26636087.0,unk,unlabelled study proposes liposome new tool pretargeted radioimmunotherapy rit solid tumor tumor pretargeting obtained using bispecific monoclonal antibody bsmab anticea × antidtpaindium complex dtpain pegylated radioactive liposome containing lipidhapten conjugate dspepegdtpain work immunospecificity tumor targeting demonstrated vitro fluorescence microscopy vivo biodistribution study method carcinoembryonic antigen ceaexpressing cell lst used either cell culture xenograft nude mouse doubly fluorescent liposome doubly radiolabeled liposome respectively used vitro vivo study case tracer lipid bilayer rhodamine indium tracer aqueous phase fluorescein iodine present targeting liposome assessed bsmab active targeting without passive targeting result data obtained lipid bilayer tracer showed fluorescent signal cell membrane two three time higher active passive targeting immunospecificity confirmed vivo tumor uptake ± idg percentage injected dose per gram tissue active targeting versus ± idg passive targeting p regarding aqueous phase tracer result slightly contrasted vitro fluorescent tracer seems released extracellular matrix correlated vivo data indeed tumor uptake lower ± idg active targeting ± idg passive targeting resulted favorable tumororgans ratio conclusion work demonstrated tumor targeting immunospecificity dspepegdtpain liposome two different method original new approach suggests potential immunospecific targeting liposome rit solid tumor,2015,"Rauscher, Aurore; Frindel, Mathieu; Rajerison, Holisoa; Gouard, Sébastien; Maurel, Catherine; Barbet, Jacques; Faivre-Chauvet, Alain; Mougin-Degraef, Marie",Frontiers in medicine,,,,,,https://doi.org/10.3389/fmed.2015.00083; https://www.ncbi.nlm.nih.gov/pubmed/26636087/,2398752.0,12
36128,36128,47686,6nxq2n3e,,Medline,Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.,10.1200/jco.2014.60.5337,,26304902.0,unk,past year survival rate child extracranial malignant germ cell tumor gcts increased significantly success achieved primarily application platinumbased chemotherapy regimen however clinical challenge gcts remain excellent outcome distributed uniformly across heterogeneous distribution age histologic feature primary tumor site despite good outcome overall likelihood cure certain site histologic condition le addition considerable longterm treatmentrelated effect survivor even modest cisplatin dosing cause significant longterm morbidity particular challenge designing new therapy gct variety specialist use different risk stratification staging system treatment approach three distinct age group childhood adolescence young adulthood traditionally pediatric cancer patient younger year treated pediatric oncologist collaboration surgical specialty colleague adolescent young adult gcts often treated medical oncologist urologist gynecologic oncologist therapeutic dilemma best define disease risk therapy toxicity appropriately reduced patient intensified others clinical biologic insight achieved collaboration set limitation age sex primary tumor site therefore international collaboration spanning different cooperative group discipline developed address challenge,2015,"Olson, Thomas A; Murray, Matthew J; Rodriguez-Galindo, Carlos; Nicholson, James C; Billmire, Deborah F; Krailo, Mark D; Dang, Ha M; Amatruda, James F; Thornton, Claire M; Arul, G Suren; Stoneham, Sara J; Pashankar, Farzana; Stark, Daniel; Shaikh, Furqan; Gershenson, David M; Covens, Allan; Hurteau, Jean; Stenning, Sally P; Feldman, Darren R; Grimison, Peter S; Huddart, Robert A; Sweeney, Christopher; Powles, Thomas; Lopes, Luiz Fernando; dos Santos Agular, Simone; Chinnaswamy, Girish; Khaleel, Sahar; Abouelnaga, Sherif; Hale, Juliet P; Frazier, A Lindsay",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,,,,https://doi.org/10.1200/jco.2014.60.5337; https://www.ncbi.nlm.nih.gov/pubmed/26304902/,3195340.0,12
36181,36181,47747,smp6f1uz,,Medline,"Preoperative embolization of skull base meningiomas: current indications, techniques, and pearls for complication avoidance.",10.3171/2018.1.focus17686,,29606046.0,unk,skull base meningioma technically challenging tumor treat deep vascular supply preclude early devascularization resection preoperative embolization arterial feeder thought decrease blood loss facilitate resection however given complex varied anatomy skull base lesion preoperative embolization without risk essential endovascular skull base neurosurgeon understand risk light potential benefit author review vascular anatomy skull base meningioma indication preoperative devascularization endovascular technique published result regarding embolization lesion,2018,"Yoon, Nam; Shah, Aatman; Couldwell, William T; Kalani, M Yashar S; Park, Min S",Neurosurgical focus,,,,,,https://doi.org/10.3171/2018.1.focus17686; https://www.ncbi.nlm.nih.gov/pubmed/29606046/,4555204.0,12
36214,36214,47784,xngjfwgp,,Medline,Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result.,10.14701/kjhbps.2015.19.4.173,,26693237.0,unk,backgroundsaims compare clinical outcome intraoperative radiofrequency ablation rfa nonanatomical hepatic resection nahr small hepatocellular carcinoma hcc method february january clinical outcome thirty four patient hcc receiving rfa nahr compared retrospectively result difference patient tumor characteristic two group received rfa nahr year recurrence rate following rfa respectively following nahr respectively p year overall survival o rate following rfa respectively respectively following nahr p find definite statistical difference recurrence rate o rate two group multivariate analysis number tumor independent prognostic factor recurrence albumin independent prognostic factor o conclusion recommend nonanatomical hepatic resection rather intraoperative rfa small sized hcc due higher recurrence rate intraoperative rfa intraoperative rfa inferior nonanatomical hepatic resection term recurrence rate need select optimal treatment considering liver function possibility recurrence,2015,"Yune, Yongwoo; Kim, Seokwhan; Song, Insang; Chun, Kwangsik",Korean journal of hepato-biliary-pancreatic surgery,,,,,,https://doi.org/10.14701/kjhbps.2015.19.4.173; https://www.ncbi.nlm.nih.gov/pubmed/26693237/,14172425.0,12
36252,36252,47829,m6804gfy,,Medline,Laparoscopic surgery for solid pseudopapillary tumor of the pancreas.,10.4293/108680813x13753907291837,,24960486.0,unk,background objective solid pseudopapillary tumor pancreas rare occur frequently young woman uncertain pathogenesis unclear clinical behavior aim evaluate clinical presentation solid pseudopapillary tumor ass efficacy treatment minimally invasive surgery method march february patient underwent laparoscopic procedure pancreas found solid pseudopapillary tumor female patient male patient median age year range year abdominal pain common presenting symptom n tumor incidentally found patient computed tomography scan obtained reason result enucleation tumor performed patient including tumor located head pancreas eight patient underwent distal pancreatectomy splenectomy whereas spleenpreserving distal pancreatectomy performed one case median tumor size cm range cm median operative time minute range minute median blood loss ml range ml distal resection performed linear stapler four patient postoperative complication median length hospital stay day range day median followup period month range month local recurrence distant metastasis found conclusion laparoscopic resection enucleation solid pseudopapillary tumor pancreas performed safely adequate resection margin even tumor located head organ,2014,"Afridi, Shabbir A; Kazaryan, Airazat M; Marangos, Irina Pavlik; Røsok, Bård I; Fretland, Åsmund A; Yaqub, Sheraz; Edwin, Bjørn",JSLS : Journal of the Society of Laparoendoscopic Surgeons,,,,,,https://doi.org/10.4293/108680813x13753907291837; https://www.ncbi.nlm.nih.gov/pubmed/24960486/,1919711.0,12
36263,36263,47841,kpocrqwg,,Medline,Giant solitary fibrous tumor of the pleura: A case report.,10.1111/1759-7714.12175,,26273386.0,unk,yearold male farmer weighing kg taken hospital experiencing exertional dyspnea shortness breath month chest roentgenogram computed tomography showed giant mass right thorax ctguided biopsy demonstrated solitary fibrous tumor pleura sftp large size tumor substantial pleural effusion right hemithorax patient referred institution radiofrequency ablation one month performed exploratory thoracotomy dissect giant mass right middle lower lobe measurement tumor cm × cm × cm weighed g histopathology resected specimen confirmed sftp patient postoperative complication six month surgery recurrence occurred,2015,"Liu, Baodong; Liu, Lei; Li, Yuanbo",Thoracic cancer,,,,,,https://doi.org/10.1111/1759-7714.12175; https://www.ncbi.nlm.nih.gov/pubmed/26273386/,31036193.0,12
36276,36276,47858,wowc6yn7,,Medline,Microwave ablation of pancreatic tumors.,10.1080/13645706.2017.1420664,,29278340.0,unk,objective evaluate clinical performance percutaneous microwave ablation mwa treatment locallyadvancedpancreaticcancer lapc material method twentytwo mwa session august march patient primary pancreatic cancer men woman meanage ± year range year given informed consent retrospectively evaluated procedure performed percutaneously ctguidance using highfrequency ghz mwa device tumor location diameter ablation diameter volume roundness duration technical success efficacy output energy complication local tumor progression defined tumor focus connected edge previously technically efficient ablation zone collected result seventeen pancreatic malignant tumor located pancreatic head five pancreatic tail initial mean tumor diameter ± mm technical success efficacy idem major complication occurred two patient showed minor complication severe local pain related mwa postablation diameter average ± mm mean ablation volume ± cm mean transverse roundness index ± mean ablation time ± min mean applied energy per treatment ± j local tumor progression documented one case available threemonth followup imaging study conclusion highfrequency ghz microwave ablation mwa treatment unresectable nonmetastatic locallyadvancedpancreaticcancer lapc show promising result regarding feasibility safety percutaneous approach shortterm followup evaluated,2018,"Vogl, Thomas J; Panahi, Bita; Albrecht, Moritz H; Naguib, Nagy Naguib Naeem; Nour-Eldin, Nour-Eldin A; Gruber-Rouh, Tatjana; Thompson, Zachary M; Basten, Lajos M",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.1080/13645706.2017.1420664; https://www.ncbi.nlm.nih.gov/pubmed/29278340/,26665115.0,12
36305,36305,47894,9wucd86m,,Medline,Non-Exposure Endoscopic-Laparoscopic Cooperative Surgery for Stomach Tumors: First Experience from the Czech Republic.,10.5946/ce.2017.076,,29301064.0,unk,backgroundaims aim study investigate use nonexposure endoscopic wallinversion surgery news combination laparoscopic endoscopic approach neoplasia nonexposure technique cleannet gastric tumor method reviewed case news cleannet performed department surgery royal vinohrady teaching hospital result department performed gastric tumor resection news n cleannet n march february case chosen resection included predominantly submucosal tumor sign dissemination local invasion early gastric carcinoma tsm tm tumor location made impossible use endoscopic submucosal dissection r resection margin confirmed case conclusion news cleannet allow en bloc nonexposed fullthickness gastric wall resection way us close first cut later approach prevent seeding peritoneal cavity tumor cell miniinvasive technique combine laparoscopic endoscopic technique preserve full function stomach,2018,"Hajer, Jan; Havlůj, Lukáš; Whitley, Adam; Gürlich, Robert",Clinical endoscopy,,,,,,https://doi.org/10.5946/ce.2017.076; https://www.ncbi.nlm.nih.gov/pubmed/29301064/,4580355.0,12
36391,36391,47995,1mv322tt,,Medline,[EUS-FNA: how to improve biopsy results? An evidence based review].,10.1055/s-0034-1385133,,25198088.0,unk,endosonography fineneedle aspiration biopsy eusfna become widespreadly available clinical tool diagnose numerous different lesion human eusfna frequently used tissuebased diagnosis lymphatic disease ranging tuberculosis sarcoidosis malignant lymphoma solid tumor pancreatic carcinoma neuroendocrine tumor subepithelial gastrointestinal tumor others outcome eusfna result however vary caused several different factor ranging experience endoscopist technical factor use stylet suction puncture skill cytopathologist take care specimen obtained eusfna though introduced since year ago eusfna still yet perfectionized several issue remain controversial among endoscopist issue include needle size type fna versus tnb needle use stylet suction fna sampling pure cytologic assessment versus cytohistologic technique grading investigator´s pathologist´s experience improvement eu training novice report briefly review actual literature summarize available evidence controversely discussed issue result support view use stylet rarely aid increase amount tissue obtained eusfna whereas use suction helpful certain situation novel cutting needle may potentially improve number size core biopsy rendered special histologic tissue processing technique inroomcytopathologist necessarily improves outcome eusfna result may role buildup eu unit become successful eusfna education requires skilled endoscopists side presumably improved objective testing practical expertise peer review introducing objective sampling parameter novel technique equipment evolve near future,2014,"Hollerbach, S; Juergensen, C; Hocke, M; Freund, U; Wellmann, A; Burmester, E",Zeitschrift fur Gastroenterologie,,,,,,https://doi.org/10.1055/s-0034-1385133; https://www.ncbi.nlm.nih.gov/pubmed/25198088/,7127071.0,12
36403,36403,48009,v76z32tb,,Medline,Multicenter experience with nonischemic multiport laparoscopic and laparoendoscopic single-site partial nephrectomy utilizing bipolar radiofrequency ablation coagulator.,10.1155/2011/636537,,21747654.0,unk,objective investigate feasibility multiport laparoendoscopic singlesite le nonischemic laparoscopic partial nephrectomy nilpn utilizing bipolar radiofrequency coagulator method multicenter retrospective review patient multiport le undergoing nilpn multiport le nilpn utilized habib x bipolar radiofrequency coagulator form hemostatic zone followed nonischemic tumor excision renorrhaphy demographic tumorperioperative characteristic outcome analyzed result successfully underwent nilpn mean tumor size cm mean operative time minute mean estimated blood loss ml preoperativepostoperative creatinine mgdl p negative margin patient developed complication developed urine leak difference multiport lesspn noted regard demographic tumor size outcome complication conclusion initial experience demonstrates nonischemic multiport lesspn safe efficacious excellent shortterm preservation renal function longterm data needed confirm oncological efficacy,2011,"Bazzi, Wassim M; Allaf, Mohamad E; Berkowitz, Jared; Atalah, Hany N; Parekattil, Sijo; Derweesh, Ithaar H",Diagnostic and therapeutic endoscopy,,,,,,https://doi.org/10.1155/2011/636537; https://www.ncbi.nlm.nih.gov/pubmed/21747654/,5697820.0,12
36457,36457,48069,2hlpjnka,,Medline,Robotic partial nephrectomy with cold ischemia and on-clamp tumor extraction: recapitulating the open approach.,10.1016/j.eururo.2012.11.029,,23183196.0,unk,describe reproducible technique achieving cold ischemia intraoperative tumor assessment robotic partial nephrectomy rpn recapitulates open approach intracorporeal cooling extraction ice total seven patient underwent ice modification rpn transperitoneal n retroperitoneal n approach gelpoint access port used camera assistant port following hilar clamping ice slush introduced gelpoint via syrinx applied kidney surface excised tumor immediately extracted gelpoint allowing gross margin assessment pathology renorrhaphy rpn achieved case successful introduction ice slush tumor extraction clamp median renal nephrometry score range one solitary kidney mean cold ischemia time min range mean estimated blood loss ml range renal parenchymal temperature °c achieved within min cold ischemia drop core body temperature °c procedure intraoperative assessment excised tumor showed adequate gross margin case final pathology confirmed negative surgical margin,2013,"Rogers, Craig G; Ghani, Khurshid R; Kumar, Ramesh K; Jeong, Wooju; Menon, Mani",European urology,,,,,,https://doi.org/10.1016/j.eururo.2012.11.029; https://www.ncbi.nlm.nih.gov/pubmed/23183196/,14172730.0,12
36472,36472,48084,mu12ej3l,,Medline,Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI.,10.1371/journal.pone.0157820,,27326456.0,unk,background myometrial smooth muscle normally within field view gynecological imaging study aimed investigate use normal myometrium internal reference endometrial cervical cancer multiphase contrastenhanced magnetic resonance imaging mcemri explore whether information regarding tumor enhancement relative myometrium could used discriminate endometrial cervical cancer method mri image contrast enhancement analyzed newly diagnosed cervical n endometrial cancer n patient signal intensity si tumor tissue nonneoplastic myometrium measured using imaging software result relative signal cervical cancer approximately higher endometrial cancer contrast administration area receiver operating characteristic curve si relative signal enhancement tumor myometrium contrast ratio used discriminate cervical cancer endometrial cancer respectively difference si normal myometrium endometrial cervical cancer patient prior contrast administration using nontumorous myometrium internal reference tumor myometrium contrast ratio significantly higher tumor tissue cervical cancer compared endometrial cancer post contrast enhancement p optimal sensitivity specificity conclusion si normalized baseline normal myometrium tumor tissue cervical cancer patient showed significant hyperintensity compared tumor tissue endometrial cancer patient contrast enhancement yielding acceptable performance use myometrium internal reference may provide alternative method analyze mcemri data,2016,"Lin, Chia-Ni; Liao, Yu-San; Chen, Wen-Chang; Wang, Yue-Sheng; Lee, Li-Wen",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0157820; https://www.ncbi.nlm.nih.gov/pubmed/27326456/,1084645.0,12
36503,36503,48121,gsh3hr16,,Medline,Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.,10.1067/j.cpradiol.2017.05.006,,28648469.0,unk,purpose microwave ablation mwa relatively newer treatment modality treatment renal cell carcinoma rcc small study examined short longterm outcome mwa applied renal tumor purpose retrospective review ass initial experience including technical short longterm success rate using radiofrequency ablation rfa mwa rcc single veteran affair va medical center material method tumor characteristic recorded using renal nephrometry score group comparison performed using univariate logistic regression analysis determine factor affecting primary treatment success failure effectiveness kaplanmeier local tumor progressionfree survival following ablation calculated result mwa rfa group significantly different primary treatment success p mwa primary treatment success associated renal criterion whereas primary success rfa group predicted smaller tumor size p primary treatment effectiveness rate significantly different mwa rfa group p although overall primary technique effectiveness associated size p univariate analysis showed significant association tumor size primary effectiveness rfa p mwa significant association renal score criterion primary treatment effectiveness rfa mwa group conclusion rfa mwa represent effective treatment modality rcc larger tumor size may associated decreased efficacy thermal ablation technique,2018,"Abboud, Salim E; Patel, Tanay; Soriano, Stephanie; Giesler, Joseph; Alvarado, Nannette; Kang, Preet",Current problems in diagnostic radiology,,,,,,https://doi.org/10.1067/j.cpradiol.2017.05.006; https://www.ncbi.nlm.nih.gov/pubmed/28648469/,25746725.0,12
36523,36523,48147,d0qb27dc,,Medline,Treatment of symptomatic focal nodular hyperplasia with percutaneous radiofrequency ablation.,10.1016/j.jvir.2009.12.385,,20138547.0,unk,author report case yearold woman taking oral contraceptive severe dysmenorrhea presented hepatic mass worsening right upper quadrant pain oral contraceptive could discontinued pelvic symptom necessitating treatment liver lesion symptomatic relief computed tomography percutaneous biopsy demonstrated mass focal nodular hyperplasia patient opted radiofrequency ablation rather surgical enucleation symptomatic relief ablation proved safe effective alternative surgery treat benign tumor permitted aggressive therapy dysmenorrhea,2010,"Hedayati, Pejman; VanSonnenberg, Eric; Shamos, Raymond; Gillespie, Thomas; McMullen, William",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2009.12.385; https://www.ncbi.nlm.nih.gov/pubmed/20138547/,206655602.0,12
36539,36539,48163,cmcthjdy,,Medline,Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry.,10.2967/jnumed.108.055525,,19164241.0,unk,unlabelled noninvasive detection epidermal growth factor receptor egfr expression malignant tumor radionuclide molecular imaging may provide diagnostic information influencing patient management aim study evaluate novel egfrtargeting protein zegfr affibody molecule radionuclide imaging egfr expression determine suitable tracer format dimer monomer optimal label method egfrspecific affibody molecule zegfr dimeric form zegfr labeled using benzyldiethylenetriaminepentaacetic acid using piodobenzoate affinity cellular retention conjugate evaluated vitro biodistribution radiolabeled affibody molecule compared mouse bearing egfrexpressing xenograft specificity egfr targeting confirmed comparison biodistribution nonegfrspecific counterpart result headtotail dimerization affibody molecule improved dissociation rate vitro dimeric form demonstrated superior cellular retention radioactivity molecular setup retention better inlabeled tracer radioiodinated counterpart vivo conjugate accumulated specifically xenograft egfrexpressing tissue retention radioactivity tumor better vivo dimeric form however absolute uptake value higher monomeric tracer best tracer inlabeled zegfr provided tumortoblood ratio h injection conclusion radiometallabeled monomeric affibody molecule zegfr potential radionuclide molecular imaging egfr expression malignant tumor,2009,"Tolmachev, Vladimir; Friedman, Mikaela; Sandström, Mattias; Eriksson, Tove L J; Rosik, Daniel; Hodik, Monika; Ståhl, Stefan; Frejd, Fredrik Y; Orlova, Anna","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.108.055525; https://www.ncbi.nlm.nih.gov/pubmed/19164241/,1500362.0,12
36560,36560,48188,txxk3mp4,,Medline,Management of von Hippel-Lindau disease-associated CNS lesions.,10.1586/ern.11.124,,21955200.0,unk,patient von hippellindau disease vhl often harbor significant disease burden within cns specifically craniospinalaxis hemangioblastomas endolymphatic sac tumor elsts majority patient vhl harbor hemangioblastomas develop elsts advance understanding natural history outcome associated surgical management vhlassociated tumor led improved management patient vhl optimizing indication surgical intervention refining surgical technique lesion reduce patient morbidity associated management syndrome article review various aspect perioperative management patient vhl surgical indication general operative principle management hemangioblastomas elsts outcome associated surgical treatment tumor,2011,"Wind, Joshua J; Lonser, Russell R",Expert review of neurotherapeutics,,,,,,https://doi.org/10.1586/ern.11.124; https://www.ncbi.nlm.nih.gov/pubmed/21955200/,28810964.0,12
36581,36581,48213,yj8j5fh4,,Medline,Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.,10.3748/wjg.v20.i6.1585,,24587635.0,unk,aim evaluate outcome radiofrequency ablation rfa therapy early hepatocellular carcinoma hcc identify survival recurrencerelated factor method consecutive patient diagnosed early hcc computed tomography ct magnetic resonance imaging mri single nodule ≤ cm multi nodule ≤ cm underwent rfa treatment curative intent january august instituto câncer estado de são paulo brazil enrolled study rfa liver tumor cm ablative margin carried ctfluoro scan ultrasonic image guidance percutaneous ablation probe procedurerelated complication recorded mo postrfa mo interval thereafter ct mri performed ass outcome complete response absence enhancing tissue tumor site incomplete response enhancing tissue remaining tumor site overall survival diseasefree survival rate estimated kaplanmeier method compared log rank test simple cox regression effect risk factor survival assessed cox proportional hazard model result total rfa session performed study period patient age year mean range mean followup time mo range study population showed predominance male sex le severe liver disease childpugh n childpugh b n single tumor maximum tumor diameter ranged mm median mm initial immediately postprocedure rate rfainduced complete tumor necrosis probability achieving complete response significantly greater patient single nodule v patient multinodules p two patient experienced major complication including acute pulmonary edema resolved intervention intestinal perforation led death year overall survival rate respectively sex tumor size initial response recurrence status influenced survival reach threshold statistical significance childpugh class model endstage liver disease score identified predictor survival simple cox regression childpugh class showed statistically significant association survival multiple cox regression analysis hr ci mo p year cumulative diseasefree survival rate respectively conclusion rfa effective therapy local tumor control early hcc patient preserved liver function best candidate,2014,"Kikuchi, Luciana; Menezes, Marcos; Chagas, Aline L; Tani, Claudia M; Alencar, Regiane Ssm; Diniz, Marcio A; Alves, Venâncio Af; D'Albuquerque, Luiz Augusto Carneiro; Carrilho, Flair José",World journal of gastroenterology,,,,,,https://doi.org/10.3748/wjg.v20.i6.1585; https://www.ncbi.nlm.nih.gov/pubmed/24587635/,21146277.0,12
36615,36615,48255,41kwef0p,,Medline,Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients.,10.1007/s00270-016-1301-x,,26860716.0,unk,objective evaluate prognostic factor associated local control diseasefreesurvival dfs oligometastatic breast cancer patient treated percutaneous thermal ablation pta material method seventynine consecutive patient ± year old breast cancer metastasis ± mm diameter involving lung liver andor bone treated using pta curative intent goal achieve complete remission association systemic chemotherapy hormonal therapy retrospectively evaluated prognostic factor associated year local control year dfs rate result year local control rate respectively tumor burden associated poorer outcome local control pta hr additional millimeter p cm hr year dfs rate respectively multivariate analysis triplenegative histological subtype increased size treated metastasis associated poorer dfs hr ci p hr ci p respectively conclusion pta effective local control breast cancer oligometastases tumor burden cm triplenegative histological subtype associated poorer outcome,2016,"Barral, M; Auperin, A; Hakime, A; Cartier, V; Tacher, V; Otmezguine, Yves; Tselikas, L; de Baere, T; Deschamps, F",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-016-1301-x; https://www.ncbi.nlm.nih.gov/pubmed/26860716/,1534602.0,12
36667,36667,48312,z5tihpen,,Medline,Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients.,10.1007/s11604-016-0601-z,,27864664.0,unk,purpose retrospective singlecenter study evaluated radiofrequency rf ablation pulmonary metastasis sarcoma material method fortysix patient sarcoma pulmonary metastasis underwent rf ablation session data regarding local tumor progression efficacy procedural adverse event aes national cancer institute common terminology criterion adverse event version overall survival o osassociated prognostic factor retrospectively evaluated using univariate analysis result local progression occurred tumor primary secondary efficacy rate year year respectively seventythree grade aes grade aes grade ≥ aes observed twentyeight patient remained alive died yielding year o rate median survival time month univariate analysis revealed extrapulmonary metastasis p noncurative rf ablation p postrf ablation diseasefree interval ≤ month p significant negative prognostic factor conclusion rf ablation safe offer good local control may viable treatment option pulmonary metastasis sarcoma,2017,"Sato, Takuya; Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Sakurai, Jun; Matsui, Yusuke; Mitsuhashi, Toshiharu; Soh, Junichi; Toyooka, Shinichi; Kanazawa, Susumu",Japanese journal of radiology,,,,,,https://doi.org/10.1007/s11604-016-0601-z; https://www.ncbi.nlm.nih.gov/pubmed/27864664/,7986381.0,12
36720,36720,48375,o2v1ndka,,Medline,"Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.",10.1002/cmmi.1596,,24764162.0,unk,db new monoclonal antibody directed extracellular domain prostatespecific membrane antigen psma overexpressed prostate cancer potential db igg fab fab fragment antibody targeting prostate cancer determined mouse bearing subcutaneous prostate cancer xenograft optimal time point imaging determined biodistribution microspect imaging study indb igg incapromab pendetide indb fab indb fab fragment mouse psmaexpressing lncap psmanegative pc tumor several time point injection inlabeled antibody format specifically accumulated lncap tumor highest uptake indb igg incapromab pendetide h pi ± injected dose per gram idg ± idg respectively whereas uptake indb fab indb fab fragment peaked h pi ± idg ± idg respectively maximum lncap tumortoblood ratio ± h pi ± h pi ± h pi ± h pi indb igg infab infab incapromab pendetide respectively lncap tumor clearly visualized microspect antibody format study demonstrates feasibility db igg fab fab fragment targeting psmaexpressing prostate cancer xenograft,2015,"Lütje, Susanne; van Rij, Catharina M; Franssen, Gerben M; Fracasso, Giulio; Helfrich, Wijnand; Eek, Annemarie; Oyen, Wim J; Colombatti, Marco; Boerman, Otto C",Contrast media & molecular imaging,,,,,,https://doi.org/10.1002/cmmi.1596; https://www.ncbi.nlm.nih.gov/pubmed/24764162/,205650856.0,12
36758,36758,48417,ozptobsd,,Medline,Transarterial Onyx Embolization of an Orbital Solitary Fibrous Tumor.,10.1159/000370048,,27171911.0,unk,solitary fibrous tumor sft uncommon mesenchymal neoplasm sometimes found orbit report case aggressive orbital sft enlarged feeding vessel successfully resected immediately transarterial embolization onyx ethylene vinyl alcohol copolymer knowledge first report showing histopathology onyx embolization material orbital sft,2015,"Hashemi, Nafiseh; Ling, Jeanie D; Soparkar, Charles; Sami, Mirwat; Ellezam, Benjamin; Klucznik, Richard; Lee, Andrew G; Chévez-Barrios, Patricia",Ocular oncology and pathology,,,,,,https://doi.org/10.1159/000370048; https://www.ncbi.nlm.nih.gov/pubmed/27171911/,191404.0,12
36796,36796,48460,7ayn6l8l,,Medline,Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.,10.1002/hed.24685,,28139028.0,unk,background parapharyngeal space tumor ppsts pose exposure challenge routinely resected transcervical approach using bluntblind finger dissection increasing risk tumor spillage neurovascular injury large ppsts located high skull base often require mandibulotomy infratemporal fossa approach baring considerable morbidity method novel minimally invasive approach described utilizes endoscopic equipment introduced transcervically circumferential separation tumor neurovascular structure skull base tumor separated removed en bloc via transoral robotic surgery tor result technique provides improved visualization safe vascular control minimum tumor stress preventing need bluntblind finger dissection allowing complete tumor removal minimizing tumor spillage nerve injury blood loss maintaining excellent cosmetic functional result conclusion approach could utilized removal large benign ppsts small ppsts located high skull base © wiley periodical inc head neck,2017,"Duek, Irit; Amit, Moran; Sviri, Gill E; Gil, Ziv",Head & neck,,,,,,https://doi.org/10.1002/hed.24685; https://www.ncbi.nlm.nih.gov/pubmed/28139028/,3629849.0,12
36837,36837,48507,9m7l59gs,,Medline,A case of a gastric granular cell tumor preoperatively diagnosed and successfully treated by single-incision laparoscopic surgery.,10.1186/s40792-020-00809-w,,32107653.0,unk,background granular cell tumor gct gastrointestinal tract rare herein describe case gastric gct diagnosed preoperatively endoscopic ultrasoundguided fine needle aspiration biopsy eusfnab successfully resected singleincision laparoscopic surgery sils case presentation yearold japanese woman tumor located angle stomach approximately cm diameter abdominal computed tomography ct revealed submucosal tumor smt finally diagnosed gastric gct using eusfnab tumor identified ct year month diagnosis therefore possibility tumor malignant performed surgical wedge resection using sils patient uneventful recovery postoperatively discharged without complication day surgery tumor pathologically diagnosed benign gct remained within muscular layer recurrence complication occurred first month since surgery conclusion gastric gcts generally benign rarely associated lymph node metastasis sils seems safe feasible surgical approach treating gcts,2020-02-27,"Yasuda, Atsushi; Yasuda, Takushi; Imamoto, Haruhiko; Hiraki, Yoko; Momose, Kohta; Kato, Hiroaki; Iwama, Mitsuru; Shiraishi, Osamu; Shinkai, Masayuki; Imano, Motohiro; Kimura, Yutaka",Surgical case reports,,,,,,https://doi.org/10.1186/s40792-020-00809-w; https://www.ncbi.nlm.nih.gov/pubmed/32107653/,211526027.0,12
36853,36853,48528,qs170nvo,,Medline,18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy.,10.2967/jnumed.112.116921,,23864719.0,unk,unlabelled potential ffdg pet change evaluated prediction response concomitant chemoradiotherapy patient locally advanced nonsmall cell lung cancer nsclc method patient ffdg pet performed treatment end second week treatment wk mo completion treatment standardized uptake value suv maximum suv metabolic tumor volume mtv total lesion glycolysis tlg obtained early metabolic change defined fractional change δtlg ffdg pet end second week compared pretreatment ffdg pet intreatment metabolic change measured serial ffdg pet correlated standard criterion response evaluation solid tumor mean ct imaging response evaluation criterion solid tumor parameter analyzed stratification progressionfree survival pfs result compared early metabolic nonresponders δtlg decrease associated significantly longer pfs pfs v p pretreatment tlg found prognostic factor pfs conclusion degree change tlg predictive response concomitant chemoradiotherapy early end second week treatment patient locally advanced nsclc pretreatment tlg prognostic pfs,2013,"Usmanij, Edwin A; de Geus-Oei, Lioe-Fee; Troost, Esther G C; Peters-Bax, Liesbeth; van der Heijden, Erik H F M; Kaanders, Johannes H A M; Oyen, Wim J G; Schuurbiers, Olga C J; Bussink, Johan","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.112.116921; https://www.ncbi.nlm.nih.gov/pubmed/23864719/,10064964.0,12
36936,36936,48626,41s5n9xw,,Medline,Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer.,10.1002/ijc.33041,,32388866.0,unk,microenvironment pancreatic cancer adenocarcinoma pdac highly desmoplastic distinct tumorrestraining tumorpromoting fibroblast subpopulation reeducation rather indiscriminate elimination fibroblast emerged new strategy combination therapy studied effect global loss profibrotic noncoding regulatory microrna mir krasdriven pdeleted genetically engineered mouse model pdac strikingly loss mir accelerated tumor initiation via mucinous cystic neoplastic lesion progression locally advanced invasive carcinoma animal precipitously succumbed early age absence tumorrestraining myofibroblasts massive infiltrate immune cell salient phenotypic feature global mir loss stromal mir activity required induction tumorrestraining myofibroblasts invivo isograft transplantation experiment low mir expression negatively correlated fibroblast gene expression signature positively immune cell gene expression signature tcga pdac data set n mirroring finding mouse model result exposed overall tumor suppressive function mir invivo pdac model result important clinical implication antimirbased inhibitory therapeutic approach consideration pdac cancer type mechanistic dissection cellintrinsic role mir cancerassociated fibroblast cell type needed inform best strategy pharmacological modulation mir activity order remodel tumor microenvironment enhance treatment response pdac article protected copyright right reserved,2020-05-10,"Schipper, Josh; Westerhuis, Jennifer J; Beddows, Ian; Madaj, Zach; Monsma, David; Hostetter, Galen; Kiupel, Matti; Conejo-Garcia, Jose R; Sempere, Lorenzo F",International journal of cancer,,,,,,https://doi.org/10.1002/ijc.33041; https://www.ncbi.nlm.nih.gov/pubmed/32388866/,218584111.0,12
37001,37001,48698,y5jz7a8c,,Medline,Splenectomy is associated with an aggressive tumor growth pattern and altered host immunity in an orthotopic syngeneic murine pancreatic cancer model.,10.18632/oncotarget.21331,,29179479.0,unk,purpose study investigate whether splenectomy influence tumor growth metastatic pattern orthotopic syngeneic murine pancreatic cancer model murine pancreatic cancer cell pan subcutaneously injected flank nude mouse small tumor fragment mm harvested subcutaneous tumor orthotopically implanted tail pancreas cbl mouse without splenectomy control group n simultaneous splenectomy splenectomy group n tumor growth metastatic pattern analyzed laparotomy day surgery tumor growth found mouse control group mouse splenectomy group p tumor volume significantly larger splenectomy group p peritoneal seeding frequently observed splenectomy group v p difference number liver kidney metastasis two group ratio tumorinfiltrating cd foxp cd foxp significantly higher control group compared splenectomy group ± v ± p ± v ± p respectively splenectomy enhanced tumor growth peritoneal seeding orthotopic syngeneic murine pancreatic cancer mouse model ramification result discussed pancreatic cancer treatment,2017,"Hwang, Ho Kyoung; Murakami, Takashi; Kiyuna, Tasuku; Kim, Se Hoon; Lee, Sung Hwan; Kang, Chang Moo; Hoffman, Robert M; Bouvet, Michael",Oncotarget,,,,,,https://doi.org/10.18632/oncotarget.21331; https://www.ncbi.nlm.nih.gov/pubmed/29179479/,19193749.0,12
37060,37060,48775,h6zgafw5,,Medline,Single-incision video-assisted thoracic resection for extrapulmonary sequestration: a case report.,10.1186/1749-8090-9-22,,24456752.0,unk,describe surgical resection extralobar pulmonary sequestration via singleincision thoracoscopic surgery sits recommend suitable surgical option yearold japanese woman admitted hospital examination chest abnormal shadow rigid mm ° videothoracoscope endograsper electric cautery passed within single small incision tumor suspended using articulating endograspers resected clipping ligation anomalous vessel final pathology determined extrapulmonary sequestration,2014,"Tamura, Masaya; Shimizu, Yosuke; Hashizume, Yasuo",Journal of cardiothoracic surgery,,,,,,https://doi.org/10.1186/1749-8090-9-22; https://www.ncbi.nlm.nih.gov/pubmed/24456752/,2038193.0,12
37072,37072,48790,jnfd3hyc,,Medline,"Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma.",10.1155/2012/390912,,23304625.0,unk,fusion technology electromagnetic em tracking enables navigation multimodality feedback let operator use different modality different part imageguided procedure may particularly helpful patient renal insufficiency undergoing kidney tumor ablation desire minimize avoid nephrotoxic iodinated contrast exposure em tracking software merges fuse different imaging modality mri ct ultrasound also display position needle real time relation preprocedure imaging may better define tumor target available intraoperative imaging em tracking successfully used ablate poorly visualized renal tumor combined use ct gadoliniumenhanced mr contrastenhanced u imaging localize tumor,2012,"Amalou, Hayet; Wood, Bradford J",Case reports in urology,,,,,,https://doi.org/10.1155/2012/390912; https://www.ncbi.nlm.nih.gov/pubmed/23304625/,18523514.0,12
37081,37081,48801,uc0ns6rn,,Medline,"Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a ""Cu(I)-click"" and ""sulfo-click"" ligation method.",10.1002/cbic.201000639,,21328514.0,unk,report sstrbinding property series four dimeric tyroctreotate analogue different spacer length nine atom peptide two analogue atom selected precursor design synthesis biological evaluation dotaconjugated dimeric tyroctreotate analogue tumor targeting compound synthesized using twostage click ligation procedure cui catalyzed dipolar cycloaddition copperclick reaction thio acidsulfonyl azide amidation sulfoclick reaction ic value dotaconjugated tyroctreotate analogue comparable internalization study showed nineatom indotalabeled tyroctreotate dimer rapid high receptor binding biodistribution study balbc nude mouse bearing subcutaneous arj tumor showed inlabeled tyroctreotate dimer nine atom high tumor uptake h pi ± id g excellent tumor retention h pi ± id g however introduction extended hydrophilic atom spacer led rapid clearance circulation limited tumor accumulation radiotracer ± id g h pi finding provide important insight dimerization spacer effect vivo property dotaconjugated tyroctreotate dimer,2011,"Yim, Cheng-Bin; van der Wildt, Berend; Dijkgraaf, Ingrid; Joosten, Lieke; Eek, Annemarie; Versluis, Cees; Rijkers, Dirk T S; Boerman, Otto C; Liskamp, Rob M J",Chembiochem : a European journal of chemical biology,,,,,,https://doi.org/10.1002/cbic.201000639; https://www.ncbi.nlm.nih.gov/pubmed/21328514/,37934300.0,12
37176,37176,48912,obab86xg,,Medline,Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.,10.1016/j.jamcollsurg.2015.04.010,,26206642.0,unk,background many rectal cancer patient experience tumor downstaging found achieve pathologic complete response pcr neoadjuvant chemoradiotherapy ncrt previous data suggest association time interval ncrt completion surgery tumor response rate including pcr however study primarily single institution small sample size aim study examine relationship longer interval ncrt pcr nationally representative cohort rectal cancer patient study design clinical stage ii iii rectal cancer patient undergoing ncrt documented surgical resection selected national cancer data base multivariable logistic regression analysis used ass association ncrtsurgery interval time week week week odds pcr relationship ncrtsurgery interval surgical morbidity tumor downstaging also examined result overall patient met inclusion criterion ncrtsurgery interval time week associated higher odds pcr odds ratio ci tumor downstaging ci longer time delay also associated lower odds day readmission ci conclusion ncrtsurgery interval time week result increased odds pcr evidence associated increased surgical complication compared interval week data support implementation lengthened interval ncrt optimize chance pcr perhaps add possibility ultimate organ preservation nonoperative management,2015,"Probst, Christian P; Becerra, Adan Z; Aquina, Christopher T; Tejani, Mohamedtaki A; Wexner, Steven D; Garcia-Aguilar, Julio; Remzi, Feza H; Dietz, David W; Monson, John R T; Fleming, Fergal J",Journal of the American College of Surgeons,,,,,,https://doi.org/10.1016/j.jamcollsurg.2015.04.010; https://www.ncbi.nlm.nih.gov/pubmed/26206642/,13585827.0,12
37195,37195,48935,h2w90n62,,Medline,Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.,10.1093/annonc/mdv041,,25646366.0,unk,background pulmonary carcinoid pc rare tumor paucity randomized study expert consensus document represents initiative european neuroendocrine tumor society provide guidance management patient method bibliographical search carried pubmed term pulmonary neuroendocrine tumor bronchial neuroendocrine tumor bronchial carcinoid tumor pulmonary carcinoid pulmonary typicalatypical carcinoid pulmonary carcinoid diagnosistreatmentepidemiologyprognosis systematic review relevant literature carried followed expert review result pc welldifferentiated neuroendocrine tumor include low intermediategrade malignant tumor ie typical tc atypical carcinoid ac respectively contrast ct scan diagnostic gold standard pc pathology examination mandatory correct classification somatostatin receptor imaging may visualize nearly primary tumor sensitive metastatic disease plasma chromogranin increased pc surgery treatment choice pc aim removing tumor preserving much lung tissue possible resection metastasis considered whenever possible curative intent somatostatin analog firstline treatment carcinoid syndrome may considered firstline systemic antiproliferative treatment unresectable pc particularly lowgrade tc ac locoregional radiotargeted therapy considered metastatic disease systemic chemotherapy used progressive pc although cytotoxic regimen demonstrated limited effect etoposide platinum combination commonly used however temozolomide shown clinical benefit conclusion pc complex tumor require multidisciplinary approach longterm followup,2015,"Caplin, M E; Baudin, E; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, R E; Travis, W D",Annals of oncology : official journal of the European Society for Medical Oncology,,,,,,https://doi.org/10.1093/annonc/mdv041; https://www.ncbi.nlm.nih.gov/pubmed/25646366/,16536744.0,12
37207,37207,48948,b5o2udic,,Medline,Retroperitoneal Laparoscopic Radical Nephrectomy for Large (>7 cm) Solid Renal Tumors: Comparison of Perioperative Outcomes with the Transperitoneal Approach.,10.1089/lap.2016.0689,,28234014.0,unk,purpose describe technique retroperitoneal laparoscopic radical nephrectomy lrn present perioperative outcome retroperitoneal lrn series large cm solid renal tumor compare transperitoneal approach material method retrospective chart review performed patient undergone lrn solid renal tumor greater cm size computed tomography ct scan june january perioperative outcome compared transperitoneal retroperitoneal approach result case transperitoneal approach group case retroperitoneal group mean tumor size cm transperitoneal approach group cm retroperitoneal group p retroperitoneal approach group operation time shorter estimated blood loss ebl lower time start diet shorter p p p respectively complication rate comparable two approach conclusion retroperitoneal lrn large cm solid renal tumor demonstrated superior result term operation time estimated blood loss time start diet transperitoneal lrn perioperative outcome complication rate comparable two approach believe sufficient experience retroperitoneal lrn may effective safe procedure large cm solid renal tumor,2017,"Kim, Hee Youn; Lee, Dong Sup; Yoo, Je Mo; Lee, Joon Ho; Lee, Seung-Ju",Journal of laparoendoscopic & advanced surgical techniques. Part A,,,,,,https://doi.org/10.1089/lap.2016.0689; https://www.ncbi.nlm.nih.gov/pubmed/28234014/,12733791.0,12
37235,37235,48980,8lir1j0d,,Medline,Ablative therapies for renal tumors.,10.1177/1756287210366708,,21789083.0,unk,owing increased use diagnostic imaging evaluating patient abdominal condition incidentally discovered kidney mass account majority renal tumor renal ablative therapy assuming important role patient borderline renal impairment renal ablation us heat cold bring cell death radiofrequency ablation cryoablation two procedure year result emerging modality renal biopsy time ablation extremely important order establish tissue diagnosis realtime temperature monitoring time radiofrequency ablation useful ensure adequacy ablation,2010,"Ramanathan, Rajan; Leveillee, Raymond J",Therapeutic advances in urology,,,,,,https://doi.org/10.1177/1756287210366708; https://www.ncbi.nlm.nih.gov/pubmed/21789083/,21830761.0,12
37241,37241,48986,9sb2wi7s,,Medline,Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.,10.1186/2191-219x-4-9,,24528513.0,unk,background neuroendocrine tumor well vascularized express specific cell surface marker somatostatin receptor glucagonlike peptide receptor glpr using riptag transgenic mouse model pancreatic neuroendocrine tumor pnet investigated potential benefit combination antiangiogenic treatment targeted internal radiotherapy method lysahxdtpainnhexendin radiopeptide selectively bind glpr expressed insulinoma neuroendocrine tumor cell coadministered oral vatalanib inhibitor vascular endothelial growth factor receptor vegfr imatinib ckitpdgfr inhibitor control group included singleagent kinase inhibitor treatment lysahxdtpanatinnhexendin monotherapy biodistribution riptag mouse pretreated oral vatalanib imatinib day dose mgkg subsequently lysahxdtpainnhexendin administered iv biodistribution assessed h therapy mouse injected mbq lysahxdtpainnhexendin treated vatalanib imatinib mgkg orally another day tumor volume tumor cell apoptosis proliferation microvessel density quantified result combination lysahxdtpainnhexendin vatalanib significantly effective single treatment p reduced tumor volume absence organ damage pretreatment mouse vatalanib led reduction tumor uptake lysahxdtpainnhexendin indicating concomitant administration vatalanib radiopeptide best approach imatinib show synergistic effect lysahxdtpainnhexendin conclusion combination mbq lysahxdtpainnhexendin mgkg vatalanib effect neuroendocrine tumor injection mbq radiopeptide alone without apparent side effect radiation damage kidney,2014,"Wicki, Andreas; Wild, Damian; Prêtre, Vincent; Mansi, Rosalba; Orleth, Annette; Reubi, Jean-Claude; Rochlitz, Christoph; Mamot, Christoph; Mäcke, Helmut R; Christofori, Gerhard",EJNMMI research,,,,,,https://doi.org/10.1186/2191-219x-4-9; https://www.ncbi.nlm.nih.gov/pubmed/24528513/,14937511.0,12
37261,37261,49011,vt3j4ury,,Medline,Laparoscopic distal pancreatectomy for a pancreatic lymphoepithelial cyst: case report and review of literature.,10.6092/1590-8577/1738,,24216557.0,unk,context lymphoepithelial cyst pancreas rare disease true pancreatic cyst cause unknown differential diagnosis broad includes many benign malignant cystic lesion pancreas surrounding organ combination imaging modality fine needle aspiration might narrow differential diagnosis however final diagnosis achieved certainty resection cyst case report present case report lymphoepithelial cyst pancreas resected laparoscopically yearold man incidentally found cystic tumor tail pancreas undergoing abdominal ultrasound showed x mm cystic mass pancreatic tail abdominal symptom laparoscopic distal pancreatectomy splenectomy performed histologic examination revealed lymphoepithelial cyst conclusion herein discus diagnostic difficulty management decision face surgeon treating pancreatic cyst,2013,"Yanagimoto, Hiroaki; Satoi, Sohei; Toyokawa, Hideyoshi; Yamamoto, Tomohisa; Hirooka, Satoshi; Yui, Rintaro; Yamaki, So; Yoshida, Kazumasa; Wada, George; Okuno, Masashi; Inoue, Kentaro; Michiura, Taku; Matsui, Yoichi; Nakano, Yorika; Sakaida, Noriko; Kwon, A-Hon",JOP : Journal of the pancreas,,,,,,https://doi.org/10.6092/1590-8577/1738; https://www.ncbi.nlm.nih.gov/pubmed/24216557/,1120408.0,12
37379,37379,49146,jr7eas0g,,Medline,Laparoscopic hepatic resection for metastatic liver tumor of colorectal cancer: comparative analysis of short- and long-term results.,10.1007/s00464-013-3165-3,,23996337.0,unk,background progress surgical technique device laparoscopic hepatectomy laphx became realizable option patient liver tumor however feasibility laphx metastatic liver tumor colorectal cancer also guaranteed oncologically study evaluated short longterm outcome laphx compared open hepatectomy openhx patient colorectal liver metastasis clm matchedpair analysis method study enrolled patient underwent laphx compared matched patient underwent openhx following parameter matched two cohort tumor size tumor location operative procedure short longterm outcome laphx compared openhx result difference observed two group term age gender tumor size operative procedure regard shortterm outcome operative time laphx ± min similar openhx ± min whereas blood loss patient underwent laphx ± ml significantly le underwent openhx ± ml incidence postoperative complication among patient underwent laphx tended lower patient underwent openhx intraabdominal abscess observed openhx group hospital stay laphx average day tended shorter openhx day respect longterm outcome two group differ significantly term year overall diseasefree survival rate conclusion laphx safe feasible option selected patient clm short longterm outcome laphx also considered acceptable,2014,"Iwahashi, Shuichi; Shimada, Mitsuo; Utsunomiya, Tohru; Imura, Satoru; Morine, Yuji; Ikemoto, Tetsuya; Arakawa, Yusuke; Mori, Hiroki; Kanamoto, Mami; Yamada, Shinichiro",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-013-3165-3; https://www.ncbi.nlm.nih.gov/pubmed/23996337/,23950550.0,12
37397,37397,49165,3lvjfthe,,Medline,Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.,10.2967/jnumed.111.092833,,21990576.0,unk,unlabelled fluorescence imaging currently attracting much interest method intraoperative tumor detection current tracer lack tumor specificity therefore technique improved tumorspecific detection tumortargeted antibody bound radioactive label tumorspecific spect pet feasible clinical setting aim present study apply antibodybased tumor detection intraoperative optical imaging using preclinical vivo mouse model method antivascular endothelial growth factor vegf antibody bevacizumab antihuman epidermal growth factor receptor antibody trastuzumab labeled nearinfrared nir fluorescence dye irdye cw tumor uptake fluorescent tracer zrlabeled radioactive counterpart pet determined human xenograftbearing athymic mouse wk tracer injection followed ex vivo biodistribution pathologic examination intraoperative imaging fluorescent vegf herpositive tumor lesion performed subcutaneous tumor intraperitoneal dissemination tumor model result tumortobackground ratio fluorescent imaging ± bevacizumab ± trastuzumab day tracer injection realtime intraoperative imaging detected tumor lesion even submillimeter level intraperitoneal dissemination tumor model result supported standard histology immunohistochemistry fluorescence microscopy analysis conclusion nir fluorescencelabeled antibody targeting vegf used highly specific sensitive detection tumor lesion vivo preclinical finding encourage future clinical study nir fluorescencelabeled tumorspecific antibody intraoperativeguided surgery cancer patient,2011,"Terwisscha van Scheltinga, Anton G T; van Dam, Gooitzen M; Nagengast, Wouter B; Ntziachristos, Vasilis; Hollema, Harry; Herek, Jennifer L; Schröder, Carolien P; Kosterink, Jos G W; Lub-de Hoog, Marjolijn N; de Vries, Elisabeth G E","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.092833; https://www.ncbi.nlm.nih.gov/pubmed/21990576/,24195678.0,12
37402,37402,49172,ul10hou2,,Medline,Our experience with laparoscopic partial gastrectomy by the 'lift-and-cut method' for gastric gastrointestinal stromal tumor with maximal preservation of the remnant stomach.,10.1007/s00464-016-5367-y,,27924391.0,unk,background wedge resection commonly used method laparoscopic partial gastrectomy gastric gastrointestinal stromal tumor gist however method involve inadvertent resection additional gastric tissue cause gastric deformation minimize volume resected gastric tissue developed laparoscopic partial gastrectomy seromyotomy call liftandcut method gastric gist report case series surgery method first seromuscular layer around tumor cut mucosa submucosa extensible tumor lifted toward abdominal cavity sufficient lifting gastric tissue tumor cut submucosal layer linear stapler thus liftandcut method finally defect seromuscular layer closed handsewn suture result april december patient underwent laparoscopic partial gastrectomy method osaka red cross hospital average operation time min range min average blood loss ml range ml intraoperative complication including tumor rupture postoperative complication regarded claviendindo grade ii higher occurred patient took sufficient solid diet discharge median postoperative hospital stay day range day median followup month range month recurrence reported conclusion laparoscopic partial gastrectomy liftandcut method safe simple widely applicable gastric gist,2017,"Okumura, Shintaro; Kanaya, Seiichiro; Hosogi, Hisahiro; Ito, Takeshi; Miura, Susumu; Okada, Toshihiro; Shimoike, Norihiro; Akagawa, Shin; Kawada, Hironori; Arimoto, Akira",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-016-5367-y; https://www.ncbi.nlm.nih.gov/pubmed/27924391/,3798324.0,12
37425,37425,49198,cq1hn91n,,Medline,Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas.,10.1111/hepr.12838,,27862748.0,unk,objective aim study clarify usefulness notouch pincer ablation procedure us bipolar electrode prevent intrasubsegmental tumor recurrence radiofrequency ablation rfa patient hepatocellular carcinoma hcc method studied consecutive patient hcc single nodule tumor diameter ≤ mm received rfa january april patient received touch ablation using monopolar bipolar rfa device received notouch ablation using bipolar rfa device pretreatment arterial portal phase dynamic computed tomography magnetic resonance image classified four enhancement pattern type type homogeneous enhancement pattern without increased arterial blood flow respectively type heterogeneous enhancement pattern septumlike structure type irregularly shaped ring structure enhancement pattern result regard intrasubsegmental tumor recurrence among patient underwent touch ablation procedure tumor recurred patient among patient underwent notouch ablation procedure tumor recurred one patient cumulative intrasubsegmental tumor recurrence rate tended higher touch ablation p multivariate cox proportional hazard analysis revealed ablation procedure touch ablation hazard ratio hr p type enhancement pattern type hr p type hr p serum desγcarboxyprothrombin level ≥ aul hr p significant predictor intrasubsegmental recurrence conclusion notouch pincer ablation procedure potential prevent intrasubsegmental recurrence rfa patient hcc,2017,"Kawamura, Yusuke; Ikeda, Kenji; Fujiyama, Shunichiro; Hosaka, Tetsuya; Kobayashi, Masahiro; Saitoh, Satoshi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Arase, Yasuji; Kumada, Hiromitsu",Hepatology research : the official journal of the Japan Society of Hepatology,,,,,,https://doi.org/10.1111/hepr.12838; https://www.ncbi.nlm.nih.gov/pubmed/27862748/,2470275.0,12
37475,37475,49251,x8n5h3ci,,Medline,Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.,10.1007/s00259-016-3319-3,,26819103.0,unk,context somatostatin receptor scintigraphy inpentetreotide sr used detect duodenopancreatic neuroendocrine tumor dpnets multiple endocrine neoplasia type men however sr limited sensitivity purpose positron emission tomographycomputed tomography petct gadotatoc higher rate sporadic dpnets detection sr little data dpnets detection men purpose compare performance gadotatoc petct sr contrastenhanced computed tomography cect diagnose dpnets men design setting singleinstitution prospective comparative study patient method nineteen consecutive men patient aged ± year underwent gadotatoc petct sr cect within month random order blinded reading image performed separately experienced physician unblinded analysis cect combined additional magnetic resonance imaging endoscopicultrasound ffluorodeoxydglucose ffdg petct histopathology result served reference standard dpnets diagnosis result sensitivity gadotatoc petct sr cect respectively p truepositive lesion detected sr also depicted gadotatoc petct gadotatoc petct detected lesion smaller size sr ± ± mm respectively p false negative gadotatoc petct included small dpnets mm ffdg petct positive aggressive dpnets false positive recorded addition wholebody mapping gadotatoc petct identified extraabdominal menrelated tumor including one neuroendocrine thymic carcinoma identified three imaging procedure one bronchial carcinoid undetected cect three meningioma undetected sr conclusion owing higher diagnostic performance gadotatoc petct alternative galabeled somatostatin analogue replace inpentetreotide investigation men patient,2016,"Morgat, Clément; Vélayoudom-Céphise, Fritz-Line; Schwartz, Paul; Guyot, Martine; Gaye, Delphine; Vimont, Delphine; Schulz, Jürgen; Mazère, Joachim; Nunes, Marie-Laure; Smith, Denis; Hindié, Elif; Fernandez, Philippe; Tabarin, Antoine",European journal of nuclear medicine and molecular imaging,,,,,,https://doi.org/10.1007/s00259-016-3319-3; https://www.ncbi.nlm.nih.gov/pubmed/26819103/,25540392.0,12
37476,37476,49252,k5c6bf7g,,Medline,Retrospective Review of Percutaneous Image-Guided Ablation of Oligometastatic Prostate Cancer: A Single-Institution Experience.,10.1016/j.jvir.2017.03.012,,28434661.0,unk,purpose retrospectively review report efficacy safety percutaneous imageguided ablation cryoablation radiofrequency ablation treatment oligometastatic prostate cancer material method institutional registry retrospectively reviewed revealed patient oligometastatic prostate cancer median age range underwent percutaneous imageguided ablation treat metastatic site subgroup patient metastasis androgendeprivation therapy adtnaïve underwent ablation delay initiation adt local tumor control progressionfree survival pfs adtfree survival procedural complication analyzed result local tumor control achieved metastasis median followup month range mo local tumor recurrence found metastasis median time local recurrence month range mo estimated pfs rate month confidence interval ci ci respectively adtnaïve patient local tumor control achieved metastasis median adtfree survival period month major procedural complication conclusion cohort patient oligometastatic prostate cancer percutaneous imageguided ablation feasible well tolerated achieved acceptable local tumor control rate percutaneous ablation may particular utility patient wish delay initiation adt,2017,"Erie, Andrew J; Morris, Jonathan M; Welch, Brian T; Kurup, A Nicholas; Weisbrod, Adam J; Atwell, Thomas D; Schmit, Grant D; Kwon, Eugene D; Callstrom, Matthew R",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2017.03.012; https://www.ncbi.nlm.nih.gov/pubmed/28434661/,22523118.0,12
37497,37497,49275,39seex9h,,Medline,Endoscopic ultrasound-guided fine-needle biopsy is superior to fine-needle aspiration in assessing pancreatic neuroendocrine tumors.,10.1055/a-0990-9611,,31579710.0,unk,background study aim pancreatic neuroendocrine tumor pannets outcome dependent upon grading ki study compared endoscopic ultrasoundguided fineneedle biopsy eusfnb fineneedle aspiration fna assessing pannets patient method pancreatic histology pannet january june included eu sampling performed prior surgical resection ki grade fna fnb sample compared surgical histology using correlation coefficient kappa value subgroup analysis performed purely solid lesion lesion cm fnb needle type result one hundred sixityfour patient pannet underwent surgical resection thirtyfive lesion underwent fna fnb confirming pannet fna sample reported kigrading compared fnb sample p compared surgical histology ki fna correlated poorly overall r solid lesion r lesion cm r whereas fnb correlated moderately overall r solid lesion r lesion cm r tumor grade showed poor agreement kappa fna overall solid lesion lesion cm whereas fnb showed moderategood agreement overall solid lesion lesion cm forktip fnb needle ki showed strong correlation surgical histology r compared reverse bevel fnb needle r fnb needle showed moderate agreement tumor grade conclusion fnb sample significantly likely fna provide adequate material kigrading showed closer match surgical histology fnb needle type require prospective investigation,2019,"Leeds, John S; Nayar, Manu K; Bekkali, Noor L H; Wilson, Colin H; Johnson, Sarah J; Haugk, Beate; Darne, Antony; Oppong, Kofi W",Endoscopy international open,,,,,,https://doi.org/10.1055/a-0990-9611; https://www.ncbi.nlm.nih.gov/pubmed/31579710/,203638035.0,12
37510,37510,49290,19hpmjdq,,Medline,Mandibular reconstruction using fresh frozen bone allograft after conservative enucleation of a mandibular odontogenic myxoma.,10.1097/scs.0b013e31824dbff6,,22565910.0,unk,purpose article report clinical radiographic histological finding case young woman affected mandibular odontogenic myxoma conservative tumor resection followed immediate reconstructive treatment using freshfrozen human bone graft instead autologous bone graft material bone regeneration odontogenic myxoma according world health organization classified benign tumor mesenchymal origin whether containing odontogenic epithelium radiological histological examination lesion confirmed presence odontogenic myxoma mm high mm long lesion underwent biopsy evaluation enucleation according literature aim patient free disease conservative enucleation lesion performed residual bone defect filled freshfrozen bone allograft month surgery evidence major complication observed computed tomography scan revealed effective bone regeneration grafted area use freshfrozen bone allograft thanks osteoinductive osteoconductive property may represent optional choice reconstruction bone defect jaw tumor removal,2012,"Albanese, Massimo; Nocini, Pier Francesco; Fior, Andrea; Rizzato, Alberto; Cristofaro, Maria Giulia; Sancassani, Guido; Procacci, Pasquale",The Journal of craniofacial surgery,,,,,,https://doi.org/10.1097/scs.0b013e31824dbff6; https://www.ncbi.nlm.nih.gov/pubmed/22565910/,206055067.0,12
37515,37515,49295,45c1canv,,Medline,Use of percutaneous microwave ablation for the treatment of bone tumors: a retrospective study of clinical outcomes in 47 patients.,10.1186/s40644-019-0275-8,,31849340.0,unk,objective present study aimed evaluate shortterm clinical performance safety percutaneous microwave ablation mwa technique treatment bone tumor method singleinstitution retrospective study investigated case bone tumor treated mwa june june study included patient benign bone tumor patient malignant bone tumor tumor located spine sacrum upper extremity lower extremity pelvis outcome regarding clinical efficacy including pain relief quality life interventionrelated complication evaluated mwa using visual analog scale va item shortform health survey sf scoring system result patient included study completed followup examination mean followup duration ± month range month significantly improved va sf score recorded initial treatment p suggesting almost patient experienced pain relief improved quality life following surgery major interventionrelated complication eg serious neurovascular injury infection occurred treatment recorded three minor posttreatment complication related thermal injury caused myofasciitis affected wound healing conclusion study shortterm efficacy mwa considerably favorable relatively low rate complication result also showed mwa effective pain relief improved patient quality life making feasible treatment alternative bone tumor,2019-12-18,"Wu, Min-Hao; Xiao, Ling-Fei; Yan, Fei-Fei; Chen, Shi-Liang; Zhang, Chong; Lei, Jun; Deng, Zhou-Ming",Cancer imaging : the official publication of the International Cancer Imaging Society,,,,,,https://doi.org/10.1186/s40644-019-0275-8; https://www.ncbi.nlm.nih.gov/pubmed/31849340/,209392915.0,12
37562,37562,49349,3zb5rhqw,,Medline,"Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population.",10.21037/jtd.2016.04.06,,27293829.0,unk,background stereotactic body radiation therapy sbrt considered standard treatment medically inoperable early stage lung cancer bronchoscopy shown effective obtaining diagnosis peripheral lung tumor staging mediastinum endobronchial ultrasound ebus placing fiducial marker fm however combination procedure single bronchoscopy studied aim study describe safety feasibility performing diagnosis systematic nodal staging placement fm single bronchoscopic procedure method retrospective review patient underwent bronchoscopy diagnosis peripheral lung cancer ebus nodal staging fm placement single procedure michael e debakey va medical center january july result twentyone patient met criterion one synchronous tumor patient asa score least twentytwo tumor diagnosed size ± cm distance pleura ± cm median duration bronchoscopy minute range minute guidedbronchoscopy provided diagnosis lung cancer case fluoroscopy rpebus utilized patient hybrid scope electromagnetic navigational bronchoscopy total lymph node ln sampled ebustbna patient least ln sampled total fm placed tumor marker retained allowed successful sbrt pneumothoraces major complication conclusion although result lengthy procedure single bronchoscopy obtaining diagnosis peripheral lung nodule systematic nodal staging fm placement safely performed highrisk patient allinone strategy could potentially expedite treatment decrease complication reduce cost prospective study needed corroborate finding,2016,"Kular, Harman; Mudambi, Lakshmi; Lazarus, Donald R; Cornwell, Lorraine; Zhu, Angela; Casal, Roberto F",Journal of thoracic disease,,,,,,https://doi.org/10.21037/jtd.2016.04.06; https://www.ncbi.nlm.nih.gov/pubmed/27293829/,19580686.0,12
37611,37611,49408,vczklgym,,Medline,Single-incision laparoscopic gastric resection for submucosal tumors: report of three cases.,10.1007/s00595-009-4204-5,,21191706.0,unk,march april three consecutive patient underwent singleincision laparoscopic gastric wedge resection submucosal tumor located anterior wall greater curvature stomach first placed two three trocars infraumbilical skin incision either elevated tumor miniloop retractor retracted gastric wall near tumor laparoscopic grasper finally resected tumor using endoscopic linear stapler singleincision laparoscopic gastric resection successfully completed three patient without need extraumbilical skin incision conversion conventional laparoscopic procedure morbidity mean operating time blood loss min ml respectively mean tumor size surgical margin mm mm respectively histopathologically two tumor diagnosed gastrointestinal stromal tumor one carcinoid tumor thus singleincision laparoscopic gastric resection submucosal tumor safe feasible performed experienced laparoscopic surgeon using conventional laparoscopic instrument,2011,"Sasaki, Akira; Koeda, Keisuke; Nakajima, Jun; Obuchi, Toru; Baba, Shigeaki; Wakabayashi, Go",Surgery today,,,,,,https://doi.org/10.1007/s00595-009-4204-5; https://www.ncbi.nlm.nih.gov/pubmed/21191706/,2069408.0,12
37628,37628,49427,srs8ckrx,,Medline,"Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.",10.1016/j.ejrad.2016.10.024,,28027741.0,unk,percutaneous radiofrequency ablation rfa treatment stage renal cell carcinoma recently gained significant attention available longterm controlled data demonstrate rfa result diseasefree cancerspecific survival comparable partial andor radical nephrectomy noncontrolled single center trial however rate treatment failure vary operator experience ablation technique may explain different outcome controlled trial major limitation lack adequate randomization case report original series overview article transarterial embolization tae percutaneous rfa promising increase tumor control reduce complication purpose study systematically review literature tae addon percutaneous rfa renal tumor specific data regarding technique tumor patient characteristic well technical clinical oncologic outcome analyzed additionally overview stateoftheart embolization material radiological perspective advanced imageguided tumor ablation ta discussed conclusion tae addon percutaneous rfa feasible effective safe treatment ta tumor difficult location tb tumor advanced radiological technique technology microwave ablation innovative embolization material softwarebased solution available available near future reduce limitation bland rfa clinical implementation extremely important performing imageguided ta highly standardized effective procedure even challenging case localized renal tumor,2017,"Sommer, C M; Pallwein-Prettner, L; Vollherbst, D F; Seidel, R; Rieder, C; Radeleff, B A; Kauczor, H U; Wacker, F; Richter, G M; Bücker, A; Rodt, T; Massmann, A; Pereira, P L",European journal of radiology,,,,,,https://doi.org/10.1016/j.ejrad.2016.10.024; https://www.ncbi.nlm.nih.gov/pubmed/28027741/,207739748.0,12
37631,37631,49430,6kapxzh5,,Medline,Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.,10.1097/mpa.0b013e318287ce21,,23587853.0,unk,objective evaluate repeatability gallium tetraazacyclododecanennnntetraacetic dotadphetryoctreotide gadotatoc positron emission tomography pet neuroendocrine tumor method five patient neuroendocrine tumor imaged gadotatoc pet twice within day maximum mean standardized uptake value suvmax suvmean kinetic parameter kpatlak kinflux target lesion measured repeatability measurement investigated result fortyseven target lesion identified wholebody pet lesion dynamic image excellent repeatability intraclass correlation coefficient suvmax suvmean kpatlak kinflux median absolute percent difference interquartile range iqr scan suvmax suvmean iqr iqr respectively median absolute percent difference kpatlak kinflux iqr iqr respectively suvmax target lesion differ scan conclusion gadotatoc pet imaging neuroendocrine tumor highly reproducible difference suvmax represents change larger measurement error observed repeated study reflect significant change biological character tumor,2013,"Menda, Yusuf; Ponto, Laura L Boles; Schultz, Michael K; Zamba, Gideon K D; Watkins, G Leonard; Bushnell, David L; Madsen, Mark T; Sunderland, John J; Graham, Michael M; O'Dorisio, Thomas M; O'Dorisio, M Sue",Pancreas,,,,,,https://doi.org/10.1097/mpa.0b013e318287ce21; https://www.ncbi.nlm.nih.gov/pubmed/23587853/,257771.0,12
37678,37678,49481,n30o8078,,Medline,Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter?,10.1016/j.jamcollsurg.2017.01.056,,28188838.0,unk,background management algorithm appendiceal adenocarcinoma well defined study sought determine whether tumor size depth invasion better correlate presence lymph node metastasis appendiceal adenocarcinoma compare rate colon adenocarcinoma study design retrospective review national cancer database performed identify patient appendiceal colonic adenocarcinoma underwent surgical resection case categorized tumor size stage rate lymph node metastasis examined function size stage result total appendiceal colonic case identified appendiceal adenocarcinoma larger tumor size associated higher stage pearson correlation ci p lymph node metastasis present tumor size cm cm cm cm cm cm respectively lymph node metastasis present situ tumor respectively difference rate lymph node metastasis appendiceal colonic adenocarcinoma tumor size cm situ tumor rate lymph node metastasis higher colonic adenocarcinoma tumor size cm tumor p conclusion appendiceal adenocarcinoma rate lymph node metastasis substantial even small tumor tumor size play role decision whether perform hemicolectomy appendectomy alone produce adequate lymph node sample right hemicolectomy performed appendiceal adenocarcinoma,2017,"Gahagan, John V; Whealon, Matthew D; Phelan, Michael J; Mills, Steven; Pigazzi, Alessio; Stamos, Michael J; Nguyen, Ninh T; Carmichael, Joseph C",Journal of the American College of Surgeons,,,,,,https://doi.org/10.1016/j.jamcollsurg.2017.01.056; https://www.ncbi.nlm.nih.gov/pubmed/28188838/,23340008.0,12
37721,37721,49529,6ov7asl9,,Medline,A single-institution experience in image-guided thermal ablation of adrenal gland metastases.,10.1016/j.jvir.2013.12.013,,24507995.0,unk,purpose ass safety technical success local control survival associated percutaneous imageguided adrenal ablation material method adult patient adrenal metastasis underwent percutaneous imageguided adrenal ablation year identified patient adrenal tumor identified technical success safety local control survival analyzed according standard criterion result patient men woman mean age age range adrenal tumor ablation procedure performed one patient cm tumor underwent planned cryoablation debulking fully anticipating untreated margin owing close proximity pancreas ie intent diminish tumor burden rather curative intervention patient treated curative intent technical success achieved tumor followup imaging performed tumor excluding patient intentional debulking n technical failure n absence followup n local recurrence developed tumor local tumor control achieved lesion mean month followup recurrencefree survival overall survival month respectively median survival month common terminology criterion adverse event version grade complication observed three ablation procedure conclusion imageguided ablation safe effective local control metastatic adrenal tumor provides minimally invasive alternative surgical resection appropriately selected patient,2014,"Welch, Brian T; Callstrom, Matthew R; Carpenter, Paul C; Wass, C Thomas; Welch, Tasha L; Boorjian, Stephen A; Nichols, Douglas A; Thompson, Geoffrey B; Lohse, Christine M; Erickson, Dana; Leibovich, Bradley C; Atwell, Thomas D",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2013.12.013; https://www.ncbi.nlm.nih.gov/pubmed/24507995/,36590199.0,12
37724,37724,49533,2j6qzzs3,,Medline,MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.,10.1172/jci.insight.126543,,30721153.0,unk,mir recently emerged important promoter antitumor immunity function lymphocyte however impact cellexpressed mir immune cell dynamic solid tumor remains unclear present study used singlecell rna sequencing define cd immune cell population different time point within bf murine melanoma tumor growing either wildtype mir cell conditional knockout tcko mouse mir required optimal cell activation reinforced cell response expense infiltrating myeloid cell myeloid cell tumor growing tcko mouse defined increase wound healing gene decreased ifnγresponse gene signature finally found mir expression predicted favorable outcome human melanoma patient associated strong immune signature moreover gene expression analysis cancer genome atlas tcga data revealed mir expression also correlate immuneenriched subtype human solid tumor together study provides unprecedented analysis cell type gene expression signature immune cell within experimental melanoma tumor elucidates role mir coordinating antitumor immune response mammalian tumor,2019,"Ekiz, H Atakan; Huffaker, Thomas B; Grossmann, Allie H; Stephens, W Zac; Williams, Matthew A; Round, June L; O'Connell, Ryan M",JCI insight,,,,,,https://doi.org/10.1172/jci.insight.126543; https://www.ncbi.nlm.nih.gov/pubmed/30721153/,73427121.0,12
37745,37745,49557,ff3b93x5,,Medline,Laparoscopic microwave thermosphere ablation of malignant liver tumors: an initial clinical evaluation.,10.1007/s00464-015-4261-3,,26091998.0,unk,background microwave ablation mwa recently recognized technology overcome limitation radiofrequency ablation aim current study evaluate safety efficacy new ghz thermosphere mwa system treatment malignant liver tumor method prospective irbapproved study patient malignant liver tumor treated mwa within month time period tumor size response mwa obtained triphasic liver ct scan done mwa ablation zone assessed complete tumor response spherical geometry result total patient average three tumor measuring cm range ablation performed laparoscopically three patient underwent combined liver resection single ablation created overlapping ablation lesion total ablation time per patient ± min morbidity mortality week ct scan tumor destruction residual lesion roundness index b transverse respectively confirming spherical nature ablation zone conclusion best knowledge first report new thermosphere mwa technology laparoscopic treatment malignant liver tumor result demonstrate safety technology satisfactory spherical ablation zone seen postprocedural ct scan,2016,"Berber, Eren",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-015-4261-3; https://www.ncbi.nlm.nih.gov/pubmed/26091998/,22570995.0,12
37776,37776,49595,btzggph6,,Medline,AirSeal system insufflator to maintain a stable pneumorectum during TAMIS.,10.1007/s10151-014-1244-7,,25421704.0,unk,transanal minimally invasive surgery tamis typically used treating intraluminal rectal tumor application recently described present use tamis tool treat chronic anastomotic fistula restorative rectal resection new insufflation device expected solve problem maintaining stable pneumorectum described,2015,"Bislenghi, G; Wolthuis, A M; de Buck van Overstraeten, A; D'Hoore, A",Techniques in coloproctology,,,,,,https://doi.org/10.1007/s10151-014-1244-7; https://www.ncbi.nlm.nih.gov/pubmed/25421704/,7793685.0,12
37780,37780,49599,6zjtovla,,Medline,Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo.,10.1186/s40425-016-0131-3,,27190628.0,unk,background ability tcells traffic penetrate tumor impact clinical efficacy tcell therapy therefore method track transferred tcells vivo needed preliminary report evaluated use concurrent spectpetct imaging monitor egress herneu specific tcells breast cancer patient extensive boneonly metastatic disease finding indium labeled tcells demonstrated similar greater viability unlabeled tcells either low high dose h incubation period vitro function labeled unlabeled tcells significantly different p either dose tcells trafficked site metastatic disease infiltrated tumor assessed spect imaging uptake h infusion varied right proximal humerus right sacrum background corrected count per pixel remained elevated h concurrent petct imaging demonstrated fluorodeoxyglucose flare measured increase tumor site uptake high site disease h flare associated focal pain tcell infusion metastatic site patient stable disease month completion tcell therapy conclusion concurrent spectpetct imaging h period tcell infusion provided evidence tcell homing disease site well tumor metabolism flare response technique may useful monitoring tcell trafficking autologous well chimeric antigen receptor tcell infusion trial registraion trial registered clinicaltrialsgov registration number nct registered november,2016,"Stanton, Sasha E; Eary, Janet F; Marzbani, Edmond A; Mankoff, David; Salazar, Lupe G; Higgins, Doreen; Childs, Jennifer; Reichow, Jessica; Dang, Yushe; Disis, Mary L",Journal for immunotherapy of cancer,,,,,,https://doi.org/10.1186/s40425-016-0131-3; https://www.ncbi.nlm.nih.gov/pubmed/27190628/,7630065.0,12
37785,37785,49604,h89bdamo,,Medline,Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody.,10.1007/s00259-013-2434-7,,23674207.0,unk,purpose tf trivalent bispecific antibody consists two antitrop fab fragment one antihistaminesuccinylglycine hsg fab fragment trop antigen found many epithelial cancer including prostate cancer pc therefore bispecific antibody could suitable pretargeting cancer study characteristic potential pretargeted radioimmunoimaging radioimmunotherapy tf radiolabeled dihsg peptide imp mouse human pc investigated method optimal tf protein dose imp peptide dose dose interval pc targeting assessed nude mouse sc pc xenograft immunopositron emission tomography petct performed using tfgaimp optimized condition potential pretargeted radioimmunotherapy prit using tf pretargeted luimp determined result tf inimp showed high fast accumulation tumor ± idg h postinjection pi optimized condition despite internalizing property tf potential prit shown retention inimp tumor h pi one cycle treatment tf luimp showed significant improvement survival compared treatment luimp alone v day p renal hematological toxicity conclusion tropexpressing pc pretargeted efficiently tf rapid uptake radiolabeled haptenpeptide imp sensitive immunopet effective therapy,2013,"van Rij, Catharina M; Lütje, Susanne; Frielink, Cathelijne; Sharkey, Robert M; Goldenberg, David M; Franssen, Gerben M; McBride, William J; Rossi, Edmund A; Oyen, Wim J G; Boerman, Otto C",European journal of nuclear medicine and molecular imaging,,,,,,https://doi.org/10.1007/s00259-013-2434-7; https://www.ncbi.nlm.nih.gov/pubmed/23674207/,32286084.0,12
37981,37981,49831,4efy3ow3,,Medline,Laparoscopic distal pancreatectomy and splenectomy for malignant tumors.,10.1007/s12029-011-9347-0,,22090189.0,unk,introduction laparoscopic distal pancreatectomy become gold standard benign tumor surgeon expertise open laparoscopic pancreatic surgery increasing number benignappearing tumor removed via minimally invasive technique found malignancy final pathology growing experience laparoscopic distal pancreatectomy begun removing preoperatively suspected malignancy distal pancreas minimally invasive technique method case collected prospectively database analyzed retrospectively case begun laparoscopically intention performing resection minimally invasive technique considered even operation ultimately converted open procedure result total case attempted four required hand assistance one required conversion open approach due delayed bleeding calcified splenic artery transected laparoscopic gia stapler device total eight patient malignant disease four found benign tumor median lymph node retrieval range positive margin morbidity rate one reoperation one mortality day conclusion laparoscopic approach malignant pancreatic tumor feasible similar morbidity mortality rate benign series tumor next confluence splenic portal vein handassisted approach may adviseable calcified splenic artery sought preoperative imaging either transected noncalcified segment controlled via open technique via hand port,2012,"Gumbs, Andrew A; Chouillard, Elie K",Journal of gastrointestinal cancer,,,,,,https://doi.org/10.1007/s12029-011-9347-0; https://www.ncbi.nlm.nih.gov/pubmed/22090189/,3053555.0,12
37991,37991,49844,9lu2cpd5,,Medline,Utilization of iron (III)-doped nanoshells for in vivo marking of nonpalpable tumors using a VX2 rabbit model.,10.1016/j.amjsurg.2016.09.013,,27776757.0,unk,background aimed evaluate potential ultrasound u visible biodegradable nanoshells n alternative wireguided localization nonpalpable tumor vivo method vx tumor injected bilateral thigh new zealand rabbit day tumor marked wire control contralateral tumor injected ml nm gasfilled silica n doppler u tumor excised hour chisquare used significance p result one rabbit excluded postoperative day due equipment failure ill effect observed n n used localize resect marked tissue wire displaced p conclusion shown preoperatively injected u visible silica n successfully used mark nonpalpable tumor vivo consistently wl,2016,"Ward, Erin P; Wang, James; Mendez, Natalie; Yang, Jian; Barback, Chris; Wang-Rodriguez, Jessica; Trogler, William; Kummel, Andrew C; Blair, Sarah",American journal of surgery,,,,,,https://doi.org/10.1016/j.amjsurg.2016.09.013; https://www.ncbi.nlm.nih.gov/pubmed/27776757/,5719653.0,12
38008,38008,49862,nhei0l4b,,Medline,Single-port laparoscopic and endoscopic cooperative surgery for a gastric gastrointestinal stromal tumor: report of a case.,10.1007/s00595-014-0870-z,,24633929.0,unk,herein report case singleport laparoscopic endoscopic cooperative surgery lecs gastric gastrointestinal stromal tumor gist yearold female endoluminal gist located near esophagogastric junction underwent lecs mucosal submucosal layer around tumor circumferentially dissected using endoscopic submucosal dissection via intraluminal endoscopy endoluminal gist exteriorized abdominal cavity tumor edge incision line closed using endoscopic linear stapler lecs successfully accomplished without need skin incision additional port length operation min blood loss ml oral intake resumed second day length hospital stay day complication noted patient excellent cosmetic result experience singleport lecs feasible safe gastric gist performed surgeon experienced laparoscopic gastric surgery,2015,"Obuchi, Toru; Sasaki, Akira; Baba, Shigeaki; Nitta, Hiroyuki; Otsuka, Koki; Wakabayashi, Go",Surgery today,,,,,,https://doi.org/10.1007/s00595-014-0870-z; https://www.ncbi.nlm.nih.gov/pubmed/24633929/,8199102.0,12
38036,38036,49894,kzi9qop0,,Medline,Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.,10.1007/s00270-010-9898-7,,20508937.0,unk,radiofrequency ablation rfa wellestablished method treatment patient lung carcinoma candidate surgical resection usually computed tomographic ct guidance used procedure thus enabling needle placement permitting evaluation complication pneumothorax bleeding ffluorodeoxyglucose fdg positron emission tomography pet generally used tumor activity assessment therefore useful followup tumor treatment method provides realtime imagebased monitoring rfa ensure complete tumor ablation would valuable tool report describe behavior preinjected fdg pet ctguided rfa nonsmallcell lung carcinoma discus value fdg tool provide intraprocedure monitor ablation size form activity changed ablation ablation led increase size blurring irregularity contour compared pretreatment imaging maximal standardized uptake value decreased slightly procedure therefore rfa fdg pet guide initial needle placement serve monitoring tool evaluate residual viable tissue procedure,2011,"Schoellnast, Helmut; Larson, Steven M; Nehmeh, Sadek A; Carrasquillo, Jorge A; Thornton, Raymond H; Solomon, Stephen B",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-010-9898-7; https://www.ncbi.nlm.nih.gov/pubmed/20508937/,11523012.0,12
38062,38062,49924,q0ciaq03,,Medline,"Bilateral adrenal myelolipomas in a woman with chronic anticoagulation, postmenopausal uterine bleeding, primary hyperparathyroidism and hyperthyroidism.",10.1097/maj.0b013e3182804a87,,23426084.0,unk,adrenal myelolipomas rare usually benign unilateral tumor management controversially discussed author present yearold african american female jehovah witness postmenopausal uterine bleeding chronic anticoagulation episodic right flank pain found bilateral myelolipomas addition primary hyperparathyroidism collaboration gynecology midline laparotomy performed remove uterus ovary addition right adrenal gland × mm myelolipoma open biopsy left adrenal mass measuring × mm revealed myelolipoma ruled malignancy pathology confirmed bilateral myelolipomas endometrial polyp leiomyomata uterus uneventful recovery patient underwent right inferior parathyroidectomy parathyroid adenoma case illustrates challenge deciding surgically intervene bilateral adrenal myelolipoma first time associate various endocrinopathies although known endocrine neoplasia syndrome variant present,2013,"Saunders, Rachel N; Koch, Christian A; Brown, Kathryn B; Hairston, Frances J; Daley, William P; Ahmed, Naveed; Vanderlan, Wesley B",The American journal of the medical sciences,,,,,,https://doi.org/10.1097/maj.0b013e3182804a87; https://www.ncbi.nlm.nih.gov/pubmed/23426084/,11020941.0,12
38098,38098,49963,pyoe5upo,,Medline,"New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones.",10.1111/jgh.14294,,29851164.0,unk,background aim aim study ass efficacy new microwave ablation mwa system emprint ablation system ablation unresectable large liver tumor ≥ mm method twentyone hepatic tumor mean diameter mm patient underwent percutaneous mwa included crosssectional study volume analyzer based computed tomography imaging used patient within month month procedure evaluate shape volume ablation zone addition computed tomography imaging performed month procedure evaluate presence residual tumor local recurrence result mean ablation time min mean overall procedure time min ablated adrenal glandinduced takotsubo stress cardiomyopathy occurred immediately mwa major complication one patient roundness index b c presented mean value respectively value near perfect sphere indicating spherical ablation zone achieved mean ablation volume larger volume tumor v cm residual tumor confirmed tumor single ablation session local recurrence conclusion experience new mwa system provides effective treatment option unresectable large liver tumor however ablate liver tumor safely necessary consider surrounding organ adrenal gland,2018,"Imajo, Kento; Tomeno, Wataru; Kanezaki, Mineo; Honda, Yasushi; Kessoku, Takaomi; Ogawa, Yuji; Yoshida, Keisuke; Yoneda, Masato; Kirikoshi, Hiroyuki; Ono, Masafumi; Kaneta, Tomohiro; Inoue, Tomio; Teratani, Takuma; Saito, Satoru; Nakajima, Atsushi",Journal of gastroenterology and hepatology,,,,,,https://doi.org/10.1111/jgh.14294; https://www.ncbi.nlm.nih.gov/pubmed/29851164/,44089756.0,12
38119,38119,49984,s2ksgg67,,Medline,Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.,10.1007/s00268-010-0878-5,,21181474.0,unk,background pancreatic neuroendocrine tumor pnets characteristic feature tumor syndrome multiple endocrine neoplasia type men von hippellindau disease vhl vhl patient exhibit pnets age year metastatic potential high tumor grown cm diameter optimal surgical treatment still challenge method report three case woman age year respectively known vhl confirmed classic organ manifestation germline mutation vhl gene diagnosed asymptomatic stage solid tumor pancreatic tail tailcorpus area measuring cm diameter accepted offer laparoscopic organsparing removal tumor result three case tumor entirely removed two case resection spleen also necessary dissection tumor major splenic vessel impossible operating time min blood loss ml histolopathology revealed benign pnets two case third patient regional lymph node metastasis complication hospital stay day conclusion organsparing laparoscopic surgery important option treating vhlassociated pnets pancreatic tail,2011,"von Dücker, Laura; Walz, Martin K; Voss, Christian; Arnold, Georg; Eng, Charis; Neumann, Hartmut P H",World journal of surgery,,,,,,https://doi.org/10.1007/s00268-010-0878-5; https://www.ncbi.nlm.nih.gov/pubmed/21181474/,27161752.0,12
38242,38242,50123,va5woapw,,Medline,Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.,10.1186/1477-7819-10-113,,22726267.0,unk,background adoptive cell therapy act tumorinfiltrating lymphocyte til patient metastatic melanoma reported overall response rate complete responder increase availability promising therapy patient advanced melanoma minimally invasive approach procure tumor til generation warranted method feasibility study performed determine safety efficacy laparoscopic liver resection generate til act retrospective review prospectively maintained database identified patient advanced melanoma visceral metastasis ajcc stage mc underwent laparoscopic liver resection october july indication resection patient receive postoperative act til result twenty patient underwent resection utilizing closed laparoscopic technique one required handassistance another required conversion open resection median intraoperative blood loss ml case performed without pringle maneuver median hospital stay day three patient experienced complication resection mortality til generated patient twelve til tested found vitro tumor reactivity eleven patient received intended act two patient rendered evidence disease surgical resection one undergoing delayed act generated til relapse objective tumor response seen patient received til one patient experiencing ongoing complete response month conclusion laparoscopic liver resection performed minimal morbidity serve effective mean procure tumor generate therapeutic til act patient metastatic melanoma,2012,"Alvarez-Downing, Melissa M; Inchauste, Suzanne M; Dudley, Mark E; White, Donald E; Wunderlich, John R; Rosenberg, Steven A; Kammula, Udai S",World journal of surgical oncology,,,,,,https://doi.org/10.1186/1477-7819-10-113; https://www.ncbi.nlm.nih.gov/pubmed/22726267/,1915187.0,12
38306,38306,50198,trcagk60,,Medline,Multiple applicator hepatic ablation with interstitial ultrasound devices: theoretical and experimental investigation.,10.1118/1.4765459,,23231283.0,unk,purpose evaluate multiple applicator implant configuration interstitial ultrasound device large volume ablation liver tumor method bioacousticthermal model using finite element method implemented ass multiple applicator implant configuration thermal ablation interstitial ultrasound energy interstitial applicator consist linear array four mmlong tubular ultrasound transducer separate dynamic power control enclosed within watercooled delivery catheter mm od author considered parallel implant two three applicator clustered configuration spaced cm apart simulate open surgical placement addition author considered two applicator implant applicator converging diverging angle ∼° ° ° simulate percutaneous placement heating experiment min performed compared simulation employing experimental parameter estimate performance parallel multiple applicator configuration vivo setting simulation performed taking account range blood perfusion level kg may occur tumor varying vascularity impact tailoring power supplied individual transducer element along length applicator explored applicator inserted nonparallel converging diverging configuration thermal dose min temperature threshold °c used define ablation zone dynamic change tissue acoustic thermal property incorporated within model result experiment ex vivo bovine liver yielded ablation zone ranging cm × cm cross section ablation zone dimension predicted simulation similar parameter experiment close agreement within mm simulation vivo heating showed min heating interapplicator spacing le cm required obtain contiguous complete ablation zone ability create complete ablation zone profile nonparallel implant illustrated tailoring applied power level along length applicator conclusion parallel implant consisting three interstitial ultrasound applicator triangular configuration yield complete ablation zone measuring cm × cm min heating larger interapplicator spacing level blood perfusion tumor may yield indentation along periphery ablation zone tailoring applied power along length applicator accommodate nonparallel implant without compromising safety,2012,"Prakash, Punit; Salgaonkar, Vasant A; Clif Burdette, E; Diederich, Chris J",Medical physics,,,,,,https://doi.org/10.1118/1.4765459; https://www.ncbi.nlm.nih.gov/pubmed/23231283/,7363128.0,12
38372,38372,50280,e7co6pnn,,Medline,Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.,10.1016/j.apradiso.2014.11.006,,25479439.0,unk,evaluated compared new bombesin analog tyrgly nlebbn conjugated dota dtpa radiolabeled low high grpr expressing tumor model peptide radiolabeled high radiochemical purity specific activity vitro assay td lncap pc cell showed affinity peptide similar higher binding internalization dotapeptide pc cell observed peptide could target pc lncap tumor vivo tumor type could visualized microspectct,2015,"Pujatti, Priscilla B; Foster, Julie M; Finucane, Ciara; Hudson, Chantelle D; Burnet, Jerome C; Pasqualoto, Kerly F M; Mengatti, Jair; Mather, Stephen J; de Araújo, Elaine B; Sosabowski, Jane K","Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine",,,,,,https://doi.org/10.1016/j.apradiso.2014.11.006; https://www.ncbi.nlm.nih.gov/pubmed/25479439/,4905798.0,12
38564,38564,50505,i9guu91p,,Medline,Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.,10.1258/ar.2011.100435,,21525107.0,unk,background radiofrequency ablation rfa accepted minimally invasive treatment renal cell carcinoma rcc however rfa fully evaluated treating rcc patient von hippel lindau vhl disease undergo surgery due serious postoperative morbidity mortality purpose evaluate role rfa rcc patient vhl disease previously undergoing renal surgery material method percutaneous rfa performed treating rccs six patient undergone radical nephrectomy n repeated nephronsparing surgery n treatment feasibility complication outcome change renal function evaluated result completely ablate rccs ablation session necessary rccs nine proximity mm one following organ bowel n ureteropelvic junction pelvis n psoas muscle n vascular pedicle n pancreas n session one major complication pneumothorax developed one session residual recurrent tumor identified ablation area however new three solid tumor le cm diameter developed followup period ablation withheld tumor grown cm size mean level serum creatinine increased mean estimated glomerular filtration rate decreased last ablation compared initial ablation p conclusion despite technical difficulty percutaneous rfa promising treatment vhl patient undergo surgery excellent treatment outcome minimal change renal function,2011,"Park, Sung Yoon; Park, Byung Kwan; Kim, Chan Kyo; Lee, Hyun Moo; Jeon, Seong Soo; Seo, Seong Il; Jeong, Byong Chang; Choi, Han Yong",Acta radiologica,,,,,,https://doi.org/10.1258/ar.2011.100435; https://www.ncbi.nlm.nih.gov/pubmed/21525107/,25473440.0,12
38582,38582,50528,4rxqqk8e,,Medline,Percutaneous Radiofrequency Ablation for the Treatment of Peripheral Nerve Sheath Tumors: A Case Report and Review of the Literature.,10.7759/cureus.2534,,29946502.0,unk,peripheral nerve sheath tumor pnsts may arise sporadically presence genetic disorder including neurofibromatosis nf type schwannomatosis patient large genetic deletion involving cdkna gene surgical resection treatment choice symptomatic pnsts offer patient potential cure however preexisting condition tumor location may limit patient surgical option radiofrequency ablation rfa may provide alternative therapeutic strategy treatment selected pnsts amenable surgical resection present case report yearold patient multiple neurofibroma underwent rfa treatment two symptomatic retroperitoneal neurofibroma review previously reported case percutaneous treatment pnsts,2018,"Mrowczynski, Oliver; Mau, Christine; Nguyen, Dan T; Sarwani, Nabeel; Rizk, Elias; Harbaugh, Kimberly",Cureus,,,,,,https://doi.org/10.7759/cureus.2534; https://www.ncbi.nlm.nih.gov/pubmed/29946502/,49427408.0,12
38621,38621,50572,j5tzjg89,,Medline,Robot-assisted enucleation of gigantic liver hemangiomas: Case series of 3 patients.,10.1016/j.ijscr.2019.06.033,,31255934.0,unk,introduction liver hemangioma benign liver lesion require surgical excision large symptomatic often tumor removed large anatomical resection sacrifice liver parenchyma needed tumor enucleation take advantage digitoclasialike technique along plane tumor pseudocapsule liver parenchyma pose challenge performed laparoscopically propose parenchymal sparing minimally invasive roboticassisted technique remove liver hemangioma presentation case three male patient symptomatic hemangioma treated center lesion located segment ii iii segment ivv respectively roboticassisted hemangioma enucleation accomplished successfully three patient procedure performed parenchymasparing intent formal segmentectomy required conversion open surgery discussion robotic platform provides powerful tool enucleation liver hemangioma enhanced vision superior suturing ability allow develop safely plane tumor pseudocapsule liver parenchyma outstanding selective control vascular supply drainage encountered dissection furthermore precision hilar dissection allows selective lobar sectorial arterial control help minimize intraoperative bleeding conclusion experience robotassisted enucleation liver hemangioma offer low morbidity fast recovery excellent cosmetic result could become therapeutic option location hemangioma allows approach,2019,"Giulianotti, Pier Cristoforo; Bustos, Roberto; Valle, Valentina; Aguiluz, Gabriela; Pavelko, Yevhen; Fernandes, Eduardo",International journal of surgery case reports,,,,,,https://doi.org/10.1016/j.ijscr.2019.06.033; https://www.ncbi.nlm.nih.gov/pubmed/31255934/,195763986.0,12
38683,38683,50644,k92og3jp,,Medline,Anorectal function and outcomes after transanal minimally invasive surgery for rectal tumors.,10.4103/0972-9941.152094,,26622116.0,unk,background transanal endoscopic microsurgery minimally invasive technique allows fullthickness resection suture closure defect large rectal adenoma selected lowrisk rectal cancer small cancer patient high risk major surgery aim given prospective study report initial clinical experience tamis evaluate effect postoperative anorectal function material method patient treated tamis benign malignant rectal tumor preoperative postoperative anorectal function evaluated anorectal manometry cleveland clinic incontinence score result mean distance tumor anal verge cm mean tumor diameter cm resection margin tumor free difference preoperative week postoperative anorectalmanometry finding mean minimum rectal sensory volume lower week surgery cleveland clinic incontinence score normal patient except one resolved week surgerythe mean postoperative followup week without recurrence conclusion transanal minimally invasive surgery safe effective procedure treatment rectal tumor performed without impairing anorectal function,2015,"Karakayali, Feza Y; Tezcaner, Tugan; Moray, Gokhan",Journal of minimal access surgery,,,,,,https://doi.org/10.4103/0972-9941.152094; https://www.ncbi.nlm.nih.gov/pubmed/26622116/,36859272.0,12
38716,38716,50679,quewzt2a,,Medline,Laparoendoscopic single-site surgery (LESS) for adnexal tumors: one surgeon's initial experience over a one-year period.,10.1016/j.ejogrb.2011.04.020,,21620559.0,unk,objective article present initial experience laparoendoscopic singlesite surgery le adnexal tumor report safety feasibility technique study design retrospectively reviewed medical record first consecutive patient underwent le adnexal tumor cheil general hospital woman healthcare center seoul korea march july retrospective chart review approved local institutional review board irb used homemade wound retractor surgical glove singleport device le procedure performed single surgeon result patient successfully underwent le treatment adnexal tumor mean age patient ± year mean body mass index ± kgm mean operative time ± min mean diameter adnexal tumor ± cm procedure included enucleation ovarian cyst n salpingooophorectomy n salpingectomy n two case suspicion malignancy underwent conversion laparotomy frozen section revealed serous ovarian adenocarcinoma n chronic inflammation n except two case pathologic diagnosis confirmed mature cystic teratoma n endometriosis n mucinous cystadenoma n serous cystadenoma n borderline ovarian tumor n hydrosalpinx n serous adenocarcinoma salpinx n ectopic pregnancy n two case required additional trocar adhesiolysis severe pelvic adhesion major intraoperative postoperative complication occurred conclusion result suggest le safe feasible alternative conventional laparoscopic surgery treatment adnexal tumor,2011,"Kim, Woo-Chul; Lee, Ji-Eun; Kwon, Yong-Soon; Koo, Yu-Jin; Lee, In-Ho; Lim, Kyung-Taek","European journal of obstetrics, gynecology, and reproductive biology",,,,,,https://doi.org/10.1016/j.ejogrb.2011.04.020; https://www.ncbi.nlm.nih.gov/pubmed/21620559/,3275056.0,12
38724,38724,50687,fn4xgmun,,Medline,"Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.",10.5152/dir.2015.14378,,26611111.0,unk,purpose aimed evaluate survival benefit achieved radiofrequency rf ablation primary metastatic lung tumor determine significant prognostic factor recurrencefree survival method fortynine patient lung cancer primary metastatic underwent computed tomographyguided percutaneous rf ablation june october total tumor metastatic primary nonsmall cell lung cancer treated rf ablation tumor diameter ranged cm median cm effectiveness treatment complication survival analyzed result primary success rate local tumor progression occurred tumor among tumor showing progression retreated rf ablation secondary success rate one two threeyear overall survival rate patient primary lung cancer respectively one two three four fiveyear overall survival rate patient metastatic lung tumor respectively one two three fouryear overall survival rate patient colorectal pulmonary metastasis respectively complication occurred session pneumothorax occurred session seven requiring imageguided percutaneous chest tube drainage tumor status solitary multiple presence extrapulmonary metastasis initial rf ablation significant prognostic factor term recurrencefree survival conclusion rf ablation safe effective treatment survival benefit selected patient primary secondary lung tumor,2016,"Akhan, Okan; Güler, Ezgi; Akıncı, Devrim; Çiftçi, Türkmen; Köse, Ilgaz Çağatay",Diagnostic and interventional radiology,,,,,,https://doi.org/10.5152/dir.2015.14378; https://www.ncbi.nlm.nih.gov/pubmed/26611111/,19347691.0,12
38808,38808,50783,4dwj4akg,,Medline,Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin.,10.1245/s10434-009-0477-6,,19430843.0,unk,background half patient colorectal cancer develop liver metastasis course disease aim present study ass efficacy radioimmunotherapy rit radiolabeled monoclonal antibody mab treat experimental colorectal liver metastasis method male wagrij rat underwent minilaparotomy intraportal injection x cc tumor cell biodistribution inlabeled mg day intravenous administration determined vivo compared isotypematched control antibody upc maximal tolerated dose mtd lulabeled mg determined therapeutic efficacy lumg mtd compared luupc saline rit administered either day tumor inoculation day tumor inoculation primary endpoint survival result inmg preferentially accumulated cc liver tumor idg whereas inupc idg mtd lumg mbqkg body weight administration lumg luupc sideeffects except transient decrease body weight survival curve group received luupc group received saline differ p administration lumg rit immediately surgery improved survival significantly compared administration luupc p whereas delayed treatment p conclusion study provides proof principle rit effective treatment modality microscopic liver metastasis whereas rit effective larger tumor,2009,"de Jong, Gabie M; Hendriks, Thijs; Eek, Annemarie; Oyen, Wim J G; Heskamp, Sandra; Bleichrodt, Robert P; Boerman, Otto C",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-009-0477-6; https://www.ncbi.nlm.nih.gov/pubmed/19430843/,12421717.0,12
38827,38827,50802,lmcsdvex,,Medline,Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.,10.1055/s-0032-1311603,,22566195.0,unk,tumorspecific uptake radiolabeled norepinephrine analogue metaiodobenzylguanidine via norepinephrine transporter radiolabeled somatostatin analogue octreotideoctreotate via somatostatin receptor offer possibility diagnose treat metastatic pheochromocytomaparaganglioma high uptake imetaiodobenzylguanidine dependent high expression vesicular monoamine transporter responsible mediating uptake biogenic amine dense core granule patient metastatic paraganglioma liver bone metastasis underwent surgical removal primary injection imetaiodobenzylguanidine inoctreotide radioactivity determined biopsy tumor normal tissue biopsy tumorblood concentration value high imetaiodobenzylguanidine h injection inoctreotide h injection study primary tumor cell culture demonstrated increased cell membrane binding internalization time imetaiodobenzylguanidine vesicular monoamine transporter antagonist reserpine norepinephrine transporter inhibitor clomipramine reduced internalization respectively h incubation result demonstrated increased cell membrane binding internalization time also inoctreotide internalization highest low concentration inoctreotide excess octreotide reduced internalization inoctreotide h incubation conclusion uptake tumorblood concentration value radiolabeled metaiodobenzylguanidine somatostatin analogue determined metastatic pheochromocytomaparaganglioma evaluate possibility use one agent therapy patient high tumorblood value clearly demonstrated therapy using radiopharmaceutical would beneficial vitro study verified specific cellmembrane binding internalization tumor cell radiopharmaceutical,2012,"Spetz, J; Dalmo, J; Nilsson, O; Wängberg, B; Ahlman, H; Forssell-Aronsson, E",Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,,,,,,https://doi.org/10.1055/s-0032-1311603; https://www.ncbi.nlm.nih.gov/pubmed/22566195/,13307387.0,12
38866,38866,50848,epf2hboo,,Medline,"Biomineral Nano-Theranostic agent for Magnetic Resonance Image Guided, Augmented Radiofrequency Ablation of Liver Tumor.",10.1038/s41598-017-14976-8,,29101365.0,unk,theranostic nanoparticles based biocompatible mineral composition significantly improve translational potential image guided cancer nanotherapy report development singlephase calcium phosphate biomineral nanoparticle ncp dualmode magnetic resonance contrast tt together radiofrequency rf mediated thermal response suitable imageguided rf ablation cancer nanoparticles np engineered provide dual mr contrast optimized doping concentration paramagnetic ion fe also render lossy dielectric character ncp leading thermal response rf exposure vivo compatibility dualmode mr contrast demonstrated healthy rat model mri mapping suggest hepatobiliary clearance hour mri guided intratumoral injection subcutaneous rat glioma orthotopic liver tumor model provide clear visualization np mri also help quantifying np distribution within tumor furthermore utilising rf mediated thermal response np treated tumor could ablated using clinically approved rf ablation system w ghz realtime vivo thermal imaging exhibit ± increase temperature change δt np treated orthotopic liver tumor δt ± °c compared untreated healthy liver control δt ± °c effect demonstrate promising nanobiomineral theranostic agent dualmode mri combined radiofrequency ablation solid tumor,2017,"Ashokan, Anusha; Somasundaram, Vijay Harish; Gowd, Genekehal Siddaramana; Anna, Ida M; Malarvizhi, Giridharan L; Sridharan, Badrinathan; Jobanputra, Rupal B; Peethambaran, Reshmi; Unni, A K K; Nair, Shantikumar; Koyakutty, Manzoor",Scientific reports,,,,,,https://doi.org/10.1038/s41598-017-14976-8; https://www.ncbi.nlm.nih.gov/pubmed/29101365/,2678147.0,12
38896,38896,50884,0ykxqwj2,,Medline,Coil-assisted RFA of poorly visible liver tumors: effectiveness and risk factors of local tumor progression.,10.1007/s00270-013-0717-9,,23925920.0,unk,objective study designed determine effectiveness percutaneously inserted coil landmark radiofrequency ablation rfa poorly visible liver tumor unenhanced computed tomography ultrasound method singlecenter retrospective study consecutive patient treated january june rfa ct guidance poorly visible liver tumor percutaneous coil insertion effectiveness evaluated rate local tumor progression ltp risk factor ltp evaluated multiple univariate analysis result mean followup month overall rate ltp increase distance coil center tumor predictive factor ltp p resulted increase time place rfa probe ltp significantly reduced case coil placed within tumor v p conclusion effectiveness coilassisted rfa poorly visible liver tumor improved centering coil tumor order facilitate placement rfa probe equal result rfa direct image guidance,2014,"Farouil, Geoffroy; Deschamps, Frederic; Hakime, Antoine; de Baere, Thierry",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0717-9; https://www.ncbi.nlm.nih.gov/pubmed/23925920/,23932082.0,12
39029,39029,51038,fm146lqa,,Medline,Computed tomographic-lymphography as a complementary technique for lymph node staging in dogs with malignant tumors of various sites.,10.1111/vru.12569,,29024279.0,unk,locoregional lymph node routinely examined order define spatial extent neoplastic disease draining pattern certain tumor type divergent expected anatomical distribution critical sample lymph node truly representing draining area aim bicenter prospective pilot study describe technique computed tomographic ctlymphography primary draining lymph node mapping tumor staging dog fortyfive dog macro microscopic tumor specified localization evaluated depending body weight ml contrast agent iohexol injected four quadrant around tumor ctimages obtained minute postinjection attenuation chosen region interest hounsfield unit hu pattern enhancement assessed lymph node precontrast study median hus interquartile range iqr intravenous postcontrast study hu iqr paired wilcoxon test p ctlymphography study primary draining lymph node significantly higher median hu value iqr onesample ttest p identified primary draining lymph node found clearly visible minute local injection often concurrent good visibility lymphatic vessel system herein described technique peritumorally injected ctcontrast agent followed subsequent ctlymphography primary draining lymph node mapping work well majority case investigated site warrant validation different tumor entity,2018,"Rossi, Federica; Körner, Maximilian; Suárez, José; Carozzi, Gregorio; Meier, Valeria S; Roos, Malgorzata; Rohrer Bley, Carla",Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association,,,,,,https://doi.org/10.1111/vru.12569; https://www.ncbi.nlm.nih.gov/pubmed/29024279/,3810157.0,12
39059,39059,51076,zv0ppu2v,,Medline,Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.,10.1007/s00270-016-1478-z,,27738818.0,unk,purpose purpose study evaluate prognostic factor survival outcome following embolotherapy neuroendocrine tumor net liver metastasis material method multicenter retrospective study patient year mean age male net liver metastasis pancreas n gut n lung n otherunknown n primary site treated conventional transarterial chemoembolization tace n transarterial radioembolization tare n transarterial embolization tae n patient tumor treatmentrelated factor evaluated prognostic effect hepatic progressionfree survival hpfs overall survival o using unadjusted propensity scoreweighted univariate multivariate cox proportional hazard model result median hpfs o month g n month g n month g tumor n respectively p tumor burden hepatic volume demonstrated month shorter median hpfs o respectively versus burden ≤ p significant difference hpfs o gut pancreas primary multivariate hpfs analysis significant difference among embolotherapy modality multivariate o analysis tare higher hazard ratio tace unadjusted cox model hr p propensity score adjusted model hr p tae differ significantly tace conclusion higher tumor grade tumor burden prognosticated shorter hpfs o tare higher hazard ratio o tace significant difference hpfs among embolotherapy modality,2017,"Chen, James X; Rose, Steven; White, Sarah B; El-Haddad, Ghassan; Fidelman, Nicholas; Yarmohammadi, Hooman; Hwang, Winifred; Sze, Daniel Y; Kothary, Nishita; Stashek, Kristen; Wileyto, E Paul; Salem, Riad; Metz, David C; Soulen, Michael C",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-016-1478-z; https://www.ncbi.nlm.nih.gov/pubmed/27738818/,23424559.0,12
39190,39190,51220,zp821k3i,,Medline,Sclerosing TSC1 Mutated Renal Cell Carcinoma: An Unusual Pattern Mimicking MITF Family Translocation Renal Cell Carcinoma.,10.1002/gcc.22860,,32418252.0,unk,tuberous sclerosis gene mtor increasingly found important role novel subtypes renal cancer particularly emerging entity eosinophilic solid cystic renal cell carcinoma rcc highgrade oncocytic renal tumor hot rcc eosinophilic vacuolated cytoplasm report unique renal neoplasm yearold woman initially mimicked mitf family translocation rcc due mixed clear eosinophilic cell extensive stromal hyalinization psammoma body yet negative tfe tfeb fluorescence situ hybridization fish next generation sequencing ng gene fusion assay cytoplasmic stippling triggered consideration tscassociated neoplasm targeted next generation sequencing assay revealed variant exon tsc resulting cg pglu truncating mutation report add morphologic spectrum tscrelated renal neoplasm including prominent stromal hyalinization potentially deceptive pattern due overlap cytoplasmic stippling eosinophilic solid cystic rcc hot rcc eosinophilic vacuolated cytoplasm debatable category example would best fit understanding entity renal neoplasm alteration tsc gene elucidate whether considered family tumor article protected copyright right reserved,2020-05-16,"Williamson, Sean R; Cardili, Leonardo; Whiteley, Lisa J; Sanchez, Jessica; Kis, Olena","Genes, chromosomes & cancer",,,,,,https://doi.org/10.1002/gcc.22860; https://www.ncbi.nlm.nih.gov/pubmed/32418252/,218680184.0,12
39220,39220,51255,nc7v3bk8,,Medline,Technical advances in endoscopic ultrasound-guided fiducial placement for the treatment of pancreatic cancer.,10.1055/s-0034-1392274,,26355267.0,unk,radiation therapy important role treatment locally advanced metastatic pancreatic cancer used alone conjunction surgery andor systemic chemotherapy challenge delivering accurate optimal radiation dose imageguided radiation therapy used improve targeting fiducial marker placed tumor used localization patient undergoing imageguided radiation therapy safety feasibility endoscopic ultrasound eusguided placement fiducials assessed reported management pancreatic cancer herein review technique efficacy safety profile eusguided fiducial placement addition highlight recent advance technological upgrade eusguided fiducial delivery system pancreatic cancer relevant practicing gastroenterologist interventional endoscopists,2015,"Chavalitdhamrong, Disaya; DiMaio, Christopher J; Siersema, Peter D; Wagh, Mihir S",Endoscopy international open,,,,,,https://doi.org/10.1055/s-0034-1392274; https://www.ncbi.nlm.nih.gov/pubmed/26355267/,18513537.0,12
39225,39225,51261,s3732r12,,Medline,Case report of successful management of intraoperative tracheal rupture during thoracoscopic esophageal resection in patient with esophageal cancer.,10.1016/j.ijscr.2019.02.045,,30884377.0,unk,introduction rupture membranous part trachea thoracoscopic transhiatal resection esophagus rare complication occurs case complication often requires thoracotomy associated prolonged pulmonary ventilation longterm pleural draining due persistent air leakage development tracheopleural fistula prolonged hospitalization high risk septic secondary cardiorespiratory complication presentation case yearold woman complained difficulty eating solid food impaired swallowing persistent pain behind sternum nausea sickness weight loss egd revealed tumor almost completely obturating lumen middle third esophagus histopathological examination showed esophageal scc ct scan confirmed × × mm tumor patient underwent thoracoscopic esophageal resection two defect tracheobronchial tree size mm mm detected successfully sewn using intracorporeal continuous stratafix suture patient diagnosed cancer middle third esophagus ptnm stage iiib discussion thorough selection patient undergoing thoracoscopic esophageal resection together gentle manipulation esophagus area adjacent trachea prevent intraoperative tracheobronchial damage timely diagnosis serious complication make possible successfully manage using thoracoscopic technique conclusion intraoperative tracheal bronchial rupture successfully managed thoracoscopic intracorporeal suture,2019,"Khitaryan, Аlexander; Miziev, Ismail; Veliev, Camil; Voronova, Olga; Golovina, Anastasiya; Zavgorodnyaya, Raisa; Kovalev, Sergey; Alibekov, Albert; Orekhov, Аlexey",International journal of surgery case reports,,,,,,https://doi.org/10.1016/j.ijscr.2019.02.045; https://www.ncbi.nlm.nih.gov/pubmed/30884377/,83460375.0,12
39233,39233,51271,e0wl1u05,,Medline,Emerging needle ablation technology in urology.,10.1097/mou.0000000000000017,,24247176.0,unk,purpose review thermal ablation urologic tumor form freezing cryoablation heating radiofrequency ablation utilized successfully treat ablate soft tissue tumor year multiple study demonstrated efficacy nearing extirpative surgery certain urologic condition technical limitation speed safety profile physical limit thermal diffusion recent finding recently desire investigate form energy effort circumvent limitation cryoblation radiofrequency ablation review focus three relatively new energy application pertain tissue ablation microwave irreversible electroporation water vapor highintensityfocused ultrasound interstitial laser discussed recently published update summary needle probebased ablative treatment continue play important role threedimensional imaging workstation move advanced radiologic interventional suite operating room surgeon likely still play pivotal role application probe ablative device essential surgeon understands fundamental device order optimize application,2014,"Leveillee, Raymond J; Pease, Karli; Salas, Nelson",Current opinion in urology,,,,,,https://doi.org/10.1097/mou.0000000000000017; https://www.ncbi.nlm.nih.gov/pubmed/24247176/,5741178.0,12
39245,39245,51286,95madgnd,,Medline,Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer.,10.1007/s00262-020-02597-6,,32388678.0,unk,cancer vaccine development proven challenging exception virally induced cancer prophylactic vaccine exist currently one fda approved vaccine treatment prostate cancer prostate cancer continues present significant unmet medical need study examine effectiveness therapeutic cancer vaccine combine iscomatrix™ adjuvant iscomatrix tolllike receptor agonist polyinosinicpolycytidylic acid poly ic fltl fmslike tyrosine kinase ligand employed trampc transgenic adenocarcinoma mouse prostate model prostate cancer selfprotein mpap prostatic acid phosphatase tumor antigen iscomatrix™mpappoly icfltl delivered therapeutic primeboost regime consistently able achieve complete tumor regression animal treated tumorfree animal protected upon rechallenge investigation underlying immunological mechanism contributing effectiveness vaccine identified innate adaptive response elicited required nk cell cd cell interferonγ found critical tumor control tumor infiltrating cd cell became disabled immunosuppressive microenvironment potential broader application cancer vaccine able demonstrate effectiveness two additional cancer model melanoma bova model b cell lymphoma eµmycgfpova,2020-05-09,"Barr, Adele M; Silva, Anabel; Prato, Sandro; Belz, Gabrielle T; Maraskovsky, Eugene; Baz Morelli, Adriana","Cancer immunology, immunotherapy : CII",,,,,,https://doi.org/10.1007/s00262-020-02597-6; https://www.ncbi.nlm.nih.gov/pubmed/32388678/,218552319.0,12
39293,39293,51339,ppq5xrku,,Medline,A noble method for intraoperative fine localization during laparoscopic gastric local resection: endoscopic submucosal cutting and light transmission.,10.1007/s00464-014-3858-2,,25277479.0,unk,background main requirement performing laparoscopic local resection early mucosal tumor stomach clearly defined cancerfree margin precise tumor localization study novel method precise intraoperative tumor localization appropriate resection porcine model introduced endoscopic submucosal cutting light transmission esclt method total case laparoscopic local resection performed pig size target lesion approximately mm imaginary lesion located high body anterior wall posterior wall lower body posterior wall angle antrum anterior wall stomach mucosal marking around lesion mucosal precutting surrounding marking submucosal cutting along precutting line using white light endoscopy sequentially performed next endoscopic light source placed directly front lesion exact ovalshaped submucosal cutting margin identified via laparoscopy laparoscopic local resection performed minimal distance stapler line submucosal cutting line confirmed size mucosal marking submucosal cutting line entire resected mucosa serosa measured result procedure completed successfully pig local resection completed lesion mean endoscopic laparoscopic procedure time min respectively mean size resected specimen marking lesion × mm ii submucosal cutting line × mm iii entire resected mucosa × mm iv entire resected serosa × mm intraoperative morbidity conclusion esclt provides precise useful method intraoperative tumor localization laparoscopic local resection stomach term minimizing resection normal stomach tissue guaranteeing adequate mucosal safety margin,2015,"Lee, Young-Joon; Park, Ji-Ho; Jeong, Sang-Ho; Ha, Chang Yoon; Kwag, Seung-Jin; Kim, Ju-Yeon; Park, Taejin; Jeong, Chi-Young; Ju, Young-Tae; Jung, Eun-Jung; Hong, Soon-Chan; Choi, Sang-Kyung; Ha, Woo-Song",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-3858-2; https://www.ncbi.nlm.nih.gov/pubmed/25277479/,23363355.0,12
39350,39350,51406,pn6kuzo1,,Medline,Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.,10.1007/s00262-020-02598-5,,32388677.0,unk,chemotherapy preferred treatment advanced stage gastric cancer gc patient developing chemoresistance tremendous challenge efficacy gc treatment treatment antitumor chemoagents recruit tumorassociated macrophage tam highly implicated chemoresistance development underlying molecular mechanism unclear demonstrate hypoxiainducible factor α hifα gc cell activated upon fluorouracil fu treatment result much accumulation mtype tam protect tumor cell chemoagents mechanistically gc cell fu treatment reactive oxygen specie accumulated induces activation hifα signaling drive expression highmobility group box lead macrophage infiltration gc tumor turn recruited tam exhibit tumorprotected mtype phenotype promote chemoresistance gc cell via producing growth differentiation factor gdf exacerbate fatty acid βoxidation tumor cell blocking gdf using antibody inhibiting fao tumor cell etomoxir efficiently gave rise tumor cell sensitivity fu therefore study demonstrates novel insight understanding cross talking tumor cell immune microenvironment provides new therapeutic target clinic treatment gastric cancer,2020-05-09,"Yu, Shan; Li, Qian; Yu, Yiyi; Cui, Yuehong; Li, Wei; Liu, Tianshu; Liu, Fenglin","Cancer immunology, immunotherapy : CII",,,,,,https://doi.org/10.1007/s00262-020-02598-5; https://www.ncbi.nlm.nih.gov/pubmed/32388677/,218552623.0,12
39361,39361,51419,9tuavzxx,,Medline,Surgical nuances for removal of tuberculum sellae meningiomas with optic canal involvement using the endoscopic endonasal extended transsphenoidal transplanum transtuberculum approach.,10.3171/2011.3.focus115,,21529173.0,unk,tuberculum sellae meningioma frequently extend optic canal radical tumor resection including involved dural attachment underlying hyperostotic bone intracanalicular tumor optic canal offer best chance simpson grade resection minimize recurrence decompression optic canal removal intracanalicular tumor also improves visual outcome since portion tumor usually cause asymmetrical visual loss purely endoscopic endonasal extended transsphenoidal approach offer direct midline trajectory immediate access tuberculum sellae meningioma without brain retraction manipulation neurovascular structure although endoscopic approach previously criticized inability remove tumor within optic canal complete simpson grade tumor removal including intracanalicular tumor dural attachment involved hyperostotic bone achieved properly selected patient excellent visualization suprasellar region inferomedial aspect optic canal allows extracapsular extraarachnoid dissection tumor critical structure using bimanual microsurgical dissection report author describe operative nuance removal tuberculum sellae meningioma optic canal involvement using purely endoscopic endonasal extended transsphenoidal transplanum transtuberculum approach specifically highlight technique endonasal bilateral optic nerve decompression removal intracanalicular tumor improve postoperative visual function demonstrated illustrative case special attention also given cranial base reconstruction prevent csf leakage using vascularized pedicled nasoseptal flap,2011,"Liu, James K; Christiano, Lana D; Patel, Smruti K; Tubbs, R Shane; Eloy, Jean Anderson",Neurosurgical focus,,,,,,https://doi.org/10.3171/2011.3.focus115; https://www.ncbi.nlm.nih.gov/pubmed/21529173/,23944510.0,12
39367,39367,51426,bs0e6bfo,,Medline,HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts.,10.1038/cdd.2013.119,,24037088.0,unk,recent data linked hypoxia classic feature tumor microenvironment function specific micrornas mirnas however whether hypoxia affect type noncoding transcript currently unknown starting genomewide expression profiling demonstrate first time functional link oxygen deprivation modulation long noncoding transcript ultraconserved region termed transcribedultraconserved region tucrs interestingly several hypoxiaupregulated tucrs henceforth named hypoxiainduced noncoding ultraconserved transcript hincuts also overexpressed clinical sample colon cancer patient show tucrs predominantly nuclear hypoxiainducible factor hif least partly responsible induction several member group one specific hincut uc hincut part retained intron host proteincoding gene olinked nacetylglucosamine transferase overexpressed epithelial cancer type consistent hypothesis tucrs important function tumor formation hincut support cell proliferation specifically hypoxic condition may critical optimal oglcnacylation protein oxygen tension limiting data give first glimpse novel functional hypoxic network comprising proteincoding transcript noncoding rna ncrnas tucrs category,2013,"Ferdin, J; Nishida, N; Wu, X; Nicoloso, M S; Shah, M Y; Devlin, C; Ling, H; Shimizu, M; Kumar, K; Cortez, M A; Ferracin, M; Bi, Y; Yang, D; Czerniak, B; Zhang, W; Schmittgen, T D; Voorhoeve, M P; Reginato, M J; Negrini, M; Davuluri, R V; Kunej, T; Ivan, M; Calin, G A",Cell death and differentiation,,,,,,https://doi.org/10.1038/cdd.2013.119; https://www.ncbi.nlm.nih.gov/pubmed/24037088/,23635450.0,12
39373,39373,51434,ctjhwo3w,,Medline,Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate.,10.2967/jnumed.111.090373,,21764798.0,unk,unlabelled peptide receptor radionuclide therapy prrt efficient treatment gastroenteropancreatic neuroendocrine tumor gep net outstanding overall response rate survival however little known particular efficacy regarding bone metastasis bm method retrospectively analyzed consecutive subgroup patient bm gep net treated prrt luoctreotate intended cycle monthly interval wk mean activity per cycle gbq availability restaging outcome data required patient inclusion baseline characteristic including age tumor origin performance score ki index tumor load tumor uptake plasma chromogranin neuronspecific enolase analyzed regarding impact tumor regression modified md anderson criterion time progression survival analysis performed using kaplanmeier curve logrank test significance level p le cox proportional hazard model uni multivariate analysis result median followup mo observed response bm consisted complete remission partial remission minor response stable disease progressive disease patient median progressionfree survival overall survival o mo confidence interval mo confidence interval respectively patient responding bm complete remission partial remission minor response exhibited trend toward better o median o reached mo compared nonresponding patient mo p ki index chromogranin level ngml contributed regression analysis conclusion bm gep net effectively controlled prrt long progressionfree survival o poor patient condition multifocality bm clearly affect treatment efficacy possibly encouraging use prrt advanced bone metastatic disease larger study needed ass predictor treatment outcome patient,2011,"Ezziddin, Samer; Sabet, Amir; Heinemann, Florian; Yong-Hing, Charlotte J; Ahmadzadehfar, Hojjat; Guhlke, Stefan; Höller, Tobias; Willinek, Winfried; Boy, Christian; Biersack, Hans-Jürgen","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.090373; https://www.ncbi.nlm.nih.gov/pubmed/21764798/,33802009.0,12
39586,39586,51678,vsbf84o9,,Medline,Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.,10.1007/s12022-020-09622-5,,32388775.0,unk,pancreatic neuroendocrine carcinoma nec rare aggressive neoplasm dismal prognosis especially metastatic negative prognostic factor vascular invasion best knowledge case pancreatic nec mismatch repair deficiency reported date describe yearold patient underwent pancreaticoduodenectomy nec located pancreatic head peripancreatic lymph node metastasis tumor necrosis prominent ki proliferative index one year diagnosis patient experienced recurrence left supraclavicular lymph node metastasis surgically removed followed standard cisplatinetoposide chemotherapy neoplastic cell showed combined loss expression mlh pm primary tumor lymph node metastasis microsatellite instability msi test using mononucleotide repeat pentaplex pcr bat bat nr nr nr revealed minimal mononucleotide shift showing deletion le bp nr bat nr nr locus mlh methylation analysis revealed absence gene promoter methylation braf kras mutation detected gut nec mismatch repair deficiency phenotype reported case represents independent factor favorable outcome likewise patient currently alive followup year pancreaticoduodenectomy unexpected finding aggressive neoplasm,2020-05-09,"Vanoli, Alessandro; Perfetti, Vittorio; Furlan, Daniela; Neri, Giuseppe; Viglio, Alessandra; Sessa, Fausto; Martino, Michele; Di Sabatino, Antonio; Solcia, Enrico; La Rosa, Stefano",Endocrine pathology,,,,,,https://doi.org/10.1007/s12022-020-09622-5; https://www.ncbi.nlm.nih.gov/pubmed/32388775/,218552323.0,12
39627,39627,51723,6pqyzo4l,,Medline,"Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone.",10.1007/s00270-018-2097-7,,30350173.0,unk,background purpose conventional treatment systemic chemotherapy surgical resection recurrent metastatic hepatoblastoma hb may inhibitive pediatric patient family already extensive therapy singleinstitution case series evaluates safety efficacy percutaneous radiofrequency ablation rfa management metastatic hb material method march february rfa used part multidisciplinary management hb recurrence metastasis child median year old attempt provide locoregional control preclude additional surgery combined local treatment metachronous metastasis included surgical metastasectomy lesion lung liver percutaneous rfa lesion lung liver bone stereotactic radiotherapy liver lesion result lesion treated rfa median diameter mm range mm local control achieved metastasis median followup month rfa range median hospitalization day major complication limited pneumothorax requiring temporary smallcaliber chest tube four child remain complete remission median followup month range primary tumor resection mean diseasefree survival month last local treatment one child succumbed rapidly progressive disease month rfa month primary tumor resection conclusion rfa provides safe effective reiterative treatment option multidisciplinary management child metastatic hb,2019,"Yevich, Steven; Calandri, Marco; Gravel, Guillaume; Fresneau, Brice; Brugières, Laurence; Valteau-Couanet, Dominique; Branchereau, Sophie; Chardot, Christophe; Aerts, Isabelle; de Baere, Thierry; Tselikas, Lambros; Deschamps, Frederic",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-2097-7; https://www.ncbi.nlm.nih.gov/pubmed/30350173/,53038876.0,12
39675,39675,51781,xohffha5,,Medline,Electromagnetic navigation system combined with High-Frequency-Jet-Ventilation for CT-guided hepatic ablation of small US-Undetectable and difficult to access lesions.,10.1080/02656736.2019.1671612,,31621440.0,unk,objective report feasibility efficacy percutaneous ablation small hepatic malignant tumor invisible ultrasound inaccessible using inplane ct guidance using combination highfrequency jetventilation hfjv electromagnetic em needle tracking method study reviewed percutaneous ablation small hepatic tumor cm performed using em navigationbased probe placement hfjv lesion invisible ultrasound difficult reach ct requiring doubleoblique approach primary outcome technical efficacy defined complete lesion coverage evaluated contrast enhanced mri month needle placement accuracy number control ct acquisition procedure time complication radiation dos assessed result twentyone patient treated lesion hepatocellular carcinoma metastasis included study mean tumor size ± mm thirtythree percent lesion located hepatic dome complete ablation obtained month mri followup ablation probe correctly placed first pas mean pathtotumor angle ± degree mean tiptotumor distance ± mm readjustment additional overlapping application resulted complete treatment patient needle placement took mean ± min mean radiation dos mgycm major complication reported conclusion percutaneous liver ablation lesion seen u requiring outofplane ct access successfully safely treated using electromagneticbased navigation jetventilation,2019,"Volpi, Stephanie; Tsoumakidou, Georgia; Loriaud, Amélie; Hocquelet, Arnaud; Duran, Rafael; Denys, Alban","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2019.1671612; https://www.ncbi.nlm.nih.gov/pubmed/31621440/,204757339.0,12
39689,39689,51797,h0t4y53u,,Medline,Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds.,10.3791/57452,,30059037.0,unk,glioblastoma gbm common aggressive primary brain cancer carry life expectancy month short life expectancy due part inability current treatment consisting surgical resection followed radiation chemotherapy eliminate invasive tumor focus treatment focus may improved tumoricidal human mesenchymal stem cell msc msc exhibit potent tumor tropism engineered express therapeutic protein kill tumor cell advancement preclinical model indicate surgical resection induces premature msc loss reduces therapeutic efficacy efficacy msc treatment improved seeding msc biodegradable polylactic acid pla scaffold msc delivery surgical resection cavity pla scaffold restores cell retention persistence tumor killing study effect mscseeded pla implantation gbm accurate preclinical model needed provide preclinical surgical protocol imageguided tumor resection gbm immunedeficient mouse followed mscseeded scaffold implantation msc engineered lentiviral construct constitutively express secrete therapeutic tnfαrelated apoptosisinducing ligand trail well green fluorescent protein gfp allow fluorescent tracking similarly u tumor cell engineered express mcherry firefly luciferase providing dual fluorescentluminescent tracking currently used investigating stem cell mediated delivery therapeutic protocol could modified investigate impact surgical resection gbm intervention,2018,"Sheets, Kevin T; Bagó, Juli R; Paulk, Ivory L; Hingtgen, Shawn D",Journal of visualized experiments : JoVE,,,,,,https://doi.org/10.3791/57452; https://www.ncbi.nlm.nih.gov/pubmed/30059037/,51871418.0,12
39712,39712,51822,vqc1bzkw,,Medline,Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?,10.1007/s00270-018-1937-9,,29582125.0,unk,purpose determine whether primary tumor side predictor radiofrequency ablation rfa outcome colorectal liver metastasis crlm material method institutional review board approved retrospective study written informed consent obtained patient january december patient underwent rfa metachronous crlm enrolled study propensity score matching method recurrence rate rr overall survival o analyzed two patient cohort primary leftside colorectal cancer lscrc primary rightside colon cancer rscc result total rr patient patient lscrc cohort lower rr nonlocal recurrence nlr rate rscc patient cohort v p v p fiveyear o rscc lscrc respectively significant difference two cohort median o v month rscc lscrc respectively p univariate analysis showed primary tumor side number liver metastasis tumor size carcinoembryonic antigen level differentiation tnm stage active chemotherapy rfa boundary significant predicting o variable subsequently entered multivariate model rscc p hazard ratio hr tumor size cm p hr significant conclusion lscrc tumor size ≤ cm independent predictor rfa crlm yield better oncologic outcome,2018,"Gu, Yangkui; Huang, Zhimei; Gu, Haifeng; Gao, Fei; Zhang, Tianqi; Huang, Senmiao; Huang, Jinhua",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-1937-9; https://www.ncbi.nlm.nih.gov/pubmed/29582125/,4333445.0,12
39746,39746,51861,w42gu7dx,,Medline,"hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.",10.1038/cddiscovery.2016.81,,28028438.0,unk,recent year new treatment option malignant melanoma patient enhanced overall survival selected patient despite new hope melanoma patient still relapse drugresistant tumor experience intrinsic resistance therapy therefore novel treatment modality beneficial subgroup patient needed trail receptor agonist suggested promising candidate use cancer treatment preferentially induce apoptosis cancer cell unfortunately first generation trail receptor agonist showed poor clinical efficacy hvtra secondgeneration trail receptor agonist improved composition giving increased potency present study showed hvtrainduced activation apoptosis leading efficient sustained reduction melanoma cell growth cell line xenograft model furthermore potential hvtra clinical setting demonstrated showing efficacy tumor cell harvested melanoma patient lymph node metastasis ex vivo drug sensitivity assay inhibition mutated braf shown regulate protein intrinsic apoptotic pathway making cell susceptible apoptosis induction attempt increase efficacy hvtra combination treatment mutated braf inhibitor vemurafenib investigated synergistic effect combination observed several cell line vitro initial cytotoxic effect observed vivo unfortunately initial increased reduction tumor growth compared hvtra mono treatment sustained related downregulation dr level vemurafenib altogether presented data imply hvtra efficiently induce apoptosis growth delay melanoma model patient material potential trail receptor agonist evaluated treatment subgroup melanoma patient,2016,"Fleten, Karianne G; Flørenes, Vivi Ann; Prasmickaite, Lina; Hill, Oliver; Sykora, Jaromir; Mælandsmo, Gunhild M; Engesæter, Birgit",Cell death discovery,,,,,,https://doi.org/10.1038/cddiscovery.2016.81; https://www.ncbi.nlm.nih.gov/pubmed/28028438/,17788766.0,12
39770,39770,51887,2sm6hf52,,Medline,"Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, (111)in-labeling, and preclinical profile.",10.1021/jm301692p,,23427837.0,unk,novel bombesin bbn antagonist synthesized coupling chelator tetraazacyclododecanetetraacetic acid dota hdpheglntrpalavalglyhisstaleunh jmv linkers increasing number βalax residue x labeling afforded respective radiotracers high purity high specific activity bioconjugate affinity gastrin releasing peptide receptor grpr determined ityrbbn high ic value lower nanomolar range radioligands poorly internalized pc cell °c radiopeptides remained intact min entering bloodstream healthy mouse injection scid mouse bearing human pc xenograft analogue showed high tumor uptake rapid background clearance via kidney urine interestingly pancreatic uptake albeit grprspecific declined rapidly time indotaβalajmv achieved highest tumor value among group ± idg v idg respectively h pi indicating βalalinker favor vivo interaction radiopeptides grpr,2013,"Marsouvanidis, Panteleimon J; Nock, Berthold A; Hajjaj, Bouchra; Fehrentz, Jean-Alain; Brunel, Luc; M'Kadmi, Céline; van der Graaf, Linda; Krenning, Eric P; Maina, Theodosia; Martinez, Jean; de Jong, Marion",Journal of medicinal chemistry,,,,,,https://doi.org/10.1021/jm301692p; https://www.ncbi.nlm.nih.gov/pubmed/23427837/,45337829.0,12
39784,39784,51902,tahz3k1a,,Medline,"Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.",10.1053/j.gastro.2015.04.053,,25957861.0,unk,esophageal adenocarcinoma eac rapidly increasing incidence western culture barretts esophagus presumed precursor lesion cancer several risk factor cancer described including chronic heartburn tobacco use white race obesity despite known association patient eac present symptom dysphagia latestage tumor small number patient identified screening surveillance program diagnostic analysis eac usually commences upper endoscopy followed crosssectional imaging endoscopic ultrasonography useful ass local extent disease well involvement regional lymph node ta eac may treated endoscopically patient tb disease may also benefit endoscopic therapy locally advanced disease generally managed esophagectomy often accompanied neoadjuvant chemoradiotherapy chemotherapy prognosis based tumor stage patient ta tumor excellent prognosis whereas patient advanced disease longterm survival,2015,"Rubenstein, Joel H; Shaheen, Nicholas J",Gastroenterology,,,,,,https://doi.org/10.1053/j.gastro.2015.04.053; https://www.ncbi.nlm.nih.gov/pubmed/25957861/,206237495.0,12
39797,39797,51915,4h59467a,,Medline,Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors.,10.1097/mnm.0000000000000915,,30234688.0,unk,purpose objective prospective study compare intravenous contrastenhanced ce fluorinefluorodeoxyglucose ffdg petcomputed tomography ce ffdg petct conventional method ctmri evaluate relationship maximum standardized uptake value suvmax fuhrman grade patient renal tumor patient method total patient male female mean age ± range year enrolled study ce ffdg petct scanning included wholebody early abdominal imaging late h intravenous ffdg administration respectively suvmax calculated primary tumor ce ffdg petct ctmri finding compared respect primary tumor staging result sensitivity ce ffdg petct primary tumor detection close ctmri ce ffdg petct resulted correct staging case compared case conventional method v patient suvmax value early pet primary tumor significantly correlated fuhrman grade p ce ffdg petct enabled detection synchronous tumor four patient one incorrectly diagnosed metastasis ct distant metastasis detected patient ce ffdg petct patient routine conventional method conclusion ce ffdg petct showed similar result compared ctmri detection primary tumor superior conventional method detection metastasis staging given highly significant correlation suvmax value fuhrman grading ce ffdg petct may play significant role evaluation patient prognosis,2018,"Gündoğan, Cihan; Çermik, Tevfik F; Erkan, Erkan; Yardimci, Aytül H; Behzatoğlu, Kemal; Tatar, Gamze; Okçu, Oğuzhan; Toktaş, Mahmut G",Nuclear medicine communications,,,,,,https://doi.org/10.1097/mnm.0000000000000915; https://www.ncbi.nlm.nih.gov/pubmed/30234688/,52298648.0,12
39821,39821,51943,8zw0v5tn,,Medline,53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.,10.1186/1471-2407-13-155,,23530749.0,unk,background bp bind tumor suppressor p key role dna damage response repair low bp expression associated decreased survival breast cancer shown interact several prognostic factor nonsmall cell lung cancer role bp pancreatic ductal adenocarcinoma pdac yet determined aimed investigate whether bp level interact established prognostic factor pdac method patient tissue available time surgical resection pdac included tissue microarray constructed using surgical specimen stained antibody bp scored expression intensity univariate multivariate statistical analysis performed investigate association bp patient survival known prognostic factor survival result association bp several established prognostic factor examined including stage tumor grade surgical margin peripancreatic extension lymph node ratio lnr ca found bp modified effect known prognostic variable including lnr ca survival outcome bp intensity low increased lnr associated decreased o hr ci p high ca associated decreased o hr ci p bp intensity high lnr ca longer associated o p p respectively conclusion study bp key player dna damage response repair found modify prognostic value two established prognostic factor lnr ca suggesting bp may alter tumor behavior ultimately impact interpret value prognostic factor,2013,"Ausborn, Natalie L; Wang, Tong; Wentz, Sabrina C; Washington, Mary Kay; Merchant, Nipun B; Zhao, Zhiguo; Shyr, Yu; Chakravarthy, Anuradha Bapsi; Xia, Fen",BMC cancer,,,,,,https://doi.org/10.1186/1471-2407-13-155; https://www.ncbi.nlm.nih.gov/pubmed/23530749/,5033376.0,12
39825,39825,51947,2zkkw0nv,,Medline,Laparoscopic spleen-preserving distal pancreatectomy with and without splenic vessel preservation: the role of the Warshaw procedure.,10.1016/j.pan.2014.09.007,,25306307.0,unk,backgroundobjectives laparoscopic spleenpreserving distal pancreatectomy lspdp lowgrade malignant pancreas tumor recently demonstrated although procedure splenic vessel preservation svp optimal lspdp svp always possible patient large tumor tumor attached splenic vessel study aimed analyze safety two procedure lspdp without svp known warshaw technique lapwt lspdp svp lapsvp method seventeen patient underwent lapwt seven patient underwent lapsvp investigated retrospectively result median followup duration range month lapwt lapsvp patient size tumor cm operative time min blood loss gr length postoperative hospital stay day peak platelet count × μl splenomegaly observed three patient respectively procedure local recurrence lapwt group splenic infarction seen four patient perigastric varix seen two patient patient observed conservatively conclusion lapwt lapsvp found safe effective case tumor relatively large close splenic vessel lapwt used appropriate procedure,2014,"Matsushima, Hajime; Kuroki, Tamotsu; Adachi, Tomohiko; Kitasato, Amane; Hirabaru, Masataka; Hidaka, Masaaki; Soyama, Akihiko; Takatsuki, Mitsuhisa; Eguchi, Susumu",Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],,,,,,https://doi.org/10.1016/j.pan.2014.09.007; https://www.ncbi.nlm.nih.gov/pubmed/25306307/,3546555.0,12
39872,39872,52004,klcggp96,,Medline,Is near infrared fluorescence imaging using indocyanine green dye useful in robotic partial nephrectomy: a prospective comparative study of 94 patients.,10.1016/j.urology.2012.01.076,,22607949.0,unk,objective compare consecutive prospective cohort patient underwent robotic partial nephrectomy rpn near infrared fluorescence nirf imaging indocyanine green dye icg previous consecutive patient cohort method total consecutive patient renal mass suspicious malignancy undergoing rpn given mg icg hilar clamping tumor excision cohort patient compared immediate previous consecutive patient undergone rpn without nirf realtime imaging using icg intraoperative perioperative postoperative parameter collected institutional review boardapproved prospective database result preoperative demographic tumor complexity according nephrometry preoperative aspect dimension used anatomic padua score similar mean warm ischemia time significantly decreased icg group v minute p median hospital stay day group significant difference seen positive margin rate icg v control p observed clavien grade iiiiv complication cohort icg v control p adverse event associated icg dye administration differential icg uptake observed selective clamping patient cystic tumor hypofluorescent tumor exophytic component angiomyelolipomas benefit could quantified nirficg transiently helpful identify vascular anatomy helpful endophytic tumor conclusion rpn using nirficg performed safely effectively decreased warm ischemia time icg cohort observed without specific measured advantage differential icg uptake different tumor lead significant difference positive margin rate,2012,"Krane, L Spencer; Manny, Theodore B; Hemal, Ashok K",Urology,,,,,,https://doi.org/10.1016/j.urology.2012.01.076; https://www.ncbi.nlm.nih.gov/pubmed/22607949/,26809683.0,12
39893,39893,52025,dnup0ull,,Medline,Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver.,10.1007/s00270-018-1898-z,,29484466.0,unk,purpose oven effect theory assumes radiofrequency ablation rfa would efficient tumor cirrhotic liver aim study compare size volume ablation zone following rfa tumor cirrhotic versus healthy liver method one hundred eleven patient underwent rfa treatment liver tumor hepatocellular carcinoma developed cirrhotic liver ie cirrhosis group tumor developed healthy liver mainly liver metastasis ie healthy liver group using rfa device retrospectively selected diameter volume ablation zone compared group end procedure fu first fu second followup fu performed month ± day month ± day postrfa respectively result difference size volume ablation zone found group fu ± mm v ± mm p ± mm v ± mm p respectively fu fu similarly difference found fu fu fu subgroup tumor treated using single radiofrequency application mean volume ablation zone decreased time fu fu without difference group conclusion contradiction oven effect theory rfa achieves ablation zone comparable size volume cirrhotic healthy liver,2018,"Cassinotto, Christophe; Denys, Alban; Gay, Frédérique; Duran, Rafael; Hocquelet, Arnaud; Piron, Lauranne; Guiu, Boris",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-1898-z; https://www.ncbi.nlm.nih.gov/pubmed/29484466/,3537163.0,12
39904,39904,52037,zo2xb2zu,,Medline,Changes in peripheral blood T-cell balance after percutaneous tumor ablation.,10.1080/13645706.2017.1310737,,28417678.0,unk,purpose evaluate change tcell balance peripheral blood following percutaneous tumor ablation material method patient underwent thermal ablation including radiofrequency n microwave ablation n cryoablation n target tumor located lung n soft tissue n liver n bone n patient peripheral blood sample collected within day ablation peripheral blood population cytotoxic tcells ctl type th type helper tcells th regulatory tcells treg measured using flow cytometry change ctltreg thth ratio ablation therapy compared using paired ttests result peripheral blood ctl population ± ± p ctltreg ratio ± ± p increased significantly ablation although significant increase ctltreg ratio found heatbased ablation ± ± p remained unchanged cryoablation ± ± p thth ratio ± ± p remained unchanged ablation conclusion ablation therapy alters tcell balance increasing systemic ctltreg ratio heatbased ablation might effective approach cryoablation enhance systemic antitumor immunity,2017,"Takaki, Haruyuki; Imai, Naoko; Thomas, Contessa T; Yamakado, Koichiro; Yarmohammadi, Hooman; Ziv, Etay; Srimathveeravalli, Govindarajan; Sofocleous, Constantinos T; Solomon, Stephen B; Erinjeri, Joseph P",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.1080/13645706.2017.1310737; https://www.ncbi.nlm.nih.gov/pubmed/28417678/,31280752.0,12
39960,39960,52099,lqomarh3,,Medline,Carotid body tumor imitator: An interesting case of Castleman's disease.,10.4103/2152-7806.171239,,26677415.0,unk,background report literature castlemans disease affecting carotid artery single previous report case castlemans disease neck originally mistaken carotid body tumor case description describe rare case castlemans disease manifesting classic radiographic hallmark carotid body tumor postoperative pathologic examination identified resected mass castlemans lymphadenopathy management particular case discussed finding highlighted conclusion present unique case tumor initially incorrectly diagnosed carotid body tumor however comprehensive treatment endovascular surgical modality subsequent pathologic examination diagnosis rare entity made,2015,"Shakir, Hakeem J; Diletti, Sara M; Hart, Alexandra M; Meyers, Joshua E; Dumont, Travis M; Siddiqui, Adnan H",Surgical neurology international,,,,,,https://doi.org/10.4103/2152-7806.171239; https://www.ncbi.nlm.nih.gov/pubmed/26677415/,20723020.0,12
39970,39970,52111,c9yu2bz2,,Medline,Ultrasound and cone beam CT fusion for liver ablation: technical note.,10.1080/02656736.2018.1509237,,30204007.0,unk,purpose ass feasibility fusion imaging intraprocedural ultrasound u contrastenhanced conebeam ct cbct small cm hepatocellular carcinoma hcc material method six patient five male one female age range mean year small mean diameter mm hcc poorly visible u underwent percutaneous microwave ablation uscbct fusion guidance general anesthesia apnea control contrast enhanced cbct acquired active tracker subsequently real time u image fused cbct image treatment performed fusion imaging guidance feasibility fusion imaging percutaneous ablation assessed correct targeting distance center tumor center ablation area mm onemonth primary technical efficacy evaluated major minor complication well overall procedural time recorded result uscbct fusion feasible case allowing completion treatment previously planned technical success correct targeting achieved case two case center tumor center ablated area respectively mm distant month ct scan tumor completely ablated primary technical efficacy major minor complication occurred mean overall procedure time min conclusion uscbct fusion feasible technique liver ablation might represent useful tool increase correct targeting poorly usvisible hcc nodule angio suite,2018,"Monfardini, Lorenzo; Orsi, Franco; Caserta, Rosalba; Sallemi, Claudio; Della Vigna, Paolo; Bonomo, Guido; Varano, Gianluca; Solbiati, Luigi; Mauri, Giovanni","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2018.1509237; https://www.ncbi.nlm.nih.gov/pubmed/30204007/,52184419.0,12
40007,40007,52150,5aekkwo6,,Medline,Ex vivo liver resection coupled with associated liver partition and portal vein ligation: Combining existing techniques to achieve surgical resectability.,10.1002/jso.25375,,30644109.0,unk,incorporation liver transplant technique hepatopancreaticobiliary surgery created opportunity resection locally advanced hepatic tumor formerly considered unresectable yearold woman presented cholangiocarcinoma involving inferior vena cava three hepatic vein right anterior portal pedicle initially deemed nonoperative case demonstrates first combined application associating liver partition portal vein ligation staged hepatectomy ex vivo resection perform r disease dependent upon resection surgical advance innovation expand spectrum intervention interdisciplinary technique,2019,"Baimas-George, Maria R; Levi, David M; Eskind, Lon B; Kirks, Russell C; Passeri, Michael; Lessne, Mark; Kardassis, Dimitrios; Salmon, Stuart; Iannitti, David A; Vrochides, Dionisios",Journal of surgical oncology,,,,,,https://doi.org/10.1002/jso.25375; https://www.ncbi.nlm.nih.gov/pubmed/30644109/,58569539.0,12
40136,40136,52301,vsjbuyu3,,Medline,Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor.,10.1021/jm101279a,,21456601.0,unk,development metabolically stable radiolabeled gastrin analogue suitable pharmacokinetics topic recent research activity imaging vector interest gastrincck receptor highly overexpressed different tumor medullary thyroid cancer neuroendocrine tumor sclc drawback current targeting agent either metabolic instability high kidney uptake present synthesis vitro vivo evaluation inlabeled dotaconjugated peptide differ spacer peptide chelate introduced uncharged hydrophilic spacers oligoethyleneglycol serine glutamine affinity radiopeptides high ic value nm improvement human serum stability fold within series compound addition kidney uptake could lowered distinctly tumortokidney ratio improved almost fold compared radiotracers charged spacers glutamic acid,2011,"Kolenc-Peitl, Petra; Mansi, Rosalba; Tamma, MariaLuisa; Gmeiner-Stopar, Tanja; Sollner-Dolenc, Marija; Waser, Beatrice; Baum, Richard P; Reubi, Jean Claude; Maecke, Helmut R",Journal of medicinal chemistry,,,,,,https://doi.org/10.1021/jm101279a; https://www.ncbi.nlm.nih.gov/pubmed/21456601/,41694561.0,12
40193,40193,52365,9bviy3ff,,Medline,Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma.,10.7150/ntno.39514,,31687321.0,unk,background objective hepatocellular carcinoma hcc common primary liver malignancy current management relies heavily locoregional therapy curative therapy bridge transplant palliative therapy locoregional therapy include ablation hepatic artery therapy embolization radioembolization study evaluate feasibility using novel antivascular ultrasound avus noninvasive locoregional therapy reduce perfusion hcc lesion rat model monitor effect contrastenhanced ultrasound imaging method hcc induced wistar rat ingestion diethylnitrosamine den week two therapy regimen avus evaluated primary regimen n utilized wcm mhz ultrasound u minute insonation ml microbubbles administered intravenous bolus alternate dose half primary intensity sonication time contrast concentration evaluated rat ass efficacy reduced dose control group n received sham therapy tumor perfusion measured avus nonlinear contrast ultrasound nlc power doppler pd quantitative perfusion measure included perfusion index pi peak enhancement pe time peak ttp perfusion area nlc pd scan total tumor area perfused scan measured postprocessing algorithm called delta projection tumor histology evaluated sign tissue injury vascular change using cd immunohistochemistry result den exposure induced autochthonous hepatocellular carcinoma lesion rat across group prior therapy significant difference nonlinear contrast observation peak enhancement perfusion index control group significant difference parameter sham treatment primary avus regimen significant change parameter p ≤ indicating substantial decrease tumor perfusion peak enhancement nonlinear contrast scan showed ± decrease tumor perfusion following reduceddose avus significant change perfusion parameter although trend nonlinear contrast observation peak enhancement perfusion index increase conclusion study translated lowintensity avus therapy realistic vivo model hcc evaluated effect tumor vasculature primary dose avus tested resulted significant vascular disruption corresponding reduction tumor perfusion reduced dose avus hand ineffective disrupting perfusion demonstrated potential enhancing tumor blood flow theranostic ultrasound acoustic energy microbubbles used monitor tumor neovasculature well disrupt vasculature treat lesion could serve potent tool delivering noninvasive locoregional therapy hepatocellular carcinoma,2019,"D'Souza, Julia C; Sultan, Laith R; Hunt, Stephen J; Gade, Terence P; Karmacharya, Mrigendra B; Schultz, Susan M; Brice, Angela K; Wood, Andrew K W; Sehgal, Chandra M",Nanotheranostics,,,,,,https://doi.org/10.7150/ntno.39514; https://www.ncbi.nlm.nih.gov/pubmed/31687321/,203635639.0,12
40205,40205,52378,z1g11knq,,Medline,Endoscopic endonasal transclival approach to a ventral pontine pediatric ependymoma.,10.3171/2013.8.peds12183,,23992235.0,unk,author report case recurrent pediatric ventral pontine ependymoma resected endonasal endoscopic transclival approach regarding option surgical approach ventral pontine tumor traditional farlateral approach associated considerable morbidity due required muscle mobilization brain retraction inline obstruction cranial nerve reaching target endoscopic endonasal transclival approach made appealing eliminating concern patient fully pneumatized sphenoid sinus laterally displaced basilar artery direct ventral location bulky disease supported unconventional choice surgical corridor achieve palliative brainstem decompression incurable recurrence,2013,"Rajappa, Prajwal; Margetis, Konstantinos; Sigounas, Dimitri; Anand, Vijay; Schwartz, Theodore H; Greenfield, Jeffrey P",Journal of neurosurgery. Pediatrics,,,,,,https://doi.org/10.3171/2013.8.peds12183; https://www.ncbi.nlm.nih.gov/pubmed/23992235/,44726986.0,12
40261,40261,52441,kf37mwuc,,Medline,Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor of the femur from hepatocellular carcinoma.,10.1007/s10147-011-0319-y,,21915771.0,unk,yearold man year history hepatocellular carcinoma hcc referred u regarding bone metastasis right proximal femur although underwent radiotherapy pain palliation local tumor control pain persisted tumor relapsed month radiotherapy thought high risk pathologic fracture given hypervascularity large tumor size prophylactic internal fixation combined adjuvant radiofrequency ablation rfa proposed reduce blood loss prevent viable tumor cell disseminated postoperative course uneventful without requiring blood transfusion preoperative symptom immediately disappeared surgery became capable weightbearing walk single cane almost asymptomatic without local progression plain radiograph died month surgery combination therapy rfa internal fixation using intramedullary nailing metastasis long bone hcc seems promising technique sufficient pain relief local control tumor adjuvant rfa may become potential option patient metastasis long bone purpose prevention tumor dissemination reduction intraoperative blood loss,2012,"Ogura, Koichi; Miyake, Ryoko; Shiina, Shuichiro; Shinoda, Yusuke; Okuma, Tomotake; Kobayashi, Hiroshi; Goto, Takahiro; Nakamura, Kozo; Kawano, Hirotaka",International journal of clinical oncology,,,,,,https://doi.org/10.1007/s10147-011-0319-y; https://www.ncbi.nlm.nih.gov/pubmed/21915771/,41199764.0,12
40303,40303,52495,kcxvee64,,Medline,Transanal endoscopic microsurgery: also for the treatment of retrorectal tumors.,10.3109/13645706.2013.872663,,24329013.0,unk,retrorectal tumor uncommon pathological entity clinical importance arises occasional malignant nature malignant transformation treatment choice presacral tumor surgical excision approach depends upon upper limit lesion presumptive pathology reviewed main feature tumor emphasis transanal endoscopic microsurgery tem viable surgical approach treatment lesion undertaken institution present small case series consisting six patient retrorectal lesion underwent local excision via tem early late postoperative outcome presented tem retrorectal lesion appears feasible safe approach remarkably low morbidity favor tem selected patient,2014,"Duek, Simon Daniel; Gilshtein, Hayim; Khoury, Wisam",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.3109/13645706.2013.872663; https://www.ncbi.nlm.nih.gov/pubmed/24329013/,2935712.0,12
40305,40305,52497,jt56jm0l,,Medline,Incidence and risk factors for rectovaginal fistula after low anterior resection for rectal cancer.,10.1007/s00384-015-2340-5,,26248793.0,unk,background rectovaginal fistula rvf rare complication low anterior resection lar rectal cancer aim study evaluate risk factor rvf lar rectal cancer method retrospective multiinstitution study female rectal cancer patient underwent lar anastomosis january december patient tumor surgeryrelated variable examined univariate multivariate analysis result overall rvf rate rvf diagnosed median postoperative day patient diagnosis rvf made hospital discharge multivariate analysis identified prognostic nutritional index pni odds ratio confidence interval ci p preoperative chemotherapy ci p tumor size ci p intraoperative bleeding ci p lateral lymph node dissection ci p independent risk factor rvf lar conclusion risk factor rvf pni preoperative chemotherapy tumor size ≧ mm intraoperative bleeding ≧ ml lateral lymph node dissection operation obtaining information risk factor great importance lar rectal cancer,2015,"Watanabe, Jun; Ota, Mitsuyoshi; Kawaguchi, Daisuke; Shima, Hidetaka; Kaida, Shuhei; Osada, Shunichi; Kamimukai, Nobuyuki; Kamiya, Noriyuki; Ishibe, Atsushi; Watanabe, Kazuteru; Matsuyama, Ryusei; Akiyama, Hirotoshi; Ichikawa, Yasushi; Oba, Mari; Endo, Itaru",International journal of colorectal disease,,,,,,https://doi.org/10.1007/s00384-015-2340-5; https://www.ncbi.nlm.nih.gov/pubmed/26248793/,22201361.0,12
40308,40308,52500,axwm98fi,,Medline,Thoracoscopic Thymectomy with Tangential Partial Resection of the Innominate Vein.,10.5761/atcs.nm.16-00220,,28637940.0,unk,herein report case thoracoscopic thymectomy partial resection brachiocephalic vein performed using subxiphoid approach suggest usefulness subxiphoid approach thymectomy could extend indication thoracoscopic thymectomy invasive tumor thoracoscopic thymectomy combined resection part brachiocephalic vein possible pathological diagnosis tumor diffuse large cell bcell lymphoma since postoperative complication minimal postoperative adjuvant chemotherapy could initiated without delay operation might unnecessary however could decrease invasiveness surgery using procedure without sternotomy thoracoscopic thymectomy using subxiphid approach seems ideal procedure surgical treatment invasive lesion,2017,"Yano, Motoki; Okuda, Katsuhiro; Kawano, Osamu; Suzuki, Ayumi; Oda, Risa; Nakanishi, Ryoichi; Haniuda, Masayuki",Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,,,,,,https://doi.org/10.5761/atcs.nm.16-00220; https://www.ncbi.nlm.nih.gov/pubmed/28637940/,207534038.0,12
40343,40343,52540,yiu12mss,,Medline,Port site recurrence and unusual diffuse subcutaneous metastases of unexpected early stage ovarian cancer after laparoscopic surgery: a case report.,10.2185/jrm.3000,,31191780.0,unk,port site recurrence rare welldocumented adverse event peculiar laparoscopic surgery report unusual outcome unexpected early stage ovarian cancer port site recurrence occurred laparoscopic surgery followed diffuse subcutaneous metastasis yearold japanese woman large tumor abdomen visited hospital intratumoral solid component detected diagnostic imaging tumor diagnosed benign ovarian tumor patient underwent left ovarian laparoscopic cystectomy contrary expectation however ovarian tumor mucinous carcinoma performed additional surgery tumor recurred umbilical area multiple subcutaneous metastasis later appeared curative effect chemotherapy radiation limited atypical metastatic distribution extremely small amount cancer might caused laparoscopic procedure protection tumor cell dissemination necessary form laparoscopic surgery,2019,"Fusegi, Atsushi; Oshima, Noriko; Nakasuji, Takashi; Ishikawa, Tomonori; Wakana, Kimio; Yoshiki, Naoyuki; Miyasaka, Naoyuki",Journal of rural medicine : JRM,,,,,,https://doi.org/10.2185/jrm.3000; https://www.ncbi.nlm.nih.gov/pubmed/31191780/,186207081.0,12
40357,40357,52557,rksxvubt,,Medline,Robotic resection of a superior sulcus neurogenic tumor.,10.1097/imi.0000000000000129,,25798734.0,unk,neurogenic tumor often occur superior sulcus apex chest cavity historically surgical approach dictated location tumor relation contiguous structure vertebral body subclavian vessel chest wall resection hampered difficulty visualization access within narrow working space shortcoming associated traditional surgical approach create potential injury nearby structure present case yearold woman superior sulcus neurogenic tumor impinging left subclavian vein underwent successful resection without injury nearby structure found robotic approach improved visualization tumor nearby structure increased instrument maneuverability relative thoracoscopic approach along le pain recovery time compared thoracotomy experience suggests robotics provides promising alternative excision superior sulcus neurogenic tumor may reduce associated morbidity,2015,"Nguyen, Duy C; Garagozlo, Cameron; Moslemi, Mohammad; Rawashdeh, Badi; Meyer, Mark; Tempesta, Barbara J; Poston, Robert; Gharagozloo, Farid",Innovations,,,,,,https://doi.org/10.1097/imi.0000000000000129; https://www.ncbi.nlm.nih.gov/pubmed/25798734/,23267013.0,12
40367,40367,52570,124kjt4l,,Medline,Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.,10.1002/path.5468,,32418210.0,unk,isocitrate dehydrogenase idh wildtype diffuse lowergrade glioma lgg usually associated poor outcome dispute clinical outcome classification presented robust gene expressionbased molecular classification idh wildtype diffuse lgg two subtypes distinct biological clinical feature discovery cohort idh wildtype diffuse lggs chinese glioma genome atlas cgga subjected clustering function analysis tumor cancer genome atlas tcga used validate finding consensus clustering transcriptional data uncovered concordant classification two robust prognostically significant subtypes idh wildtype lgg sub associated poorer outcome characterized significantly higher immune cytolytic score macrophage upregulation immune exhaustion marker sub elevated lymphocyte plasma cell showed relatively favorable survival somatic alteration analysis revealed sub showed frequently deleted region locus cdknacdknb dmrta corf mtap furthermore developed validated fivegene signature better application acquired stratification data demonstrate biological prognostic heterogeneity within idh wildtype diffuse lggs deepen molecular understanding tumor entity article protected copyright right reserved,2020-05-17,"Wu, Fan; Li, Guan-Zhang; Liu, Han-Jie; Zhao, Zheng; Chai, Rui-Chao; Liu, Yu-Qing; Jiang, Hao-Yu; Zhai, You; Feng, Yue-Mei; Li, Ren-Peng; Zhang, Wei",The Journal of pathology,,,,,,https://doi.org/10.1002/path.5468; https://www.ncbi.nlm.nih.gov/pubmed/32418210/,218679591.0,12
40464,40464,52690,9ppe98sg,,Medline,Single-port transanal endoscopic microsurgery: a developing technique.,10.1097/sle.0b013e31828fa91f,,24710231.0,unk,introduction transanal endoscopic microsurgery widely used valid technique established indication however cost surgical anoscopes available center many author described transanal resection rectal tumor single laparoscopy port sils system material method analyzed case patient undergoing transanal resection sils device clinical surgical oncological data assessed result median distance anal margin cm range cm median tumor size cm range cm median operating time minute range min postsurgical rectorrhagia occurred case two case adenocarcinoma adenoma mucosa without tumor remnant margin negative case conclusion transanal resection rectal tumor using sils technique feasible procedure longer series prospective study necessary,2014,"Valero-Navarro, Graciela; Pellicer-Franco, Enrique; Soria-Aledo, Victor; Mengual-Ballester, Monica; Garcia-Marin, Jose A; Guillen-Paredes, Pilar; Aguayo-Albasini, Jose L","Surgical laparoscopy, endoscopy & percutaneous techniques",,,,,,https://doi.org/10.1097/sle.0b013e31828fa91f; https://www.ncbi.nlm.nih.gov/pubmed/24710231/,25630111.0,12
40494,40494,52725,fhh8b15l,,Medline,Single-Piece Titanium Plate Cranioplasty Reconstruction of Complex Defects.,10.1097/scs.0000000000004311,,29481497.0,unk,background different method described reconstruction cranial defect orbital defect complex contouring orbital roof frontal bone creates significant design challenge prefabricated cranioorbital reconstruction describing first reported patient combined skull orbital roof reconstruction singlepiece titanium plate cranioplasty author present new method combined complex cranioorbital reconstruction method yearold lady presented large rightsided frontal enplaque meningioma involving right orbit sphenoid wing complete resection would require reconstruction skull orbital roof surgical preplanning involved marking resection margin threedimensional printed acrylonitrilebutadienestyrene model margin used virtually resect tumor generate repaired surface titanium plate fabricated using hydrostatic pressing dprinted mold orbital roof portion reentrant surface handfinished lateral canthus temporalis muscle suspension hole prefabricated cranioplasty plate result patient underwent hemicraniectomy tumor resection guided custommade dprinted cutting guide surgical defect reconstructed prefabricated titanium plate achieving good functional cosmetic result conclusion singlepiece titanium plate cranioplasty effective novel reconstruction method complex cranioorbital defect,2018,"Luo, Joseph; Morrison, David Anthony; Hayes, Alex John; Bala, Arul; Watts, Guy",The Journal of craniofacial surgery,,,,,,https://doi.org/10.1097/scs.0000000000004311; https://www.ncbi.nlm.nih.gov/pubmed/29481497/,3598981.0,12
40549,40549,52790,u058gda9,,Medline,Total inverse transgastric resection with transoral specimen removal.,10.1007/s00464-014-4037-1,,25539694.0,unk,background laparoscopic local excision accepted gastrointestinal stromal tumor gist benign lesion stomach yet tumor gastroesophageal junction posterior wall distal antrum difficult approach tumor often must exposed via gastrotomy using rendezvous maneuver method total intragastric laparoscopic resection using pneumogastrum rigid laparoscope conventional laparoscopic instrument described intuitive video method two case total inverse transgastric resection involved resection submucosal gist one front wall cardia posterior wall antrum third case required excision large prepyloric cystic lesion leading gastric outlet stenosis insertion three trocars laparoscopic control trocar introduced stomach pneumogastrum established two additional mm trocars intragastrally placed intragastric endoscopy rigid optic provided excellent view tumor exposed resected linear stapler specimen inserted endo pouch™ sutured orally inserted gastric tube endo pouch™ gently pulled transorally removal intragastric trocars entrance point laparoscopically closed result first second case retrieved gist tumor third case retrieved gastritis cystica profunda postoperative course uneventful conclusion gastric gist resected laparoscopically negative margin safely achieved regardless size tumor frontwall exophytic backwall gist addressed laparoscopic wedge resection tumor gastrojejunal junction prepyloric region fundus well submucous gist gastric backwall best approached intragastric laparoscopic resection transoral specimen retrieval interesting option smaller tumor,2015,"Lamm, Sebastian H; Steinemann, Daniel C; Linke, Georg R; Eucker, Dietmar; Simon, Thomas; Zerz, Andreas; Stoll, Reinhard",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-4037-1; https://www.ncbi.nlm.nih.gov/pubmed/25539694/,13177115.0,12
40551,40551,52792,8szgiv4j,,Medline,A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.,10.1186/1471-2407-14-120,,24559118.0,unk,background ovarian cancer recognized number distinct disease primarily defined histological subtype clear cell ovarian carcinoma ccc ovarian endometrioid carcinoma ec may arise endometriosis frequently harbor mutation arida tumor suppressor gene studied influence histological subtype protein expression reverse phase protein array rppa assessed proteomic change associated arida mutationbafa expression ec ccc method immunohistochemistry ihc bafa expression performed chemotherapynaive ovarian carcinoma ccc ec highgrade serous ovarian carcinoma hgsc whole tumor lysates prepared frozen banked tumor sample profiled rppa using antibody arida mutation identified exome sequencing pikca mutation characterized malditof mass spectrometry sam significance analysis microarrays performed determine differential protein expression histological subtype arida mutation status multivariate logistic regression used ass impact arida mutation statusbafa expression akt phosphorylation pakt pikca mutation type pten expression included model bafa knockdown performed clear cell line using sirna arida result marked difference protein expression observed driven histotype compared hgsc sam identified protein differentially expressed ccc ec included pikakt pathway protein regulating cell cycle apoptosis transcription signaling pathway including steroid hormone signaling multivariate model showed tumor loss bafa expression showed significantly higher level aktthr aktser phosphorylation p ccc case pakt similarly significantly increased tumor bafa loss ihc knockdown bafa sirna three ccc cell line wild type arida showed increase either paktthr pakts suggesting pakt tumor tissue indirectly regulated bafa expression conclusion proteomic assessment ccc ec demonstrates remarkable difference protein expression dependent histotype thereby characterizing cancer akt phosphorylation associated aridabafa deficient tumor however ovarian cancer mechanism remains elucidated,2014,"Wiegand, Kimberly C; Hennessy, Bryan T; Leung, Samuel; Wang, Yemin; Ju, Zhenlin; McGahren, Mollianne; Kalloger, Steve E; Finlayson, Sarah; Stemke-Hale, Katherine; Lu, Yiling; Zhang, Fan; Anglesio, Michael S; Gilks, Blake; Mills, Gordon B; Huntsman, David G; Carey, Mark S",BMC cancer,,,,,,https://doi.org/10.1186/1471-2407-14-120; https://www.ncbi.nlm.nih.gov/pubmed/24559118/,11853611.0,12
40703,40703,52980,0wcn3sa8,,Medline,Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.,10.1002/1878-0261.12203,,29658179.0,unk,targeting different member akt pathway promising therapeutic chance solid tumor including breast cancer variable expression level akt isoforms opposite effect tumor growth metastasis however make difficult select inhibitor used specific breast tumor subtypes using vitro vivo model demonstrated vav ectopically expressed invasive breast tumor derived cell downmodulates akt acting expression andor activation level depending tumor subtype decreased pakt ser level common effect vav upmodulation suggesting breast tumorderived cell independently phenotype vav interferes signaling pathway ended specifically recruit akt ernegative cell line silencing vav induced expression activation akt retrospective analysis early invasive breast tumor allowed establish prognostic significance paktvav relationship particular low vav level negatively influence followup patient low pakt primary tumor subjected adjuvant chemotherapy use specific pan akt inhibitor may sufficient may even detrimental increasing level vav could new approach improve breast cancer outcome might particularly relevant tumor triplenegative phenotype targetbased therapy currently available,2018,"Grassilli, Silvia; Brugnoli, Federica; Lattanzio, Rossano; Marchisio, Marco; Perracchio, Letizia; Piantelli, Mauro; Bavelloni, Alberto; Capitani, Silvano; Bertagnolo, Valeria",Molecular oncology,,,,,,https://doi.org/10.1002/1878-0261.12203; https://www.ncbi.nlm.nih.gov/pubmed/29658179/,4887643.0,12
40734,40734,53014,m6kqxtyo,,Medline,Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation.,10.1007/s00345-012-0823-3,,22249341.0,unk,purpose identify preoperative factor associated surgical complication successful diagnostic renal biopsy laparoscopic percutaneous radiofrequency ablation rfa renal mass order help aid preoperative patient counseling renal rfa method reviewed institutional review board approved database november january containing tumor treated either laparoscopic lrfa percutaneous rfa ctrfa preoperative patient demographic tumor characteristic intraoperative surgical data collected along biopsy result clinicopathologic outcome result rfa performed renal tumor lrfa ctrfa nondiagnostic biopsy occurred tumor procedure performed complication occurred procedure multivariate analysis showed ctrfa v lrfa increase likelihood nondiagnostic biopsy ci p increased tumor size p synchronous ablation p increased risk major complication decreased surgeon experience p tumor close collecting system p increased risk complication conclusion preoperative recommendation made patient future suggest counseling patient undergoing rfa percutaneous approach increase risk nondiagnostic biopsy increased tumor size increase risk major complication tumor ablated increase risk major complication tumor close collecting system may increase risk complication,2013,"Castle, Scott M; Gorin, Michael A; Gorbatiy, Vladislav; Leveillee, Raymond J",World journal of urology,,,,,,https://doi.org/10.1007/s00345-012-0823-3; https://www.ncbi.nlm.nih.gov/pubmed/22249341/,25689502.0,12
40741,40741,53021,c0tq8e6s,,Medline,A back-to-back tumor composed of papillary renal cell carcinoma and oncocytoma treated by laparoscopic partial nephrectomy: a case report.,10.1186/s13256-018-1662-7,,29779490.0,unk,background renal oncocytoma common benign renal tumor papillary renal cell carcinoma second common histologic subtype renal cell carcinoma renal tumor containing different component papillary renal cell carcinoma oncocytoma extremely rare case presentation renal mass incidentally detected yearold korean woman computed tomographic scan showed mm multicystic mass calcification lower pole right kidney underwent laparoscopic partial nephrectomy without perioperative complication found papillary renal cell carcinoma oncocytoma tumor mass conclusion possibility mixed malignant tumor considered treating benign tumor oncocytoma,2018,"Kang, Su Hwan; Seo, Won Tae; Kang, Pil Moon; Rhew, Hyun Yul; Jeon, Yo Han; Cheon, Bong Kwon; Kim, Taek Sang",Journal of medical case reports,,,,,,https://doi.org/10.1186/s13256-018-1662-7; https://www.ncbi.nlm.nih.gov/pubmed/29779490/,29157034.0,12
40776,40776,53067,blk3wj1m,,Medline,A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases.,10.5152/dir.2018.17017,,29317376.0,unk,purpose aimed retrospectively compare local tumor control rate low frequency lf high frequency hf microwave ablation device treatment cm lung metastasis method total patient tumor treated lf system mhz patient tumor treated hf system mhz january march computed tomography ct scan performed prior hour ablation used measure size ablation zone calculate ablation margin subsequent ct used detect local tumor progression possible predictive factor local progression analyzed patient minimum followup month median month lf group month hf group result ablation margin p blood vessel proximity p colorectal origin p significantly associated local progression rate local progression rate lf ablation hf ablation month local progressionfree survival rate lf group hf group significant difference survival curve p conclusion hf ablation resulted larger ablation margin fewer local progression compared lf ablation,2018,"Vogl, Thomas J; Roman, Andrei; Nour-Eldin, Nour-Eldin A; Hohenforst-Schmidt, Wolfgang; Bednarova, Iliana; Kaltenbach, Benjamin",Diagnostic and interventional radiology,,,,,,https://doi.org/10.5152/dir.2018.17017; https://www.ncbi.nlm.nih.gov/pubmed/29317376/,25462555.0,12
40807,40807,53105,90wd9m0o,,Medline,Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.,10.1016/j.jvir.2012.11.021,,23352855.0,unk,purpose evaluate feasibility safety clinical outcome radiofrequency rf ablation treatment liver metastasis gastrointestinal stromal tumor gist material method seven consecutive patient gist liver metastasis received rf ablation computed tomographic ct fluoroscopic guidance liver metastasis solitary two patient multiple five patient mean maximum tumor diameter cm± range cm addition feasibility safety local tumor progression overall gistrelated survival associated rf ablation assessed result liver metastasis treated rf session contrastenhanced ct showed disappearance tumor enhancement rf procedurerelated complication occurred local tumor progression developed one tumor mean followup period months± range mo new liver metastasis untreated liver lung metastasis developed one patient one patient died subarachnoid hemorrhage month rf ablation gistrelated death occurred respective overall gistrelated survival rate confidence interval year conclusion rf ablation feasible safe useful therapeutic option treatment gist liver metastasis,2013,"Yamanaka, Takashi; Takaki, Haruyuki; Nakatsuka, Atsuhiro; Uraki, Junji; Fujimori, Masashi; Hasegawa, Takaaki; Sakuma, Hajime; Yamakado, Koichiro",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2012.11.021; https://www.ncbi.nlm.nih.gov/pubmed/23352855/,5938145.0,12
40868,40868,53173,q48fa7av,,Medline,The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.,10.2967/jnumed.111.101675,,22984220.0,unk,unlabelled patient suspected yet localized neuroendocrine tumor net early diagnosis reliable exclusion crucial optimal individual prognosis therapy despite recourse several imaging modality definite diagnosis net challenging therefore tested gadotatate petct tool improved diagnosis cohort patient suspected nonlocalized net method gadotatate petct recording obtained consecutive patient meeting least one following criterion clinical suspicion net n elevated blood level tumor marker n imagebased suspicion net n presence net validated histopathology n clinical followup ± wk n result patient net histologically verified frequently located small bowel pancreas lung stomach twelve patient tumor nonneuroendocrine origin patient benign tumor gadotatate petct identified net case excluded presence net nonnet patient indicating sensitivity specificity petct gave falsepositive result patient falsenegative another patient indicating positive negative predictive value respectively accuracy chromogranin level significantly higher petpositive patient v ngml p patient verified net v ngml p conclusion patient suspected net due clinical symptom elevated level tumor marker indeterminate tumor suggestive net gadotatate petct highly accurate thus supporting use clinical routine diagnostics,2012,"Haug, Alexander R; Cindea-Drimus, Ramona; Auernhammer, Christoph J; Reincke, Martin; Wängler, Björn; Uebleis, Christopher; Schmidt, Gerwin P; Göke, Burkhard; Bartenstein, Peter; Hacker, Marcus","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.111.101675; https://www.ncbi.nlm.nih.gov/pubmed/22984220/,729575.0,12
40881,40881,53189,v9a3ttvl,,Medline,Influence of blood vessel on the thermal lesion formation during radiofrequency ablation for liver tumors.,10.1118/1.4811135,,23822457.0,unk,purpose major obstacle radiofrequency ablation rfa heat treatment nonuniform heating thermal lesion heat sink caused large blood vessel treatment could lead high tumor recurrence patient objective study help comprehend rfa heat treatment thermal lesion formation using computer simulation thus provide helpful assistance planning rfa method rfa heat treatment popular minimally invasive treatment method primary metastatic liver tumor heat treatment studied numerical calculation finite difference model used solve partial differential equation simple threedimensional cubic geometry model maximum tissue temperature used critical index reaching thermal lesion rfa cylindrical rf cooltip electrode internally cooled constant water temperature rfa thermal lesion studied various impact single countercurrent blood vessel traversing thermal lesion several factor considered location diameter orientation blood vessel electrode result result show thermal lesion size decrease lesion blood perfusion rate increase single large blood vessel orthogonal rf electrode cause le undercooled volume thermal lesion one parallel rf electrode furthermore convective energy may easily damage parallel vessel surrounding normal tissue rfa small blood vessel larger vessel slow blood flow rate rfa could form taillike thermal lesion formation could damage vessel downstream spot conclusion study suggested incomplete rf tumor ablation still exists within cm distance large blood vessel rf electrode liver could significant impact local tumor recurrence rate second thermally significant vessel existed inevitably within lesion avoiding rf cooltip electrode placement next parallel large blood vessel would better heat treatment rf heating additionally reduced blood flow rate could help reduce significant cooling large blood vessel,2013,"Huang, Huang-Wen",Medical physics,,,,,,https://doi.org/10.1118/1.4811135; https://www.ncbi.nlm.nih.gov/pubmed/23822457/,206451728.0,12
40983,40983,53311,azesf3k2,,Medline,"Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.",10.1245/s10434-018-6633-0,,29978372.0,unk,background onestep nucleic acid amplification osna cytokeratin messenger rna intraoperative diagnostic procedure detection lymph node metastasis objective study aimed construct intraoperative nomogram using osna prediction nonsentinel lymph node nsln metastasis four axillary lymph node aln metastasis method breast cancer patient n underwent sentinel lymph node sln biopsy slns examined intraoperatively osna sln metastasis treated completion aln dissection calnd retrospectively analyzed randomly divided training n validation n set result clinicopathological parameter available preoperatively intraoperatively multivariate analysis training set revealed clinical tumor size total tumor load ttl determined osna significantly associated nsln metastasis clinical tumor size number macrometastatic slns ttl significantly associated four aln metastasis nomogram nsln metastasis four aln metastasis constructed using parameter area receiver operating characteristic curve auc validation set diagnostic accuracy similar previously reported postoperative nomogram conclusion constructed intraoperative nomogram using osna prediction nsln metastasis four aln metastasis nomogram accurate conventional postoperative nomogram might helpful decision making regarding indication calnd choice adjuvant chemotherapeutic regimen radiation field,2018,"Shimazu, Kenzo; Sato, Nobuaki; Ogiya, Akiko; Sota, Yoshiaki; Yotsumoto, Daisuke; Ishikawa, Takashi; Nakamura, Seigo; Kinoshita, Takayuki; Tsuda, Hitoshi; Ohi, Yasuyo; Akiyama, Futoshi; Noguchi, Shinzaburo",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-018-6633-0; https://www.ncbi.nlm.nih.gov/pubmed/29978372/,49573783.0,12
41017,41017,53357,z03x2j50,,Medline,Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes.,10.1016/j.juro.2012.09.075,,23009872.0,unk,purpose evaluated change renal function renal cryoablation partial nephrectomy based tumor complexity according renal nephrometry score material method retrospectively reviewed data patient renal tumor solitary kidney underwent renal cryoablation partial nephrectomy december january renal tumor complexity categorized group renal nephrometry score low intermediate high baseline demographic data perioperative parameter followup data including renal function collected comparison made among similar tumor complexity result renal cryoablation partial nephrectomy group patient tumor patient identified respectively renal tumor complexity renal cryoablation provided better perioperative outcome term median operative time estimated blood loss transfusion hospital stay complication median change serum creatinine estimated glomerular filtration rate slightly greater partial nephrectomy group however difference statistically significant tumor complexity three patient renal cryoablation group partial nephrectomy group required longterm dialysis conclusion patient solitary kidney renal cryoablation associated superior perioperative outcome compared partial nephrectomy specifically partial nephrectomy associated greater loss renal function renal cryoablation regardless extent tumor complexity,2013,"Panumatrassamee, Kamol; Kaouk, Jihad H; Autorino, Riccardo; Lenis, Andrew T; Laydner, Humberto; Isac, Wahib; Long, Jean-Alexandre; Eyraud, Remi; Kassab, Ahmad; Khalifeh, Ali; Hillyer, Shahab; Rizkala, Emad; Haber, Georges-Pascal; Stein, Robert J",The Journal of urology,,,,,,https://doi.org/10.1016/j.juro.2012.09.075; https://www.ncbi.nlm.nih.gov/pubmed/23009872/,36707494.0,12
41033,41033,53375,6u6anms2,,Medline,Laparoscopic endoscopic cooperative surgery (LECS) for the upper gastrointestinal tract.,10.21037/tgh.2017.03.20,,28616596.0,unk,developed laparoscopic endoscopic cooperative surgery lecs technique combine endoscopic submucosal dissection esd laparoscopic gastric resection resect gastric submucosal tumor smts many researcher reported lecs feasible technique gastric submucosal tumor resection regardless tumor location including esophagogastric junction egj recently japanese national health insurance system approved lecs insurance coverage widely applied gastric submucosal tumor resection initially applied lecs gastric smts without ulcerative lesion due concern possibility tumor cell seeding peritoneal cavity procedure termed classical lecs expand indication lecs gastric epithelial neoplasm modified lecs procedure inverted lecs nonexposed endoscopic wallinversion surgery news combination laparoscopic endoscopic approach neoplasia nonexposure technique cleannet closed laparoscopic endoscopic cooperative surgery closedlecs developed applied patient gastric epithelial neoplasm future perspective lecs plan combine modified lecs procedure sentinel node sn navigation surgery snns clinical cstage ia gastric cancer resection strategy could minimally invasive surgical technique cstage ia early gastric cancer,2017,"Matsuda, Tatsuo; Nunobe, Souya; Ohashi, Manabu; Hiki, Naoki",Translational gastroenterology and hepatology,,,,,,https://doi.org/10.21037/tgh.2017.03.20; https://www.ncbi.nlm.nih.gov/pubmed/28616596/,38964238.0,12
41039,41039,53382,zupf8yzy,,Medline,Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.,10.2967/jnumed.113.122499,,24337606.0,unk,unlabelled targeting cancer cell vitamin b cobalamin hampered unwanted physiologic tissue uptake mediated transcobalamin adhering good manufacturing practice developed new mtccobalamin derivative mtccoamidobutylpyridinylmethylaminoacetato cobalamin mtcpamacobalamin derivative show binding transcobalamin recognized haptocorrin protein present circulation notably expressed many tumor cell prospective study investigated cancerspecific uptake mtcpamacobalamin patient various metastatic tumor method ten patient biopsyproven metastatic cancer included dynamic imaging started immediately injection mbq mtcpamacobalamin wholebody scintigrams obtained min h relative tumor activity using spectct tumor region h measured comparison diseasefree lung parenchyma patient received μg cobalamin intravenously injection mtcpamacobalamin study population comprised patient adenocarcinoma lung squamous cell carcinoma hypopharyngeal region prostate adenocarcinoma breast colon adenocarcinoma result median age study group ± six patient showed positive tumor uptake mtcpamacobalamin wholebody scintigraphy scan positive patient colon adenocarcinoma lung adenocarcinoma hypopharyngeal squamous cell carcinoma breast adenocarcinoma renal uptake left kidney predosing cobalamin increased tumor uptake improved bloodpool clearance best image quality achieved predose ug cold cobalamin mean patient dose ± msvpatient conclusion knowledge report first time mtcpamacobalamin imaging patient metastatic cancer disease show tumor targeting feasible,2014,"Sah, Bert-Ram; Schibli, Roger; Waibel, Robert; von Boehmer, Lotta; Bläuenstein, Peter; Nexo, Ebba; Johayem, Anass; Fischer, Eliane; Müller, Ennio; Soyka, Jan D; Knuth, Alexander K; Haerle, Stefan K; Schubiger, Pius August; Schaefer, Niklaus G; Burger, Irene A","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.113.122499; https://www.ncbi.nlm.nih.gov/pubmed/24337606/,22213489.0,12
41041,41041,53384,15rounhl,,Medline,Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.,10.18632/oncotarget.10026,,27329596.0,unk,objective study aimed investigate effect oral antiviral treatment prognosis hepatitis b virus hbvrelated hepatocellular carcinoma hcc radiofrequency rf ablation method january december patient without history antiviral treatment treated rf ablation single hbvrelated hcc divided patient two group patient received n receive antiviral treatment n based whether oral antiviral treatment administered rf ablation median duration antiviral treatment month hcc recurrence overall survival compared two group full cohort propensity scorematched cohort result matched cohort probability hcc recurrence year nonantiviral treatment group antiviral treatment group p probability overall survival year nonantiviral treatment group antiviral treatment group p multivariable analysis showed risk factor hcc recurrence included large tumor size hazard ratio hr p hbv dna serum level hr p serum afp level ≥ ngml hr p overall survival associated larger tumor size hr p childpugh class b hr p oral antiviral treatment rf ablation significantly associated lower risk tumor recurrence death hr p hr p conclusion use oral antiviral treatment curative rf ablation associated favorable outcome term tumor recurrence overall survival patient hbvrelated hcc,2016,"Sohn, Won; Kang, Tae Wook; Choi, Sun-Kyu; Jung, Sin-Ho; Lee, Min Woo; Lim, Hyo Keun; Cho, Ju-Yeon; Shim, Sang Goon; Sinn, Dong Hyun; Gwak, Geum-Youn; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Rhim, Hyunchul; Paik, Yong-Han",Oncotarget,,,,,,https://doi.org/10.18632/oncotarget.10026; https://www.ncbi.nlm.nih.gov/pubmed/27329596/,3682918.0,12
41082,41082,53438,m8l9y6ci,,Medline,Thermoablation of Bone Tumors.,10.1055/s-0042-100477,,26981915.0,unk,unlabelled aim article review significance percutaneous thermal ablation treatment bone tumor describe available ablation technique well advantage disadvantage specific setting detail radiofrequency ablation rfa microwave ablation mwa laser ablation high intensity focused ultrasound hifu cryoablation presented second part review curative palliative indication treatment benign malignant bone tumor discussed includes especially rfa laser cryoablation treatment osteoid osteoma well palliative treatment painful bone metastasis example mean mwa mrguided hifu key point • various thermoablative technique demonstrate specific advantage disadvantages• radiofrequency ablation evidencebased method choice treating osteoid osteoma• laser ablation primarily suited treatment small lesion hand feet• intrinsically analgesic effect cryoablation advantageous treating painful lesions• palliative treatment painful bone metastasis example performed using mwa mrguided hifu combined cementoplasty citation format • ringe ki panzica von falck c thermoablation bone tumor fortschr röntgenstr,2016,"Ringe, K I; Panzica, M; von Falck, C",RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,,,,,,https://doi.org/10.1055/s-0042-100477; https://www.ncbi.nlm.nih.gov/pubmed/26981915/,42266636.0,12
41145,41145,53506,jfitz4rl,,Medline,Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?,10.1371/journal.pone.0077076,,24116203.0,unk,although efficient delivery distribution treatment agent whole tumor essential successful tumor treatment distribution agent visualized however singlephoton emission computed tomography spect delivery uptake radiolabeled peptide visualized neuroendocrine tumor model overexpressing somatostatin receptor heterogeneous peptide uptake often observed tumor hypothesized peptide distribution tumor spatially related tumor perfusion vessel density permeability imaged quantified dcemri neuroendocrine tumor model four subcutaneous ca tumorbearing lewis rat injected somatostatinanalog indtpaoctreotide mbq spectct mri scan acquired mri spatially registered spectct dcemri analyzed using semiquantitative quantitative method correlation spect dcemri investigated spearmans rank correlation coefficient spect uptake value grouped decile corresponding median dcemri parametric value vice versa linear regression analysis median parameter value combined datasets tumor area low peptide uptake correlated low perfusiondensity permeability dcemriderived parameter combining datasets highest linear regression found peptide uptake semiquantitative parameter r average correlation coefficient spect dcemriderived parameter ranged p parameter primarily associated exchange blood extracellular extravascular space parameter linear relation peptide uptake observed conclusion exchangerelated dcemriderived parameter seemed predict peptide uptake better contrast amount related parameter consequently fast efficient diffusion vessel wall tissue important factor peptide delivery dcemri help elucidate relation vascular characteristic peptide delivery treatment efficacy may form basis predict targeting efficiency,2013,"Bol, Karin; Haeck, Joost C; Groen, Harald C; Niessen, Wiro J; Bernsen, Monique R; de Jong, Marion; Veenland, Jifke F",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0077076; https://www.ncbi.nlm.nih.gov/pubmed/24116203/,14353670.0,12
41167,41167,53529,o9081t9r,,Medline,Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer.,10.1007/s10151-012-0882-x,,22936590.0,unk,objective report first experience transanal total mesorectal excision tme rectal cancer using singleport equipment pure natural orifice transluminal endoscopic surgery note procedure discus advantage disadvantage technique patient rectal cancer selected according preoperative evaluation criterion pursestring suture placed rectum distal tumor using procedure prolapse hemorrhoid pph anoscope fullthickness incision rectal wall made circumferentially purse string threechannel cannula inserted artificial orifice insufflated entire mesorectum dissected upward according principle tme pneumoperitoneum created opening rectouterine pouch sigmoid colon mesentery dissected inferior mesenteric vessel ligated divided dissection sufficient length sigmoid colon pph anoscope threechannel cannula removed rectum sigmoid colon brought anus tumor resected removal specimen stapled endtoend anastomosis fashioned rectum sigmoid colon operative time min mesorectum completely removed negative distal circumferential margin final pathological stage ptnm one positive lymph node patient recovered uneventfully surgery purenotes performed transanal singleport laparoscopic tme rectal cancer appears feasible safe,2013,"Zhang, H; Zhang, Y-S; Jin, X-W; Li, M-Z; Fan, J-S; Yang, Z-H",Techniques in coloproctology,,,,,,https://doi.org/10.1007/s10151-012-0882-x; https://www.ncbi.nlm.nih.gov/pubmed/22936590/,207058338.0,12
41247,41247,53617,jgpuvs69,,Medline,"Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.",10.1159/000507118,,32408300.0,unk,background identification highrisk stage ii colorectal cancer crc patient potential candidate adjuvant chemotherapy challenging current clinical guideline rely mainly histopathological marker relatively weak prognostic value motivates search prognostic marker method explorative study aimed identify potential candidate gene mutation facilitate differentiation subgroup patient crc stage ii panelbased massive parallel sequencing used genetically characterize tumor tissue patient radically operated crc stage ii developed recurrent cancer followup genetic data compared patient without cancer recurrence tumor located colon rectum association tumor differentiation grade result genetic variation atm corf associated recurrencefree survival previous report regarding association braf mutation higher age diagnosis tumor location colon confirmed apc braf kras mutation associated tumor differentiation grade multiple correspondence analysis revealed obvious clustering patient studied clinical characteristic indicating genetic signature observed unique individual conclusion taken together demonstrated utility panelbased massive parallel sequencing explore pathogenesis crc stage ii identified promising candidate gene mutation associated cancer recurrence tumor location differentiation grade patient crc stage ii merit investigation,2020-05-14,"Dimberg, Jan; Andersson, Roland E; Haglund, Sofie",Oncology,,,,,,https://doi.org/10.1159/000507118; https://www.ncbi.nlm.nih.gov/pubmed/32408300/,218648694.0,12
41278,41278,53657,pshirnuz,,Medline,Intraoperative Tumor Perforation is Associated with Decreased 5-Year Survival in Colon Cancer: A Nationwide Database Study.,10.1177/1457496916683091,,28737074.0,unk,background widely held belief intraoperative tumor perforation colon cancer impairs survival cause local recurrence although prognostic importance remains unclear aim aim study ass effect unintended intraoperative tumor perforation postoperative mortality longterm survival material method national cohort study based data prospectively maintained nationwide colorectal cancer database included colon cancer patient resected curative intent result intraoperative tumor perforation produced significantly impaired year survival compared nonperforated colon cancer intraoperative tumor perforation independent risk factor death hazard ratio confidence interval significantly increased day postoperative mortality compared nonperforated tumor p showed tumor fixation emergency operation laparotomy associated increased risk intraoperative tumor perforation conclusion nationwide study demonstrates intraoperative tumor perforation colon cancer associated statistically significant reduced longterm survival increased postoperative mortality,2017,"Bundgaard, N S; Bendtsen, V O; Ingeholm, P; Seidelin, U H; Jensen, K H",Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society,,,,,,https://doi.org/10.1177/1457496916683091; https://www.ncbi.nlm.nih.gov/pubmed/28737074/,1875223.0,12
41379,41379,53774,342ox89a,,Medline,CT-Guided Microwave Ablation of Liver Tumors in Anatomically Challenging Locations.,10.1007/s00270-018-2007-z,,29948004.0,unk,purpose ass feasibility outcome microwave ablation mwa hepatic tumor anatomically challenging location material method total patient hepatic tumor referred ctguided mwa included retrospective institutional review boardapproved study one hundred twentyfive tumor median size mm range mm subcapsular location n andor transpleural approach applied n identified group compared tumor central intrahepatic location group n median size mm range mm technical success complication local tumor progression ltp evaluated risk factor analyzed using univariate analysis logistic regression kaplanmeier curve p deemed significant result technical success group group complication occurred n tumor pneumothorax n hematoma n complication occurred significantly le often group n hematoma p major complication transpleural approach number capsule puncture identified risk factor complication p median followup day ltp comparable group v p use hydrodissection independent factor associated ltp p hr conclusion ctguided hepatic mwa subcapsular tumor subdiaphragmatic tumor requiring direct transpleural approach feasible increased minor major complication ltp differ significantly group,2018,"Vo Chieu, Van Dai; Werncke, Thomas; Hensen, Bennet; Wacker, Frank; Ringe, Kristina I",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-018-2007-z; https://www.ncbi.nlm.nih.gov/pubmed/29948004/,47018285.0,12
41411,41411,53812,oswwjsv3,,Medline,[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.,10.1089/cbr.2013.1552,,24820805.0,unk,aim aim improve peptide receptor radionuclide therapy effect patient gastroenteropancreatic neuroendocrine tumor gepnet liver metastasis explored effect intraarterial ia administration indtpaoctreotide indtpaoc tumor uptake animal model patient study method preclinical study administering indtpaoc intravenously iv ia biodistribution study performed rat hepatic somatostatin receptor subtype sstpositive tumor clinical study patient neuroendocrine liver metastasis injected twice indtpaoc first injection given iv week later second injected ia hepatic artery planar image abdomen made hour injection blood sample taken urine collected pharmacokinetic modeling performed iv ia data patient based model additional lu dosimetry calculation iv ia administration performed result preclinical study showed twofold higher indtpaoc tumor uptake ia administration iv injection patient data showed large variability radioactivity increment liver metastasis ia administration compared iv administration renal radioactivity significantly lower ia administration lu dosimetry simulation patient using maximum kidney radiation dose gy showed ia administration resulted mean increase tumor radiation dose fold conclusion preclinical clinical data indicate ia administration radiolabeled somatostatin analog via hepatic artery significantly increase radionuclide uptake gepnet sstpositive liver metastasis hour postinjection although effect ia administration differ patient,2014,"Pool, Stefan E; Kam, Boen L R; Koning, Gerben A; Konijnenberg, Mark; Ten Hagen, Timo L M; Breeman, Woulter A P; Krenning, Eric P; de Jong, Marion; van Eijck, Casper H J",Cancer biotherapy & radiopharmaceuticals,,,,,,https://doi.org/10.1089/cbr.2013.1552; https://www.ncbi.nlm.nih.gov/pubmed/24820805/,22678598.0,12
41650,41650,54093,4qut6lq9,,Medline,Infarct volume after glioblastoma surgery as an independent prognostic factor.,10.18632/oncotarget.11482,,27566556.0,unk,postoperative ischemia associated reduced functional independence measured karnofsky performance score kp correlate well overall survival study suggest postoperative hypoxia might initiate infiltrative tumor growth therefore aim study analyze impact infarct volume overall survival progression free survival pfs glioblastoma patient patient surgery newly diagnosed glioblastoma iv retrospectively assessed pre postoperative kp date deathlast followup histopathological marker recorded pre postoperative tumor volume volume postoperative infarction manually segmenteda significant correlation infarct volume postoperative kp decrease p observed infarct volume showed significant impact overall survival p pfs p univariate analysis effect increased subgroup patient neartotal tumor resection overall survival p pfs p infarct volume remained independent prognostic factor overall survival multivariate analysis hr p including prognostic factor age extent resection postoperative kpspostoperative infarct volume significantly correlate independent factor overall survival glioblastoma surgery besides influence perioperative infarction postoperative kp postoperative hypoxia might also effect tumor biology initiating infiltrative growth therefore impaired survival,2016,"Bette, Stefanie; Wiestler, Benedikt; Kaesmacher, Johannes; Huber, Thomas; Gerhardt, Julia; Barz, Melanie; Delbridge, Claire; Ryang, Yu-Mi; Ringel, Florian; Zimmer, Claus; Meyer, Bernhard; Boeckh-Behrens, Tobias; Kirschke, Jan S; Gempt, Jens",Oncotarget,,,,,,https://doi.org/10.18632/oncotarget.11482; https://www.ncbi.nlm.nih.gov/pubmed/27566556/,4643738.0,12
41652,41652,54096,2hg6totr,,Medline,Robot-assisted whipple's operation for solid pseudopapillary tumour of pancreas.,10.1007/s11701-012-0362-3,,27000900.0,unk,solid pseudopapillary tumor rare tumor pancreas slow growing low malignant potential prognosis excellent surgical resection report case solid pseudopapillary tumor pancreas uncinate process increasing interest minimal access surgery pancreatic lesion however conventional laparoscopic whipples operation technically difficult benign characteristic tumor well advance robotic surgery robot assisted approach ideal alternative case operation performed fiveport approach use da vinci surgical system intuitive surgical inc sunnyvale ca usa operative time min operative blood loss ml post operative course uneventful patient discharged post operative day case demonstrates feasibility robot assisted whipples operation extensively reported literature,2013,"Ng, Cathy P C; Yang, George P C; Tang, Chung Ngai",Journal of robotic surgery,,,,,,https://doi.org/10.1007/s11701-012-0362-3; https://www.ncbi.nlm.nih.gov/pubmed/27000900/,25352576.0,12
41762,41762,54224,df2l6htc,,Medline,Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer.,10.1016/j.radonc.2015.10.005,,26475250.0,unk,purpose aim study quantify interfractional esophageal tumor position variation using marker investigate use marker setup verification material method sixtyfive marker placed tumor volume esophageal cancer patient identified computed tomography ct followup conebeam ct patient calculated pairwise distance marker time evaluate geometric tumor volume variation quantified marker displacement relative bony anatomy estimated variation systematic σ random error σ bony anatomybased setup verification visually inspected whether marker inside planning target volume ptv attempted markerbased registration result minor time trend substantial fluctuation pairwise distance implied tissue deformation overall σσ leftrightcranialcaudalanteriorposterior direction mm proximal stomach mm bony anatomybased setup correction marker inside ptv however due large tissue deformation markerbased registration feasible conclusion generally interfractional position variation esophageal tumor pronounced cranialcaudal direction proximal stomach currently markerbased setup verification feasible clinical routine use marker facilitate setup verification inspecting whether ptv cover tumor volume adequately,2015,"Jin, Peng; van der Horst, Astrid; de Jong, Rianne; van Hooft, Jeanin E; Kamphuis, Martijn; van Wieringen, Niek; Machiels, Melanie; Bel, Arjan; Hulshof, Maarten C C M; Alderliesten, Tanja",Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,,,,,,https://doi.org/10.1016/j.radonc.2015.10.005; https://www.ncbi.nlm.nih.gov/pubmed/26475250/,12089358.0,12
41779,41779,54245,zlgg90uq,,Medline,Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.,10.1158/1535-7163.mct-09-0862,,20354120.0,unk,ffluorodeoxyglucose ffdg common molecular imaging agent oncology high sensitivity specificity detecting several cancer antibody could enhance specificity therefore procedure developed radiolabeling small approximately da hapten peptide ga f compare specificity ffdg detecting tumor using pretargeting procedure mouse implanted carcinoembryonic antigen cea ceacamexpressing lst human colonic tumor ceanegative tumor inflammation induced thigh muscle bispecific monoclonal anticea x antihapten antibody given mouse hour later mbq ga flabeled hapten peptide administered intravenously within hour tissue showed high specific targeting gaimp idg uptake tumor low uptake normal tissue eg tumortoblood ratio ceanegative tumor idg inflamed muscle idg ffdg localized efficiently tumor idg also inflamed muscle idg several normal tissue thus pretargeted gaimp provided better specificity sensitivity positron emission tomography petcomputed tomography image reinforced improved specificity pretargeting method flabeled imp distributed similarly tumor normal tissue galabeled imp indicating either radiolabeled hapten peptide could used thus pretargeted immunopet exceptionally well shortlived radionuclides highly sensitive procedure specific ffdgpet mol cancer ther c aacr,2010,"Schoffelen, Rafke; Sharkey, Robert M; Goldenberg, David M; Franssen, Gerben; McBride, William J; Rossi, Edmund A; Chang, Chien-Hsing; Laverman, Peter; Disselhorst, Jonathan A; Eek, Annemarie; van der Graaf, Winette T A; Oyen, Wim J G; Boerman, Otto C",Molecular cancer therapeutics,,,,,,https://doi.org/10.1158/1535-7163.mct-09-0862; https://www.ncbi.nlm.nih.gov/pubmed/20354120/,13226820.0,12
41792,41792,54260,ozc19ojz,,Medline,Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer.,10.18632/oncotarget.26769,,31007844.0,unk,background treatment patient multiple synchronous tumor challenging complex use next generation sequencing ng may help identification germline mutation gene involved common etiology tumor thus allowing common effective therapeutic strategy patient method describe unexpected positive result obtained young woman relapsed chemoresistant stage ivb cervical synchronous stage iv lung cancer underwent interdisciplinary approach including palliative surgery laparoscopic total pelvic exenteratio followed chemoimmunotherapy protocol antiprogrammed death pd antibody nivolumab plus metronomic cyclophosphamide treatment choice based tumor pdligand assessment ng analysis identification potential treatment target outcome included tumor objective response patientcentered outcome pain performance status overall quality life result laparoscopic surgery obtained immediate symptom control allowed early start medical treatment one month combined therapy start patient achieved significant improvement performance status pain overall quality life month resumed working month treatment observed objective dimensional metabolic response currently month cycle nivolumab patient continuing benefit treatment complete remission good performance status working leading selfdependent life conclusion study strongly affirms efficacy interdisciplinary approach including surgical innovative medical strategy based immunotherapy patient advanced chemoresistant synchronous cervical lung cancer present finding support use ng drive targeted rational treatment especially heavily pretreated patient,2019,"Madeddu, Clelia; Kotsonis, Paraskevas; Lavra, Fabrizio; Chiappe, Giacomo; Melis, Luca; Mura, Ester; Scartozzi, Mario; Macciò, Antonio",Oncotarget,,,,,,https://doi.org/10.18632/oncotarget.26769; https://www.ncbi.nlm.nih.gov/pubmed/31007844/,121637796.0,12
41813,41813,54284,2boecer9,,Medline,Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.,10.1159/000367999,,25376283.0,unk,objective purpose study evaluate risk factor local recurrence radiofrequency ablation rfa hepatocellular carcinoma hcc measuring ≤ cm method study involved patient hccs measuring ≤ cm undergone rfa initial treatment mean tumor diameter cm median followup period day evaluated postrfa cumulative local recurrence rate analyzed risk factor contributing clinical outcome result cumulative local recurrence rate year respectively among case complete safety margin sm rfa developed local tumor recurrence cumulative rate local tumor recurrence year respectively among case incomplete sm local tumor recurrence developed cumulative rate local tumor progression year respectively multivariate analysis significant risk factor tumor location liver surface irregular gross type sm mm conclusion even hcc measuring ≤ cm location gross type tumor carefully evaluated rfa performed,2014,"Kono, Masashi; Inoue, Tatsuo; Kudo, Masatoshi; Chishina, Hirokazu; Arizumi, Tadaaki; Takita, Masahiro; Kitai, Satoshi; Yada, Norihisa; Hagiwara, Satoru; Minami, Yasunori; Ueshima, Kazuomi; Nishida, Naoshi; Murakami, Takamichi",Digestive diseases,,,,,,https://doi.org/10.1159/000367999; https://www.ncbi.nlm.nih.gov/pubmed/25376283/,37380768.0,12
41817,41817,54288,85kyyhjr,,Medline,Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.,10.1245/s10434-013-3031-5,,23720072.0,unk,background although many previous study local ablation outcome hepatocellular carcinoma hcc dichotomized tumor size cm cutoff determine prognostic significance growing number report describe excellent outcome larger tumor address logic cm cutoff beyond small singlecenter experience stratified patient cm tumor size interval hypothesized diseasespecific survival ds would vary significantly adjacent group method patient treated local ablation hcc ≤ cm identified surveillance epidemiology end result database logrank test multivariable cox proportional hazard model used compare ds curve adjacent study group result patient included study female median age year year ds significantly lower patient cm tumor compared cm tumor v p adjusted model ds vary significantly size interval cm patient cm tumor however poorer prognosis compared patient cm tumor hazard ratio confidence interval p ds also fell tumor size increased cm v conclusion study emphasizes cm size possibly cm size informative predictive threshold ablating hcc variability ds occurred specifically tumor size future research field either adopt cm breakpoint provide evidence alternative threshold,2013,"Groeschl, Ryan T; Gamblin, T Clark; Turaga, Kiran K",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-013-3031-5; https://www.ncbi.nlm.nih.gov/pubmed/23720072/,8839380.0,12
41935,41935,54421,qcfsqr43,,Medline,Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.,10.2214/ajr.17.18290,,28678572.0,unk,objective objective study ass technical success safety oncologic renal function outcome ctguided percutaneous thermal ablation synchronous multiple renal mass single session material method retrospective analysis patient men woman median age year biopsyproven multifocal renal cell carcinoma rcc mass treated radiofrequency ablation rfa cryoablation microwave ablation mwa performed preablation postablation followup serum blood urea nitrogen creatinine estimated glomerular filtration rate gfr level recorded evaluate stability renal function technical success complication treatment response oncologic outcome overall survival assessed result biopsyproven rccs treated patient median tumor size cm range cm mean renal radius exophytic v endophytic property nearness tumor collecting system sinus anterior v posterior location relative polar line nephrometry score range mean padua preoperative aspect dimension used anatomical score range mean centrality index cindex range mean ablation time minute range minute technical success achieved tumor complication nine classified claviendindo grade complication complete response achieved tumor local progressionfree rccspecific diseasefree overall survival rate imaging followup time mean year range year respectively conclusion ctguided percutaneous thermal ablation safe effective durable treatment intervention multifocal renal mass,2017,"Zhou, Wenhui; Uppot, Raul N; Feldman, Adam S; Arellano, Ronald S",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.17.18290; https://www.ncbi.nlm.nih.gov/pubmed/28678572/,22597399.0,12
42015,42015,54516,oxvcvo7c,,Medline,Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8+ T cells and inhibiting tumor AKT/MAPK pathway.,10.1002/cpt.1894,,32418204.0,unk,propranolol suppresses tumor growth variety preclinical solid tumor model number proposed cell signaling immunological mechanism want confirm potential mechanism including reduced phosphorylation aktmapk pathway well enhanced cd tcellmediated antitumor immune response clarify mechanism propranolol activity colorectal cancer therapeutic activity propranolol assessed ctwt tumor engrafted balbc mouse effect propranolol treatment also examined randomizing patient undergoing surgical resection previously untreated colorectal cancer propranolol placebo group treated week prior surgery ctwt tumor size smaller propranolol vehicle control propranolol downregulated expression paktperkpmek tumor tissue frequency tumor cd cell significantly elevated propranololtreated mouse expression gzmbifnγtbet cd tcell population significantly increased propranolol treated mouse tumor tissue propranololtreated surgical specimen expression perk decreased frequency cd significantly elevated expression gzmb cd tcell population significantly increased propranololtreated subject together data show propranolol simultaneously activating autologous cd cell decreasing expression paktperkpmek mouse tumor model inhibiting expression perk clinical colorectal cancer effort needed dissect whether pathway required antitumor effect activity old drug moved forward,2020-05-17,"Liao, Ping; Song, Kun; Zhu, Zhanwei; Liu, Zhaoqian; Zhang, Wei; Li, Wei; Hu, Jiali; Hu, Qian; Chen, Cuiyu; Chen, Bohua; McLeod, Howard L; Pei, Haiping; Chen, Ling; He, Yijing",Clinical pharmacology and therapeutics,,,,,,https://doi.org/10.1002/cpt.1894; https://www.ncbi.nlm.nih.gov/pubmed/32418204/,218679002.0,12
42076,42076,54580,hqdicepq,,Medline,Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.,10.1021/bc300659k,,23763444.0,unk,gastrinreleasing peptide receptor grprbb molecular target visualization prostate cancer work focused development highaffinity hydrophilic antagonistic bombesinbased imaging agent pet spect bombesin antagonist analog dpheglntrpalavalglyhisstaleunh dphestaleubombesin synthesized conjugated triazacyclononanennn″triacetic acid nota via diethylene glycol peg linker resulting conjugate notapegdphestaleubombesin notaprm labeled ga min positron emitter day gamma emitter labeling stability specificity inhibition efficiency ic dissociation constant kd labeled compound well cellular retention internalization investigated pharmacokinetics dual isotope ingalabeled peptide normal nmri mouse pc tumorbearing balbc nunu mouse also studied notaprm labeled ga radiochemical yield conjugate shown high specificity binding affinity grpr kd value determined ± pm inlabeled compound saturation binding experiment addition natin natganotaprm showed low nanomolar binding inhibition concentration ic ± nm ± nm respectively competitive binding assay internalization rate radiolabeled conjugate slow radiometallabeled tracer demonstrated rapid blood clearance via kidney grprspecific uptake pancreas normal mouse tumor targeting biodistribution study mouse bearing pc xenograft displayed high specific uptake tumor ± idg ga ± idg high tumortobackground ratio tumorblood ± ga ± h pi pmol peptide xenograft visualized gamma micropet camera shortly injection conclusion antagonistic bombesin analog notapegdpheglntrpalavalglyhisstaleunh notaprm promisindg candidate prostate cancer imaging using pet spectct,2013,"Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar; Sörensen, Jens; Larhed, Mats; Sandström, Mattias; Selvaraju, Ram Kumar; Malmberg, Jennie; Tolmachev, Vladimir; Orlova, Anna",Bioconjugate chemistry,,,,,,https://doi.org/10.1021/bc300659k; https://www.ncbi.nlm.nih.gov/pubmed/23763444/,25441056.0,12
42088,42088,54600,uskdwmjh,,Medline,Laparoscopic resection of a lymphangiomatous cyst of the colon: a case report.,10.1186/1752-1947-5-431,,21892928.0,unk,introduction lymphangiomatous cyst submucosal mass rarely found gastrointestinal tract often neck oral cavity skin cyst benign tumor mostly clinically silent symptom include abdominal pain diarrhea rectal bleeding pathogenesis remains unclear case presentation routine ultrasound examination caucasian yearold woman structure raised suspicion ovarian cyst found mri showed cm cystic lesion cecal region laparoscopic exploration revealed unexpected contact ascending colon cyst including base portion colon resected laparoscopically histological examination revealed cystic lymphangioma conclusion lymphangiomatous cyst colon rare lesion although pathology benign recommended treatment resection performed minimal invasiveness,2011,"Hoffmann, Jonas; Kirschniak, Andreas; Scharf, Gregor; von Feilitzsch, Maximilian; Königsrainer, Alfred; Zdichavsky, Marty",Journal of medical case reports,,,,,,https://doi.org/10.1186/1752-1947-5-431; https://www.ncbi.nlm.nih.gov/pubmed/21892928/,12784443.0,12
42106,42106,54619,mz54p7sp,,Medline,Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.,10.1016/j.jvir.2017.10.026,,29395898.0,unk,purpose test hypothesis given current resection eligibility criterion colorectal liver metastasis clm prior hepatectomy would associated improved local tumor control survival percutaneous ablation clms material method singleinstitution retrospective study included consecutive patient clms treated ablation radiofrequency ablation microwave ablation cryoablation january december local tumor progressionfree survival ltpfs recurrencefree survival rf organ overall survival o calculated using kaplanmeier method time ablation compared patient n without n prior hepatectomy cox regression model used identify ltpfs predictor result median overall followup period month range month threeyear actuarial ltpfs patient level v p significantly higher patient without prior hepatectomy respectively similarly year rf v p o v p improved patient prior hepatectomy multivariate analysis predictor worse ltpfs prior hepatectomy hazard ratio hr confidence interval ci p minimal ablation margin mm hr ci p rasmutant tumor hr ci p conclusion prior hepatectomy clms associated improved local tumor control percutaneous ablation postresectiondeveloped clms,2018,"Odisio, Bruno C; Yamashita, Suguru; Huang, Steven Y; Kopetz, Scott E; Ahrar, Kamran; Mizuno, Takashi; Conrad, Claudius; Aloia, Thomas A; Chun, Yun Shin; Gupta, Sanjay; Vauthey, Jean-Nicolas",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2017.10.026; https://www.ncbi.nlm.nih.gov/pubmed/29395898/,3395079.0,12
42126,42126,54642,3wdb4gfe,,Medline,Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma.,10.5152/tjg.2017.16641,,28294951.0,unk,backgroundaims study purpose compare efficacy coenhanced ultrasonography u sonazoidenhanced u conventional u detecting local tumor residue percutaneous radiofrequency rf ablation therapy hepatocellular carcinoma material method february march lesion hepatocellular carcinoma patient treated percutaneous rf ablation tumor residue detected patient contrastenhanced computed tomography patient examined conventional u sonazoidenhanced u mlbody sonazoid intravenous administration coenhanced u ml co hepatic arterial administration result tumor residue confirmed coenhanced u patient sensitivity patient sonazoidenhanced u sensitivity lesion detected modality located deeper sonographic depth p patient conventional u sensitivity lesion detected modality smaller term sonographic tumor size p conclusion although coenhanced u requires angiography superior sonazoidenhanced u conventional u detecting tumor residue particularly deepseated one percutaneous rf ablation,2017,"Hamanaka, Jun; Goto, Tohru; Nishigori, Shuhei; Seki, Shihoko; Ida, Tomonori; Morohashi, Taiki; Ohara, Hiroshi; Inamori, Masahiko; Maeda, Shin",The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,,,,,,https://doi.org/10.5152/tjg.2017.16641; https://www.ncbi.nlm.nih.gov/pubmed/28294951/,4028046.0,12
42265,42265,54813,jqn9irbo,,Medline,Percutaneous Microwave Ablation of Renal Angiomyolipomas.,10.1007/s00270-015-1201-5,,26390876.0,unk,purpose evaluate safety efficacy usguided percutaneous microwave mw ablation treatment renal angiomyolipoma aml material method january april seven patient female male mean age renal amls sporadic type tuberous sclerosis associated mean size ± cm range cm treated highpowered gascooled percutaneous mw ablation u guidance tumoral diameter volume ctmr enhancement measured pretreatment immediate postablation delayed postablation imaging clinical symptom creatinine assessed followup visit result ablation technically successful major complication encountered mean ablation parameter ablation power w range w using ml hydrodissection fluid per patient min range min immediate postablation imaging demonstrated mean tumor diameter volume decrease cm cm respectively delayed imaging followup obtained mean interval month median range demonstrated mean tumor diameter volume decrease cm cm respectively tumoral enhancement decreased immediate postprocedure delayed imaging ctmr parameter indicating decreased tumor vascularity patient required additional intervention patient experienced spontaneous bleeding postablation conclusion early experience highpowered gascooled percutaneous mw ablation demonstrates safe effective modality devascularize decrease size renal amls,2016,"Cristescu, Mircea; Abel, E Jason; Wells, Shane; Ziemlewicz, Timothy J; Hedican, Sean P; Lubner, Megan G; Hinshaw, J Louis; Brace, Christopher L; Lee, Fred T",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-015-1201-5; https://www.ncbi.nlm.nih.gov/pubmed/26390876/,19576493.0,12
42313,42313,54876,qxyirn88,,Medline,"Single-port-access, hand-assisted laparoscopic surgery for benign large adnexal tumors versus single-port pure laparoscopic surgery for adnexal tumors.",10.1007/s00464-011-1939-z,,22038160.0,unk,background singleportaccess handassisted laparoscopic surgery spahals method intended provide surgical outcome advantage similar spapure laparoscopic surgery spapls patient benign large adnexal tumor reduce spillage tumor content study aimed ass feasibility methodology spahals benign large adnexal tumor compare surgical outcome spahals spapls performed single surgeon hj r method march february patient underwent spa adnexal surgery spapls procedure performed candidate conventional laparoscopic adnexal surgery whereas spahals performed patient large adnexal tumor patient demographic surgical outcome two group compared result median adnexal tumor size larger patient underwent spahals underwent spapls v cm p spillage occurred four patient spahals group compared patient spapls group p relative risk spillage time higher spapls spahals group confidence interval ci adnexaconserving surgery significantly frequent spahals group spapls group v p additional procedure le frequent spahals group v p median estimated blood loss significantly lower spahals group v ml p two group differ significantly median operation time v min complication rate v postoperative hospital stay v day conclusion finding showed spahals extracorporeal adnexal surgery allows thorough evaluation peritoneal structure complete surgery benign large adnexal tumor retaining advantage spa adnexal surgery furthermore technique may reduce intraperitoneal spillage rate benign large adnexal tumor,2012,"Roh, Hyun-Jin; Lee, Soo-Jeong; Ahn, Jun-Woo; Kwon, Yong-Soon; Cho, Hyun-Jin; Kim, Dae-Yeon",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-011-1939-z; https://www.ncbi.nlm.nih.gov/pubmed/22038160/,1521026.0,12
42342,42342,54906,i6xgpg9n,,Medline,Comparison of Kidney Function in the Early Postoperative Period in Transperitoneal Robot-Assisted Laparoscopic Partial Nephrectomy Between Anterior and Posterior Renal Tumors: A Propensity Score-Matched Study.,10.1089/end.2017.0654,,29092632.0,unk,objective compare early postoperative renal function transperitoneal robotassisted laparoscopic partial nephrectomy rapn anterior posterior renal tumor patient method study included patient underwent transperitoneal rapn anterior posterior renal tumor tumor position defined renal nephrometry score minimize selection bias anterior posterior tumor patient variable adjusted using propensity score matching result patient classified anterior tumor posterior tumor matching patient included group mean preoperative estimated glomerular filtration rate egfr mlmin mean tumor size mm decrease early postoperative nadir egfr v p significantly higher posterior tumor anterior tumor however difference improved month surgery v p surgical outcome including operative time warm ischemia time wit complication surgical margin status length hospital stay significantly different two group multivariate analysis entire cohort posterior tumor v anterior tumor odds ratio p longer wit p high tumor complexity v low complexity p independent predictor development decrease early postoperative egfr conclusion posterior tumor greater decrease early postoperative nadir egfr anterior tumor equivalent surgical outcome including similar renal function month surgery setting transperitoneal rapn,2018,"Takagi, Toshio; Kondo, Tsunenori; Yoshida, Kazuhiko; Kobayashi, Hirohito; Iizuka, Junpei; Okumi, Masayoshi; Ishida, Hideki; Tanabe, Kazunari",Journal of endourology,,,,,,https://doi.org/10.1089/end.2017.0654; https://www.ncbi.nlm.nih.gov/pubmed/29092632/,789888.0,12
42356,42356,54921,w9iuc12u,,Medline,Laparoscopic surgery after endoscopic resection for rectal cancer and neuroendocrine tumors.,10.1007/s00464-014-3832-z,,25277475.0,unk,background endoscopic resection er tumor cause inflammation edema fibrosis adhesion surrounding tissue however little known effect er subsequent laparoscopic surgery rectal tumor objective retrospective study analyze effect er subsequent laparoscopic surgery rectal tumor method twentyeight patient underwent laparoscopic surgery rectal adenocarcinoma submucosal invasion rectal neuroendocrine tumor hospital january december group patient underwent laparoscopic surgery previous er compared group patient underwent laparoscopic surgery without previous er result though fibrosis involved submucosa polypectomy endoscopic mucosal resection fibrosis endoscopic submucosal dissection involved muscularis propria two patient subserosa one patient statistically significant difference clinical outcome group conclusion laparoscopic surgery er rectal tumor safe feasible laparoscopic surgery reasonable firstchoice radical treatment rectal tumor er,2015,"Inoue, Takashi; Nakagawa, Tadashi; Nakamura, Shinji; Ueda, Takeshi; Nishigori, Naoto; Kawasaki, Keijiro; Obara, Shinsaku; Nakamoto, Takayuki; Nakajima, Yoshiyuki; Koyama, Fumikazu; Fujii, Hisao",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-3832-z; https://www.ncbi.nlm.nih.gov/pubmed/25277475/,21316320.0,12
42366,42366,54933,bcqa87rn,,Medline,Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.,10.1097/sla.0b013e3181ff313a,,21217519.0,unk,objective aim study test hypothesis adjuvant radioimmunotherapy rit prevents recurrent liver metastasis andor result improved survival tumorectomy experimental model background although partial hepatectomy improve year survival patient colorectal liver metastasis recurrent tumor growth liver occurs frequently radioimmunotherapy using radiolabeled monoclonal antibody directed tumorassociated antigen considered suited treating minimal residual disease could therefore serve adjuvant surgery method liver metastasis induced male wagrij rat minilaparotomy intrahepatic injection × cc tumor cell biodistribution radiolabeled monoclonal antibody mg directed kda cell surface antigen cc tumor model determined day intravenous administration therapeutic efficacy lumg compared sham antibody upc labeled activity dose lu saline radioimmunotherapy administered either day tumorectomy day tumor cell inoculation day later primary endpoint survival result radiolabeled mg preferentially accumulated tumor lesion liver reaching maximum day postinjection ± injected dose per gram administration lumg luupc resulted transient decrease body weight sign clinical discomfort registered survival curve group received luupc group received saline differ p administration rit immediately surgery improved survival compared administration control antibody hazard ratio hr p even pronounced survival adjusted weight resected tumor hr p therapeutic efficacy delayed treatment seemed likely hr p survival early administration differ delayed administration hr p conclusion study provides proof principle rit effective adjuvant treatment modality surgical treatment colorectal liver metastasis,2011,"de Jong, Gabie M; Hendriks, Thijs; Eek, Annemarie; Oyen, Wim J G; Nagtegaal, Iris D; Bleichrodt, Robert P; Boerman, Otto C",Annals of surgery,,,,,,https://doi.org/10.1097/sla.0b013e3181ff313a; https://www.ncbi.nlm.nih.gov/pubmed/21217519/,25964946.0,12
42419,42419,54993,6uk1707h,,Medline,Model-Based Tumor Growth Dynamics and Therapy Response in a Mouse Model of De Novo Carcinogenesis.,10.1371/journal.pone.0143840,,26649886.0,unk,tumorigenesis complex multistep process depends numerous alteration within cell contribution surrounding stroma ability model macroscopic tumor evolution high fidelity may contribute better predictive tool designing tumor therapy clinic however attempt model tumor growth mainly developed validated using data xenograft mouse model fail capture important aspect tumorigenesis including tumorinitiating event interaction immune system present study investigate tumor growth therapy dynamic mouse model de novo carcinogenesis closely recapitulates tumor initiation progression maintenance vivo show rate tumor growth effect therapy highly variable mouse specific using gompertz model describe tumor growth twocompartment pharmacokinetic pharmacodynamic model describe effect therapy mouse treated fu show intermouse growth variability considerably larger intramouse variability correlation tumor growth drug kill rate result show vivo tumor growth regression double transgenic mouse model highly variable within subject mathematical model used capture overall characteristic variability order model become useful tool design optimal therapy strategy ultimately clinical practice subjectspecific modelling strategy necessary rather approach based average behavior given subject population could provide erroneous result,2015,"Loizides, Charalambos; Iacovides, Demetris; Hadjiandreou, Marios M; Rizki, Gizem; Achilleos, Achilleas; Strati, Katerina; Mitsis, Georgios D",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0143840; https://www.ncbi.nlm.nih.gov/pubmed/26649886/,1838268.0,12
42535,42535,55131,vhtn3ar3,,Medline,[Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].,10.1055/s-0041-105701,,26480056.0,unk,neuroendocrine neoplasia seldom increasing hold true incidence even prevalence since patient able live disease quite long time european neuroendocrine tumor society enets well society nanets north american neuroendocrine tumor society nccn national comprehensive cancer network esmo european society medical oncology published diagnostic therapeutic guideline present review aim summarize actual guideline practicebased diagnostic therapeutic algorithm also wish point open question discussed multidisciplinary approach,2015,"Grabowski, P; Hörsch, D",Zeitschrift fur Gastroenterologie,,,,,,https://doi.org/10.1055/s-0041-105701; https://www.ncbi.nlm.nih.gov/pubmed/26480056/,28687403.0,12
42544,42544,55142,z3uoujoe,,Medline,Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.,10.2967/jnumed.108.060392,,19443585.0,unk,unlabelled antihuman epidermal growth factor receptor herneu antibody trastuzumab administered patient herneuoverexpressing breast cancer wholebody noninvasive herneu scintigraphy could help ass quantify herneu expression lesion including nonaccessible metastasis aim study develop clinicalgrade radiolabeled trastuzumab clinical herneu immunopet scintigraphy improve diagnostic imaging guide antibodybased therapy support early antibody development pet radiopharmaceutical zrtrastuzumab compared spect tracer intrastuzumab tested clinic already method trastuzumab labeled zr comparison minimal dose trastuzumab required optimal smallanimal pet imaging biodistribution determined human herneupositive negative tumor xenograftbearing mouse result trastuzumab efficiently radiolabeled zr high radiochemical purity specific activity antigenbinding capacity preserved radiopharmaceutical proved stable solvent human serum tested protein dos minimal dose trastuzumab microg proved optimal imaging comparative biodistribution study showed higher level zrtrastuzumab herneupositive tumor herneunegative tumor especially day mean sem v percentage injected dose per gram tissue good correlation smallanimal pet image biodistribution data zrtrastuzumab intrastuzumab uptake tumor r conclusion clinicalgrade zrtrastuzumab showed high herneuspecific tumor uptake good resolution,2009,"Dijkers, Eli C F; Kosterink, Jos G W; Rademaker, Anna P; Perk, Lars R; van Dongen, Guus A M S; Bart, Joost; de Jong, Johan R; de Vries, Elisabeth G E; Lub-de Hooge, Marjolijn N","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.108.060392; https://www.ncbi.nlm.nih.gov/pubmed/19443585/,12338129.0,12
42572,42572,55178,w5kbo44v,,Medline,"Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.",10.1038/s41598-018-22697-9,,29540809.0,unk,recent study suggested postoperative hypoxia might trigger invasive tumor growth resulting diffusemultifocal recurrence pattern aim study analyze distinct recurrence pattern association postoperative infarct volume outcome consecutive glioblastoma patient analyzed met inclusion criterion initial tumor diagnosis surgery postoperative diffusionweighted imaging tumor recurrence followup distinct pattern contrastenhancement initial diagnosis first tumor recurrence multifocal growthprogression contact duraventricle ependymal spread localdistant recurrence recorded two blinded neuroradiologists association radiological pattern survival postoperative infarct volume analyzed unimultivariate survival analysis binary logistic regression analysis increasing postoperative infarct volume patient significantly likely develop multifocal recurrence recurrence contact ventricle contact dura patient multifocal recurrence hazard ratio hr p significantly shorter o patient recurrent tumor contact ventricle hr p ependymal spread hr p distant recurrence hr p significantly shorter postprogression survival multivariate analysis including wellestablished prognostic factor like age karnofsky performance score kp therapy extent resection pattern primary tumor postoperative infarct volume might initiate hypoxiamediated aggressive tumor growth resulting multifocal diffuse recurrence pattern impaired survival,2018,"Bette, Stefanie; Barz, Melanie; Huber, Thomas; Straube, Christoph; Schmidt-Graf, Friederike; Combs, Stephanie E; Delbridge, Claire; Gerhardt, Julia; Zimmer, Claus; Meyer, Bernhard; Kirschke, Jan S; Boeckh-Behrens, Tobias; Wiestler, Benedikt; Gempt, Jens",Scientific reports,,,,,,https://doi.org/10.1038/s41598-018-22697-9; https://www.ncbi.nlm.nih.gov/pubmed/29540809/,3833525.0,12
42579,42579,55186,s8b2361r,,Medline,Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model.,10.1186/s13550-019-0564-z,,31754913.0,unk,background combining modality using duallabeled antibody may allow preoperative intraoperative tumor localization could used imageguided surgery improve complete tumor resection trastuzumab monoclonal antibody human epidermal growth factor receptor duallabeled trastuzumab fluorophore irdyecw radioactive label used multimodal imaging herpositive breast cancer aim study demonstrate feasibility hertargeted multimodal imaging using inindtpatrastuzumabirdyecw orthotopic breast cancer model method trastuzumab conjugated pisothiocyanatobenzyl itcdiethylenetriaminepentaacetic acid dtpa irdyecwnhs ester subsequently labeled dose escalation study biodistribution μg inindtpatrastuzumabirdyecw determined h injection balbc nude mouse orthotopic high herexpressing tumor also biodistribution study performed low herexpressing breast cancer model addition multimodal imageguided surgery performed group autoradiography fluorescence microscopy immunohistochemically stained slice tumor compared colocalization tumor tissue expression fluorescence radiosignal result based biodistribution data μg dose duallabeled trastuzumab tumortoblood ratio ± chosen subsequent study inindtpatrastuzumabirdyecw specifically accumulated orthotopic herpositive bt tumor ± iag whereas uptake orthotopic low herexpressing mcf tumor significantly lower ± iag p bt tumor could clearly visualized microspectct fluorescence imaging subsequently imageguided resection performed immunohistochemical analysis bt tumor demonstrated correspondence fluorescence radiosignal high expression conclusion duallabeled trastuzumab showed specific accumulation orthotopic herpositive bt breast tumor microspectct fluorescence imaging enabled imageguided tumor resection clinical setting inindtpatrastuzumabirdyecw could valuable preoperative detection metastatic tumor spectct imaging intraoperative localization using gamma probe fluorescence imageguided surgery improve radical resection tumor tissue patient herpositive tumor,2019-11-21,"Deken, Marion M; Bos, Desirée L; Tummers, Willemieke S F J; March, Taryn L; van de Velde, Cornelis J H; Rijpkema, Mark; Vahrmeijer, Alexander L",EJNMMI research,,,,,,https://doi.org/10.1186/s13550-019-0564-z; https://www.ncbi.nlm.nih.gov/pubmed/31754913/,208190966.0,12
42649,42649,55267,20q76p44,,Medline,Initial experience with robot-assisted retroperitoneal partial nephrectomy for suspected renal cell carcinoma.,10.1007/s11701-014-0470-3,,27637837.0,unk,nephronsparing surgery accepted standard care small renal mass minimally invasive technique increasingly gained recognition roboticassisted transperitoneal partial nephrectomy ratpn well described report assessing retroperitoneal approach therefore present initial experience roboticassisted retroperitoneal partial nephrectomy rarpn identified patient singlesurgeon irbapproved database underwent rarpn suspected renal cell carcinoma result showed mean pathologic tumor size cm sd median renal nephrometry score mean estimated blood loss cc sd mean warm ischemia time min sd intraoperative postoperative complication mean length stay day sd average month followup mean decrease renal function rarpn effective alternative ratpn safely successfully applied selected patient tumor amenable nephron preservation,2014,"Emtage, Justin B; Buethe, David D; Russell, Christopher M; Sexton, Wade J",Journal of robotic surgery,,,,,,https://doi.org/10.1007/s11701-014-0470-3; https://www.ncbi.nlm.nih.gov/pubmed/27637837/,44949414.0,12
42692,42692,55318,6787d6pp,,Medline,The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery.,10.1016/j.juro.2011.12.075,,22425095.0,unk,purpose investigated effect sunitinib locally advanced primary renal carcinoma tumor ability facilitate subsequent surgery material method patient unresectable primary renal tumor without distant metastasis received mg sunitinib continuous daily dosing phase ii trial computerized tomography performed every week determine surgical resectability primary end point trial percentage patient renal cell carcinoma initially unresectable primary tumor could undergo nephrectomy sunitinib therapy result patient enrolled study distant metastasis total renal tumor evaluable response median change primary renal cell carcinoma tumor decrease corresponding median absolute reduction cm median reduction primary renal cell carcinoma tumor clear cell histology absolute reduction cm compared increase cm absolute increase nonclear cell tumor patient met primary end point able undergo nephrectomy preoperative sunitinib patient viable renal cell carcinoma surgical specimen surgical morbidity consistent prior experience nephrectomy patient without preoperative therapy conclusion sunitinib initial therapy patient locally advanced feature primary tumor feasible resulted antitumor effect enabled subsequent surgery subset patient prospective study required refine suitable application approach,2012,"Rini, Brian I; Garcia, Jorge; Elson, Paul; Wood, Laura; Shah, Shetal; Stephenson, Andrew; Salem, Mohammed; Gong, Michael; Fergany, Amr; Rabets, John; Kaouk, Jihad; Krishnamurthi, Venkatesh; Klein, Eric; Dreicer, Robert; Campbell, Steven",The Journal of urology,,,,,,https://doi.org/10.1016/j.juro.2011.12.075; https://www.ncbi.nlm.nih.gov/pubmed/22425095/,19939188.0,12
42707,42707,55336,2ausra68,,Medline,"Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.",10.1016/j.jvir.2014.02.021,,24703321.0,unk,purpose report compare outcome radiofrequency ablation treatmentnaïve first primary metachronous synchronous lung tumor material method institutional review boardapproved retrospective study reviewed patient men woman median age age range treatmentnaïve lung tumor treated radiofrequency ablation tumor patient included ta tb first primary n metachronous n synchronous n tumor adenocarcinoma n squamous cell carcinoma n unspecified n median tumor diameter mm range mm surveillance computed tomography positron emission tomographycomputed tomography performed median period month range mo technical success effectiveness rate overall progressionfree year year year survival calculated according stage first primary metachronous synchronous tumor status result technical success effectiveness local control occurred ta tumor tb tumor local progression rate first primary tumor higher metachronous p synchronous p tumor estimated year year year local tumor progressionfree survival estimated year year year overall survival survival outcome similar patient first primary metachronous synchronous tumor conclusion radiofrequency ablation result good local control progressionfree survival patient treatmentnaïve lung tumor including patient metachronous synchronous tumor,2014,"Ridge, Carole A; Silk, Mikhail; Petre, Elena N; Erinjeri, Joseph P; Alago, William; Downey, Robert J; Sofocleous, Constantinos T; Thornton, Raymond H; Solomon, Stephen B",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.02.021; https://www.ncbi.nlm.nih.gov/pubmed/24703321/,206659303.0,12
42738,42738,55370,jdl465e6,,Medline,Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.,10.1159/000315236,,20616590.0,unk,purpose confirm safety effectiveness technique assist radiofrequency ablation rfa difficult case retrospectively evaluated successful treatment rate early complication local tumor progression patient method june april total patient nodule treated difficult case artificial pleural effusion assisted ablation performed patient nodule artificial ascitesassisted ablation performed patient nodule cooling endoscopic nasobiliary drainage enbd tubeassisted ablation performed patient nodule tumor well visualized conventional bmode ultrasonography u contrastenhanced usassisted ablation levovist sonazoid virtual ct sonographyassisted ablation performed contrastenhanced usassisted ablation performed patient nodule virtual ct sonographyassisted ablation performed patient nodule result total complete ablation achieved nodule difficult case rfa artificial pleural effusion artificial ascites enbd complete response confirmed case contrastenhanced u ct sonographyassisted ablation complete response early complication recognized case case recovered invasive treatment local tumor recurrence investigated nodule patient nodule positive tumor recurrence assisted technique artificial pleural effusion case artificial ascites enbd tube case virtual ct sonography contrastenhanced u conclusion although local tumor progression need carefully monitored assisted technique rfa difficult case well tolerated expand indication rfa,2010,"Inoue, Tatsuo; Minami, Yasunori; Chung, Hobyung; Hayaishi, Sousuke; Ueda, Taisuke; Tatsumi, Chie; Takita, Masahiro; Kitai, Satoshi; Hatanaka, Kinuyo; Ishikawa, Emi; Yada, Norihisa; Hagiwara, Satoru; Ueshima, Kazuomi; Kudo, Masatoshi",Oncology,,,,,,https://doi.org/10.1159/000315236; https://www.ncbi.nlm.nih.gov/pubmed/20616590/,23975452.0,12
42748,42748,55381,tvdbpcok,,Medline,En bloc resection of a C-1 lateral mass osteosarcoma: technical note.,10.3171/2015.12.peds15496,,26966885.0,unk,osteosarcoma aggressive primary bone tumor currently treated multimodality therapy including en bloc resection demonstrated confer survival benefit intralesional resection author present case yearold girl c lateral mass osteosarcoma treated stage en bloc resection spinal reconstruction technically complex feasibility en bloc resection spinal osteosarcoma explored pediatric population,2016,"Clarke, Michelle J; Price, Daniel L; Cloft, Harry J; Segura, Leal G; Hill, Cindy A; Browning, Meghen B; Brandt, Jon M; Lew, Sean M; Foy, Andrew B",Journal of neurosurgery. Pediatrics,,,,,,https://doi.org/10.3171/2015.12.peds15496; https://www.ncbi.nlm.nih.gov/pubmed/26966885/,2549413.0,12
42756,42756,55389,yq8kl3ci,,Medline,Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.,10.1371/journal.pone.0139752,,26431204.0,unk,introduction radiofrequency ablation rfa used local treatment liver cancer rfa effective small cm tumor tumor cm tendency leave viable tumor cell margin cleft overlapping ablation zone increase possibility incomplete ablation local recurrence lysothermosensitive liposomal doxorubicin ltld thermally sensitive liposomal doxorubicin formulation intravenous administration rapidly release drug content exposed temperature °c used rfa ltld release doxorubicin vasculature around zone ablationinduced tumor cell necrosis killing micrometastases ablation margin may reduce recurrence effective thermal ablation alone purpose purpose study optimize rfa procedure used combination ltld maximize local deposition doxorubicin swine liver model pig anaesthetized liver surgically exposed pig received single mgm dose clinical ltld formulation thermodox® subsequently ablation performed either sequential overlapping needle insertion left medial lobe total ablation time minute respectively two different rfa generator probe evaluated final ablation ablation zone plus cm margin dissected examined doxorubicin concentration lcm fluorescence conclusion mean cmax plasma total doxorubicin μgml end infusion overall increased heat time minute show increase amount doxorubicin deposited μgg width ablation target margin doxorubicin delivered determined tissue homogenization lcm detection doxorubicin fluorescent imaging tissue,2015,"Swenson, Christine E; Haemmerich, Dieter; Maul, Donald H; Knox, Bridget; Ehrhart, Nicole; Reed, Robert A",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0139752; https://www.ncbi.nlm.nih.gov/pubmed/26431204/,7248640.0,12
42757,42757,55390,qlqhvsgd,,Medline,"Laparoscopic distal, subtotal gastrectomy for advanced gastric cancer.",10.1007/s11605-014-2666-2,,25338659.0,unk,objective study show laparoscopic subtotal distal gastrectomy lymphadenectomy safe appropriate method resection advanced gastric cancer study conducted designated nci cancer center subject study patient advanced gastric malignancy including transmural penetration tumor andor nodal disease requiring subtotal distal gastrectomy main outcome measure description technique laparoscopic subtotal distal gastrectomy antral distal body tumor conclusion laparoscopic approach advanced gastric malignancy subtotal distal gastrectomy lymphadenectomy safe oncologically appropriate procedure provides excellent outcome,2015,"Ben-David, Kfir; Tuttle, Rebecca; Kukar, Moshim; Oxenberg, Jacqueline; Hochwald, Steven N",Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,,,,,,https://doi.org/10.1007/s11605-014-2666-2; https://www.ncbi.nlm.nih.gov/pubmed/25338659/,2766664.0,12
42871,42871,55520,qmritsxn,,Medline,Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.,10.1371/journal.pone.0170536,,28107508.0,unk,background gastrin releasing peptide receptor grpr somatostatin receptor sstr overexpressed primary breast cancer bc making ideal candidate receptormediated nuclear imaging therapy aim study determine whether receptor also suitable target metastatic bc method mrna expression human bc sample studied vitro autoradiography associated radioligand binding next grpr sstr mrna level paired primary bcs metastasis different site measured quantitative reverse transcriptase polymerase chain reaction receptor mrna expression level associated clinicopathological factor expression level primary tumor corresponding metastasis compared result binding grpr sstr radioligands tumor tissue correlated significantly receptor mrna expression high grpr sstr mrna level associated estrogen receptor esrpositive tumor p receptor significant difference grpr mrna expression primary tumor versus paired metastasis regarding sstr mrna expression also significant difference majority case apart liver ovarian metastasis showed significantly lower expression compared corresponding primary tumor p p respectively conclusion targeting grpr sstr nuclear imaging andor treatment potential improve bc care primary well metastatic disease,2017,"Dalm, Simone U; Schrijver, Willemijne A M E; Sieuwerts, Anieta M; Look, Maxime P; Ziel-van der Made, Angelique C J; de Weerd, Vanja; Martens, John W; van Diest, Paul J; de Jong, Marion; van Deurzen, Carolien H M",PloS one,,,,,,https://doi.org/10.1371/journal.pone.0170536; https://www.ncbi.nlm.nih.gov/pubmed/28107508/,15612653.0,12
42890,42890,55540,lugwpp9p,,Medline,Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma.,10.3390/cancers11020195,,30736463.0,unk,metastatic pheochromocytoma paraganglioma ppgl incurable neuroendocrine tumor goal treatment include palliating symptom reducing tumor burden little known use radiofrequency ablation rfa cryoablation cryo percutaneous ethanol injection pei treat metastatic ppgl performed retrospective study patient age year older metastatic ppgl treated ablative therapy mayo clinic usa june november outcome measure radiographic response procedurerelated complication symptomatic improvement thirtyone patient metastatic ppgl lesion treated rfa cryo pei procedure median duration followup month range ⁻ month nondeceased patient radiographic local control achieved lesion improvement metastasisrelated pain symptom catecholamine excess achieved procedure thirtythree procedure known complication claviendindo grade ii iv v complication occurred procedure respectively patient metastatic ppgl ablative therapy effectively achieve local control palliate symptom,2019,"Kohlenberg, Jacob; Welch, Brian; Hamidi, Oksana; Callstrom, Matthew; Morris, Jonathan; Sprung, Juraj; Bancos, Irina; Young, William",Cancers,,,,,,https://doi.org/10.3390/cancers11020195; https://www.ncbi.nlm.nih.gov/pubmed/30736463/,73418994.0,12
42898,42898,55550,q0909f96,,Medline,Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study.,10.1007/s00270-016-1547-3,,27999917.0,unk,purpose phase ii prospective study investigates possible benefit radiofrequency ablation rfa combined hepatic arterial chemoembolization using degradable starch microsphere dsm mixed mitomycin c mmc nonsurgical candidate colorectal liver metastasis material method study approved respective institutional review board included nonsurgical candidate fewer liver tumor cm smaller single lesion cm smaller percutaneous rfa performed immediately chemoembolization using dsmmmc primary secondary endpoint local tumor control rate safety year recurrencefree overall survival rate result study examined patient male female tumor mean maximum diameter ± cm standard deviation range cm mean age ± year range year local tumor progression developed tumor patient mean followup ± month range month year local tumor control rate confidence interval ci patient basis ci tumor basis respective year overall recurrencefree survival rate ci ci median survival time month fever adverse event requiring treatment patient conclusion combination therapy safe exhibiting strong anticancer effect colorectal liver metastasis might contribute patient survival,2017,"Yamakado, Koichiro; Inaba, Yasutaka; Sato, Yozo; Yasumoto, Taku; Hayashi, Sadao; Yamanaka, Takashi; Nobata, Koji; Takaki, Haruyuki; Nakatsuka, Atsuhiro",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-016-1547-3; https://www.ncbi.nlm.nih.gov/pubmed/27999917/,10939485.0,12
42905,42905,55557,10dyxsw3,,Medline,Comparative Evaluation of the Biodistribution Profiles of a Series of Nonpeptidic Neurotensin Receptor-1 Antagonists Reveals a Promising Candidate for Theranostic Applications.,10.2967/jnumed.115.170530,,26940767.0,unk,unlabelled neurotensin receptor ntr promising target diagnostic imaging targeted radionuclide therapy aim study evaluate biodistribution profile series newly developed diarylpyrazolebased ntr antagonist regarding suitability diagnostic potentially radiotherapeutic agent method bp bp bp labeled injected intravenously ntrpositive ht xenograftbearing nude mouse h administration spectct image acquired mouse sacrificed ex vivo determination tissueassociated radioactivity result highcontrast tumor visualization spectct image achieved using compound study ex vivo biodistribution study confirmed high persistent tumor uptake peaking h injection inbp ± percentage injected dose per gram idg h injection inbp ± idg inbp ± idg tumortonormaltissue ratio obtained inbp inbp consistently greater conclusion basis superior biodistribution profile compared previously reported radiolabeled ntr ligand inbp ideal candidate development theranostic tracer,2016,"Schulz, Jörg; Rohracker, Martin; Stiebler, Marvin; Goldschmidt, Jürgen; Grosser, Oliver S; Osterkamp, Frank; Pethe, Annette; Reineke, Ulrich; Smerling, Christiane; Amthauer, Holger","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.115.170530; https://www.ncbi.nlm.nih.gov/pubmed/26940767/,9835959.0,12
42911,42911,55568,1bb11hu4,,Medline,Malignant melanotic Xp11 neoplasms exhibit a clinicopathological spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.,10.1002/path.5470,,32418203.0,unk,classification distinct group mesenchymal neoplasm first described xp translocation perivascular epithelioid cell tumor pecoma recently term melanotic xp neoplasm xp neoplasm melanocytic differentiation proposed remains challenging controversial collected melanotic xp neoplasm largest series date comprehensive evaluation fourteen case along alveolar soft part sarcoma asp conventional pecomas control group normal tissue submitted rna sequencing followup available patient showed year overall survival o year diseasefree survival dfs respectively similar asp significantly worse conventional pecoma univariate analysis location occurring kidney versus kidney infiltrative growth pattern nuclear pleomorphism mitotic activity ≥ hpf necrosis lymphovascular invasion found associated o andor dfs multivariate analysis identified location factor found independently correlate dfs importantly rna sequencingbased clustering analysis segregated melanotic xp neoplasm asp clearly tumor including conventional pecoma xp translocation renal cell carcinoma rcc formed compact cluster representative largely similar expression signature study first clearly define true biologic nature melanotic xp neoplasm distinctive malignant mesenchymal tumor rather simply pecoma variant occasionally unpredictable behavior meanwhile melanotic xp neoplasm asp likely represent phenotypic variant entity distinct conventional pecoma xp translocation rcc based important finding melanotic xp neoplasm might reclassified distinctive entity together asp independent pecoma future revision current world health organization category tumor soft tissue bone improved reclassification article protected copyright right reserved,2020-05-17,"Wang, Xiao-Tong; Fang, Ru; Zhang, Ru-Song; Ye, Sheng-Bing; Li, Rui; Wang, Xuan; Pan, Rui; Liu, Chong; Chen, Jie-Yu; Zhao, Ming; Teng, Xiao-Dong; Yu, Wen-Juan; Li, Yu-Jun; Wang, Feng-Hua; Zhang, Jian-Guo; Yang, Qi-Chang; Zhang, Yong-Sheng; Lu, Zhen-Feng; Ma, Heng-Hui; Zhou, Xiao-Jun; Xia, Qiu-Yuan; Rao, Qiu",The Journal of pathology,,,,,,https://doi.org/10.1002/path.5470; https://www.ncbi.nlm.nih.gov/pubmed/32418203/,218680527.0,12
43005,43005,55677,6wk49r70,,Medline,Transumbilical single-incision laparoscopic wedge resection for gastric submucosal tumors: technical challenges encountered in initial experience.,10.5230/jgc.2012.12.3.173,,23094229.0,unk,purpose report initial clinical experience singleincision laparoscopic gastric wedge resection submucosal tumor material method medical record patient underwent singleincision laparoscopic gastric wedge resection july march reviewed retrospectively demographic data clinicopathologic surgical outcome assessed result mean tumor size cm range cm tumor mostly located anterior wall along greater curvature stomach nine ten procedure performed successfully without use additional trocars conversion laparotomy one patient underwent conversion multiport laparoscopic surgery get simultaneous cholecystectomy safely mean operating time minute range minute mean postoperative hospital stay day range day serious perioperative complication observed submucosal tumor final pathologic report revealed gastrointestinal stromal tumor schwannomas heterotopic pancreas conclusion singleincision laparoscopic gastric wedge resection gastric submucosal tumor feasible safe performed experienced laparoscopic surgeon technique provides favorable cosmetic result also short hospital stay low morbidity carefully selected candidate,2012,"Park, Ji Yeon; Eom, Bang Wool; Yoon, Hongman; Ryu, Keun Won; Kim, Young-Woo; Lee, Jun Ho",Journal of gastric cancer,,,,,,https://doi.org/10.5230/jgc.2012.12.3.173; https://www.ncbi.nlm.nih.gov/pubmed/23094229/,2365798.0,12
43038,43038,55716,8w8xbmqk,,Medline,Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.,10.1007/s11604-019-00843-1,,31102138.0,unk,purpose radiofrequency ablation rfa hepatocellular carcinoma hcc difficult ass ablative margin precisely comparing pre postrfa ct image prospectively studied am using magnetic resonance imaging mri preadministered superparamagnetic iron oxide spio spio safe kidney disease patient material method hepatocellular carcinoma patient treated rfa within h spio administration tweighted mri performed day later visualized hypointense rim ablation status classified rim completely surrounded tumor rim partly discontinuous without tumor protrusion rim partly discontinuous tumor protrusion minimal thickness measured tumor retreated consecutively result total hccs ablated patient evaluated local recurrence rate year tumor tumor p addition local recurrence seen tumor ≥ mm conclusion mri preadministered spio useful determining precisely ≥ mm recommended curative rfa trial registration number study registered umin clinical trial registry umin,2019,"Fukuda, Kuniaki; Mori, Kensaku; Hasegawa, Naoyuki; Nasu, Katsuhiro; Ishige, Kazunori; Okamoto, Yoshikazu; Shiigai, Masanari; Abei, Masato; Minami, Manabu; Hyodo, Ichinosuke",Japanese journal of radiology,,,,,,https://doi.org/10.1007/s11604-019-00843-1; https://www.ncbi.nlm.nih.gov/pubmed/31102138/,156055579.0,12
43049,43049,55727,eldi7010,,Medline,Recurrent Subcutaneous Teratoma in an Adult Red-crowned Amazon Parrot (Amazona viridigenalis).,10.1647/2017-331,,31124613.0,unk,approximately yearold wildcaught redcrowned amazon parrot amazona viridigenalis evaluated subcutaneous mass right keel cytologic examination fine needle aspirate mass suggestive granulomatous inflammation mass surgically excised parrot treated oral nonsteroidal antiinflammatory drug histologically mass diagnosed teratoma stratified squamous epithelial neuroectodermal component tumor cell extended surgical margin two year later neoplasm recurred regrowth neuroectodermal component neoplasm removed surgically recurred month later necessitating third surgery histopathologic examination confirmed recurrence original neoplasm instance incomplete margin excision,2019,"Lauer, Savannah; Pinkerton, Marie E; Mans, Christoph; Doss, Grayson A",Journal of avian medicine and surgery,,,,,,https://doi.org/10.1647/2017-331; https://www.ncbi.nlm.nih.gov/pubmed/31124613/,109615678.0,12
43126,43126,55815,cwqjs3ar,,Medline,Development of a pancreatic tumor animal model and evaluation of NOTES tumor enucleation.,10.1007/s00464-011-1686-1,,21487862.0,unk,background laparoscopic distal pancreatectomy associated high morbidity mortality note tumor enucleation may provide alternative laparoscopic distal pancreatectomy goal study determine feasibility note tumor creation enucleation multidisciplinary approach method lineararray endoscopic ultrasound eu endoscope used inject thermosensitive aba triblock polymer mixed methylene blue stomach wall distal pancreas using gauge eu needle due thermosensitive character polymer solidifies response body temperature creating artificial tumor seventeen swine underwent note transgastric pancreatic tumor enucleation nine nonsurvival animal sacrificed immediately note procedure subsequent necropsy eight survival animal observed day procedure subsequently sacrificed followed necropsy result procedure performed successfully pig studied nonsurvival survival animal using pure note approach without laparoscopic port complication included two esophageal dissection nonsurvival group survival group caused introduction endoscopic overtube unrelated actual surgical procedure survival animal two small splenic laceration caused retraction endoscopic forceps hemostasis achieved prior closure gastrotomy necropsy animal sufficient closure gastrotomy site conclusion creation artificial pancreatic tumor via eu guidance feasible pancreatic tumor enucleation using transgastric note approach technically feasible could alternative laparoscopic distal pancreatectomy development adoption adaptation technique require development sophisticated specialized tool improve safety profile procedure,2011,"Matthes, Kai; Thakkar, Shyam J; Lee, Suck-Ho; Gromski, Mark A; Lim, Robert B; Janschek, Johannes; Jones, Stephanie B; Jones, Daniel B; Chuttani, Ram",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-011-1686-1; https://www.ncbi.nlm.nih.gov/pubmed/21487862/,13554680.0,12
43151,43151,55843,nut9tpcu,,Medline,Exfoliated malignant cells at the anastomosis site in colon cancer surgery: the impact of surgical bowel occlusion and intraluminal cleaning.,10.1007/s00384-011-1148-1,,21302117.0,unk,purpose exfoliated malignant cell present along staple line anastomosis may responsible anastomotic recurrence colon cancer aimed ass impact surgical bowel occlusion around tumor intraluminal lavage presence exfoliated malignant cell anastomosis site patient colon cancer method prospective study patient colon cancer requiring right hemicolectomy january september randomly assigned control group surgical bowel occlusion patient notouch group underwent surgical bowel occlusion around tumor tumor manipulation patient fluid used intraoperatively irrigate portion bowel clamped distal tumor examined cytologically exfoliated cell cytological class iv v considered malignant result control group patient exfoliated malignant cell terminal ileum distal colon anastomosis site respectively however patient notouch group exfoliated malignant cell site frequency exfoliated malignant cell distal colon anastomosis site significantly lower notouch group p exfoliated malignant cell found upon saline irrigation ml either group conclusion measure surgical bowel occlusion around tumor intraluminal lavage prevent eliminate exfoliated malignant cell anastomotic site patient colon cancer,2011,"Hasegawa, Junichi; Nishimura, Junichi; Yamamoto, Shunsuke; Yoshida, Youichirou; Iwase, Kazuhiro; Kawano, Kiyoshi; Nezu, Riichiro",International journal of colorectal disease,,,,,,https://doi.org/10.1007/s00384-011-1148-1; https://www.ncbi.nlm.nih.gov/pubmed/21302117/,9736577.0,12
43208,43208,55904,0mi5of8m,,Medline,Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation.,10.1007/s00270-013-0546-x,,23354960.0,unk,study evaluated safety feasibility clinical utility hyaluronic acid gel injection separate gastrointestinal tract tumor liver radiofrequency ablation rfa eleven patient liver tumor measuring cm mean ± standard deviation ± cm adjacent gastrointestinal tract received rfa mixture hyaluronic acid gel contrast material volume ± ml range ml injected tumor gastrointestinal tract computed tomographicfluoroscopic guidance tumor separated gastrointestinal tract cm distance ± cm injection hyaluronic acid gel subsequent rfa performed without complication patient although tumor enhancement disappeared patient local tumor progression found patient followup ± month range month conclusion hyaluronic acid gel injection safe useful technique avoid thermal injury adjacent gastrointestinal tract liver rfa,2013,"Hasegawa, Takaaki; Takaki, Haruyuki; Miyagi, Hideki; Nakatsuka, Atsuhiro; Uraki, Junji; Yamanaka, Takashi; Fujimori, Masashi; Sakuma, Hajime; Yamakado, Koichiro",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-013-0546-x; https://www.ncbi.nlm.nih.gov/pubmed/23354960/,1061082.0,12
43235,43235,55935,w3nlsrd1,,Medline,Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors.,10.1021/pr900414f,,19795908.0,unk,blood circulates nearly every organ including tumor therefore plasma logical source search tumorderived protein peptide challenge plasma complex bodily fluid composed high concentration normal host protein obscure identification tumorderived molecule simplify plasma examined low molecular weight lmw fraction plasma peptidome using liquid chromatographytandem mass spectrometry lcmsms method plasma peptidome patient ductal adenocarcinoma pancreas dap prominent peptide identified qsox parent protein peptide stable whole blood h present dap patient patient intraductal papillary mucinous neoplasm ipmn qsox peptide never identified plasma peptidome normal healthy donor using method immunohistochemical staining dap tissue section antiqsox antibody show overexpression qsox tumor adjacent stroma normal duct three four pancreas tumor cell line also express qsox protein western blot analysis first report qsox peptide plasma dap patient make rare connection peptide plasma cancer patient overexpression parent protein tumor,2009,"Antwi, Kwasi; Hostetter, Galen; Demeure, Michael J; Katchman, Benjamin A; Decker, G Anton; Ruiz, Yvette; Sielaff, Timothy D; Koep, Lawrence J; Lake, Douglas F",Journal of proteome research,,,,,,https://doi.org/10.1021/pr900414f; https://www.ncbi.nlm.nih.gov/pubmed/19795908/,207742533.0,12
43326,43326,56040,hcb5yckd,,Medline,Clinical translation of a PSMA inhibitor for 99mTc-based SPECT.,10.1016/j.nucmedbio.2017.01.012,,28193503.0,unk,background prostatespecific membrane antigen psma highly overexpressed advanced prostate cancer galabeled psma inhibitor ipsma currently used prostate cancer detection pet imaging availability simple efficient reproducible radiolabeling procedure essential developing new spect radiopharmaceutical clinical translation aim research prepare mtceddahyniclysnalureaglu mtceddahynicipsma obtained lyophilized kit formulation evaluate vitro vivo radiopharmaceutical binding prostate cancer cell overexpressing psma well mtceddahynicipsma normal biodistribution human preliminary uptake patient prostate cancer method mtc labeling performed adding sodium pertechnetate solution phosphate buffer ph lyophilized formulation containing hynicipsma edda tricine mannitol stannous chloride radiochemical purity evaluated reversedphase hplc itlcsg analysis stability study human serum performed sizeexclusion hplc vitro cell uptake tested using prostate cancer cell lncap blocked nonblocked receptor biodistribution tumor uptake determined lncap tumorbearing nude mouse blocked nonblocked receptor image obtained using microspectct wholebody image three healthy men two patient histologicallyconfirmed prostate cancer one previous gapsmascan acquired h h mtceddahynicipsma administration radiochemical purity result vitro vivo study showed high radiopharmaceutical stability human serum specific recognition psma high tumor uptake ± idg h rapid blood clearance mainly kidney elimination preliminary image patient demonstrated ability mtceddahynicipsma detect tumor metastasis prostate cancer well gapsma conclusion result obtained study warrant dosimetry clinical study determine specificity sensitivity mtceddahynicipsma,2017,"Ferro-Flores, Guillermina; Luna-Gutiérrez, Myrna; Ocampo-García, Blanca; Santos-Cuevas, Clara; Azorín-Vega, Erika; Jiménez-Mancilla, Nallely; Orocio-Rodríguez, Emmanuel; Davanzo, Jenny; García-Pérez, Francisco O",Nuclear medicine and biology,,,,,,https://doi.org/10.1016/j.nucmedbio.2017.01.012; https://www.ncbi.nlm.nih.gov/pubmed/28193503/,5304598.0,12
43356,43356,56075,g23ok1c9,,Medline,Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.,10.1007/s00261-018-1464-9,,29450606.0,unk,purpose compare transarterial chemoembolization tace monotherapy combination tace microwave ablation mwa local control cm hepatocellular carcinoma hcc method patient hcc cm treated tace monotherapy combination tace mwa single institution retrospectively reviewed twentyfour hccs median diameter cm patient male median age year treated using tace monotherapy combination tace mwa used treat hccs median diameter cm patient male median age year microwave ablation performed target time two week following tace individual tumor followed serial contrastenhanced ct mr response treatment evaluated tumorbytumor basis using mrecist criterion primary outcome local tumor progression ltp data analyzed using fisher exact test categorical variable wilcoxon rank sum test continuous variable time ltp estimated kaplanmeier method result relative tace monotherapy tace mwa provided trend toward lower rate ltp v p higher complete response rate v p time ltp month v month p significantly longer tace mwa group compared tace monotherapy conclusion combination therapy tace microwave ablation improves local control increase time ltp cm hcc,2018,"Smolock, Amanda R; Cristescu, Mircea M; Hinshaw, Audrey; Woo, Kaitlin M; Wells, Shane A; Ziemlewicz, Timothy J; Lubner, Meghan G; Dalvie, Prasad S; Louis Hinshaw, J; Brace, Christopher L; Ozkan, Orhan S; Lee, Fred T; Laeseke, Paul",Abdominal radiology,,,,,,https://doi.org/10.1007/s00261-018-1464-9; https://www.ncbi.nlm.nih.gov/pubmed/29450606/,3287830.0,12
43376,43376,56099,xvc711s2,,Medline,A Case of Prenatally Diagnosed Wilms Tumor Managed With Laparoscopic Nephrectomy.,10.1016/j.urology.2017.10.045,,29155194.0,unk,present case prenatally diagnosed wilms tumor subsequent operative approach management patient referred institution abnormal prenatal renal ultrasound computed tomography scan delivery showed multifocal enhancing left renal mass patient underwent uncomplicated left laparoscopic radical nephrectomy retroperitoneal lymph node sampling using novel hidden incision endoscopic surgery technique final pathology revealed favorable histology stage ii wilms tumor patient underwent adjuvant chemotherapy vincristine dactinomycin based eea regimen highlight diagnostic pathway perioperative management surgical approach early postoperative followup case report,2018,"Toussi, Amir; Granberg, Candace F; Gargollo, Patricio C",Urology,,,,,,https://doi.org/10.1016/j.urology.2017.10.045; https://www.ncbi.nlm.nih.gov/pubmed/29155194/,4240766.0,12
43451,43451,56188,3x4t35eg,,Medline,Mastoid Epidermoid Tumor and Associated Dural Arteriovenous Fistula with Venous Sinus Occlusion.,10.1016/j.wneu.2017.08.047,,28830738.0,unk,background dural arteriovenous fistula davf abnormal vascular connection arterial venous channel within dura mater although davfs linked type intracranial tumor first case reporting association davf epidermoid tumor case description middleaged patient chronic headache presented borden type ii davf draining right transverse sigmoid junction also found epidermoid tumor right mastoid patient underwent staged embolization fistula transvenous transarterial route continuous intraoperative venous pressure monitoring confirmed marked reduction intracranial venous pressure patient symptom completely resolved however fistula still remained residual davf surgically disconnected epidermoid tumor resected procedure conclusion case demonstrates davf associated epidermoid tumor tumor compromise venous outflow lead intracranial venous hypertension development davf venous pressure monitoring offer objective method verify resolution venous hypertension might correlate resolution clinical symptom,2017,"Yoon, Jang W; Hamade, Youssef J; Navarro, Ramon; Brown, Benjamin L; Lundy, Larry; Tawk, Rabih G",World neurosurgery,,,,,,https://doi.org/10.1016/j.wneu.2017.08.047; https://www.ncbi.nlm.nih.gov/pubmed/28830738/,205723950.0,12
43507,43507,56257,nq18fx4t,,Medline,"A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.",10.1186/s12885-018-4544-x,,29884132.0,unk,background synovial sarcoma s rare tumor occurring predominantly adolescent young adult dismal prognosis advanced phase report firstinhuman phase monoclonal antibody otsa targeting fzd overexpressed s present normal tissue labelled radioisotope used molecular vehicle specifically deliver radiation fzd expressing s lesion method patient progressive advanced s included first step trial otsa vivo biodistribution lesion uptake evaluated repeated whole body planar spectct scintigraphies h till h iv injection mbq inotsa dosimetry study also evaluated liver absorbed dose using yotsa second step patient significant tumor uptake randomized mbq arm mbq arm b yotsa radionuclide therapy result january june pt median age year advanced s enrolled even though inotsa liver uptake appeared intense estimated absorbed liver dose le gy patient tracer intensity greater mediastinum patient consistent sufficient tumor uptake proceed treatment yotsa randomized arm patient arm b patient randomized due worsening p common grade ≥ aes reversible hematological disorder frequent arm b objective response observed best response stable disease patient lasting week patient conclusion radioimmunotherapy targeting fzd feasible s patient patient presented least one lesion inotsa uptake tumor uptake heterogeneous sufficient select pt yotsa treatment recommended activity clinical investigation mbq yotsa however hematological toxicity le energetic particle emitter radioisopotes lutetium may better option wider therapeutic index trial registration study registered nct website registration code nct november third,2018,"Giraudet, Anne-Laure; Cassier, Philippe Alexandre; Iwao-Fukukawa, Chicaco; Garin, Gwenaelle; Badel, Jean-Noël; Kryza, David; Chabaud, Sylvie; Gilles-Afchain, Laurence; Clapisson, Gilles; Desuzinges, Claude; Sarrut, David; Halty, Adrien; Italiano, Antoine; Mori, Masaharu; Tsunoda, Takuya; Katagiri, Toyomasa; Nakamura, Yusuke; Alberti, Laurent; Cropet, Claire; Baconnier, Simon; Berge-Montamat, Sandrine; Pérol, David; Blay, Jean-Yves",BMC cancer,,,,,,https://doi.org/10.1186/s12885-018-4544-x; https://www.ncbi.nlm.nih.gov/pubmed/29884132/,47003157.0,12
43604,43604,56372,8j3wgxzq,,Medline,Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases.,10.1016/j.jvir.2014.11.013,,25612808.0,unk,purpose retrospectively evaluate longterm survival outcome radiofrequency rf ablation colorectal lung metastasis evaluate factor associated improved survival material method eightyfour patient male female median age colorectal lung metastasis median size cm underwent rf ablation session thirteen patient viable extrapulmonary recurrence time rf ablation primary endpoint patient survival prognostic factor associated survival determined univariate multivariate analysis secondary endpoint local tumor progression adverse event per national cancer institute common terminology criterion adverse event version result followup median duration mo patient died estimated overall survival o rate year respectively median o time mo multivariate analysis revealed carcinoembryonic antigen cea level least ngml rf ablation p presence viable extrapulmonary recurrence time rf ablation p independent negative prognostic factor local tumor progression rate tumor grade adverse event observed two session grade adverse event observed conclusion rf ablation colorectal lung metastasis provided favorable longterm survival low incidence severe adverse event independent prognostic factor high cea level rf ablation presence viable extrapulmonary recurrence time rf ablation,2015,"Matsui, Yusuke; Hiraki, Takao; Gobara, Hideo; Iguchi, Toshihiro; Fujiwara, Hiroyasu; Nagasaka, Takeshi; Toyooka, Shinichi; Kanazawa, Susumu",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2014.11.013; https://www.ncbi.nlm.nih.gov/pubmed/25612808/,21844462.0,12
43640,43640,56413,4rex87uk,,Medline,Improved targeting of radio-frequency ablation probes and thermal sensors: a preliminary investigation of flat-panel CT-guided ablation of renal tumors performed in the cardiac catheterization laboratory.,10.1089/end.2010.0702,,21671757.0,unk,flatpanel detector ct fdct provides crosssectional ctimages offering improved workspace using fluoroscopic guidance thermal probe placement radiofrequency ablation rfa needle thermal sensor purpose article test feasibility fdct application renal tumor ablation hybrid operating room environment eleven patient renal mass diagnosed preprocedurally contrastenhanced ct scan underwent core biopsy simultaneous ctrfa general anesthesia fdct guidance cardiac catheterization laboratory scan taken preablation tumor targeting intermittently probe placement guidance temperature sensor postablation perioperative postoperative outcome pathologic result radiographic followup recorded patient target temperature °c guide treatment end point reached tumor periphery biopsy pathology showed renalcell carcinoma benign indeterminate biopsy result three clavien grade complication occurred one patient showed evidence recurrent disease postoperative ct scan experience found fdctguided ablation small renal tumor feasible using advanced targeting system,2011,"Leveillee, Raymond J; Castle, Scott M; Salas, Nelson; Doshi, Mehul; Gorbatiy, Vladislav; O'Neill, William",Journal of endourology,,,,,,https://doi.org/10.1089/end.2010.0702; https://www.ncbi.nlm.nih.gov/pubmed/21671757/,9738097.0,12
43660,43660,56433,1h3mgeoi,,Medline,Molecular imaging of mesothelioma with (99m)Tc-ECG and (68)Ga-ECG.,10.1155/2012/232863,,22645409.0,unk,developed ethylenedicysteineglucosamine ecg alternative ffluorodeoxydglucose ffdg cancer imaging ecg localizes nuclear component cell via hexosamine biosynthetic pathway study evaluate feasibility imaging mesothelioma mtcecg gaecg ecg synthesized thiazolidinecarboxylic acid tetraoacetylaminodglucopyranose followed reduction sodium liquid ammonia yield ecg ecg chelated mtctin ii gaga chloride vitro vivo study mesothelioma highest tumor uptake mtcecg min post injection declined min post injection tumor uptake idg tumorlung tumorblood tumormuscle count density ratio mtcecg min ± ± ± ± ± ± ± ± gaecg min ± ± ± ± ± ± ± ± ffdg min ± ± ± ± ± ± ± ± respectively tumor could clearly visualized mtcecg gaecg mesotheliomabearing rat mtcecg gaecg showed increased uptake mesothelioma suggesting may useful diagnosing mesothelioma also monitoring therapeutic response,2012,"Zhang, Yin-Han; Bryant, Jerry; Kong, Fan-Lin; Yu, Dong-Fang; Mendez, Richard; Edmund Kim, E; Yang, David J",Journal of biomedicine & biotechnology,,,,,,https://doi.org/10.1155/2012/232863; https://www.ncbi.nlm.nih.gov/pubmed/22645409/,14931821.0,12
43662,43662,56435,fi47swsl,,Medline,"Feasibility of Intraoperative Nerve Monitoring in Preventing Thermal Damage to the ""Nerve at Risk"" During Image-Guided Ablation of Tumors.",10.1007/s00270-015-1287-9,,26718961.0,unk,purpose ass feasibility intraoperative neurophysiologic monitoring ionm imageguided percutaneous thermal ablation tumor material method february october retrospective review imageguided percutaneous thermal ablation intervention using ionm performed data compiled using electronic medical record imaging study result twelve patient treated ablation intervention patient realtime feedback monitoring neurologist used adjust applicator placement ablation setting ionm technically feasible procedure complication related monitoring ablation nerve risk remained intact patient could followed none developed new nerve deficit minimum month ablation conclusion ionm safe feasible use imageguided thermal ablation tumor vicinity nerve outcome study demonstrate potential utility imageguided ablation intervention,2016,"Marshall, Richard H; Avila, Edward K; Solomon, Stephen B; Erinjeri, Joseph P; Maybody, Majid",Cardiovascular and interventional radiology,,,,,,https://doi.org/10.1007/s00270-015-1287-9; https://www.ncbi.nlm.nih.gov/pubmed/26718961/,6752942.0,12
43893,43893,56700,lwofdtvx,,Medline,Radiolabeling of rituximab with (188)Re and (99m)Tc using the tricarbonyl technology.,10.1016/j.nucmedbio.2010.05.010,,21220126.0,unk,introduction successful clinical study immunotherapy patient nonhodgkins lymphoma nhl use antibody rituximab rtx targeting cd bcell tumor rituximab radiolabeled β emitter could potentiate therapeutic efficacy antibody virtue particle radiation report direct radiolabeling approach rituximab mtc retricarbonyl core isolink technology method native format antibody rtxwt well reduced form rtxred labeled mtcreco partial reduction disulfide bond produce free sulfhydryl group sh achieved mercaptoethanol radiolabeling efficiency vitro human plasma stability well transchelation toward cysteine histidine investigated immunoreactivity binding affinity determined ramos andor raji cell expressing cd biodistribution performed mouse bearing subcutaneous ramos lymphoma xenograft result radiolabeling efficiency kinetics rtxred superior rtxwt mtc h rtxred v h rtxwt mtccortxred used without purification vitro vivo study whereas recortxred purified eliminate free reprecursor radioimmunoconjugates stable human plasma h °c contrast displacement experiment excess cysteinehistidine showed significant transchelation case mtccortxred prepurified recortxred conjugate revealed high binding affinity cd antigen kd nm tumor uptake recortxred idg idg mtccortxred h injection value organ tissue similar compound example tumortoblood tumortoliver ratio mtccortxred recortxred h pi conclusion rituximab could directly stably labeled matched pair mtcre using isolink technology retention biological activity labeling kinetics yield need improvement potential routine application radioimmunodiagnosis therapy,2011,"Dias, Carla Roberta; Jeger, Simone; Osso, João Alberto; Müller, Cristina; De Pasquale, Christine; Hohn, Alexander; Waibel, Robert; Schibli, Roger",Nuclear medicine and biology,,,,,,https://doi.org/10.1016/j.nucmedbio.2010.05.010; https://www.ncbi.nlm.nih.gov/pubmed/21220126/,23721247.0,12
43966,43966,56787,nh2dmplz,,Medline,Primary adrenal leiomyosarcoma with lymph node metastasis: a case report.,10.1186/s12957-016-0936-z,,27368929.0,unk,background leiomyosarcoma typically originate smooth muscle cell leiomyosarcoma potentially arising adrenal gland extremely rare mesenchymal tumor associated delayed diagnosis poor prognosis case presentation yearold man visited department complaining right hypochondriac pain computed tomography demonstrated solid mass measuring cm diameter right kidney corresponding right adrenal gland lymph node mass appeared invaded ivc wall right adrenalectomy lymphadenectomy performed microscopic examination revealed primary adrenal leiomyosarcoma lymph node metastasis adjuvant therapy performed patient remains recurrencefree month postoperatively conclusion experienced rare case primary adrenal leiomyosarcoma aggressive surgical resection including vascular reconstruction may associated improved survival,2016,"Onishi, Tomoya; Yanagihara, Yutaka; Kikugawa, Tadahiko; Miura, Noriyoshi; Noda, Terutaka; Kakuda, Toshio; Kitazawa, Riko; Tanji, Nozomu",World journal of surgical oncology,,,,,,https://doi.org/10.1186/s12957-016-0936-z; https://www.ncbi.nlm.nih.gov/pubmed/27368929/,17190689.0,12
43993,43993,56820,wlj64w87,,Medline,Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.,10.1097/md.0000000000003338,,27057913.0,unk,radiofrequency thermal ablation rfa widely used local solitary liver tumor control however benefit rfa colorectal cancer liver metastasis refractory chemotherapy remains unknownwe retrospectively enrolled consecutive colorectal adenocarcinoma patient synchronous liver metastasis refractory chemotherapy whose life expectancy month study investigate outcome rfa associated prognostic factor rfa introduced patient enrollment time interval rfa recurrence liver metastasis overall survival recorded age sex carcinoembryonic antigen level primary tumor location postoperative adjuvant chemotherapy regimen size number metastatic liver lesion recorded cox regression analysis used determine prognostic significancethirtynine patient accepted rfa chemotherapy whereas chose receive chemotherapy alone patient ≤ liver metastasis median survival duration month respectively p dominant liver tumor size v ≥ cm significantly associated median survival v month respectively p carcinoembryonic antigen level v month ≤ v ngml respectively p besides radiofrequency thermal ablation plus chemotherapy associated better median overall survival chemotherapy alone v month respectively p multivariate analysis radiofrequency thermal ablation treatment number liver tumor significant prognostic factor survival result revealed patient treated radiofrequency thermal ablation longer progressionfree interval treated chemotherapy alone v month respectively p hence radiofrequency thermal ablation safe effective adjunct treatment chemotherapy,2016,"Yang, Po-Chih; Lin, Been-Ren; Chen, Yi-Chang; Lin, Yu-Lin; Lai, Hong-Shiee; Huang, Kai-Wen; Liang, Jin-Tung",Medicine,,,,,,https://doi.org/10.1097/md.0000000000003338; https://www.ncbi.nlm.nih.gov/pubmed/27057913/,11748809.0,12
44016,44016,56847,icmhdze1,,Medline,Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.,10.1016/j.urology.2011.10.065,,22386399.0,unk,objective analyze perioperative oncologic outcome cm renal tumor treated laparoscopic radical nephrectomy lrn highvolume academic center indication lrn expanded include larger cm lesion method institutional minimally invasive urologic surgery database present reviewed patient undergoing lrn cm mass american joint committee cancer clinical stage tnm result patient tumor cm tumor cm patient tumor cm presented often symptom often hematuria often highgrade tumor v p also greater proportion papillary renal cell carcinoma v p often upstaged v p tumor upstaged perinephric extension renal vein invasion larger tumor greater blood loss average v ml respectively p converted open surgery often v p total patient experienced postoperative complication year recurrencefree survival cancerspecific survival rate respectively significant predictor recurrencefree survival multivariate model clear cell histologic type high fuhrman grade renal vein invasion perinephric extension note ptb predictor recurrence conclusion lrn favorable perioperative oncologic outcome large cm renal mass open conversion rate complication rate respectively clear cell histologic feature highgrade tumor renal vein invasion perinephric extension tumor size poor prognostic indicator cohort,2012,"Pierorazio, Phillip M; Hyams, Elias S; Lin, Brian M; Mullins, Jeffrey K; Allaf, Mohamad E",Urology,,,,,,https://doi.org/10.1016/j.urology.2011.10.065; https://www.ncbi.nlm.nih.gov/pubmed/22386399/,11733659.0,12
44048,44048,56884,6jgtqnf8,,Medline,Preparation of (99m)Tc carbonyl DTPA-bevacizumab and its bioevaluation in a melanoma model.,10.1007/s12149-014-0887-9,,25038907.0,unk,objective objective study explore potential mtc carbonyl labeled dtpabevacizumab tumor imaging agent bevacizumab avastin humanized monoclonal antibody moab inhibits vascular endothelial growth factor vegf method bevacizumab conjugated paraisothiocyanatobenzyl diethylenetriamine pentaacetic acid pscnbndtpa subsequently radiolabeled mtc via mtc carbonyl synthon radioconjugate purification characterized sehplc vitro stability determined histidine challenge experiment biodistribution study determine uptake tumor carried melanoma model result radiochemical purity mtc carbonyl labeled antibody radiolabeled antibody exhibited good stability histidine challenge experiment h stored °c biodistribution study mouse bearing melanoma showed significant tumor uptake ± idg h pi reduced ± idg coinjection cold bevacizumab conclusion mtc carbonyldtpabevacizumab conjugate good radiochemical purity excellent stability good specificity vegf indicates potential radioimmunoscintigraphy agent various cancer,2014,"Kameswaran, Mythili; Pandey, Usha; Sarma, Haladhar Dev; Samuel, Grace",Annals of nuclear medicine,,,,,,https://doi.org/10.1007/s12149-014-0887-9; https://www.ncbi.nlm.nih.gov/pubmed/25038907/,21386937.0,12
44181,44181,57049,pcr508bu,,Medline,Combination therapy of TACE and CT-guided partial hepatic segment ablation for liver cancer.,10.1080/13645706.2018.1462833,,29671661.0,unk,aim study aimed investigate safety efficacy combination therapy transcatheter arterial chemoembolization tace ctguided percutaneous partial hepatic segment ablation material method liver cancer patient undergoing tace plus partial segment ablation retrospectively analyzed patient characteristic collected tace performed patient ablation ablation ct imaging used evaluate treatment followup overall survival o local tumor progression free survival ltpfs calculated result twentythree patient liver tumor included median tumor maximum diameter mm range mm complete response rate combination therapy one two three fouryear overall survival rate respectively threeyear survival rate bclc stage c hcc patient one two threeyear ltpfs rate respectively tumor maximum diameter vascular invasion partial treatment response independent risk factor ltpfs one patient suffered major complication conclusion tace combined partial hepatic segment thermal ablation safe effective treatment liver cancer patient especially advanced disease,2018,"Wang, Yang; Ma, Liang; Sheng, Shoupeng; Yuan, Zhuhui; Zheng, Jiasheng; Li, Wei",Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy,,,,,,https://doi.org/10.1080/13645706.2018.1462833; https://www.ncbi.nlm.nih.gov/pubmed/29671661/,4951006.0,12
44226,44226,57101,lbnbkqfh,,Medline,Surgical placement of biologic mesh spacers prior to external beam radiation for retroperitoneal and pelvic tumors.,10.1016/j.prro.2012.06.008,,24674365.0,unk,purpose determine feasibility surgical placement biologic mesh spacers displace bowel radiationsensitive organ prior external beam radiation difficult retroperitoneal pelvic tumor method material tumor resected possible intraoperative electron radiation therapy ioert directed tumor tumor bed selected patient biologic mesh spacers comprised cadaveric human skin treated remove cell preserve extracellular matrix alloderm lifecell branchburg nj placed around tumor tumor bed external radiation technique included proton beam radiation therapy pbrt intensity modulated radiation therapy imrt result patient primary sarcoma n radiationassociated sarcoma n isolated metastasis n retroperitoneum pelvis one patient received preoperative radiation three tumor marginally resected r resection tumor left situ patient received ioert gy tumor tumor bed sheet biologic mesh used spacers around tumor tumor bed displace small bowel colon ureter bladder pancreas average distance closest organ prior mesh placement mm mesh placement mm preoperative postoperative radiation gy delivered imrt pbrt early complication mesh placement late complication possibly related radiation included vertebral body compression fracture deep vein thrombosis meshrelated infection none mesh required removal patient currently remain free disease progression month conclusion biologic mesh spacers placed around tumor tumor bed displace radiationsensitive organ may allow safer delivery external beam radiation,2013,"Yoon, Sam S; Chen, Yen-Lin; Kambadakone, Avinash; Schmidt, Benjamin; DeLaney, Thomas F",Practical radiation oncology,,,,,,https://doi.org/10.1016/j.prro.2012.06.008; https://www.ncbi.nlm.nih.gov/pubmed/24674365/,207439544.0,12
44237,44237,57113,yfm9s3g9,,Medline,Cerebellar hemangioblastoma supplied by persistent hypoglossal artery.,10.1136/jnis.2011.004705,,21990467.0,unk,author report unique case intramedullary cerebellar hemangioblastoma supplied persistent hypoglossal artery case recognition persistent hypoglossal artery angiographic imaging crucial identifying tumor blood supply guiding decision perform craniotomy without tumor embolization,2012,"Binning, Mandy J; Siddiqui, Adnan H",Journal of neurointerventional surgery,,,,,,https://doi.org/10.1136/jnis.2011.004705; https://www.ncbi.nlm.nih.gov/pubmed/21990467/,207000800.0,12
44333,44333,57232,gvtjpxcz,,Medline,Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: a pilot study.,10.1186/s12885-016-2421-z,,27387955.0,unk,background detecting superficial head neck squamous cell carcinoma hnscc endoscopy challenging limited morphological hallmark iodine applied head neck lesion due severe mucosal irritation γglutamyltranspeptidase ggt cell surface enzyme overexpressed several cancer reported γglutamyl hydroxymethyl rhodamine green ggluhmrg fluorescent targeting agent enzymatically activated becomes fluorescent cleavage ggtspecific sequence activated within minute application animal model investigated whether early hnscc detected applying ggluhmrg clinical sample method ggluhmrg applied four hnscc cell line fluorescence observed fluorescence microscopy flow cytometry immunohistological examination performed three recent case endoscopic submucosal dissection esd investigate ggt expression fluorescence imaging ggluhmrg eight clinical sample resected esd surgery performed fluorescence intensity tumor normal mucosa region interest roi prospectively measured result four ggluhmrgapplied cell line emitted green fluorescence immunohistological examination demonstrated ggt highly expressed hnscc recent three esd case barely normal mucosa fluorescence imaging showed iodinevoiding lesion became fluorescent within minute application ggluhmrg eight resected tumor tumor roi fluorescence intensity significantly higher normal mucosa five minute ggluhmrg application conclusion fluorescence imaging ggluhmrg would useful early detection hnscc,2016,"Mizushima, Takeshi; Ohnishi, Shunsuke; Shimizu, Yuichi; Hatanaka, Yutaka; Hatanaka, Kanako C; Hosono, Hidetaka; Kubota, Yoshimasa; Natsuizaka, Mitsuteru; Kamiya, Mako; Ono, Shouko; Homma, Akihiro; Kato, Mototsugu; Sakamoto, Naoya; Urano, Yasuteru",BMC cancer,,,,,,https://doi.org/10.1186/s12885-016-2421-z; https://www.ncbi.nlm.nih.gov/pubmed/27387955/,8725782.0,12
44361,44361,57263,og06awuz,,Medline,Late emergence of contrast-enhancing fat necrosis mimicking tumor seeding after renal cryoablation.,10.1016/j.jvir.2013.07.006,,24365507.0,unk,defining radiographic treatment success percutaneous renal ablation challenging due variable ablation zone imaging finding time present report describes two case progressively evident enhancing softtissue nodule perinephric fat year cryoablation despite feature concerning tumor recurrence computed tomography magnetic resonance imaging biopsy revealed fat necrosis case renal ablation zone softtissue nodule appear long ablation enhance contrast medium mimic applicator tract ablation zone tumor seeding may require biopsy confirmation benignity,2014,"Durack, Jeremy C; Richioud, Bertrand; Lyon, James; Solomon, Stephen B",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2013.07.006; https://www.ncbi.nlm.nih.gov/pubmed/24365507/,206658714.0,12
44366,44366,57270,mauopb2t,,Medline,Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.,10.1021/bc900465y,,20302291.0,unk,radiolabeled cholecystokinin cck peptide analogue used peptide receptor radionuclide imaging therapy tumor expressing cckgastrin receptor earlier finding indicated sulfated cck scck asptyrosohmetglytrpmetaspphenh may better characteristic peptide receptor radionuclide therapy prrt gastrin analogue however scck contains easily hydrolyzable sulfated tyrosine residue two methionine residue prone oxidation describe synthesis stabilized scck analogue resistant hydrolysis oxidation hydrolytic stability achieved replacement tyrosoh moiety robust isosteric sulfonate phepchsoh replacement methionine norleucine nle homopropargylglycine hpg avoided undesired oxidation sidereactions phenylalanine analogue phepchsoh ltyrosine synthesized modification known synthetic route incorporated three peptide scckphepchsohmet scckphepchsohnle scckphepchsohhpg peptide nterminally conjugated macrocyclic chelator dota tetraazacyclododecanennnntetraacetic acid radiolabeled vitro binding assay cckrexpressing hek cell revealed three peptide showed specific binding receptormediated internalization binding affinity value ic nanomolar range vitro oxidation study demonstrated peptide nle hpg indeed resistant oxidation vivo targeting study mouse arj tumor showed tumor uptake highest indotascck indotascckphepchsohnle idg respectively h pi peptide methionine residue replaced norleucine indotascckphepchsoh nle showed promising vivo characteristic investigated radionuclide imaging therapy cckrexpressing tumor,2010,"Roosenburg, Susan; Laverman, Peter; Joosten, Lieke; Eek, Annemarie; Oyen, Wim J G; de Jong, Marion; Rutjes, Floris P J T; van Delft, Floris L; Boerman, Otto C",Bioconjugate chemistry,,,,,,https://doi.org/10.1021/bc900465y; https://www.ncbi.nlm.nih.gov/pubmed/20302291/,22834068.0,12
44377,44377,57282,5kb06ydd,,Medline,Off-clamp robot-assisted partial nephrectomy for complex renal tumors.,10.1089/end.2012.0353,,22788753.0,unk,background purpose considering potential impact warm ischemia time wit renal functional outcome robotassisted partial nephrectomy rapn many technique reduce eliminate wit studied present institutional experience progression using one techniqueoffclamp rapnas well result technique management complex case patient method retrospective chart review patient undergoing offclamp rapn performed underwent offclamp rapn complex tumor complex feature included hilar location completely endophytic growth ipsilateral multifocality case hilar vessel dissected clamped result mean tumor size cm standard deviation sd mean nephrometry score sd one intraoperative complication occurred mean estimated blood loss ml sd mean operative time minute sd wit minute case mean length stay day sd one patient needing postoperative blood transfusion clavien ii complication final pathology result demonstrated clearcell carcinoma n papillary carcinoma n angiomyolipoma n oncocytoma n cystic nephroma n margin negative tumor resected mass estimated glomerular filtration rate egfr decreased average mlmin sd p mean followup day sd five patient radiographic followup least month evidence disease recurrence conclusion offclamp rapn safely effectively performed even case complex tumor occurs higher estimated blood loss minimal change egfr experienced patient undergoing offclamp rapn average followup roughly month longer followup direct comparison conventional clamped rapn technique needed establish efficacy offclamp rapn complex case,2012,"Kim, Eric H; Tanagho, Youssef S; Sandhu, Gurdarshan S; Bhayani, Sam B; Figenshau, R Sherburne",Journal of endourology,,,,,,https://doi.org/10.1089/end.2012.0353; https://www.ncbi.nlm.nih.gov/pubmed/22788753/,10828299.0,12
44408,44408,57319,d128by1g,,Medline,"Local surgical, ablative, and radiation treatment of metastases.",10.3322/caac.20013,,19364702.0,unk,local therapy directed toward specific tumor mass known effective treating earlystage cancer surprise considerable historical experience using local therapy metastatic disease recent year increasing interest use local therapy metastasis likely arisen improvement systemic therapy absence effective systemic therapy local treatment often considered futile given difficulty eliminating site identifiable metastatic disease well reality regarding rapid natural history uncontrolled tumor dissemination however higher likelihood patient surviving longer effective systemic therapy even cured goal eradication residual metastasis via potent local therapy rationalized however rationalization evidencebased avoid harming patient established benefit although surgical metastectomy remains common firstline standard among local therapy nonsurgical alternative including thermal ablation stereotactic body radiotherapy become increasingly popular generally le invasive surgery demonstrated considerable promise eradicating macroscopic tumor rather eliminating need local therapy improvement systemic therapy appear increasing prudent utilization modern local therapy patient presenting advanced cancer,2009,"Timmerman, Robert D; Bizekis, Costas S; Pass, Harvey I; Fong, Yuman; Dupuy, Damian E; Dawson, Laura A; Lu, David",CA: a cancer journal for clinicians,,,,,,https://doi.org/10.3322/caac.20013; https://www.ncbi.nlm.nih.gov/pubmed/19364702/,25423810.0,12
44456,44456,57376,e3dwpra9,,Medline,Management of large adnexal tumors by isobaric laparoendoscopic single-site surgery with a wound retractor.,10.1016/j.ejogrb.2012.10.016,,23122034.0,unk,objective report experience isobaric transumbilical laparoendoscopic singlesite surgery management large adnexal tumor exceeding g excised tissue weight including cystic content study design case wound retractor used make working port cm vertical umbilical incision surgical view secured abdominal walllift method intraabdominal fan retractor system tumor punctured sand balloon catheter cystic content aspirated surgical procedure performed conventional laparoscopic instrument vision rigid ° mm endoeye laparoscope clinical data regarding patient demographic surgical outcome retrospectively analyzed result october april patient large adnexal tumor treated median age patient year previous abdominal surgery noted nine case median tumor diameter cm emergency surgery performed two case adnexal torsion one case tumor rupture three case intrauterine pregnancy treated late first trimester unilateral salpingooophorectomy performed case unilateral cystectomy performed five case unilateral salpingooophorectomy contralateral cystectomy bilateral cystectomy performed two case unilateral salpingectomy unilateral salpingooophorectomy contralateral salpingectomy performed one case median excised tissue weight g median surgical duration min median blood loss ml extended hospitalization required two case due elevated inflammatory parameter one case pregnancy due hyperemesis gravidarum one case pregnancy due subchorionic hematoma readmission due postoperative pelvic abscess noted one case conservatively managed major surgical complication experienced present technique yielded minimal postoperative scar concealed within umbilicus conclusion transumbilical wound retraction system combined intraabdominal fan retractor appears contribute favorably laparoendoscopic singlesite surgery management large adnexal tumor device permit flexible wide circumferential access efficient wound retraction instrumentation without need closed condition associated pneumoperitoneum,2013,"Takeda, Akihiro; Imoto, Sanae; Mori, Masahiko; Yamada, Junko; Nakamura, Hiromi","European journal of obstetrics, gynecology, and reproductive biology",,,,,,https://doi.org/10.1016/j.ejogrb.2012.10.016; https://www.ncbi.nlm.nih.gov/pubmed/23122034/,25848616.0,12
44517,44517,57448,0r8gvx86,,Medline,Liver tumor ablation: percutaneous and open approaches.,10.1002/jso.21364,,20017157.0,unk,global incidence liver cancer greater million case year surgical resection applicable still standard care patient various liverdirected regional therapy developed effort treat vast majority unresectable liver tumor article review principle behind various ablation therapy currently available malignant liver tumor outcome,2009,"Padma, Srikanth; Martinie, John B; Iannitti, David A",Journal of surgical oncology,,,,,,https://doi.org/10.1002/jso.21364; https://www.ncbi.nlm.nih.gov/pubmed/20017157/,23936687.0,12
44539,44539,57476,bccboqfy,,Medline,The importance and timing of optic canal exploration and decompression during endoscopic endonasal resection of tuberculum sella and planum sphenoidale meningiomas.,10.1227/neu.0b013e318258e23d,,22517253.0,unk,background suprasellar meningioma often invade optic canal ocs feasibility removing tumor minimalaccess endonasal route demonstrated importance safety timing oc exploration decompression well described objective create simple decisiontree algorithm oc exploration decompression endonasal endoscopic surgery planum sphenoidale tuberculum sella meningioma method identified consecutive series planum sphenoidale tuberculum sella meningioma resected endonasally late oc exploration decompression performed patient extent resection visual outcome complication recorded result five patient oc invasion magnetic resonance imaging endoscopic inspection reveal additional oc invasion oc opened bilaterally patient unilaterally patient gross total resection achieved patient goal vision improved patient ocs opened stable ocs opened patient bitemporal hemianopsia improved unilateral deterioration oc invasion tumor extremely adherent optic nerve average followup month patient glasgow outcome scale score cerebrospinal fluid leak conclusion exploration decompression oc feasible safe important optimize visual outcome minimize recurrence planum sphenoidale tuberculum sella meningioma resected endonasally may important open canal early surgery tumor debulking performed without manipulating optic nerve early decompression however technically feasible,2012,"Attia, Moshe; Kandasamy, Jothy; Jakimovski, Dejan; Bedrosian, Jeffrey; Alimi, Marjan; Lee, Dennis L Y; Anand, Vijay K; Schwartz, Theodore H",Neurosurgery,,,,,,https://doi.org/10.1227/neu.0b013e318258e23d; https://www.ncbi.nlm.nih.gov/pubmed/22517253/,39121229.0,12
44567,44567,57508,826irqj6,,Medline,Review of robot-assisted partial nephrectomy in modern practice.,10.15586/jkcvhl.2015.23,,28326257.0,unk,partial nephrectomy pn currently standard treatment renal tumor minimally invasive pn offer decreased blood loss shorter length stay rapid convalescence improved cosmesis due challenge inherent laparoscopic partial nephrectomy dissemination stifled robotassisted partial nephrectomy rapn offer intuitive platform perform minimally invasive pn one fastest growing robotic procedure among surgical subspecialties rapn continues improve upon oncological functional outcome renal tumor extirpative therapy herein describe surgical technique outcome complication rapn,2015,"Potretzke, Aaron M; Weaver, John; Benway, Brian M",Journal of kidney cancer and VHL,,,,,,https://doi.org/10.15586/jkcvhl.2015.23; https://www.ncbi.nlm.nih.gov/pubmed/28326257/,10735280.0,12
44570,44570,57512,3azigru1,,Medline,Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.,10.1016/j.biomaterials.2015.03.043,,25934284.0,unk,ultrasound molecular imaging great potential impact early disease diagnosis evaluation disease progression development targetspecific therapy paper two neuropilin nrp targeted peptide crppr atwlppr conjugated onto surface lipid microbubbles mb evaluate molecular imaging tumor angiogenesis breast cancer model development molecular imaging agent using crppr particular importance due previously demonstrated internalizing capability similar ligand vitro crppr mb bound nrpexpressing cell line time atwlppr mb nontargeted nt mb respectively binding inhibited pretreating cell nrp antibody vivo backscattered intensity within tumor relative nearby vasculature increased time ∼ min circulation crpprtargeted contrast agent providing high contrast image angiogenic tumor approximately initial signal crppr mb remained bound majority circulating mb cleared min time greater atwlppr nt mb respectively finally day first injection found crppr mb cleared faster circulation tumor accumulation reduced likely due complementmediated recognition targeted microbubble decrease angiogenic vasculature respectively summary find crppr mb specifically bind nrpexpressing cell provide effective new agent molecular imaging angiogenesis,2015,"Zhang, Hua; Tam, Sarah; Ingham, Elizabeth S; Mahakian, Lisa M; Lai, Chun-Yen; Tumbale, Spencer K; Teesalu, Tambet; Hubbard, Neil E; Borowsky, Alexander D; Ferrara, Katherine W",Biomaterials,,,,,,https://doi.org/10.1016/j.biomaterials.2015.03.043; https://www.ncbi.nlm.nih.gov/pubmed/25934284/,32855795.0,12
44644,44644,57593,3t3ainy6,,Medline,Percutaneous Trans-Tracheal Endoscopic Approach: A Novel Technique for the Excision of Benign Lesions of Thoracic Trachea.,10.1089/lap.2017.0224,,28723308.0,unk,introduction currently neoplasm trachea lower airway demand open transcervical approach without thoracotomy describe novel minimally invasive approach intraluminal lesion thoracic trachea called percutaneous transtracheal endoscopic approach ptea apart obvious advantage potentially morbid open procedure technique certain peculiar benefit rigid flexible bronchoscopic approach material method yearold male patient glomus tumor thoracic trachea detailed workup informed written consent taken percutaneous transtracheal excision general anesthesia foremost step procedure awake fiberoptic guided intubation using microlaryngeal tracheal tube followed elective tracheotomy subsequently lower end microlaryngeal tube carefully pushed inside trachea cuff tube lie distal tumor cuff inflated operating area sealed lower airway aid continuous inhalational anesthesia prevent aspiration blood surgeon sitting head end removed tumor tracheotomy endoscopic guidance achieving absolute hemostasis neck wound closed result patient complete removal tumor without aspiration intraoperatively postoperative period anesthetic agent could delivered uninterrupted secured airway operative area separated sealed cuff microlaryngeal tube conclusion excision benign luminal lesion lower trachea novel approach ptea many distinct fool proof advantage comparison transoral laryngoscopicbronchoscopic transcervical approach,2018,"Sharma, Suresh C; Devaraja, K; Kairo, Arvind; Kumar, Rakesh",Journal of laparoendoscopic & advanced surgical techniques. Part A,,,,,,https://doi.org/10.1089/lap.2017.0224; https://www.ncbi.nlm.nih.gov/pubmed/28723308/,1165632.0,12
44645,44645,57595,rsygcqjn,,Medline,Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody.,10.1016/j.nucmedbio.2011.04.005,,22137850.0,unk,introduction human epidermal growth factor receptor type overexpression support proliferation androgenindependent prostate cancer pc radionuclide molecular imaging expression disseminated pc would aid selection patient likely responder targeting therapy study evaluated whether aby affibody molecule small ∼ kda herbinding scaffold protein produce superior tumortonontumor ratio compared obtained use radiolabeled humanized antiher antibody trastuzumab influence v radiolabel evaluated tracer method aby labeled using tetraazacyclododecanetetraacetic acid chelator sitespecifically coupled cterminus via maleimido derivative trastuzumab labeled using chxa″ diethylene triamine pentaacetic acid dtpa chelator indirect radioiodination insuccinimidylparaiodobenzoate used targeting protein biodistribution labeled targeting protein evaluated mouse bearing du pc xenograft result use residualizing inlabel facilitated better tumor uptake better tumortonontumor ratio targeting agent inaby provided tumor uptake ± injected dose per gram tissue idg tumortoblood ratio ± already h postinjection maximum tumortonontumor ratio inchxdtpatrastuzumab achieved h postinjection whereas tumor uptake ± idg tumortoblood ratio ± biodistribution data confirmed gammacamera imaging conclusion radiolabeled aby affibody molecule provides higher contrast imaging herexpressing pc xenograft radiolabeled trastuzumab residualizing radiometal label aby provides better contrast imaging herexpressing pc xenograft nonresidualizing radiohalogen,2011,"Malmberg, Jennie; Sandström, Mattias; Wester, Kenneth; Tolmachev, Vladimir; Orlova, Anna",Nuclear medicine and biology,,,,,,https://doi.org/10.1016/j.nucmedbio.2011.04.005; https://www.ncbi.nlm.nih.gov/pubmed/22137850/,37118703.0,12
44761,44761,57722,54q76noa,,Medline,Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.,10.2214/ajr.12.8618,,23345372.0,unk,objective purpose article compare efficacy complication rate percutaneous radiofrequency ablation rfa cryoablation treatment renal mass measuring cm smaller material method retrospective review performed patient tumor measuring cm smaller treated thermal ablation two hundred fiftysix tumor patient treated rfa mean ± sd tumor size ± cm tumor patient treated cryoablation mean tumor size ± cm major complication efficacy measured technical success local tumor recurrence rate recorded result five technical failure including one among tumor treated rfa four among tumor treated cryoablation p tumor treated rfa followup beyond month seven developed local tumor recurrence mean year treatment range year tumor treated cryoablation followup beyond month four developed local tumor recurrence mean year treatment range year biopsyproven renal cell carcinoma estimated local recurrencefree survival rate year rfa respectively compared respectively cryoablation p major complication occurred rfas cryoablation procedure p conclusion rfa cryoablation effective treatment renal mass measuring cm smaller major complication either procedure infrequent,2013,"Atwell, Thomas D; Schmit, Grant D; Boorjian, Stephen A; Mandrekar, Jay; Kurup, A Nicholas; Weisbrod, Adam J; Chow, George K; Leibovich, Bradley C; Callstrom, Matthew R; Patterson, David E; Lohse, Christine M; Thompson, R Houston",AJR. American journal of roentgenology,,,,,,https://doi.org/10.2214/ajr.12.8618; https://www.ncbi.nlm.nih.gov/pubmed/23345372/,3392380.0,12
44832,44832,57800,e69eej3n,,Medline,Surgical treatment of gallbladder carcinoma: a critical review.,10.1007/s13304-015-0328-x,,26563387.0,unk,gallbladder carcinoma relatively uncommon cancer gastrointestinal gi tract medical literature full nihilistic report treatment gallbladder carcinoma especially due resistance current radiotherapeutic chemotherapeutic treatment modality difficult surgical approach complete resection tumor herein review current diagnostic therapeutic approach rare gi cancer,2015,"Kakaei, Farzad; Beheshtirouy, Samad; Nejatollahi, Seyed Mohammadreza; Zarrintan, Sina; Mafi, Mohammad Reza",Updates in surgery,,,,,,https://doi.org/10.1007/s13304-015-0328-x; https://www.ncbi.nlm.nih.gov/pubmed/26563387/,28597436.0,12
44913,44913,57898,rnbbv98t,,Medline,A novel technique to minimize deformation of the stomach in laparoscopic partial gastrectomy for intraluminal gastric GISTs.,10.1089/lap.2014.0184,,25181572.0,unk,background laparoscopic approach would difficult perform without causing deformation stomach managing gastrointestinal stromal tumor gist intraluminal type especially located posterior gastric wall around gastroesophageal junction pylorus intraluminal gist usually require excessive resection gastric wall cure present novel surgical technique successful management intraluminal gastric gist minimizes deformation stomach regardless tumor location material method operating surgeon handle tumor holding tissue surrounding tumor performs seromyotomy using ultrasonically activated device along outer edge tumor tumor gradually protrudes like extraluminal tumor seromyotomy proceeds seromyotomy along tumor come point tumor sufficiently turn gastric serosa tumor look like pedunculated extraluminal gist two seromuscular suture applied close exfoliated seromuscular layer tip two seromuscular suture held pulled toward ventral side staple line aligned line minor axis stomach finally complete tumor removal minimal seromuscular resection accomplished applying linear stapler result patient resumed oral ingestion day surgery showed sign anastomotic constriction obstruction conclusion laparoscopic procedure gastric gist simple allows u easy precise removal tumor closure gastric wall minimum necessary resection regardless location growth form tumor,2014,"Hirahara, Noriyuki; Matsubara, Takeshi; Kidani, Akihiko; Hyakudomi, Ryoji; Fujii, Yusuke; Tajima, Yoshitsugu",Journal of laparoendoscopic & advanced surgical techniques. Part A,,,,,,https://doi.org/10.1089/lap.2014.0184; https://www.ncbi.nlm.nih.gov/pubmed/25181572/,10875876.0,12
44951,44951,57939,nuycyuqc,,Medline,Radiofrequency ablation of liver cancers adjacent to the gallbladder without gallbladder isolation under contrast-enhanced ultrasound monitoring: a preliminary study.,10.1080/02656736.2018.1539776,,30489164.0,unk,purpose purpose study investigate feasibility safety efficacy intraprocedural contrastenhanced ultrasound ceus monitoring radiofrequency ablation rfa liver cancer adjacent gallbladder gb without gb isolation material method may july patient liver cancer adjacent gb ≤ mm intended undergo ultrasoundguided rfa without gb isolation hospital prospectively enrolled rfa procedure ceus employed evaluate therapeutic response perfusion intact gb wall outcome gb liver cancer followed recorded result patient male female liver cancer mean mm range mm adjacent gb enrolled tumor abutted gb tumor located within mm gb rfa procedure intraprocedural ceus evaluation demonstrated perfusion gb wall intact patient technical success rate rfa according contrastenhanced ctmr one month rfa technical efficacy rate followup period range month median month local tumor progression occurred major complication arised overall survival year thickening gb wall detected patient thickness gb wall returned preablation level five patient conclusion ceusmonitored rfa liver cancer adjacent gb without gb isolation feasible safe effective,2019,"Long, Yinglin; Yan, Ronghua; Li, Kai; Luo, Liping; Zeng, Qingjing; Tan, Lei; Zhang, Man; Zheng, Rongqin; Xu, Erjiao","International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",,,,,,https://doi.org/10.1080/02656736.2018.1539776; https://www.ncbi.nlm.nih.gov/pubmed/30489164/,54111249.0,12
44975,44975,57968,2yt88twu,,Medline,Sonographic diagnosis of abscess following breast-conserving surgery with insertion of nonabsorbable mesh.,10.1002/jcu.22148,,24659502.0,unk,immediate mesh insertion recently used breast reconstruction breastconserving surgery report case abscess formation following immediate nonabsorbable mesh insertion breastconserving surgery article demonstrate multimodal breast imaging feature pathologic correlation case addition illustrate characteristic sonographic finding nonabsorbable mesh fiber differentiate gossypiboma caused retained surgical sponge tumor recurrence,2014,"Song, Sung Eun; Seo, Bo Kyoung; Son, Gil-Soo; Kim, Young-Sik",Journal of clinical ultrasound : JCU,,,,,,https://doi.org/10.1002/jcu.22148; https://www.ncbi.nlm.nih.gov/pubmed/24659502/,7617414.0,12
44983,44983,57977,1dmkd623,,Medline,Management and prevention of acute bleedings in the head and neck area with interventional radiology.,10.1186/s13005-016-0103-3,,26803587.0,unk,background interventional neuroradiology becoming important interdisciplinary treatment acute haemorrhage due vascular erosion vascular tumor head neck area author report acute extracranial haemorrhage emergency situation also preventive embolization good vascularized tumor preoperatively outcome method retrospective analysis patient underwent interdisciplinary approach orl department interventional neuroradiology ½ year department otorhinolaryngology klinikum rechts der isar technical university munich germany outcome analysed term success embolization blood loss survival rate treatment failure result patient treated acute haemorrhage twentyfive attributable vascular erosion case malignant tumor affected vessel common carotid artery well internal external part branch like ascending pharyngeal facial superior thyroid artery altogether patient treated malignant tumor attributable acute haemorrhage due epistaxis tonsillectomy benign tumor bleeding attributable inflammation treatment patient consisted either unsuccessful approach via exposure package bleeding electrocoagulation surgical ligature followed embolization primary treatment via interventional embolizationstenting conclusion common monitoring patient orl interventional neuroradiology important alternative especially treatment severe acute haemorrhage following vascular erosion malignant tumor benign disease also preoperative embolization good vascularized tumor must taken account prevent severe blood loss acute intraoperative bleeding,2016,"Storck, Katharina; Kreiser, Kornelia; Hauber, Johannes; Buchberger, Anna-Maria; Staudenmaier, Rainer; Kreutzer, Kilian; Bas, Murat",Head & face medicine,,,,,,https://doi.org/10.1186/s13005-016-0103-3; https://www.ncbi.nlm.nih.gov/pubmed/26803587/,5928189.0,12
45029,45029,58028,a8pk5f65,,Medline,Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study.,10.3348/kjr.2016.17.5.742,,27587963.0,unk,objective evaluate feasibility angled cooltip electrode radiofrequency ablation small superficial subcapsular liver tumor abutting abdominal wall order traverse normal liver parenchyma thereby obtain favorable configuration ablation margin material method study retrospectively analyzed small superficial subcapsular liver tumor abutting abdominal wall patient treated radiofrequency ablation march june using cooltip electrode manually modified create ° angle junction exposed insulated segment tumor hepatocellular carcinoma n metastasis n cholangiocellular carcinoma rectosigmoid cancer maximum diameter mm mean ± mm ultrasonographic guidance electrode tip advanced depth tumor epicenter cm margin tip redirected penetrate tumor radiofrequency ablation minimal ablation margin measured immediate posttreatment ct radiological image medical record evaluated success rate length minimal ablation margin complication result technical success rate obtaining complete necrosis tumor procedurerelated complication minimal ablation margin ranged mm mean ± mm ctmri followup day mean ± day revealed local recurrence distant recurrence patient conclusion using angled cooltip electrode radiofrequency ablation small superficial subcapsular tumor abutting abdominal wall may feasible technique obtaining adequate ablation margin lower complication rate,2016,"Park, Sung Il; Kim, Il Jung; Lee, Shin Jae; Shin, Min Woo; Shin, Won Sun; Chung, Yong Eun; Kim, Gyoung Min; Kim, Man Deuk; Won, Jong Yun; Lee, Do Yun; Choi, Jin Sub; Han, Kwang-Hyub",Korean journal of radiology,,,,,,https://doi.org/10.3348/kjr.2016.17.5.742; https://www.ncbi.nlm.nih.gov/pubmed/27587963/,1468636.0,12
45067,45067,58073,uvv2a75a,,Medline,Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases.,10.1007/s00464-014-3999-3,,25427420.0,unk,background relationship width surgical margin local distant recurrence colorectal liver metastasis crlm remain controversial analyzed impact surgical margin laparoscopic liver resection llr crlm using parenchymalsparing approach overall o recurrencefree survival rf method january october first llr crlm performed retrospectively analyzed ultrasonic aspirator used parenchyma division r margin defined tissue width mm result mean followup ± month o rf year respectively major resection rate median margin width mm r resection recorded case twentytwo patient hepatic recurrence underwent repeat hepatectomy r margin significantly related lower rf survival p affect o multivariate analysis showed lesion located posterosuperior segment hr ci p well blood loss hr ci p independent risk factor tumor recurrence carcinoembryonic antigen level mcgl affected o hr ci p resection two tumor significantly associated r margin hr ci p discussion laparoscopic parenchymalsparing surgery crlm compromise oncological outcome allowing higher percentage repeat hepatectomy r margin risk factor tumor recurrence overall survival presence multiple lesion independent risk factor r margin also major disadvantage technique,2015,"Montalti, Roberto; Tomassini, Federico; Laurent, Stéphanie; Smeets, Peter; De Man, Marc; Geboes, Karen; Libbrecht, Louis J; Troisi, Roberto I",Surgical endoscopy,,,,,,https://doi.org/10.1007/s00464-014-3999-3; https://www.ncbi.nlm.nih.gov/pubmed/25427420/,2859710.0,12
45072,45072,58079,1v09q1hc,,Medline,In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.,10.2967/jnumed.114.153023,,25791989.0,unk,unlabelled breast cancer bc consists multiple subtypes defined various molecular characteristic instance estrogen receptor er expression method visualizing bc include mammography mr imaging ultrasound nuclear medicinebased method mtcsestamibi ffdg pet unfortunately lacking specificity peptide receptor scintigraphy peptide receptor radionuclide therapy successfully applied imaging therapy somatostatin receptorexpressing neuroendocrine tumor using somatostatin receptor radioligands basis similar rationale radioligands targeting gastrinreleasing peptide receptor grpr might offer specific method imaging therapy bc aim study explore application grpr radioligands imaging therapy bc introducing valid preclinical vitro vivo model method grpr expression clinical bc specimen correlation er expression studied vitro autoradiography grpr agonist inamba grpr expression also analyzed bc cell line applying inamba internalization assay quantitative reverse transcriptase polymerase chain reaction vitro cytotoxicity luamba determined grprexpressing bc cell line td spectct imaging biodistribution studied mouse subcutaneous orthotopic erpositive td mcf xenograft injection grpr antagonist injmv result human bc specimen bc cell line found express grpr grpr tumor expression positively p χ correlated er expression human bc specimen treatment td cell mbq luamba resulted reduction cell vitro furthermore subcutaneous orthotopic tumor bc cell line successfully visualized vivo spectct using injmv td tumor exhibited higher uptake mcf xenograft conclusion targeting grprexpressing bc tumor using grpr radioligands promising nuclear imaging therapy especially erpositive bc patient,2015,"Dalm, Simone U; Martens, John W M; Sieuwerts, Anieta M; van Deurzen, Carolien H M; Koelewijn, Stuart J; de Blois, Erik; Maina, Theodosia; Nock, Berthold A; Brunel, Luc; Fehrentz, Jean-Alain; Martinez, Jean; de Jong, Marion; Melis, Marleen","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.114.153023; https://www.ncbi.nlm.nih.gov/pubmed/25791989/,9187259.0,12
45078,45078,58085,iuvdn9o5,,Medline,Total laparoscopic surgery for treatment of leiomyoma of the transverse colon in a patient with an abdominal mesh: A case report.,10.1016/j.ijscr.2019.09.043,,31610453.0,unk,introduction gastrointestinal stromal tumor common mesenchymal tumor gastrointestinal tract however gastrointestinal leiomyoma relatively rare surgical resection recommended leiomyoma gastrointestinal stromal tumor colon present case performed laparoscopic right hemicolectomy intraabdominal anastomosis treating leiomyoma transverse colon patient abdominal mesh presentation case yearold woman history right subtotal adrenalectomy right mastectomy incidentally found abdominal mass followup computed tomography ct scan confirmed gastrointestinal stromal tumor mesentery following abdominal contrastenhanced ct planned surgical resection preoperative diagnosis tumor cm diameter however undergone transverse rectus abdominis myocutaneous tram flap reconstruction right mastectomy tram flap replaced abdominal mesh hence total laparoscopic surgery performed avoid damaging mesh owing risk mesh infection laparotomy revealed tumor originated transverse colon thus transverse colectomy intraabdominal anastomosis performed total operative time blood loss h min ml respectively postoperative leakage mesh infection observed resected specimen revealed leiomyoma without malignancy discussion successfully performed colectomy minimized resection range intraabdominal anastomosis conclusion total laparoscopic surgery effective colonic leiomyoma abdominal mesh avoid meshrelated complication,2019,"Fujimoto, Goshi; Osada, Shunichi",International journal of surgery case reports,,,,,,https://doi.org/10.1016/j.ijscr.2019.09.043; https://www.ncbi.nlm.nih.gov/pubmed/31610453/,204702857.0,12
45167,45167,58188,agqj8uhd,,Medline,Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.,10.1111/j.1440-1746.2010.06559.x,,21054516.0,unk,background aim kupffer imaging contrastenhanced ultrasonography ceus sonazoid last min longer may useful ultrasoundguided percutaneous tumor ablation utility sonazoid radiofrequency ablation rfa hepatocellular carcinoma hcc investigated study method analyzed total hcc nodule detected dynamic computed tomography patient detectability nodule compared ceus conventional ultrasonography effectiveness treatment assessed comparing mean number treatment session rfa patient treated ceus historical control matched tumor background condition result detectability tumor nodule conventional ultrasonography ceus p sixtynine nodule patient additionally detected ceus number additionally detected tumor nodule positively correlated serum albumin level p number rfa session ± ceus compared ± historical control p conclusion ceus sonazoid useful hcc detection patient wellconserved liver function reservoir decrease rfa session number indicated utility sonazoid rfa treatment hcc,2011,"Masuzaki, Ryota; Shiina, Shuichiro; Tateishi, Ryosuke; Yoshida, Haruhiko; Goto, Eriko; Sugioka, Yosuke; Kondo, Yuji; Goto, Tadashi; Ikeda, Hitoshi; Omata, Masao; Koike, Kazuhiko",Journal of gastroenterology and hepatology,,,,,,https://doi.org/10.1111/j.1440-1746.2010.06559.x; https://www.ncbi.nlm.nih.gov/pubmed/21054516/,5190992.0,12
45171,45171,58193,cf2lkk3z,,Medline,Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.,10.1053/j.gastro.2016.02.070,,26946344.0,unk,background aim role radiation therapy treatment patient pancreatic ductal adenocarcinoma pda controversial randomized controlled trial investigating efficacy radiation therapy patient locally advanced unresectable pda reported mixed result effect ranging modest benefit worse outcome compared control therapy investigated whether radiation cause inflammatory cell acquire immunesuppressive phenotype limit therapeutic effect radiation invasive pda accelerates progression preinvasive focus method investigated effect radiation therapy pcrelslkrasgd kc pcrelslkrasgdlsltrprh kpc mouse well cbl mouse orthotopic tumor grown fc cell derived kpc mouse mouse given neutralizing antibody macrophage colonystimulating factor csf mcsf f pancreata exposed dos radiation ranging gy analyzed flow cytometry result pancreata kc mouse exposed radiation higher frequency advanced pancreatic intraepithelial lesion focus invasive cancer pancreata unexposed mouse control radiation reduced survival time month greater proportion macrophage radiation treated invasive preinvasive pancreatic tumor immunesuppressive mlike phenotype compared control mouse pancreata mouse exposed radiation fewer cd cell control greater number cd cell thelper tregulatory cell phenotype adoptive transfer cell irradiated pda tumor control mouse accelerated tumor growth radiation induced production mcsf pda cell neutralizing antibody mcsf prevented radiation altering phenotype macrophage tumor increasing antitumor tcell response slowing tumor growth conclusion radiation treatment cause macrophage murine pda acquire immunesuppressive phenotype disabled tcellmediated antitumor response mcsf blockade negates effect allowing radiation increased efficacy slowing tumor growth,2016,"Seifert, Lena; Werba, Gregor; Tiwari, Shaun; Giao Ly, Nancy Ngoc; Nguy, Susanna; Alothman, Sara; Alqunaibit, Dalia; Avanzi, Antonina; Daley, Donnele; Barilla, Rocky; Tippens, Daniel; Torres-Hernandez, Alejandro; Hundeyin, Mautin; Mani, Vishnu R; Hajdu, Cristina; Pellicciotta, Ilenia; Oh, Philmo; Du, Kevin; Miller, George",Gastroenterology,,,,,,https://doi.org/10.1053/j.gastro.2016.02.070; https://www.ncbi.nlm.nih.gov/pubmed/26946344/,5423696.0,12
45173,45173,58195,cbknwgvt,,Medline,Percutaneous ablation of peribiliary tumors with irreversible electroporation.,10.1016/j.jvir.2013.10.012,,24262034.0,unk,purpose ass biliary complication irreversible electroporation ire ablation hepatic tumor located cm major bile duct material method retrospective review conducted percutaneous ire ablation hepatic tumor within cm common left right hepatic duct single institution january september computed tomography imaging performed treatment examined evidence bile duct dilatation stricture leakage serum bilirubin alkaline phosphatase level analyzed evidence biliary injury result hepatic metastasis patient least one tumor within cm common left right hepatic duct treated ire ablation session median tumor size treated cm mean cm ± range cm laboratory value obtained ire considered abnormal four treatment session three patient bilirubin mgdl alkaline phosphatase ul abnormal value transient two session two patient prolonged elevation value one required stent placement condition appeared secondary tumor progression rather bile duct injury conclusion clinical experience suggests ire may treatment option centrally located liver tumor margin adjacent major bile duct thermal ablation technique contraindicated study extended followup period necessary establish safety profile ire setting,2014,"Silk, Mikhail T; Wimmer, Thomas; Lee, Kyungmouk S; Srimathveeravalli, Govindarajan; Brown, Karren T; Kingham, Peter T; Fong, Yuman; Durack, Jeremy C; Sofocleous, Constantinos T; Solomon, Stephen B",Journal of vascular and interventional radiology : JVIR,,,,,,https://doi.org/10.1016/j.jvir.2013.10.012; https://www.ncbi.nlm.nih.gov/pubmed/24262034/,30484220.0,12
45313,45313,58365,1rpup91j,,Medline,The role of radioprotective spacers in clinical practice: a review.,10.21037/qims.2018.06.06,,30050786.0,unk,delivery high dose radiotherapy tumor often limited proximity surrounding radiosensitive normal tissue even using modern technique intensity modulated radiation therapy imrt previous study reported placement spacer effectively displace normal tissue distance away lesion thus allowing safe delivery highdose radiation application radioprotective spacers first reported year ago regarding radiotherapy tongue abdominal cancer recently increasingly used prostate cancer review focus published data concerning feature different type spacers application various tumor site placementrelated complication costeffectiveness spacers also discussed increasing use highprecision radiotherapy clinical practice especially paradigmchanging stereotactic body radiotherapy sbrt robust study warranted establish role radioprotective spacers material development novel placement technique,2018,"Tang, Qiuying; Zhao, Feng; Yu, Xiaokai; Wu, Lingyun; Lu, Zhongjie; Yan, Senxiang",Quantitative imaging in medicine and surgery,,,,,,https://doi.org/10.21037/qims.2018.06.06; https://www.ncbi.nlm.nih.gov/pubmed/30050786/,51724825.0,12
45330,45330,58383,nzqst4ap,,Medline,Identification and characterization of a peptide with affinity to head and neck cancer.,10.2967/jnumed.108.058123,,19223422.0,unk,unlabelled combination therapy improved quality life patient squamous cell carcinoma head neck hnsccs decisively changed prognosis targeted therapy enhance accumulation drug tumor may realized using tumorspecific binding peptide paper identifies characterizes hnscc affine peptide method phage library comprising different displayed peptide peptide enriched vitro selection round hno tumor cell subsequently gained peptide sequence hnsprgdlavlghkyconh hbp synthesized amide labeled vitro study binding kinetics competition performed different hnscc cell line furthermore stability peptide evaluated human serum vivo biodistribution ilabeled peptide determined hnscc tumorbearing nude mouse result validated human hnscc tumor tissue section using fluorescencelabeled hbp competition experiment performed determine binding sequence validate target result hbp motif enriched phage sequenced labeled ihbp showed binding different hnscc cell line maximum binding hno cell applied dose per cell inhibitory concentration nm stability experiment human serum showed halflife min different hnscc tumor xenograft ihbp accumulated rapidly stable uptake min intravenous application peptide immunohistochemistry hnscc tissue section exhibited tumor staining hbp whereas normal tissue remained negative sequence mutation competition experiment revealed intrinsic rgd motif combination intrinsic lxxl motif responsible binding ability hbp rgdlxxl sequence within peptide known indicates binding occurs via alphavbeta rather alphavbeta integrin conclusion within sequence hbp rgdlxxl motif likely targeting alphavbeta receptor integrin family cell adhesion receptor hbp represents promising lead structure development targeted therapy diagnostic procedure patient hnscc,2009,"Nothelfer, Eva-Maria; Zitzmann-Kolbe, Sabine; Garcia-Boy, Regine; Krämer, Susanne; Herold-Mende, Christel; Altmann, Annette; Eisenhut, Michael; Mier, Walter; Haberkorn, Uwe","Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,,,,https://doi.org/10.2967/jnumed.108.058123; https://www.ncbi.nlm.nih.gov/pubmed/19223422/,45813295.0,12
45355,45355,58412,p7bex538,,Medline,Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.,10.1245/s10434-013-3140-1,,23897007.0,unk,background objective work evaluate feasibility histopathological analysis tissue extracted multitined electrode ass whether tissue characteristic used biomarkers oncologic outcome lung tumor radiofrequency rf ablation method treatmentrelated data regarding rf ablation lung malignancy institution collected using health insurance portability accountability actcompliant ablation database institutional review board waiver obtained study immunohistochemical analysis tissue extracted electrode lung tumor rf ablation performed proliferation ki apoptosis caspase patient tumor demographic ablation parameter recorded local tumor progressionfree survival lpfs diseasespecific survival ds overall survival o assessed using kaplanmeier methodology multivariate analysis determined factor affecting oncological outcome result total lung tumor patient ablated specimen classified coagulation necrosis cn kipositive tumor cell viable tumor size similar cn ki group p median lpfs versus month ki cn group year lpfs respectively p median o month p median ds month p ki cn group respectively identification ki tumor cell tripled risk death cancer hazard ratio hr confidence interval ci p tripled risk local tumor progression ltp hr ci p conclusion ki tumor cell electrode pulmonary tumor rf ablation independent predictor ltp shorter lpfs ds,2013,"Sofocleous, Constantinos T; Garg, Sandeep K; Cohen, Perry; Petre, Elena N; Gonen, Mithat; Erinjeri, Joseph P; Downey, Robert J; Travis, William D; Solomon, Stephen B",Annals of surgical oncology,,,,,,https://doi.org/10.1245/s10434-013-3140-1; https://www.ncbi.nlm.nih.gov/pubmed/23897007/,22160813.0,12
45404,45404,58471,hrns9c1h,,Medline,Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.,10.1177/0148607115581838,,25888676.0,unk,background doxorubicin dox one effective antitumor agent broad spectrum malignancy however doxinduced cardiotoxicity form major cumulative doselimiting factor glutamine ω polyunsaturated fatty acid pufas putatively cardioprotective various stress andor potential chemosensitizing effect cancer chemotherapy method antitumor activity cardiotoxicity dox treatment evaluated simultaneously matbiii mammary adenocarcinoma tumorbearing rat model treated dox cumulative dose mgkg single combined treatment parenteral glutamine gkg ω pufas gkg eicosapentaenoic acid gkg docosahexaenoic acid administered every day starting day chemotherapy initiation end study day result glutamine alone significantly prevented doxrelated deterioration cardiac function reduced serum cardiac troponin level diminished cardiac lipid peroxidation affecting tumor inhibition kinetics single ω pufa treatment significantly enhanced antitumor activity dox associated intensified tumoral oxidative stress enhanced tumoral dox concentration potentiating cardiac dysfunction increasing cardiac oxidative stress intriguingly providing glutamine ω pufas together consistently confer greater benefit conversely individual benefit cardiotoxicity chemosensitization mostly attenuated completely lost combined conclusion data demonstrate interesting differentiality even dichotomy response tumor host single parenteral glutamine ω pufa treatment intriguing glutamine × ω pufa interaction observed draw question common assumption additive benefit combination nutrient beneficial individual basis,2016,"Xue, Hongyu; Ren, Wenhua; Denkinger, Melanie; Schlotzer, Ewald; Wischmeyer, Paul E",JPEN. Journal of parenteral and enteral nutrition,,,,,,https://doi.org/10.1177/0148607115581838; https://www.ncbi.nlm.nih.gov/pubmed/25888676/,206449958.0,12
45410,45410,58479,2n6bhjzf,,Medline,Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI.,10.1186/s13550-016-0160-4,,26769345.0,unk,background model system solidtumor patientderived xenograft pdx model characterized high peptide receptor expression histological tissue homogeneity used study radiopeptide targeting solidtumor model high tumor uptake targeting peptide expected however vivo spect image showed substantial heterogeneous radioactivity accumulation despite homogenous receptor distribution tumor xenograft assessed vitro autoradiography hypothesized delivery peptide tumor cell dictated adequate local tumor perfusion study relationship sequential spectct mri performed ass role vascular functionality radiopeptide accumulation method highresolution spect dynamic contrastenhanced dcemri acquired six mouse bearing pc pdx tumor expressing gastrinreleasing peptide grp receptor two hour prior spect imaging animal received mbq indotaβalajmv pmol image acquired using multipinhole spectct directly spect imaging mr image acquired dedicated animal scanner dcemr image quantified using semiquantitative quantitative model dcemr spect image spatially aligned compute correlation radioactivity dcemriderived parameter tumor result whereas histology vitro autoradiography multipleweighted mri scan showed homogenous tissue characteristic spect dcemri showed heterogeneous distribution pattern throughout tumor average spearmans correlation coefficient spect dcemri ranged exchangerelated dcemri perfusion parameter conclusion positive correlation shown exchangerelated dcemri perfusion parameter amount radioactivity accumulated measured spect demonstrating vascular function important aspect radiopeptide distribution solid tumor combined use spect mri added crucial information perfusion efficiency versus radiopeptide uptake solid tumor showed functional tumor characteristic varied locally even tissue appeared homogenous current standard assessment technique,2016,"Haeck, J C; Bol, K; de Ridder, C M A; Brunel, L; Fehrentz, J A; Martinez, J; van Weerden, W M; Bernsen, M R; de Jong, M; Veenland, J F",EJNMMI research,,,,,,https://doi.org/10.1186/s13550-016-0160-4; https://www.ncbi.nlm.nih.gov/pubmed/26769345/,1163519.0,12
47479,47479,60692,453q288g,,WHO,Impact du SARS-CoV2 sur la structuration de la prise en charge du cancer : exemple de la tenue des RCP de cancérologie en Occitanie./ [COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie],10.1016/j.bulcan.2020.05.001,,,unk,work examines impact sarscov epidemic organizational recommendation issued since march tumor board tb activity tumor board activity measured tumor board sheet extracted oncologic electronic file january april precontainment activity compared activity containment period also equivalent period number meeting held average number file reviewed per meeting including first presentation average number physician attendance evaluation criterion study covered tb held multidisciplinary team meeting mtm reviewed file including first submission moderate decrease number meeting march number file examined decreased following month even third period physician number attended mtm also decreased negative impact higher mediterranean part region first study tumor board activity covering large region little affected pandemic show impact participation mtm moderate addition tumor board followed recommendation optimizing quorum however decrease average mtm activity particularly first submission suggests potential delay patient management complementary qualitative quantitative work warranted estimate real impact carcinologic outcome,2020,"Grosclaude, Pascale; Azria, David; Guimbaud, Rosine; Thibault, Séverine; Daubisse, Laetitia; Cartron, Guillaume; Renaudie, Marie-José; Dalbies, Pierre-Adrien; Delord, Jean-Pierre; Bauvin, Eric",Bull. cancer,,#306160,,,,https://doi.org/10.1016/j.bulcan.2020.05.001,218666128.0,12
47480,47480,60693,453q288g,,WHO,Impact du SARS-CoV2 sur la structuration de la prise en charge du cancer : exemple de la tenue des RCP de cancérologie en Occitanie./ [COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie],10.1016/j.bulcan.2020.05.001,,,unk,work examines impact sarscov epidemic organizational recommendation issued since march tumor board tb activity tumor board activity measured tumor board sheet extracted oncologic electronic file january april precontainment activity compared activity containment period also equivalent period number meeting held average number file reviewed per meeting including first presentation average number physician attendance evaluation criterion study covered tb held multidisciplinary team meeting mtm reviewed file including first submission moderate decrease number meeting march number file examined decreased following month even third period physician number attended mtm also decreased negative impact higher mediterranean part region first study tumor board activity covering large region little affected pandemic show impact participation mtm moderate addition tumor board followed recommendation optimizing quorum however decrease average mtm activity particularly first submission suggests potential delay patient management complementary qualitative quantitative work warranted estimate real impact carcinologic outcome,2020,"Grosclaude, Pascale; Azria, David; Guimbaud, Rosine; Thibault, Séverine; Daubisse, Laetitia; Cartron, Guillaume; Renaudie, Marie-José; Dalbies, Pierre-Adrien; Delord, Jean-Pierre; Bauvin, Eric",Bull. cancer,,#276659,,,,https://doi.org/10.1016/j.bulcan.2020.05.001,218666128.0,12
50160,50160,63575,rbchwvc3,5eae33d6b4a413f246755b871b7254df0d463827,BioRxiv,An easily adopted murine model of distal pancreatectomy for investigating immunotherapy efficacy in resectable pancreatic adenocarcinoma,10.1101/2020.03.17.990903,,,biorxiv,background although surgery provides greatest therapeutic benefit eligible pancreatic ductal adenocarcinoma pdac patient significantly improve survival majority patient unfortunately understanding therapeutic benefit combining surgery different treatment modality including promising immunotherapeutics limited current lack easily adopted surgical model purpose study develop surgically resectable model pdac immunocompetent mouse use preclinical investigation material method surgically resectable orthotopic tumor generated injecting pan cell tail pancreas fifteen day post implantation primary tumor tail pancreas resected laparotomy preserving spleen splenic function tumor growth immune phenotyping survival assessed following surgical resection primary tumor mass result expected orthotopic tumor implant recapitulated many major histological hallmark pdac including disrupted lobular structure vascular invasion preservation splenic immune cell viability function associated improved survival following surgery alone however preoperative vaccination gvax associated improved survival impacted surgery conclusion represents first murine model surgically resectable murine model pdac recapitulates known pathological hallmark human disease immune competent model allowing spleen preservation relatively simple easily adopted approach provides ideal platform examine efficacy potential immunotherapy combination pdac surgery patient,2020-03-18,"Baxter, Katherine E; de Souza, Christiano Tanese; Tai, Lee-Hwa; Yaghini, Pasha; Daneshmand, Manijeh; Bell, John C; Lichty, Brian D; Kennedy, Michael A; Auer, Rebecca C",bioRxiv,,,,document_parses/pdf_json/5eae33d6b4a413f246755b871b7254df0d463827.json,,https://doi.org/10.1101/2020.03.17.990903,214726966.0,12
51235,51235,64747,4jycukj3,8e014e2133b319d93ba7e9341ffe33bab3f9e265,PMC,A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model,,PMC4808025,26621839.0,cc-by,cancer immunotherapy attractive antigenspecific cellmediated antitumor therapy especially induction cytotoxic lymphocyte report evaluated human ctl epitopeinduced antitumor effect human lung cancer xenograft model tumor associated antigen l tal highly expressed human lung cancer cell line tumor specimen compared normal lung tissue tal derived peptide strongly inhibited tumor growth cancer metastasis prolonged survival time hlaa transgenic mouse immunized formulation thelper th peptide synthetic cpg odn adjuvant montanide isa isa adoptive transfer peptideinduced ctl cell hlaa transgenic mouse human tumor xenograft scid mouse significantly inhibited tumor growth furthermore combination ctlpeptide immunotherapy gemcitabine additively improved therapeutic effect preclinical evaluation model provides useful platform develop efficient immunotherapeutic drug treat lung cancer demonstrates promising strategy benefit antitumor immune response worthy development clinical trial,2015-11-26,"Sher, Yuh-Pyng; Lin, Su-I; Chen, I-Hua; Liu, Hsin-Yu; Lin, Chen-Yuan; Chiang, I-Ping; Roffler, Steve; Chen, Hsin-Wei; Liu, Shih-Jen",Oncotarget,,,,document_parses/pdf_json/8e014e2133b319d93ba7e9341ffe33bab3f9e265.json,document_parses/pmc_json/PMC4808025.xml.json,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808025/,,12
51484,51484,65096,q6qv1wt8,,Medline,Sea turtles: old viruses and new tricks.,,,15458663.0,unk,recent year seen inexplicable increase frequency appalling disease sea turtle fibropapillomatosis likely caused herpesvirus cause tumor grow throughout turtle body new research led disturbing conclusion recent humaninduced environmental change responsible,2004,"Jones, Adam G",Current biology : CB,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/15458663/,2284926.0,12
51511,51511,65125,nj4cukp9,,Medline,Antitumor activity and biochemical effects of topsentin.,,,1867631.0,unk,topsentin bisindolylimidazole marine natural product inhibited proliferation cultured human murine tumor cell micromolar concentration ic value ranged microm active vivo p leukemia tc mgkg qd b melanoma tc mgkg qd tumor effect microm topsentin hr exposure incorporation radiolabeled precursor p cell indicated inhibition dna synthesis lesser extent rna synthesis whereas synthesis protein unaffected fluorescence spectral change competitive binding experiment ethidium bromide indicated topsentin interacted dna evidence intercalation observed dna unwinding study competitive binding experiment hoechst cc indicated topsentin bound dna minor groove,1991,"Burres, N S; Barber, D A; Gunasekera, S P; Shen, L L; Clement, J J",Biochemical pharmacology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/1867631/,6619644.0,12
51600,51600,65228,dch8xz02,,Medline,[Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma].,,,16683401.0,unk,backgroundaim peritoneal metastasis leading cause therapeutic failure operative treatment patient gastric adenocarcinoma free cancer cell might induce indicate early peritoneal seeding subsequent peritoneal metastasis aim study determine frequency presence free cancer cell peritoneal cavity patient surgically treated gastric adenocarcinoma relation certain clinical operative pathohistological paramethers method inside period april april total patient underwent intraoperative peritoneal lavage cytological examination immediately laparotomy ml physiologic saline heated degree c introduced abdominal cavity mannualy dispersed collected region around gastric tumor pouch douglas nucleated cell layer smeared four glass slide every patient dyed maygrünwaldgiemsa stain cytological finding defined positive negative according presence cancer cell frequency positive cytological finding compared location diameter cancer pathohistological type carcinoma pathohistological stage disease lymph node liver andor peritoneal metastasis type surgical procedure result free cancer cell found patient cytological finding negative statistically highly significant difference p frequency positive cytological finding found group patient without cancer invasion serosa cancer diameter cm cm stage disease ii iii iv macroscopically present without metastasis section lymphadenectomy palliative procedure free cancer cell statistically frequently p detected patient lymph node metastasis comparing patient lymph node involvement result univariate analysis showed cancer diameter cm tumor invasion serosa pathohistological stage disease iii iv macroscopically visible metastasis important risk factor free cancer cell detection conclusion peritoneal lavage cytology shown useful tool detection group patient greatest risk peritoneal dissemination frequency positive cytological finding highly associated diameter tumor cancer invasion serosa cytological examination peritoneal lavage fluid improved accuracy staging selection patient might benefit neoadjuvant chemotherapy,2006,"Kostić, Zoran; Cuk, Vladimir; Bokun, Radojka; Ignjatović, Dragan; Usaj-Knezević, Slavica; Ignjatović, Mile",Vojnosanitetski pregled,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/16683401/,27156683.0,12
51669,51669,65309,u2i29c1o,,Medline,Radiofrequency ablation of phalangeal osteoid osteoma: technical challenges encountered in small bones.,,,21762067.0,unk,osteoid osteoma benign bone tumor characterized generally le cm nidus surrounded zone reactive sclerosis frequently located femur tibia hand case may presented upper extremity previous year treatment usually open surgery enbloc resection curettage tumor various minimal invasive percutaneous treatment including radiofrequency ablation became popular last year report difficulty encountered radiofrequency ablation treatment small bone described yearold female case osteoid osteoma,2011,"Ozbek, Orhan; Nayman, Alaaddin; Koç, Osman; Küçükapan, Ahmet; Ozbek, Seda; Kerimoğlu, Ulkü",Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/21762067/,29976403.0,12
51757,51757,65420,bi3zkftn,,Medline,Pathologic and immunohistochemical findings in a feline aortic body tumor.,,,15017037.0,unk,presence heartbase tumor diagnosed ultrasound imaging yearold female domestic shorthaired cat presenting dyspnea pleural effusion presence modified transudate hematology clinical chemistry unremarkable owner elected euthanasia necropsy locally extensive firm multilobulated nodule surrounded pulmonary vein tumor composed lobule large polygonal cell separated fine fibrovascular stroma tumor cell infiltrated myocardium neoplastic embolus present metastasis macroscopically detectable tumor cell immunohistochemically positive chromogranin synaptophysin faintly neuronspecific enolase negative vimentin cytokeratin alpha smooth muscle actin glial fibrillary acidic protein thyreoglobulin calcitonin based histologic immunohistochemical finding diagnosis chemodectoma made,2004,"Paltrinieri, S; Riccaboni, P; Rondena, M; Giudice, C",Veterinary pathology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/15017037/,34935303.0,12
52085,52085,65815,zlu88pgl,,Medline,Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location.,,,26289913.0,unk,conducted retrospective cohort study investigate predisposing factor local recurrence complication percutaneous radiofrequency ablation rfa hepatocellular carcinoma hcc hcc patient n＝ consecutively treated rfa male female median age year enrolled patient nodule median size mm ablated predisposing factor overall recurrence local recurrence context tumor location complication examined local recurrence observed nodule year local recurrence rate respectively multivariate cox proportional hazard analysis revealed large tumor size ＞cm tumor location adjacent major portal branch hepatic vein small ablated margin ＜mm independent predisposing factor local recurrence rfa hr＝ tumor location adjacent major portal branch hepatic vein diaphragm also revealed risk factor liver damage due rfa hcc adjacent major portal vein hepatic vein associated higher risk local recurrence complicationstherefore special precaution necessary applying rfa hcc near vessel even tumor located easytopuncture site,2015,"Toshimori, Junichi; Nouso, Kazuhiro; Nakamura, Shinichiro; Wada, Nozomu; Morimoto, Yuki; Takeuchi, Yasuto; Yasunaka, Tetsuya; Kuwaki, Kenji; Ohnishi, Hideki; Ikeda, Fusao; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide",Acta medica Okayama,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26289913/,21802987.0,12
52357,52357,66150,yytlmum2,,Medline,Increasing Role of Image-Guided Ablation in the Treatment of Musculoskeletal Tumors.,,,27870683.0,unk,last decade percutaneous treatment musculoskeletal msk tumor become established routine clinical care also undergoing number advancement ablative technique palliate painful skeletal metastasis gained wide acceptance goal ablation evolved include local control oligometastases desmoid tumor bone consolidation augmentation frequently used conjunction instead ablation skeletal tumor stabilize pathologic fracture prevent morbidity could result fracture caused tumor progression procedure traditionally performed cement injection although additional percutaneous consolidation stabilization device developed technique monitor ablation zone adjacent structure intraprocedurally applied increase number tumor amenable treatment include method depict displace monitor critical structure adjacent targeted msk tumor finally role ablation comprehensive care patient msk tumor continues change evolving triage patient radiation therapy surgical resection stabilization percutaneous ablative consolidative management,2016,"Kurup, Anil Nicholas; Callstrom, Matthew R",Cancer journal,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27870683/,34318104.0,12
52374,52374,66170,06k2bs4s,,Medline,Targets of anticytokine therapy and the risk of infections in humans and mice.,,,17917545.0,unk,purpose review examine type risk infection human mouse deficient proinflammatory cytokine naturally occurring manipulated genetic defect tumor necrosis factor interleukin interferongamma examined increased susceptibility protection infection recent finding interleukinp interferongammablockers may lead increased incidence infection intracellular bacteria parasite fungi addition may see viral infection interferongammablockers increased risk infection unlikely either interleukin interleukinblockers interleukinblockers may lead increased risk infection extracellular bacteria virus parasite fungi summary tumor necrosis factor knockout mouse increased susceptibility pathogen reported normally controlled granuloma formation patient treated tumor necrosis factorblockers twofold increase granulomatous infection predominantly reactivation latent tuberculosis found infection detected tumor necrosis factor knockout mouse accurate predicting infection observed using tumor necrosis factorblockers similar correlation exists cytokine use interferongamma interleukinp blocker possibly interleukin blocker lead increased risk severe infection care taken new cytokine blockersantagonists introduced,2007,"van de Vosse, Esther; van Agtmael, Michiel A",Current opinion in rheumatology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/17917545/,31206597.0,12
52543,52543,66374,21mxrkkx,,Medline,Solitary Fibrous Tumor of the Stomach Treated with Laparoscopic and Endoscopic Cooperative Surgery.,,,26369266.0,unk,yearold japanese woman melena underwent upper gastrointestinal endoscopy preoperatively diagnosed sarcoma stomach physical examination revealed abnormality finding upper gastrointestinal endoscopy showed pedunculated submucosal tumor measuring mm antrum enhanced computed tomography showed wall thickening gastric antrum patient underwent laparoscopic endoscopic cooperative surgery lecs wedge resection stomach excised tumor measured × × mm size histopathology showed spindleshaped cell submucosal layer immunohistochemistry showed tumor positive cd bcl mic final diagnosis solitary fibrous tumor sft stomach postoperative course uneventful evidence recurrence observed month followup report case sft arising stomach treated wedge resection lecs,2015,"Nabeshima, Kazuhito; Tomioku, Mifuji; Nakamura, Kenji; Yasuda, Seiei",The Tokai journal of experimental and clinical medicine,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26369266/,9137596.0,12
52671,52671,66524,ad5kxzc0,,Medline,Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.,,,22469241.0,unk,apoptosis occurs interval time administration apoptosisinducing therapy tumor change technetium mtctricarbonyl co hisannexin hisann accumulation time examined colobearing mouse divided six treatment group control fluorouracil fu mgkg irinotecan mgkg oxaliplatin mgkg bevacizumab mgkg panitumumab mgkg mtcco hisann injected hour posttreatment microsinglephoton emission computed tomography performed immunostaining caspase apoptosis survivin antiapoptosis lcii autophagy marker also performed different dynamic mtcco hisann uptake observed colorectal cancer xenograft model response single dose three different chemotherapeutics fu irinotecan oxaliplatin bevacizumabtreated mouse showed increased uptake radiotracer peak mtcco hisann uptake panitumumabtreated mouse observed hour posttreatment confirmed caspase immunostaining irinotecan oxaliplatin bevacizumabtreated tumor significant correlation established radiotracer uptake caspase immunostaining r p r p r p respectively fu panitumumabtreated mouse correlation coefficient r p r p respectively optimal timing annexin imaging start different treatment colo model determined,2012,"Vangestel, Christel; Van de Wiele, Christophe; Mees, Gilles; Mertens, Koen; Staelens, Steven; Reutelingsperger, Chris; Pauwels, Patrick; Van Damme, Nancy; Peeters, Marc",Molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22469241/,22707150.0,12
52869,52869,66763,5vd50x70,,Medline,Rare extra-adrenal paraganglioma mimicking a painful Schwannoma: case report.,,,25285725.0,unk,introduction paragangliomas originate chromaffin tissue primarily found zuckerkandl body year old man investigated abdominal mri chronic backache lasted year case report mri revealed incidental mass paraaortic region adrenal lodge characteristic solid nodular mass seem arise adrenal gland abdominal ct showed mass localized prior left adrenal gland radiologist reported mass malignant peripheral nerve sheath tumor schwannoma stay hospital tumoral marker chromogranin neuronspecific enolase dosed concentration ngml ngml patient back pain treated first ketorolac without resolution problem ketorolac plus tramadol elastomeric pump relief finally continuous infusion morphine since exact nature neoplasm known ct guided biopsy technically feasible laparoscopic excision mass transperitoneal anterior submesocolic approach well left adrenalectomy planned surgery patient longer needed morphine postoperative course uneventful result histopathological finding consisted periadrenal paraganglioma extraadrenal paragangliomas rarely recognized preoperative study often due capacity mimicking type tumor conclusion paragangliomas could successfully resected laparoscopy difficult distinguish tumor investigated even preoperative finding argue something else,2014,"Picchetto, Andrea; Paganini, Alessandro M; Balla, Andrea; Quaresima, Silvia; Cantisani, Vito; D'Ambrosio, Giancarlo; Lezoche, Emanuele",Annali italiani di chirurgia,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25285725/,8450701.0,12
52967,52967,66876,c3l9kxy9,,Medline,Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene-bearing mice.,,,7513605.0,unk,mouse containing activated vharas oncogene driven mouse mammary tumor virus promoterenhancer produced le tumor necrosis factor tnf genetically identical animal without inbred oncomice containing vharas oncogene inbred fvb mouse without grown month splenocytes isolated stimulated vitro produce tumor necrosis factor tnf gammainterferon ifn tnf production cell oncomice significantly decreased compared cell fbv mouse tendency decrease significant difference seen ifn release observation suggest oncogene may play role immune system,1993,"Chen, G J; Colombo, L L; Lopez, M C; Watson, R R",Cancer letters,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/7513605/,38800698.0,12
53023,53023,66939,lrxzsm4c,,Medline,Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors.,,,21439259.0,unk,comparison somatostatin receptor scintigraphy gastrin receptor scintigraphy using indtpaminigastrin mg showed added value diagnosing neuroendocrine tumor investigated whether galabeled gastrin analogue dotamg suited positron emission tomography pet could improve image quality targeting cholecystokinin cckgastrin receptorpositive tumor cell dotamg labeled either ga vitro investigated using arj rat tumor cell line biodistribution examined balbc nude mouse subcutaneous arj tumor vivo pet imaging performed using preclinical petcomputed tomographic scanner dotamg showed high receptor affinity vitro biodistribution study revealed high tumor uptake gadotamg ± idg hour postinjection coadministration excess unlabeled peptide blocked tumor uptake ± idg indicating cckgastrin receptormediated uptake p biodistribution gadotamg similar indotamg subcutaneous intraperitoneal tumor clearly visualized smallanimal pet imaging mbq gadotamg galabeled dotamg specifically accumulate cckgastrin receptorpositive arj tumor similar biodistribution apart kidney arj tumor clearly visualized micropet therefore gadotamg promising tracer pet imaging cckgastrin receptorpositive tumor human,2011,"Brom, Maarten; Joosten, Lieke; Laverman, Peter; Oyen, Wim J G; Béhé, Martin; Gotthardt, Martin; Boerman, Otto C",Molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/21439259/,1609873.0,12
53248,53248,67205,xks5rfeg,,Medline,Therapeutic and diagnostic implications of Hsp90 activation.,,,15177193.0,unk,molecular chaperone heatshock protein hsp involved stabilization conformational maturation many signaling protein deregulated cancer hsp inhibition result proteasomal degradation client protein lead potent antitumor activity hsp inhibitor allylaminogeldanamycin aag presently clinical trial recent work identified role hsp multiple signal transduction pathway revealed molecular mechanism tumor selectivity hsp inhibitor result activated highaffinity conformation hsp tumor review discus recent advance understanding tumor hsp treatment diagnosis cancer addition role hsp nononcological disease also discussed,2004,"Kamal, Adeela; Boehm, Marcus F; Burrows, Francis J",Trends in molecular medicine,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/15177193/,31091475.0,12
53708,53708,67751,3yjchf3l,,Medline,"Reconstruction with latissimus dorsi, external abdominal oblique and cranial sartorius muscle flaps for a large defect of abdominal wall in a dog after surgical removal of infiltrative lipoma.",,,27476526.0,unk,animal presented largesized infiltrative lipoma abdominal wall noted year lipoma confirmed histological examination previous biopsy infiltrative feature identified computerized tomography scan surgical removal created largesized abdominal defect closed combination latissimus dorsi external abdominal oblique muscle flap pedicle pattern small dehiscence distal end muscle flap resulted smallsized abdominal hernia repaired cranial sartorius muscle flap day surgery dog good general health sign tumor recurrence month followup,2016,"Feng, Yu-Ching; Chen, Kuan-Sheng; Chang, Shih-Chieh",The Journal of veterinary medical science,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27476526/,16413862.0,12
53765,53765,67821,2ywafm0p,,Medline,Equine laparoscopy: gonadectomy.,,,23532903.0,unk,laparoscopic removal gonad male female horse regularly performed variety reason female horse common indication ovariectomy include behavioral problem sign abdominal pain linked estrus another indication abnormal enlarged ovary typically due ovarian neoplasia common granulosa thecal cell tumor ovariectomy also treatment option ovarian hematoma abnormality addition ovariectomy used sterilize mare intended artificial insemination embryo transfer program,2013,"Caron, John P",Compendium,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23532903/,37241781.0,12
53952,53952,68039,sjr6e77m,,Medline,The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.,,,24982375.0,unk,aim doseresponse relationship doxorubicin superabsorbent drugeluting microspheres established study investigated relationship dose delivery parameter pertain toxicity response surgically resectable hepatocellular carcinoma hcc patient method twentyfive patient resectable hcc randomly assigned divided four group receiving either bland mg mg mg doxorubicin loaded super absorbent polymer microspheres patient undergoing surgical resection response evaluation criterion solid tumor recist european association study liver easlbased volumetric response performed one month surgical resection reference tumor performed two month adverse event collected regular interval result fiftysix percent patient demonstrated complete response according easl criterion opposed according recist v criterion residual tumor identified group mg ± mg ± mg ± mg ± total adverse event grade occurred average per patient grade difference noted bland embolic drugloaded group subset analysis demonstrate significantly increased degree necrosis mgloaded group p strong correlation existed arterial phase computer tomography easlbased response histopathology r p group residual tumor conclusion histology correlate strongly onemonth postprocedural imaging response optimized mg loading per vial adverse event reflection embolization relationship loading dose administered dose doxorubicin,2014,"Klass, Darren; Owen, David; Buczkowski, Andrezj; Chung, Stephen W; Scudamore, Charles H; Weiss, Alan A; Yoshida, Eric M; Ford, Jo-Ann E; Ho, Stephen; Liu, David M",Anticancer research,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24982375/,30753039.0,12
54052,54052,68158,3ejfeidk,,Medline,Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging.,,,27277828.0,unk,purpose recently showed number carboxylated nearinfrared fluorescent nirf cyanine dye posse strong necrosis avid property vitro well different mouse model spontaneous therapyinduced tumor necrosis indicating potential use cancer diagnostic prognostic purpose previous study detection cyanines achieved whole body optical imaging technique due limited penetration nearinfrared light suitable investigation deeper cm within human body therefore order facilitate clinical translation purpose present study generate necrosis avid cyaninebased nirf probe could also used single photon emission computed tomography spect necrosis avid nirf cyanine hq radiolabeled indium via chelate diethylene triamine pentaacetic acid dtpa procedure necrosis avid property radiotracer indtpahq examined vitro vivo different breast tumor model mouse using spect optical imaging moreover biodistribution study performed examine pharmacokinetics probe vivo result using optical imaging radioactivity measurement vitro showed selective accumulation indtpahq dead cell using spect biodistribution study necrosis avidity radiotracer confirmed mouse breast cancer model spontaneous tumor necrosis mcf human breast cancer model chemotherapyinduced tumor necrosis conclusion radiotracer indtpahq possessed strong selective necrosis avidity vitro various mouse model tumor necrosis vivo indicating potential clinically applied diagnostic purpose monitor anticancer treatment efficacy,2016,"Stammes, Marieke A; Knol-Blankevoort, Vicky T; Cruz, Luis J; Feitsma, Hans R I J; Mezzanotte, Laura; Cordfunke, Robert A; Sinisi, Riccardo; Dubikovskaya, Elena A; Maeda, Azusa; DaCosta, Ralph S; Bierau, Katja; Chan, Alan; Kaijzel, Eric L; Snoeks, Thomas J A; van Beek, Ermond R; Löwik, Clemens W G M",Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27277828/,17515577.0,12
54194,54194,68330,npgzhiii,,Medline,Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.,,,22418025.0,unk,multimodal bioluminescence bli singlephoton emission computed tomographycomputed tomography spectct imaging investigated mean monitor somatostatin receptor subtype sstpositive neuroendocrine tumor subcutaneously implanted liver metastasis animal model mouse rat ultimately model use studying ssttargeted peptide receptor radionuclide therapy prrt ca cell transfected green fluorescent proteinluciferase plasmid construct cell inoculated subcutaneously shoulder nude mouse nontransfected cell left shoulder transfected cell right shoulder bli spectct imaging biodistribution analysis ex vivo autoradiography tumor performed bli spectct imaging also performed intrahepatic tumor model rat caliper volume measurement transfected tumor could correlated bli measurement r spectct imaging showed high level accumulation indtpaoctreotide control transfected tumor confirmed biodistribution analysis autoradiography subcapsular inoculation transfected cell rat liver resulted intrahepatic tumor could visualized spectct bli transfection ca tumor cell alter growth property cell line expression sst transfected tumor could clearly visualized bli spectct imaging transfected sstpositive tumor cell line could represent novel preclinical model tumor monitoring study aim optimizing prrt neuroendocrine tumor,2012,"Pool, Stefan E; ten Hagen, Timo L M; Koelewijn, Stuart; de Jong, Marion; Koning, Gerben A",Molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22418025/,25802933.0,12
54423,54423,68602,6p6mctdb,,Medline,Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.,,,15952188.0,unk,background blood vessel tumor express higher level aminopeptidase n apn compared normal tissue reported peptide contain asparagineglycinearginine ngr sequence home apn tumor vasculature increased expression apn tumor vascular endothelium therefore offer opportunity target ngr peptidelinked therapeutic reagent tumor method determine whether additional ngr sequence could improve endothelial homing biologic activity human endostatin modified genetically introduce ngr motif ngrendostatin expressed yeast vitro biologic activity ngrendostatin compared native protein endothelial cell proliferation migration ngrmodified endostatin used tumor localization study finally effect endostatin ngrendostatin tumor growth determined two model system result human endostatin internal ngr sequence accessible bind apn however addition ngrsequence amino terminus resulted strong binding inhibition endothelial cell apn ngrendostatin showed increased binding endothelial cell compared native protein increased binding endostatin also coincided improved antiangiogenic property endostatin ngr modification improved tumor localization consequence effectively inhibited ovarian carcinoma growth athymic nude mouse conclusion study demonstrated human endostatin modified genetically improve ability inhibit tumor growth,2005,"Yokoyama, Yumi; Ramakrishnan, Sundaram",Cancer,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/15952188/,23600734.0,12
54700,54700,68930,gf0y0g3k,,Medline,Intestinal adenocarcinoma with pancreas and lymph node metastases in a captive cotton-top tamarin (Saguinus oedipus).,,,15528865.0,unk,case intestinal adenocarcinoma metastasis pancreas regional lymph node found yearold captive female cottontop tamarin saguinus oedipus intermittent diarrhea necropsy tumor mass located ileocecal junction causing circumferential thickening annular stenosis microscopically lesion primary metastatic site showed typical feature mucinous adenocarcinoma seen human including intracellular extracellular mucin production characteristic appearance signet ring tumor cell diagnosis confirmed histological evaluation positive cytokeratin immunostain mucin production demonstrated pa alcian blue stain speculated development intestinal carcinoma partly attributable excessive absorption diet refined food unbalanced nutrition nature animal develop stress easily,2004,"Liu, Chen-Hsuan; Chen, Yu-Ting; Wang, Pao-Jung; Chin, Shih-Chien",The Journal of veterinary medical science,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/15528865/,33343705.0,12
54718,54718,68954,wobsyenq,,Medline,Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.,,,12747770.0,unk,tyrosinaserelated protein gptrp trp melanosomal membrane glycoprotein recognized antibody tcells patient melanoma xenogeneic dna immunization gptrp generates antibodydependent tumor immunity autoimmune depigmentation contrast xenogeneic trp dna immunization induces immunity mediated cd tcells role ifngamma generation tumor immunity autoimmune depigmentation two model investigated tumor protection minimal depigmentation observed immunization human trp dna mouse deficient ifngamma ligand repletion recombinant murine ifngamma restored tumor immunity experiment using il deficient mouse demonstrated tumor immunity unaffected autoimmune depigmentation potentially accelerated consistent downmodulation autoimmunity trp il contrast ifngamma required generation immunity gptrp fact exogenous ifngamma ablated autoantibody response gptrp xenogeneic dna immunization consistent downregulatory effect ifngamma result show immunity trp following dna immunization us ifngammadependent th pathway immunity gptrp downregulated ifngamma,2001,"Wolchok, J D; Srinivasan, R; Perales, M A; Houghton, A N; Bowne, W B; Blachere, N E",Cancer immunity,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/12747770/,673640.0,12
54827,54827,69078,q56r7hgj,,Medline,Discrimination of Different Brain Metastases and Primary CNS Lymphomas Using Morphologic Criteria and Diffusion Tensor Imaging.,,,27643802.0,unk,purpose brain metastasis common complication cancer occur patient malignancy aim retrospective study differentiate metastasis different primary tumorscns lymphyomas using morphologic criterion fractional anisotropy fa apparent diffusion coefficient adc material method morphologic criterion hemorrhage cyst pattern contrast enhancement location reported consecutive patient brain metastasesprimary cns lymphoma fa adc value measured region interest roi placed contrastenhancing tumor part necrosis nonenhancing peritumoral region neptr difference histopathological subtypes metastasis analyzed using nonparametric test decision tree hierarchical clustering analysis result significant difference found morphologic criterion hemorrhage pattern contrast enhancement diffusion measurement significant difference different tumor entity found adc analyzed contrastenhancing tumor part among single tumor entity primary cns lymphoma showed significantly lower median adc value contrastenhancing tumor part adclymphoma v adcnolymphoma p differentiation type metastasis possible using fa adc conclusion morphologic difference among main subtypes brain metastasescns lymphoma however due high variability common type metastasis low specificity prospective differentiation remained challenging dti including fa adc reliable tool differentiation different histopathological subtypes brain metastasis except cns lymphoma showing lower adc value biopsy surgery staging remain essential diagnosis key point • histopathological subtypes brain metastasescns lymphoma show different morphologic feature mri• primary cns lymphoma show significantly reduced adc values• dti reliable tool differentiation brain metastasis citation format • bette wiestler b delbridge c et al discrimination different brain metastasis primary cns lymphoma using morphologic criterion diffusion tensor imaging fortschr röntgenstr,2016,"Bette, S; Wiestler, B; Delbridge, C; Huber, T; Boeckh-Behrens, T; Meyer, B; Zimmer, C; Gempt, J; Kirschke, J",RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27643802/,25649932.0,12
54849,54849,69100,vsuhed56,,Medline,"Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses.",,,8231085.0,unk,different biological material tested murine viral contamination using mouserat antibody production test tumor examined contaminated considerable difference contamination rate became evident transplantable tumor vitro vivo passage compared tumor propagated animal positive whereas tumor propagated vitro contaminated highest rate contamination detected mouse tumor testing specimen mouse origin revealed contaminated sample propagated mouse positive murine virus moreover human tumor passaged athymic nude mouse rat tumor positive lymphocytic choriomeningitis virus detected hamster tumor frequent contaminant lactic dehydrogenase elevating virus followed reovirus lymphocytic choriomeningitis virus minute virus mouse mouse hepatitis virus rat coronaviruses kilham rat virus mycoplasma pulmonis contamination reovirus minute virus mouse found cell line tested monoclonal antibody preparation hybridoma cell contained lactic dehydrogenase virus contamination two pathogen detected four mouse tumor one cell line,1993,"Nicklas, W; Kraft, V; Meyer, B",Laboratory animal science,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/8231085/,40877197.0,12
54981,54981,69251,hmvkdg1h,,Medline,Preoperative embolization of carotid chemodectoma: a technical challenge that can be customized according to angioarchitecture. Illustrative cases.,,,24355187.0,unk,preoperative embolization carotid paraganglioma increasingly used reduce risk surgical bleeding obtaining precise extensive tumor resection currently technique customized consideration different tumor angioarchitecture thanks embolic material different vascular penetration solid particle polyvinylalcohol pva histoacryl glue liquid polymer onyx® two case swelling dissection volume progression time came observation patient yearold woman studied neck ultrasound imaging computed tomography ct andor magnetic resonance mr case radiological investigation confirmed clinical suspicion carotid paraganglioma patient sent angiography control preoperative devascularization lesion treatment performed general anesthesia using depending type tumor vasculature case solid particle pva histoacryl glue case onyx® covidien irvine patient successfully underwent excision lesion via cervicotomy within week embolization procedure without complication histological finding confirmed diagnosis chemodectoma macrophage infiltrates seen region previously embolized oneyear followup evidence recurrent disease preoperative embolization vascular lesion neck represents safe technique yield best result customized type vascularization lesion enabling use appropriate material depending case treated,2013,"Faragò, Giuseppe; Castellani, Carlotta; Ponzi, Silvano; Jankovic, Claudio; Saginario, Vittorio; Berardi, Carlo; Pollo, Bianca; Ciceri, Elisa F",The neuroradiology journal,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24355187/,23623168.0,12
55062,55062,69345,4ymxpuwu,,Medline,"[Comparative morphology of lymphoepithelial carcinoma in primary tumor, metastasis, and xenograft (author's transl)].",,,6258549.0,unk,tissue lymphoepithelial tumor metastasis transplanted subcutaneously thymusaplastic nude mouse day peasize tumor developing transplanted murine passage second passage tumor growing faster material taken light electron microscopy result compared data obtained primary nasopharyngeal carcinoma metastasis tumor cell metastasis xenograft showed morphological criterion nonkeratinizing squamous epithelial carcinoma undifferentiated type ultrastructural criterion human npctumor cell present including cytoplasmic deposit corona virus herpes viruslike particle within nucleus cytoplasm,1980,"Arnold, W; Huth, F; Lindenberger, J; Vosteen, K H",Archives of oto-rhino-laryngology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/6258549/,45246765.0,12
55439,55439,69782,b26mcjc3,,Medline,Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy: A retrospective study.,,,27893681.0,unk,treatment option liver cancer patient large tumor cm andor portal vein tumor thrombosis limited new treatment strategy badly needed study determine safety treatment efficacy new minimally invasive treatment strategyliver segment thermal ablationlatestage hepatocellular carcinoma patient included treated percutaneous ablation destroy entire tumorcontaining liver segment reduce reoccurrence prolong survival transcatheter arterial chemoembolization used ablation label tumor margin patient followed routinelythe patient followed month mean overall survival o n month range patient bclc stage b n average o month stage c n mean o month range patient reoccurred within year reoccurred month postoperatively average alphafetoprotein dropped μgl postoperatively severe intra postoperative complication observedour preliminary data indicated transcatheter arterial chemoembolization segment ablation safe benefit survival significantly latestage hepatocellular carcinoma patient prospective multicenter randomized trial comparing focal segment ablation ongoing china trial registry number chictrtrc,2016,"Li, Wei; Wang, Yang; Gao, Wenfeng; Zheng, Jiasheng",Medicine,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27893681/,15715483.0,12
55491,55491,69839,zg6sa37k,,Medline,Role of computer tomography and endoscopic ultrasonography in assessing portal and superior mesenteric vessels invasion in cephalo-pancreatic adenocarcinoma.,,,29051395.0,unk,aim aim study evaluate information given contrastenhanced computer tomography cect ultrasound endoscopy eu regarding vascular involvement cephalopancreatic cancer data compared intraoperative finding material method choose analyze often interested vessel tumor development superior mesenteric artery sma superior mesenteric vein smv portal vein pv patient included study n cephalopancreatic tumor diagnosed institute positive histology pancreatic adenocarcinoma exclusion criterion tumor site head pancreas including metastasis tumor involvement common hepatic artery celiac trunk inferior cava vein aorta cect eu diagnosis performed another center delay day diagnostic imaging surgery result diagnosing sma invasion cect accuracy eu accuracy diagnosing pv smv involvement cect accuracy eu accuracy accuracy two combined examination diagnosing vascular invasion conclusons type examination showed good accuracy diagnosing vascular invasion separately combination two may used cect result uncertain provides higher chance correct diagnosis key word pancreatic cancer resectability criterion vascular invasion,2017,"Bodea, Raluca; Seicean, Andrada; Vasile, Tudor; Calinici, Tudor; Ciuca, Irina; Al Hajjar, Nadim; Iancu, Cornel; Iordache, Constantin",Annali italiani di chirurgia,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/29051395/,25797203.0,12
55652,55652,70024,8y2thm7y,,Medline,TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma.,,,17278102.0,unk,many immune therapeutic strategy development melanoma treat metastatic disease prevent disease reoccurrence however human melanoma cell often deficient antigen processing appears play role expansion escape immunosurveillance example expression transporter associated antigen processing tap tap downregulated mouse melanoma cell line bf result lack tumorassociated antigen processing low surface expression mhc class molecule low immunogenicity observe restoration tap expression transfection resurrects processing presentation viral antigen melanomaassociated antigen trp immunization irradiated bfrtap transfected cell generates ctls capable killing bfrtap transfected target bf target deficient tap furthermore bfrtap transfectants grow significantly slower rate mouse bf cell experimental model closely recapitulates clinical situation treatment bf tumor mouse vaccinia virus vector expressing tap also significantly decrease tumor growth vivo furthermore tumor treated vaccinia tap significantly reduced number immunosuppressive cdil positive tumor infiltrating lymphocyte therefore tap expression restores antigen presentation immunogenicity bf melanoma cell concomitantly reduces immunosuppressive il production local tumor site thereby increasing immunosurveillance mechanism tumor,2007,"Zhang, Qian-Jin; Seipp, Robyn P; Chen, Susan S; Vitalis, Timothy Z; Li, Xiao-Lin; Choi, Kyung-Bok; Jeffries, Andrew; Jefferies, Wilfred A",International journal of cancer,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/17278102/,23037180.0,12
55933,55933,70369,k6365x9z,,Medline,Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats.,,,2846887.0,unk,oncogenic capacity myccontaining strain feline leukemia virus felv termed lcfelv examined inoculation virus neonatal kitten like myccontaining strain felv lcfelv may induce relatively short latency necessarily induce thymic lymphosarcoma viremic animal naturally occurring experimentally induced tumor tcell lymphoma contain clonally integrated lcfelv proviral dna readily cultivated vitro presence absence exogenously supplied interleukin acquisition myc felv decrease period latency appearance tumor expand spectrum tumor induced felv alone,1988,"Levy, L S; Fish, R E; Baskin, G B",Journal of virology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/2846887/,12267960.0,12
56253,56253,70754,iw27twk9,,Medline,Contrast enhanced ultrasound and computer tomography diagnosis of solid and mixed pancreatic tumors - analysis of confounders.,,,23012670.0,unk,aim aim study evaluate leading cause discrepancy imaging study contrast enhanced ultrasound ceus contrast enhanced computer tomography cect diagnosis histology patient presenting tertiary referral center previously detected pancreatic mass standard abdominal ultrasound method performed prospective longitudinal observational study patient pancreatic mass patient solid pancreatic tumor patient cystic mixed pancreatic mass tumor ceus cect feature analyzed compared final histological diagnosis result testing performance ceus cect evaluating benign malignant etiology pancreatic mass obtained probability ceus cect randomly selected individual pancreatic tumor group imaging result indicating suspicion malignancy obtained discordance histopathological diagnosis patient ceus patient cect multiple regression analysis two variable independently influenced discordance two imaging method histological conclusion enhancement pattern tumor nature solid v cystic conclusionsceus cect showed good diagnostic performance differentiating benign malignant pancreatic tumor enhancement pattern tumor nature solid v cystic independent confounders imaging histological diagnosis,2012,"Vasile, Tudor Andrei; Feier, Diana; Socaciu, Mihai; Anton, Ofelia Maria; Seicean, Andrada; Iancu, Cornel; Zaharie, Toader; Badea, Radu",Journal of gastrointestinal and liver diseases : JGLD,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23012670/,26631379.0,12
56314,56314,70827,otqdkw6m,,Medline,"18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.",,,22469242.0,unk,treatment colorectal liver metastasis evaluation treatment efficacy utmost importance decision making aim present study explore ability preclinical imaging modality detect experimental liver metastasis nine male wagrij rat underwent laparotomy intraportal injection cc tumor cell day tumor induction sequential positron emission tomography pet computed tomography ct magnetic resonance imaging mri scan acquired rat time point three rat euthanized metastasis liver documented histologically topographically liver divided eight segment image finding compared segmentbysegment basis histopathologic finding sixtyfour liver segment analyzed contained tumor deposit overall sensitivity pet ct mri respectively detection tumor histologic diameter exceeding mm n sensitivity pet ct mri respectively overall specificity pet ct mri respectively study showed encouraging detectability sensitivity preclinical imaging small liver tumor provides valuable information imaging technique designing future protocol,2012,"de Jong, Gabie M; Hendriks, Thijs; Bleichrodt, Robert P; Dekker, Helena M; Mus, Roel D M; Gotthardt, Martin; Visser, Eric P; Oyen, Wim J G; Boerman, Otto C",Molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22469242/,33373130.0,12
56617,56617,71181,as6y3re3,,Medline,Laparoscopic-Assisted Endoscopic Resection of a Gastric Leiomyoma.,,,25642406.0,unk,leiomyoma infrequent benign intestinal tumor arise age location within gastrointestinal gi tract tumor cause symptom including abdominal pain obstruction intussusception volvulus gi bleeding amass resected symptomatic open surgical resection considered standard removing tumor however recent improvement endoscopic laparoscopic equipment made possible utilize minimally invasive technique tumor removal including complete endoscopic resection endoscopicassisted laparoscopic resection present case adolescent female large mass located gastroesophageal junction gej causing gi bleeding given location mass near gej morbidity associated surgical resection performed laparoscopicassisted complete endoscopic resection tumor addition tumor unusual immunohistochemicalstaining pattern focal expression marker often seen gi stromal tumor elucidating gray area two tumor class potential implication patient followup laparoscopicassisted endoscopic resection benign tumor useful technique employed facilitate resection mucosal subserosal mass near gej minimal morbidity,2014,"Acker, Shannon; Dishop, Megan; Kobak, Gregory; Vue, Padade; Somme, Stig",European journal of pediatric surgery reports,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25642406/,2578035.0,12
56963,56963,71605,hfync4z4,,Medline,Effect of 26 week magnetic field exposures in a DMBA initiation-promotion mammary gland model in Sprague-Dawley rats.,,,10334209.0,unk,several study suggested exposure hz magnetic field promote chemically induced breast cancer rat group female spraguedawley rat initiated single mg gavage dose dimethylbenzaanthracene dmba day age followed exposure ambient field sham exposed hz magnetic field either gauss g field intensity hz field g hday daysweek week vehicle control group without dmba included rat palpated weekly presence tumor effect magnetic field exposure body weight gain time appearance mammary tumor end week animal killed mammary tumor counted measured mammary gland mass found grossly examined histologically mammary gland carcinoma incidence p decrease dmba control g hz g hz g hz group respectively total number carcinoma p decrease p decrease dmba control g hz g hz g hz group respectively number fibroadenoma varied lowest number g hz exposure group measurement tumor revealed difference tumor size group breast cancer initiationpromotion study female spraguedawley rat evidence hz magnetic field promoted breast cancer condition assay study support hypothesis magnetic field exposure promote breast cancer rat model,1999,"Boorman, G A; Anderson, L E; Morris, J E; Sasser, L B; Mann, P C; Grumbein, S L; Hailey, J R; McNally, A; Sills, R C; Haseman, J K",Carcinogenesis,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/10334209/,22724512.0,12
57102,57102,71761,9eyu9wy6,,Medline,Extreme liver surgery as treatment of liver tumors involving the hepatocaval confluence.,,,26960560.0,unk,objective analyze characteristic surgical technique morbidity survival patient treated extreme liver surgery material method present series consecutive patient malignant liver tumor hepatocaval confluence treated single center extreme liver surgery april march data collected prospectively analyzed spss result patient included male female mean age ± year old median comorbidities according charlson age comorbidity index tumor metastasis colorectal cancer patient received neoadjuvant chemotherapy preoperative portal embolization performed major hepatectomies performed extended right hepatectomy left extended hepatectomy patient needed vascular reconstruction postoperative morbidity grade ii patient according dindoclavien classification intraoperative mortality postoperative mortality rate day due hepatic failure biliary fistula december patient still alive mean survival month ecog performance status conclusion extreme liver surgery carry high rate morbidity mortality seem increase age higher tumor volume according literature therapeutic option consider patient low comorbidity suffering malignant neoplasm involve hepatocaval confluence treatment curative intention performed,2016,"Codony, C; López-Ben, S; Albiol, M; Falgueras, L; Castro, E; Codina-Barreras, A; Casellas, M; Gil, J; Codina-Cazador, A; Figueras, J",Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26960560/,24521910.0,12
57399,57399,72113,qqhqhqq7,,Medline,Coronavirus-associated antibodies in nasopharyngeal carcinoma and infectious mononucleosis.,,,6268032.0,unk,coronaviruslike particle found within cytoplasm npc tumor cell within cytoplasm tumor cell regional metastasis within tumor cell grown nude mouse immunologic identification coronaviruses culture human tracheal epithelium mrcc used inoculated known coronavirus strain whereas blood serum npc patient n contain significantly elevated antibody titer corona virus unselected serum patient without npc showed low antibody titer n patient suffering infectious mononucleosis n showed titer pattern similar npc patient demonstration antigenantibody reaction within npc tumor cell cytoplasm serum high antibody content coronaviruses deriving npc patient anticoronavirus serum rabbit used indirect immunofluorescence npc tumor cell showed bright cytoplasmic fluorescence fluorescence seen tumor cell exposed human serum known low absent corona antibody titer normal rabbit serum result indicate next dna virus infection ebv rna virus infection coronavirus may play role npc well infectious mononucleosis,1981,"Arnold, W; Klein, M; Wang, J B; Schmidt, W A; Trampisch, H J",Archives of oto-rhino-laryngology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/6268032/,9345556.0,12
57599,57599,72358,3fwssn91,,Medline,[Initial division of the left renal vein before dissection of left renal vein occluded by intracaval tumor thrombus].,,,22075606.0,unk,november march performed initial division left renal vein occluded tumor thrombus six case left renal cancer toranomon hospital left renal vein completely occluded tumor thrombus case order ligate left renal artery first behind dilated left renal vein must dissect left kidney arterial blood flow massive bleeding numerous engorged collateral vein around left kidney inevitable furthermore access left renal artery difficult large tumor therefore initially divided left renal vein without arterial blood flow followed division left renal artery nephrectomy dissecting tumor without blood flow extirpated intracaval tumor thrombus median time operation hour minute median amount blood loss ml tumor stage ptb four case ptc two case complication observed surgery except one case lymphocele another case chylous ascites initial division left renal vein considered useful surgical approach left renal cancer occluded left renal vein especially tumor large,2011,"Kurosawa, Kazuhiro; Okita, Ryuji; Motoshima, Takanobu; Fujioka, Masashi; Abe, Hiromitsu; Morikawa, Hirofumi; Okaneya, Toshikazu; Komatsu, Hideki",Hinyokika kiyo. Acta urologica Japonica,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22075606/,23598680.0,12
57673,57673,72450,br93yjtj,,Medline,Tongue rotation for reconstruction after rostral hemiglossectomy for excision of a liposarcoma of the rostral quadrant of the tongue in a dog.,,,24155451.0,unk,yearold female beagle dog presented lingual liposarcoma full staging disease show evidence metastasis tongue rotation reconstruction rostral hemiglossectomy performed removal mass surgical technique may useful tongue reconstruction trauma tumor excision,2013,"Montinaro, Vincenzo; Boston, Sarah E",The Canadian veterinary journal = La revue veterinaire canadienne,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24155451/,28878456.0,12
57702,57702,72482,jt6euuog,,Medline,"Preoperative embolization of hypervascular thoracic, lumbar, and sacral spinal column tumors: technique and outcomes from a single center.",,,24070089.0,unk,existing literature preoperative spine tumor embolization limited size patient cohort diversity tumor histology report present experience preoperative embolization hypervascular thoracic lumbar sacral spinal column tumor largest series date conducted retrospective review angiogram preoperative embolizations tumor involving thoracic lumbar sacral spinal column tumor vascularity evaluated conventional spinal angiography graded normal adjacent vertebral body severe tumor blush arteriovenous shunting embolic material included poly vinyl alcohol pva particle detachable platinum coil rarely liquid embolics degree embolization graded complete nearcomplete partial anesthesia record reviewed document blood loss surgery renal cell carcinoma thyroid carcinoma leiomyosarcoma common tumor total tumor histology hemangiopericytoma highest mean vascularity tumor type least five representative case followed renal cell carcinoma thyroid carcinoma pva particle used case detachable platinum coil used case complete nearcomplete partial embolizations achieved case respectively new postprocedure neurologic deficit complication longterm morbidity mean intraoperative blood loss hypervascular tumor treated preoperative embolization cc preoperative embolization hypervascular thoracic lumbar sacral spine tumor performed high success rate high degree safety high volume center,2013,"Nair, Sreejit; Gobin, Y Pierre; Leng, Lewis Z; Marcus, Joshua D; Bilsky, Mark; Laufer, Ilya; Patsalides, Athos","Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences",,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24070089/,33179542.0,12
58418,58418,73323,k8mbvurd,,Medline,[Transanal endoscopic microsurgery (TEM)].,,,10666724.0,unk,minimally invasive surgery mandatory rectal tumor reduce surgical complication improve quality life conventional transanal procedure one minimally invasive surgery rectal tumor still often difficult reach middle upper third rectum due anatomical characteristic transanal endoscopic microsurgery tem technique allows radical resection rectal tumor distal well proximal third rectum performing radical surgery using technique requires preoperative estimation tumor extension histologically xray image allow provide safe radical excision rectal tumor department patient rectal tumor evaluated risk factor using barium enema endoscopic ultrasound punch biopsy etc fifty patient rectal cancer cartinoid adenoma undergone radical tem operation converted open surgery case rectal perforation radical open surgery performed tem patient since cancer invasion revealed postoperatively upon histological examination conclude tem useful technique radical resection rectal tumor associated low rate postoperative complication high surgical success rate,1999,"Yamasaki, K; Shirouzu, K",Nihon Geka Gakkai zasshi,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/10666724/,19314580.0,12
58526,58526,73448,ait7kz5m,,Medline,In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.,,,22954184.0,unk,cholecystokinin cck receptor overexpressed several human tumor type medullary thyroid carcinoma small cell lung cancer several ligand cck receptor cckr developed radionuclide targeting tumor study evaluated whether radiolabeled dotascck stabilized derivative dotascckphepchsoh nle suitable imaging cckrpositive tumor using dotamg reference vivo targeting cckrpositive tumor dotascck dotascckphepchsoh nle dotamg labeled ga evaluated balbc nude mouse subcutaneous acckr tumor biodistribution study singlephoton emission computed tomography spect positron emission tomography pet performed hour postinjection peptide specifically accreted cckrexpressing tumor indotascck indotascckphepchsoh nle showed good tumor retention idg idg respectively hour postinjection petcomputed tomographic ct spectct scan subcutaneous acckr tumor clearly visualized low uptake scck peptide intestine whereas radiolabeled dotamg showed high kidney uptake idg scck peptide showed low uptake kidney sulfated cck analogue combined high tumor uptake low retention kidney therefore promising tracer imaging cckrpositive tumor,2012,"Roosenburg, Susan; Laverman, Peter; Joosten, Lieke; Eek, Annemarie; Rutjes, Floris P J T; van Delft, Floris L; Boerman, Otto C",Molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22954184/,22659399.0,12
58539,58539,73461,kwt85hdf,,Medline,Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report.,,,26012132.0,unk,introduction report present primary mullerian carcinosarcoma localized incisional hernia ie anterior abdominal wallthere data literature localization extragenital mullerian carcinosarcoma case outline patient previous medical history rightsided ovarian cystadenocarcinoma managed hysterectomy bilateral ovariectomy chemotherapy incisional hernia occurred year operation mullerian carcinosarcoma right border incisional hernia year later tumor spreading abdominal cavity pelvis full thickness abdominal wall resection coexisting incisional hernia resulted large x cm abdominal wall defect managed modified component separation technique implanting mesh conclusion major abdominal wall resection abdominal wall reconstruction using modified component separation technique reinforced mesh could one possible solution surgical treatment primary malignant mixed mullerian tumor localized abdominal wall,2015,"Žuvela, Marinko; Micev, Marjan; Terzić, Milan; Šaranović, Djordjije; Galun, Danijel; Milićević, Miroslav",Srpski arhiv za celokupno lekarstvo,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26012132/,22701213.0,12
58864,58864,73857,yb2opcdf,,Medline,An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.,,,23483532.0,unk,vacuolar atpase vatpase play important role tumor progression metastasis novel peptide isoform vatpase called antd shown exert immunoregulatory role tumor microenvironment controlling maturation monocyte toward tumorassociated macrophage phenotype data indicate antd bind surface monocyte antd preferentially endocytosed proinflammatory monocyte bearing cdcd phenotype associated monocytetomacrophage maturation process antd binding internalization led production proinflammatory cytokine interleukin ilα ilβ cdcd classical cdcd intermediate monocyte antd internalized via macropinocytosis mechanism utilizing scavenger receptor however inhibition antd endocytosis reduce cytokine production monocyte point existence two receptor respond antd scavenger receptor mediate cellular uptake hitherto unidentified receptor stimulating production inflammatory cytokine monocyte receptor may important generating localized inflammation often required promote tumor growth hence may constitute novel target development anticancer drug,2013,"Kwong, Christina; Gilman-Sachs, Alice; Beaman, Kenneth",Oncoimmunology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23483532/,16384882.0,12
58963,58963,73972,9tqgwec3,,Medline,Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience.,,,22037265.0,unk,application radiofrequency ablation treatment lung cancer group okayama university graduate school medicine dentistry pharmaceutical science began june present report review year experience treatment modality okayama university hospital local efficacy radiofrequency ablation treatment lung cancer depends tumor size type electrode used tumor type important factor prevention local failure may acquisition adequate ablative margin combination embolization radiation therapy enhances local efficacy local failure may salvaged repeating radiofrequency ablation particularly small tumor survival rate radiofrequency ablation quite promising patient clinical stage nonsmall cell lung cancer pulmonary metastasis colorectal cancer hepatocellular carcinoma renal cell carcinoma complication caused radiofrequency ablation treated conservatively majority case however attention paid rare serious complication review show radiofrequency ablation promising treatment patient lung cancer,2011,"Hiraki, Takao; Gobara, Hideo; Mimura, Hidefumi; Toyooka, Shinichi; Fujiwara, Hiroyasu; Yasui, Kotaro; Sano, Yoshifumi; Iguchi, Toshihiro; Sakurai, Jun; Tajiri, Nobuhisa; Mukai, Takashi; Matsui, Yusuke; Kanazawa, Susumu",Acta medica Okayama,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22037265/,348306.0,12
59156,59156,74202,usf8z2bd,,Medline,Bladder cancer. Clinical practice guidelines in oncology.,,,19813320.0,unk,urothelial tumor represent spectrum disease range prognosis diagnosis established point within urothelial tract patient remains risk developing new lesion different location similar advanced stage continued monitoring recurrence essential part management recurrence superficial managed endoscopically within category disease refined method determine prognosis guide management based molecular staging development goal optimizing individual patient likelihood cure chance organ preservation patient extensive disease newer treatment typically involve combinedmodality approach using recently developed surgical procedure threedimensional treatment planning precise delivery radiation therapy although appropriate case offer promise improved quality life prolonged survival finally within category metastatic disease number new agent identified appear superior currently considered standard therapy expert believe therefore treatment urothelial tumor evolve rapidly next year improved outcome patient stage disease,2005,"Montie, James E; Bahnson, Robert R; Cohen, Samuel M; Drucker, Beverly; Eisenberger, Mario A; El-Galley, Rizk; Herr, Harry W; Hudes, Gary R; Kuzel, Timothy M; Lange, Paul H; Patterson, Anthony; Pollack, Alan; Richie, Jerome P; Seigne, John; Shipley, William U; Small, Eric J; Trump, Donald L; Walther, Philip J; Wilson, Timothy G",Journal of the National Comprehensive Cancer Network : JNCCN,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/19813320/,11167228.0,12
59455,59455,74555,3n4yjjnw,,Medline,Colorectal endoscopic submucosal dissection: a systematic review and meta-analysis.,,,27747275.0,unk,background study aim endoscopic submucosal dissection esd advanced endoscopic technique allows enbloc resection gastrointestinal tumor systematically review medical literature order evaluate safety efficacy colorectal esd patient method performed comprehensive literature search medline embase ovid cinahl cochrane study reporting clinical efficacy safety profile colorectal esd result included study tumor patient female underwent colorectal esd r resection rate ci significant betweenstudy heterogeneity p partly explained difference continent p study design p duration procedure p marginally average tumor size p endoscopic en bloc curative resection rate ci ci respectively rate immediate delayed perforation ci ci respectively rate immediate delayed major bleeding ci ci average postoperative follow month rate tumor recurrence ci among r resection ci among without r resection overall irrespective resection status recurrence rate ci conclusion metaanalysis largest comprehensive assessment colorectal esd date showed colorectal esd safe effective colorectal tumor warrant consideration firstline therapy expert operator available,2016,"Akintoye, Emmanuel; Kumar, Nitin; Aihara, Hiroyuki; Nas, Hala; Thompson, Christopher C",Endoscopy international open,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27747275/,9364385.0,12
60443,60443,75703,hkrz5ufg,,Medline,[A Case of Gastric Schwannoma Diagnosed Preoperatively].,,,32408331.0,unk,patient yearold woman found abnormality upper gastrointestinalugitract via contrastimaging study symptomscomputed tomographyctrevealed tumor measuring approximately mm diameter antrum stomachthe tumor diagnosed gastric schwannoma using endoscopic ultrasonographyguided fineneedle aspirationeusfnapreoperative ct revealed multiple lymph adenopathy around antrum led suspicion lymph node metastasis patient underwent laparoscopic partial gastrectomy confirmation absence lymph node metastasis intraoperative rapid diagnosis,2020-05-01,"Mitsui, Hideo; Yoshida, Tomoyuki; Yoshimoto, Eri; Iizuka, Doichiro; Yoshida, Takashi; Kanazawa, Nobuo; Kuroiwa, Kojiro",Gan to kagaku ryoho. Cancer & chemotherapy,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32408331/,218649233.0,12
60469,60469,75736,yvz1ubzs,,Medline,Enzymatic degradation study of 111In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging radiopharmaceuticals.,,,30587465.0,unk,neuroendocrine tumor net rare tumor often impose graveyard threat tumor characterized expression various gprotein coupled receptor including cholecystokinin cck receptor b minigastrin peptide investigated theranostic purpose cck receptor positive net minigastrin analogue apho modified engineering enzyme susceptible tetrapeptide sequence apho peptide reduce random degradation lysosome enzyme pave way random trafficking patient body dipeptide addition cterminus four modified minigastrin peptide mgcl investigated lysosome cathepsin b catb enzyme susceptibility fate arj cancer cell line indium labeled mgcl peptide also studied target tumor nontarget saccumulation using tumor induced mouse rphplc analysis result showed nonspecific cleavage standard inaph inmgcl specific cleavage noted case inmgcl effect specific nonspecific cleavage biodistribution tumor induced nude mouse model indicates promising accumulation inmgcl inmgcl inmgcl radiotracers inmgcl showed le accumulation inmgcl inmgcl showed highest targettokidney ratio tk ie respectively whereas standard compound showed tk conclusion two indium labeled analogue ie inmgcl inmgcl showed promising sensitivity tumor andcould tested investigation reach preclinical study,2018,"Naqvi, Syed Ali Raza; Yameen, Muhammad; Hussain, Zaib; Asim, Sadia; Usman, Muhammad; Khan, Naeemul Haq; Abbas, Khizar",Pakistan journal of pharmaceutical sciences,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/30587465/,53684519.0,12
60507,60507,75783,lntrpns4,,Medline,Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist.,,,23133805.0,unk,chemokine receptor cxcr biomarker overexpressed ductal carcinoma situ dci hence cxcrtargeted molecular imaging approach may diagnostic value challenging premalignant lesion indium labeled cxcr peptideantagonist indtpaactz used visualize cxcrexpression mammary intraepithelial neoplastic outgrowth mino mouse tumor model resembling human dci mino lesion development longitudinally monitored using spetct tracer uptake compared uptake control lesion expression cxcr validated using immunohistochemistry flow cytometric analysis uptake indtpaactz related tumor angiogenesis using incdtpargdfk twentyfour hour tracer injection mino lesion could discriminated low cxcrexpressing control tumor degree angiogenesis based αvβ integrin expression tumor type similar uptake indtpaactz early mino lesion significantly lower larger intermediate latestage lesion twoandahalftimes p seventimes p respectively intermediate late stage lesion show higher degree membranous cxcrstaining immunohistochemistry flow cytometric analysis study conclude indtpaactz used visualize cxcrexpression mino lesion longitudinally,2012,"Buckle, Tessa; van Berg, Nynke S; Kuil, Joeri; Bunschoten, Anton; Oldenburg, Joppe; Borowsky, Alexander D; Wesseling, Jelle; Masada, Ryo; Oishi, Shinya; Fujii, Nobutaka; van Leeuwen, Fijs Wb",American journal of nuclear medicine and molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23133805/,37001946.0,12
60600,60600,75894,2xcqlrvv,,Medline,Circulating Tumour Cells in Patients with Malignant Lung Tumors Undergoing Radio-frequency Ablation.,,,25964562.0,unk,backgroundaim radiofrequency ablation rfa increasingly utilised technique patient surgicallyuntreatable lesion effect therapy circulating tumor cell ctc unknown far aware first study evaluate effect rfa ctc patient malignant lung tumor immediately posttreatment patient method nine patient primary metastatic lung tumor underwent rfa therapy june november blood sample taken rfa filtered screencell ctc capture device result general increase ctc case found largest increase seen metastatic group conclusion study demonstrates manipulation ablative procedure lung tumor lead immediate dissemination tumor cell effect unknown require investigation,2015,"Chudasama, Dimple; Rice, Alexandra; Anikin, Vladimir; Soppa, Gopal; Dalal, Paras",Anticancer research,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25964562/,15136862.0,12
61840,61840,77330,cie37phr,,Medline,Evolution of bombesin conjugates for targeted PET imaging of tumors.,,,23024746.0,unk,bombesin receptor intense investigation molecular target since overexpressed several prevalent solid tumor rationally designed synthesized series modified bombesin bn peptide analog study influence charge spacers nterminus well amino acid substitution receptor binding affinity pharmacokinetics enabled development novel culabeled bn peptide pet imaging targeted radiotherapy bn receptorpositive tumor result show nterminally positively charged peptide ligand significantly higher affinity human gastrin releasing peptide receptor grpr negatively charged uncharged ligand ic ± v ± v ± nm replacement nle met deletion dtyr resulted fold higher affinity contrary significant change human grpr binding modification nterminal th th th position bn induced slight influence affinity mouse grpr cuiicptaβala bn cuiibzh showed highest internalization rate pc cell relatively slow efflux subnanomolar affinity grpr interestingly cubzh also displayed similar affinity human bn receptor subtypes vivo study showed cubzh high accumulation pc xenograft allowed clearcut visualization tumor pet imaging addition cptaglycine derivative forming hippuranetype spacer enhanced kidney clearance radiotracer data indicate specie variation bn receptor play important role screening radiolabeled bn well positive charge metallated complex nterminal significantly increase affinity human grpr application observation enabled novel ligand cubzh clearly visualize pc tumor vivo study provides strong starting point optimizing radiopeptides targeting carcinoma express bn receptor subtypes,2012,"Zhang, Hanwen; Abiraj, Keelara; Thorek, Daniel L J; Waser, Beatrice; Smith-Jones, Peter M; Honer, Michael; Reubi, Jean Claude; Maecke, Helmut R",PloS one,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23024746/,16494935.0,12
61963,61963,77475,09ckmfht,,Medline,Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways.,,,12379743.0,unk,investigated aid heart without cardiomyopathy using immunocytochemistry computerized image analysis regarding role hiv protein tumor necrosis factor ligand hiv cardiomyopathy hivcm hivcm cardiomyocyte apoptosis significantly related expression inflammatory cell gp tumor necrosis factoralpha hivcm heart active caspase component mitochondrioncontrolled apoptotic pathway element death receptormediated pathway tumor necrosis factoralpha fa ligand expressed strongly macrophage weakly cardiomyocytes hivcm showed significantly greater macrophage infiltration cardiomyocyte apoptosis rate compared nonhivcm hiv entered cultured neonatal rat ventricular myocytes macropinocytosis replicate hiv gpinduced apoptosis rat myocytes mitochondrioncontrolled pathway inhibited heparin aoprantes pertussis toxin suggesting cardiomyocyte apoptosis induced signaling chemokine receptor conclusion patient hivcm cardiomyocytes die mitochondrion death receptorcontrolled apoptotic pathway,2002,"Twu, Cheryl; Liu, Nancy Q; Popik, Waldemar; Bukrinsky, Michael; Sayre, James; Roberts, Jaclyn; Rania, Shammas; Bramhandam, Vishnu; Roos, Kenneth P; MacLellan, W Robb; Fiala, Milan",Proceedings of the National Academy of Sciences of the United States of America,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/12379743/,6835297.0,12
63148,63148,78881,mxswcg8h,,Medline,Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.,,,22006031.0,unk,purpose evaluate treatment effect complication outcome percutaneous stereotactic radiofrequency ablation srfa intrahepatic cholangiocarcinoma icc patient method eleven consecutive patient nine men two woman total inoperable icc initial lesion lesion newly detected followup two local recurrence underwent srfa december june two different radiofrequency ablation rfa device internally cooled electrode used tumor diameter ranged cm median cm total srfa session performed efficacy srfa evaluated contrastenhanced computed tomography magnetic resonance imaging month treatment every month result primary technical effectiveness rate followup every month revealed three local recurrence two successfully retreated resulting secondary technical effectiveness rate total rfa session three major complication occurred could managed interventionally mean followup time month range month one year overall survival rate respectively median overall survival month according life table method eight patient still alive end followup conclusion srfa effective treatment unresectable icc even tumor large located close major vessel srfa show survival benefit compared palliative treatment option may also considered firstline local treatment icc selected patient,2012,"Haidu, Marion; Dobrozemsky, Georg; Schullian, Peter; Widmann, Gerlig; Klaus, Alexander; Weiss, Helmut; Margreiter, Raimund; Bale, Reto",Cardiovascular and interventional radiology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22006031/,23284889.0,12
63156,63156,78892,n6ysd54i,,Medline,"Hand-assisted, conventional and laparoendoscopic single-site surgery for partial nephrectomy without ischemia using a microwave tissue coagulator.",,,25015604.0,unk,purpose report experience minimally invasive partial nephrectomy without ischemia using microwave tissue coagulator mtc handassisted laparoscopic partial nephrectomy halpn conventional laparoscopic partial nephrectomy clpn laparoendoscopic singlesite surgery partial nephrectomy lesspn retrospectively compared result technique better define individual role benefit material method july september patient small exophytic renal tumor underwent halpn n clpn n lesspn n procedure surgeon used mtc circumferential coagulation around tumor coagulation tumor resected without renal pedicle clamping result mean operative time min halpn clpn lesspn group respectively two patient one halpn group one lesspn group converted laparotomy due inability maintain hemostasis however conversion ischemic partial nephrectomy radical nephrectomy difference halpn clpn lesspn noted term estimated blood loss measured analgesic requirement outcome complication conclusion believe technique feasible minimize risk unexpected collateral thermal damage appropriate mtc needle puncture deciding use halpn clpn lesspn finding suggest choice surgical approach depend patient individual circumstance,2014,"Nozaki, Tetsuo; Asao, Yoshihiro; Katoh, Tomonori; Yasuda, Kenji; Fuse, Hideki",Urology journal,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25015604/,23008553.0,12
63228,63228,78976,20yvsv48,,Medline,[Microwave ablation of liver tumors as a new instrument for minimally invasive liver surgery].,,,19606722.0,unk,incidence primary secondary liver tumor increasing hepatic resection remains treatment choice hepatic tumor various reason vast majority patient liver tumor suitable resection patient candidate several imageguided focal thermal ablative therapy alternative resection currently available ablative technique include cryotherapy radiofrequency ablation rfa microwave ablation mwa laser ablation highintensity focused ultrasound ablation hifu ethanol injection presently rfa widely heatbased technology used treatment liver malignancy due availability efficacy low complication rate however rfa timeconsuming associated higher recurrence rate larger lesion mwa new thermal ablative technique us electromagnetic energy produce coagulation necrosis mwa several advantage rfa improved convection profile consistently higher intratumoral temperature larger ablation volume faster ablation time option using multiple antenna simultaneously report first experience using mwa coviden valleyab mhz generator ablation liver tumor respect previous experience rfa study review current literature rfa mwa treatment liver malignance opinion although experience limited mwa appears safe effective technology hepatic tumor ablation case may superior alternative rfa,2009,"Stańczyk, Marek; Zegadło, Arkadiusz; Zwierowicz, Tomasz; Zak, Dariusz; Bogusławska, Romana; Maruszyński, Marek",Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/19606722/,23620312.0,12
63309,63309,79064,vnqnkckj,,Medline,The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation.,,,22189480.0,unk,aim present study ass diagnostic usefulness fluorine fluorodeoxyglucose ffdg positron emission tomographycomputed tomography petct prediction local recurrence malignant lung tumor analyzing preradiofrequency ablation rfa maximal standardized uptake value suvmax performed historical cohort study consecutive malignant lung tumor treated rfa january may okayama university hospital selected lung tumor examined petct within day rfa divided primary metastatic group according tertiles suvmax calculated recurrence odds ratio medium group high group compared low group using multivariate logistic analysis examined relationship suvmax recurrence crude model adjusted factor tumor higher suvmax showed higher recurrence odds ratio medium group high group respectively tumor size also increased recurrence odds ratio thought mainly due selection bias excluded tumor le mm diameter study demonstrated prerfa suvmax petct may prognostic factor local recurrence malignant lung tumor,2011,"Harada, Sosuke; Sato, Shuhei; Suzuki, Etsuji; Okumura, Yoshihiro; Hiraki, Takao; Gobara, Hideo; Mimura, Hidefumi; Kanazawa, Susumu; Kaji, Mitsumasa; Fujiwara, Toshiyoshi",Acta medica Okayama,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/22189480/,42281780.0,12
63374,63374,79138,krx8zg8d,,Medline,Single port VATS resection of a sessile solitary fibrous tumour of the visceral pleura. A case report.,,,26394843.0,unk,unlabelled solitary fibrous tumour visceral pleura rare neoplasm derives mesenchymal cell adjacent mesothelial tissue pleura surgical resection treatment choice benign lesion healing resulting half malignant local recurrence occur malignant case rare solitary benign tumor may result incomplete conservative surgery lack identification tumor operation growth synchronous neoplasm independent removed surgical resection also burdened difficulty size tumor relationship adjacent structure identification vascular peduncle report case yearsold male sessile left solitary fibrous tumour visceral pleura mass x x cm attached thanks large planting base lateral basal segment left lower lobe patient treated single port video assisted approach cm skin incision case knowledge represents first resection single port vat sessile sftp large plating base generally third sftp resection treated single portal access key word solitary fibrous tumour uniportal vat,2015,"Mazzella, Antonio; Izzo, Alessandro; Amore, Dario; Cennamo, Antonio; Cerqua, Francesco Saverio; Perrotta, Fabio",Annali italiani di chirurgia,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26394843/,43852837.0,12
63573,63573,79367,qfcesatx,,Medline,Radiofrequency ablation for the management of liver tumors.,,,12901246.0,unk,background radiofrequency ablation recently become viable treatment option unresectable primary secondary lesion confined liver objective study local therapeutic efficacy side effect complication radiofrequency ablation treatment hepatocellular carcinoma liver metastasis first reported experience radiofrequency ablation treating malignant hepatic tumor israel method fifteen consecutive patient aged year lesion patient hcc secondary liver tumor underwent radiofrequency ablation general anesthesia rita ninearray cm thermal ablation catheter model generator used mean diameter tumor cm range cm three lesion cm diameter small lesion measured cm medium measured cm large result complete necrosis found hccs computed tomography scan remainder diffuse tumor recurrence demonstrated three lesion lipiodol injection one local tumor recurrence metastasis group complete necrosis found lesion one major complication peritonitis treated antibiotic four minor complication right pleural effusion small subcapsular hematoma monitored conclusion radiofrequency ablation appears effective safe relatively simple procedure treatment liver tumor,2003,"Bachar, Gil N; Greif, Franklin; Mor, Eytan; Tur-Kaspa, Ran; Belenky, Alexander",The Israel Medical Association journal : IMAJ,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/12901246/,45009998.0,12
63790,63790,79633,dhzrztlp,,Medline,Development of NGR peptide-based agents for tumor imaging.,,,23133793.0,unk,molecular imaging allows direct visualization target characterization cellular pathway long high signalbackground ratio achieved requires sufficient amount probe accumulate imaging region asnglyarg ngr tripeptide selected phage display specifically target tumor vasculature recognizing aminopeptidase n apn cd receptor membrane tumor cell peptide internalized cytoplasma endosomal pathway hence ngr serve ideal candidate tumor imaging conjugated fluorescent radiolabeled imaging probe herein highlight recent development ngr peptide based imaging tumor although still preliminary stage ngr probe shown potential promising agent future clinical application,2011,"Wang, Rongsheng E; Niu, Youhong; Wu, Haifan; Amin, Mohamad Nassir; Cai, Jianfeng",American journal of nuclear medicine and molecular imaging,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23133793/,2654239.0,12
63801,63801,79647,d3ozfzvt,,Medline,Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.,,,27781199.0,unk,background aim extractedoverlay fusion imaging novel computed tomographymagnetic resonanceultrasonography ctmrus imaging technique target tumor virtual ablative margin extracted ctmr volume data synchronously overlaid u image investigated applicability technique intraoperative evaluation radiofrequency ablation rfa hepatocellular carcinoma hcc method retrospective study analyzed hccs treated rfa using extractedoverlay fusion imaging guidance evaluation perform rfa electrode inserted targeting tumor virtual mm ablative margin overlaid u image following ablation contrastenhanced u ceus performed ass ablative margin minimal ablative margin categorized three group margin mm protrusion ii margin mm iii margin ≥ mm margin assessment based positional relationship overlaid tumor plus margin perfusion defect ablation zone tumor group underwent repeat ablation group ii iii final classification compared obtained retrospectively created fusion image pre postrfa ct mr imaging ctctmrmr fusion imaging result treatment evaluation impossible using ceus six hccs tumor located far body surface remaining hccs categorization minimal ablative margin ceus extractedoverlay fusion imaging ctctmrmr fusion imaging agreement tumor cohens quadraticweighted kappa coefficient good agreement p conclusion extractedoverlay fusion imaging combined ceus feasible evaluation rfa enables intraoperative treatment evaluation without need perform contrastenhanced ct,2016,"Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Kogita, Sachiyo; Sawai, Yoshiyuki; Fukuda, Kazuto; Iwamoto, Takayuki; Okabe, Junya; Takamura, Manabu; Fujita, Norihiko; Hori, Masatoshi; Takehara, Tetsuo; Kudo, Masatoshi; Murakami, Takamichi",Liver cancer,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27781199/,11090668.0,12
63859,63859,79707,rsjvrper,,Medline,Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols.,,,23226755.0,unk,hepatocellular carcinoma hcc one common cancer type worldwide percutaneous radiofrequency ablation rfa hcc introduced japan established major local treatment method worldwide including japan comparing outcome resection rfa comparable case limited fewer tumor size cm smaller many report based rfa become main treatment small hccs rfa introduced system toho university medical center omori hospital treat nearly hcc case annually rfa although individual medical facility use method rfa would like share experience rfa treatment protocol,2012,"Masayoshi, Takahashi; Wakui, Noritaka; Sumino, Yasukiyo",Experimental and therapeutic medicine,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/23226755/,28368032.0,12
64160,64160,80074,ngqfn03h,,Medline,Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.,,,2997998.0,unk,unique subline balbc mouse designated balbcv exhibit intermediate mammary tumor incidence harbor distinct milktransmitted mouse mammary tumor virus mmtv balbcv subline used study molecular basis potential virushost interaction involving cell surfaceexpressed mmtv protein cell surface iodination identified virusspecific protein expressed balbcv primary mammary tumor cell grown culture contrast chmmtvproducing cell line expressed mmtv gp balbcv tumor cell lacked gp expressed instead k envrelated protein kenv protein also detected surface metabolically labeled balbcv tumor cell external immunoprecipitation technique expression kenv restricted mammary tissue balbcv mouse also expressed mmtv protein biochemical analysis established kenv modified nlinked glycosylation ilabeled kenv rapidly released medium tumor cell culture recovered form soluble protein g pellet biologic function cell surfaceexpressed viral protein remains unknown,1985,"Slagle, B L; Butel, J S",Virology,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/2997998/,24205121.0,12
64208,64208,80135,521vdq9q,,Medline,"Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model.",,,27685133.0,unk,purpose study examine correlation quantitative dynamic contrastenhanced dce magnetic resonance imaging mri microvessel density mvd necrotic partial necrotic viable tumor using rabbit vx liver tumor model nine rabbit used study complete necrotic area cna partial necrotic area pna viable tumor area vta liver tumor experimentally induced radiofrequency ablation rfa dcemri data processed based extended kety model estimate ktrans vp parameter boundary among cna pna vta delineated based stain image mvd assessed subregion vx tumor based correlation phparameters ktrans vp mvd cna pna ktrans value positively correlated mvd r p vta found positive correlation ktrans value mvd r p measuring pna vta mean ktrans value positively correlated mean mvd r p rabbit vx liver tumor model ktrans value correlated well mvd count pna vta liver tumor,2016,"Moon, Jungwon; Kim, Jae-Hun; Choi, Dongil; Yang, Jehoon; Lee, Min Woo; Choi, Yoon-La; Rhim, Hyunchul",Journal of applied clinical medical physics,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/27685133/,4514062.0,12
64272,64272,80211,osqcciae,,Medline,"Influence of viral infections on body weight, survival, and tumor prevalence in Fischer 344/NCr rats on two-year studies.",,,2554057.0,unk,sendai virus sv pneumonia virus mouse pvm rat coronavirussialodacryoadenitis virus rcvsdav common viral infection rat national cancer institutenational toxicology program ncintp study influence viral infection body weight survival prevalence spontaneous tumor fncr rat diet control group five different laboratory evaluated tumor prevalence evaluated investigation included following leukemia tumor anterior pituitary lung salivary gland harderian gland sex adrenal pheochromocytoma male rat mammary tumor female rat sv pvm rcvsdav infection associated significant p le decrease body weight male female rat male rat group pvm infection lower prevalence leukemia male rat group rcvsdav infection higher prevalence anterior pituitary tumor corresponding uninfected group female rat group sv infection greater survival higher prevalence lung tumor group without sv infection however none tumor prevalence survival difference statistically significant interlaboratory variability timerelated effect taken account,1989,"Rao, G N; Haseman, J K; Edmondson, J",Laboratory animal science,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/2554057/,8891201.0,12
64724,64724,80741,0kvh8nmr,,Medline,Immunohistochemical characterization of a hepatic neuroendocrine carcinoma in a cat.,,,18182524.0,unk,hepatic mass identified yearold female mixedbreed cat died spontaneously clinical history progressive emaciation ptyalism persistent coryza necropsy cmdiameter yellowbrown firm multilobulated tumor identified liver microscopically mass consisted neoplastic cell arranged small closely packed nest within thin fibrovascular stroma cell medium sized polygonal fine argyrophilic cytoplasmic granule nucleus predominantly round finely stippled chromatin indistinct nucleolus mitotic figure numerous immunohistochemically neoplastic cell immunoreactive chromogranin neuronspecific enolase nse cytokeratin aeae weakly labeled synaptophysin tumor negative glial fibrillary acidic protein gfap vimentin cytokeratins vascular embolus intrahepatic micrometastasis also identified chromogranin feature consistent hepatic neuroendocrine carcinoma emphasized importance using panel antibody diagnose rare tumor,2008,"Ferreira-Neves, Patricia; Lezmi, Stéphane; Lejeune, Typhaine; Rakotovao, Farasao; Dally, Claire; Fontaine, Jean-Jacques; Bernex, Florence; Cordonnier, Nathalie","Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc",,,,,,https://www.ncbi.nlm.nih.gov/pubmed/18182524/,24193923.0,12
65198,65198,81301,w51kr8sv,,Medline,Preoperative embolization of meningiomas with low-concentration n-butyl cyanoacrylate.,,,26412880.0,unk,aim study determine clinical safety efficacy preoperative embolization meningioma lowconcentration nbutyl cyanoacrylate nbca nineteen case hypervascular intracranial meningioma treated preoperative embolization nbca using wedged superselective catheterization feeding artery refluxholdreinjection technique clinical data patient radiological intrasurgical finding reviewed tumor successfully devascularized without neurological complication marked reduction tumor staining extensive nbca penetration achieved case perioperative blood transfusion required two case result indicate preoperative embolization meningioma lowconcentration nbca safe effective,2015,"Yamamoto, Taiki; Ohshima, Tomotaka; Nishihori, Masahiro; Goto, Shunsaku; Nishizawa, Toshihisa; Shimato, Shinji; Kato, Kyozo",Nagoya journal of medical science,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/26412880/,16658929.0,12
65242,65242,81352,06cjenfa,,Medline,Diagnosis and treatment of a dermal malignant melanoma in an African lion (Panthera leo).,,,24063101.0,unk,yrold intact male african lion panthera leo presented mo history left maxillary lip swelling physical examination cmdiameter ulcerated round firm pigmented mass level left maxillary canine tooth noticed organ system examined within normal limit multiple biopsy mass collected fixed neutral buffered formalin histopathologic evaluation biopsy revealed malignant dermal melanoma hematologic plasma biochemical parameter within normal reference range thoracic radiograph taken day following initial presentation showed evidence metastasis tumor computed tomography skull neck performed evaluate local tumor invasion plan hypofractionated radiation therapy therapy included four weekly treatment gray externalbeam hypofractionated radiation four bimonthly immunotherapy treatment following treatment regime tumor size reduced surgical excision performed major side effect associated radiation immunotherapy seen six month diagnosis hematologic plasma biochemical parameter within normal limit thoracic radiograph showed evidence metastasis lion showed clinical sign disease lion continue receive immunotherapy every mo rest life author knowledge first report successful treatment malignant dermal melanoma externalbeam hypofractionated radiation immunotherapy surgical excision african lion,2013,"Steeil, James C; Schumacher, Juergen; Baine, Katherine; Ramsay, Edward C; Sura, Patricia; Hodshon, Rebecca; Donnell, Robert L; Lee, Nathan D",Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/24063101/,21850229.0,12
65262,65262,81377,dlehpuyj,,Medline,uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.,,,25895028.0,unk,pre intraoperative diagnostic technique facilitating tumor staging paramount importance colorectal cancer surgery urokinase receptor upar play important role development cancer tumor invasion angiogenesis metastasis overexpression found majority carcinoma study aim develop first clinically relevant antiupar antibodybased imaging agent combine nuclear realtime nearinfrared nir fluorescent imaging zw conjugation binding capacity investigated validated vitro using spectrophotometry cellbased assay vivo three human colorectal xenograft model used including orthotopic peritoneal carcinomatosis model image small tumor nuclear nir fluorescent signal showed clear tumor delineation h h postinjection highest tumortobackground ratio ± h using fluorescence ± h radioactivity mm sized tumor could clearly recognized fluorescent rim study showed feasibility uparrecognizing multimodal agent visualize tumor imageguided resection using nir fluorescence whereas nuclear component assisted preoperative noninvasive recognition tumor using spect imaging strategy assist surgical planning subsequent precision surgery reduce number incomplete resection,2015,"Boonstra, Martin C; van Driel, Pieter B A A; van Willigen, Danny M; Stammes, Marieke A; Prevoo, Hendrica A J M; Tummers, Quirijn R J G; Mazar, Andrew P; Beekman, Freek J; Kuppen, Peter J K; van de Velde, Cornelis J H; Löwik, Clemens W G M; Frangioni, John V; van Leeuwen, Fijs W B; Sier, Cornelis F M; Vahrmeijer, Alexander L",Oncotarget,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25895028/,7965254.0,12
65462,65462,81613,91kphe8h,,Medline,Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses.,,,17253141.0,unk,aim study estimate incidence gastrointestinal stromal tumor previous diagnosis confirmed andor revised immunohistochemical mutational analysis reviewed surgically excised gastrointestinal lesion hospital mesenchymal tumor examined cd expression immunohistochemistry every cdnegative mesenchymal tumor subjected mutational analysis kit pdgfra exon result showed approximately gastrointestinal stromal tumor misdiagnosed immunohistochemical analysis cd expression performed approximately misdiagnosed mutation analysis available approximately patient gastrointestinal malignancy taiwan treated hospital average newly diagnosed gastrointestinal stromal tumor hospital case per year estimated annual incident gastrointestinal stromal tumor taiwan therefore annual incidence gastrointestinal stromal tumor per million taiwanese,2007,"Tzen, Chi-Yuan; Wang, Jia-Hua; Huang, Ying-Jie; Wang, Man-Ning; Lin, Pei-Chun; Lai, Guan-Lin; Wu, Chiao-Yun; Tzen, Chin-Yuan",Digestive diseases and sciences,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/17253141/,9484500.0,12
65868,65868,82160,ohsu2rl5,,WHO,Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia,,,,unk,december new coronavirus pneumonia covid broke wuhan hubei spread rapidly nationwide january national health committee classified covid pneumonia one b class infectious disease treated class infectious disease epidemic period routine diagnosis treatment tumor patient affected varying degree special period performed superiority multidisciplinary team diagnosis treatment achieved accurate diagnosis treatment patient hepatobiliary malignant tumor provided support patient limited medical resource helped survive epidemic period basis fully understanding new coronavirus pneumonia treatment strategy changed timely epidemic appropriate treatment method adopted minimize adverse effect epidemic tumor treatment,2020,"WU, Fan; SONG, Yan; ZENG, Huiying; YE, Feng; RONG, Weiqi; WANG, Liming; WU, Jianxiong",Chinese Journal of Oncology,,#6020,,,,,211556424.0,12
65869,65869,82161,zb6vziyv,,WHO,[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of COVID-19],,,,unk,objective december new coronavirus pneumonia covid broke wuhan hubei spread rapidly nationwide january national health committee classified covid pneumonia one b class infectious disease treated class infectious disease epidemic period routine diagnosis treatment tumor patient affected varying degree special period performed superiority multidisciplinary team diagnosis treatment achieved accurate diagnosis treatment patient hepatobiliary malignant tumor provided support patient limited medical resource helped survive epidemic periodon basis fully understanding new coronavirus pneumonia treatment strategy changed timely epidemic appropriate treatment method adopted minimize adverse effect epidemic tumor treatment,2020,"Wu, F; Song, Y; Zeng, H Y; Ye, F; Chen, B; Rong, W Q; Wang, L M; Niu, L J; Wu, J X",Zhonghua Zhong Liu Za Zhi,,#32108460,,,,,211556424.0,12
66093,66093,82546,rju0sqi0,,WHO,Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment,,,,unk,background objective although nanoparticle preparation great potential treatment tumor nanoparticle preparation achieved desired therapeutic effect reason abnormal tumor microenvironment prevents nanoparticles effective concentrating reaching tumor area therefore necessary better understand effect abnormal tumor microenvironment transvascular transport nanoparticles overcome critical problem method paper tumor abnormal vascularinterstitial model established transvascular transport process nanoparticles simulated model computational fluid dynamic cfd modeling result simulation result showed transport efficiency nanoparticles decreased increasing interstitial fluid pressure ifp nanoparticles could cross blood vessel wall ifp approached blood vessel wall pressure interestingly transport efficiency nanoparticles first increased blood flow velocity decreased blood flow velocity conclusion result showed continuous malignant development tumor ability nanoparticles passively diffuse almost disappeared enhanced permeability retention epr effect nanoparticles disappeared disappearance pressure gradient inside tumor result provided guidance future research vascular transport pathway mechanism nanoparticles,2020,"Gao, Yan; Shi, Yanbin; Fu, Mengguang; Feng, Yihua; Lin, Guimei; Kong, Deyin; Jiang, Bo",Comput Methods Programs Biomed,,#32408237,,,,,218648149.0,12
66345,66345,82947,polph8hb,,WHO,Increase of mtDNA number and its mutant copies in rat brain after exposure to 150 MeV protons,,,,unk,proton beam therapy widely used treating brain tumor despite efficacy treatment use therapy met limitation associated possible damage normal brain tissue located beyond tumor site context exploration harmful effect proton normal brain tissue particular interest investigated change total mitochondrial dna mtdna copy number identified mtdna mutant copy three brain region hippocampus cortex cerebellum rat irradiation wholehead mev proton dos gy study performed month old male spraque dawley rat n group mtdna copy number determined realtime pcr level mtdna heteroplasmy estimated using surveyor nuclease technology result show head exposure proton level mtdna copy number three rat brain region increase significantly level mtdna mutant copy increase significant elevation observed hippocampus conclusion increase mtdna mutant copy may contribute mitochondrial dysfunction accompanied increased oxidative stress different brain region promote development neurodegenerative disease induction carcinogenesis,2020,"Abdullaev, Serazhutdin; Bulanova, Tatiana; Timoshenko, Gennady; Gaziev, Azhub I",Mol. Biol. reports,,#32388700,,,,,218562107.0,12
67225,67225,84440,djj9y4tm,,WHO,Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods,,,,unk,purpose highly accurate robust computeraided system based quantitative highthroughput breast imaging reporting data system birads feature dynamic contrastenhanced magnetic resonance imaging dcemri drive success radiomic application breast cancer diagnosis aim build stable system highly reproducible radiomics feature make diagnostic performance independent datasets bias segmentation method method applied dataset patient including malignant benign tumor two mri manufacturer case philip system case ge system first manual annotation dunet dunet applied different segmentation method second designed extracted feature six modality dcemri based birads third feature selection conducted betweenclass distance utilized eliminate effect dataset bias caused two machine concordance correlation coefficient intraclass correlation coefficient deviation employed evaluate influence three segmentation method eliminated feature redundancy using genetic algorithm finally three classifier including support vector machine svm bagged tree knearest neighbor evaluated performance diagnosing malignant benign tumor result total feature preserved high stability reproducibility final feature set showed robust performance factor achieved area curve accuracy sensitivity specificity differentiating benign malignant tumor svm classifier using manually segmentation result conclusion final selected feature reproducible show little dependence segmentation method data perturbation high stability effectiveness diagnosis across factor illustrate preserved feature used prognostic analysis help radiologist diagnosis breast cancer,2020,"Qiao, Mengyun; Li, Chengkang; Suo, Shiteng; Cheng, Fang; Hua, Jia; Xue, Dan; Guo, Yi; Xu, Jianrong; Wang, Yuanyuan",,,#32388693,,,,,218552450.0,12
67290,67290,84545,mqnem6bm,,WHO,"Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence?",,,,unk,purpose congenital adrenal hyperplasia cah rare autosomal recessive disease cah due hydroxylase deficiency account case aimed share first case coexistence simple virilizingtype congenital adrenal hyperplasia mutation cypa triple translocation ovarian granulose cell tumor method yearold female patient presented clinic complaining abdominal pain distension physical examination revealed palpable abdominal mass virilism ambiguous genitalia clitoramegaly hyperpigmentation contrastenhanced abdominal computed tomography showed giant mass originating right tuboovarian structure result patient operated light clinicoradiological feature mentioned giant mass weighing g detected right tuboovarian structure laparotomy mass excised right tuboovarian structure immunohistochemical examination revealed ovarian granulosa cell tumor high serum concentration oh progesterone measured baseline µg bolus synthetic acth genetic analysis screened sixpoint mutation large deletion noncommon mutation using restriction fragment length polymorphism rflp method pcr sequencing cyp gene respectively patient detected homozygous mutation addition metaphase examined triple translocation conclusion coexistence congenital adrenal hyperplasia triple chromosomal translocation ovarian granulosa cell tumor described previously coexistence may sign new syndrome,2020,"Akbulut, Sami; Ceylan, Senay Durmaz; Tuncali, Timur; Sogutcu, Nilgun",,,#32388791,,,,,218552452.0,12
68541,68541,86679,8o3mludy,,WHO,Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China,,,,unk,outbreak novel coronavirus pneumonia ncp become public health emergency china chinese authority health agency devoted great effort control disease surgeon specialized treatment gastrointestinal tumor always aware prevention ncp incorporate awareness every detail clinical practice patient gastrointestinal tumor preadmission screening done order rule ncp realtime rtpcr panel chest ct scan conducted patient fever gt travel history hubei province within day contact history resident wuhan district within day prevention measure medical staff screennegative admitted patient also enhanced false negative possible medical instrument properly discarded disinfected according standardized procedure established local center disease control prevention cdc surgical operation reduced minimal level prevent cross infection special period surgical intervention benign tumor postponed malignant tumor multidisciplinary therapy mdt recommended nonsurgical antitumor therapy selected higher priority neoadjuvant therapy highly recommended gastrointestinal cancer advanced stage meet indication nccn guideline gastric cancer stage gerectal cancer stage geunresectable colon cancer gastric esophagogastricjunction egj malignant tumor obstruction managed gastric tube decompression stent placement relieve symptom transnasal enteral feeding tube intubationpercutaneous endoscopic gastrostomy could adopted ensure enteral nutrition supply colorectal malignancy simple intestinal obstruction stent placement achieve high success rate help avoid emergency surgery also creates better condition subsequent surgery transcatheter arterial embolization hemostasis alternative choice gastrointestinal tumor bleeding however emergency operation still must performed patient acute uncontrolled bleeding obstruction alternative treatment measure fail case suspicious confirmed ncp must reported local cdc department invasive intervention must performed designated isolation area tertiary prevention measure must adopted anesthetist additional face mask medical goggle protection prevent respiratory droplet transmission preventive enterostomy preferable lower digestive tract surgery thoroughly disinfecting operating room surgery necessary fever surgery must carefully differentiated whether caused postsurgery abdominal infectioninflammation ncp singleroom isolation related examination performed according standard procedure believe unprecedentedly joint effort doctor patient eventually win war ncp,2020,"CHEN, Yonghe",Chinese Journal of Gastrointestinal Surgery,,#2332,,,,,211214450.0,12
68542,68542,86680,zm039y08,,WHO,[Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China],,,,unk,outbreak novel coronavirus pneumonia ncp become public health emergency china chinese authority health agency devoted great effort control disease surgeon specialized treatment gastrointestinal tumor always aware prevention ncp incorporate awareness every detail clinical practice patient gastrointestinal tumor preadmission screening done order rule ncp realtime rtpcr panel chest ct scan conducted patient fever â travel history hubei province within day contact history resident wuhan district within day prevention measure medical staff screennegative admitted patient also enhanced false negative possible medical instrument properly discarded disinfected according standardized procedure established local center disease control prevention cdc surgical operation reduced minimal level prevent cross infection special periodsurgical intervention benign tumor postponed malignant tumor multidisciplinary therapy mdt recommended nonsurgical antitumor therapy selected higher priority neoadjuvant therapy highly recommended gastrointestinal cancer advanced stage meet indication nccn guideline gastric cancer stage rectal cancer stage unresectable colon cancer gastric esophagogastricjunction egj malignant tumor obstruction managed gastric tube decompression stent placement relieve symptom transnasal enteral feeding tube intubationpercutaneous endoscopic gastrostomy could adopted ensure enteral nutrition supply colorectal malignancy simple intestinal obstruction stent placement achieve high success rate help avoid emergency surgery also creates better condition subsequent surgery transcatheter arterial embolization hemostasis alternative choice gastrointestinal tumor bleeding however emergency operation still must performed patient acute uncontrolled bleeding obstruction alternative treatment measure fail case suspicious confirmed ncp must reported local cdc department invasive intervention must performed designated isolation area tertiary prevention measure must adopted anesthetist additional face mask medical goggle protection prevent respiratory droplet transmission preventive enterostomy preferable lower digestive tract surgery thoroughly disinfecting operating room surgery necessary fever surgery must carefully differentiated whether caused postsurgery abdominal infectioninflammation ncp singleroom isolation related examination performed according standard procedure believe unprecedentedly joint effort doctor patient eventually win war ncp,2020,"Chen, Y H; Peng, J S",Zhonghua Wei Chang Wai Ke Za Zhi,,#32074786,,,,,211214450.0,12
68934,68934,87312,c8gq0cbf,,WHO,High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy,,,,unk,backgroundaim great proportion patient rectal cancer initially present locally advanced disease potentially benefit neoadjuvant concurrent chemoradiotherapy ccrt downstaging surgery however risk clinical outcome stratification remain great challenge aimed find potential biomarker predict effect neoadjuvant ccrt rectal cancer method identified epiregulin ereg significant predictive marker neoadjuvant ccrt response published rectal cancer transcriptome data set gse collected biopsy specimen rectal cancer patient received neoadjuvant ccrt followed radical proctectomy performed ereg immunohistochemistry analyzed hscores examined correlation expression level ereg clinicopathological feature tumor regression grade survival including diseasespecific survival ds locoregional recurrencefree survival lrfs metastasisfree survival mefs result high ereg expression significantly related early pretreatment pretx posttreatment posttx tumor status p p pretx posttx negative nodal status n p p le vascular perineurial invasion p p higher tumor regression grade p survival analysis high ereg expression significantly associated better ds p lrfs p mefs p multivariate analysis high ereg expression remained prognostically significant better ds p hazard ratio conclusion data suggest ereg potential predictive marker therapeutic target rectal cancer patient receiving neoadjuvant ccrt,2020,"Lin, Cheng-Yi; Hsieh, Pei-Ling; Chou, Chia-Lin; Yang, Ching-Chieh; Lee, Sung-Wei; Tian, Yu-Feng; Shiue, Yow-Ling; Li, Wan-Shan",Oncology,,#32408308,,,,,218650087.0,12
69249,69249,87871,o6q83g0k,,WHO,Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles,,,,unk,background ovarian cancer lethal gynecologic cancer fifth leading cause cancerrelated mortality woman worldwide despite various attempt improve diagnosis therapy ovarian cancer patient survival rate patient still dismal mainly diagnosed late stage ovarian cancer arise neoplastic transformation ovarian surface epithelial cell usually referred epithelial ovarian cancer eoc unlike human cancer disseminated bloodborne metastatic route eoc traditionally thought disseminated direct migration ovarian tumor cell peritoneal cavity omentum via peritoneal fluid recently shown however eoc also disseminated bloodborne metastatic route challenging previous thought ovarian cancer metastasis conclusion review current understanding updated cellular molecular mechanism underlying eoc metastasis discus detail two main metastatic route eoc ie transcoelomic metastasis hematogenous metastasis emerging concept bloodborne eoc metastasis led exploration significance circulating tumor cell ctc novel noninvasive prognostic marker daunting cancer also evaluate role tumor stroma including cancer associated fibroblast cafs tumor associated macrophage tam endothelial cell adipocytes dendritic cell extracellular matrix ecm component eoc growth metastasis lastly discus therapeutic approach targeting eoc unraveling mechanism underlying eoc metastasis open avenue design new therapeutic option instance understanding molecular mechanism involved hematogenous metastasis eoc biology ctc detailed mechanism eoc cell take advantage stromal cell may help find new opportunity targeting eoc metastasis,2020,"Yousefi, Meysam; Dehghani, Sadegh; Nosrati, Rahim; Ghanei, Mahmoud; Salmaninejad, Arash; Rajaie, Sara; Hasanzadeh, Malihe; Pasdar, Alireza",Cellular oncology (2011. Online),,#32418122,,,,,218652525.0,12
69800,69800,88835,jr0qmg6r,,WHO,How did lomustine become standard of care in recurrent glioblastoma?,,,,unk,glioblastoma common malignant primary intrinsic brain tumor incidence increase age male often affected firstline management includes maximum safe surgical resection followed involvedfield radiotherapy plus concomitant six cycle maintenance temozolomide chemotherapy standard care recurrence much le well defined minority patient offered second surgery reirradiation data positive impact survival randomized trial lacking majority patient eligible salvage therapy receive systemic treatment mostly nitrosoureabased regimen depending availability bevacizumab alone various combination clinical trial lomustine alone increasingly used control arm assigning drug standardofcare position setting recurrent glioblastoma review activity lomustine treatment diffuse glioma adulthood various setting compelling data lomustine stem three randomized trial lomustine combined procarbazine vincristine pcv regimen newly diagnosed setting together radiotherapy improved survival pcv restricted patient isocitrate dehydrogenasemutant tumor agent possible exception regorafenib shown superior activity lomustine recurrent glioblastoma activity largely restricted patient tumor omethylguanine dna methyltransferase mgmt promoter methylation hematological toxicity notably thrombocytopenia often limit adequate exposure,2020,"Weller, Michael; Le Rhun, Emilie",Cancer Treat Rev,,#32408220,,,,,218648915.0,12
69838,69838,88898,wnuuzo9g,,WHO,Coexistence of DIPNECH and carotid body paraganglioma: is it just a coincidence?,,,,unk,summary describe case yearold woman almost simultaneous appearance diffuse idiopathic pulmonary neuroendocrine cell hyperplasia dipnech carotid body paraganglioma interest year earlier patient underwent total thyroidectomy due papillary thyroid carcinoma meantime submitted mastectomy treat invasive ductal carcinoma breast order explain lesion extensive genetic study performed result showed positivity presence tumor suppressor gene palb whose presence already detected niece breast cancer patient underwent different procedure treat lesion currently symptomfree year followup learning point presence two rare neoplasm single person raise suspicion common etiology best knowledge first case show coexistence dipnech paraganglioma contribution palb gene etiology rare neoplasm possibility,2020,"Pedro, J; Cunha, F M; Neto, V; Hespanhol, V; Martins, D F; Guimarães, S; Varela, A; Carvalho, D",,,#32408270,,,,,218649219.0,12
69840,69840,88901,khf8vo64,,WHO,Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?,,,,unk,billion cell undergo turnover die via apoptosis throughout lifetime prompt clearance apoptotic cell debris phagocytic cell process known efferocytosis important maintaining tissue homeostasis accordingly impaired efferocytosis due defective clearance disrupted stage lead growing number inflammation immunerelated disease although numerous study shown mechanism efferocytosis role disorder nontumor tumor disease remains poorly understood review summarizes process signal molecule efferocytosis efferocytosisrelated function nontumor atherosclerosis lung disease etc tumor disease breast cancer prostate cancer etc well describes role involved cytokine note dual role efferocytosis abovementioned disorder paradoxical effect among nontumor tumor disease term inflammation resolution immune response disease progression briefly intact efferocytosis cytokine promote tissue repair contribute tumor progression via tumor microenvironment macrophage politzerization additionally review provides potential target associated tam receptor cytokine tumor necrosis factor cxcl suggesting potential novel therapeutic way treating disease,2020,"Lin, Danfeng; Kang, Xiaodiao; Shen, Lu; Tu, Sheng; Lenahan, Cameron; Chen, Yiding; Wang, Xiaochen; Shao, Anwen",,,#32346605,,,,,216553974.0,12
69921,69921,89029,v4h4ezca,,WHO,Machine learning approach for prediction of hearing preservation in vestibular schwannoma surgery,,,,unk,vestibular schwannoma patient functional hearing status surgical resection preserving hearing feasible hearing level tumor size location tumor known candidate predictor used machine learning approach predict hearing outcome vestibular schwannoma patient underwent hearing preservation surgery middle cranial fossa retrosigmoid approach reviewing medical record patient pathologically confirmed vestibular schwannoma included patient record study hearing preservation regarded positive postoperative hearing within serviceable hearing rule categorical variable included surgical approach continuous variable covered audiometric vestibular function test largest diameter tumor four different algorithm lined comparison accuracy support vector machinesvm gradient boosting machinegbm deep neural networkdnn diffuse random forestdrf average accuracy predicting hearing preservation ranged svm dnn current study first incorporate machine learning methodology prediction successful hearing preservation surgery although larger population may needed better generalization study could aid surgeon decision perform hearing preservation approach vestibular schwannoma surgery,2020,"Cha, Dongchul; Shin, Seung Ho; Kim, Sung Huhn; Choi, Jae Young; Moon, In Seok",Sci Rep,,#32346085,,,,,216560038.0,12
69950,69950,89079,7uy192sr,,WHO,Adenoid Cystic Carcinoma of Bartholin's Gland: What Is the Best Approach?,,,,unk,background summary among vulvar cancer primary adenoid cystic carcinoma acc bartholin gland rare tumor characterized slow growth high local aggressiveness remarkable recurrence rate due rarity treatment remains challenge oncologist gynecological surgeon key message present paper report clinical radiological histological feature acc bartholin gland review literature data treatment option particular focus potential role particle radiation therapy,2020,"Barcellini, Amelia; Gadducci, Angiolo; Laliscia, Concetta; Imparato, Sara; Vitolo, Viviana; Preda, Lorenzo; Valvo, Francesca",Oncology,,#32408297,,,,,218650436.0,12
70082,70082,89331,sj15lvfq,,WHO,Scatter imaging during lung stereotactic body radiation therapy characterized with phantom studies,,,,unk,collecting photon scattered therapy beam scatter imaging creates image treated volume two phantom used ass possible application scatter imaging markerless tracking lung tumor stereotactic body radiation therapy sbrt treatment scatterimaging camera assembled csi flatpanel detector mm diameter pinhole collimator scatter image collected irradiation phantom megavoltage photon ass scatter image quality spherical phantom lung tumor cm diameter placed inside static anthropomorphic phantom show efficacy technique moving target cm diameter position simulated tumor tracked scatter image sinusoidal motion mm amplitude hz frequency dynamic lung phantom openfield dynamic conformal arc dca volumetric modulated arc therapy vmat delivery anatomical feature identifiable static phantom scatter image collected mu delivered dose cm diameter lung tumor contrasttonoise ratio contrasttonoise ratio increase tumor size delivered dose dynamic motion position cm diameter lung tumor identified rootmeansquare error mm open field frame integration dca vmat respectively based phantom study scatter imaging potential technique markerless lung tumor tracking sbrt without additional imaging dose quality scatter image may collected low clinically relevant dos mu scatter image capable submillimeter tracking precision modulation decrease accuracy,2020,"Jones, Kevin C; Turian, Julius V; Redler, Gage; Cifter, Gizem; Strologas, John; Templeton, Alistair; Bernard, Damian; Chu, James C H",Phys. med. biol,,#32408276,,,,,218646806.0,12
70146,70146,89443,icx3twg3,,WHO,[A Case of Gastric Schwannoma Diagnosed Preoperatively],,,,unk,patient yearold woman found abnormality upper gastrointestinalugitract via contrastimaging study symptomscomputed tomographyctrevealed tumor measuring approximately mm diameter antrum stomachthe tumor diagnosed gastric schwannoma using endoscopic ultrasonographyguided fineneedle aspirationeusfnapreoperative ct revealed multiple lymph adenopathy around antrum led suspicion lymph node metastasis patient underwent laparoscopic partial gastrectomy confirmation absence lymph node metastasis intraoperative rapid diagnosis,2020,"Mitsui, Hideo; Yoshida, Tomoyuki; Yoshimoto, Eri; Iizuka, Doichiro; Yoshida, Takashi; Kanazawa, Nobuo; Kuroiwa, Kojiro",Gan To Kagaku Ryoho,,#32408331,,,,,218649233.0,12
70346,70346,89781,ti4or302,,WHO,Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of novel coronavirus pneumonia,,,,unk,since outbreak novel coronavirus pneumonia december diagnosis treatment patient cancer facing great challenge although oncologist fighting front line epidemic special period protect patient family medical staff infection novel coronavirus also minimize impact epidemic diagnosis treatment patient cancer combining guideline diagnosis treatment tumor clinical experience epidemic period discus strategy diagnosis treatment followup malignant tumor digestive system article,2020,"ZHANG, Yun; XU, Jianming",Chinese Journal of Oncology,,#6242,,,,,211564191.0,12
70347,70347,89782,gyopeo9o,,WHO,[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of COVID-19],,,,unk,since outbreak covid december diagnosis treatment patient cancer facing great challenge although oncologist fighting front line epidemic special period protect patient family medical staff infection novel coronavirus also minimize impact epidemic diagnosis treatment patient cancer combining guideline diagnosis treatment tumor clinical experience epidemic period discus strategy diagnosis treatment followup malignant tumor digestive system article,2020,"Zhang, Y; Xu, J M",Zhonghua Zhong Liu Za Zhi,,#32112549,,,,,211564191.0,12
70694,70694,90416,gjb2al7q,,WHO,Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer,,,,unk,microenvironment pancreatic cancer adenocarcinoma pdac highly desmoplastic distinct tumorrestraining tumorpromoting fibroblast subpopulation reeducation rather indiscriminate elimination fibroblast emerged new strategy combination therapy studied effect global loss profibrotic noncoding regulatory microrna mir krasdriven pdeleted genetically engineered mouse model pdac strikingly loss mir accelerated tumor initiation via mucinous cystic neoplastic lesion progression locally advanced invasive carcinoma animal precipitously succumbed early age absence tumorrestraining myofibroblasts massive infiltrate immune cell salient phenotypic feature global mir loss stromal mir activity required induction tumorrestraining myofibroblasts invivo isograft transplantation experiment low mir expression negatively correlated fibroblast gene expression signature positively immune cell gene expression signature tcga pdac data set n mirroring finding mouse model result exposed overall tumor suppressive function mir invivo pdac model result important clinical implication antimirbased inhibitory therapeutic approach consideration pdac cancer type mechanistic dissection cellintrinsic role mir cancerassociated fibroblast cell type needed inform best strategy pharmacological modulation mir activity order remodel tumor microenvironment enhance treatment response pdac article protected copyright right reserved,2020,"Schipper, Josh; Westerhuis, Jennifer J; Beddows, Ian; Madaj, Zach; Monsma, David; Hostetter, Galen; Kiupel, Matti; Conejo-Garcia, Jose R; Sempere, Lorenzo F",Int. j. cancer,,#32388866,,,,,218584111.0,12
71216,71216,91311,qctr5x74,,WHO,Sclerosing TSC1 Mutated Renal Cell Carcinoma: An Unusual Pattern Mimicking MITF Family Translocation Renal Cell Carcinoma,,,,unk,tuberous sclerosis gene mtor increasingly found important role novel subtypes renal cancer particularly emerging entity eosinophilic solid cystic renal cell carcinoma rcc highgrade oncocytic renal tumor hot rcc eosinophilic vacuolated cytoplasm report unique renal neoplasm yearold woman initially mimicked mitf family translocation rcc due mixed clear eosinophilic cell extensive stromal hyalinization psammoma body yet negative tfe tfeb fluorescence situ hybridization fish next generation sequencing ng gene fusion assay cytoplasmic stippling triggered consideration tscassociated neoplasm targeted next generation sequencing assay revealed variant exon tsc resulting cg pglu truncating mutation report add morphologic spectrum tscrelated renal neoplasm including prominent stromal hyalinization potentially deceptive pattern due overlap cytoplasmic stippling eosinophilic solid cystic rcc hot rcc eosinophilic vacuolated cytoplasm debatable category example would best fit understanding entity renal neoplasm alteration tsc gene elucidate whether considered family tumor article protected copyright right reserved,2020,"Williamson, Sean R; Cardili, Leonardo; Whiteley, Lisa J; Sanchez, Jessica; Kis, Olena",Genes chromosomes cancer,,#32418252,,,,,218680184.0,12
71229,71229,91336,98kxkipe,,WHO,Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer,,,,unk,cancer vaccine development proven challenging exception virally induced cancer prophylactic vaccine exist currently one fda approved vaccine treatment prostate cancer prostate cancer continues present significant unmet medical need study examine effectiveness therapeutic cancer vaccine combine iscomatrix adjuvant iscomatrix tolllike receptor agonist polyinosinicpolycytidylic acid poly ic fltl fmslike tyrosine kinase ligand employed trampc transgenic adenocarcinoma mouse prostate model prostate cancer selfprotein mpap prostatic acid phosphatase tumor antigen iscomatrixmpappoly icfltl delivered therapeutic primeboost regime consistently able achieve complete tumor regression animal treated tumorfree animal protected upon rechallenge investigation underlying immunological mechanism contributing effectiveness vaccine identified innate adaptive response elicited required nk cell cd cell interferonî found critical tumor control tumor infiltrating cd cell became disabled immunosuppressive microenvironment potential broader application cancer vaccine able demonstrate effectiveness two additional cancer model melanoma bova model b cell lymphoma eµmycgfpova,2020,"Barr, Adele M; Silva, Anabel; Prato, Sandro; Belz, Gabrielle T; Maraskovsky, Eugene; Baz Morelli, Adriana",,,#32388678,,,,,218552319.0,12
71247,71247,91378,0os0if1t,,WHO,Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer,,,,unk,chemotherapy preferred treatment advanced stage gastric cancer gc patient developing chemoresistance tremendous challenge efficacy gc treatment treatment antitumor chemoagents recruit tumorassociated macrophage tam highly implicated chemoresistance development underlying molecular mechanism unclear demonstrate hypoxiainducible factor hif gc cell activated upon fluorouracil fu treatment result much accumulation mtype tam protect tumor cell chemoagents mechanistically gc cell fu treatment reactive oxygen specie accumulated induces activation hif signaling drive expression highmobility group box lead macrophage infiltration gc tumor turn recruited tam exhibit tumorprotected mtype phenotype promote chemoresistance gc cell via producing growth differentiation factor gdf exacerbate fatty acid ßoxidation tumor cell blocking gdf using antibody inhibiting fao tumor cell etomoxir efficiently gave rise tumor cell sensitivity fu therefore study demonstrates novel insight understanding cross talking tumor cell immune microenvironment provides new therapeutic target clinic treatment gastric cancer,2020,"Yu, Shan; Li, Qian; Yu, Yiyi; Cui, Yuehong; Li, Wei; Liu, Tianshu; Liu, Fenglin",,,#32388677,,,,,218552623.0,12
71308,71308,91475,zdo8aeqo,,WHO,Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift,,,,unk,pancreatic neuroendocrine carcinoma nec rare aggressive neoplasm dismal prognosis especially metastatic negative prognostic factor vascular invasion best knowledge case pancreatic nec mismatch repair deficiency reported date describe yearold patient underwent pancreaticoduodenectomy nec located pancreatic head peripancreatic lymph node metastasis tumor necrosis prominent ki proliferative index one year diagnosis patient experienced recurrence left supraclavicular lymph node metastasis surgically removed followed standard cisplatinetoposide chemotherapy neoplastic cell showed combined loss expression mlh pm primary tumor lymph node metastasis microsatellite instability msi test using mononucleotide repeat pentaplex pcr bat bat nr nr nr revealed minimal mononucleotide shift showing deletion le bp nr bat nr nr locus mlh methylation analysis revealed absence gene promoter methylation braf kras mutation detected gut nec mismatch repair deficiency phenotype reported case represents independent factor favorable outcome likewise patient currently alive followup year pancreaticoduodenectomy unexpected finding aggressive neoplasm,2020,"Vanoli, Alessandro; Perfetti, Vittorio; Furlan, Daniela; Neri, Giuseppe; Viglio, Alessandra; Sessa, Fausto; Martino, Michele; Di Sabatino, Antonio; Solcia, Enrico; La Rosa, Stefano",Endocr. pathol,,#32388775,,,,,218552323.0,12
71478,71478,91780,wyza7v3o,,WHO,Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma,,,,unk,isocitrate dehydrogenase idh wildtype diffuse lowergrade glioma lgg usually associated poor outcome dispute clinical outcome classification presented robust gene expressionbased molecular classification idh wildtype diffuse lgg two subtypes distinct biological clinical feature discovery cohort idh wildtype diffuse lggs chinese glioma genome atlas cgga subjected clustering function analysis tumor cancer genome atlas tcga used validate finding consensus clustering transcriptional data uncovered concordant classification two robust prognostically significant subtypes idh wildtype lgg sub associated poorer outcome characterized significantly higher immune cytolytic score macrophage upregulation immune exhaustion marker sub elevated lymphocyte plasma cell showed relatively favorable survival somatic alteration analysis revealed sub showed frequently deleted region locus cdknacdknb dmrta corf mtap furthermore developed validated fivegene signature better application acquired stratification data demonstrate biological prognostic heterogeneity within idh wildtype diffuse lggs deepen molecular understanding tumor entity article protected copyright right reserved,2020,"Wu, Fan; Li, Guan-Zhang; Liu, Han-Jie; Zhao, Zheng; Chai, Rui-Chao; Liu, Yu-Qing; Jiang, Hao-Yu; Zhai, You; Feng, Yue-Mei; Li, Ren-Peng; Zhang, Wei",J. pathol,,#32418210,,,,,218679591.0,12
71671,71671,92136,zubrx3nt,,WHO,"Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade",,,,unk,background identification highrisk stage ii colorectal cancer crc patient potential candidate adjuvant chemotherapy challenging current clinical guideline rely mainly histopathological marker relatively weak prognostic value motivates search prognostic marker method explorative study aimed identify potential candidate gene mutation facilitate differentiation subgroup patient crc stage ii panelbased massive parallel sequencing used genetically characterize tumor tissue patient radically operated crc stage ii developed recurrent cancer followup genetic data compared patient without cancer recurrence tumor located colon rectum association tumor differentiation grade result genetic variation atm corf associated recurrencefree survival previous report regarding association braf mutation higher age diagnosis tumor location colon confirmed apc braf kras mutation associated tumor differentiation grade multiple correspondence analysis revealed obvious clustering patient studied clinical characteristic indicating genetic signature observed unique individual conclusion taken together demonstrated utility panelbased massive parallel sequencing explore pathogenesis crc stage ii identified promising candidate gene mutation associated cancer recurrence tumor location differentiation grade patient crc stage ii merit investigation,2020,"Dimberg, Jan; Andersson, Roland E; Haglund, Sofie",Oncology,,#32408300,,,,,218648694.0,12
71848,71848,92463,o0e9oiey,,WHO,Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8+ T cells and inhibiting tumor AKT/MAPK pathway,,,,unk,propranolol suppresses tumor growth variety preclinical solid tumor model number proposed cell signaling immunological mechanism want confirm potential mechanism including reduced phosphorylation aktmapk pathway well enhanced cd tcellmediated antitumor immune response clarify mechanism propranolol activity colorectal cancer therapeutic activity propranolol assessed ctwt tumor engrafted balbc mouse effect propranolol treatment also examined randomizing patient undergoing surgical resection previously untreated colorectal cancer propranolol placebo group treated week prior surgery ctwt tumor size smaller propranolol vehicle control propranolol downregulated expression paktperkpmek tumor tissue frequency tumor cd cell significantly elevated propranololtreated mouse expression gzmbifnîtbet cd tcell population significantly increased propranolol treated mouse tumor tissue propranololtreated surgical specimen expression perk decreased frequency cd significantly elevated expression gzmb cd tcell population significantly increased propranololtreated subject together data show propranolol simultaneously activating autologous cd cell decreasing expression paktperkpmek mouse tumor model inhibiting expression perk clinical colorectal cancer effort needed dissect whether pathway required antitumor effect activity old drug moved forward,2020,"Liao, Ping; Song, Kun; Zhu, Zhanwei; Liu, Zhaoqian; Zhang, Wei; Li, Wei; Hu, Jiali; Hu, Qian; Chen, Cuiyu; Chen, Bohua; McLeod, Howard L; Pei, Haiping; Chen, Ling; He, Yijing",Clin. pharmacol. ther,,#32418204,,,,,218679002.0,12
72099,72099,92865,1wjlnzh5,,WHO,Malignant melanotic Xp11 neoplasms exhibit a clinicopathological spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification,,,,unk,classification distinct group mesenchymal neoplasm first described xp translocation perivascular epithelioid cell tumor pecoma recently term melanotic xp neoplasm xp neoplasm melanocytic differentiation proposed remains challenging controversial collected melanotic xp neoplasm largest series date comprehensive evaluation fourteen case along alveolar soft part sarcoma asp conventional pecomas control group normal tissue submitted rna sequencing followup available patient showed year overall survival o year diseasefree survival dfs respectively similar asp significantly worse conventional pecoma univariate analysis location occurring kidney versus kidney infiltrative growth pattern nuclear pleomorphism mitotic activity hpf necrosis lymphovascular invasion found associated o andor dfs multivariate analysis identified location factor found independently correlate dfs importantly rna sequencingbased clustering analysis segregated melanotic xp neoplasm asp clearly tumor including conventional pecoma xp translocation renal cell carcinoma rcc formed compact cluster representative largely similar expression signature study first clearly define true biologic nature melanotic xp neoplasm distinctive malignant mesenchymal tumor rather simply pecoma variant occasionally unpredictable behavior meanwhile melanotic xp neoplasm asp likely represent phenotypic variant entity distinct conventional pecoma xp translocation rcc based important finding melanotic xp neoplasm might reclassified distinctive entity together asp independent pecoma future revision current world health organization category tumor soft tissue bone improved reclassification article protected copyright right reserved,2020,"Wang, Xiao-Tong; Fang, Ru; Zhang, Ru-Song; Ye, Sheng-Bing; Li, Rui; Wang, Xuan; Pan, Rui; Liu, Chong; Chen, Jie-Yu; Zhao, Ming; Teng, Xiao-Dong; Yu, Wen-Juan; Li, Yu-Jun; Wang, Feng-Hua; Zhang, Jian-Guo; Yang, Qi-Chang; Zhang, Yong-Sheng; Lu, Zhen-Feng; Ma, Heng-Hui; Zhou, Xiao-Jun; Xia, Qiu-Yuan; Rao, Qiu",J. pathol,,#32418203,,,,,218680527.0,12
73334,73334,94694,bf2o39sq,e52c04caa85880ec10ef5275a67cc3ea3a91a9c1,Medline; PMC,Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics,10.18632/oncotarget.25886,PMC6112759,30159133.0,cc-by,endoplasmic reticulum er stress activated various pathological physiological condition including unfolded protein response upr restore homeostasis upr signaling pathway initiated doublestranded rnaactivated protein kinase pkr like er kinase perk inositol requiring enzyme α ireα activating transcription factor atf vital tumor growth aggressiveness microenvironment remodeling resistance cancer therapeutic review focus role er stress activity upr signaling pathway involved tumor formation uncontrolled cell proliferation various cancer viral malignancy,2018-08-07,"Asha, Kumari; Sharma-Walia, Neelam",Oncotarget,,,,document_parses/pdf_json/e52c04caa85880ec10ef5275a67cc3ea3a91a9c1.json,document_parses/pmc_json/PMC6112759.xml.json,https://doi.org/10.18632/oncotarget.25886; https://www.ncbi.nlm.nih.gov/pubmed/30159133/,52123036.0,12
73766,73766,95236,031u33fy,ca731f0dff68b1e1537c53be5c9aecef3b45d246,Medline; PMC,Activity screening and structure–activity relationship of the hit compounds targeting APN/CD13,10.1111/j.1472-8206.2010.00844.x,PMC7164084,20636366.0,no-cc,aminopeptidase n apn play important role tumor progression participates progress proliferation attachment angiogenesis tumor invasion make apn good chemical therapeutic anti‐tumor target study series chemically synthesized apn inhibitor tested anti‐tumor activity three effective compound chosen according mtt assay enzyme inhibitory anti‐tumor specificity angiogenesis invasion determined evaluate activity three compound compound markedly inhibit enzyme activity apn angiogenesis endothelial cell invasion es‐ cell little effect viability k express low level apn data indicated tested compound apn hit compound also kinetic assay determine inhibition constant constructed three‐dimensional quantitative structure–activity relationship model analyze structure–activity relationship direct design novel apn inhibitor anti‐tumor agent data demonstrate tested compound developed novel candidate anticancer agent,2011-03-09,"Wang, Xuejian; Jing, Fanbo; Zhu, Huawei; Fang, Hao; Zhang, Jian; Xu, Wenfang",Fundam Clin Pharmacol,,,,document_parses/pdf_json/ca731f0dff68b1e1537c53be5c9aecef3b45d246.json,document_parses/pmc_json/PMC7164084.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/20636366/; https://doi.org/10.1111/j.1472-8206.2010.00844.x,669903.0,12
73972,73972,95499,nixkopi2,6f2e32a73006b640437e8e6ac2c62a90e2cfed5a,Medline; PMC,"Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer",10.1007/978-1-59745-561-9_30,PMC7122391,19565923.0,no-cc,review deal avian paramyxovirus newcastle disease virus ndv describes property explain oncolytic activity tumorselective replication behavior immunestimulatory capacity human cell strong interferon response normal cell upon contact ndv appears basis good tolerability virus cancer patient immune stimulatory property whereas weak interferon response tumor cell explains tumor selectivity replication oncolysis various concept use virus cancer treatment pointed result clinical study summarized reverse genetics technology made possible recently clone genome introduce new foreign gene thus generating new recombinant virus future used transfer new therapeutic gene tumor also immunize new emerging pathogen modular nature gene transcription undetectable rate recombination lack dna phase replication cycle make ndv suitable candidate rational design safe stable vaccine gene therapy vector,2008-12-27,"Schirrmacher, Volker; Fournier, Philippe",Gene Therapy of Cancer,,,,document_parses/pdf_json/6f2e32a73006b640437e8e6ac2c62a90e2cfed5a.json,document_parses/pmc_json/PMC7122391.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/19565923/; https://doi.org/10.1007/978-1-59745-561-9_30,206671745.0,12
74022,74022,95558,sysxn8qo,,Medline; WHO,[Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China].,10.3760/cma.j.issn.1671-0274.2020.02.001,,32074786.0,unk,outbreak novel coronavirus pneumonia ncp become public health emergency china chinese authority health agency devoted great effort control disease surgeon specialized treatment gastrointestinal tumor always aware prevention ncp incorporate awareness every detail clinical practice patient gastrointestinal tumor preadmission screening done order rule ncp realtime rtpcr panel chest ct scan conducted patient fever ℃ travel history hubei province within day contact history resident wuhan district within day prevention measure medical staff screennegative admitted patient also enhanced false negative possible medical instrument properly discarded disinfected according standardized procedure established local center disease control prevention cdc surgical operation reduced minimal level prevent cross infection special periodsurgical intervention benign tumor postponed malignant tumor multidisciplinary therapy mdt recommended nonsurgical antitumor therapy selected higher priority neoadjuvant therapy highly recommended gastrointestinal cancer advanced stage meet indication nccn guideline gastric cancer stage ≥ rectal cancer stage ≥ unresectable colon cancer gastric esophagogastricjunction egj malignant tumor obstruction managed gastric tube decompression stent placement relieve symptom transnasal enteral feeding tube intubationpercutaneous endoscopic gastrostomy could adopted ensure enteral nutrition supply colorectal malignancy simple intestinal obstruction stent placement achieve high success rate help avoid emergency surgery also creates better condition subsequent surgery transcatheter arterial embolization hemostasis alternative choice gastrointestinal tumor bleeding however emergency operation still must performed patient acute uncontrolled bleeding obstruction alternative treatment measure fail case suspicious confirmed ncp must reported local cdc department invasive intervention must performed designated isolation area tertiary prevention measure must adopted anesthetist additional face mask medical goggle protection prevent respiratory droplet transmission preventive enterostomy preferable lower digestive tract surgery thoroughly disinfecting operating room surgery necessary fever surgery must carefully differentiated whether caused postsurgery abdominal infectioninflammation ncp singleroom isolation related examination performed according standard procedure believe unprecedentedly joint effort doctor patient eventually win war ncp,2020-02-25,"Chen, Y H; Peng, J S",Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,,#1673,,,,https://www.ncbi.nlm.nih.gov/pubmed/32074786/; https://doi.org/10.3760/cma.j.issn.1671-0274.2020.02.001,211214450.0,12
74045,74045,95584,bdup691x,,Medline; WHO,[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia],10.3760/cma.j.cn112152-20200227-00137,,32108460.0,unk,december new coronavirus pneumonia covid broke wuhan hubei spread rapidly nationwide january national health committee classified covid pneumonia one b class infectious disease treated class infectious disease epidemic period routine diagnosis treatment tumor patient affected varying degree special period performed superiority multidisciplinary team diagnosis treatment achieved accurate diagnosis treatment patient hepatobiliary malignant tumor provided support patient limited medical resource helped survive epidemic periodon basis fully understanding new coronavirus pneumonia treatment strategy changed timely epidemic appropriate treatment method adopted minimize adverse effect epidemic tumor treatment,2020,"Wu, F.; Song, Y.; Zeng, H. Y.; Ye, F.; Rong, W. Q.; Wang, L. M.; Wu, J. X.",Zhonghua zhong liu za zhi [Chinese journal of oncology],,#2977,,,,https://doi.org/10.3760/cma.j.cn112152-20200227-00137; https://www.ncbi.nlm.nih.gov/pubmed/32108460/,211556424.0,12
74102,74102,95657,wrua5rwk,,Elsevier; Medline; PMC,Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor,10.1016/j.bmcl.2013.04.031,PMC7172075,23664876.0,no-cc,probestin potent aminopeptidase n apn inhibitor originally isolated bacterial culture broth report probestin synthesis solid phase peptide synthesis spps method evaluated activity inhibit angiogenesis using chicken embryo chorioallantoic membrane cam assay cam tumor xenograft model result study demonstrate probestin inhibits angiogenic activity tumor growth,2013-06-15,"Pathuri, Gopal; Thorpe, Jessica E.; Disch, Bryan C.; Bailey-Downs, Lora C.; Ihnat, Michael A.; Gali, Hariprasad",Bioorg Med Chem Lett,,,,,document_parses/pmc_json/PMC7172075.xml.json,https://api.elsevier.com/content/article/pii/S0960894X1300512X; https://doi.org/10.1016/j.bmcl.2013.04.031; https://www.sciencedirect.com/science/article/pii/S0960894X1300512X; https://www.ncbi.nlm.nih.gov/pubmed/23664876/,38636717.0,12
76967,76967,99188,ctduuscs,4232f77920d1db299493e752a749c8c66c8ba0b7,Medline; PMC; WHO,"Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis",10.1186/s13045-020-00883-5,PMC7197362,32366279.0,cc-by,novel coronavirus ncov emerging causative agent first described late december cause severe respiratory infection human notably many affected patient covid people malignancy moreover cancer identified individual risk factor covid addition expression angiotensin converting enzyme ace receptor covid aberrantly expressed many tumor however systematic analysis ace aberration remained elucidated human cancer analyzed genetic alteration rna expression dna methylation ace across tumor notably overexpression ace observed including colon adenocarcinoma coad kidney renal papillary cell carcinoma kirp pancreatic adenocarcinoma paad rectum adenocarcinoma read stomach adenocarcinoma stad lung adenocarcinoma luad addition hypo dna methylation ace also identified ace highly expressed tumor conclusively study first time curated genetic epigenetic variation ace human malignancy notably study bioinformatics assay functional clinical validation warranted,2020-05-04,"Chai, Peiwei; Yu, Jie; Ge, Shengfang; Jia, Renbing; Fan, Xianqun",J Hematol Oncol,,#165275,,document_parses/pdf_json/4232f77920d1db299493e752a749c8c66c8ba0b7.json,,https://doi.org/10.1186/s13045-020-00883-5; https://www.ncbi.nlm.nih.gov/pubmed/32366279/,218494948.0,12
77147,77147,99403,z34j1434,8a2084e797381e496aabd78bb9565a133e924fb1,Medline; PMC,Regulation of efferocytosis as a novel cancer therapy,10.1186/s12964-020-00542-9,PMC7199874,32370748.0,cc-by,efferocytosis physiologic phagocytic clearance apoptotic cell modulates inflammatory response immune environment subsequently facilitates immune escape cancer cell thus promoting tumor development progression efferocytosis equilibrium formed perfect coordination among “ findme ” “ eatme ” “ ’ teatme ” signal signaling pathway affect proliferation invasion metastasis angiogenesis tumor cell also regulate adaptive response drug resistance antitumor therapy therefore efferocytosisrelated molecule pathway potential target antitumor therapy besides supplementing conventional chemotherapy radiotherapy immunotherapy efferocytosistargeted therapy could enhance therapeutic efficacy reduce offtarget toxicity promote patient outcome,2020-05-05,"Zhou, Yunxiang; Yao, Yihan; Deng, Yongchuan; Shao, Anwen",Cell Commun Signal,,,,document_parses/pdf_json/8a2084e797381e496aabd78bb9565a133e924fb1.json,document_parses/pmc_json/PMC7199874.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/32370748/; https://doi.org/10.1186/s12964-020-00542-9,218513397.0,12
77710,77710,100067,y7y3uc2m,a4eece66ddfa81cdcf0c8de475adf780a8e880ea; 0ecfef63c618aa8b484e5c165e98f6e2613e7f63,Elsevier; Medline; PMC,Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?,10.1016/j.omto.2020.04.010,PMC7186127,32346605.0,no-cc,billion cell undergo turnover die via apoptosis throughout lifetime prompt clearance apoptotic cell debris phagocytic cell process known efferocytosis important maintaining tissue homeostasis accordingly impaired efferocytosis due defective clearance disrupted stage lead growing number inflammation immunerelated disease although numerous study shown mechanism efferocytosis role disorder nontumor tumor disease remains poorly understood review summarizes process signal molecule efferocytosis efferocytosisrelated function nontumor eg atherosclerosis lung disease tumor disease eg breast cancer prostate cancer well describes role involved cytokine note dual role efferocytosis abovementioned disorder paradoxical effect among nontumor tumor disease term inflammation resolution immune response disease progression briefly intact efferocytosis cytokine promote tissue repair contribute tumor progression via tumor microenvironment macrophage politzerization additionally review provides potential target associated tam tyro axl mertk receptor cytokine tumor necrosis factor α cxcl suggesting potential novel therapeutic way treating disease,2020-06-26,"Lin, Danfeng; Kang, Xiaodiao; Shen, Lu; Tu, Sheng; Lenahan, Cameron; Chen, Yiding; Wang, Xiaochen; Shao, Anwen",Mol Ther Oncolytics,,,,document_parses/pdf_json/a4eece66ddfa81cdcf0c8de475adf780a8e880ea.json; document_parses/pdf_json/0ecfef63c618aa8b484e5c165e98f6e2613e7f63.json,document_parses/pmc_json/PMC7186127.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/32346605/; https://www.sciencedirect.com/science/article/pii/S2372770520300607?v=s5; https://api.elsevier.com/content/article/pii/S2372770520300607; https://doi.org/10.1016/j.omto.2020.04.010,216553974.0,12
78912,78912,101542,4gbrg4jf,,Medline; WHO,[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of novel coronavirus pneumonia],10.3760/cma.j.cn112152-20200227-00141,,32112549.0,unk,since outbreak novel coronavirus pneumonia december diagnosis treatment patient cancer facing great challenge although oncologist fighting front line epidemic special period protect patient family medical staff infection novel coronavirus also minimize impact epidemic diagnosis treatment patient cancer combining guideline diagnosis treatment tumor clinical experience epidemic period discus strategy diagnosis treatment followup malignant tumor digestive system article,2020,"Zhang, Y.; Xu, J. M.",Zhonghua zhong liu za zhi [Chinese journal of oncology],,#3026,,,,https://doi.org/10.3760/cma.j.cn112152-20200227-00141; https://www.ncbi.nlm.nih.gov/pubmed/32112549/,211564191.0,12
78929,78929,101561,u6strrib,e05c7165987a9b706d1ab55ebb210bd571a59e5a,Medline; PMC,Discovery and antitumor activities of constituents from Cyrtomium fortumei (J.) Smith rhizomes,10.1186/1752-153x-7-24,PMC3574041,23379693.0,cc-by,background cyrtomium fortumei j smith important chinese herbal medicine biological function however systematic comprehensive study phytochemical cyrtomium fortumei j smith bioactivity limited result using bioassayguided technique ethyl acetate nbuoh extract rhizome cyrtomium fortumei j smith shown exhibit good antitumor activity consequently leading isolation compound compound isolated plant first time inhibitory activity compound investigated tumor cell mgc pc vitro mtt thiazolyl blue tetrazolium bromide assay result showed pimpinellin potent cytotoxic activity three cell line ic value ± μm ± μm ± μm respectively mechanism antitumor action indicated pimpinellin inhibited growth mgc cell via induction tumor cell apoptosis apoptosis ratio h treatment μm conclusion study suggests compound root cyrtomium fortumei j smith could inhibit growth human carcinoma cell moreover pimpinellin inhibited growth tumor cell via induction tumor cell apoptosis,2013-02-04,"Yang, Shengjie; Liu, Mingchuan; Liang, Na; Zhao, Qi; Zhang, Yuping; Xue, Wei; Yang, Song",Chem Cent J,,,,document_parses/pdf_json/e05c7165987a9b706d1ab55ebb210bd571a59e5a.json,document_parses/pmc_json/PMC3574041.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/23379693/; https://doi.org/10.1186/1752-153x-7-24,5814853.0,12
81302,81302,104449,sd117tzs,db162ca7c3474f8458b25876670790493e18f920,Medline; PMC,The Epidemiology of Primary Central Nervous System Tumors at the National Neurologic Institute in Saudi Arabia: A Ten-Year Single-Institution Study,10.1155/2020/1429615,PMC7044490,32256589.0,cc-by,objective study aimed describing epidemiological trend primary cns tumor child adult national neurologic institute saudi arabia method retrospective epidemiological approach used data obtained department pathology registry file pathology report record patient registered january december diagnosis primary cns tumor brain spinal cord selected data sex age tumor location histologic type collected classification based international classification disease oncology rd edition icdo result nine hundred ninetytwo case primary cns tumor throughout ten year reviewed adult pediatric age group nonmalignant tumor dominated adult population malignant tumor frequent pediatric population glioma constituted common neoplastic category child adult common single tumor entity meningioma icdo histology code medulloblastomas icdo histology code common single tumor entity pediatric age group conclusion institutionbased detailed descriptive epidemiological study patient primary cns tumor saudi arabia contrast regional international study medulloblastomas institution frequent pilocytic astrocytomas limitation study included referral bias histologybased methodology,2020-02-15,"Almutrafi, Amna; Bashawry, Yara; AlShakweer, Wafaa; Al-Harbi, Musa; Altwairgi, Abdullah; Al-Dandan, Sadeq",J Cancer Epidemiol,,,,document_parses/pdf_json/db162ca7c3474f8458b25876670790493e18f920.json,document_parses/pmc_json/PMC7044490.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/32256589/; https://doi.org/10.1155/2020/1429615,212425061.0,12
81774,81774,105012,7n3f3wrz,a03f649135d42858e9619d36c614d8faff51dafb,Medline; PMC,Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs,10.18632/oncotarget.25532,PMC6047675,30034623.0,cc-by,potent transcription inhibitor actinomycin used several cancer report discovery naturally occurring antibiotic inhibits two human neutral aminopeptidases cellsurface alanine aminopeptidase intracellular methionine aminopeptidase type metallocontaining exopeptidases participate tumor cell expansion motility target anticancer therapy show peptide portion actinomycin actinomycin x required effective inhibition loss region change mechanism interaction two structurally le complex actinomycin analog containing phenoxazone chromophore questiomycin actinocin appear competitive inhibitor aminopeptidases potency similar noncompetitive macrocyclic parent compound ki micromolar range mode action four compound enzyme demonstrated molecular modeling docking corresponding active site knowledge give new perspective actinomycin d action tumor suggests new avenue molecule medical application,2018-06-29,"Węglarz-Tomczak, Ewelina; Talma, Michał; Giurg, Mirosław; Westerhoff, Hans V.; Janowski, Robert; Mucha, Artur",Oncotarget,,,,document_parses/pdf_json/a03f649135d42858e9619d36c614d8faff51dafb.json,document_parses/pmc_json/PMC6047675.xml.json,https://doi.org/10.18632/oncotarget.25532; https://www.ncbi.nlm.nih.gov/pubmed/30034623/,49886229.0,12
81917,81917,105185,gjpmqnrb,a55db95f2f8b19bdbdd94b66fcbe008f8b661add,Elsevier; Medline; PMC,Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides,10.1016/j.ejmech.2018.07.062,PMC7111280,30098481.0,els-covid,focused nucleoside library constructed around ′cethynyldribofuranose sugar scaffold coupled variously modified purine nucleobases resulting nucleoside probed ability inhibit tumor cell proliferation well activity panel relevant human virus caryl substituted purine nucleoside found weakly active several csubstituted deazapurine nucleoside elicited potent antiproliferative activity activity spectrum evaluated nci tumor cell line panel indicating activity several solid tumor derived cell line analog equipped deaza chloroaminopurinyl base evaluated metastatic breast tumor mdamblm xenograft model inhibited tumor growth reduced formation lung metastasis revealed bli analysis dideazanucleoside analog showed interesting activity hcmv result highlight potential advantage recombining known sugar nucleobase motif library design strategy discover novel antiviral antitumor agent,2018-09-05,"Hulpia, Fabian; Noppen, Sam; Schols, Dominique; Andrei, Graciela; Snoeck, Robert; Liekens, Sandra; Vervaeke, Peter; Van Calenbergh, Serge",European Journal of Medicinal Chemistry,,,,document_parses/pdf_json/a55db95f2f8b19bdbdd94b66fcbe008f8b661add.json,document_parses/pmc_json/PMC7111280.xml.json,https://api.elsevier.com/content/article/pii/S0223523418306275; https://doi.org/10.1016/j.ejmech.2018.07.062; https://www.sciencedirect.com/science/article/pii/S0223523418306275; https://www.ncbi.nlm.nih.gov/pubmed/30098481/,51979031.0,12
82392,82392,105761,ifnc53my,62b348dd9761ec78af4d53ad162a747cd300edce,Medline; PMC,Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines,10.1186/1423-0127-18-21,PMC3062584,21385449.0,cc-by,antigenspecific immunotherapy using dna vaccine emerged attractive approach control tumor another novel cancer therapy involves employment vascular disrupting agent dimethylxanthenoneacetic acid dmxaa current study aimed test combination dmxaa treatment human papillomavirus type hpv e dna vaccination enhance antitumor effect especific cd cell immune response treated mouse determined treatment dmxaa generates significant therapeutic effect tc tumor enhance antigenspecific immune response tumor bearing mouse found combination dmxaa treatment e dna vaccination generates potent antitumor effect especific cd cell immune response splenocytes tumor bearing mouse furthermore dmxaamediated enhancement suppression especific cd cell immune response generated crte dna vaccination found dependent time administration dmxaa also applicable antigenspecific vaccine addition determined inducible nitric oxide synthase inos play role immune suppression caused dmxaa administration dna vaccination study significant implication future clinical translation,2011-03-08,"Peng, Shiwen; Monie, Archana; Pang, Xiaowu; Hung, Chien-Fu; Wu, T-C",J Biomed Sci,,,,document_parses/pdf_json/62b348dd9761ec78af4d53ad162a747cd300edce.json,document_parses/pmc_json/PMC3062584.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/21385449/; https://doi.org/10.1186/1423-0127-18-21,2901563.0,12
82652,82652,106075,6spdol1c,f53cfd54d5a928ae69d18e86d879757eb903cf1c,Elsevier; Medline; PMC,Chapter 4 Ligand-directed Cancer Gene Therapy to Angiogenic Vasculature,10.1016/s0065-2660(09)67004-8,PMC7172741,19914451.0,els-covid,gene therapy strategy cancer remained active area preclinical clinical research one current limitation successful trial relative transduction efficiency produce therapeutic effect intratumoral injection mainstay many treatment regimen date approach hindered hydrostatic pressure within tumor always applicable tumor subtypes vasculartargeting strategy introduce alternative method deliver vector higher local concentration minimization systemic toxicity moreover therapeutic targeting angiogenic vasculature often lead enhanced bystander effect improving efficacy identification functional systemically accessible molecular target challenging approach vivo phage display phagebased viral delivery vector provide platform upon vascular targeting vector may become viable translational approach,2009-12-31,"Driessen, Wouter H.P.; Ozawa, Michael G.; Arap, Wadih; Pasqualini, Renata",Advances in Genetics,,,,document_parses/pdf_json/f53cfd54d5a928ae69d18e86d879757eb903cf1c.json,document_parses/pmc_json/PMC7172741.xml.json,https://doi.org/10.1016/s0065-2660(09)67004-8; https://www.ncbi.nlm.nih.gov/pubmed/19914451/; https://api.elsevier.com/content/article/pii/S0065266009670048; https://www.sciencedirect.com/science/article/pii/S0065266009670048,19460133.0,12
82796,82796,106241,3apcrax8,a229fdb6110f2e50deb76e3b0c9ac3f1ec3b337e; 55daa64c00153ebff7bbedb8f0fd36e3dc6b9d2a,Elsevier; Medline; PMC,Gene- and Viral-Based Therapies for Brain Tumors,10.1016/j.nurt.2009.04.007,PMC3052738,19560744.0,els-covid,summary advance understanding controlling gene expression set stage alter genetic material fight prevent disease brain tumor among one first human malignancy targeted gene therapy protein coded dna neoplastic disease ultimately result expression lack thereof one protein eg coded oncogene tumor suppressor gene respectively theory therefore disease could treated expression appropriate protein affected cell gene therapy experimental treatment involves introducing genetic material dna rna cell made important advance past decade within short time span moved conceptual laboratory research stage clinical translational trial brain tumor efficient approach gene delivery based viral vector proven relatively safe cns despite occasional case morbidity death nonneurosurgical trial however human response various viral vector predicted reliable manner animal experimentation size consistency extent experimental brain tumor mouse model reflect large necrotic infiltrative nature malignant glioma furthermore problem delivering genetic vector solid brain tumor efficiency situ gene transfer remains one significant hurdle gene therapy,2009-07-31,"Asadi-Moghaddam, Kaveh; Chiocca, E. Antonio",Neurotherapeutics,,,,document_parses/pdf_json/a229fdb6110f2e50deb76e3b0c9ac3f1ec3b337e.json; document_parses/pdf_json/55daa64c00153ebff7bbedb8f0fd36e3dc6b9d2a.json,,https://doi.org/10.1016/j.nurt.2009.04.007; https://www.sciencedirect.com/science/article/pii/S1933721309000919; https://api.elsevier.com/content/article/pii/S1933721309000919; https://www.ncbi.nlm.nih.gov/pubmed/19560744/,25415663.0,12
82905,82905,106375,y5js9tj8,e1deea5ae40c7bcd8f9f297ef4b293f4268ff209,Elsevier; Medline; PMC,TBX2 and TBX3: The special value for anticancer drug targets,10.1016/j.bbcan.2010.07.001,PMC7127380,20624445.0,els-covid,tbx tbx member tbox family transcription factor implicated embryonic development unlike member tbox family tbx tbx mammalian tbox factor function transcriptional repressor mediated repression domain cterminal addition role development recent evidence suggests tbx tbx overexpressed number cancer including melanoma breast liver lung pancreas ovarian cervical cancer however little information mechanism tbox gene contribute tumorigenesis upregulation tbx tbx suppresses expression parf pcip promotes bypass senescence inactivation p pathway tbx functionally interacts prb prb modulates tbx functional specificity addition tbx player wnt signaling tbx downstream target wntbetacatenin pathway overexpression tbx tbx represses expression ecadherin demonstrated prerequisite epithelial tumor cell invasion moreover tbx shown interact egr block multiple downstream tumor suppressor review current knowledge tbx tbx tumorigenesis prospect special value development targetbased anticancer drug,2010-12-31,"Lu, Juan; Li, Xiang-Ping; Dong, Qi; Kung, Hsiang-fu; He, Ming-Liang",Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,,,,document_parses/pdf_json/e1deea5ae40c7bcd8f9f297ef4b293f4268ff209.json,document_parses/pmc_json/PMC7127380.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/20624445/; https://www.sciencedirect.com/science/article/pii/S0304419X1000051X; https://api.elsevier.com/content/article/pii/S0304419X1000051X; https://doi.org/10.1016/j.bbcan.2010.07.001,10270577.0,12
83056,83056,106554,5e68dk8v,,Medline; WHO,[Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19],10.3760/cma.j.cn112141-20200302-00168,,32174096.0,unk,objective explore management strategy patient gynecological malignant tumor outbreak transmission covid method retrospectively analyzed clinical characteristic treatment disease outcome three patient gynecological malignancy associated covid renmin hospital wuhan university proposed management strategy patient gynecological tumor underriskof covid result based national diagnosis treatment protocol well research progress covid three patient covid treated meanwhile also appropriately adjusted treatment plan accordance clinical guideline gynecological tumor pneumonia cured patient one patient died covid conclusion patient gynecological malignant tumor highrisk group prone covid gynecological oncologist need carry education prevention control treatment according specific condition actively preventing controlling covid diagnosis treatment gynecological malignant tumor carried orderly safe manner,2020,"Zhang, J; Peng, P; Li, X; Zha, Y F; Xiang, Y; Zhang, G N; Zhang, Y",Zhonghua Fu Chan Ke Za Zhi,,#8634,,,,https://www.ncbi.nlm.nih.gov/pubmed/32174096/; https://doi.org/10.3760/cma.j.cn112141-20200302-00168,212729605.0,12
83620,83620,107265,3ph033lw,772730b5d9f1213ae01902ca77b544cef2ba59b5,Medline; PMC,The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies,10.1371/journal.pone.0210796,PMC6336379,30653571.0,cc-by,tumorinfiltrating immune cell impact tumor growth progression inhibitory cd receptor cdr suppresses activation myeloid cell lack pathway result reduction tumor growth conversely tumorigenic effect cdr triggering also described investigated role cdr activation syngeneic mouse tumor model showed agonistic cdr antibody reached tumor significant impact tumor growth minor effect infiltration immune myeloid cell effect reproduced using two different anticdr clone contrast showed cddeficiency decrease melanoma tumor burden presence either endogenous tumorexpressed cd restored growth metastatic melanoma focus basis finding conclude blockade endogenous ligand cd prevented tumorigenic effect cdrexpressing myeloid cell tumor microenvironment whereas agonistic anticdr effect tumor development,2019-01-17,"Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Kryczka, Tomasz; Boon, Louis; Golab, Jakub; Meyaard, Linde; Rygiel, Tomasz P.",PLoS One,,,,document_parses/pdf_json/772730b5d9f1213ae01902ca77b544cef2ba59b5.json,document_parses/pmc_json/PMC6336379.xml.json,https://doi.org/10.1371/journal.pone.0210796; https://www.ncbi.nlm.nih.gov/pubmed/30653571/,58621144.0,12
83785,83785,107478,gu0930s3,8f9fa3cbbbdba190f2feb9d877578a2b3a1ed655,Elsevier; PMC,Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells,10.1016/0042-6822(85)90102-3,PMC7130887,2997998.0,els-covid,unique subline balbc mouse designated balbcv exhibit intermediate mammary tumor incidence harbor distinct milktransmitted mouse mammary tumor virus mmtv balbcv subline used study molecular basis potential virushost interaction involving cell surfaceexpressed mmtv protein cell surface iodination identified virusspecific protein expressed balbcv primary mammary tumor cell grown culture contrast chmmtvproducing cell line expressed mmtv gp balbcv tumor cell lacked gp expressed instead k envrelated protein k env protein also detected surface metabolically labeled balbcv tumor cell external immunoprecipitation technique expression k env restricted mammary tissue balbcv mouse also expressed mmtv protein biochemical analysis established k env modified nlinked glycosylation ilabeled k env rapidly released medium tumor cell culture recovered form soluble protein g pellet biologic function cell surfaceexpressed viral protein remains unknown,1985-05-31,"Slagle, Betty L.; Butel, Janet S.",Virology,,,,document_parses/pdf_json/8f9fa3cbbbdba190f2feb9d877578a2b3a1ed655.json,,https://www.sciencedirect.com/science/article/pii/0042682285901023; https://api.elsevier.com/content/article/pii/0042682285901023,24205121.0,12
83856,83856,107568,rdmaaowm,,Elsevier; Medline; PMC,Joint detection of tumor markers with imaging ellipsometry biosensor,10.1016/j.tsf.2014.01.043,PMC7125654,32287449.0,no-cc,tumor marker detection contributes early diagnosis cancer however due lack detection specificity result act direct evidence confirm cancer occurrence clinic joint detection tumor marker may improve detection specificity trial clinical diagnosis hepatocellular carcinoma αfetoprotein αlfucosidase ferritin combined detected labelfree phase sensitive high throughput imaging ellipsometry biosensor ieb eightytwo serum quantitatively detected ieb result agreement clinical standard approach evaluated receiver operating characteristic analysis specificity joint detection improves remarkably ieb hepatocellular carcinoma foreseen joint detection tumor marker ieb potential clinical cancer diagnosis,2014-11-28,"Niu, Yu; Kang, Tengfei; Jin, Gang",Thin Solid Films,,,,,document_parses/pmc_json/PMC7125654.xml.json,https://www.sciencedirect.com/science/article/pii/S0040609014000741; https://www.ncbi.nlm.nih.gov/pubmed/32287449/; https://api.elsevier.com/content/article/pii/S0040609014000741; https://doi.org/10.1016/j.tsf.2014.01.043,138129025.0,12
84469,84469,108302,layv0hbg,fb6788c2df8f67c390e1702687a22f52d0ae0e96,Medline; PMC,Three-dimensional tumor cell cultures employed in virotherapy research,10.2147/ov.s165479,PMC6130269,30234074.0,cc-by-nc,oncolytic virotherapy constitutes upcoming alternative treatment option broad spectrum cancer entity however despite great research effort still single u food drug administrationeuropean medicine agencyapproved oncolytic virus available clinical use one reason gap promising preclinical data limited clinical success since oncolytic virus biological agent might require realistic vitro tumor model common monolayer tumor cell culture provide meaningful predictive preclinical evaluation result realistic invitro tumor model threedimensional tumor cellculture system employed preclinical virotherapy research review provides overview spheroid hydrogel tumor cell culture organotypic tumortissue slice organotypic raft culture tumor organoids utilized context oncolytic virotherapy furthermore also discus advantage disadvantage technique difficulty threedimensional tumor cellculture system applied specifically virotherapy research,2018-09-05,"Kloker, Linus D; Yurttas, Can; Lauer, Ulrich M",Oncolytic Virother,,,,document_parses/pdf_json/fb6788c2df8f67c390e1702687a22f52d0ae0e96.json,document_parses/pmc_json/PMC6130269.xml.json,https://doi.org/10.2147/ov.s165479; https://www.ncbi.nlm.nih.gov/pubmed/30234074/,52302640.0,12
84588,84588,108447,xv30f1ve,3120ea8763d50603309035c1d5843f15a6130de5,Medline; PMC,Viruses as key modulators of the TGF‐β pathway; a double‐edged sword involved in cancer,10.1002/rmv.1967,PMC7169117,29345394.0,no-cc,transforming growth factor‐β tgf‐β signaling pathway key network cell signaling control vital process proliferation differentiation apoptosis epithelial‐mesenchymal transition migration thus acting double‐edged sword normal development disease particular organ fibrosis vascular disorder cancer early tumorigenesis pathway exerts anti‐tumor effect suppressing cell cycle inducing apoptosis late stage function tumor promoter enhancing tumor invasiveness metastasis signaling pathway perturbed environmental genetic factor microbial interference mutation respectively way present review describes modulation tgf‐β pathway oncogenic human viral pathogen virus main mechanism virus interferes tgf‐β signaling seems alteration either tgf‐β protein expression activation modulation tgf‐β receptor smads factor interfering level function alteration none‐smad pathway indirect interaction pathway modulation transcriptional co‐activatorrepressor regulator pathway given axial role pathway tumorigenesis regarded attractive target cancer therapy hence investigation subject may represent molecular target among either tgf‐β signaling molecule viral factor treatment management viral infection consequence cancer,2018-01-18,"Mirzaei, Habibollah; Faghihloo, Ebrahim",Rev Med Virol,,,,document_parses/pdf_json/3120ea8763d50603309035c1d5843f15a6130de5.json,document_parses/pmc_json/PMC7169117.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/29345394/; https://doi.org/10.1002/rmv.1967,3755849.0,12
84882,84882,108824,can4cvkx,84b4e11342098e8595165eff814c004ec50d3e0e,Medline; PMC,The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications,10.3389/fonc.2019.00852,PMC6733886,31552177.0,cc-by,nafamostat mesylate nm synthetic serine protease inhibitor first placed market japan tobacco approved treat inflammatoryrelated disease pancreatitis recently increasing number study highlighted promising effect nm inhibiting cancer progression alone combination treatment study shown nm attenuates various malignant tumor including pancreatic colorectal gastric gallbladder hepatocellular cancer review based several activating pathway including canonical nuclear factorκb nfκb signaling pathway tumor necrosis factor receptor tnfr signaling pathway tumorigenesisrelated tryptase secreted mast cell summarize anticancer property nm existing study vitro vivo addition efficacy side effect nm cancer patient summarized detail clarify nm antitumor activity clinical trial devoted validating clinical application underlying mechanism needed future,2019-09-03,"Chen, Xi; Xu, Zhijie; Zeng, Shuangshuang; Wang, Xiang; Liu, Wanli; Qian, Long; Wei, Jie; Yang, Xue; Shen, Qiuying; Gong, Zhicheng; Yan, Yuanliang",Front Oncol,,,,document_parses/pdf_json/84b4e11342098e8595165eff814c004ec50d3e0e.json,document_parses/pmc_json/PMC6733886.xml.json,https://doi.org/10.3389/fonc.2019.00852; https://www.ncbi.nlm.nih.gov/pubmed/31552177/,201711261.0,12
85564,85564,109659,sxux2ujo,10d5a17a8cfc4407042a218f9d7acb53c41056e2,Medline; PMC,"STING, DCs and the link between innate and adaptive tumor immunity",10.1016/j.molimm.2017.12.001,PMC6768428,29273394.0,no-cc,cancer immune system intimately related much bulk tumor comprised stromal leukocyte immune function serve promote inhibit tumor growth invasion metastasis lymphocyte adaptive immune system essential tumor immunity cell generated crosspriming tumor associated antigen dendritic cell dc essential process serving cellular link innate adaptive immunity prerequisite priming adaptive immune response dc must take tumor antigen process present context major histocompatibility complex mhc dc also serve sensor innate activation signal cancer necessary activation effective priming cancer specific cell discus role dc sensing cancer priming adaptive response tumor furthermore present essential role stimulator interferon gene sting signaling pathway producing type interferon ifns essential process,2017-12-20,"Vatner, Ralph E.; Janssen, Edith M.",Mol Immunol,,,,document_parses/pdf_json/10d5a17a8cfc4407042a218f9d7acb53c41056e2.json,document_parses/pmc_json/PMC6768428.xml.json,https://doi.org/10.1016/j.molimm.2017.12.001; https://www.ncbi.nlm.nih.gov/pubmed/29273394/,207011075.0,12
86118,86118,110334,8wmqxhnx,75943bd9d66d4da733b90c737f82841f38a4a627,Elsevier; Medline; PMC,Tracheobronchial Tumors: Radiologic–Pathologic Correlation of Tumors and Mimics,10.1067/j.cpradiol.2019.04.003,PMC7115773,31076268.0,els-covid,tracheobronchial mass encompass broad spectrum entity ranging benign malignant neoplasm infectious inflammatory process article review crosssectional finding tracheal tumor tumorlike entity correlate imaging finding histologic pathology discus pearl pitfall accurately diagnosing classifying tracheal tumor mimic,2019-04-08,"Bedayat, Arash; Yang, Eric; Ghandili, Saeed; Galera, Pallavi; Chalian, Hamid; Ansari-Gilani, Kianoush; Guo, Heiwei Henry",Curr Probl Diagn Radiol,,,,document_parses/pdf_json/75943bd9d66d4da733b90c737f82841f38a4a627.json,document_parses/pmc_json/PMC7115773.xml.json,https://doi.org/10.1067/j.cpradiol.2019.04.003; https://www.sciencedirect.com/science/article/pii/S0363018818303037; https://www.ncbi.nlm.nih.gov/pubmed/31076268/; https://api.elsevier.com/content/article/pii/S0363018818303037,145896143.0,12
86254,86254,110510,2hsholg9,d9d4133eb946b4e7c849acdd755275e3b9ae74b9,Medline; PMC,"Not gene therapy, but genetic surgery—the right strategy to attack cancer",10.3103/s089141680903001x,PMC7089455,32214647.0,no-cc,review suggest divide approach united common term “ gene therapy ” two broad strategy first one us methodology targeted therapy characteristic gene role agent targeted certain molecular component presumably crucial cancer maintenance contrast technique strategy aimed destruction tumor whole using feature shared cancer example relatively fast mitotic cell division active angiogenesis first strategy “ true ” gene therapy second one like genetic surgery surgeon cut tumor scalpel interest knowing delicate mechanism cancer emergence progression try substantiate idea last strategy right one simplicity paradoxically adequate supercomplexity tumor originates general complexity cell regulation strongly disturbed tumor cell especially complexity tumor evolving cell population affecting also ecological niche formed neighboring normal cell tissue analysis widely used “ surgery ” suicide geneprodrug combination presented detail,2009-10-08,"Sverdlov, E. D.",Mol,,,,document_parses/pdf_json/d9d4133eb946b4e7c849acdd755275e3b9ae74b9.json,,https://doi.org/10.3103/s089141680903001x; https://www.ncbi.nlm.nih.gov/pubmed/32214647/,24053243.0,12
86630,86630,110957,y8z8gkpb,bd25781927e8eb5b121981ac6081cde159606c83,Medline; PMC,Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis,10.4046/trd.2013.75.6.256,PMC3884114,24416057.0,cc-by-nc,imatinib mesylate targeted therapy act inhibiting tyrosine kinase bcrabl fusion oncoprotein specific chronic myeloid leukemia cml ctransmembrane receptor specific gastrointestinal stromal tumor interstitial pneumonitis rare adverse event imatinib therapy clinically difficult distinguish infectious pneumonia frequently occur due underlying disease standard treatment imatinibinduced pneumonitis discontinue medication optionally administer corticosteroid however case successful retrial imatinib describe case successful rechallenge imatinib patient imatinibinduced interstitial pneumonitis cml without recurrence underlying disease month followup,2013-12-24,"Go, Seong Woo; Kim, Boo Kyeong; Lee, Sung Hak; Kim, Tae-Jung; Huh, Joo Yeon; Lee, Jong Min; Hah, Jick Hwan; Kim, Dong Whi; Cho, Min Jung; Kim, Tae Wan; Kang, Ji Young",Tuberc Respir Dis (Seoul),,,,document_parses/pdf_json/bd25781927e8eb5b121981ac6081cde159606c83.json,document_parses/pmc_json/PMC3884114.xml.json,https://doi.org/10.4046/trd.2013.75.6.256; https://www.ncbi.nlm.nih.gov/pubmed/24416057/,16032680.0,12
86669,86669,111006,irr9g03q,241ba286b5b231ad009c7e9a28c85aacbdff49a9,Medline; PMC,Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors,10.1186/1471-2407-10-118,PMC2868050,20346172.0,cc-by,background clinical course human papillomavirus hpv associated bowenoid papulosis condyloma acuminatum anogenital tumor still unknown evaluated molecule relevant cellular proliferation regulation apoptosis hpv associated anogenital tumor method investigated level telomerase activity inhibitor apoptosis protein iaps family ciap ciap xiap cmyc mrna expression level specimen bowenoid papulosis specimen condyloma acuminatum anogenital area overall phosphorylated p akt pribosomal protein pebinding protein ebp expression level examined immunohistochemistry anogenital tumor without positive telomerase activity result positive telomerase activity detected bowenoid papulosis condyloma acuminatum compared normal skin p contrast expression level bowenoid papulosis indicated ciap ciap xiap mrna significantly upregulated compared condyloma acuminatum sample p p p respectively normal skin p p p respectively overall bowenoid papulosis high risk hpv strongly promoted iaps family cmyc condyloma acuminatum significantly activate gene immunohistochemically pakt p expression associated positive telomerase activity pebp expression conclusion combined analysis iaps family cmyc mrna expression telomerase activity level paktps expression may provide clinically relevant molecular marker hpv associated anogenital tumor,2010-03-27,"Mitsuishi, Tsuyoshi; Iwabu, Yukie; Tokunaga, Kenzo; Sata, Tetsutaro; Kaneko, Takehiko; Ohara, Kuniaki; Ohsawa, Ikuroh; Oda, Fumino; Yamada, Yuko; Kawana, Seiji; Ozaki, Kohji; Nakatake, Mayuka; Yamada, Osamu",BMC Cancer,,,,document_parses/pdf_json/241ba286b5b231ad009c7e9a28c85aacbdff49a9.json,document_parses/pmc_json/PMC2868050.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/20346172/; https://doi.org/10.1186/1471-2407-10-118,14676189.0,12
87467,87467,112015,qbvqny97,a36ff9ac7a441a594c80f7f4bbfeebe918171fb9,Elsevier; Medline; PMC,Armed oncolytic viruses: A kick-start for anti-tumor immunity,10.1016/j.cytogfr.2018.03.006,PMC7108398,29576283.0,els-covid,oncolytic virus ov virus specifically result killing tumor cell represent promising class cancer therapy recently focus ov therapy field shifted direct oncolytic effect immune stimulatory effect ov therapy function “ kick start ” antitumor immune response releasing tumor associated antigen release inflammatory signal combining ov immune modulators could enhance efficacy immune ov therapy additionally genetic engineering ov allows local expression immune therapeutic thereby reducing related toxicity different option modify tumor microenvironment combination ov therapy explored possibility obstacle combination discussed review,2018-06-30,"de Graaf, J. F.; de Vor, L.; Fouchier, R.A.M.; van den Hoogen, B. G.",Cytokine & Growth Factor Reviews,,,,document_parses/pdf_json/a36ff9ac7a441a594c80f7f4bbfeebe918171fb9.json,document_parses/pmc_json/PMC7108398.xml.json,https://api.elsevier.com/content/article/pii/S1359610118300352; https://www.ncbi.nlm.nih.gov/pubmed/29576283/; https://www.sciencedirect.com/science/article/pii/S1359610118300352; https://doi.org/10.1016/j.cytogfr.2018.03.006,4328523.0,12
87515,87515,112076,4dhk8eq5,,Elsevier; PMC,Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene-bearing mice,10.1016/0304-3835(93)90236-3,PMC7125649,7513605.0,els-covid,mouse containing activated vharas oncogene driven mouse mammary tumor virus promoterenhancer produced le tumor necrosis factor tnf genetically identical animal without inbred oncomice containing vharas oncogene inbred fvb mouse without grown month splenocytes isolated stimulated vitro produce tumor necrosis factor tnf γinterferon ifn tnf production cell oncomice significantly decreased compared cell fbv mouse tendency decrease significant difference seen ifn release observation suggest oncogene may play role immune system,1993-11-01,"Chen, Guan-Jie; Colombo, Lucas L.; Lopez, Maria C.; Watson, Ronald R.",Cancer Letters,,,,,,https://www.sciencedirect.com/science/article/pii/0304383593902363; https://api.elsevier.com/content/article/pii/0304383593902363,38800698.0,12
87946,87946,112605,yj9mb88g,17f00e096a5f3ce94278a77011e6f38d7a47c618,Medline; PMC,Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer,10.1111/cas.14230,PMC6942430,31710162.0,cc-by-nc,breast cancer prevalent malignancy among woman although endocrine therapy effective development endocrine resistance major clinical challenge tumor microenvironment tme promotes tumor malignancy tumor‐associated macrophage tam within tme play crucial role endocrine resistance herein aimed elucidate relationship tam endocrine‐resistant phenotype breast cancer macrophage cultured conditioned medium cm tamoxifen‐sensitive mcf‐s ‐resistant mcf‐r mcf breast cancer cell polarization detected cd immunofluorescence determine effect endocrine resistance mcf cell cultured supernatant different tam treated tamoxifen cc‐chemokine ligand ccl immunohistochemistry carried pathological section patient invasive estrogen receptor‐positive breast cancer found macrophage cultured cm mcf‐s mcf‐r cell induced tam obvious polarization latter tamoxifen resistance increased culture tam medium tam secreted ccl increased endocrine resistance breast cancer cell activation pikaktmtor signaling pathway high expression ccl correlated infiltration cdmacrophages r p patient high ccl expression presented shorter progression‐free survival low ccl expression p conclude ccl secreted tam activates pikaktmtor signaling promotes endocrine resistance feedback loop tme suggesting ccl tam may novel therapeutic target patient endocrine‐resistant breast cancer,2019-12-19,"Li, Dongbo; Ji, Hongfei; Niu, Xingjian; Yin, Lei; Wang, Yiran; Gu, Yucui; Wang, Jinlu; Zhou, Xiaoping; Zhang, Han; Zhang, Qingyuan",Cancer Sci,,,,document_parses/pdf_json/17f00e096a5f3ce94278a77011e6f38d7a47c618.json,document_parses/pmc_json/PMC6942430.xml.json,https://doi.org/10.1111/cas.14230; https://www.ncbi.nlm.nih.gov/pubmed/31710162/,207944402.0,12
88991,88991,113875,grmqnooy,923a7dafa1e42845d89f85dc308cddb83c155d09,Elsevier; Medline; PMC,Dendrimer– and polymeric nanoparticle–aptamer bioconjugates as nonviral delivery systems: a new approach in medicine,10.1016/j.drudis.2020.03.009,PMC7151348,32283193.0,els-covid,aptamers rna dna oligonucleotides interacting form unique target conformation high affinity specificity emerging powerful class ligand therapeutic application addition dendrimers welldefined nanosized symmetric polymeric molecule review provide analysis use dendrimers modified aptamers nonviral vector specifically target tumor cell various anticancer agent encapsulated dendrimers complexing aptamers including epirubicin camptothecin bclxl short hairpin shrna fluorouracil rhodaminelabeled dextran type polymeric nanoparticle np–aptamer bioconjugates also developed loaded ptiv derivative target specific tumor cell,2020-04-10,"Mignani, Serge; Shi, Xangyang; Ceña, Valentin; Majoral, Jean-Pierre",Drug Discov Today,,,,document_parses/pdf_json/923a7dafa1e42845d89f85dc308cddb83c155d09.json,document_parses/pmc_json/PMC7151348.xml.json,https://www.sciencedirect.com/science/article/pii/S1359644620301161?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32283193/; https://api.elsevier.com/content/article/pii/S1359644620301161; https://doi.org/10.1016/j.drudis.2020.03.009,215724620.0,12
89148,89148,114057,func9pn8,0b5332aa6d764546da2ae1303a71656ae7b2ed7c,Elsevier; PMC,Sea Turtles: Old Viruses and New Tricks,10.1016/j.cub.2004.09.038,PMC7126648,15458663.0,els-covid,recent year seen inexplicable increase frequency appalling disease sea turtle fibropapillomatosis likely caused herpesvirus cause tumor grow throughout turtle body new research led disturbing conclusion recent humaninduced environmental change responsible,2004-10-05,"Jones, Adam G.",Current Biology,,,,document_parses/pdf_json/0b5332aa6d764546da2ae1303a71656ae7b2ed7c.json,document_parses/pmc_json/PMC7126648.xml.json,https://api.elsevier.com/content/article/pii/S0960982204007225; https://www.sciencedirect.com/science/article/pii/S0960982204007225,2284926.0,12
89261,89261,114196,e7pfolxs,d0a7af58aa5e272f1c7aef4e6908dd3059d9173e,Medline; PMC,Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno‐associated virus/phage,10.1016/j.molonc.2012.08.001,PMC3553581,22951279.0,cc-by,bacteriophage phage virus infect bacteria shown promise vehicle targeted cancer gene therapy albeit poor efficiency recently generated improved version phage vector incorporating ci genetic element adeno‐associated virus aav novel aavphage hybrid aavp efficiently delivered systemically administered therapeutic gene various tumor target displaying integrin tumor‐targeting ligand phage capsid however inherent limitation bacteriophage mean aavp vector still need improved one limitation aavp mammalian cell may susceptibility proteasomal degradation proteasome upregulated cancer known constitutes barrier gene delivery certain eukaryotic virus report inhibition proteasome improved targeted reporter gene delivery aavp cancer cell vitro tumor vivo intravenous vector administration tumor‐bearing mouse also show enhanced targeted tumor cell killing aavp upon proteasome inhibition aavp particle persisted significantly cancer cell vitro tumor vivo systemic administration accumulated polyubiquitinated coat protein result suggest proteasome indeed barrier tumor targeting aavp indicate combination proteasome‐inhibiting drug aavp considered clinical anticancer therapy,2012-08-21,"Przystal, Justyna M.; Umukoro, Eloho; Stoneham, Charlotte A.; Yata, Teerapong; O'Neill, Kevin; Syed, Nelofer; Hajitou, Amin",Mol Oncol,,,,document_parses/pdf_json/d0a7af58aa5e272f1c7aef4e6908dd3059d9173e.json,document_parses/pmc_json/PMC3553581.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/22951279/; https://doi.org/10.1016/j.molonc.2012.08.001,28684554.0,12
89303,89303,114247,1vjdvp8q,cd2f584c21a2bc13a089348c021044609e55dc06,Elsevier; Medline; PMC,Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate,10.1016/j.intimp.2020.106495,PMC7152898,32298965.0,no-cc,autophagy important mechanism tumor escape allowing tumor cell recover damage induced chemotherapy radiation therapy immunotherapy contributing development resistance pharmacological inhibition autophagy contributes increase efficacy antineoplastic agent exposing tumor cell low concentration select autophagyinducing antineoplastic agent increase immunogenicity enhances ability stimulate dendritic cell dc maturation tested whether application autophagyinhibiting agent chloroquine cq combination low concentration fluorouracil fu increase ability tumor cell induce dc maturation dc sensitized lysate hct cell previously exposed combination enhanced dc maturationactivation ability matured dc also increased allogeneic responsiveness cd cd cell showed greater proliferative response dc sensitized control lysates cell expanded cocultures cd pd produced higher level ifnγ lower level il consistent preferential activation th cell cocultures autologous dc lymphocyte improved generation cytotoxic lymphocyte assessed expression cda perforin granzyme b drug combination increased expression gene related ceacam family becn atgs maplcb ulk sqstm tumor suppressor pcbp furthermore decreased expression gene related metastasis tumor progression bnip bnipl fosl he lamb loxl ndrg pha pikr noted combination fu cq increase ability tumor cell drive dc maturation enhances ability dc stimulate cell response,2020-04-13,"Zamame Ramirez, Jofer Andree; Romagnoli, Graziela Gorete; Falasco, Bianca Francisco; Gorgulho, Carolina Mendonça; Sanzochi Fogolin, Carla; dos Santos, Daniela Carvalho; Junior, João Pessoa Araújo; Lotze, Michael Thomas; Ureshino, Rodrigo Portes; Kaneno, Ramon",Int Immunopharmacol,,,,document_parses/pdf_json/cd2f584c21a2bc13a089348c021044609e55dc06.json,document_parses/pmc_json/PMC7152898.xml.json,https://doi.org/10.1016/j.intimp.2020.106495; https://www.sciencedirect.com/science/article/pii/S1567576920306354; https://www.ncbi.nlm.nih.gov/pubmed/32298965/; https://api.elsevier.com/content/article/pii/S1567576920306354,215741034.0,12
89344,89344,114303,cgqixu3g,de22df7c68cc8f64265c0a26ef9f2acd53520ef6,Medline; PMC,Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection,10.1186/1479-5876-11-6,PMC3551837,23294544.0,cc-by,background chemokine cxcl reported play important role progression many malignancy breast cancer papillary thyroid carcinoma role cxcl colorectal carcinoma crc remains established purpose study investigate expression pattern significance cxcl crc progression method colorectal carcinoma specimen matched adjacent normal colorectal mucosa specimen collected expression cxcl clinical sample examined immunostaining effect cxcl colorectal carcinoma cell proliferation measured mtt assay brdu incorporation assay colony formation assay impact cxcl migration invasion colorectal carcinoma cell determined transwell assay matrigel invasion assay respectively result cxcl expression significantly upregulated tumor tissue compared adjacent nontumorous mucosa tissue p tumoral cxcl expression level significantly correlated tnm tumornodemetastasis stage histodifferentiation tumor size multivariate cox regression analysis high cxcl expression tumor specimen n stage iii patient associated increased risk disease recurrence risk ratio ci p elevated cxcl expression tumor specimen n stage iiiiv patient correlated worse overall survival risk ratio ci p functional study demonstrated enforced expression cxcl sw colorectal carcinoma cell resulted aggressive phenotype contrast knockdown cxcl expression could mitigate proliferative migratory invasive potential hct colorectal carcinoma cell conclusion taken together cxcl might potential novel prognostic factor predict disease recurrence overall survival could potential target postoperative adjuvant therapy crc patient,2013-01-07,"Zeng, Jun; Yang, Xudan; Cheng, Lin; Liu, Rui; Lei, Yunlong; Dong, Dandan; Li, Fanghua; Lau, Quek Choon; Deng, Longfei; Nice, Edouard C; Xie, Ke; Huang, Canhua",J Transl Med,,,,document_parses/pdf_json/de22df7c68cc8f64265c0a26ef9f2acd53520ef6.json,document_parses/pmc_json/PMC3551837.xml.json,https://doi.org/10.1186/1479-5876-11-6; https://www.ncbi.nlm.nih.gov/pubmed/23294544/,14307060.0,12
89785,89785,114843,sibli6r5,bc4d62b08a22fd16f454479c41132f04481e167b,Medline; PMC,Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma,10.1007/s12032-014-0181-7,PMC7090555,25129313.0,no-cc,main cause death colorectal carcinoma crc patient tumor metastasis however underlying molecular mechanism largely unknown present study novel metastasisrelated gene fibrinogenlike protein fgl characterized role crc metastasis underlying molecular mechanism clinical significance fgl investigated using tissue microarray analysis sample patient crc molecular effect fgl crc cell determined using rna interference ectopic expression fgl overexpression fgl examined immunohistochemistry crc patient determined independent predictor overall survival p depletion fgl expression inhibited tumor progression epithelialtomesenchymal transition emt vitro vivo ectopic overexpression fgl enhanced cell invasion induced emt vitro result suggest fgl play important oncogenic role crc aggressiveness inducing emt fgl could employed novel prognostic marker effective therapeutic target crc,2014-08-17,"Qin, Wen-Zheng; Li, Quan-Lin; Chen, Wei-Feng; Xu, Mei-Dong; Zhang, Yi-Qun; Zhong, Yun-Shi; Ma, Li-Li; Hu, Jian-Wei; Cai, Ming-Yan; He, Meng-Jiang; Yao, Li-Qing; Zhou, Ping-Hong",Med Oncol,,,,document_parses/pdf_json/bc4d62b08a22fd16f454479c41132f04481e167b.json,document_parses/pmc_json/PMC7090555.xml.json,https://doi.org/10.1007/s12032-014-0181-7; https://www.ncbi.nlm.nih.gov/pubmed/25129313/,31970392.0,12
90553,90553,115788,3cjr1rol,2d52f749447305c563ad79d271e80221af9b86f0,Elsevier; Medline; PMC,Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations,10.1016/j.canlet.2018.06.034,PMC7117025,29960048.0,els-covid,tumor microenvironment complex cancer stem cell csc member within community population posse capacity selfrenew cause cellular heterogeneity tumor cscs resistant conventional antiproliferative drug order curative imperative cscs must eliminated cancer therapy variety dietary phytochemical repositioned drug act synergistically conventional anticancer agent review advocate development novel approach namely combination therapy incorporating phytochemical repositioned drug target cscs cover select dietary phytochemical curcumin resveratrol egcg genistein repurposed drug metformin niclosamide thioridazine chloroquine five eight curcumin resveratrol egcg genistein metformin listed “ halifax project ” explores “ concept lowtoxicity ‘ broadspectrum ’ therapeutic approach could simultaneously target many key pathway mechanism ” compound discus mechanism action model anticsc activity identified well advantage challenge potential combination therapy,2018-10-01,"Chan, Marion M.; Chen, Rensa; Fong, Dunne",Cancer Letters,,,,document_parses/pdf_json/2d52f749447305c563ad79d271e80221af9b86f0.json,document_parses/pmc_json/PMC7117025.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/29960048/; https://doi.org/10.1016/j.canlet.2018.06.034; https://www.sciencedirect.com/science/article/pii/S0304383518304403; https://api.elsevier.com/content/article/pii/S0304383518304403,49648430.0,12
90658,90658,115911,2behvv3b,00b88130d2a7c8489e209742494303b6731d7544,Medline; PMC,Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model,10.1186/s13036-019-0207-y,PMC6805443,31649751.0,cc-by,background baculovirus bv autographa californica multiple nuclear polyhedrosis virus used numerous protein expression system ability infect insect cell serf useful vaccination vector several benefit low clinical risk posttranslational modification ability recently reported dendritic cell dc infected bv stimulated antitumor immunity recombinant bv rbv also strongly stimulated peptidespecific tcells antitumor immunity study stimulation immune response egova tumor mouse recombinant baculovirusbased combination vaccine expressing fragment covalbumin frcovabv rbv evaluated result constructed rbv expressing fragment c frc tetanus toxin containing promiscuous mhc iibinding sequence povalbumin ovum peptide function mhc pathway result showed rbv activated cd tcellmediated response much efficiently wildtype bv wtbv experiment egova tumor mouse model showed rbv significantly decreased tumor volume increased survival compared wildtype bv frcova dna vaccine group addition significant antitumor effect classic prophylactic therapeutic vaccination observed rbv egovainduced tumor compared control conclusion finding showed frcovabv rbv induced antitumor immunity paving way use bv immunotherapy malignancy,2019-10-22,"Kondou, Keigo; Suzuki, Tomoyuki; Chang, Myint Oo; Takaku, Hiroshi",J Biol Eng,,,,document_parses/pdf_json/00b88130d2a7c8489e209742494303b6731d7544.json,document_parses/pmc_json/PMC6805443.xml.json,https://doi.org/10.1186/s13036-019-0207-y; https://www.ncbi.nlm.nih.gov/pubmed/31649751/,204848244.0,12
90943,90943,116262,pxa02bkm,9d7ebfb48928ae82891a82ccc60ddb90b85b4bb9,Elsevier; PMC,An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging,10.1016/j.biomaterials.2020.120089,PMC7196320,,no-cc,photodynamic therapy developed prospective cancer treatment recent year nevertheless conventional photosensitizers suffer lacking recognition specificity tumor causing severe side effect normal tissue enzymeactivated photosensitizers capable solving conundrum due high selectivity towards tumor apn aminopeptidase n apncd tumor marker become crucial targeting substance owing highly expressed cell membrane surface various tumor become key point research antitumor drug fluorescence probe based herein apnactivated nearinfrared nir photosensitizer apncyi tumor imaging photodynamic therapy firstly developed successfully applied vitro vivo study showed apncyi could activated apn tumor cell hydrolyzed fluorescent cyioh specifically located mitochondrion cancer cell exhibited high singlet oxygen yield nir irradiation efficiently induced cancer cell apoptosis dramatically vivo assay balbc mouse showed apncyi could achieve nir fluorescence imaging λem nm endogenous apn tumor possessed efficient tumor suppression effect nir irradiation,2020-05-03,"Zhou, Xiao; Li, Haidong; Shi, Chao; Xu, Feng; Zhang, Zhen; Yao, Qichao; Ma, He; Sun, Wen; Shao, Kun; Du, Jianjun; Long, Saran; Fan, Jiangli; Wang, Jingyun; Peng, Xiaojun",Biomaterials,,,,document_parses/pdf_json/9d7ebfb48928ae82891a82ccc60ddb90b85b4bb9.json,document_parses/pmc_json/PMC7196320.xml.json,https://api.elsevier.com/content/article/pii/S0142961220303355; https://www.sciencedirect.com/science/article/pii/S0142961220303355?v=s5,218482279.0,12
91192,91192,116567,pej5quj5,4bede63b3a4332f5fd84cbbaf18794027be769b0; aee23efe3ff6e5b3fb5ce7f7323457c5eb802bfc,Elsevier; Medline; PMC,Emmprin and KSHV: new partners in viral cancer pathogenesis,10.1016/j.canlet.2013.05.037,PMC3728473,23743354.0,green-oa,emmprin cd basigin multifunctional glycoprotein expressed higher level cancer cell stromal cell tumor microenvironment direct effect within tumor cell promotion tumorstroma interaction emmprin participates induction tumor cell invasiveness angiogenesis metastasis chemoresistance although contribution cancer progression widely studied role emmprin viral oncogenesis still remains largely unclear small body available literature implicates emmprinassociated mechanism viral pathogenesis tumorigenesis summarize data review focusing role emmprin pathogenesis associated kaposi sarcomaassociated herpesvirus kshv common etiology cancer arising setting immune suppression also discus future direction mechanistic study exploring role emmprin viral cancer pathogenesis,2013-09-01,"Dai, Lu; Bai, Lihua; Lu, Ying; Xu, Zengguang; Reiss, Krys; Valle, Luis Del; Kaleeba, Johnan; Toole, Bryan P.; Parsons, Chris; Qin, Zhiqiang",Cancer Letters,,,,document_parses/pdf_json/4bede63b3a4332f5fd84cbbaf18794027be769b0.json; document_parses/pdf_json/aee23efe3ff6e5b3fb5ce7f7323457c5eb802bfc.json,document_parses/pmc_json/PMC3728473.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/23743354/; https://www.sciencedirect.com/science/article/pii/S0304383513004230; https://api.elsevier.com/content/article/pii/S0304383513004230; https://doi.org/10.1016/j.canlet.2013.05.037; http://europepmc.org/articles/pmc3728473?pdf=render,23488962.0,12
91592,91592,117054,0dqu3p3y,b676932f2403fa6fdb1f7be005c943d5bdc4acd9,Elsevier; PMC,Therapeutic and diagnostic implications of Hsp90 activation,10.1016/j.molmed.2004.04.006,PMC7128344,15177193.0,els-covid,molecular chaperone heatshock protein hsp involved stabilization conformational maturation many signaling protein deregulated cancer hsp inhibition result proteasomal degradation client protein lead potent antitumor activity hsp inhibitor allylaminogeldanamycin aag presently clinical trial recent work identified role hsp multiple signal transduction pathway revealed molecular mechanism tumor selectivity hsp inhibitor result activated highaffinity conformation hsp tumor review discus recent advance understanding tumor hsp treatment diagnosis cancer addition role hsp nononcological disease also discussed,2004-06-01,"Kamal, Adeela; Boehm, Marcus F; Burrows, Francis J",Trends in Molecular Medicine,,,,document_parses/pdf_json/b676932f2403fa6fdb1f7be005c943d5bdc4acd9.json,document_parses/pmc_json/PMC7128344.xml.json,https://www.sciencedirect.com/science/article/pii/S1471491404001030; https://api.elsevier.com/content/article/pii/S1471491404001030,31091475.0,12
92487,92487,118157,pwkyxegx,6fb61f6ad63e23acc3d8d94d4acc38424e68ca1e,Medline; PMC,"Polyoxometalates Active Against Tumors, Viruses, and Bacteria",10.1007/978-3-642-41004-8_4,PMC7122307,24420711.0,no-cc,polyoxometalates pm discrete metaloxide cluster anion high solubility water photochemically electrochemically active property wide variety structure molecular size subnano submicrometers various combination metal also symmetry highly negative charge one reason structural variety originates conformation change due condensed aggregation structural assembly strongly depends environmental parameter solution ph concentration coexistent foreign inorganic andor organic substance course application physicochemical property pm medical field antitumoral antiviral antibacterial activity developed realization novel inorganic medicine provides biologically excellent activity never replaced approved medicine several pm candidate clinical us licensed toward chemotherapy solid tumor human gastric cancer pancreatic cancer dna rna virus hsv hiv influenza sars drugresistant bacteria mrsa vrsa recent year nhprimoo∙ho pm menhhmov oohmovio∙ho pm solid tumor kptiwo∙ho pm prinhhptiwoo∙ho pm khvosbwo∙ho pm virus kpwo∙ho pm ksimoo∙ho simo pm mrsa vrsa result discussed point view chemotherapeutic clarification review,2013-11-22,"Yamase, Toshihiro",Biomedical Inorganic Polymers,,,,document_parses/pdf_json/6fb61f6ad63e23acc3d8d94d4acc38424e68ca1e.json,document_parses/pmc_json/PMC7122307.xml.json,https://doi.org/10.1007/978-3-642-41004-8_4; https://www.ncbi.nlm.nih.gov/pubmed/24420711/,21411381.0,12
93248,93248,119081,gqqzekfk,6b749617eb4a9f2760720a1b2a061cd0d45f9e3f,Medline; PMC,Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen,10.1186/1480-9222-14-2,PMC3298716,22304896.0,cc-by,background widely understood tumor cell express tumorassociated antigen taas many usually low immunogenicity example carcinoembryonic antigen cea specifically expressed human colon cancer cell viewed lowimmunogenic taa activate host immunity specific taas suppress tumor growth therefore becomes important cancer therapy development result enhance immune efficiency cea mouse received fused partial cea gene exogenous sarscov fragment oral vaccination attenuated salmonella typhimurium strain transformed plasmid encoding ceasarscov fusion gene balbc mouse elicited significant increase tnfα il serum addition smaller tumor volume observed ctceabearing mouse received ceasarscov gene therapy comparison administered cea alone conclusion administration fusing ceasarscov fragment may provide promising strategy strengthening antitumor efficacy lowimmunogenic endogenous tumor antigen,2012-02-03,"Lin, Chen-Si; Kao, Shih-Han; Chen, Yu-Cheng; Li, Chi-Han; Hsieh, Yuan-Ting; Yang, Shang-Chih; Wu, Chang-Jer; Lee, Ru-Ping; Liao, Kuang-Wen",Biol Proced Online,,,,document_parses/pdf_json/6b749617eb4a9f2760720a1b2a061cd0d45f9e3f.json,document_parses/pmc_json/PMC3298716.xml.json,https://doi.org/10.1186/1480-9222-14-2; https://www.ncbi.nlm.nih.gov/pubmed/22304896/,16740924.0,12
93610,93610,119517,h7sp1fl1,e6e0d612cdd2548fa604d72cf5766f84fbea26bc,Elsevier; PMC,Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: Modelo basado en un crecimiento exponencial,10.1016/j.ad.2020.05.001,PMC7211725,,els-covid,resumen antecedentes objetivos la pandemia del coronavirus covid ha provocado un confinamiento indefinido una posible consecuencia de esta situación e un retraso en los procedimientos asistenciales de la patologías comunes el objetivo de este estudio e estimar el hipotético impacto en la supervivencia que tendría el aumento del tamaño tanto para los carcinoma de células escamosas cce como de los melanoma material método estudio observacional retrospectivo de cohortes multicéntrico se desarrolló un modelo de crecimiento exponencial para cada tumor basado en el tiempo de evolución que refiere el paciente resultados se incluyeron un total de pacientes con cces localizados en la cabeza el cuello pacientes con melanoma cutáneo se calculó una curva de crecimiento exponencial para cada tumor se estimó el tamaño del tumor tras me tras el diagnóstico en la muestra los cce mayores de cm mm de grosor definidos como pasaron de en el grupo de estudio real una estimación de tras me de retraso quirúrgico estimado se estimó una disminución de la supervivencia específica de enfermedad see de un los años respectivamente tras tres me de retraso para los melanoma los melanoma ultragruesos mm pasaron del en el grupo de estudio al tras me de demora la see los años del grupo de estudio descendió un en ambo tiempos conclusiones en ausencia de un adecuado diagnóstico tratamiento de los pacientes con cce melanoma en la actual situación de confinamiento en españa podemos llegar asistir un considerable aumento de los casos de cce melanoma gruesos de gran tamaño se deben fomentar los esfuerzos para promocionar la autoexploración facilitar el acceso los dermatólogos para aumentar la demora de estos pacientes background objective spain situation indefinite lockdown due ongoing coronavirus disease covid pandemic one consequence lockdown delay medical surgical procedure common disease aim study model impact survival tumor growth caused delay patient squamous cell carcinoma scc melanoma material method multicenter retrospective observational cohort study constructed exponential growth model scc melanoma estimate tumor growth patientreported onset surgical excision different time point result data patient scc head neck patient cutaneous melanoma included exponential growth curve calculated tumor type estimated tumor size month potential surgical delay proportion patient scc diameter cm thickness mm increased patient initial study group estimated month delay diseasespecific survival year patient whose surgery delayed month decreased respectively proportion patient ultrathick melanoma mm increased initial study group month five year diseasespecific survival decreased patient treated potential delay month conclusion absence adequate diagnosis treatment scc melanoma current lockdown situation spain expect see considerable increase large thick sccs melanoma effort must taken encourage selfexamination facilitate access dermatologist order prevent delay,2020-05-11,"Tejera-Vaquerizo, A.; Cañueto, J.; Toll, A.; Santos-Juanes, J.; Jaka, A.; Ferrandiz, C.; Sanmartín, O.; Ribero, S.; Moreno-Ramírez, D.; Almazán, F.; Fuente, M. J; Podlipnik, S.; Nagore, E.",Actas Dermosifiliogr,,,,document_parses/pdf_json/e6e0d612cdd2548fa604d72cf5766f84fbea26bc.json,,https://www.sciencedirect.com/science/article/pii/S0001731020301423?v=s5; https://api.elsevier.com/content/article/pii/S0001731020301423,218571606.0,12
93650,93650,119563,0cdqhrcw,37b8370c74a009c160261131c67828bc5432095d,Elsevier; Medline; PMC,Chapter 7 IFN Inducibility of Major Histocompatibility Antigens in Tumors,10.1016/s0065-230x(08)00407-7,PMC7125809,19055946.0,els-covid,interferon represent protein family pleiotropic function including immunomodulatory cytostatic cytotoxic activity based effect interferon involved innate well adaptive immunity thereby shaping tumor host immune response cytokine alone combination successfully implemented treatment malignancy however recently demonstrated tumor cell could resistant interferon treatment may associated escape tumor cell immune surveillance therefore aim chapter summarize frequency impaired interferon signal transduction underlying molecular mechanism clinical relevance,2008-12-31,"Seliger, Barbara; Ruiz‐Cabello, Francisco; Garrido, Federico",Advances in Cancer Research,,,,document_parses/pdf_json/37b8370c74a009c160261131c67828bc5432095d.json,document_parses/pmc_json/PMC7125809.xml.json,https://doi.org/10.1016/s0065-230x(08)00407-7; https://www.sciencedirect.com/science/article/pii/S0065230X08004077; https://www.ncbi.nlm.nih.gov/pubmed/19055946/; https://api.elsevier.com/content/article/pii/S0065230X08004077,9168726.0,12
93891,93891,119863,ur5dhsio,bfcbf00580ce41765daa88a384016a408ff1d97b; 69aedd78e1e142120aa6b2f424b95ff5337895b7,Elsevier; Medline; PMC,In vivo detection of circulating tumour cell clusters by photodiagnostic spectroscopy,10.1016/j.pdpdt.2020.101755,PMC7153531,32298800.0,no-cc,background demonstrate new diagnostic method photodiagnostic infrared spectroscoppy pdis able detect circulating tumor cluster circulating tumor cell circulatory system method pdis method based photodiagnostic physic high resolution spectroscopy using calibrated spectroscopic data diagnostic analysis blood screening spectrum using confocal laser scanning mikcroscopy indocyangreenuptake different cell line breast cancer cell studied result pdis supply calibrated diagnostic data presence absence ctc ctc cluster bloodstream sensitivity therefore pdis suited control blood cancer patient respect ctc ctc cluster resolution one ctc one ctc cluster per blood volume pdis distinguishes different phenotype ctc cluster conclusion circulating tumor cell slusters play key role metastatic process formed solid tumor appropriate object validate cancer treatment recognice cancer formation pdis calibrated diagnostic method allows evaluate result solid tumor treatment chemotherapy treatment optimize individual cancer treatment strategy,2020-04-13,"Schikora, Detlef",Photodiagnosis Photodyn Ther,,,,document_parses/pdf_json/bfcbf00580ce41765daa88a384016a408ff1d97b.json; document_parses/pdf_json/69aedd78e1e142120aa6b2f424b95ff5337895b7.json,document_parses/pmc_json/PMC7153531.xml.json,https://api.elsevier.com/content/article/pii/S1572100020301083; https://www.sciencedirect.com/science/article/pii/S1572100020301083?v=s5; https://doi.org/10.1016/j.pdpdt.2020.101755; https://www.ncbi.nlm.nih.gov/pubmed/32298800/,215747290.0,12
93923,93923,119898,9x0530cb,256e71fbec91690b85b212f52942406f4689c165,Elsevier; Medline; PMC,A Juxta-Articular Myxoma of the Thumb A Case Report,10.1016/j.jhsg.2020.04.002,PMC7167580,32313878.0,els-covid,juxtaarticular myxoma benign tumor mostly encountered vicinity larger joint case hand reported present case juxtaarticular myxoma metacarpophalangeal joint thumb yearold man preoperative diagnostic workup included mrangiography ultrasound histochemical examination resected tumor established diagnosis definitively followup mri scheduled without clinical suspicion tumorrecurrence month postoperatively reveal obvious recurrence month patient full motion without pain declined imaging,2020-04-20,"Claudi, Carolin; Ganser, Joachim; Andreisek, Gustav; Vrugt, Bart",J Hand Surg Glob Online,,,,document_parses/pdf_json/256e71fbec91690b85b212f52942406f4689c165.json,,https://api.elsevier.com/content/article/pii/S2589514120300256; https://www.sciencedirect.com/science/article/pii/S2589514120300256?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32313878/; https://doi.org/10.1016/j.jhsg.2020.04.002,216027744.0,12
94004,94004,120003,5arpo7gn,9c9f4048c8a20fe4874977a6cffc56ebfeab6edf,Medline; PMC,Spontaneous and experimentally induced pathologies in the naked mole rat (Heterocephalus glaber),10.1134/s0006297917120094,PMC7088389,29486700.0,no-cc,naked mole rat heterocephalus glaber rüppell unique eusocial rodent unusually long lifespan therefore study spontaneous experimentally induced pathology animal one important task gerontology various infection noninfectious pathology including agedependent change tumor described naked mole rat frequent pathology trauma bite wound purulent septic complication traumatic injury renal tubular calcinosis chronic progressive nephropathy hepatic hemosiderosis testicular interstitial cell hyperplasia calcinosis cutis cardiomyopathy dysbiosisrelated infectious lesion digestive system however summarized data pathology including tumor incidence cause mortality insufficient publication result experiment pathology induced naked mole rat problem could subject promising future study without adequate study mechanism providing long lifespan naked mole rat impossible well elucidation cause tumor resistance specie,2017-12-15,"Manskikh, V. N.; Averina, O. A.; Nikiforova, A. I.",Biochemistry (Mosc),,,,document_parses/pdf_json/9c9f4048c8a20fe4874977a6cffc56ebfeab6edf.json,,https://www.ncbi.nlm.nih.gov/pubmed/29486700/; https://doi.org/10.1134/s0006297917120094,4229863.0,12
94183,94183,120230,bn8440sg,8989cf875a47e45c9b30112581c2fa008fb6025d,Elsevier; Medline; PMC,"Antiproliferative cyclodepsipeptides from the marine actinomycete Streptomyces sp. P11-23B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis",10.1016/j.phytochem.2016.12.010,PMC7111624,28049552.0,els-covid,two cyclodepsipeptides known cyclodepsipeptide valinomycin isolated culture marine actinomycete streptomyces sp pb structure established based nmr hresims msms spectroscopic interpretation well chemical degradation streptodepsipeptides pa pb inhibited proliferation different glioma cell line ic value ranging μm μm streptodepsipeptide pa found block cell cycle gg phase induce apoptosis glioma cell investigation demonstrated streptodepsipeptide pa downregulated expression hk pfkfb pkm gls fasn important tumor metabolic enzyme data study suggested targeting multiple tumor metabolic regulator might one antiglioma mechanism streptodepsipeptide pa possible mechanism class streptodepsipeptides reported herein,2017-03-31,"Ye, Xuewei; Anjum, Komal; Song, Tengfei; Wang, Wenling; Liang, Ying; Chen, Mengxuan; Huang, Haocai; Lian, Xiao-Yuan; Zhang, Zhizhen",Phytochemistry,,,,document_parses/pdf_json/8989cf875a47e45c9b30112581c2fa008fb6025d.json,document_parses/pmc_json/PMC7111624.xml.json,https://api.elsevier.com/content/article/pii/S0031942216302953; https://www.ncbi.nlm.nih.gov/pubmed/28049552/; https://doi.org/10.1016/j.phytochem.2016.12.010; https://www.sciencedirect.com/science/article/pii/S0031942216302953,37128239.0,12
94194,94194,120247,zbxiaofl,afc99572834c677cd4f66c22e98eda2012f6f320; 1ecbabb9d0605dcfa2504148930aa1b7322cea27,Medline; PMC,Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination,10.1007/s00109-008-0370-y,PMC2535907,18542898.0,no-cc,urgent need develop new innovative therapy control cancer antigenspecific immunotherapy employment proteasome inhibitor emerged two potentially plausible approach control cancer current study explored combination dna vaccine encoding calreticulin crt linked human papillomavirus type e antigen crte proteasome inhibitor bortezomib ability generate especific immune response antitumor effect vaccinated mouse found combination treatment bortezomib crtedetox dna generated potent especific cd cell immune response better therapeutic effect tc tumor tumorbearing mouse compared monotherapy furthermore found treatment bortezomib led increased apoptosis tc tumor cell could render tc tumor cell susceptible lysis especific cd cell data significant implication future clinical translation electronic supplementary material online version article doisy contains supplementary material available authorized user,2008-06-10,"Tseng, Chih-Wen; Monie, Archana; Wu, Chao-Yi; Huang, Bruce; Wang, Mei-Cheng; Hung, Chien-Fu; Wu, T.-C.",J Mol Med (Berl),,,,document_parses/pdf_json/afc99572834c677cd4f66c22e98eda2012f6f320.json; document_parses/pdf_json/1ecbabb9d0605dcfa2504148930aa1b7322cea27.json,document_parses/pmc_json/PMC2535907.xml.json,https://doi.org/10.1007/s00109-008-0370-y; https://www.ncbi.nlm.nih.gov/pubmed/18542898/,19344806.0,12
95667,95667,122065,f3ynbps9,41d0c75e25a257485a79211632b5c9ed93d4df14,Medline; PMC,The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms,10.1186/1477-3155-11-36,PMC3832906,24219600.0,cc-by,background need limit sideeffects nanoparticles increasingly studied drugcarrying targeting tool previously reported scheme produce proteinbased selfassembling nanoparticles act antigen display platform attempted use system cancertargeting making use cterminal bombesin peptide high affinity receptor known overexpressed certain tumor well nterminal polyhistidine tag used radiolabeling technetium tricarbonyl result order increase circulation time experimented pegylated unpegylated varities typo particle also tested effect incorporating different number bombesins per nanoparticle biophysical characterization determined configuration assemble regular particle relatively monodisperse size distribution peak – nm carbonyl method used labeling produced approximately labeled nanoparticles vitro nanoparticles showed high binding specific nonspecific pc prostate cancer cell vivo high uptake observed nanoparticle type spleen cd nunu mouse decreasing significantly course hour high uptake also observed liver low uptake seen pancreas tumor xenograft conclusion data suggest nanoparticles nonspecifically taken reticuloendothelial system low uptake pancreas tumor indicate little specific targeting pegylation increasing amount bombesins per nanoparticle significantly improve targeting particular uptake spleen primary organ immune system highlight potential nanoparticles vaccine carrier also decrease liver spleen radioactivity time implies nanoparticles broken cleared important finding show nanoparticles safely used vaccine platform without risk prolonged side effect furthermore demonstrates technetium carbonyl radiolabeling proteinbased nanoparticles used evaluate pharmacokinetic property vivo,2013-11-12,"Yang, Yongkun; Neef, Tobias; Mittelholzer, Christian; Garcia Garayoa, Elisa; Bläuenstein, Peter; Schibli, Roger; Aebi, Ueli; Burkhard, Peter",J Nanobiotechnology,,,,document_parses/pdf_json/41d0c75e25a257485a79211632b5c9ed93d4df14.json,document_parses/pmc_json/PMC3832906.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/24219600/; https://doi.org/10.1186/1477-3155-11-36,15271316.0,12
96651,96651,123261,bbqx2lxw,0892e16c218542d3a099d7b10aec24cab4bfce55,Medline; PMC,Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model,10.18632/oncotarget.9114,PMC5085160,27145284.0,cc-by,advance treatment metastatic clear cell renal cell carcinoma ccrcc led improved progressionfree survival many patient however therapy toxic rarely achieve durable longterm complete response curative herein used single bicistronic lentiviral vector develop new combination immunotherapy consists human anticarbonic anhydrase ix caixtargeted chimeric antigen receptor car cell engineered secrete human antiprogrammed death ligand pdl antibody tumor site local antibody delivery led marked immune checkpoint blockade tumor growth diminished time tumor weight reduced – compared anticaix car cell alone humanized mouse model ccrcc expression pdl ki tumor decreased increase granzyme b level found car cell antipdl igg isotype capable mediating adcc also able recruit human nk cell tumor site vivo armed secondgeneration car cell empowered secrete human antipdl antibody ccrcc milieu combat cell exhaustion innovation field provide renewed potential car cell immunotherapy solid tumor limited efficacy currently seen,2016-04-29,"Suarez, Eloah Rabello; Chang, De-Kuan; Sun, Jiusong; Sui, Jianhua; Freeman, Gordon J.; Signoretti, Sabina; Zhu, Quan; Marasco, Wayne A.",Oncotarget,,,,document_parses/pdf_json/0892e16c218542d3a099d7b10aec24cab4bfce55.json,document_parses/pmc_json/PMC5085160.xml.json,https://doi.org/10.18632/oncotarget.9114; https://www.ncbi.nlm.nih.gov/pubmed/27145284/,20665004.0,12
98194,98194,125133,fqvj56jl,,Medline; PMC,Creation and preliminary characterization of a Tp53 knockout rat,10.1242/dmm.009704,PMC3529357,22917926.0,cc-by-nc-sa,tumor suppressor tp play crucial role cancer biology tp gene mutated gene human cancer trp knockout mouse model widely used cancer etiology study search cure cancer limitation model organism might help overcome via pronuclear microinjection zinc finger nuclease zfns created tp knockout rat contains bp deletion exon resulting frameshift premature termination open reading frame cohort homozygous tpδδ heterozygous tpδ wildtype rat tpδδ rat lived average day death removal study clinical sign abnormality formation tumor half tpδ removed study year age tumor formation tpδ tpδδ rat developed wide spectrum tumor commonly sarcoma interestingly strikingly high incidence brain lesion especially tpδδ animal believe mutant rat line useful studying cancer type rarely observed mouse carcinogenicity assay drug development,2012-08-23,"McCoy, Aaron; Besch-Williford, Cynthia L.; Franklin, Craig L.; Weinstein, Edward J.; Cui, Xiaoxia",Dis Model Mech,,,,,document_parses/pmc_json/PMC3529357.xml.json,https://doi.org/10.1242/dmm.009704; https://www.ncbi.nlm.nih.gov/pubmed/22917926/,29915951.0,12
98409,98409,125382,9lr09kny,49c8f45d390502809816b630ee23375427ea0fb6,Medline; PMC,Intestinal gastrointestinal stromal tumor in a cat,10.1292/jvms.16-0605,PMC5383177,28163271.0,cc-by-nc-nd,yearold kg spayed female domestic shorthaired cat month history anorexia weight loss abdominal ultrasonography computed tomography revealed exophytic mass originating jejunum poor central poor peripheral contrast enhancement day surgical resection jejunum mass cm margin endtoend anastomosis performed histopathological examination revealed mass transmural invasive cancer showing exophytic growth originating small intestinal muscle layer immunohistochemical analysis tumor cell revealed diffuse positivity kit protein negativity desmin mass diagnosed gastrointestinal stromal tumor gist ultrasonographic finding indicated tumor probably metastasized liver omentum seen human dog owner rejected treatment last visit day knowledge first report intestinal tumor metastasis feline gist imaging feature,2017-02-04,"SUWA, Akihisa; SHIMODA, Tetsuya",J Vet Med Sci,,,,document_parses/pdf_json/49c8f45d390502809816b630ee23375427ea0fb6.json,document_parses/pmc_json/PMC5383177.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/28163271/; https://doi.org/10.1292/jvms.16-0605,3754196.0,12
99502,99502,126734,78dznsqw,07aeb351d3d1ca9f8fe05a2eafd27813be01022b; cfbb869e732b53165379ce89ee061a4cb3d8f7d1,Elsevier; Medline; PMC,The aqueous extract from Toona sinensis leaves inhibits microglia-mediated neuroinflammation,10.1016/j.kjms.2013.09.012,PMC7118447,24444536.0,no-cc,leaf toona sinensis wellknown traditional oriental medicine prescribed treatment enteritis infection recently aqueous extract toona sinensis leaf tsl demonstrated many biological effect vitro vivo central nervous system microglial activation proinflammatory response considered important therapeutic strategy neuroinflammatory disorder cerebral ischemia alzheimers disease parkinson disease present study attempted validate effect tsl microgliamediated neuroinflammation stimulated lipopolysaccharide lp inflammatory parameter production nitric oxide inducible synthase tumor necrosis factorα evaluated result demonstrate tsl suppresses lpsinduced production tumor necrosis factorα secretion inducible synthase protein expression concentrationdependent manner without causing cytotoxicity addition inhibitory effect tsl lpsstimulated bv microglia extended posttreatment suggesting therapeutic potential tsl therefore work provides future evaluation role tsl treatment neurodegenerative disease inhibition inflammatory mediator production activated microglia,2013-11-01,"Wang, Chao-Chuan; Tsai, Yee-Jean; Hsieh, Ya-Ching; Lin, Rong-Jyh; Lin, Chih-Lung",Kaohsiung J Med Sci,,,,document_parses/pdf_json/07aeb351d3d1ca9f8fe05a2eafd27813be01022b.json; document_parses/pdf_json/cfbb869e732b53165379ce89ee061a4cb3d8f7d1.json,document_parses/pmc_json/PMC7118447.xml.json,https://api.elsevier.com/content/article/pii/S1607551X13002490; https://doi.org/10.1016/j.kjms.2013.09.012; https://www.ncbi.nlm.nih.gov/pubmed/24444536/; https://www.sciencedirect.com/science/article/pii/S1607551X13002490,36197147.0,12
99589,99589,126844,g6ynt0f9,f06ef04db2928aa8b627475a04a65d227ea97c1a,Elsevier; Medline; PMC,Proprotein convertases: Key players in inflammation-related malignancies and metastasis,10.1016/j.canlet.2019.12.027,PMC7115805,31899298.0,els-covid,many cancer occur location inflammation due chronic irritation andor infection tumor microenvironment contains various different inflammatory cell mediator orchestrate diverse neoplastic process including proliferation survival adhesion migration parallel tumor cell adapted signaling molecule used inflammatory cell selectins chemokines well receptor invasion extravasation subsequently metastasis expression andor activation majority molecule mediated proprotein convertases pc protease expressed tumor cell inflammatory cell review analyzes potential role enzymatic system inflammationassociated cancer impacting malignant metastatic potential cancer cell describing possible use pc new antiinflammatory therapeutic approach tumor progression metastasis,2020-03-31,"Siegfried, Geraldine; Descarpentrie, Jean; Evrard, Serge; Khatib, Abdel-Majid",Cancer Letters,,,,document_parses/pdf_json/f06ef04db2928aa8b627475a04a65d227ea97c1a.json,document_parses/pmc_json/PMC7115805.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/31899298/; https://doi.org/10.1016/j.canlet.2019.12.027; https://www.sciencedirect.com/science/article/pii/S030438351930641X; https://api.elsevier.com/content/article/pii/S030438351930641X,209671635.0,12
102222,102222,130085,4otfzw34,8b4c7bd63dceaa9bab63a5ceefc1fdb203d1b784,Elsevier; PMC,Antitumor activity and biochemical effects of topsentin,10.1016/0006-2952(91)90031-y,PMC7111053,1867631.0,els-covid,topsentin bisindolylimidazole marine natural product inhibited proliferation cultured human murine tumor cell micromolar concentration ic value ranged μm active vivo p leukemia c mgkg qd b melanoma c mgkg qd tumor effect μm topsentin hr exposure incorporation radiolabeled precursor p cell indicated inhibition dna synthesis lesser extent rna synthesis whereas synthesis protein unaffected fluorescence spectral change competitive binding experiment ethidium bromide indicated topsentin interacted dna evidence intercalation observed dna unwinding study competitive binding experiment hoechst cc indicated topsentin bound dna minor groove,1991-07-25,"Burres, Neal S.; Barber, Dustan A.; Gunasekera, Sarath P.; Shen, Linus L.; Clement, Jacob J.",Biochemical Pharmacology,,,,document_parses/pdf_json/8b4c7bd63dceaa9bab63a5ceefc1fdb203d1b784.json,,https://api.elsevier.com/content/article/pii/000629529190031Y; https://www.sciencedirect.com/science/article/pii/000629529190031Y,6619644.0,12
102453,102453,130364,6uhlk3t5,,Medline; PMC,Die Beziehungen zwischen Coronaviren und Nasopharynxkarzinom,10.1007/bf00501739,PMC7087655,32216253.0,no-cc,within cytoplasm npc tumor cell corona virus like particle described earlier controlling immunfluorescent study using anticoronarabbit serum revealed antigen localization within tumor cell cytoplasm vice versa blood serum npcpatients reveal significatively higher corona antibody titer blood serum npcpatients result open theory next well known ebvinfection corona virus infection play important role npc tumor biology question remains open whether interacting function rnavirus infection corona dnavirus infection ebv nasopharyngeal carcinoma,1981-01-01,"Arnold, W.; Klein, M.; Wang, Y. B.; Schmidt, W. A. K.",Arch Otorhinolaryngol,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32216253/; https://doi.org/10.1007/bf00501739,58717673.0,12
102647,102647,130592,tfy3sza0,bd44d72a9c41b1c382bd180da10a1f7ef38d2d56,Medline; PMC,Retargeting of Viruses to Generate Oncolytic Agents,10.1155/2012/798526,PMC3265223,22312365.0,cc-by,oncolytic virus therapy based ability virus effectively infect kill tumor cell without destroying normal tissue virus seem natural preference tumor cell virus require modification tropism specifically enter replicate cell review aim describe transductional targeting strategy currently employed specifically redirect virus towards surface receptor tumor cell three major strategy distinguished involve incorporation new targeting specificity viral surface protein ii incorporation scaffold viral surface protein allow attachment targeting moiety iii use bispecific adapter mediate targeting virus specified moiety tumor cell strategy key feature advantage limitation discussed example given potential cause sustained multiround infection—a desirable characteristic eradicating tumors—particular attention given virus engineered become selftargeted genomic expression bispecific adapter protein,2011-11-14,"Verheije, M. H.; Rottier, P. J. M.",Adv Virol,,,,document_parses/pdf_json/bd44d72a9c41b1c382bd180da10a1f7ef38d2d56.json,document_parses/pmc_json/PMC3265223.xml.json,https://doi.org/10.1155/2012/798526; https://www.ncbi.nlm.nih.gov/pubmed/22312365/,2915287.0,12
104011,104011,132273,xs5v3uc3,87b89bf780d8b197cc35fe32a83878cab23d8fda,Medline; PMC; WHO,Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic,10.1007/s11060-020-03523-7,PMC7200051,32372178.0,no-cc,challenge neurosurgical patient management surgical decisionmaking – covid worldwide pandemic immense neverbeforeseen generation neurosurgeon casebased formatted report present mount sinai hospital new york ny department neurosurgery institutional experience epicenter pandemic guiding principle current management intracranial skull base spine tumor detailed explanation surgical reasoning tumor case tailored assist neurosurgeon across united state face complex operative decision put forth reality pandemic,2020-05-05,"Kessler, Remi A.; Zimering, Jeffrey; Gilligan, Jeffrey; Rothrock, Robert; McNeill, Ian; Shrivastava, Raj K.; Caridi, John; Bederson, Joshua; Hadjipanayis, Constantinos G.",J Neurooncol,,#175869,,document_parses/pdf_json/87b89bf780d8b197cc35fe32a83878cab23d8fda.json,document_parses/pmc_json/PMC7200051.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/32372178/; https://doi.org/10.1007/s11060-020-03523-7,218513496.0,12
104699,104699,133133,rhamrtfu,d9912aeecf51b0e95f7d0bc4ba806aef374b089a,Elsevier; Medline; PMC,Overview of Microarray Analysis of Gene Expression and its Applications to Cervical Cancer Investigation,10.1016/s1028-4559(08)60005-4,PMC7129792,18182341.0,els-covid,summary cervical cancer one leading female cancer taiwan rank fifth cause cancer death female population human papillomavirus established causative agent cervical neoplasia cervical cancer however tumor biology involved prognosis different cell type early cancer tumor response radiation advanced cancer remain largely unknown introduction microarray technology provided genomewide strategy searching ten thousand gene simultaneously review first summarize two type microarrays oligonucleotides microarray cdna microarray review study functional genomics cervical cancer gene expression study involved cervical cancer cell line cervical cell cancer versus normal ectocervix cancer tissue different histology radioresistant versus radiosensitive patient combinatorial gene expression associated chromosomal amplification discussed particular ceacam tacstd sp msln shown upregulated adenocarcinoma increased expression level ceacam tacstd significantly correlated poorer patient outcome hand gene including apoptotic gene eg bik tegt ssi hypoxiainducible gene eg hifa ca tumor cell invasion metastasis gene eg ctsl ctsb plau cd noted echo hypothesis increased tumor hypoxia lead radiation resistance cervical cancer radiation,2007-12-31,"Chao, Angel; Wang, Tzu-Hao; Lai, Chyong-Huey",Taiwanese Journal of Obstetrics and Gynecology,,,,document_parses/pdf_json/d9912aeecf51b0e95f7d0bc4ba806aef374b089a.json,,https://api.elsevier.com/content/article/pii/S1028455908600054; https://www.ncbi.nlm.nih.gov/pubmed/18182341/; https://doi.org/10.1016/s1028-4559(08)60005-4; https://www.sciencedirect.com/science/article/pii/S1028455908600054,26077853.0,12
104872,104872,133367,i545fylb,ced9f999cbac8dd42c387e3fa680cd68f4317cc0; 5ae8a3abce0fb0647d9f164f9ad1716abfb6dd61,Elsevier; Medline; PMC,Adoptive Immunotherapy against Allogeneic Kidney Grafts in Dogs with Stable Hematopoietic Trichimerism,10.1016/j.bbmt.2008.08.005,PMC2603466,18940673.0,hybrid-oa,dog given nonmyeloablative conditioning marrow graft two dog leukocyte antigen dla identical littermate donor developed stable trichimerism stably accepted subsequent kidney graft one marrow donor without need immunosuppression used trichimeras evaluate strategy adoptive immunotherapy solid tumor using kidney tumor surrogate three dlaidentical trichimeric recipient established simultaneously infusing marrow two dlaidentical donor dog dlaidentical recipient conditioned gy total body irradiation given short course postgrafting immunosuppression confirming stable hematopoietic engraftment kidney transplanted one two marrow donor respective trichimeric recipient peripheral blood lymphocyte pbl kidney donor used sensitize alternate marrow donor donor lymphocyte infusion dli sensitized dog given trichimeric recipient whereupon chimerism graftversushost disease gvhd kidney rejection monitored dli observed prompt rejection transplanted marrowdonor kidney disappearance corresponding hematopoietic chimerism presumably owing shared minor histocompatibility antigen host chimerism also disappeared gvhd skin gut liver developed native kidney showing lymphocytic infiltration remained functionally normal current study demonstrated certain experimental condition kidney organ ordinarily involved graftversushost reaction targeted sensitized donor lymphocyte,2008-11-01,"Graves, Scott S.; Hogan, William J.; Kuhr, Christian; Diaconescu, Razvan; Harkey, Michael; Sale, George E.; Stone, Brad; Georges, George E.; Storb, Rainer",Biology of Blood and Marrow Transplantation,,,,document_parses/pdf_json/ced9f999cbac8dd42c387e3fa680cd68f4317cc0.json; document_parses/pdf_json/5ae8a3abce0fb0647d9f164f9ad1716abfb6dd61.json,document_parses/pmc_json/PMC2603466.xml.json,https://api.elsevier.com/content/article/pii/S1083879108003480; https://www.sciencedirect.com/science/article/pii/S1083879108003480; https://doi.org/10.1016/j.bbmt.2008.08.005; https://www.ncbi.nlm.nih.gov/pubmed/18940673/; http://www.bbmt.org/article/S1083879108003480/pdf,23652742.0,12
105467,105467,134095,k3vjqumq,cb62f467ee641118d0b7d0b6244c6f7aa800416f,Medline; PMC,Roles of N‐Myc and STAT interactor in cancer: From initiation to dissemination,10.1002/ijc.30043,PMC5069610,26874464.0,cc-by-nc-nd,n‐myc stat interactor nmi protein mostly studied physical interaction transcription factor play critical role tumor growth progression metastasis nmi inducible protein thus intracellular level location vary dramatically influencing diverse array cellular function context‐dependent manner physical interaction nmi binding partner linked many aspect tumor biology including dna damage response cell death epithelial‐to‐mesenchymal transition stemness thus discovering detail function nmi could reveal key insight transcription factor like c‐myc stats brca contextually regulated although normal physiological function nmi yet discovered potential role pathology ranging viral infection cancer review provides timely perspective unfolding role nmi specific focus cancer progression metastasis,2016-03-11,"Pruitt, Hawley C.; Devine, Daniel J.; Samant, Rajeev S.",Int J Cancer,,,,document_parses/pdf_json/cb62f467ee641118d0b7d0b6244c6f7aa800416f.json,document_parses/pmc_json/PMC5069610.xml.json,https://www.ncbi.nlm.nih.gov/pubmed/26874464/; https://doi.org/10.1002/ijc.30043,823515.0,12
